fjc %o ■ g/oe: e TV 2-/77 ^
UMASS/AMHERST
aieobb D2ba sivb i
ASSESSMENT MANUAL
U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE • Public Health Service
Alcohol, Drug Abuse, and Mental Health Administration
Digitized by the Internet Archive
in 2010 with funding from
Boston Library Consortium IVIember Libraries
http://www.archive.org/details/ecdeuassessmentm1933guyw
ECDEU
ASSESSMENT
MANUAL FOR
PSYCHOPHARMACOLOGY
Revised, 1976
William Guy, Ph.D.
Biometric Laboratory
The George Washington University
Kensington, Maryland
U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
Public Health Service
Alcohol, Drug Abuse, and Mental Health Administration
National Institute of Mental Health
Psychopharmacology Research Branch
Division of Extramural Research Programs
5600 Fishers Lane
Rockville, Maryland 20852
This publication was supported by NliVlH grant i\/lH-22019,
from the Psychopharmacology Research Branch,
Division of Extramural Research Programs.
DHEW Publication No. (ADM) 76-338
Printed 1976
CONTENTS
Acknowledgements 6
I ntroduct ion 9
Participation in ECDEU Program 11
Description of ECDEU Battery 12
Time Table for Using tine ECDEU Battery 1^
General Instructions 19
The Identification (ID) Block 23
Coding Duration of Study 25
Research Plan Report (021-RPR) 27
ECDEU Order Form (07^-EOF) ^9
General Scoring Sheet (050-GSS) 53
Encoding Non-Standard Data 59
DEMOGRAPHIC PACKET 65
Children's Personal Data Inventory (043-CPDl) 71
Children's Symptom History (044-CSH) 87
Adult Personal Data Inventory (041-APDl) 93
Prior Medication Record (046-PMR) 109
PSYCHIATRIST PACKETS 113
PEDIATRIC SCALES
Children's Psychiatric Rating Scale (027-CPRS) 123
Children's Diagnostic Scale (030-CDS) 131
Diagnostic Cr i ter ia-Ped iatr ic Psychopharmacology Conference 135
Children's Diagnostic Classification (031-CDC) 1^1
Instructions for CDC - Werry 1^3
Diagnosis for Psychopharmacologica 1 Studies - Werry 1^7
ADULT SCALES
Brief Psychiatric Rating Scale (047-BPRS) 157
Comments - Overall 166
Depression Status Inventory (072-DSl) 171
Comments - Zung 176
Hamilton Depression Scale (049-HAMD) 179
Comments - Hamilton 186
Hamilton Anxiety Scale (048-HAMA) 193
Anxiety Status Inventory (051-ASl) 199
Comments - Zung 204
Wittenborn Psychiatric Rating Scale (052-WITT) — 205
Comments - Wittenborn 210
UNIVERSAL SCALES
Clinical Global Impressions (028-CGl) - - - -217
Dosage Record and Treatment Emergent Symptoms Scale (029-DOTES) 223
Patient Termination Record (032-PTR) 245
NURSE PACKET 253
Children's Behavior Inventory (034-CB I ) 257
Nurses' Observation Scale for Inpatient Evaluation (039-NOSIE) 265
Comments - Honigfeld 271
Plutchik Geriatric Rating Scale (040-PLUT) 275
Nurses' Global Impressions (042-NGl) 283
INDEPENDENT PEDIATRIC SCALES
Teacher Questionnaire (035-T(l) 287
parent Questionnaire (036-PQ.) 293
Parent-Teacher Questionnaire (037-PTQ) 299
Rating Scales for Use with Children - Conners 303
INDEPENDENT ADULT SCALES
Self-Report Symptom Inventory (053-SCL-90) 313
Comments - Derogatis, Lipman, and Covi 320
Self-Rating Depression Scale (073-SDS) 333
Self-Rating Anxiety Scale (05^-SAS) 337
Comments - Zung 3^0
INDEPENDENT ADVERSE REACTION SCALES
TESS Write-In Scale (033-TWIS) - - --- 3^1
Subject's Treatment Emergent Symptom Scale (O38-STESS) 3^7
Laboratory Data (055-LAB) -- 351
Clinical Laboratory Standards in Pediatric Psychopharmacology - Gershon 365
Clinical Laboratory Test Standards for Schizophrenics -
McGlashan and Cleary 379
MEDICAL SCALES
Physical and Neurological Examination for Soft Signs (O^l-PANESS) 383
Manual for Scored Examination for Soft Signs - Abbott Lab. and Close 39^
PSYCHOLOGIST PACKET kOJ
PEDIATRIC SCALES 411
Wechsler I ntel 1 igence Sea le for Children (O6O-WISC) 4l5
Wide Range Achievement Test (062-WRAT) k]7
Porteus Mazes (06I-MAZE) - — - 4l8
Goodenough-Harr is Figure Drawing Test (O63-GOOP) 422
Bender Gestalt Test - Koppitz Scoring (064-BENDK) 423
Psychological Examination Behavior Profile (O66-PEBP) 429
Performance Tests for Children - Sprague 435
ADULT SCALES - — - - 443
Wechsler Adult I ntell igence Scale (O67-WAIS) 446
Porteus Mazes (See Page 418)
Bender Gestalt Test - Pascal -Suttel 1 Scoring (O68-BENDP) 448
Wechsler Memory Scale (O69-WMEM) 449
Friedhoff Task Behavior Scale (O7O-FTBS) 450
Assembl ing Data for Shipment 451
Alternative Types of Data Submission 454
Data Shipment (07I-DS) 455
DOCUMENTATION (THE DATA PACKAGE)
The Processing System (BLIPS II) 468
Contents of the Data Package 469
Editing and Error Correction 472
Raw and Computed Listings ■ 474
Means and Standard Deviations 474
Frequency Tables 474
Cross-Tabulat ions 474
Graphic Displays 480
Data Inventory 483
The Analytic Cohort 483
Narrative Summary 483
Comments on Statistical Procedures - Cleary and Yang 486
Research Completion Report 497
APPENDICES
1. Occupation Categories 5)6
2. DSM-11 and WHO Diagnostic Codes 521
3. Formats for Non-Standard Instruments 528
Profile of Mood States (056-POMS) 529
Frostig Developmental Test of Visual Perception (O65-FROST) 532
Abnormal Involuntary Movement Scale (II7-AIMS) 534
Crichton Geriatric Rating Scale (201-CRICHT) 538
Beck Depress ion Inventory (203-BECK) Sk]
Guild Memory Test (205-GUILD) Shk
Physician Questionnaire (208-PHYS) 546
inpatient Multidimensional Persona I i ty Sea 1 e (210-IMPS) 5^9
Physician's Outpatient Psychopathol ogy Scale (211-POPS) 559
Memory for Designs Test (212-MF-D) 562
Phillips Scale of Premorbid Adjustment in Schizophrenia (213-PHIL) 564
Sandoz Clinical Assessment-Geriatric (238-SCAG) 568
Clyde Mood Scale (239-CLYDE) 572
Hopkins Symptom Checklist (240-HSCL) 575
Self-Rat ing Symptom Scale (010-SRSS) 579
Global Assessment Scale (241-GAS) 583
Tartu Psychometric Battery (242-TARTU) 586
ACKNOWLEDGEMENTS
This revision of the 1970 ECDEU Assessment Manual represents the cooperative
effort of many individuals whose comments and criticisms have served to sustain
the ECDEU program as an evolving entity. The adult elements of the ECDEU Assess-
ment Battery have been modified and expanded over the period of the last decade
as a consequence of the interactions among those investigators employing the
Battery in clinical drug trials, the pharmaceutical industry, the Psychopharmacol -
ogy Research Branch of the National Institute of Mental Health and the Biometric
Laboratory of The George Washington University. The size of this group makes it
difficult to acknowledge every individual by name as I would wish, and, therefore,
appreciation for their contributions is extended collectively but no less warmly.
The newer pediatric section of the ECDEU Assessment Battery is the culmina-
tion of several years of effort on the part of the Pediatric Psychopharmacol ogy
Conference which was organized under the auspices of the Psychopharmacol ogy Research
Branch. The contributions of this Conference have been summarized in a 1973 Special
Issue of the Psychopharmacol ogy Bulletin, entitled "Pharmacotherapy of Children" and
are happily acknowledged here.
A number of individuals have been kind enough to provide special commentaries
for sections of the Manual, A list of these contributing authors is given below.
To them, and to the developers of all the assessment instruments cited in this Manual,
deep appreciation is expressed.
The emergence of the present Assessment Battery has been accompanied by the
development of a data processing system called the Biometric Laboratory Information
Processing System (BLIPS). To the entire staff of the Biometric Laboratory - and
particularly to those cited below - I want to extend special thanks for the ingenu-
ity and patience they have shown during the several years of almost continuous de-
signing and redesigning of BLIPS.
W.G.
CONTRIBUTING AUTHORS
Patricia A. Cleary, M.S.
John H. Close, M.D.
C. Keith Conners, Ph.D.
Lino Covi , M.D.
Leonard R. Derogatis, Ph.D.
Barbara Fish, M.D.
Samuel Gershon, M.D.
Rachel G i ttelman-Klein, Ph.D.
Max Rami Iton, M.D.
Gilbert Honigfeld, Ph.D.
Donald F. Klein, M.D.
Ronald S. Lipman, Ph.D.
Thomas McGlashan, M.D.
John E. Overal 1 , Ph.D.
Robert L. Sprague, Ph.D.
John Werry, M.B . ,Dipl .Psychiat
J. Richard Wittenborn, Ph.D.
Kenneth Yang, B.A.
Will iam W. K. Zung, M.D.
Biometric Laboratory, The George Washington University
Abbott Laboratories
Western Psychiatric Institute & Clinic, Pittsburgh, Pa.
Johns Hopkins University, Baltimore, Maryland
Johns Hopkins University, Baltimore, Maryland
University of California at Los Angeles
New York University Medical Center
Hillside Hospital, New York
University of Leeds, Leeds, England
Sandoz Pharmaceuticals
Hillside Hospital, New York
Psychopharmacology Research Branch
Chestnut Lodge, Rockville, Maryland
University of Texas Medical Branch, Galveston, Texas
University of Illinois, Champaign, Illinois
University of Auckland, New Zealand
Rutgers University
Biometric Laboratory, The George Washington University
Veterans Administration Hospital, Durham, North Carolina
PSYCHOPHARMACOLOGY RESEARCH BRANCH
Jerome Levine, M.D.
Wil 1 iam Petrie, M.D.
Nina Schooler, Ph.D.
BIOMETRIC LABORATORY, THE GEORGE WASHINGTON UNIVERSITY
Luis Agu i lar
Roland R. Bonato, Ph.D.
Mary Cronin
Mary-Alice Good ridge
Barbara Holmes
Nina Kit
Robert McCarter, M.S.
David Schaffer, M.S.
Richard Schoenberg
Richard W. Switalski, M.A.
C la rise Wi 1 1 iams
Robert L. Zimmermann, Ph.D.
INTRODUCTION
This revision of the 1970 assessment manual describes the redesigned and
expanded ECDEU Assessment Battery. Developed under the auspices of the
Psychopharmacology Research Branch of the National Institute of Mental Health,
the original and present assessment batteries have been an integral part of
their Early Clinical Drug Evaluation program (ECDEU) . The present product has
evolved through a continuous interplay of interests among the participants in
the ECDEU program - the investigators, the pharmaceutical industry, the Food
and Drug Administrat ion, Psychopharmacology Research Branch and the Biometric
Laboratory of The George Washington University.
Intended for an audience with diverse interests, the general plan of the
Manual mimics the usual order of events as they occur in a research study, i.e.,
from the planning phase to the analyses and interpretation of results. Indi-
vidual instruments are presented in the order in which they are employed and
are further categorized by purpose. Comments by their respective authors follow
the description of the instruments. Being cognizant of the need for brevity,
descriptions of the instruments, for the most part, have been kept to a minimum.
For those who wish more detailed information about a particular scale and its
psychometric properties, references have been provided and it is suggested that
contact be made with the author/s.
Def in i t i veness is not implied in the choice of scales included in the
Battery. A large number of scales with demonstrated utility in psychopharma-
cologica] assessment were discussed and evaluated by the ECDEU participants. The
final selection was made by consensus. Thus, many scales of equal merit were
omitted; but, through the versatility of the General Scoring Sheet, these scales
may be processed and analyzed with almost equal facility. Several of the pediatric
scales are frankly experimental. When the participants of the Pediatric Workshop
felt that there were no completely satisfactory scales available for a particular
assessment area, they set about to construct a new scale to serve the purpose.
Necessarily, these new instruments have not yet undergone the degree of psycho-
metric validation which characterizes the more venerable scales of the Battery.
Recognizing the needs of the field, however, these new scales have been introduced
with the understanding that psychometric analyses will be performed concurrently
with their use.
In conjunction with the dissemination of the standard assessment battery, the
Biometric Laboratory has provided processing and analytical services to the partici-
pants of the ECDEU program. The Biometric Laboratory Information Processing System
(BLIPS) has been developed to generate standard documentation for the individual
study. Consisting of a series of descriptive and statistical data displays as well
as card output, the documentation provides the investigator with the fundamental
analyses of his study based on an edited ("clean") data set. Given the uniqueness
of a given study, standard documentation can not meet all specific needs. To the
extent possible, however, requests for special analyses will be serviced. While
the extent to which the investigator makes use of these services is at his discre-
tion, both the Biometric Laboratory and Psychopharmacology Research Branch stand
ready to provide assistance in the planning of the study; the selection and schedul-
ing of assesg,ments , the training of personnel in the use of the Battery and the
choice of statistical techniques.
10
PARTICIPATION IN ECDEU PROGRAM
As originally conceived, the ECDEU program consisted primarily of grant-
supported clinical investigators working in tine common area of psychotropic
drug evaluation (both new and established compounds). One of the problems
they encountered, and task they accomplished, was the development of a uniform
battery of clinical assessment instruments known as the ECDEU Standard Report-
ing System, first introduced for utilization in 1967. The rationale behind
this effort was twofold. First, it was felt that such a system would enhance
both the quality of early clinical drug research and allow greater general iza-
bility of results across studies and investigating units. Second, data collected
on common forms could be stored in a data bank for future study and research.
Since the implementation of this Standard Reporting System and the Biometric
Laboratory Information Processing System (BLIPS), the ECDEU program has evolved
into more than an extramural grant support program for psychotropic drug research
teams. In collaboration with The George Washington University Biometric Labora-
tory, the ECDEU Standard Reporting System has been made available to any investi-
gator interested in conducting clinical trials, whether federally grant supported
or not. To utilize these services, the investigator is requested to:
1. Submit a Research Plan Report (021-RPR) and agree to
send the study data to the Biometric Laboratory.
2. Collect sufficient information about the subjects in
his study so that the data can be entered into the ECDEU
data bank. This means, essentially, that a core of data
must be collected for each patient. Such a core of data
includes :
a. Demographic information; e.g.. The
Adult Personal Data Inventory.
b. At least one major rating scale of
efficacy or psychopathology; e.g., the
Brief Psychiatric Rating Scale.
c. Information on dosage and toxicity; e.g.,
the Dosage Record and Treatment Emergent
Symptoms Scale.
In return, he receives a sufficient number of assessment scales to conduct his
research. Once the trial is completed, the forms are returned to the Biometric
Laboratory for processing and data analyses, the results of which are sent to
the investigator in the form of a standard data package. The rating scales and
data processing services are provided at no charge - our sole "remuneration" be-
ing the opportunity to add the investigator's data to the data bank. It should
be stressed that an investigator's data and/or results are never published or
disseminated to others without his permission.
II
Along with extending participation in the ECDEU program to a larger group
of investigators, greater latitude in the types of studies which are considered
appropriate for the services is now permitted. Originally, only studies -focussed
on the investigation of drug effects were accepted. Now, studies in which the
investigation of drug effects is peripheral may be submitted. This is particularly
true in the pediatric area where the need for standardization data is great.
Investigators who are uncertain about the appropriateness of their study are urged
to contact the Biometric Laboratory or Psychopharmacology Research Branch.
GENERAL DESCRIPTION OF THE BATTERY
The most prominent feature of the new Battery - expansion aside - is the
redesigned format of the scales. In the original Battery, the scales were self-
contained with both items and their response positions preprinted on the form.
While this format provided maximal rater legibility, the amount of data retrievable
per page was low; and, since it was necessary to record identifying information on
each page, the rater was faced with a great deal of redundant encoding. To offset
these problems, items and response positions were separated. A universal answer
sheet called the General Scoring Sheet was designed to serve as a means of encoding
not only responses to the scales included in the Battery, but any type of data which
an investigator might wish to encode.
Coupled with the General Scoring Sheet, a number of assessment packets were
developed. Each of these packets constructed of durable plastic contains the items
of a set of related assessment instruments. Selecting the desired instruments from
this set, a rater encodes responses on the General Scoring Sheet while retaining
the packet for subsequent use.
Figure 1 illustrates the manner in which the packets are used. Spiral bindings
appear on 3 sides of the packet. Upon opening the cover, there are 3 sections each
attached to one of the spiral binders. Along the top are "headers", i.e., sections
which contain instructions and scalepoints for a specific scale. The 2 lower sections
open up from the middle and contain items for specific scales. The instructional
header and the appropriate item pages for a specific scale are color-coded for the
convenience of the rater. When all of the headers and pages are open, the back
cover of the packet can be seen, and it is here that a General Scoring Sheet is
placed - fixed by a positioning tab. With the General Scoring Sheet in place, the
rater flips to the desired header and page; finds the appropriate area of the
General Scoring Sheet exposed and is ready to encode. There are presently 5 packets
in the Battery:
1. Demographic - containing 3 instruments for both pediatric
and adult populations.
2. Pediatric - containing 6 instruments for rating psychopathology ,
diagnosis, adverse reactions and termination status.
3. Adult - containing 9 instruments - 3 of which are also contained
in the Pediatric packet - for adult populations.
k. Nurse - containing k pediatric and adult behavioral scales for
rating by ward or para professional personnel.
5. Psychologist - containing 9 pediatric and adult psychometric scales.
12
FIGURE I
THE ASSESSMENT PACKET
PACKET CLOSED
Header
PAGES AND HEADERS
OPENED
COVER OPENED
f^kvcr^ot'fprfcrtuT
vj*=t-tr-T>«r*
\>^
-iA^^'^TI^
Pages
Header and page opened
to a specific scale
Positioning Tab
General Scoring Sheet
13
In addition to the 28 scales contained within 5 packets, there are 15 inde-
pendent (self-contained) instruments. Table I catalogues all of the scales which
comprise the standard ECDEU Assessment Battery and classifies them by applicabili-
ty, format, content and rater. Applicability refers to the population (s) for
which a scale is appropriate. Format indicates whether a scale is designed for
opscan or not and whether it is contained within a packet or is independent. The
content areas are: demographic (Dem) , efficacy (Ef f) , toxicity (Tox) , medical
(Med), psychometric (Psy) and administrative (Adm) . Finally, the rater is designa-
ted. Fourteen of the ^3 instruments are "universal" - reflecting the integration
and compatibility of the Battery across diverse research populations.
TIME TABLE FOR USING THE ECDEU BATTERY
Table 2 depicts the usual order in which investigators employ various instru-
ments in the ECDEU Assessment Battery during the 3 major phases of a research study ■
planning, data collection and analyses.
Planning phase - Having developed an hypothesis and a research design to test
it, the investigator decides to utilize the assessment instruments and services of
the ECDEU program. Generally, he will have prepared his own written protocol from
which he can extract the information required on the Research Plan Report (RPR).
The RPR serves to notify the Biometric Laboratory and Psychopharmacology Re-
search Branch that a study is contemplated and that it is expected to take a certain
length of time for completion. Along with its intrinsic - and more important -
value as a description of ongoing research, the RPR serves to alert the Laboratory
to its future work load and, upon receipt of the data, to the nature of the study
and the procedures employed. Along with the RPR, an ECDEU Order Form (EOF) request-
ing the quantities of forms necessary to carry out his study is completed and
mailed to the Biometric Laboratory. Should problems be encountered in completing
the RPR or EOF, assistance can be obtained from the Biometric Laboratory.
Data Collection Phase - With the availability of the General Scoring Sheet,
the choice of assessment instruments is not limited to the standard ECDEU scales.
The investigator may select those devices which he feels will best serve his needs -
provided that he supplies the core of information required for ECDEU services,
(p. .11).
For new investigators unfamiliar with the instruments, the most frequent
choice patterns of experienced ECDEU investigators working with adult populations
may be helpful. The listing of these patterns should not be construed as obliga-
tory but merely as a guide,
1. Neuroleptic Studies with Schizophrenic Populations
a. Brief Psychiatric Rating Scale (BPRS)
b. Clinical Global Impressions (CGl)
c. Nurses' Observation Scale (NOSIE)
]k
0}
(U
t- \ 03 (D (D •
a) 4-1 4-1 ._ Q. •— •—
j: c c x: ^v x: o
fDl-l-— >~— >-3
a)<D(Dcui/i(uui(U
w E E
Q.-D TJ
O < <
L,_M_4_l4_ X X xxi
U_M_l4_l+.000(U
UJUJLUUJI— [— h- 2:
F
F
F
. M- ^E
E
CIJ
<u
0)
H- U
o
o
Q
• LU Q
o
4-q-4-l4_4-l4_M_ X E^-H-^-H-
E E
< <
— o
H
Z >- 4-' 4-1
— LU 1— — Q.
s: — D -u X
CO — I TD 3
LU CO — <C O
_J UJ CO
00 CO <
< CO CJ
I- < — -W
_l Q. X
Li. Q. C
O Q- —
<
_j j: X
X X X X
xxxxxxxxx
X X X X X
X X X X
X X X X
Q) 1/1
— Ul
o —
CO o
<;j en c 1- u
Q— — O— 0(J-l-'>
O I- — — ID C
Ul 4-1
C C -D
O en s-
— i_ O
(U ui E u
— U1 LU 0)
C (D (0 —
■— 4-ifD<U ' al — u o in <u
O >- 4-1
_ (D(U4-'4-l4-IQ£— CO(Dl/)Q.EC
mP4-»Q^m(nLn d irt "> E^O
cn — I- .-
C 4-1
Qiui/iQ. ouaiini-4-)ui4-i — — uinj
CO CO 1/1 I- 0) 4-1
a)E04-iQc^cc— iii/i>- —
O
1-
F
—
c
Ll.
0)
>.
m
nj
a.
lO
c
O C O 1- (D
— O — Q. C
> — L. E c
(0 4-14-1 O
0) — 1_ (/I
(U
OJ Q- Q Q •—
— 1- O U -C
Q-(l)int/)t/)— i/i(/i(/)0
T5-- i_-a--- >
JTS-CCDdJCCCl/l
U 1- U t_ 1_ i-
(D=)"D"04-i l-TO-a-OM-
(1)LU — — — o — — — 0)
(/) Q — — D — — — — —
d) (J JZ JZ -U L-JZ^^ U
aC'LLiuo<Q-(->ouaQ
OJ
(L)
(U
in
4-1
to
c
4-1
1-
•—
3
0)
Xi
T3
•—
CO
O.
X
4-1
a:
o
\-
F
(U
c
(0
^
0
L-
c
Q
■a-
4-1
c
i3
U
d)
o
(/I
L.
0)
H
c
c
o
r—
q:
1/1
0
o
>»J3
(D
4-1
l/l
4-1
4-1
4-1
c
U
(i)
c
(U
>—
t—
(U
0)
•—
CT
(U
u
■—
•—
•—
4-1
c
(D
•—
Q.
F
F
y.
4-'
•—
U)
+J
(U
(D
(D
c
•—
^
O
<D
o
IE
J-
<
13
o
o
a.
— (U > — —
— dJ o —
(D 3 4-1 (D
C O" CL U
C E CO
O 1- >s
— OJ CO C
0)
03
1 —
U
•—
(O
u-
()
1_
u
O
0.
>
•
(D
>
j:
(D
0)
(D 05 "D J: CO 1-
OJ X U C <U Q.
4-iLUCOn5CQJ^<U —
OQ 1- l_ (0 t/1 4-1
(1) 0) J3 (U (/) U 4-1 I
U1l/)t303<U(D l-O)
-ja — o'3a)04-i
coj^ca o*!— Q. —
l/l Q 4-1 Q.
^v).ci/i a)4-i4-ia:3U(Du!)
-DOJOOJ^CCI 0)
>~ 3 1- U
1- QJ 4-1 -O
OJ —
E —
o
E m
(D H
X
CD <U O
CEO
— Q.
(/) 4-1 (/) O
— L. 3 u (0
j: 3 — 3 <u
o z a. z I-
0) (U
U V. — CO
(u nj (U LLi
Q. Q. CO I-
J= O -C -o
. >, 1_
l/l o
Q- M-
■— 4-1 (/I
15
UI
(/)
$
a.
<->
>-
—1
<
Data Shipment-
accompanying data sent
to Blometric Laborator
Research Completion
Report-fol lowing
analyses of data
2
HE ECDEU BATTERY
N PHASE
POSTTREATMENT
packet )
Packet )
)-— Repeated at
ehavioral) least once
es )
Patient
Termination
Record
TABLE
TIME TABLE FOR USING T
DATA COLLECT 10
PRETREATMENT
Demographic Packet
Prior Medication Sheet
Psychiatrist
Psychologist
Nurse Packet
Independent B
Seal
UJ
(/>
z
z
a.
Research Plan Report
ECDEU Order Form
16
2. Antidepressant Studies
a. Hamilton Depression Scale (HAMD)
b. Clinical Global Impressions (CGl)
c. Depression Status Inventory (DSl)
d. Self Rating Depression Scale (SDS)
3. Anxiolytic Studies
a. Ham i 1 ton Anxiety Scale (HA^V\)
b. Clinical Global Impressions (CGl)
c. Anxiety Status Inventory (AS I )
d. Self Rating Anxiety Scale (SAS)
e. Self Report Symptom Inventory (SCL-90)
Along with appropriate demographic information, the assessment of side effects,
and the recording of dosages through the use -of an instrument such as the Dosage
Record and Treatment Emergent Symptom Scale (DOTES) should be considered. Finally,
information concerning the disposition of subjects; e.g.. Patient Termination
Record (PTR) , should be gathered.
Analytic phase - Two administrative forms are completed at this phase. The
new Data Shipment (071-DS) serves such a vital function in BLIPS II that process-
ing of a study simply cannot proceed without an accompanying DS. The Research
Completion Report (059-RCR) completes the transaction by documenting the investiga-
tor's overall conclusions and future plans as based on the results of his study.
17
GENERAL
INSTRUCTIONS
For the rater, the substantive judgments he makes are of paramount importance -
not the way in which he records those judgments on a sheet of paper. These
instructions, unfortunately, are concerned with the unavoidable mechanics of encod-
ing those judgments on op-scan sheets. It has been our experience that encoding
errors are - by far - the prime reason for delays and misinterpretations during
data processing. It is important, therefore, that raters become familiar with the
"do's" and "don't's" of op-scan encoding.
1. For those unfamiliar with it, the optical scan (op-scan) format can be
frustrating, since it places strict constraints upon the rater. The op-scan reader
is a sensitive machine which compulsively records intended as well as unintended
marks. It should be remembered that an op-scan page is entirely covered with a
field of response positions. Though not visible to the rater, these positions are
"read" by the op-scan machine. With appropriate programming, many - but not all -
of these extraneous positions can be suppressed. Consequently, some will be
"triggered" by superfluous or incorrectly entered marks. Therefore, FOR ALL OP-SCAN
SCALES, the following rules must be observed:
A. USE ONLY A #2 PENCIL. Ink, ball point, felt markers, etc.
will not be "read" at all or will be read haphazardly.
DO NOT MAKE EXTRANEOUS MARKS ON THE GENERAL SCORING SHEET
OR ANY OTHER FORM. Writing, when permissible, must be
completely confined to the areas specified. Extra marks
and/or writing in prohibited areas trigger multiple responses
which will be rejected later during the editing process.
Example - On the TESS Write-in Scale (TWIS), the rater wishes
to record the presence of the symptom "giggling" as mild and
possibly related to the drug. He encodes as follows:
2. OTHER SYAAPTOM fConf.n
(fiin ffiis block)
y(l^L.^\\_j2'
MOft
MILD ERa/e SEVE
Remole PoSMble P
able Delir
:3=: ---A
In this example, both INTENSITY and RELATIONSHIP may be re-
jected in the editing process because the lower part of the
"'g'"s intrude into the "INTENSITY" and "REU\T I ONSH I P" areas
and may be read by the op-scan reader as illegal multiple
responses. The correct way to encode "giggling" is:
4. OTHER SYMPTOM JConfme wnfmg w.(h,n th,s b/ocW
INTENSITY
MOD-
RELATIONSHIP
MILD
ERATE
SEVERE
None Remote Possible Probable Delined
—
-.a-
:*=
rieii -.z\--z .«- ==3=: r:4ii
Here the rater has confined his writing completely within the
specified area and no illegal multiple responses are evoked.
20
CONFINE YOUR MARK WITHIN THE TWO PARALLEL LINES. Slashes
or flourishes which extend beyond the parallels result in
multiple responses; i.e., 2 response positions being "read"
by the op-scan machine. Marks which do not fill in all of
the space between the parallels, on the other hand, may not
be "read" at all .
Examples:
Incorrect Correct
D. DO NOT USE STAPLES OR PAPER CLIPS to affix forms or pages
together. Similarly, DO NOT PUNCH HOLES in the forms.
E. Please ERASE THOROUGHLY when changing a response. Failure
to erase cleanly usually results in both the partially erased
and corrected responses being "read".
F. WHEN NUMERICAL VALUES ARE REQUIRED, ALL INDICATED DIGITS MUST
BE MARKED including leading and following zeros.
Example: Given a 3-digit field, the rater wishes to record ]k.
•«■ ::*! ::*! ~»: ::*= -5:: ~frz =:fc ;:8:: "St:
Correct ::ft: MM "*: "»: ii*: "-&- "fc: -*: -ft^ "*:
::»: ::*: "»! ::>: m^ ..&-. z.tfz -fc ::fc ::St:
i:ft:
i:*:
::»:
Z-.X--
::*:
::&:
"*::
::*;
"ft:
"Sb:
l.ncorrect
3:ft:
-*>
::»:
i:J:i
::«::
::S:
::ft:
::fc
lift:
::Sb:
=ft:
"t:
=*:
ZZtLZ
■^
zz&z
::fci
"3ti
=8::
::fc
NOTE - Numerical values of more than one digit are always encoded
vertically on 2 or more rows.
21
2. Generally, the scales require the rater to assess effects which are
directly observable either in word or deed. Inferences should be minimized.
While this restricts the rater, variability related to rater experience and
theoretical orientation is reduced.
3. With some exceptions, the scales require a time-limited evaluation,
i.e., the presence, absence and/or intensity of symptom at the time of the
rating or within a specified time span prior to the rating. For example, on
the Children's Psychiatric Rating Scale (CPRS) the subject reports feeling
depressed "a couple of months ago, but not now". Since the time span for this
item (35) is "now or within the past 7 days", the rater marks the item "Not
Present". At the discretion of the principal investigator and with appropriate
communication to the Biometric Laboratory, alternative time spans may be
specified for a particular study objective. Suggested rating spans, where
applicable, are given with each scale.
k. Raters often exhibit a tendency to remain in the conservative center
of a scale. When undecided about two alternatives, the rater should choose
the response nearer the extreme end of the scale. For example, if undecided
whether to rate "mild" or "moderate" on an item in which there has been a
positive change from "severe", the rater should choose "mild" - the alternative
nearer the positive end of the scale. Similarly, the rater should choose the
alternative representing the higher degree of pathology when he is undecided
about the severity of illness. In essence, raters should choose the more
"radical" response in either the direction of improvement or deterioration.
5. The style of interview is left to the discretion of the rater. Most
raters quickly establish a method from which the material necessary for rating
can be extracted. Generally, the method takes the form of a semi -structured
interview in which target areas are explored in a more or less consistent
sequential fashion. It is suggested, however, that raters not change interview-
ing techniques during the course of a study.
6. It is strongly urged that every effort be made to maintain the same
rater for all assessments of a given subject on a given scale.
7. The processing system has been programmed to expect a response for all
items. Raters are, therefore, urged to complete all items on all forms they use.
When this is not possible, the rater should utilize the "Not Ascertained" or "Not
Assessed" response positions. "Not Ascertained" should be interpreted as not
available, not applicable, no answer, or in those instances where the information
is considered specious or improbable. "Not Assessed" indicates that the rater
made no effort to elicit the information.
8. While the investigator has complete freedom to employ any additional
assessment techniques he wishes, the standard scales, their formats and items
must not be modified or altered. It is imperative that data sent to the
Biometric Laboratory be constituted under the contexts provided in this manual.
22
9. It is not possible to construct a manual which provides answers for
all situations or contingencies. Should questions arise, feel free to contact
either Biometric Laboratory or Psychopharmacology Research Branch by mail or
telephone.
ENCODING THE IDENTIFICATION BLOCK
The identification (ID) block consists of 8 horizontal rows - 20 response
positions (columns) to each row - and uniformly appears on all op-scan forms.
The ID block provides response positions for the encoding of:
1. Patient Initials
2. Patient Number and Sex
3. Rater Number
'+. Sheet Number
5. Period (Rating) Number
THE IDENTIFICATION (ID) BLOCK
PATIENT INITIALS
NUMBER
MALES 001
TO
499: FEMALES 500 TO 998
:A-:
*:
:^-
:©::
.iz:
:*::
Gzz
:W:
:(:-
rrjr:
:«:: :
:lr: :5::
r*
zzAz: :;&::
*"
::7::
-"8-:
:-9::
:*.---
:L::
-M--
:W:
©:
FIRST
INITIAL
::?::
zGpz
;«::
::$:;
::T::
«:: :
-.1:: :5::
::3-
..^.. PATIENT. .s..
"^"NUMBER-*-
«;■-
.:?::
■-«::
:r9::
:«::
^-
-W'
:;X:r
::Y::
-zii
:«:r :
:!:: :5::
:=a--
:-4;: ::§:-
«"
"C"
:«::
::9::
:-A::
-t--
:JX::
SECOND
::p::
iyzz
zxazz
::(::
::$;:
"T"
;]:: r^::
:!:: ::?::
'"*' RATER '*"
-.^.NUMBER -^.
"7--
:.-7r:
::8::
ZZ3-Z
INITIAL
:«::
V:
-W-
::X::
::Y::
r^
:«:: :
:]:: ::?::
:*
PERIOD
«:■-
::^::
:«:-
:-§-:
"tt:
:3::
::2::
::3::
.:t:
SHEET
::S:
: = 6:
"^:
::»;
rift:
H
:!:: :2::
: 4;; ;:§::
« -
::7;:
inlhs
:*:
--:§ :
"tt:
-.3"
:r2::
Z--A-.
=;*,-
NO.
-.z5.z
: = fe:
"S:
::&:
iiS:
z-Qz: z
::?:
^^
--4::
Complete and accurate encoding of the ID block is of paramount importance. In
BLIPS, errors and/or omissions within this block are regarded as "catastrophic
errors"; i.e., errors which half any further processing of the data. Delays can
be lengthy since ID problems may bring the entire data set under suspicion and,
consequently; require extensive verification.
1. Patient Initials - First initial refers to given name; second to surname.
Patient initials are utilized only during the editing phase; they never enter the
data bank, thereby preserving patient anonymity.
2. Patient Number and Sex - Patient number requires a 3-digit code. Numbers
between 001 and 499 designate male; 500 to 999 female. The investigator is required
to assign numbers to his research sample. Any 3 digit numbers, withinthe stricture
on sex - may be used; although it is the usual practice of investigators to assign
numbers sequentially as subjects enter the study. In double-blind studies, care
should be taken that the assigned Patient Numbers do not form a pattern which might
reveal treatment assignment. ALL 3 DIGITS MUST BE ENCODED including leading and
fol 1 owi ng zeros .
23
3. Rater Number -A 2-digit code assigned by the investigator is required.
Wherever possible, it is suggested that investigators maintain the same numbers
for their "permanent" raters, i.e., those who rate in a series of studies.
Sections of some of the scales; e.g., CPDI, PMR , etc. may be completed by
different Individuals. In these cases, assign the number of that rater who has
completed the greater portion of the scale.
k. Sheet Number - A 2-digit code which identifies, for computer processing,
the data which is encoded on a specific General Scoring Sheet. Sheet Numbers for
the scales within the various rater packets are given with the instructions for
each scale and must be adhered to by raters. For non-standard scales or data setS;
the investigator may assign any number from 80-99. Unlike PERIOD NUMBER which
corresponds to the time when a particular rating is performed, SHEET NUMBER FOR A
SPECIFIC SCALE OR DATA SET REMAINS CONSTANT THROUGHOUT THE STUDY. Thus, if a
rating scale; e.g.. Insipid Reaction Scale, is encoded on the GSS and assigned
Sheet Number "80" at the initial rating; this number "80" must be assigned to all
subsequent ratings of the Insipid Reaction Scale.
5. Period Number - a 3~digit code encoded by the investigator is required.
The code designates the time when a specific rating is made. Two digits are pro-
vided for the numeric and one digit for the units of time - hours, days, weeks,
months .
Examples :
1. To enter \k days; code as follows:
-*-
--^--
=:3=:
PERIOD
--^-
::7::
;*:
r;5::
i:2;:
:*:
"4* -:^--
i:©:--
:iT::
;*:
Hours
Days
Weeks
Months
To enter 8 weeks;" code as follows:
•^
ril::
zzSzz
:*=
PERIOD
:*:
zi7i:
:*:
III::
--:S-Z
::*;
zzAzz ::§::
zz^z
zzr-z
Hours
Days
Weeks
Months
--*:
i:li:
::2r:
•*•
:a;z=
"-Note that the leading zero is encoded: 08 NOT blank 8.
3. To enter the initial rating; code as follows:
i:l:: r:2ri ::3::
Hours Days
::S=: =«== --T-- -^- =*=
Weeks Months
Time units should be consistent on all scales throughout a study, whenever
possible. Code Week 01, Week 02, Week Ok or Day 01, Day 14, Day 28, NOT Week 01;
Day ]k. Month 01. While uniform use of any of the time units is acceptable, it
is suggested that DAYS be used whenever possible.
2k
In most studies, assessments are planned at regular intervals (Week 00, 02,
Ok, etc.) although the actual assessment may not be completed on the precise
schedule. For uniformity, raters should encode PERIOD according to the study
protocol. Example: Assessment is scheduled for Day 1^ but the rater is unable
to accomplish it until Day 15. Encode Day 1^ - not 15 - as 15 would appear as
an aberrant assessment in subsequent analyses and be deleted. Should a subject
be prematurely terminated, however, and an assessment made at the time, encode
the real time of the assessment even though it is "off schedule".
CODING DURATION OF STUDY - In order to achieve uniformity within a given study
and across different studies, duration of study should - in all cases - be coded
in the following manner. The initial rating should be encoded "000". Duration
in the study for any subject is counted from the initial rating to the final
rating whether or not this time period corresponds to the actual period of drug
(treatment) administration. This method of counting is necessary to encompass
those studies in which more than one pretreatment (pre-drug) assessments are
made. Similarly, the cessation of treatment may or may not coincide with the
final rating. Many studies employ more than one follow-up rating after the treat-
ment (drug) has been stopped. In this coding system, both pretreatment and follow-
up phases are included in determining total duration of the study IF assessments
are made which span these pretreatment and followup phases.
Exampl es
1
The Investigator plans to have a 2-week drying out period following
which the first ratings will be made. He then will administer his
test drug for k weeks. He plans to make additional ratings 2 weeks
and k weeks after the initiation of treatment. There will be no
followup assessments. Duration of this study would be calculated
and coded as follows:
DRY-OUT PERIOD
DURATION (DAY)
RATING
DRUG
STARTS
00
1st
14
2nd
DRUG
ENDS
28
3rd
The investigator plans a study exactly as before (1) but adds a
rating at the beginning of the drying-out period and 2 weeks
following the cessation of drug treatment. Duration in this study
would now be calculated and coded as follows:
DRY-OUT PERIOD
DURATION (DAY) 00
RATING 1st
DRUG
STARTS
14
2nd
28
3rd
DRUG
ENDS
42
4th
56
5th
25
3. A crossover study is planned in which the sequence, Drug A - PBO -
Drug B, will be employed. Each treatment will be of 2-week duration
with assessments every week. Duration would be calculated and coded
as fol lows :
CROSSOVER
DURATION (DAY)
RATINGS
DRUG A-
PBO-
-DRUG B-
1
00
1st
07
2nd
14
3rd
21 28
'tth 5th
35
6th
7th
SHADED AREAS - All independent scales; i.e., those with items printed
directly upon them, will have one or more shaded areas in the identifi-
cation block and possibly one or more within the text of the scale.
The shaded areas with the ID are "prohibited areas" and NO MARKS OF ANY
SORT are permitted. Similarly, shaded areas within the text of a scale
are for coding only and writing should never be done here. This type
of error has been so prevalent in the past that cautions are repeated
throughout the Manual wherever there is the possibility of its occurrence,
CARD FORMAT - IDENTIFICATION BLOCK - (513, 212, 51x, 11, 15, H, 13)
This format for identification is universal for all ECDEU card outputs,
1 tem
Col.
Unit No.
1-3
Study No.
k-e
Subject No.
7-9
Form No.
10-12
I tem
Card No.
Data Field
Col .
18-19
20-75
Treatment Assignment" 76-J
Assessment Period 13-15
Rater No. 16-17
''Treatment Assignment - This code will designate the specific treatment assignment
for each individual subject. The information is obtained from Data Shipment
(071-DS), Item V, patient Identification. The coding is as follows:
Factor
1 Assignment
- Col
76
Factor
2 Assignment
- Col
77
Factor
3 Assignment
- Col
78
Specia
Ass Ignment
Coding
- Col
79
26
021 RPR
RESEARCH
PLAN
REPORT
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
DO NOT WRITE IN THIS BOX
PUBLIC HEALTH SERVICE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
UNIT NO.
NATIONAL INSTITUTE OF MENTAL HEALTH
STUDY NO.
PSYCHOPHARMACOLOGY RESEARCH BRANCH
RESEARCH PLAN REPORT
RPR NO.
GENERAL INSTRUCTIONS
The Research Plan Report is designed to collect data concerning psychopharmacological research
procedures in a format suitable for computer processing. The restrictions of such a format plus the
great variety in research designs may create some difficulties in choosing a response. The investigator
is asked, however, to make every effort to complete the form according to the instructions. If aspects
of your study cannot be described appropriately under a given item or if the space provided is inade-
quate for your response, please describe the details on page 11 or on a separate sheet and attach to
the form. Submission of the investigator's complete protocol would also be appreciated so that errors
of interpretation can be avoided.
Specific instructions for this form (RPR) are given on pages 12-15 and should be read PRIOR TO
COMPLETING THE FORM. This revision of the RPR, MH-9-21, Rev. 1 -73 (Blue) supersedes all
other versions. Please discard all old forms, MH-9-13, Rev. 2-71 (Buff).
I. IDENTIFICATION
NAME OF INVESTIGATOR/S
TITLE OF STUDY
STARTING DATE
Month
ANTICIPATED COMPLETION DATE
Month Year_
PURPOSE/S - Briefly state purpose/s and any specific hypotheses of the study
If you concur, the Research Plan Report which you submit can be released to the scientific community
in the form of a short narrative description of the study. Chemical formulae may be held confidential
even if other information is released.
Is this RPR a revision or modification of a previously submitted one?
n Yes D No
If YES, give Unit and Study numbers assigned to original RPR:
May data on this form be given to the scientific community? CD Yes CH No
Should chemical formulae be held confidential? □ Yes CD No
Will ECDEU forms be used and data be sent to the Biometric Laboratory? CD Yes CD No
Mail this completed form to:
MH-9-21
Rev. 1-73
ECDEU Data Analyses
Biometric Laboratory
George Washington University
11501 Huff Court
Kensington, Maryland 20795
28
FORM APPROVED
OMB NO. 68-R965
ALL CARDS
CODE:
COL.:
DO NOT WRITE HERE - FOR BIOMETRIC LAB USE ONLY
2-4
5-7
REVISION
21
n. DESCRIPTION OF DRUG/S EMPLOYED
TEST DRUGS
DO NOT WRITE HERE
CODE
CARD 01
b. Synonyms
1. Test
Drug
No. 1:
c. Manufacturer
d. FDA (or appropriate regulatory agency) status
1 . Approved for prescribing or sale and for the present indication or use
2. Approved for prescribing or sale but jVOT" for the present indication or use
3. Not approved for any use
Single Drug D 1
Combination Drug D 2
INV NO. 1
D 1
D2
D3
b. Synonyms
2. Test
Drug
No. 2:
c. Manufacturer
d. FDA (or appropriate regulatory agency) status
1 . Approved for prescribing or sale and for the present indication or use
2. Approved for prescribing or sale but A'OT' for the present indication or use
3. Not approved for any use
MAN NO. 2
D 1
D2
03
3. Presumed
Clinical
Action/s:
01
02
03
04
05
06
99
TEST DRUG
NO. 1
Neuroleptic
A nx ioly tic/Sedative
Antidepressant
Stimulant
Psychotomimetic
Hypnotic
Unknown
01
02
03
04
05
06
99
TEST DRUG
NO. 2
Neuroleptic
A nxioly tic/Sedative
Antidepressant
Stimulant
Psychotomimetic
Hypnotic
Unknown
Other Action (Test Drug No. 1)
Other Action (Test Drug No. 2)
4. For Investigations of New Uses For Established Drugs
NEW NO. 1
Test Drug
The generally accepted action is:
45-48
No. 1
The action to be tested in this study is:
NEW NO. 2
Test Drug
The generally accepted action is:
49-52
No. 2
The action to be tested in this study is:
MH-9-21
Rev. 1-73
29
5. Chemical Cla»/ej (If known)
UU NUT WRITE HERE
COL. CODE
TEST
DRUC
NO. 1
TEST
DRUG
NO. 2
CHEMICAL CLASSES
TEST
DRUG
NO. 1
TEST
DRUC
NO. 2
CHEMICAL CLASSES
53-68
CLASS NO. 1
101
Phenothiazines
Phenothiazine analogues & isosteres
Lysergic acid derivatives
Reserpine & derivatives
Harmine & derivatives
Other indole derivatives
Cannabis derivatives
Chromone derivatives
Benzodiazepines
Barbiturates
Heterocyclic butyrophenones
Other nitrogen heterocycles
Benzodioxane derivatives
Other non-nitrogen heterocycles
401
Phenylethylamine derivatives
Phenylacetic acid derivatives
Diphenylmethane derivatives
Benzoic acid derivatives
Other aromatic compounds
Glycols
Carbamates
Carbinols
Amides & hydrazides
Amines & hydrazines
Other aliphatic compounds
Unknown
59-64
:lassno.2
102
402
201
403
202
404
203
405
204
501
301
502
302
503
303
504
305
505
306
506
307
999
308
309
6. For NEW DRUGS, draw chemical structure
65
FOi^MULAE
66
PUBLIC
67
SCALES
68-71
PURPOSE
B. COMPARISON
DRUG/S
1. Does the study employ comparison drugs?
D Yes If Yes,
a No
which? Standards D 1
Active Placebo D 2
Inert Placebo D 3
Both Standard/s and Placebo/sD 4
17-18
CARD 02
19
COMPARE
2. Comparison
a. Name
Single Drug D 1
Combination Drug D 2
20-24
STD NO. 1
Drug
No. 1:
b. Manufacturer
25-27
MAN NO. 1
3. Comparison
Drug
No. 2:
a. Name
Single Drug D 1
Combination Drue D 2
28-32
STD NO. 2
b. Manufacturer
33-35
MAN NO. 2
4. Placebo:
a. Composition
36-40
PBO
b. Manufacturer
41-43
MAN-PBO
III.
POPULATION
1. Total number of subjects in study:
2. Sex: Males Only D 1
Females Only D 2
Both Sexes D 3
4. Aqe Ranoe: From To
3. Maturity:
ChUdien D 1
Adolescents D 2
Adults D 3
Geriatric D 4
44-46
NO. 5
DEMOGRAPHY:
47
SEX
48
MATUR
49-50
AGEFflOM
51-52
AGE TO
MH-9-21
Rev. 1-73
PAGE 3
30
B.
SUBJECT
STATUS:
1. (Check One)
Inpatient
1
2. (Check One)
Acute
1
Outpatient
2
Chronic
2
Both
3
Both
3
Not Applicable
9
Not Applicable
9
DO NOT WRITE HERE
PRINCIPAL
DIAGNOSTIC
CATEGORIES:
1. Adult Check all applicable (Omit if study involves childrerh only)
Psychoneuroses-Anxiety States
Psychoneuioses-Depressive States
Personality Disorders
Mental Deficiency
Psychophysiological Disorders
Vailed Psychiatric Disorders
Non-Psychiatric Population
Organic Brain Disorders
Geriatric Disorders
Alcoholism
Manic-Depressive-Manic Phase
Manic-Depressive-Depressive Phase
Psychotic Depressions
Schizophreiua
Other Categories (WHO diagnoses may be gi
13
15
17
20
22_ _
ven here)
2. Children
Childhood Schizophreiua
Overanxious Reaction
Unsocialized Aggressive Reaction
Hyperactive Reaction
Withdrawing Reaction
Speech Disturbance*
Learning Disturbance*
^Special Symptom Disturbances
71
72
Tic*
Sleep Disorder*
78
79
73
Feeding Disturbance*
81
74
Enuresis*
82
75
Encopresis*
83
76
Varied Psychiatric Disorders
84
77
Non-Psychiatric Population
85
Other Categories (WHO diagnoses may be given here)
D.
BASIS FOR
DIAGNOSIS:
MH-9-21
R«v. 1-73
Check method/s for determining diagnoses of research sample:
Psychiatric Case Record
Investigator's Clinical Judgment
Iiiflependent Clinical Judgment
Clinical Target Symptoms
Psychometric (CutofO Score,
:/s* □
•// "Psychometric Score/s" checked, describe method:
19-26 DX BASE
Other Methods (Specify):,^
PAGE 4
31
Check all conditions which would lead
you to exclude (or remove) an individual
DO NOT WRITE HERE
from the study:
COL.
CODE
\cute or Chronic Brain Syndrome
History of Convulsive Disorder
History of CNS Disease
Mental Deficiency
Psychosuigery
27 Electroconvulsive Therapy
28 Alcoholism
29 Drug Addiction
30 Pregnancy
31 Females of Childbearing Age
—
32
33
34
35
36
27
EXCLUDE
28
29
30
31
32
Allergic 37 Hepatic 39 Pulmonary 41
Cardiac 38 Hematologic 40 Renal 42
33
E.
34
EXCLUSION
35
CRITERIA:
Other Medical Illness or Condition (Specify
):
36
37
38
Anv Other Exclusion Criteria (Specify):
39
40
41
42
43-50
1. For inpatient studies - During the study, the population will reside:
(Check all applicable)
1 D One RESEARCH ward sDOne Institution (hospital)
20 More than one ' 4DMore than one institution (hospital)
RESEARCH ward gQ y„ ^^^ administrative control of principal investigator
eDA^of under administrative control of principal investigator
51-53
RES- la
b.
1 DOne CLINICAL ward sDOne Institution (hospital)
2nMore than one 4DMore than one institution (hospital)
CLINICAL ward gQ (/„jg^ administrative control of principal investigator
eX3Not under administrative control of principal investigator
54-56
CLIN - lb
F.
RESEARCH
SETTING:
c. Describe, in detail, research settings which do not fit in the above categories:
57-60
SET - 1c
2. For outpatient studies - During the study the population will be admitted:
(Check all applicable)
a.
FROM- '*'-' ^"^ "'*■"'"* ^" ^_. SDOne SDCommunity mental health center
2D More than one ' 4DMore than one eDOther psychiatric clinic
catchment area ^QChjy ^^^^^^ „„t„
SDPsychiatric section (OPD) of a
general hospital
gDOffice of private practitioner
61-67
OUT - 2a
b. Describe, in detail, research settings which do not fit the above categories:
68-71
SET - 2b
MH-9-21
Rev. 1-73
PAGE 5
32
IV. PROTOCOL
DO NOT WRITE HERE
A. CLASS OF STUDY
COL.
CODE
1. Clinical Pharmacology: Phase I (Activity, toxicity, dose tolerance)
Early Phase II (Efficacy, dose range, small sample, non-blind)
-
1
2
3
4
5
6
17-18
CARD 04
2. Clinical Trial: Late Phase II (Blind, efficacy, comparative agent)
Phase III (Definitive efficacy trial, large sample size)
—
19
PHASE
3. Special Drug Study: (EEC, metabolism, dose response, etc.)
4. Special Non-Drug Focussed Study: (Demographic, methodological, etc.)
EXPERIMENTAL DESIGN
a. Drug alone or compared with another drug/s: Test Drug/s Only
01
TYPE-DES
Test vs. Placebo
02
Test vs. Comparison Drug
03
Test vs. Comparison vs. Placebo
04
05
b. Two ormore test conditions in the same drug: 2 or more Dose Levels
2 or more "Brands"
06
1. Type:
2 or more Dosage Forms
07
08
20-21
c. Drug in combination with or compared to Drug vs. Individual Psychotherapy
non-drug treatment : Dnig vs. Behavior Modification
09
Drug vs. Group Psychotherapy
10
d. Other type (Specify):
(Insert Number)
LENGTH TIME
OF PERIOD UNIT
22-24
DRY
a "nrying-oiit" period? Fl Yet If Yf, length yuttl he: Days
n No Weeks
1
2
TYPE-DRY
"Drying-out" period will employ: No Treatment
n 1
25
Placebo
n 2
b. Drug administration period will be:
Hours
1
2
RX-ADM
2. Duration:
Days
Weeks
3
26-28
Months
4
c. Post treatment (follow-up) period will be:
1
2
POST
Davs
Weeks
3
29-31
Months
4
None
D 000
Describe duration and drug sequences to be employed. Duration should apply to the first
sequence and will be adjusted for other sequences. Code drugs as follows:
17-18
CARD 05
Test Drug No. 1 = Tl Comparison Drug No. 1 = CI Placebo = PBO
Test Drug No. 2 = T2 Comparison Drug No. 2 = C2
Duration coded in: id Hours 2[I]Days 3O Weeks 40 Months
19
CROSSOVER
UNIT
TREATMENT
20-25
3. For
DURATION
SEQUENCE
No. 1
No. 2
No. 3
No
. 4
26-31
Designs
32-37
Only:
38-43
44-49
so-se
MH-0-21
Rev.
PAGE 6
33
C. DOSAGE ADMINISTRATION
DO NOT WRITE HERE
TEST DRUG
COMPARISON DRUG
PLACEBO
1
2
3
4
5
6
7
8
COL.
CODE
17-18
No. 1
Tablet
Capsule
"Spansule"
Liquid
I.V.
S.Q.
LM.
Depot
No. 2
No. 1
Tablet
Capsule
"Spansule"
Liquid
I.V.
S.Q.
LM.
Depot
No. 2
Tablet
Capsule
"Spansule"
Liquid
I.V.
S.Q.
I.M.
Depot
—
1
1
1
1
32-41
FORM
2
2
2
2
3
3
3
3
1. Form:
4
4
4
4
5
5
5
5
6
6
6
6
7
7
7
7
8
8
8
8
Other:
Other:
Other:
a. Fixed/unchanging — dosage fixed in protocol prior to study at a single level,
e.g., 5 mg/day for 10 days
D 1
42
SCHED
2. Dosage
b. Fixed/changing - dosage fixed in protocol prior to study with increasing or de-
creasing levels; e.g., 100 mg. for first week; 200 for second; 300 for third, etc.
02
Schedule:
c. Flexible - dosage changed according to needs of subject
03
d. Fixed/flexible - dosage fixed in protocol for earlier dosages with option to
"individualize" dosage according to needs of the subject later on
04
a. Record Dosage Schedules Below
If flexible dosage schedule, give initial and maximum dosage.
Enter TOTAL DAILY DOSE at each appropriate time period.
For combination drugs, use Test No. 1 for component A and Test No. 2 for component B.
T«t1
Test 2
Comp 1
Comp 2
CARD 06
CARD 07
CARD 08
CARD 09
DOSAGE LEVELS
3. Dosage
TEST DRUG
COMPARISON DRUG
Protocol:
No. 1
No. 2
No. 1
No. 2
Time
Period
Dosage
Time
Period
Dosage
Time
Period
Dosage
Time
Period
Dosage
PERIOD/
DOSE
1
19-24
i
25-30
31-36
37-42
43-48
49-54
55-60
61-66
b. Dosages are recorc
Other (Specify):_
Jed in: (Oieck appropriate unit for dosage) "^'^S
mg
gm
mg/kg
J 1
Zl 2
O 3
11 4
67
DOSE UNIT
c. Time
Other
periods are recorded in: (Check appropriate unit for time) Hours
Days
Weeks
Months
(Specifv):
O 1
02
O 3
04
68
TIME UNIT
MH-9-21
Rev. 1-73
PAGE 7
34
1
DO NOT WRITE HERE
D. CONTROL PROCEDURE
COL.
CODE
1.
Procedure will be: Nonblind □ 1
Double bUnd □ 2
17-18
CARD 10
19
BLIND
2.
Subjects will be assigned to treatment by: Strict Random Number
1
2
3
4
20
ASSIGN
Se<]uential Assignment
Matching
StratiTied-random
(Describe under "other")
Other:
3.
Will other conconnitant non-drug therapies be permitted for the research population?
1 — 1 Yes If Yes, which therapies? Individual Psychotherapy
1
2
3
4
5
21
CON-THER
f~l Nn Group Psychotherapy
Behavior Modification
Varied Psychological Therapies
Other Therapies
Specify Other:
4.
Will any other drug therapies be permitted? (Check all applicable)
22-23
ANCILL
No other drug therapies for any reason
1
2
3
4
5
6
Only remedial medications, i.e., medications for the amelioration of adverse reactions
Antiparkinson medication will be given prophylactically to all subjects
Medication/s for medical conditions prescribed for subject prior to study will be permitted
Non-study psychotropic medication may be administered in emergency (crisis) situation
No restriction of use of other drug therapies
Describe, in detail, other procedures which do not fit the above categories:
E. ASSESSMENT INSTRUMENTS
(Check all applicable instruments)
Others:
PDI
r-i
24
25
24
DEMO
1.
CPDI
25
Demographic:
Others:
CSH
r-n
26
27
28
26
DIAG
2.
CDC,
27
Diagnostic:
CDS
28
29-30
DEMO/
MH-9-21
Rev. 1-73
E. ASSESSMENT INSTRUMENTS (Continued) |
DO NOT WRITE HERE
Adult Behavioral Rating Scales
31 ncGi
32 Dbprs
33nNOSIE
34 nHAM Depression
35 Oh AM Anxiety
36 DwiTT
37 DPLUT
nthPTs-
38 QlMPS
39 nzUNG Depression
40 DSRSS
41 nsCL-90
42 DpOMS
43nBECK
44 DdRI
COL.
CODE
31
EFF-ADULT
32
33
34
35
36
37
38
39
3.
40
Efficacy:
41
42
43
44
45-*6
Children's Behavioral Rating Scales
47 nCGI
48 DCPRS
49 DcbI
Others:
50nPQ
51 DtQ
52 nPEBP
47
EFF-CHILD
48
49
50
51
52
53-54
55 DWAIS/WISC
56 DmAZE
57 DbENDER
58 DWRAT
Others:
59 nGOOD
eoDRT
61 nCFF
62 LJContinuous Performance
55
PSYCHO
4
56
Psychometric
and
57
58
59
60
61
62
63-64
5.
65 nDOTES 66 DtESS 67 DsTESS
Others:
65
ADVERSE
66
Reaction:
67
68-69
Hematology
19 Dngb
20 DhcI
21 DrBC
22nWBC
Other:
23 nDifferential
24 Dsed. Rate
25 nPlatelet
26 □prothrombin Time
17-18
CARD 11
19
HEMAT
20
21
22
23
24
25
6.
26
Laboratory
27-28
Tests:
Serum Chemistry
29 D Electrolytes
30 LJ Liver function tests
31 lJ Kidney function tests
Other:
32 CD Sugar Metabolism
33 D Blood fats
34 CD Thyroid function tests
29
SERUM
30
31
32
33
34
35-36
MH-9-21
Rev. 1-73
PAGE 9
36
Urine
nthcr-
37 n Sp.Gr.
SsDpH
39 LJ Albumin
40 n Sugar
41 □ Microscopic
42 O Electrolytes
DO NOT WRITE HERE
6
COL.
CODE
Laboratory
Tests
(Continued)
37
URINE
38
39
40
41
42
43-44
Tests on
nthRf
Other Biological Specimens
45 n Saliva 46 D Feces
47 D Cerebrospinal Fluid
45
BIOL '
46
47
48^9
7.
nthRr-
50 CJ Physical Examination
51 1 — 1 Neurological Examination
52 D PANESS
53 D EKG
54 D EEG
55 n SUt Lamp
50
MED
51
52
53
54
55
8.
56-57
Any
58-60
MISC
Other
Procedures:
How many different individuals (e.g., psychiatrists/psychologists)
will perform the major behavioral ratings? No.
Will "multiple raters" be used, i.e., 2 or more individuals performing simultaneous
or concurrent ratings of the same subject? (Check One)
No Do
YesDl
ASSESSMENT SCHEDULE
MH-9-21
Rev. 1-73
For Time Periods, check appropriate time units (days, weeks, etc.) and write in the assessmen
to be employed. In the four other columns, mark (X) in all rows where ratings will be made.
Circle the periods where drug treatment begins and ends. Designate initial (first) rating as "OC
t periods
".
. Ol
. 02
] Months
For adverse reaction only
a. If symptoms are to be rated only if and when they occur; check here
64
TIME
UNIT
b. If symptoms are to be rated at each dosage change; check here
c. If symptoms are to be rated on a fixed schedule, complete in manner described above.
65-70
INITIAL
PERIOD
Check whether time periods refer to: 1 D Hours 2 0 Days 3 0 Weeks 4C
17-18
CARD 12
TIME
PERIOD
MAJOR
BEHAVIORAL
SCALE
MAJOR
PSYCHOMETRIC/
PERFORMANCE
ADVERSE
REACTION
LABORATORY
TESTS
19-24
2nd
25-30
3rd
31-36
4th
37-42
5th
43^48
6th
49-54
7th
55-60
8th
61-64
BEGIN-END
65
37
H. TYPE OF DATA ANALYSIS
DO NOT WRITE HERE
COL. CODE
1. Pre (Middle) Post — one way analyses of rating periods
Di
ANALYSIS
2. Treatment (groups) Comparison — e.g., drugs x periods
D:
3. Factorial — more than 2 factors, e.g., drugs x periods x diagnosis
Describe factorial design:
03
4. Crossover — two or more treatments in same subjects
Da
5. Other:
REMARKS:
MH-9-21
Rev. 1-73
PAGE 11
38
SPECIFIC INSTRUCTIONS
II. DESCRIPTION OF DRUG/S EMPLOYED
The term "Test Drug" refers to the investigational drug;
while "Comparison Drug" refers to the control drug. As
used here, these terms are not necessarily synonymous to
the same ones used by FDA or other regulatory agencies.
Space limitations allow a maximum of. four drugs to be
encoded — two Test Drugs under A and two Comparison
Drugs under B of this section. In some instances, these
space limitations may force arbitrary assignment of drugs to
Test or Comparison categories; e.g., one test vs. three
control drugs. Space is provided to encode a PLACEBO in
addition to the maximum of four drugs.
The terms Test and Comparison may be used in various
ways; not only as test versus control drugs but also to de-
scribe any test versus control situation (different brands of
the same drug, different populations or age groups, high
versus low doses, liquid versus tablet, etc.). In such cases,
record the usual or standard medication as Comparison and
the new or unusual form as Test.
A. TEST DRUGS
la. Name — Give the generic name for the drug or, if
none yet exists, give the code number.
Single/Combination — "Single drug" means a drug
consisting of one compound. "Combination drug"
refers to two or more compounds given as a single
treatment, even if the components are not enclosed
within a single "capsule" or "tablet". The drug
Triavil, for example, is a combination of amitrip-
tyline (Elavil) plus perphenazine (Trilafon). To
record this drug, write in ONE space the generic
name of each component — amitriptyline and per-
phenazine. Do NOT record the two components
as Test Drug No. 1 and Test Drug No. 2.
b. Synonyms — Give only the more frequently used
synonyms, trade names and/or code numbers.
c. FDA — Answer on the basis of the drug's FDA
status for general use and for the use/indication
being tested in the study. Example - A drug ap-
proved for use in general adult populations is to be
tested for use in children. It is not approved for
such a population by the appropriate regulatory
agency. Check 2 - "Yes, approved for prescribing
or sale but not for the present indication or "use"
in this case.
3. Presumed Clinical Action — Two columns are pro-
vided for studies which involve two test drugs. In
these studies be sure to mark the action for each
drug in the correct column. For example, if thio-
thixene is Test Drug No. 1 and imipramine is Test
Drug No. 2, check "neuroleptic" in column No. 1
and "anti-depressant" in column No. 2. When
Combination drugs are present, mark the action of
each component of the combination in the column.
For example, if the combination drug, Triavil (ami-
triptyline -H perphenazine) is Test Drug No. 1
check both "anti-depressant" and "neuroleptic" in
column 1.
MH-9-21 INSTRUCTIONS
Rev. 1-73
New Uses For Established Drugs - To be com-
pleted when a drug has an established psychotropic
action, e.g., neuroleptic; and is being studied for
some other presumed action, e.g., anti-depressant;
or when a non-psychotropic drug, e.g., an analgesic
is tested for psychotropic action, e.g., anxiolytic.
5. Chemical Classes — The classification is based on
that of Usdin and Efron in their book "Psychotro-
pic Drugs and Related Compounds". From the
code numbers (101—506) choose the lowest num-
ber which is applicable to your Test Drug. If the
drug, for instance, is both a heterocycle (307) and
a carbamate (502), check only (307). For those
drugs where chemical class is as yet unknown
check (999). For studies involving 2 Test Drugs
and/or Combination drugs, follow the procedure
described under A3, "Presumed Clinical Action".
III. POPULATION
C. PRINCIPAL DIAGNOSTIC CATEGORIES
Complete either subsection 1 - Adult or 2 - Chil-
dren. You may record a maximum of four
categories. If the population is so heterogeneous
that four of the categories can not account for the
bulk of the sample, check "Varied Psychiatric Dis-
orders". World Health Organization (WHO)
diagnostic entities may be recorded under "Other
Categories" if the investigator chooses.
D. BASIS FOR DIAGNOSIS
Psychiatric Case Record - refers to use of diagnosis
contained in the subject's case (hospital) record as
the determinant.
Investigator's Clinical Judgment - refers to the
determination of diagnosis by the principal inves-
tigator or member of the research team.
Independent Clinical Judgment - indicates deter-
mination by an individual not directly involved in
the study, e.g., a consultant - not a member of the
research team - whose function is to ascertain or
verify the appropriateness of the diagnosis.
Clinical Target Symptoms - refers to the clinical
judgment of the presence or absence of specific
synptoms or characteristics;
Psychometric Scores - refers to determination by
the use of specific score/s on a psychometric assess-
ment instrument/s; e.g., subjects rated below a
specified severity (score) on a scale are ineligible
(cutoff) for acceptance into the study sample.
F. RESEARCH SETTING
Research ward refers to a unit specifically organ-
ized for research purposes. Residents on a research
ward are selected primarily on the basis of research
requirements.
IV. PROTOCOL
A. CLASS OF STUDY
Check ONE of the six alternatives
39
B. EXPERIMENTAL DESIGN
C. DOSAGE ADMINISTRATION
Type - Check ONE of the ten alternatives listed
under a, b, and c or write in a more appropriate
description under d.
Type of Drying-out — If a Placebo is used only during
drying-out period and the design is not conceptualized
as a crossover, DO NOT designate the study as Test
versus Placebo.
Duration — For each of the subheadings a, b and c,
insert numerals on the line before the appropriate
time unit to indicate the length of the period. For
example, an investigator plans to have a 2-week, no
treatment drying-out period followed by 6 weeks of
drug administration and no follow-up, Item 2a, 2b
and 2c would be completed as follows;
M Yes
D No
Drying-out period will employ
a. Drying-out period?
Days
JL Weeks ,
No Treatment W
Placebo D
b. Drug administration period M/ill be:
Hours
Days
O Weeks
Form — Check ONE of the dosage forms for each
group in the study. For example, in a study con-
sisting of 2 drug groups - Test and Comparison -
in which both groups receive their medication in
tablet form, check "tablet" under both Test and
Comparison columns. "Spansule" refers to a sus-
tained release form. Depot refers to a drug contained
in a vehicle for I.M. injection which allows for slow
release and long action.
Dosage Schedule — Dose ranges rather than specific
doses are often fixed in the protocol prior to the
study and should be coded according to level; e.g.,
3 to 7 mg/day for 10 days would be coded as
Fixed/unchanging; 75 to 125 mg/day for the first
week, 172-225 mg/day for the second week, etc.
would be coded as Fixed/changing.
Dosage Protocol
Example / — Test and comparison drugs with a Fixed/
changing schedule. The total daily dose for the test
drug will be 50 mg. for 1 week; 100 mg. for 1 week;
200 mg. for 1 week, etc. For the comparison drug,
the total daily dose will be: 25 mg. for 1 week, 50
mg. for 1 week, 75 mg. for 1 week, etc.
Code as follows:
c. Post treatment (follow-up)
period will be:
.Hours
-Days
-Weeks
-Months
None
^
Crossover — Example: In a study involving a test drug,
(T1) comparison drug (CI) and placebo (PBO), the
investigator plans to vary the order in which the treat-
ments are given. He plans to administer each of the
drugs for 4 weeks and the placebo for 2 weeks. One
half of the research sample will be placed on one
sequence or the other. Coding is as follows:
Duration is recorded in:
DDays
gweeks DMonths
TREATMENT |
Duration*
Sequence No. 1
Sequence No. 2
2
PBO
CI
4
T1
PBO
2
PBO
T1
4
CI
PBO
•Duration applies to Sequence No. 1. It is assumed that the
durations for Sequence No. 2 would be shifted along with the
treatments, e.g., 4, 2, 4, 2.
A Latin square design involving Test Drug No. 1, (T1), Comparison
Drug No. 1 (CD, Comparison Drug No. 2 (C2) and Placebo (PBO)
would be completed as follows:
MH-9-21
Rev. 1-73
Treatment
Duration
Treatment Sequences |
1
2
3
4
2
T1
CI
C2
PBO
2
CI
C2
PBO
T1
2
C2
PBO
T1
CI
2
PBO
T1
CI
C2
PAGE 13
40
Time
Period
Test
Drug
No. 1
Time
Period
Comparison
Drug
No. 1
1
50
1
25
1
100
1
50
1
200
1
75
b. Dosages are recorded in:
llVmg 2D meg
c. Time periods are recorded in:
1 DHours 20 Days
3Dgm 4Dmg/kg
sEWeeks 4nMonths
Example 2 — Test and comparison drugs with a flex-
ible schedule. Over a 4 week period a range of 10—
100 mg. of test drug is to be administered; 100-500
mg. for the comparison drug.
Code as follows:
Time
Period
Test
Drug
No. 1
Time
Period
Comparison
Drug
No. 1
4
10-100
4
100-500
(Units of dosage and time omitted for brevity)
Example 3 — Combination test drug and 2 compari-
son drugs with a Fixed/changing schedule. Component
A of combination is coded under Test No. 1 and
Component B under Test No. 2. Dosage is changed
as indicated.
Time
Period
Test
Drug
No. 1
Time
Period
Test
Drug
No. 2
Time
Period
Com-
parison
Drug
No. 1
Time
Period
Com-
parison
Drug
No. 2
1
50
1
5
1
50
1
5
2
100
2
10
2
100
2
10
2
150
2
15
2
150
2
15
3. Dosage Protocol (Continued)
Example 4 — Test drug in depot form and comparison
drug in tablet form. Depot form (200 mg) is pre-
sumed to be effective for 4 weeks. Initial dose of
comparison drug is 50 mg and it increased 50 mg each
week to maximum of 200 mg.
Time
Period
Test
Drug
No. 1
Time
Period
Comparison
Drug
No. 1
4
200
1
50
1
100
1
150
1
200
Example 5 — Test and comparison drug with a fixed/
flexible schedule. Dosages for both test and compari-
drugs are raised 100 mg each week for first 3 weeks of
6— week study. Dosages can then be "individualized"
according to needs of subject. (Write in "open" to
indicate "individualizing").
Time
Period
Test
Drug
No. 1
Time
Period
Comparison
Drug
No. 1
1
100
1
100
1
200
1
200
1
300
1
300
3
Open
3
Open
D. CONTROL PROCEDURE
1. Blindness — Single blind studies should be checked
Nonblind.
2. Treatment Assignment —Strict random number refers
to the use of a table of random numbers for assign-
ment of subjects.
Matching refers to any attempt at specific matching
of individuals. Sequential assignment refers to select-
tion and/or assignment by order or sequence, i.e.,
alternating treatments to subjects as they are ad-
mitted; choosing every nth subject, etc. Stratified
random — a variant of "matching" in which groups
rather than individuals are selected on basis of a set of
characteristics, e.g., sex, age, etc.
3. Concomitant Therapies — Refers to therapies which
may be given to patients as part of their treatment
but which are not a part of the research design.
G. ASSESSMENT SCHEDULE
Example 1 ■ Using the BPRS as his major behavioral
rating scale, an investigator plans to make an assess-
ment at pre-treatment, 2, 4, 6 and 8 weeks. Drug
treatment will begin immediately following the initial
rating and cease following the final rating. Ratings of
adverse reactions and laboratory tests will be made at
pre-treatment, 4 and 8 weeks. No psychometric/per-
formance scales will be employed.
Time
Period
Major
Behavioral
Scale
Major
Psychometric
Performance
Adverse
Reaction
Basic
Laboratory
®
X
X
X
02
X
04
X
X
X
06
X
(g)
X
X
X
Example 2 — On the major behavioral rating scale, the
investigator plans to make assessments at the begin-
ning and end of a 2 week drying-out period; the 1st,
3rd and 5th weeks of drug administration and 2 weeks
after cessation of treatment. (Psychometric/perform-
ance tests, adverse reaction and laboratory tests are to
be rated as marked).
Code as follows;
NOTE THAT THE TIME PERIODS ARE NUMBERED IN
SEQUENCE REGARDLESS OF INITIATION/CESSATION
OF DRUG ADMINISTRATION.
Time
Period
Major
Behavioral
Scale
Major
Psychometric
Performance
Adverse
Reaction
Basic
Laboratory
00
X
X
©
X
X
X
X
03
X
X
05
X
X
©
X
X
X
X
09
X
X
MH-9-21
Rev. 1-73
PAGE 14
41
GLOSSARY OF ASSESSMENT INSTRUMENTS
1.
Demographic:
PDI
Patient Data Inventory
CPDI
Children's Patient Data Inventory
CDS
Children's Diagnostic Scale
2.
Diagnostic:
CDC
CSH
Children's Diagnostic Classification
Children's Symptom History
Adult Behavioral Rating Scales
Children's Behavioral Rating Scales
CGI
Clinical Global Impressions
CGI
Clinical Global Impressions
BPRS
Brief Psychiatric Rating Scale
CPRS
Children's Psychiatric Rating Scale
NOSIE
Nurses' Observation Scale for
CBI
Children's Behavior Inventory
Inpatient Evaluation
PQ
Parents' Questionnaire
HAM Depression Hamilton Depression Scale
TO
Teacher's Questionnaire
HAM Anxiety
Hamilton Anxiety Scale
PEBP
Psychological Examination Behavior Profile
WITT
Wittenborn Psychiatric Rating Scale
3.
Efficacy:
PLUT
IMPS
ZUNG
SRSS
SCL-90
POMS
BECK
DRI
Plutchik Geriatric Rating Scale
Inpatient Multidimensional
Psychiatric Scale
Zung Self-Rating Depression Scale
Self-Rating Symptom Scale
Symptom Check List
Profile of Mood States
Beck Depression Inventory
Discharge Readiness Inventory
WAIS
Wechsler Adult Intelligence Scale
4.
Psychometric
Wise
Wechsler Intelligence Scale for Children
and
MAZE
Porteus Mazes
Performance
BENDER
Bender Gestalt Test
Tests:
WRAT
GOOD
RT
CFF
Wide Range Achievement Test
Goodenougfi-Harris Draw-A-Man Test
Reaction Time
Critical Flicker Fusion
5.
Adverse
DOTES
Dosage Record and Treatment Emergent Symptoms
Reaction:
TESS
Treatment Emergent Symptom Scale
STESS
Self-Rating Treatment Emergent Symptom Scale
Hgb
Hemoglobin
6.
Laboratory
Hot
Hematocrit
Tests:
RBC
WBC
Sp. Gr.
Red Blood Count
White Blood Count
Specific Gravity
PAN ESS
Physical and Neurological Examination for Soft Signs
7.
Medical:
EKG
EEG
Electrocardiogram
E lectroencephalogram
MH-9-21
Rev. 1-73
k2
Developed within the ECDEU program, the Research Plan Report (RPR) is a
43- item, self-contained scale for the recording of research procedures. The
RPR is not formatted for optical scanning. It is, in essence, a summary proto-
col in which the purposes of the study are recorded, the size and nature of the
population delineated, the investigational and comparative agents described, the
duration and dosage set forth, the experimental conditions to be observed and the
assessment procedures recorded. The value of the instrument extends beyond its
usefulness for describing the design of a given study. As a data file, it can
serve to describe the current status of research activities among a large group
of investigators as well as provide an historical record of past activities. At
this writing, data on over 1000 research protocols are on file.
APPLICABILITY - For all research populations
UTILIZATION - Once per study. Completed prior to the initiation of the study.
SPECIAL INSTRUCTIONS
The investigator should be familiar with the instructions printed on the form
itself as well as those contained below. Since no one form or the items contained
therein can possibly cover all eventualities, investigators are asked to include a
copy of their research protocol along with the RPR. An extensive coding system has
been developed for the RPR which contains many more categories for each item than
those printed on the RPR itself. With the investigator's personal protocol at hand,
it has been possible to categorize almost all research procedures within the general
framework of the RPR.
Use of the RPR - Investigators may - and indeed are encouraged to - submit RPR's
for their studies whether or not they intend to use ECDEU assessment instruments or
Biometric Laboratory processing services.
Unit and Study Numbers - These numbers are assigned by the Biometric Laboratory.
When an RPR is received, a notice will be sent to the investigator acknowledging
receipt and will give the unit and study number assigned to that RPR. This 6-digit
identification number should be referred to in all subsequent correspondence regard-
ing that particular study so that misinterpretations can be minimized.
RPR Revision or Modification - If the investigator makes substantive changes
in his study, a new RPR should be submitted. The original RPR can thus be "updated"
in the ECDEU data bank.
Confidentiality - Investigators may request that all or part of the information
on an RPR be held confidential. For many reasons, new chemical formulae may need to
be confidential and data pertaining to this area can be withheld while disseminating
the other RPR information to the scientific community.
ECDEU Forms - Indicates that ECDEU forms will be employed either wholly or in part.
^3
II. Drug/s Employed - This section focuses on a description of the agents or
conditions to be studied. "Test drug" can refer to ANY TEST CONDITION;
"Comparison drug" to ANY COMPARISON CONDITION. Examples:
a. An atypical dosage of Drug A (test condition) vs. a typical dosage
of Drug A (comparison condition) using the same drug in both
instances.
b. "Brand X" (Test) vs. "Standard Brand" (Comparison).
c. Drug A given once a day (Test) vs. Drug A given 3 X a day (Comparison).
d. Drug A given in "depot" form (Test) vs. Drug A given in tablet form
(Comparison) .
e. Drug A given with a smile (Test) vs. Drug A given without a smile
(Comparison) .
f. Withdrawal of Drug A with PBO substitution (Test) vs. Withdrawal of
Drug A without PBO (Comparison).
Space limitations allow recording of 2 "Tests", 2 "Comparisons" and a placebo.
Which drugs or conditions are designated as "Test" or "Comparison" is left to
the investigator and this decision may often be an arbitrary one.
Combination Drugs - This phrase seems to cause confusion. The intent here is
to describe the condition in which 2 or more drugs are given simultaneously as
ONE treatment; i.e., the investigator presumes that the combination has a
different effect than either of the components used singly. Combination treat-
ments may also consist of drug and non-drug Components; e.g., Drug and ECT,
Drug and Psychotherapy, Drug and Conditioning, etc.
Manufacturer - Should be interpreted as the SUPPLIER of the drug/s employed in
the study. The supplier is not necessarily the actual manufacturer of the drug/s.
I I, A, 3. Presumed Clinical Action/s - The categories contained in this section
are based on the classification, developed by the International Reference Center
for information on Psychotropic Drugs. Table 3 describes this classification in
detail .
I I, A, 5. Chemical Class - Investigators may leave this section blank if they are
uncertain of the classification of a drug. With very new drugs, a drawing of the
chemical structure is most helpful in arriving at correct classification. When
classifying a combination drug, check a class for each component - both in the
appropriate column.
kk
TABLE 3
PSYCHOTROPIC DRUG CLASSIFICATION - INTERNATIONAL REFERENCE CENTER NETWORK
DRUG GROUPS
SYNONYMS
WORKING DEFINITION
SUB-GROUPS EXAMPLES
NEUROLEPTICS:
Major Tranquilizers
Neuroplegics
Psychoplegics
Psycholeptics
Antipsychotics
Non-hypnotic drugs
with antipsychotic
effects
Phenothiazine Derivatives .... Chlorpromazine
Thioridazine
Fluphenazine
Benzoquinolizine Derivatives . . . Tetrabenazine
Thioxanthene Derivatives .... Chlorprothixene
Butyrophenone Derivatives . . . Haloperidol
■^auwolfia Alkaloids Reserpine
Other:
ANXIOLYTICS:
Antianxiety Drugs
Minor Tranquilizers
Sedatives
Non-hypnotic drugs
with antianxiety
effects but without
antipsychotic effects
Benzdiazepine Derivatives .... Chlordiazepoxide
Oxazepam
Glycol Derivatives Meprobamate
Phenaglycodol
Carbinols Phenprobamate
Diphenylmethane Derivatives . . . Methaqualone
Hydroxine
Barbiturates Phenobarbital
Amobarbital
Other:
ANTI-
DEPRESSANTS:
Thymoleptics
Thymoanaleptics
Psychoanaleptics
Psychic Energizers
Drugs which elevate
mood and relieve
depression
MAO-lnhibitors Isocarboxazid
Nialamide
Phenelzine
Tranylcypromine
Desipramine
Amitriptyline
Protriptyline
Other:
STIMULANTS:
Psychoanaleptics
Psychotonics
Analeptics
Psychomotor Stim-
ulants
Drugs which accelerate
psychomotor function
and activity and improve
performance under
conditions of fatigue
^henylethylamine Derivatives. . . Amphetamine
Methamphetamine
Other: Phenmetrazine
Methylphenidate
Pipradol
PSYCHO-
TOMIMETICS:
Psycholytics
Psychodysleptics
Hallucinogenics
Psychedelics
Eidetics
Drugs producing
alteration in conscious-
ness, characterized by
perceptual and
emotional changes with-
out disorientation
Phenylethylamine Derivatives . . . Mescaline
Indole-alkaloids LSD
Psilocybin
Tryptamine Deriva-
tives
'iperidine Derivatives Ditran
Phencyclldine
Other:
HYPNOTICS:
Soporifics
Somnifacients
Psycholeptics with
sleep-inducing and
sleep-sustaining
effects
Sarbiturates Secobarbital
Pentobarbital
Mon-Barbiturates Glutethimide
Ethchlorvynol
Ethinamate
Other:
45
Example 1 - Test Drug No, 1 Is a combination of ami tr Iptyl Ine (Class -
Phenothiaz i ne analogue and isosteres) and perphenazine (Class -
Pbenothiaz ines) . This combination of drugs will be administered
as a single test condition. Code by checking both 101 and 102
under the column "Test Drug No. 1".
5. Chemical Class/es (If known)
TEST
DRUG
NO. 1
TEST
DRUG
NO. 2
CHEMICAL CLASSES
DK
NO.
X
101
Phenothiazines
Phenothiazine analogues & isosteres
X
102
201
Lyserc'' -ivatives
Example 2 - Test Drug No. 1 is a single drug, ami tr iptyl Ine, and Test Drug
No. 2 Is a single drug, perphenazine. Each Is to be administered
to one of two Independent groups. Code Test Drug No. 1 in its
appropriate column; Te^t Drug No. 2 in its appropriate column.
5. Chemical Class/es (If known)
TEST
DRUG
NO. 1
TEST
DRUG
NO. 2
CHEMICAL CLASSES
TF
D
r
101
X
Phenothiazines
X
102
Phenothiazine analogues & isosteres
-•"• acid derivatives
ll,B. Comparison Drug/s - Refers to any control or standard condition against
which the test condition is to be compared. A frequent misinterpretation in
completing the RPR occurs in studies where 2 drugs (conditions) are employed
and, although the investigator is actually going to compare these conditions,
he encodes both of them as "Test Drugs". For uniformity in the Data Bank,
categorizing one drug as "Test" and one as "Comparison" Is preferred - even
though this may be arbitrary from the investigator's point of view.
III,A,1. Total Number of Subjects In Study - Give an estimate of the sample
size you plan to achieve, even though it may be a tentative one.
II1,C. Principal Diagnostic Categories - Up to 4 categories of diagnoses have
been allotted In the coding system. Populations which exceed this limitation
should be coded "Varied Psychiatric Disorders". The spaces labeled "Other
Categories" may be used to record any additional diagnoses or to record the
World Health Organization (WHO) diagnoses.
III,D. Basis for Diagnosis -When the response "Psychometric (Cut-Off) Score/s"
is checked, specify the nature of the "cutoff score".
Examples :
BPRS Total Score of 30 or more
Hamilton Anxiety Scale Total Score of 25 or more
BPRS Thought Disorder Factor Score of k or more
46
III.F. Research Setting - For Items F,l,a and F,i,b, 3 MARKS are required,
Exampl e:
The population will reside on one clinical ward in one hospital.
The ward is not under the investigator's administrative control.
....isuative contiol of principu. .
b.
I^fcne CLINICAL ward S^One Institution (hospital)
CLINICAL ward
4nMore than one institution (hospital)
50Under administrative control of principal investigator
^fSiVol under administrative control of principal investigator
c. Describe, in detail, research settings which h^
For mixed inpat ient/outpatient studies, fill in both sections of this item. The
distinction between a research and clinical ward may be confusing. A clinical
ward is one organized for treatment purposes. Patients residing on such a ward
may be selected as research subjects but the ward itself is not organized as a
research ward. Catchment area refers to a geographical subdivision of a larger
area (metropolitan area, ward, city, county, state, province, etc.) from which a
given agency receives its clients.
IV,B,2a. "Drying-out" period - In addition to checking the presence and length
of a drying-out period, the investigator should indicate whether "no treatment"
or PBO will be employed during this period. Should some other condition be main-
tained during the drying-out period, describe the nature of the condition.
IV,B,2c. Posttreatment (follow-up) period - Refers to the period immediately
following the cessation of drug administration and during which assessment procedures
will be conducted.
IV, C, 2. Dosage Schedule - A single dose ("one-shot") would be coded as "Fixed-
unchanging". When recording "Dosage Protocol" for a single dbse, give the time
period over which the dose is presumed effective and the amount of the dose. Single
dose is coded the same way as "Depot" although its length of action may be
considerably shorter.
E. Assessment instruments - When recording assessment instruments not printed on
the RPR, give the FULL NAME of the instrument since there can be confusion in the
interpretation of initials or partial titles. This is particularly important in
describing laboratory tests or medical procedures. Citation of instruments here
does NOT constitute an order for supplies. To obtain supplies, use the ECDEU Order
Form (07^-EOF). (See pp. 50-52).
IV, F Raters - Question 1 refers to the number of individuals performing the major
behavioral ratings; e.g., the Children's Psychiatric Rating Scale and Clinical Global
Impressions are selected by the Investigator as his major instruments and he and 2
other colleagues will perform all of these ratings; enter "3" for the item.
^7
DOCUMENTATION
Documentation for the RPR is both study-specific and general. For the
study itself, the RPR provides the information for the "Description" paragraph
contained in the Narrative Summary which accompanies each standard data analyses
package and in the PRB Information Reporting and Retrieval System. For general
documentation, the focus is on some selected subset of RPR's or RPR items con-
tained in the ECDEU data bank, e.g., all studies reported in a given period of
time; all Phase II studies; all double blind studies involving a given drug, etc,
For the investigator, the PRB Information Reporting and Retrieval System is the
primary source of general documentation of RPR information. A full description
of this system and its use may be found in ECDEU Intercom, January, 1973i
Vol. 2, No. 6. An offset of this Intercom issue may be obtained by writing to
Program Head, ECDEU, Psychopharmacology Research Branch, NIMH, Room 9-101,
5600 Fishers' Lane, Rockville, Maryland, 20852.
48
074 EOF
ECDEU
ORDER
FORM
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
PUBLIC HEALTH SERVICE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
FOR BIOMETRIC LABORATORY USE
UNIT. NO.
ECDEU ORDER FORM (EOF)
RECEIVED
SENT
INSTRUCTIONS: Please use ECDEU Order Form (EOF) when requesting supplies. Be sure to give COMPLETE mailing
address. See reverse side for description of scales contained within packets. A Research Plan Report
(21 - RPR) MUST be completed describing the study for which supplies are requested.
Has an RPR been completed? □ Yes ■ attached
□ Yes - previously sent ECDEU Study No.
MAIL TO: Biometric Laboratory
ECDEU Data Analysis
The George Washington University
11501 Huff Court
Kensington, Maryland 20795
NAME OF PRINCIPAL INVESTIGATOR
TO BE SENT TO: (Complete only if supplies to be sent to person
other than principal investigator or to different address)
SUPPLIES
REQUESTED
INSTITUTION/AGENCY
NAME
BY:
Number and Street
Number and Street
City, State, Zip Code
City, State, Zip Code
Form
No.
ITEM
No.
Requested
No.
Sent
Form
No.
ITEM
No.
Requested
No.
Sent
807
Assessment Manual
38
STESS
Self Rating Treatment
Emergent Symptom Scale
801
Blue
Demographic Packet
41
PANESS
Physical and Neurological
Examination for Soft Signs
802
Green
Psychiatrist Packet - Child
46
PMR
Prior Medication Record
b03
Gold
Psychiatrist Packet - Adult
50
GSS
General Scoring Sheet
804
Orange
Nurse Packet
53
SCL-90
Symptom Checklist - 90
805
White
Psychologist Packet
54
SAS
Self Rating Anxiety Scale
806
Red
Social Adjustment Packet
55
LAB
Laboratory Data
21
RPR
Research Plan Report
59
RCR
Research Completion Report
33
TWIS
Treatment Emergent Symptoms
Write-in Scale
71
DS
Data Shipment
35
TO
Teacher Questionnaire
73
SDS
Self Rating Depression Scale
36
PQ
Parent Questionnaire
74
EOF
ECDEU Order Form
37
PTQ
Parent-Teacher Questionnaire
117
AIMS
Abnormal Involuntary
Movement Scale
MH-9-74
Rev. 2-75
50
NOTES ON FORMS
A full description of the ECDEU forms and their usage as well as the BLIPS processing system is given In
the Assessment Manual. PACKETS refer to reusable, semipermanent binders which contain sets of scales
organized by professional discipline and/or specific population. A separate answer sheet — General Scoring
Sheet — must be used in conjunction with the packets. In requesting packets, base your needs on the num-
ber of raters — NOT the number of subjects. Keep in mind that packets are reusable and need not be
ordered anew for each study.
The contents of the packets are:
Demographic Packet (Blue)
43 CPDI Children's Personal Data Inventory
44 CSH Children's Symptom History
45 APDI Adult Personal Data Inventory
Psychiatrist Packet - Child (Green)
27 CPRS Children's Psychiatric Rating Scale
28 CGI Clinical Global Impressions
29 DOTES Dosage Record and Treatment Emergent Symptoms
30 CDS Children's Diagnostic Scale
31 CDC Children's Diagnostic Classification
32 PTR Patient Termination Record
Psychiatrist Packet - Adult (Gold)
47 BPRS Brief Psychiatric Rating Scale
72 DSI Depression Status Inventory
49 HAMD Hamilton Depression Scale
48 HAMA Hamilton Anxiety Scale
51 ASI Anxiety Status Inventory
52 WITT Wittenborn Psychiatric Rating Scale
28 CGI Clinical Global Impressions
29 DOTES Dosage Record and Treatment
Emergent Symptoms
32 PTR Patient Termination Record
Nurse Packet (Orange)
34
CBI
39
NOSIE
40
PLUT
42
NGI
Children's Behavior Inventory
Nurse's Observation Scale for Inpatient
Observation
Plutchik Geriatric Rating Scale
Nurse's Global Impressions
Psychologist Packet (White)
Children
60 Wise Wechsler Intelligence Scale for Children
62 WRAT Wide Range Achievement Test
61 MAZE Porteus Mazes
63 GOOD Goodenough— Harris Figure Drawing Test
64 BENDK Bender Gestalt Test - Koppitz Scoring
66 PEBP Psychological Examination Behavior Profile
Adult
67 WAIS Wechsler Adult Intelligence Scale
61 MAZE Porteus Mazes
68 BENDP Bender Gestalt Test - Pascal-Suttell Scoring
69 WMEM Wechsler Memory Scale
70 FTBS Friedhoff Task Behavior Scale
Social Adjustment Packet (Red) — In preparation, probable contents:
58
57
DRI
SADJ
Discharge Readiness Inventory
Social Adjustment Scale
MH 9-
21 RPR Research Plan Report Describes the clinical study. Af/4/VD/4 TO/?/ for all investigations
33 TWIS Treatment Emergent Symptoms -
Write-in Scale Necessary for recording side effects not printed on the Dosage Record
and Treatment Emergent Symptoms
37 PTQ Parent-Teacher Questionnaire . . Contains the ten items common to both the Teacher and Parent
Questionnaires and usually employed in conjunction with them for
repeated assessments
50 GSS General Scoring Sheet Necessary answer sheet for all packets. Also employed for the encoding
of non-standard data
59 RCR Research Completion Report . . . Describe the investigator's conclusions of his study. Completed after
data analysis
71 DS Data Shipment Supplies necessary information for BLIPS processing. MANDATORY
for all data submissions to the Biometric Laboratory
54 SAS Self -Rating Anxiety Scale and
73 SDS Self-Rating Depression Scale . . . Subject-rated versions of the clinician-rated Anxiety Status Inventory
and Depression Status Inventory
117 AIMS Abnormal Involuntary Movement
Scale . Examination procedures and rating scale for dyskinetic movements
MH 9-74 (Back)
Rev. 2-75 C ]
The ECDEU Order Form (EOF) is an administrative form for the distribution
of ECDEU assessment material. It supersedes ECDEU Order Form (101-EOF).
UTILIZATION - Whenever supplies are requested from ECDEU Data Analyses of the
Biometric Laboratory.
SPECIAL INSTRUCTIONS
1. Materials will be sent only upon receipt of a completed Research Plan
Report, describing the study for which the supplies are requested. If additional
supplies are needed for a study for which an RPR was previously submitted, be
sure to include the assigned ECDEU Study Number.
2. Investigators are strongly urged to use the EOF when requesting supplies.
Orders given by telephone or contained within letters primarily related to other
matters are too easily misplaced - resulting in angry investigators and frustrated
BLIPS bookkeepers. Emergencies do arise, however, and, under these circumstances,
telephone orders will be accepted.
3. Investigators should restrict the quantity of supplies requested to that
required for immediate use. "Stockpiling" of supplies is discouraged. It is
suggested that investigators request only those supplies necessary to fulfill the
assessment needs of the study or studies "ready to go" in the immediate future.
k. The new packets are expensive to produce and investigators should under-
stand that they cannot be distributed with the largess'we might wish. Since they
are sem i -permanent , packets should be serviceable for use in several studies or by
several raters. Replacement of unserviceable packets will be made at reasonable
intervals .
5. Since facsimiles of the Battery are contained within this Manual, copies
of the Manual rather than the actual packets and instruments should be requested
for training and educational purposes.
6.' This form may be duplicated when originals are not available.
DOCUMENTATION
Documentation for the EOF is basically an "inhouse" bookkeeping operation.
52
050 GSS
GENERAL
SCORING
SHEET
The General Scoring Sheet (GSS) is the basic ECDEU form for the encoding
of data in op-scan format. It is the IBM Optical Scan Form No. 551 upon which
the ECDEU identification block has been imprinted. The GSS replaces the
General Purpose Scale (00-GP) .
APPLICABILITY - All research populations and all types of numeric data.
UTILIZATION - The GSS may be used in 2 ways :
1. In conjunction with the various packets
2. As a means for encoding non-standard data
for BLIPS processing.
DATA FIELD FORMAT - The data matrix of the GSS (Figure 2) is bounded by the
coord i nates :
Rows (Horizontal) 1 - 41
Columns (Vertical) 1 - 20
There are 820 response positions within this matrix. Not all 820 positions can
be encoded at any single time, however. Note that there are four "quadrants"
of response positions: Cols. 1 - 5; 6 - 10; 11-15 and 16 - 20. On any given
row within a "quadrant", any 3 of the 5 response positions can legally be marked
at the same time.
Examples:
1 -^
•ate
•^^
-Sz--
"*:
2-to
-^
-ii
.».
:;*:
3«te
-i-
::2:r
;i3:r
•ta
Amam
irjir
.^
.».
==*=
5-*.
i=3=:
^.
-tr
m^
6-to.
..i..
:=£=
-^
^i
7 --A--
-te
-te
-fc.
-.--Apz
9-zft--
«i-
-»>
:*:
-«.
9 =-et=
•te
;=2:r
1^
-te
10=*.
-.-.Uz
^m
^.
1
Thus, a maximum of 492 response positions can be utilized - legally - at any
given time.
Four matrix coordinates are required to locate any data set:
Rows R. to R
I n
Columns C. to C
I n
5h
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU
GENERAL SCORING
SHEET [50-GSS)
^^
MTI»1T INITIALS
NUMBER
MALES OOWO 4^9 NUMBER FEMALES 50C
TO
998
—
:«:: :*::
:■»■■- :V::
:!*:
:»:
:*:
:«::
:«::
:«::
RRST
:*:
INITIAL
i:Y::
:f::
:*::
:J::
:«::
:*:
:*t:
:«::
F
:-J::
IGURE
:*:
2.*.
:*:
::l:: :2::
::l:: .2zz
::1:: :2::
:3:: :*-: :i:
PATIENT
:3:: :3»:: :i:
li: :*: :i:
:*:
:A:
:*:
::7::
::7::
::7::
::&:
::a:
::&:
::ft:
::a:
::»:
—
b*
€::
:*:
:«::
:*::
:«::
:»:
::(::
::J::
:*:
::t:: :«::
J:: :*:
*:
::&:
::7::
::ft:
::a:
—
r? :t::
:«*:
:»:
:«::
:«::
IhllTIAL
:*::
:i::
:*:
:*:
:3::
::T::
~~I0 EHLir.i-\.Miiur4 . Dio«^ih~
::6:
::7t:
::&:
—
:«:: :V::
:*:
:*:
:*:
::l:: :«:: :3:: :*:
PERIOD
::(:: :«:: :3: :=»::
Hours , Days
:*:
:*:
Weeks
:3::
:*:
:*:
::7i:
::7^:
Months
::*:
::&:
::e:
::»:
::S:
—
:«:: ::»:;
:*: ::»::
:*:
:*:
:3::
:i-:
■■"*= SHEET
:*: NO.
:i:
:i:
:*:
:*:
::7i:
::7::
::»:
::&:
::»:
::9:
—
■mT 1:0:: ::)::
:*::
:*:
:*:
:*:
:*:
::7^:
:*:
;*: Row 1:0::
2z :3:: A-z j ^p5::
:*:
::7::
:*:
:A:
-"
2:*: ::t::
■2".
:*:
:4::
:*:
:*:
::7^:
::»:
:*: 2:0::
::t:
:2:: :3:: -A-z
:5::
::&:
::7::
::&:
:A:
""
rr*: ::.::
2.:
li:
::*:
:*
::6::
z.T-Z
•
O W 3 G
I
2 :3:: :*:
::5::
:*:
::7::
:*:
i:^
__^
4:*: ::!::
.2".
:3::
Az.
:*:
:-*:
z.r-z
:*:
:*: 4:C::
:;t:
2:: :3:: ::«:;
:5::
:*:
::7::
::a:
::*:
^_
5:©:: ::(::
ii::
:i:
:*:
:*:
:*:
z.r-z
::»:
::»: 5:S::
:;t::
:2:: :*: :*:
:*:
:*:
::7::
::&:
::a:
__
t:*: ::!::
:*:
:*:
::*:
:*:
:*:
::7;:
:*:
::»: 6:*:
::t::
:2:: :3:: :*:
:*:
:*:
::7::
::a:
::a:
—
;:«:: ::t::
:«::
:i:
:*:
:*:
:*:
::T::
::»:
::»: 7*:
::t::
:2:: :*: :*:
:*:
:*:
::7::
::»:
::a:
—
$:*: ::(::
:*:
:.3::
:*:
:*:
:*:
::T::
:*:
:*: 8*:
::(::
:2:: :*: :*:
:*:
:*:
::7::
:&:
::&:
_
♦ :*: ::t::
:*:
:*:
A^z
:*:
:*:
::7::
:*:
::»: 9:*:
::t::
:2:: :*: :*:
:*:
:*:
::7::
::»:
::»:
~~
10:*: ::(::
:*:
:*:
:*:
:*:
:*:
::?::
:*:
::»: 10:*:
::(::
::2:: :.3:: :*:
:*:
:*:
::7::
::&:
::»:
^
1|:«:: ::)::
:*:
::»:
::*:
:*:
:*:
::T::
:*:
:*: 11 :0::
::►::
:2:: :3:: :=»::
:*:
:&:
::7::
:*:
:*:
~~
IJ:*: ::|::
:*:
:*:
:*:
:*:
:*:
:i7^:
::»:
::*: 12=0
::t::
:2:: :3:: -A-z
:*:
:&:
::7::
:*:
:*:
^~
13:*: ::|::
:*:
:*:
::*:
:*:
::©::
::7i:
:«:
::»: 13:*:
::(::
.2.Z :3:: :=»::
:*:
:*:
::7::
:*:
::»:
^~
H:*: ::|::
:*:
:*:
Azz
:*:
::&:
:.7^:
::&:
::»: 14:*:
::t::
:2:: :3:: :34::
:*:
:*:
::7::
:*:
:*:
~
.15:*: ::(::
:*:
:*:
::*:
::5::
::e::
::?::
::»:
::»: 15*:
::(;:
:2:: :3:: :*:
:*:
:*:
::7::
::&:
::»:
~
U^*: ::!::
:*:
:3::
:=*:
::5::
::&:
::7^:
::e::
::&: IJ:*:
::t::
.2.1 :3:: :*:
zzSizz ::&:
::7::
:*:
::»:
~"
iT*: ::(::
:*:
:*:
:4::
:*:
::e:
::?::
:S:
::9: 17:*:
::(::
^7::
::&:
~^
IZ
!«:«:: --*---
:*:
::5::
:^:
::S:
:«::
::?::
::e::
::»: 18:*:
::|:
:2:: :*: :*:
:*:
:*:
::7::
:*:
::»:
"""
If:*: ::t::
:*:
:*:
::*:
::6::
:«:
::?::
::8::
::9: 19:*:
:C::
:2:: :3:: :*:
:*:
:*:
::7::
::&:
::*:
_^
20:*: ::|::
:*:
::*:
::4::
:*:
::e:
::7i:
::»:
::»: 20:*:
Q
::2:: :*: :*:
:*:
:*:
::7::
:*:
::»:
—"
22:*: ::):: :*: :*:
::5::
:*:
:*:
:*:
::?;:
::T::
:*:
::»:
:*: 21 :0::
::9: 22*:
Mz
:U:
:2:: :3:: :*:
:2:: :3:: :*:
:i:
:i::
zz&zz
zz&zz
. ::7::
::7::
zd&zz
::&:
:A:
::a:
^
23*: ::|::
:*:
:*:
:at: ::&::
■- HAL F-—
::e::
::7^:
::»:
::»:
23 *
24:*:
25:*:
M
:N
::t::
:2:: :3:: :*:
z2:z :*: ::»::
:2;: :*: -Azz
:ic:
::6:
::&:
::7::
::7::
::&:
::8::
::a:
::a:
^
25*: ::|::
:*:
::»:
::6::
::e:
::7^:
::8::
::&:
::&:
::&:
::7::
::a:
::&:
^
2t:*: ::|::
:*:
::3::
:at:
::5::
::e::
::7^:
::e::
::&: 26:*:
::t::
2^z :3:: ::«::
::&:
:*:
::7::
::&:
::»:
^_
27:*: ::(::
:*:
:*:
:at:
::S::
::e::
::T::
::»:
::»: 27 *:
::(;:
:2:: :*: ::4::
::&:
:*:
::7::
::&:
::9:
^~
21:*: ::)::
:*:
:-5::
::*:
::S::
:*:
::T::
::»:
::»: 28*:
::)::
:2:: :3:: -Azz
::&:
:*:
::7::
::&:
::9:
""
2»:*: ::|::
:*:
::3::
::4::
::S::
::6::
::T::
::R:
::»: 29:*:
::(::
z2r.z :*: ::*:
::&:
::&:
::7::
::»:
::9:
__
30* ::|::
:*:
::S::
::*:
:*:
::e:
::T::
::»:
::»: 30:*:
::(::
:*: ::3:: ::*:
:*:
::£:
::7::
::&:
::9:
"^
31:*: ::j::
:*:
::3::
:=*:
:*:
:«:
zzT-Z
::&:
::»: 31 *:
::t::
:2:: :3:: :^:
:*:
:*:
::7::
zzSzz
::9:
^^
32:*: -■->---
:*:
:*:
13*::
:*:
:*:
::?::
::8::
::»: 32:*:
::l::
2:: :*: :*:
:*:
:*:
::7::
::»:
::a:
_
M:*: ::(::
:*:
:*:
::*:
:*:
::&:
::T::
::&:
::»: 33:*:
::t::
:2:: :*: :*:
:*:
::&:
::7::
::»:
::9:
~~
34:*: ::|::
:*:
:-3::
::*:
:*:
::e::
::?::
::&:
::ft: 34:*:
::t::
:2:: :3:: :*:
:i:
::&:
::7::
::a:
::a:
__
35:*: ::(::
:*:
::*:
::*:
::&:
::&:
;:?::
::e::
::»: 35:*:
::t::
:2:: ziizz .Azz
::&:
::&:
::?::
::a;
::9:
__
3*:*: ::|::
:*:
:*:
::*:
::&:
::&:
::7i:
::&:
::ft: 3*:*:
::|::
:2:: :*: ::«::
::5::
::&:
::^:
::&:
::9:
^~
: 37*: ::|::
:*:
::3::
::*:
::5::
:*:
::7::
::&:
::9: 37:*:
::(::
:*: :*: :*:
::5::
:*:
::7t:
::&:
::»-
^~
5 3«:*: ::«::
:*:
::3::
::*:
::S:
:«:
::T::
::»:
::»: 38:*:
::):;
:*: :3:: :*:
::&:
:*:
::7::
::a:
::»:
~~
- 3»:*: ::|::
:*:
::3::
:at::
::*:
::e::
::7i:
::»:
::»: 39:*:
::(::
::2:: :*: :*:
::S:
::e::
:7::
::a:
::9:
40*: ::)::
:*:
r:S:r
::*:
:*:
::&:
::?::
::&:
::»
::)::
::2:: :3:: ::*:
::&:
::&:
::7::
::a:
::9:
<
:S^r t
:*:
3
::3::
4
::*:
5
::&:
6
::&:
7
::7::
0
::»:
9
^i1
55
::!::
Ui
::£:
13
::i: :*: J
74 J5 -^
k#
::6:
77
::7::
'.8
::a:
79
fo
SPECIAL INSTRUCTIONS
The GSS consists of an original and a carbon which are attached at the
side of the set. Since only the original sheet can be processed by the op-
scan reader, carbons should be retained by the investigator for his files and
NEVER be sent to the Biometric Laboratory for processing. Care should be ex-
ercised in detaching the carbon so that the original copy is not mutilated.
When the GSS is used in conjunction with the packets, the rater should
follow the printed instructions carefully.
1. Encode ALL INFORMATION requested in the identification (ID)
block for EACH GSS used.
a. Patient Initials
b. patient Number
c. Rater Number
d. Period Number and Time Unit
e. Sheet Number
2. Insert a new GSS when instructed to do so and again complete
the ID block.
3. Use the Sheet Number specified in the packet instructions. Sheet
Number - unlike Period Number - remains constant; i.e., it is
always the same for a given scale or set of scales. Even when
the investigator plans to use only a portion of the scales within
a packet, he must adhere to the specified Sheet Numbers.
k. Follow the instructions for coding items carefully. Responses
must be coded in precise locations or they will be rejected com-
pletely or decoded incorrectly in subsequent processing. Raters
should not become confused by the- numbers printed over each re-
sponse position. Raters familiar with the NOSIE and its real
scale points - l,2,3,^t5 - may be disturbed by the GSS response
position numbers - 5,6,7f8,9. Through programming, the 5-9
positions will be translated 1 - 5 in all output. The 0 to 9
labeling of GSS response positions is simply for rater orienta-
tion. The "number" is not "read" by the opscan reader - just
the position.
5. If you wish to change a response, erase the incorrect response
comp 1 e te 1 y .
6. Finally, DO NOT FOLD, SPINDLE, STAPLE OR MUTILATE the GSS in any
fashion. If, despite these prohibitions, you still feel an un-
controllable urge to use paper clips, PLEASE affix them to the
BOTTOM EDGE of the GSS.
56
TYPES OF ENCODING
It might have been much less confusing for the rater if a single method
of encoding a response had been adopted. To do this, however, the rater
would have been faced with many more sheets of paper to complete - each with
an identification block to fill. To avoid this, a variety of encoding tech-
niques have been used to "paci<" data on the fewest sheets possible. The type
chosen in any given situation has been based primarily on specific space
requirements. The response positions required to encode an item can be assigned
in several ways.
Examples:
1. One item along a single row (horizontal). This is the most common
type of encoding. Scale points may vary from 2 to 10.
DRUG
Analgesic-narcotic
YES
CLASSROOM BEHAVIOR
Fidgeting
Prttty Very
Much Much
TENSION
Physical and motor manifestations of tension "nervous-
ness," and heightened activation level. Tension should
be rated solely on the basis of physical signs and motor
behavior and not on the basis of subjective experiences
of tension reported by the patient
MODES-
EX-
NOT
VERY
MILD
MODER'
ATEIY
SEVERE TREMEIY
PKESENT
MILD
ATE
SEVERE
SEVERE
In a single column (vertical)
are possible.
For items where multiple responses
13. SPECIAL SYMPTOMS
Check presence of a symptom by mar
king "0" on the proper row.
If no special symptoms present mark
'0" on row 21 .
A.
No symptoms
21
B.
Speech disturbance
22
C.
Specific learning disturbance .
23
D.
Tic
24
25
E.
Other psychomotor disorder .
F.
Disorder of sleep
26
G.
Feeding disturbance
27
H.
Enuresis
28
1.
Encopresis
29
J.
Cephalalgia
30
22:*:
24:*:
25 a^
26:*:
28:*:
29:*:
30*:
57
3. Two or more items in a single row - Used primarily on the demographic
instruments where space is at a premium.
Subject's Race is:
Code both b and c on Row 4
0 = Caucasoid
1 = Negroid
2 = Mongoloid
3 = Other
Has Subject's Residence Been:
5 = Primarily urban
6 = Primarily suburban
7 = Primarily rural
h. Several items having a common code and requiring several rows and columns,
Has either parent or present surrogate been:
Mark one response for 0 = Neither parent 2 = Father
each item using this code: ^ ^ ^^^^^^ 3 ^ g^,^ ^^^^^^^
Out of home (3 months or longer) due to physical or mental illness .
Separated (3 months or longer) due to marital difficulties . . . .
Cruel or abusive (to patient, spouse, siblings, etc.)
Not a steady worker or competent housewife
-&z
>4b
Hi:
==»:
"*
22
zftz
z-izz
•*•
"»:
;:*
23
•*•
zzizz
r:2:=
--3:z
--4:
24
:;&=
"t;
-=2:=
-^
"*:
25
A single item requiring several rows - Used primarily for the
encoding of numeric values of more than one digit.
a^ r=2:i :3::
;rh: ::2:: :J::
III:: z-Szz iri:
Sai -jaiz :d::
:Ar zzSr- -^-_ --:J-- ;;&! "ft:
MAXIMUM
lA: TOTAL :;5c: -^- --r_-_ "B: iifti
DAILY
:A: DOSE IN ::&; iife: =i7i: :r&: irft:
MILUGRAMS
a^m :iQ: iOBz IQ&O
58
ENCODING
NONSTANDARD
DATA
The independent use of the GSS follows the procedures established for the now
obsolete General Purpose Scale, Providing a larger data matrix, the GSS may be
used for the encoding of a wide variety of numeric data in a format corresponding
to the standard BLIPS identification and data fields. It enables investigators
to submit non-standard assessment material in a format which will permit rapid
processing and standard - as well as non-standard - analyses.
UTILIZATION - Dependent upon type of data
DATA FIELD MATRIX - The entire GSS matrix, or any part of it, may be used
for non-standard data.
LOCATING DATA ON THE GSS MATRIX
A non-standard data set can be located within any portion of the GSS matrix.
The choice of location depends on the size of the data set; i.e., the number of
items, the number of scale points, the number of individual scales to be encoded,
convenience in encoding and/or transcribing, etc. Generally, the investigator
should try to "pack" data by encoding as much of his data set on one GSS as
possible. Remember that more than one non-standard assessment instrument can
be encoded on a single GSS provided that the data pertains to a single subject
and a single rating period.
Figures demonstrates some of the locations which might be used when encod-
ing two non-standard scales. Scale A is a 10-item scale with 10 scale points; B
is a scale with 10 items and 5 scale points. Note that only a few of the possible
locations are illustrated. Also be aware that the numbers printed at each of the
response positions are for the convenience of the rater and do not necessarily have
to correspond to the actual scale points of given instrument. For example, Scale B!s
actual scale points are 0, 1,2, 3. ^', but, the two extreme right locations of B
utilize the response positions 5, 6, 6, 7, 9. This need not concern the investiga-
tor since the response positions will be "normalized"; i.e., changed to actual scale
points, through computer programming.
ITEM FORMAT
Item format can vary according to the needs of the investigator EXCEPT THAT
ONLY ROW CODING CAN BE EMPLOYED. The investigator cannot employ column-wise coding -
either totally or partially - since this would require extensive and individualized
programming. Items can have different size fields; i.e., number of rows, or
different scale points and both can be interspersed. All data within an item,
however, must be uniform. If an item varies from 1 to 125, all data must be encoded
in 3 rows, e.g., 001, 014, 122, NOT blank blank 1, blank 14, etc.
SPECIAL INSTRUCTIONS
1. Data encoded on a single GSS MUST PERTAIN to a SINGLE subject. Do not
encode data from different subjects on the same sheet.
60
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (SO-GSS)
PATIENT INITIALS
:t::
HRST
INITIAL
NUMBER MALES 001 TO 499
:0:: ::(:: -Zzz zzizz :*r
F
:©:: ::h: :2i: =3:: :*:
SECOND
INITIAL
FIGURE 3
tATER
SAMPLE LOCATIONS FOR NON-STANDARD DATA "^
NUMBER FEMALES 500 TO 998
SHEET
NO.
:-^:
::7i:
:3::
Days
iT
13:
14:
IS:
16:
17:
1|:
1»:
20:
21:
22:
23:
24:
25:
26:
27:
21:
2»:
30
31 =
w
n
Kz
16:
17:
»=
10=
:=(::
::(::
:*: =
^z ::^:
:*: ::?;:
:*i ::T::
:*: ::T::
:*: :rT::
:*: ::Tb:
*: :*
*: =*
*: :*
*: :--»
Row
::(:: zz^z ::J:r
::e: zzT_z
::e:: "T::
:*: zzT-z
B
LBIrr ^T- t^ -t
=5::
:*:
zzT.
*:
::&:
zzTz
*:
;:€::
zzTz
*:
:*;
-zT-
=S::
:*=
zzfz
*:
"&:
::7:
6
::6::
7
::7:
8
2iOr:
3r©:r
4:0::
7=*:
|:0::
»:S:
1:0::
I2:0::
13 :0::
14=0::
IS:*:
I6:«::
17:0::
II :0::
!»:©::
W:0::
22 O::
23 O::
M:0::
85 :0::
J6:0::
!7:0=:
»:«::
»:0::
»:«:
31 :0::
32 zO::
33:0::
34:0::
35:0::
36:0::
37:*:
31 :0::
39 O::
:(:: :2:: i*: :*
:[:: :2:: :3=: :^:
:t:: :2:: :*: :*
„,: . ,., ,.
It:: m0 :3:: :*:
:»:: :2;: li: i*
^
61
:«:: :*:
rar: -^z
:i" :3:: :*:
B
r3::
:*: :3::
zzAz
zzAz
:*:
i:. ::&: ::7:: :A
iS: :*: ::7:: :*
*: ::&: ::T:: :*
*: :*r irTi: :*
:*: :*: ::7:: :*:
:*: :*: :i7:: :*:
:?=: :A:
:2:: zzizz
:«:: :3:i
:2:: :*:
;:T:: ::&: ::»:
:*: :*: ::7::
:2::
:a::
-i^z
:*:
:=*:
15
:*:
:*:
;:T:r
::8::
::a:
:i:
-Z&LZ
;:7i:
:-&:
::ft:
:*:
:*:
::7::
::&:
::a:
::&:
:;&:
:*:
B
::&:
::»:
::&:
::&:
:=&::
::&:
::7::
::»:
irS:
::&:
zz&z
::^:
::&:
::»:
::&:
::&:
:r7::
::»:
"Si
:*:
::&:
r:7::
::»:
::»:
«^
::&:
::7::
::&:
::ft:
2. Similarly, do not encode data from different assessment periods on
the same GSS .
3. Data pertaining to groups of subjects, e.g., summated data, means
scores, may be encoded on the GSS. If you wish to compare these data with
another group/s, the rules for the single subjects MUST be observed - only
one group on one GSS: only one assessment period of the group on one GSS.
k. When encoding the identification block, follow the instructions
exactly as you would when using a standard ECDEU assessment instrument.
5. SHEET NUMBERS from 80 to 99 MUST be used when encoding non-standard
data. The Sheet Number - once assigned to a data set - must be used consis-
tently throughout a given study.
6. Should the data set from a single assessment period for a given sub-
ject (group) be greater than the matrix of a single GSS, use another GSS and
differentiate it from the first by assigning a different SHEET number to it;
e.g., 80 for the first GSS; 81 for the second.
7. When an item is missing at a given rating period, leave ENTIRE field
blank; i.e., use a field of blanks as a missing data code.
8. When a value for an item is recorded, there should be NO BLANKS with-
in the field; e.g., encode 021, NOT blank 21.
9. It is not necessary to encode decimal points; but the placement of
the decimal MUST be consistent within a SINGLE field. For example, the rater
wishes to encode these four scores - 1.65, 10.41, 106.8, .37. They should be
encoded in a field large enough to encompass all of them. For these k scores,
the necessary field is xxx.xx; and the scores are coded as follows:
00165
01041
10680
00037
Note again that the decimal point is omitted in this example. It will appear
in output when the proper format statement is inserted into programs; e.g., F6.2.
10. I terns need not necessarily be encoded continuously, i.e., space may be
left between items. The rater must, however, clearly indicate such "gaps".
11. Scale points may differ from item to item. I terns may be continuous or
discontinuous. The scale points may be given any name or designations. Examples
of different scale possibilities are:
62
a)
Not present
Very mi
Id
Mi Id
Moderate
b)
Never
Rarely
Occas iona 1 ly
c)
None
Once
Twice
d)
0-.9
1.0-1.9
2.0-2.9
3.0-3.9
e)
Present
Absent
f)
True
False
g)
Yes
No
h)
+
-
i)
A
A + B
A + B + C
j)
++
+ -
- +
—
12. The investigator MUST send a copy of each scale or data set encoded on
the GSS . In all instances, the investigator must identify clearly the positions
in which he has encoded each item and, if it is not obvious from the actual scale,
the scale points and/or range of scores of each item. For example:
Rows Name of Item
1-3 Variable 1 050 to 500
k-5 Variable 2 01 to 20
6 Variable 3 0 to 9
7-8 Variable k 10.00 to 99-99
9 Variable 5 True = 0; False = 1
13. More often than not, data will be transcribed from the original forms
to GSS. The investigator may, however, wish to use GSS for direct encoding of
observations. This may be accomplished by means of a template; e.g., a fold of
paper covering 1/2 of a side upon which the items to be rated are typed so that
they are aligned with response positions on the other half of GSS. (Figured).
This home-made template, like the rater packets, can thus be reused and the prob-
lem of transcribing data eliminated.
14. It is ESSENTIAL that the location of all non-standard data be described
in Item 11 of Data Shipment (071-DS). Without this information, BLIPS processing
cannot be accomplished.
63
FIGURE k
TEMPLATES FOR ENCODING NON-STANDARD DATA
Sk
THE
DEMOGRAPHIC
PACKET
The Demographic Packet contains three instruments - two for pediatric and one
for adult populations. The demographic scales are:
Chi Idren Adul t
Children's Persona] Data Inventory Adult Personal Data Inventory
Children's Symptom History
Figures 5 to 7 present data matrices for each of the scales. These matrices
indicate the encoding location of each scale item as well as the GSS sheet number
upon which it appears. These locations are FIXED and MAY NOT BE ALTERED. To do
so will render the data non-processable.
Manipulating the sections of the packet and inserting the General Scoring
Sheets may require some practice. The instructions on the back of the front cover
of the packet should, however, provide the information needed to develop the
necessary dexterity. It is important to state again, however, that the rater
ALWAYS USE THE ASSIGNED SHEET NUMBERS for the scales - EACH AND EVERY TIME he
uses them. Period Number changes, but Sheet Number never changes for a particular
instrument .
Raters are cautioned that encoding for the Children's Personal Data Inventory
(CPDI) is rather complicated. Since the CPDI acquires a large amount of informa-
tion, "packing" of the data was necessary in order to encode everything on one GSS
sheet. This was accomplished by formatting more than one item on a single row,
thereby . requi ri ng the rater to make multiple marks in specific response positions.
The rater must be particularly alert to follow the instructions carefully.
The Demographic Packet contains items which require varying degrees of
professional "expertise" - from a clerical recording of a wel 1 -documented event
to subtle judgments of development, motivation and veracity. A background in
psychiatric social work would seem ideal for a rater of this packet, although such
a background is not a requirement. What is paramount is the rater's ingenuity and
persistence in acquiring complete and reliable information. The manner in which
demographic 'data should be collected is succintly described by the following
excerpt from "Soothe, H. H.; and Schooler, N. R.; Instruction Manual for Brief
Social History for Studies in Schizophrenia, Psychopharmacology Bulletin, 8, 1,
23-24, January, 1972.
"Ideally the interviewer is so familiar with the content of the instrument
that he can lead the discussion to each item in whatever way is most
comfortable to the person interviewed, rather than by a rigid adherence
to the word order of items in the form. He may not even want to have the
form in sight, but may want to rely on his notes to complete the recording
after the interview is finished. In any event it is good practice to check
through the form before the informant leaves, to make sure that no items
have been overlooked.
66
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
—
PATIENT INITIALS
:A: "ft:
:-.tl: zz\tz
::e:
:ift:
:AW:
::D:
:ist:
::X:
zzizz
:«:
::V^:
::fi:
FIRST
::R::
INITIAL
::Z:
NUMBER
FIGURE 5
MATRIX FOR
CHILDREN'S PERSON)
DATA INVENTORY
::it: ::»: ::»: :*:
::3!:: ::&: ::»: ::()::
MALES 001
-> -2::
a::
TO 499
r^:: ::«::
:4:: :^::
:^:: :^::
NUMBER
::&:
PATIENT
::5::
::a::
FEMALES 500 TO 998
::fc: ::?:: ::&: ::»::
::fc: ::7:: ::&: ::9::
::fc: ::?:: ::8:: ::9::
::!£: -Uz
-C:
::M:
:«<:
::B:
:*t:
::X:
::£::
zzQz
::)|t:
::F::
SECOND
::P:i
INITIAL
::£:
:«:
'\L
2::
::J:: :*:
Hours
zzizz
:3::
:3::
::4::
r:4::
RATER
::*:
::&:
::fc: ::?::
::&: ::?::
::&:
::8::
::»::
:*:
^
„U. zz\tz
::3::
::3::
Doys
::i:
::4::
::4::
PERIOD
::S::
::5::
/Veeks
::3:
::6:: ::?::
::fc: ::7::
Months
::4::
::8::
::8::
:*:
::?::
—
.-
-1
::2::
::*:
::!:
::!:
::*:
::±:
SHEET "S:
NO. ..5.
::6::
::&:
__
u
::J::
—
Row
1 .az z
-Zz
::i:
::3::
::*:
;:5::
::&:
::i:
::8:: ::*:
Row 1 ::Q:: j"
::J:: zzizz
la
::3::
::4::
r:5::
::fc: ::?::
::8::
::»::
__
::*:
- ::;:
::6::
::S:
::8:: ::9::
::ft: :^
2::Q::
::3::
::*:
:Lit:
::S::
::£:
zzbzz ::?::
::6:: ::7::
::8::
;:a:;
::»::
:*:
^
4::tt:
5:0:: ::J::
6^^^^ ---r-
::2::
::*:
::*:
:;S;:
: :fc:
z 9:
::a: ::9::
i. ^..
ll? i
"Tl
::*-
1
^.i...
;? f
! -
:*:
—
::*:
::5;i
^f ::.:
::fc:
::&:
zzjzz
::S:
::ft: ::S::
5::Q::
6 ::e::
::j:: ::2::
::):: ::2::
izz
zzSzz
:Lit:
::5::
::5::
:;6:: ;:7::
::6:: ::7::
::&::
::8::
::?::
:.^:
^
7..0ZZ :
B::ft: ::1::
9::fl:: ::J::
::*:
::2::
::*:
• ::S:
z.bzz
::f::
::&: ::9::
7::e::
8::e::
;:J:: ::2::
::a:: ::2::
::2::
:ii»::
::4::
■ Id —
::5::
:*:
::6:: ::?::
::6:: ::7::
::8::
:*:
::9::
:*:
__
:i«::
^^ ::;:
::ft::
::f::
::&: ::&:
—
1P ^--
::4::
_LL-
::£:
::6:: ::7::
:*:
:*:
:*:
::»::
—
0::(t: ^«
::2::
:qp-
Sh -&^
■^1
le
::&: -.9:
—
rr;i: ' ::,::
2::e:: ::)::
3:: ::)::
::2::
::2::
:*:
:*:
::4::
:i4::
5d ^
::&:
::6::
::fc:
::S;
::&: ::ft:
::&; ::9:
11 :*:
?fl --2=:
:m
:it:
(
^^
9h ^:
■M
^
I2'::e::
I3::e::
::!:: :;2:-
::i:: ::2::
:J::
:*:
r-4::
::4::
2c
::S::
::5::
::»:: ::?::
::*:: ::7.,
::8::
::8::
::9::
::9:
—
^
:*:
::*::
::5;:
::&:
::ft:
::ftr ::9::
Sz,Ckz ..t.
6 :: ::t:
::i:
irSt:
::a::
::3b:
::*:
::a::
5e
::&:
::fc:
::£>::
::?::
::?::
::ft: ::9::
::&: ziSt:
I4::e::
::J:: zzizz
..iii iAi
:*:
:.4::
2d
::S::
zifcr zrTi:
::&:
::9::
^
^
z-.i--
::*:
::5;:
::fc:
::7::
::&: ::ft:
16:6::
U,zz^z_
::J:: ::2::
::J:: ::2::
:*:
JZ^
:it::
::4::
2e
,2f_
::S::
::6:: ::?::
::&:
::8::
::8::
::»::
::*:
::»-
::»::
::9::
—
7::tt: ::t:
8::ft: ::i:
9 :: ::±:
::2::
::2::
::*:
::*:
5f ^"=
::5::
::&:
::6::
::?::
::J::
::B:: ::9t:
::ft: ::ft:
—
I8::e::
::3:; ::2::
::J:: ::2::
zSzz
:^:
::4::
2g
2h
::5::
::&:
::&:: ::?::
::*:: ::?::
—
^
::3::
::*:
::5::
::fc:
::?::
::&: ::9::
—
JO::ft: ::i:
M ::tt: ::±:
::2;:
::*:
::a::
::&:
::*:
::*:
=^ ::
::fe:
::fc:
::J::
::a:: ::*:
::&: ::9t:
20 ::&:
21 ::&:
::3:: ::2::
::J:: ::2::
:*:
:*:
::*:
::4::
2i
-2i_
::5::
::5::
::6:: ::?::
::6:: ::?::
::8::
::&:
::»::
::9::
—
,^^
::a::
::*:
::&:
::&:
-:5t:
::ft: :;9:r
22 ::e::
23 ::&:
24 ::&::
25 ::&:
2k :i:
21 i:
2m ^--
2ti ^=
::3::
:--3::
:*:
::3::
::4::
::4::
::4::
::4::
::$::
::&:
::S::
:^:
::6:: ::?::
::6:: ::?::
::fc: ::?::
::&:
::&:
::&:
::«::
::S:
::8::
::&:
::8::
::8::
::8::
::»::
::&:
::&:
::8::
::*:
::»::
::»::
::St:
::*:
::9::
::5t:
::*:
::Sr:
::*;
::9::
::»:
::»::
::*:
::»::
—
k3:A: :a::
M::a:: ::3::
25:: ::3::
::2::
::2::
::3::
::$::
::4::
::4::
5h ^
::&:
::6::
::&:
::J::
::S:
::&: ::9t:
::&: ::9:r
^
::3::
::4::
::&:
::fc:
::?::
::8:: ::9::
::fc:
zr-z
—
26 :A: ::3::
i7::e:: ::3::
J8:-l ::i::
::2::
::2::
::3::
::3::
::4::
::d::
5i ^'
::&:
::fc:
::fc:
::?::
::fc:
::a:: ::9i:
::&: ::9i:
26 ::e::
27 ::e::
28 :ra::
29:*:
30:*:
31 :*:
32:*=
33:*:
34:*:
S5 -*-
::):: ::2::
::J:: zz^z
::J:: ::2::
::J:: ::2::
::3:: ::2::
::J:: ::2::
;:!:: ::?::
::}-.; :*:
::):: ::2::
:*:
:*:
:*:
:*:
:*:
::3::
:*:
:*:
::3::
::4::
::4::
::4::
::4::
::4:;
::4::
::4::
:2t:
::4::
3a
3b
3c
2d
2e
2f
2g
2h
2i
. 21_
::5::
-S:
::S:
::5::
::&:
::S::
::S::
::S::
::S::
::6::
::fc:
::6::
::6::
::6::
::6::
::fc:
::6::
::6::
::7::
::7::
::?::
::?::
zzr-z
::?::
::?::
::7::
::?::
-zr-z
—
::!:
::(t:
::&:
::fc:
::?::
lift: ::fc:
—
!9*:^'"::3::
}0::6:: :;J::
n::. ::i::
::2::
:=2::
::3c:
::3::
::*:
r:tr
.::S::
5J ::.:
::fc:
::fc:
::?::
-ft: ::fc:
::&: ::fc:
^
::3::
::*:
::&:
::fc:
::?::
::fc: ::9t:
—
» :a: :3::
13. A. ::i::
J4:., ::,::
::2::
zz2zz
::3::
::3:
::*:
:3l::
5k ^="
::5::
::fc:
::fc:
::7::
::?::
::ft: ::9t:
i:ft: ::»::
—
::3::
:=1::
::5:r
::6::
::S:
::&: ::9::
—
IT----::
36 .A: ::!::
:i:
::3::
::*::
51 ="^
::&:
::fc:
::fc:
::?::
::S:
lift: r:*:
—
36 r*: 1
::!:: 4^
::3::
::4::
] c
::S:r
Ah r.z
"^
—
J7 ^ :::
lEKi:
::*::
'jn H
0=
:: 'in - -»==
37:*:
38-*:
::l:: ::2::
:4::
::4::
4c
::&:
zziszz ::7::
::&:
::9::
—
J8::tor-. :-!::
::2::
z-3zz
^b4::
::&:
::7::
::&: r:9::
.^^ft^_^^
—
39 :*:
::l ::2::
::}:: :*:
::l:: ::2::
::3::
::3::
L^
::&:
::fe: ::?::
::»::
::9t:
40:*: ::5::
:=2::
::3::
zzizz
rnfe^M^'
L^
-?::
:-8::| ::9::
40:*:
:^::
:=t::
4d
::S:=
zztfz ::?::
::fc: ::?::
::&:
::»::
41 :A: ::J::
::2::
::3::
z-jizz
7 ::5::
::fc:
::?::
::ft: ::9:^
67
:*:
.
Co
/s;7
2
3
4
S
6
7
8
9 70
11
12 13
74
75
J6
77
18
79
201
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS]
PATIENT INITIALS
z-Jcz -.-.&-. "C:
::t: -Mz
-.z\tz .Mz
iiK:
FIRST
INITIAL
-K: "Ji: -*i
NUMBER MALES 001 TO 499
NUMBER FEMALES 500 TO 998
=:|fc=
rie= =:£>= ::£:-
--*»: ;*t; ::Or
FIGURE 6
MATRIX FOR
CHILDREN'S SYMPTOM HISTORY
zfzz
::8:r
zlzz
"tr
zjzz
==8:=
zfzz
:=8:=
zlzz
"8::
rift:
=*= SHEET "»=
4^- NO. ..^.
::0:r
»W 1 zttz
iiti
11*:
::»:
n*
•kzzttz
iiti
11*1
II*:
::*
Zzzttz
iiti
nil
::*:
::*
X.-ttz
=:*:
::*:
::*:
::*
5 ::<>::
lit:
::»:
::*:
::*
6 ::(»:=
iiti
::*:
::*:
::*
7::e:=
iijii
::!::
::*:
::*
8=:ft:
mil
::»:
::*:
::*
9=:ftr
i:*:
::*:
::*
10=:e:=
112::
n*:
::*
1 1 ==6::
iiiii
llj::
::*:
::*
12 lift:
::*:
:*:
--4Z
13==ft:
::2:
:*:
:i4i
UiiCbr
::i:
nil
::*.
15 ==6:=
lit:
::2::
nil
::*:
16 lift:
nil
::2::
nil
n*:
17i:ft:
nil
::2::
nil
::*:
18==ft:
::ii
nil
nil
::*:
1»z=ftr
II±:
::4:
nil
::*.
20::ft=
::±:
::5t:
iii:
n*-
21 rrft:
::±:
::*:
nil
-z4t
22::a:
::±i
::*:
nil
zz4tz
23 I A:
iiJi:
liti
nil
:i4i
24:rftr
iiJi:
iiti
iii:
iiii:
25==ft:
iiJii
lit:
::!:
::*:.
26 lift:
iiJii
iiti
::3i:
Il4i
27rra::
iilii
lit:
nil
II*:
28 lift:
iiJi:
nil
iifti
::*
29 lift!
::!::
lit:
nil
::*:
SOiifti
::J::
lltl
nil
::*:
31 iifti
::3::
lit:
nil
::*.
32iifti
::i:
::t:
nil
::d:
33iAi
::»::
:i::
i:3::
:3*:
34i:fti
::!::
1:2::
i3::
::4i
SSiifti
::»::
:ii
i3::
:i4:
36idfti
lllii
:i:
:J::
:^:
37i=fci
ilJii
:±:
::3:i
::4:
38iifti
iilii
irti
::3::
:i«:
39iiftr
lllii
iiti
i:3n
:i4:
40iifti
:iJ:i
iiti
i3==
nil
41iifti
iiJii
lit:
iiSii
nil
tMs: 1
2
3
4
5
nS:
::&:
::&:
::&:
nS:
nS:
::&:
::&: ::»:
::»: ::ft:
::a:: ::ft:
::8:: ::*:
:8::
:St:
nil
:rft:
::i:
::i:
:ii:
::i:
::ii
nft: ::St:
i:ft: ::St:
::ft: ::9t:
::ft: ::*:
ni: ::t:
nft: ni:
::ft: ::i:
nft: ::i:
nft: nil
nil
::ft:
:ift:
::ft:
nil
6
ifti ::i:
:ft: ::i:
::i:
::i:
::t: :i
9 7
Row 1 ::ft:
2::ft:
3 nft:
4::ft:
5::ft:
6::ft:
7::ft:
8::ft:
9:A:
10:*:
11 :*:
12:*:
13:*:
14:*:
15:*:
16:*:
17::ft:
18:*:
19::ft:
20 ::ft:
21 ::ft:
22 ::ft:
23 ::ft:
24 ::tt:
25 ::ft:
26 ::ft:
27 ::ft:
28 ::ft:
29:*:
30:*:
31 :*:
32:*:
33 1*1
34:*:
35:*:
36:*:
37:*:
38:*:
39 1*1
nj:: :*:
::3n ::<::
PERIOD
::i: ::&:
: 7:: ::e::
:*:
—
:H |Y
iMlL
;» 1 Y
W 1 Y
i —
\^a^--
-TTT
17b:
17e :
17d:
17e.
17£.
-5::6a =
::i:6b :
::i:6e =
==s=6dl
==i=6d2-
==i=6d3
==i=6e =
: 1 ft:
:: la -,n
= lb 8::
::»:-
40 S:z
n9:H
41 ::t:
::9^
42 zzt-
42a t=
42b t=
:: 2 =8==
:- 2a ::
=- 2bl
::7 2b 2
::i 2b3
==. 2b4
=- 2b 5
. 2e^:
:=. 2d =
::9 ~
= =* ~
::*-■:
43 -2==
18:*
::9
44a :
44b .::
44c -
19 4::
19a :
19b -:
19e :
19d :
19e::
19f ::
19g=:
::Sn7::fc:
::i:7a ::
:*: 7b :
:iS:i7C =
=5:=7dl=
==5:=7d2
==5::7d3
==5==7e.
==s=7£I
::5::7£2
nS: 7f 3
==^=7g =
: = *: 7h :
::5:: 7 il
lis: 7:i2
::*: 7d3
:* : —
:*:, ~
:*::
45 :*:
==*=; IZ
nJ:: ::2::
::9:-
::Jn ::2::
nl:: ::t:
::3:: ::2::
::J^ 3 ==8:=
::?^3a .:
==?= 3b 1
==? 3b2
==J 3b3
==i 3b4
----^- 3b5=
::,. 3e =
==* : ~
::J:: ::2::
::!:: ::2::
20 t:
; 20a::
::9:-: ~
ZZ9--1
::!:: ::2::
::ln ::t:
::3:: ::2n
21::4::
- 21a::
21b :
21^ :
::9:;| "
==*"-' ~
::»: ~
::J:: ::2::
::J^ 4 ==8::
==?^ 4a 1
==3i 4a 2
::s 4a3
::J^-4fe::
■--^ 4cl
::j^ 4e2
nf 4e3
==?- 4dl
::3t: 4(1-2
==^-=4d'3
==3^=4e =
n*^
::3:: ::2::
: 22::4::
::9::; ~
::J:: ::t:
: 23==*:
23a-
= 23b =
::S -i ~
::ln ::*:
::&: 8 =«==
::9.'
::!:: ::2::
::&: 9 :6l:
::§-.-! ~
::3n ::2::
- 2A---^-
= 10^*^-
= lOal
-- 10a2
= lOaa
=^10b
= 10c =
:i9:-
::§:,
::9r
::9-
z-9:
::8:
::9:
::»:
::*:
::St:
:i9::
ni:
::i
ni:
::St:
::9::
20
zzizz ::2::
z 25:=4i:
■""
::!:: ::2::
: 26=*:
IZ
::J:: ::2::
= 27=^--
—
::!:: ::2::
: 28=-t=
__
::!:: :*:
: 29=*=
—
::J:: ::2::
: 30=*=
:: ll::fc:
=^ Hal
=- lla2
== 11«3
■~~
::J:: :a::
: 31::*::
::^:5::ft:
::^: 53 :
^ 5b =
::ji: 5^ ::
zzrz 5^1
::3t 5<J2
^'^^ 5d3
nJ.: 5S :
~
::J:: :*:
: 32:*:
::J:: ::2::
= 33=*=
^~
::l:: ::Ji:
: 34:^:
:: 12 *=
^
iilii iijii
I 35:*:
: 13 fc:
^
iilii ii2ii
: 36:*:
-- 14 ^=
"~
:iln n2n
-3/^^
=^ 1.5 T
nJ:: ::2=:
: 38=*=
"l6^
nl:: :a::
: =^q=*=
= 17 -
nS.: 6 ^:
12 13 *
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
PATIENT INITIALS
lUk: "ft:
::R: ::t:
::li: ::it:
zCz
zMz
:«:
::D:
:*t:
::»:
::£::
:«:
::>-.:
FIRST
INITIAL
::?::
::P::
::£:
:«:
:«:
::«:
::»:
M
ADU
DAT
::»:
::a:
FIGURE
NUMBER MALE!
7
001
-:3-z
:*:
::a::
TO 499
::3:: ::«::
::3:: ::»::
::3:: ::«::
NUMBER
-iz
PATIENT
-5lz
::&:
FEMALES 50C
::6:: ::3fc:
::6:: ::ifc:
::fc: ::S:
TO
::&:
::8::
::8::
>98
::»::
::S=:
::»::
—
::!£:
::ft:
::l;:
z.\t--
::£:
zMz
:JW:
::B:
:*t:
::)t:
zzfrz
:.r-z
SECOND
INITIAL
::R:
::P::
::£:
:«:
::©:
:*f:
::|t
^TRIX FOR
LT PERSONAL
A INVENTORY
::«: :*; ::»::
Hours
::»: ::0:: ::*:
:*:
1:2::
::2::
::3::
::3::
::«::
RATER
:S::
:£:
::6::
::fc:
::J::
::?::
::8::
::8::
:*:
:*:
.^
::U:
:4::
::3::
Doys
::2::
::*::
::4::
PERIOD
:5::
:5::
eeks
:a:
::6::
zzbzz
::7::
::7::
Months
:;»::
::«::
:*:
:*:
:*:
—
::tt:
-i-|
::2:r
::2::
1:3::
::d::
::*:
SHEET
NO.
::»:
::5:
::»:
::6:
::?:
::S:
—
K
^
Row
1 rtt:
2::a:
3::f:
I2c
::*:
2::
-3:-
•I
::*:
::&:
::fc:
::K:
::&:
::9t:
Row
[1 :(^: ^
Uzft: ::t:
::2:i
::3::
::J::
::4:r
1
=5::
:5::
::6::
iiT::
::?::
::e::
::8::
-z9z
::«:
::*:
12c
::&:
::&:
::fc:
::fc:
::3t:
::3t:_
::&:
::ft:
::*:
^
3 ::a:: |::j ?
^
::3::
:*:
::4::
]
:5::
:5::
:5::
::fc:
::4::
ZZftLZ
::?::
::?::
::7::
::8::
::8::
:*:
:*:
:*:
:*:
—
4::a::
5::8::
12d
::4::
l *^
::2::
::»:
::*:
::&:
::fc:
::?!::
::&:
::9::
4 ::a:: ::3: 3
::2:n
^*n
::*:
12d
::S:
::&:
::fc:
::fr:
::K:
::J::
::&:
::8::
::9::
::Sb:
5::a:: ::a 4
::2::
:*:
::4::
~~
6 ::&: [^3::
::2::
:*:
::4::
5al
::6::
::?::
:*:
J*i
7:ze::
8 ::<>::
12e
::J::
> i:
::J::
::>:
::*:
::*:
12e
::&:
::*:
::6::
::*:
::3I::
::Jb:
::&:
::»:
::9t:
::«::
17 ::&:: ¥l::'
TT"
■^sr
::4::
— 5a5
::6::
::7::
:*:
■^
8:*: rnr"
.J^^L.
.^^j.
-7^
1
1
*:
.:»:
:*:
::4c:
::ec:
::7:t
::?::
::J::
•mm
:*J \d^.
:*: :*:
::8:: ::»::
::8:: :*:
—
1
0::6::
::t:
::*:
::*:
12f
::S:
::fc:
::3I::
::ft:
::Sb:
10:*: !"»::
Li
&J-
rU::
—
1 ::«>::
2::*::
3r*:
4::B::
5:reb:
6::ft:
7::fi::
8::ft:
9::tt:
IO::ft:
21 :rftr
22::a:
1 ::^:
:: 2 -*:
----■ 3 =*
::.4 ::i:
:: 5 ::St:
:: 6 3^
--'7 ■-'=-
--■- 8 -*=
:: 9 ::i:
:. 10 i:
:.. Hi:
:: Ig zz
:*:
:*:
:*:
::a::
::!:
::ak:
::a::
riat:
::!:
::a::
::&:
::a::
::*:
:*i
:*:
::*:
::«::
::«::
::4::
::*:
::*:
::4::
::*:
4
12g
::&:
::&:
::&:
::&:
::S:
i:S:
::&:
::&:
::&:
::&:
::5::
::&:
::6::
::fc:
::fc:
r:fc:
::fc:
::fc:
:r6::
::fc:
::fc:
::fc:
::&:
::6::
:r3l::
::*:
::*:
::S:
::*:
::S:
::*:
zzfzz
::5!::
::3I::
::*:
::»:
::»:
::&:
::ft:
::»:
::»:
i:ft:
::&:
rrft:
::&:
::&:
::&:
::&:
::8::
::&:
::a::
::&:
::e::
::e::
::e::
:r8::
::8:r
::B::
I*:
::*:
::a::
-=
::ac:
:*:
::8::
9
::Sk:
11 :*: J::l::
i^
^
:U::
::4::
^
"St:
zzazz
::1:
::»:
12:*: -i.
13:*: :-«::
--S::
:*:
:*:
^_
::4::
7
::S::
::6::
::^:
::8::
::»::
^
IS:*: 1 «a
P
:*:
:*:
::S::
::6::
::!fc:
::8::
::»::
::St:
::Str
::St:
::9::
::a::
::»::
::»:
::»:
16:*: ::l::
17:*: ::!::
18:*: ::!::
:*:
:*:
:*:
:*:
:*:
:*:
::4::
:*:
::4::
8b
::$::
::S::
::»::
::ec:
::»::
::T::
::?::
:*:
::»::
::e::
::»::
::Jt:
—
20 ::e:: ::!::
21 ::&: ::J::
22 ::&: ::J::
23:*: ::!::
::*:
:*:
::2::
::2::
:*:
:*:
:*:
:*:
::4::
::4::
:*:
::4::
8c
::»:
::*:
:=5::
::*:
::fc:
::«c:
::6::
::T::
::7::
::7::
::Jt:
::«::
::«::
::»:
::8::
::*
::»::
::jc;
_z^
^
14 :A:
25 :A:
26r:e::
27::ft:
28::e::
19 -..(tz
30=:e:z
31 ::a::
32::e::
33 r A:
::a::
::]::
::]::
::3::
::a::
::t:
::t:
::t:
::i:
:±:
::8::
::2::
::*:
::2::
::2::
::2::
::2::
::2::
::2::
::2::
:*:
:*:
:*:
:*:
::9::
::i:
::9::
::9::
::3c:
=:a::
=:3::
::4::
::J::
::*:
::*:
::*:
::*:
::*:
::*::
::dt:
::*:
:34::
13b
13c
13d
13e
13f
13g
13h
131
13j
12K
::&:
::5::
::5::
::&:
::5::
::&:
::fc
::&:
::S::
::&:
::S::
:rfc:
::*::
:;fcr
::fc:
::t:
::6::
::&:
:rfc:
::fcr
::6::
::fc:
::3!::
::3t:
::3t:
::5t:
::*:
zzfzz
::*:
::J::
rrS:
::jtr
^~
::St:
::9::
::Sb:
::a::
::Sb:
::9t:
::9::
::9::
::9::
::Sb:
.*:
::St:
=53
:A:
?A^
::9t:
24 ::e:: 1 - 9a
25:*: ::!::
26 :*: ::J::
rS:
I*
::4::
::»:
::6::
::Jt:
::»:
::*:
:*:
:*:
:*:
:*:
::*:
::4::
9b
::*:
::&:
zz^z_
::6::
::t:
zzT-z
zzT-z
_z^^
::8::
::»:
::*
::*
^
Sft:*: ::1::
29 :*r ::»::
:*:
:*:
:*:
:*:
-*-
:^:
zztzz
::4::
9c
::S:
::5::
::6::
::6::
::(c:
zzjzz
z-r-z
r
::8::
::»:
::^:
::*:
::*:
^
31 :*: 1- IC
32 :*: rnr"
-fc:
:*:
1-
:*:
::4::
:^
lia
::*:
i3
::6::
::6::
::»::
::ec:
zzT-z
::Jt:
::Jt:
::?::
::«::
::»:
::8::
::»:
"*:
::»::
::*:
::»::
—
33:*: ::l:
"Fl
::4::
::«::
::»:
::*:
__
34=*:
35r=fc:
3S
pT"
3
::*::
1
::&:
::5::
::6::
::6::
::6::
::6::
::fc
::31::
::3i::
::J::
sljjz;
^^
r*
^~
ii^iw
:*:
:=!::
J5:*: ::!::
J^:*: ::l::
:dt::
:*:
:*:
::«::
12a
::*:
::6::
zzfzz
::»:
::*:
—
STsr
37:*:
::l::
::!:: '
::3::
:*:
:34::
::<::
^3?
::5::
^_
^y:*: ::.::
}8::ef: ::l::
:±:
::2::
:4::
:*:
::<::
::4::
12b
::&:
::S:
::6::
::6c:
::?::
::3t
::»:
::»::
::*:
!^
ST*-
::!::-*:
r?r
::3::
::i::
::&:
::fc:
^^
Z!
B^^*r
::!::
^
:*:
■^3^
^
f::6::
::J::
::3!::
::3i::
S
39:*: ::l::
::Sr.:
:*:
::J::
73
::3::
:*:
:*:
74
zztzz
zzAzz
:3»::
75
::S::
::»:
::*:
7fi
::6::
::6::
::6::
77
::?::
::3t:
::J!::
7«
::8::
:=»:
::8::
79
::»:
::»:
20
40:*:
|::1::
El?"
:*:
::4:=
::&:
::fcj
69 I ::!::
' 72
41::et:
Cols: 1
::J::
9
::2::
3
:*:
4
::«::
::&:
6
::fc:
7
The number and length of interviews needed to complete the form depend on
a variety of factors, such as the personalities of the informants, their
availability for interviews, the style of the interviewer, etc. Whenever
possible, the interviewer should obtain a sufficient number of informants
to cover the included items in the patient's life span adequately. For a
married adult this ideally means a minimum of two people, a spouse and a
parent. Available hospital records as well as additional knowledgeable
informants are desirable. In fact, in dealing with schizophrenic patients
who may be disconnected from any familial setting, an informant such as the
landlady of the rooming-house, a neighbor, or such significant other person
may be preferable as a source of reliable information about the patient's
present circumstances to a relative who has had no real and recent contact
with the patient. In each case, the objective is to acquire pertinent,
reliable information, whatever the source.
Some of the information requested concerns straightforward, factual matters,
such as those specified by the first few items in the form. On the other
hand, a much larger body of material is not strictly "factual" but is subject
to interpretation, and the interviewer must often probe for additional
illuminating information. For example, the discussion about the patient's
past may lead the interviewer to suspect that the patient had been psych iatr ical ly
sick before, despite the informant's earlier statement that the present illness
was the first. By a skillful question, however, the interviewer may elicit
information that confirms or eliminates his hunch.
Every interviewer has to contend with the empirical fact that there is no "one
truth" about a mental illness. To reconcile fragments of historical data and
to arrive at an interpretation which most closely resembles the "objective truth"
is one of the interviewer's most challenging tasks. It requires knowledge,
ingenuity, skill and time. There are circumstances, however, which make it
impossible to obtain reliable information. In these rare instances, the
interviewer is asked to mark "not ascertained" rather than to provide answers
which are mainly guesses."
ERRATA - Raters should make the following corrections in their Demographic Packets:
1. Children's Personal Data Inventory (O^S-CPDl)
Page R-2 - Item 6b. Should read "Mark both 'b and c on Row kO" , NOT "Row 20".
2. Children's Symptom History (044-CSH)
Page L-4 - Item 2b. The word "stomach-aches" is misspelled.
Page L-5 - I tern 7. Insert the letter "i" to the last question of
this item "How do you deal with them?"
Page L-5, Item 11a, Response No. 1 "Not at all" should read "Just a little".
3. Adult Personal Data Inventory (045-APDl)
a) Page L-9 - Item 8a. Insert "15" for Row Number.
b) page L-9 - Item 8b. Text should read "Code diagnosis from those
listed in ECDEU Manual using 4 digits for DSM 11 (Rows 16 - 19)
or k digits for WHO (Rows 16 - 19)".
c) Page R-3 - Item 12e. The Row Numbers for this item should read
"7-9", NOT "5-9".
70
043 CPDI
CHILDRENS
PERSONAL DATA
INVENTORY
CHILDREN'S PERSONAL DATA INVENTORY
INSTRUCTIONS: Insert General Scoring Sheet and Code 10 for Sheet Number. Code 000 for PERIOD.
Raters are cautioned to be particularly careful in coding their responses since several items
have sub parts which must be coded on the same row. Follow the coding instructions carefully.
Complete once for each subject. Please answer all items.
If information is not ascertained, mark a field of "9"s, e.g., 9, 99, 999 etc.
Mark on right half of scoring sheet on row specified
IDENTIFICATION (Note: Sex of subject is coded within Patient Number)
Subject's Age:
Marl^ time units - 1 = mo
nths; 2 = years
and give numeric (2 digits
) on Rows 2 ■ 3
Subject's Race
s: Code both b and c
0 = Caucasoid
1 ■= Negroid
2 = Mongoloid
3 = Other
on Row 4
Has Subject's Residence Been:
5= Primarily urban
6 ^ Primarily suburban
7 - Primarily rural
Subject is the enter number (2 digits) child .
of enter number (2 digits) ch i Id ren , .
(Only child is coded "the 01 child of 01 childn
Is Subject One of Twins, Triplets, etc.?
0= No
1 = Yes, homozygous
2 = Yes, heterozygous
3 = Yes, unknown zygosity
The Subject's Present Fa
(Mark all applicable o
0 = Natural mother
1 = Natural father
2 = Step-parent
3 = Adoptive parent/s
4 = Paid foster parents
lily Constellation Co
' Row 10)
sof:
5 = Adult relative/s Igrandparen
7 = Subject not living with family;
non-psychiatric institution
8 = Subject not living with family,
psychiatric institution/unit
PARENTS' DEfWOGRAPHY
Is either NATURAL parent: Codeboth a and b on Row 11
Dead? 0 - No 2 = Yes, father
1 - Yes, mother 3 = Yes, both
5= No
6 = Yes, mothe
7 = Yes, father
8= Yes, both
Mother or mother surrogate presently in the home
(2 digits) 00 = Not applicable
Father or father surrogate presently in the hon
(2 digits) 00 = Not applicable ....
Continue marking on right half of scoring sheet on row specified
PARENTS' EDUCATION
Mother or Present Surrogate Code highest level attained for MOTHER
Father or Present Surrogate Code highest level attained for FA THER
0= Not applicable
1 = Graduate professional training
2 = College graduate
3 = Some college or technical school
4 = High school graduate
5 = Some high school (10-11)
6 = Junior high school (7,8,9)
7 = Less than 7 years of school
9 ^" Not ascertained
PARENTS' OCCUPATION
Mother's or Female Surrogate's Present Occupational Status is:
Father or Male Surrogate's Present Occupational Status is:
Use this code for g and h: 0 = Not applicable
1 = Full time gainful employment
2 = Part time gainful employment
3= Unemployed
4 = Dependent spouse or student
5 = Recipient of public or private
Mother's or Female Surrogate's Highest Occupational Attainment is:
Fathers or Mate Surrogate's Highest Occupational Attainment is:
Use this code for i and j. See Manual for detailed list of occupations.
1 = Higher executive, proprietor of large concern, major professional
2 = Business manager of large concern, proprietor of medium-sized
business, lesser professional
3 = Administrative personnel, owner of small independent business,
minor professional
4 ^ Clerical or sales worker, Technician, ov/ner of little business
5 = Skilled manual employee
6 = Machine operator, semi-skilled employee
7 - Unskilled employee
8 = Never worked in paid employment
9 = Not ascertained
Has either parent or present surrogate been:
Mark one response for 0 = Neither parent
each item using this code: i = m he-
Out of home (3 months or longer) due to physical c
Separated (3 months or longer) due to marital diff i
Cruel or abusive (to patient, spouse, siblings, etc.)
Not a steady worker or competent houiev/rfe
2 = Father
3 = Both parents
r mental illness .
ulties . . . .
ROv7
72
CHILDREN'S PERSONAL DATA INVENTORY
Continue marking on right half of scoring sheet on row specified
FAMILY HISTORY OF PSYCHIATRIC ILLNESS
Has there been a history of psychiatric illness in family member/s?
Mark aft applicable 0 = None of the members
for each item using , _ m . ■ „ .u
.. . , ^ 1 = Natural mother
this code:
2 = Natural father
3 = Siblings
Non-psychotic psychiatric disturbance
Manic-depressive disturbance
Other major affective disturbance .
Schizophrenia
Other psychotic disturbance
Hospitalized for any psychiatric illness
Mental deficiency
Excessive use of alcohol ....
Excessive use of drugs
Imprisonment
5 = Present mother
surrogate
6 = Present father
surrogate
SUBJECT'S HISTORY OF PSYCHIATRIC ILLNESS
Code both a and b on Row 36
1 = Not in any type of psychiatric treatment
2 = In psychiatric treatment as an outpatient
3 = In partial hospitalization, e.g., day or night
hospital, halfway house, etc.
4 = Hospitalized (24 hour)
Prior to this episode^ 5 = Never had any type of psychiatric treatment
' ' 6 = Received psychiatric outpatient treatment
(Mark all applicable) ., „ -j^ . ^- ^-ii. -i-
^^ ' 1 = Received treatment m partial hospitalization
setting
8 = Received treatment in 24-hour hospital
"Psychiatric treatment" should be interpreted broadly to include all forms
of therapy whose basic function is the alleviation of emotional, behavioral
or mental disturbance. "Partial hospitalization" and 24-hour hospitaliza-
tion include all forms of treatment environments in which the subject
spends a substantial part of the day or, in the latter case, the full day.
Age (years) when first received treatment for psychiatric illness (2 digits)
00 = Never treated
Estimate total duration of ALL outpatient psychiatric treatment -
exclusive of present episode
Give time units ( 0 = days; 1 = weeks; 2 = months; 3 =
duration (2 digits)
EXAMPLE: Subject's total treatment amounts to 10 months.
Code 210. 000 = No outpatient treatment
/\4ark on left half of scoring sheet on row specified
SUBJECTS HISTORY OF PSYCHIA TRIC ILLNESS - Continued
Estimate total duration of ALL partial hospitalization - exclusive <
present episode
Give time units ( 0 = days; 1 = weeks; 2 = months; 3 = years)
and duration (2 digits) 000 = No partial hospitalization
Estimate total duration of ALL hospitalizations (24 hour) exclusive
of present episode
Give time units ( 0 = days; 1 = weeks; 2 = months; 3= years)
and duration (2 digits)
EXAMPLE: Subject's total hospitalization amounts to 4 years
Code 304 000 = No hospitalizations
Duration of present episode
Mark whether coded in 0 = days 1 = weeks 2 = months 3 = years
and give duration (2 digits) 000 = Not applicable
SUBJECT'S DEVELOPMENTAL HISTORY
Code a, b and c on Row 10
Pregnancy and Neonatal Course Were:
0 = Normal
1 = Suspected abnormalities
2 = Definite abnormalities
3 = Not ascertained
Were there infant fei
4 = YES
5= NO
6 = Not ascertained
ding problems?
Colic?
7 = YES
8= NO
9 = Not ascertained
For each of the following items d through V., record mor
2 digits and judge rate of development on next row:
Age (months) first ate solids - not pureed or strained food
Considered 0 = Slow; 1 = Normal 2 = Fast
Age
(months) first fed self with a
spoon
Considered 0 = Slow
1 = Normal, 2= Fast
Age
(months) sat unsupported
Considered 0 = Slow
1 = Normal; 2= Fast
Age
(months) first walked by self without holding on
Considered 0 = Slow
1 = Normal: 2= Fast
Age (months) first words other than Mama and Dadda
Considered 0 = Slow; 1 = Normal, 2 = Fast
73
CHILDREN'S PERSONAL DATA INVENTORY
ROW
NO.
Continue marking on left half of scoring sheet on row specified
26-27
28
Age (months) of speaking 3-word sentences
Considered 0 = Slow; 1 = Normal; 2 = Fast
29-30
31
32-33
34
j-
Age
(months) trained bladder during day
Considered 0 = Slow; 1 = Nornnal,
2 =
Fast
k.
Age
(months) trained bowels
Considered 0 = Slow; 1 = Normal,
2 =
Fast
1.
Age
(year) began menstruating (2 digits)
00 = Not applicable
Mark m. n and o all on Row 37
Masturbates?
0= NO 1 = YES
2 = Not ascertained
n. Does he/she dress in clothes or play with toys of opposite sex?
3 = NO 4 = YES 5 = Not ascertained
o. Does he/she express a desire to grow up to be a member of
opposite sex?
6 = NO 7 = YES 9 = Not ascertained
SUBJECT'S SCHOOL HISTORY
Current Grade Placement (2 digits)
Number grades 01 — 12
20 = Preschool 23 = Special or Ungraded
21 = Nursery 24 = Not in school
22 = Kindergarten
Mark both b and c on Row 20
Child's School History is Best Characterized by:
0 = Not applicable
1 = No significant problems
Minor problems or
occasional difficulties
3 = Major problems seen
only in current year
■ Major problems throughout
school history with periods
of quiescence; "up and down'
Major problems almost con-
tinually since entrance into
school
In General Academic Achievement Has Been:
6 = Above average
7 = Average
8 = Below average
ATTITUDE TOWARD PRESENT TREATMENT
At pretreatment, the attitudes of the child and his parent/s were:
Make 2 marks (one for child, one for family) both on Row 41
0 = Child positive
1 = Child Indifferent
2 = Child ambivalent
3 = Child negative
4 = Child's attitude
not ascertained
5 = Family positive
6 = Family indifferent
7 = Family ambivalent
8 = Family negative
9 = Family attitude
not ascertained
Ih
The Children's Personal Data Inventory (CPDl) is a 55-item scale formatted
for use with the General Scoring Sheet. Its purpose is to gather social and
demographic data concerning the child and his family. The content of the CPDl
was developed by members of the Pediatric Psychopharmacology Workshop. Wherever
possible, items were made compatible with similar items contained in the Adult
Personal Data Inventory (045-APDl).
APPLICABILITY - Children to age 15.
UTILIZATION - Once per subject
CARD FORMAT - ITEMS
CARD 01 = (19x, 211, 12, 211, 222, II, 13, 211, 212, 1011, 1012, 211, 12)
Item Column Item Column
Sex*
20
la
21 - 23
b
Ik
c
25
d
26 - 29
e
30
f
31 - 33
2a
3^
b
35
c
36 - 37
d
38 - 39
e
ho
f
k\
9
kl
h
hi
i
kk
J
kS
2k
46
1
47
m
48
n
49
3a
50 - 51
b
52 - 53
c
54 - 55
d
56 - 57
e
58 - 59
f
60 - 61
g
62 - 63
h
64 - 65
i
66 - 67
j
68 - 69
ka
70
b
71
c
72 - 73
* = This item is added to the card output.
CARD 02 = (19x, 4l3, 311, 813, 12, 311, 12, 211, 12, 211, 12)
Item
Column
4d
20 - 22
e
23 - 25
f
26 - 28
g
29 - 31
5a
32
b
33
c
34
d
35 - 37
e
38 - 40
f
41 - 43
g
44 - 46
h
47 - 49
i
50 - 52
tem
Column
5j
53 - 55
k
56 - 58
1
59 - 60
m
61
n
62
o
63
6a
64 - 65
b
66
c
67
7
68 - 69
Soc.Class M** 70
'" •" F*>> 71
Developmental
Index-'nv 72-73
**= These items are calculated and punched on the card via programming,
75
SPECIAL INSTRUCTIONS
All of the items on the CPDI can be encoded on one General Scoring Sheet.
As a result of this "packing of data", raters are cautioned that the encoding
procedures are intricate and that close attention should be paid to the
instructions printed on the scale and given below.
I tern la. Age - Three marks are required for the encoding of this item:
a designation of the time unit - month or year - in Row 1
and the numeric for age in Rows 2 and 3.
Examples:
Subject is 6 years old. Encode 206.
l:.ft= ~t: .^ ..*: :=*: ---&- ==fc: --r.- "ft: IfS:: .J I me Unit
2>«> ::t: ---t-. z-.t-. -.-.4:z ----&-- ~fc: "3t: "ft: ::*:-•
3::fti ---t-- ----t- ::»- ::*: --&- "^ "S: ::ft: ^^i: -* N Ume ra 1
Subject is 72 months old. Encode 172.
1 ::ft: -fc ~±: ::*: ::*: ::S:: ::fc: ::7:: ::8:: ::»::— J J me Unit
2 ::ft: --t: ::4: ::*: ::*: ::5:: ::fc: avhi ::8:: :*: -1
3::ft: -3. -ft. .=3:: =:*: ::&: ::fc: .r.- :*: :*: J Numeral
Age encoded in years should be given to the nearest whole
year; age in months to the nearest whole month.
Item lb and Ic. Race and Residence - Both of these items are encoded on Row k.
Subjects of mixed racial heritage should be encoded "Other".
Example: Subject is negroid and her residence is
primarily urban. Encode 1 and 5.
A----0:-- -*• ::*: :=*= ==*-
::fc: -.-.Jzz ::ft: ::*:
Where there is difficulty in deciding primacy of residence,
encode the most recent residence.
Example: For approximately one-half of his life, a boy lived
in an urban area. Since then, however, his residence
has been suburban. Encode "Primarily suburban".
4::a:: ::t: ::2:: ::3:: ::*: =:S:: mtm ::?:: :*: :*:
76
Item Id. Sibling sequence - Consider only maternal natural siblings. Encode
the child's position in the sibling sequence in Rows 5-6 and the
total number of siblings in Rows 7-8.
Example: The child is the fourth of six children. Do not leave
any blank rows and encode as follows:
5-*. ::*: "i= -ztL- :=*= "i= "fr: =;*: ==ft
6;=©:= rrt: :r2:z -J:; >^. -.&- r^fcz =:Z:i zzBi
"Sb-
""H Chi Id's pos it ion
8;:0:= zzy.z ==2:= rrjrr 1:14:1 -&: >^ i^Jt: "8:= i:9:=J TOtB 1 Siblings
7-ft» "li: "i: "J:: 1:4:: .z&: zztt: -zfzz =z8:; ::!: .
I tern If. Present family constellation - The rater should mark all
individuals living together as a family at the start of the
study. All responses are encoded on Row 10.
Examples:
a. The child lives with his mother and stepfather. There
are two natural siblings and one step-sibling living in
the home along with a maiden aunt. Encode 0-2-5-6 on Row 10.
10-^ .--i.-- -*. ;:3:: -4ZZ -*. -^ -r.- ,,6:: ==9::
Mother Stepfather Aunt Siblings
b. The chi Id is a state ward. His family is unknown and he is
currently residing at the state orphanage. Encode as follows:
1 0 =*: --i--- --^-- --^-- :^: -^-- -^-- «l~ ==8== =*:
t
1 nst i tut ion
To conserve space on card decks, a coding system has been
developed which reduces the multiple entries of this item to a
2-digit field. The codes are given in Table h. These codes
should NOT be used by raters when recording (encoding) data.
They are generated as output.
Example:
Output Code 33 = Response positions 0, 1 and 6; I.e., the rater
coded mother, father and siblings as constituting the present
family constellation.
77
TABLE k
CODES FOR CPDI ITEM If - PRESENT FAMILY CONSTELLATION
4-> — Q.
Card
Response
Code
0
1
2
3
k
5
6
7
8
9
Pos it ions
00
X
9
0!
X
6
02
X
5
03
X
X
5.6
Ok
X
k
05
X
X
k.e
06
X
X
k,5
07
X
X
X
4,5,6
08
X
3
09
X
X
3.6
10
X
X
3.5
11
X
X
X
3,5.6
12
X
2
13
X
X
2.6
14
X
X
2,5
15
X
X
X
2.5,6
16
X
1
17
X
X
1,6
18
X
X
1.5
19
X
X
X
1,5,6
20
X
X
1 ,2
21
X
X
X
1.2.6
22
X
X
X
1,2,5
23
X
X
X
X
1.2,5.6
2k
X
0
25
X
X
0.6
26
X
X
0,5
27
X
X
X
0.5.6
28
X
X
0.2
29
X
X
X
0,2,6
30
X
X
X
0,2,5
31
X
X
X
X
0.2,5,6
32
X
X
0,1
33
X
X
X
0,1,6
3k
X
X
X
0,1.5
35
X
X
X
X
0,1,5,6
36
X
7
37
X
8
88
Ml
egal
or 1
mprc
>babl
e F£
imil^
f Cor
iste
lat
on
78
Item 2. Parents' Demography - Items 2a and 2b refer to NATURAL PARENTS.
Subsequent items (2c through 2n) refer to natural parents or
their surrogates - whichever are PRESENTLY part of the family
constellation, i.e., at the beginning of the study.
Item 2a and 2b. These items are both encoded on Row 11.
Example: Neither of the child's natural parents are dead or
divorced. Encode 0 - 5 on Row 11.
1 1 ■•■ ::»:: =*- :*; ::4:: »*■ ;;t; ::*: "ft: ::St:
Dead Divorced
When information about the natural parents is not available,
response position "k" may be used to indicate lack of informa-
tion about death; position "9" to indicate lacl< of information
about divorce.
Items 2g through 2j . Parents' occupational status - The parents'
present occupational status (items 2g and 2h) are encoded
on l^ows 18 (mother) and 19 (father) using the 5 categories
given. More than one response may be encoded. Multiple
entries will be recoded on card decks using the following
1-digit system.
Rater should If he wishes
Encode these Response/s Description
S 2,5 Part-time employment and recipient of
ass istance
7 3,5 Unemployed and recipient of assistance
8 4,5 Dependent student/spouse and recipient
of assistance
The parents' highest occupational status (Items i and j) are
encoded on Rows 20 (mother) and 21 (father) using the 8
categories given. A list of occupations adapted from
Hollingshead are given in Appendix I and should be used in
classifying specific occupations.
Example: Fathe;r is a skilled machinist who is currently
unemployed and receiving public assistance.
Encode both "unemployed" (3) and "receiving
public assistance" (5) .on Row 19. Encode "skilled
machinist" (5) on Row 21.
19::ft= ::fe ::£: mS^
Present Status
2\zdtz =*: zzAz :Az zz4= mtm irfc: ::fc ~fc -sti Highest StatUS
79
COMPUTATION OF SOCIAL CLASS
Social class for each parent is computed from their highest educational
level and highest occupational level using the Hollingshead method.
(Hoi 1 ingshead, A.B., Two Factor Index of Social Position, I965 Yale Station,
New Haven, Connecticut, 195'/).
The calculation of computed score for social class is as follows:
Factor Weight
Occupation Score (1-7) X 7 = Weighted score
Education Score (1-7) X k = Weighted score
Sum of weighted scores = Computed Score
Social Class is assigned on basis of Computed Score as follows:
Class Computed Score
I 11-17
II 18 - 27
III 28-43
IV Mf - 60
V 61-77
Example: A graduate of a college nursing program is currently
employed as an OR (Operating Room) supervisor. Her
social class is calculated as follows:
Occupation = 2 x 7 = 1^+
Computed score = 22 Social Class = 2
Education =2x4= 8
22
Social class for each parent is calculated via programming and documented in
the output.
80
?^^
•'%)■
I terns 2k through 2n. Each of these k items requires a single response using
the code provided:
0 = I tern applies to neither parent.
1 = Item applies to mother only.
2 = Item applies to father only.
3 = I tern applies to both parents.
Example: The father, a sporadic worker, left the home
6 months ago after assaulting his wife. The
mother has been hospitalized for psychiatric
illness for periods up to one year. She is
considered a poor housekeeper but has never
been abusive to the children. Encode as follows;
22 "ft: :ii" "t- m^ -.Jt-. Qut of home
22-A-. -i-.- w^m -..i=- --^- Marital
24=:ft: "J" "^ -^- -^ Cruel
25=:ft= ----i--- --^-- <^m z-n^-. Not steady
Item 3. Family History of Psychiatric Illness - For each of the 10 items
(a through j), one to five positions may be encoded depending on
the number of family members exhibiting the condition.
Example: While none of the members of this typical family are
considered psychotic, the father has been hospitalized
for alcoholism. The mother and youngest daughter are
considered mentally retarded and an older brother is
in prison for selling drugs to support his habit. Encode
as fol lows:
26 =.-6::
:it:
::2.--
^fc
z:A::
::&:
::fc:
::?::
::B::
rrSt:
a
27 «M
i:t:
::fc
::»::
::*::
::&:
::t::
:zJ::
r:ft:
::9t:
b
28 ate
zzi"
"2::
r:!:
::«::
::S:
::t:
::3t:
::ft:
"St:
c
29^
::fc:
;;2::
::!:
::<::
::&:
::6::
::*:
::&:
::9ti
d
30 lite
:it:
riii
::9t:
::*::
::5::
::*::
::?::
::8::
::Sk:
e
31 -.-Az
::tr
>ite
::!:
::A:
::ft:
::fc:
::3i::
::&:
::9t:
f
32r:ft:
-te
::*:
-te
::*:
::ft:
::fc:
::Jt:
::&:
::»::
g
33::e::
zzUz
-te
:a:r
:=«::
::&:
::6::
::?::
::B::
::Sfcr
h
3A-.d6z.
zzlii
:±:
-^
:=«::
::5::
::fc:
::Jt:
::ft:
::9b:
1
35:*=
"Ir:
1:4::
i«.
:3«::
::*::
::fc:
::J::
::8::
::»::
J
The multiple entries possible on this item have been reduced to a 2-digit
coding system which will appear on all card decks. (Table 5).
81
TABLE 5
CODES FOR CPDI ITEM 3a-3j - FAMILY PSYCHIATRIC ILLNESS
^ ^ en
J-J 4-1 c
— u
Card
Response
Code
0
1
2
3
5
6
9
Pos it ions
GO
X
9
01
X
6
02
X
5
03
X
X
5,6
Ok
X
3
05
X
X
3,6
06
X
X
3,5
07
X
X
X
3,5,6
08
X
2
09
X
X
2,6
10
X
X
2,5
11
X
X
X
2,5,6
12
X
X
2,3
13
X
X
X
2,3,6
14
X
X
X
2,3,5
15
X
X
X
X
2,3,5,6
16
X
1
17
X
X
1,6
18
X
X
1,5
19
X
X
X
1,5,6
20
X
X
1,3
21
X
X
X
1,3,6
22
X
X
X .
1,3,5
23
X
X
X
X
1,3,5,6
2k
X
X
1 ,2
25
X
X
X
1,2,6
26
X
X
X
1,2,5
27
X
X
X
X
1 ,2,5,6
28
X
X
X
I ,2,3
29
X
X
X
X
1,2,3.6
30
X
X
X
X
1,2,3.5
31
X
X
X
X
X
1,2,3.5,6
32
X
0
82
tern k. Subject's History of Psychiatric Illness - Item ka , Treatment
Status, and I tern 4b, Prior History, are both encoded on Row 36.
Only ONE Treatment Status may be marked; but as many marks as
necessary (maximum of 3) may be used for Prior History.
Example: The child - currently hospitalized (24-hour) - has
had previous outpatient treatment and previous
24-hour hospitalizations. Encode 4-6-8 on Row 36.
36:A= --U- -.:3^. .^- ■^m -i:- mtm -r.- •^ ;;»:
t t t
Present Previous Previous
Hosp. OP Hosp.
As noted within the Demographic Packet, "psychiatric trfeatment"
should be interpreted broadly to include all forms of generally
accepted therapies; e.g., chemotherapy, individual and group
psychotherap ies , behavior modification, counseling for behavioral or
emotional problems, etc., provided by any of the professionally
recognized disciplines; e.g., psychiatrist, pediatrician,
physician, psychologist, social worker, supervised paraprofess ional s ,
etc .
Since multiple entries are possible (maximum of 3) on 4b, a 1-digit
coding system has been developed for card decks.
Code Response Positions Description
0 9 Not Ascertained
1 8 24-hour hospitalization
2 7 Partial hospitalization
3 7,8 Partial , 24-hour
4 6 Outpatient
5 6,8 Outjsatient, 24-hour
6 6,7 Outpatient, partial hospitalization
7 6,7,8 Outpatient, partial, 24-hour
8 5 Never had treatment
Item 4c. First treated - Encode the age at which the subject first
received any psychiatric treatment. To record the fact
that the subject has never been "treated", the rater must
encode "00" - leaving the item blank will be interpreted
as missing data. The code "99" indicates Not Ascertained.
83
Items kd through kg. Duration of Treatments - Each of these k items
requires a 3~digit entry: one digit indicating
the time unit and 2 digits indicating the numeric
for duration. Whichever time unit is employed,
encode to the nearest whole unit.
Examples: If time unit is weeks: 11 days is encoded as 2 weeks.
If time unit is months: 11 weeks is encoded as 3 months.
If time unit is years: 13 months is encoded as 1 year.
"Outpatient psychiatric treatment" is to be interpreted broadly to include
all forms of accepted therapy for behavioral or emotional disorders for which
there are no " i n-res idence" requirements; e.g., outpatient hospital clinics,
office visits to private practitioner, "the 50-minute hour", child guidance
clinics, etc. "Partial hospitalization" refers to all therapies in which there
is a "residency" requirement - either in terms of a certain portion of the day
or in terms of a specific living situation; e.g., day hospitals, night hospitals
half-way houses, etc. "2^ hour hospitalization" refers to therapies in which
full time residency is a requirement; e.g., public or private psychiatric
hospitals, psychiatric wards of general hospitals, schools for the emotionally
disturbed, etc.
I tern 5. Subject's Developmental History - I terns 5a, b and c are all
encoded on Row 10. Note that response positions 3 and 6 as
well as 9 serve as "Not Ascertained" for this 3~part encoding.
Example: Pregnancy and neonatal course were considered
normal, however, the child had feeding problems
and colic. Encode O-k-J on Row 10.
10i.«. -i.- -..%-. zr:== -*. -.-&-- z-M-.- ■*. .=6:= ==9::
Pregnancy Feeding Colic
I terns 5d through 5k. Each of these items requires the recording of age
in months and a judgment of developmental normality.
If the information for one of the items is not
available, CODE '999".
The following table - supplied by Dr. Rachel G i ttelman-Kl e i n
provides developmental norms for each of the 8 items. Other
developmental inventories which may be of interest are:
1. Frankenburg, W. K. and Dodds , J, B., The Denver Developmental
Screening Test, J. Pediatrics, 71, 2, I8I-I9I, August, I967.
2. Ireton, H. R. and Thwing, E. J., Minnesota Child Development
Inventory, published by Interpretive Scoring Systems, kkO]
W. 76th St., Minneapolis, Minnesota, 1972.
84
MONTHS
1 tern
Slow
Normal
Fast
5d
First
ate sol ids
13
or
more
8-12
7
or
less
e
First
fed self
2k
or
more
12-23
11
or
less
f
First
sat alone
8
or
more
5-7
k
or
less
g
First
wa 1 ked
]k
or
more
11-13
10
or
less
h
First
words
21
or
more
12-20
11
or
less
i
Speak
ng sentences
^3
or
more
2it-U2
23
or
less
J
Trained bladder
29
or
more
18-28
17
or
less
k
Trained bowels
25
or
more
15-24
14
or
less
Developmental History Score - Items 5d through 5k are used to
calculate a developmental score. Using the 3-point scale, the
8 items are added together and the sum is divided by the number
of items minus "Not Ascertained". Five of the 8 items must be
present, however, for a score to be computed. Developmental
scores below 1 reflect slower development; those above 1 reflect
accelerated development.
I tern 51. Age of Menstruation - This item requires the encoding of the
YEAR of menarche.. The code, "00" - NOT 2 blanks - indicates
"Not applicable"; The code "99" indicates "Not Ascertained".
No judgment of developmental normality is required.
Items 5m, These 3 items are all coded on Row 37. Response positions 2
5n, and and 5 as well as 9 serve to indicate "Not Ascertained".
5o.
Example: A child who masturbates but does not crossdress
or express a desire to be a member of the opposite
sex should be encoded 1-3-6 on Row 37-
37 ::&:: ata ::2=; ^m :^i
Masturbates |
Crossdress
Oppos i te
Sex
85
Item 6. Subject's School History
6a, Current grade placement - give 2-cligit numeric code for grades 01
through 12 or use the following special codes:
20 - Preschool
21 - Nursery
22 - Kindergarten
23 - Special or ungraded
2k - Not in school
99 - Not ascertained
When child is in-between grades, e.g., has finished the fourth
grade and is about to enter (promoted to) the fifth, encode the
higher grade (05) •
Item 6b Note that both of these items should be encoded on Row ^0 - NOT
and 6c. Row 20 as indicated on the packet. Both require a "global
judgment"; i.e., an overall characterization of the child's
behavior and academic achievement.
Example: The child has shown major problems only in the current
year and his overall academic achievement is considered
above average. Encode 3-6 on Row kO.
40 zdOzz "Jir ==J" .^mm. -^zz "*: ■*» "Jt: "8:= --9:z
/
Problems Achievement
Item 7. Attitude toward Present Treatment - Judgments of both the child's
and the family's attitudes are required and both are encoded on
Row k] . Note that response position k as well as 9 are used to
indicate "Not Ascertained".
Example: Although the child feels positive toward treatment,
her family is decidedly negative. Encode 0-8 on Row ^1
41 -i- z-l.-- --:i-z =:3" --A---- "*= "«== --^- -•• -=*=
Child Family
Documentat ion
a. Raw score printout
b. Frequency Tables
c. Cross-tabulations
86
044 CSH
CHILDRENS
SYMPTOM
HISTORY
CHILDREN'S SYMPTOM HISTORY
INSTRUCTIONS: Insert New General Scoring Sheet and Code 11 for Sheet Number. Code 000 for PERIOD.
Mark NO or YES tor ALL items in bold type. All items in light type (a., b., c, etc.) mark only
NO YES
EXAMPLE: 2b
the YES responses.
What time of day does he/she have stomach-aches?
1 . Morning
2. Day
3. Evening
4. Night
5. Varies
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND
DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
Mark each item on right half of scoring sheet on row specif ied
Mark NO or YES in columns 18 and 19
Does he/she ever have severe headaches? .
Is he/she sick with them? . . . .
Does it affect his/her sight at all? . .
Does he/she ever have stomach-aches? ....
Does he/she vomit when he/she has stomach-aches?
What time of dav does he/she have stomaches?
1. Morning
2. Day
3. Evening
4. Night
5. Varies
Are stomach-aches more on weekends than during the week? .
Does he/she get stomach-aches during school holidays?
Is he/she ever sick at his/her stomach (Nauseated) ?
Does he/she vomit when he/she is nauseated?
What time of day is he/she nauseated? .... 1. Morning
2. Day
3. Evening
4. Night
5. Varies
Is he/she nauseated more on weekends?
Does he/she ever wet his/her bed?
How often does he/she wet the bed? 1. Occasionally
2. Often
3. Constantly
Has he/she always wet the bed?
When did he/she start? 1. 2-5 years old
2. After 5
3. After 10
What is the longest period he/she has been dry? . . 1, Days
2. Weeks
3. Months
Does he/she wet when away from home such as
when with relatives or on holiday?
Does he/she ever wet his/her pants? ....
Does he/she wet his/her pants regularly? .
Has he/she always wet his/her pants? .
Did he/she start before he/she was 5 years old?
What is the longest period he/she has been dry?
Days
Weeks
Months
Does he/she v
with relatives
when away from home such £
3n holiday?
ill him/herself? .
Columns
12 13
16
19
Continue marking NO or YES in columns 16 and 17 on row specified
rRBWI
Continued
Does he/she soil him/herself regularly?
Has he/she always soiled him/herself regularly?
Did he/she start before he/she was 5 years old? . . . " . .
What is the longest period he/she has been clean? 1. Days
2. Weeks
3. Months
Does he/she ever have temper tantrumi?
What are they like? Does he/she scream? ,
Does he/she lie on 4he floor?
Does he/she break things? ,
How of ten? 1. Daily
2. A few times per week
3, A few times per month
Do they last a long time?
What seems to bring them on? . . . 1 . Spontaneous , . . ,
2. Frustration or stress
3. Fatigue
Does he/she have tantrums when at school?
Does he/she have tantrums when with relatives or friends? . . . .
How do you deal with them? 1. Ignore
2. Restrain
3. Punish
Has he/she in the last year c
ried or been tearful when going to school? .
Has he/she ever refused to go to school?
Has he/she ever truanted from school?.
How often? 1. Once only
2. Occasionally
3. Often
Did he/she go home when he/she should have been at school?
Did other children truant with him/her?
Does he/she gat on with his/her brothers/sisten?
How much do they fight and squabble? .... 1. Not at all
2. Quite a bit
3. A lot
12. Does he/she get along with you?
13. Does he/she get along with your husband/wife?
E he/she an affectionate child?
15. Does he/she stutter or stammer?
16. Has he/she any other difficulty with speech?
17. Has he/she ever taken things that don't belong to him/her?
CHILDREN'S SYMPTOM HISTORY
Continue marking NO or YES in columns 14 and 15 on row specified
17. Continued
m. Does he/she take things frequently?
b. Did he/she take things from home?
c. Did he/she take things at school?
d. Did he/she take things from shops?
•. Was he/she with others when he/she took things?
I. Any contact with police?
18. Is there any difficulty now with eating?
19. It ther* any difficulty now with sleeping?
a. Does he/she have any difficulty getting off to sleeps
b. Does he/she ever wake in the night?
c. Does he/she scream?
d. Does he/she conne to your bed?
•. Does he/she ever have nightmares or wake up with bad dreams? .
f. Does he/she ever walk in his/her sleep?
g. Does he/she wake early? (More than normal for age)
20. Is he/she a fidgety child?
a. Are there times when he/she doesn't fidget at all?
21. Is he/she a destructive child?
a. Does he/she break up his/her own things?
b. What about other people's things?
c. Does he/she break things frequently
22. Does he/she gel into things that don't concern him/her?
23. Does he/she tend to get into a lot of fights?
a. Are they "friendly" fights?
b. Are they "real" fights?
24. Does he/she get on poorly with other children?
25. Has he/she got any particular friends?
26. Does he/she see them frequently outside school?
Z7. Does he/she get bullied or picked on at all?
28. Do«she/she tend to pick on or bully other children?
29. Is he/she a good mixer?
30. Does he/she tend to do things on his/her own?
31. Does he/she worry a lot about things?
32. Does he/she get irritable or cross easily?
33. Is he/she generally unhappy or miserable?
34. Does he/she have any mannerisms or tics such as twitches of his/her face
or shoulders?
35. Does he/she suck his/her thumb?
36. Does he/she suck anything else?
37. Does he/she bite his/her nails?
38. Does he/she bite pencils or anything else?
39. Is he/she disobedient a lot?
Continue marking NO or YES in columns 12 and 13 on row specified
39. Continued
a. Is he/she disobedient with other people?
40. Is his/her concentration poor?
41. Has he/she got anythirtg he/she's afraid of — like dogs or cats — or the dark?
42. Does he/she tend to be over-fussy about things?
a. Are there things he/she insists on doing only in a special way — like
getting dressed or v^rashing?
b. Has he/she got any silly habits or rituals?
43.
Does he/she tell lies?
Does he/she now, or at any time in the past, show the following signs of
an unusual amount of activity?
Wears out crib, toys, faster than other children?
Wears out bike, toys, faster than other children?
Wears out shoes, clothes, faster than other children?
45. Would you say he/she is very overactive or restless?
89
The Children's Symptom History (CSH) is a 104-item, 2-point scale formatted
for the General Scoring Sheet. The CSH is an extension of the Children's Personal
Data Inventory (CPDl) and is designed to record the occurrence of syrtiptoms during
the child's life as reported by the CPDl informant/s. The CSH was adapted by the
Pediatric Psychopharmacology Conference from a medical and social history
questionnaire developed by Satterfield.
APPLICABILITY
Children to 15
UTILIZATION
TIME SPAN RATED
Once for each subject
No specific time span for many of the items; others
have clearly delineated time spans.
CARD FORMAT - ITEMS
CARD 01 = (19x, 56ll)
Item Column
1
20 - 22
2
23 - 31
3
32 - 39
CARD
02 =
(19x, 5611)
Item
Column
7f-7i
20 - 27
8
28
9
29
10
30 - 35
11
36 - 39
12
ko
13
k]
]k
k2
CARD
03 =
(19x, 2211)
1 tern
Column
29
20
30
21
31
2i
32
23
33
2k
34
25
35
26
36
27
37
28
Item
Item
k
5
6
7-7e
Column
Item
Column
kO - 51
52 - 59
60 - 67
68 - 75
I tern
Column
!5
43
22
67
16
Mf
23
68 - 70
17
45 - 51
24
71
18
52
25
72
19
53 - 60
26
73
20
61 - 62
27
74
21
63 - 66
28
75
Column
38
29
39
30 - 31
40
32
41
33
42
34 - 36
^3
37
44
38 - 40
45
41
Total
Score
42-44
90
COMPUTATION OF TOTAL SCORE - Total score for the CSH is calculated so as to
reflect the degree of pathology; i.e., the higher the score the greater the
number of symptoms reported as present in the child's history. Items encoded
YES are scored as "1"; those encoded NO are scored as "0". The exceptions to
this rule are as follows:
a. Items scored on a scale of 1 to 3
ka - Constantly = 3, Often = 2, Occasionally = I
kc - After 10 = 3, After 5 = 2, 2 - 5 years = I
kd - Days = 3, Weeks = 2, Months = 1
5d - Days = 3, Weeks = 2, Months = I
6d - Days = 3, Weeks = 2, Months = 1
yd - Daily = 3, Few Times-week = 2, Few Times-month = 1
7f - Spontaneous = 3. Frustration = 2, Fatigue = 1
10a - Often = 3, Occasionally = 2, Once = 1
lla - A lot = 3, Quite a bit = 2, A little = 1
b. Items reflected in scoring;
i.e., NO = "1"
Items not included
in total score
12
25
13
26
]k
29
20a
30
23a
2b 7i
2c I Ob
2d lOc
3b i7e
3c
Total Score = Sum of Items
SPECIAL INSTRUCTIONS
Range =0-115
Time Span Rated - Note that the CSH contains some items which ask whether a
symptom HAS EVER OCCURRED in the child's lifetime and others which ask whether
a symptom occurs at a specific time or under specific conditions. Since most
of the rating instruments in the Battery have a uniform, circumscribed time-
span for all items, the rater is cautioned to be particularly alert to varying
"time" conditions of the CSH items.
Obtaining Symptom History - While it is not necessary to follow the sequence
of items, the rater is urged to make every effort to elicit responses to all
items. Should the respondent be uncertain or ambiguous about the presence of
a symptom or the rater question the validity of the response, the item should
be left blank.
Encoding Dependent Items - The CSH has a quas i-Guttman quality to it in that
series of items are dependent upon positive response/s to previous item/s. To
reduce the encoding required of the rater, ONLY THE ITEMS IN BOLD TYPE MUST
ALWAYS pE MARKED YES OR NO. These are the "numbered" items (1-45). The items
in light type ("lettered" items) should be marked only when the response is
positive, i.e., YES or present.
91
Example 1: A "NO" response to Item 5 automatically means that Items
5a, 5b, 5c, 5d, and 5e should ALL be encoded "NO". Encode
"N0"(7) in Row 33, Column 18 and leave Rows 3^ tnrough kO ,
Columns 18 and 19 blank.
33
34
b.
Has he/she always wet his/her pants? ....
35
c.
Did he/she start before he/she was 5 years old? .
36
d.
What is the longest period he/she has been dry? .
. 1. Days
37
2. Weeks
38
3. Months
39
e.
Does he/she wet when away from home such as
with relatives or on holiday?
40
33
^
--.^
5
34
:i7::
-zii
5a
35
llil
zzttz:
b
36
==?::
z-8::
c
37
zzj-.-.
-t:
dl
38
z-:t.-.
"t:
d2
39
"Sr
rrB::
d3
40
-.zjz.-.
-z^
e
Example 2: If the response to Item 5 is YES, then one or more positive
responses to 5a, 5b, 5c, 5d, and 5e should be encoded, as in
the fol lowing:
The child does wet her pants and has always done
so since the age of h. The longest dry period is
estimated to be in weeks. She does not wet away
from home.
5.
33
a.
Does he/she wet his/her pants regularly? .
34
b.
35
36
c.
Did he/she start before he/she was>5 years old? .
d.
What is the longest period he/she has been dry? .
. 1. Days
37
2. Weeks
38
3. Months
39
e.
Does he/she wet when away from home such as
with relatives or on holiday?
,
40
33 zzT-z -». 5
34 -z^-z >^ 5 a
35 z^T-z -*. b
36 ---T- -^ c
37 ==3ti ==8:r dl
38 -ziz -*■ d2
39 =::?== "8:: d3
40 -*■ "8:= e
Uses of the Scale - While the CSH is primarily for use as an adjunct to the CPDI
at the initial assessment, it might also be considered for use as a criterion
measure by making repeated ratings over the course of the study. There are haz-
ards in employing the CSH in this manner. Since the CSH is primarily historical,
symptoms may have been present in the "distant past" but not present immediately
prior to the study. This may lead to distortions when attempting to use the
instrument for the assessment of change.
Item 1 la, page L-5
Note that the first scale point should read
"Just a little", NOT "Not at all".
DOCUMENTATION
a. Raw sdore printout
b. Total score printout
c. Variance analysis
92
045 APDI
ADULT
PERSONAL DATA
INVENTORY
ADULT PERSONAL DATA INVENTORY
INSTRUCTIONS: Insert General Scoring Sheet and Code 12 for Sheet Number.
Items 1 through 10 are required for BLIPS processing and MUST BE COMPLETED FOR EACH SUBJECT.
PERIOD is coded as "000". Mark a field of 9's when data are "Not Ascertained".
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
Mark on right half of scoring sheet on row specified
SUBJECT'S AGE: {2 digits)
SUBJECT'S SEX:
1 = Male
2 = Female
SUBJECT'S RACE: (Mark one)
0 = Caucasoid
1 = Negroid
2 = Mongoloid
3 = Other
0 = Never married
1 = Presently married for first time
2 = Presently married with previous marriage/s
3 = Previously but not presently married (separated
or divorced)
4 = Previously but not presently married (widowed)
SOCIOECONOMIC STATUS
Occupation Use scale given below for 1 and 2. See Manual for
detailed list of occupations
1. Subject's highest occupational attainment is:
2. Head of Household's highest occupational attainment is
If subject is Head of Household, code "0" here (Row 7)
1 = Higher executive, proprietor of large concern, major professiona
2 = Business manager of large concern, proprietor of medium-sized
, lesser professi
3 = Administrative personnel, owner of smi
minor professional
4 = Clerical or sales worker, technician, ow
5 = Skilled manual employee
6 = Machine operator, semi-skilled employe
7 = Unskilled employee
8 = Never worked in paid employment
9 = Not ascertained
itl independent busini
ler of little business
Education
1. Using scale provided, code highest level attained by the SUBJECT
2. Code highest level attained by HEAD 6F HOUSEHOLD . . .
If subject is Head of Household, code "0" here (Row 9}
1 = Graduate or professional training (Individuals who have completed
or who have attended one year of a recognized professional course)
2 = College or university graduate (Individuals who have completed a
four year college or university course leading to a recognized
college or university degree)
3 = Partial college training (Individuals who have completed at least one
year but not a full college course; individuals who have attended at
least one year of, or who have completed a recognized Junior
college, technical school, nursing school, etc.)
4 = High school graduate (Private preparatory, public, parochial or
trade school)
5 = Partial high school (Individuals who completed grades JO or 11
but did not complete high school)
6 = Junior high school (Individuals who completed grades 7, 8 and 9)
7 = Less than seven years of school
9 = Information not available
Continue marking on right half of scoring sheet on row specified
TREATMENT STATUS
Subject is presently: (Mark one)
1 = Not in any type of psychiatric treatment
2 = In psychiatric treatment as an outpatient
3 = In partial hospitalization, e.g., day or night hospital, halfway house, etc.
4 = Hospitalized (24 hour)
Prior to this episode, subject has: (Mark all applicable)
V = Never had any type of psychiatric treatment
2 = Received psychiatric outpatient treatment
3 = Received treatment in partial hospitalization setting
4 = Received treatment in 24— hour hospital
"Psychiatric treatment" should be interpreted broadly to include all forms
of therapy whose basic function is the alleviation of emotional, behavioral
or mental disturbance. "Partial hospitalization" and "24— hour hospitali-
zation" include all forms of treatment environments in which the subject
spends a substantial part of the day or, in the latter case, the full day.
DURATION OF PRESENT EPISODE
Code whether in: 0 = Days 1 = Weeks 2 = Months 3 = Years
and give length (2 digits)
EXAMPLES: Present episode = 1 1 Weeks Code 1 1 1
Present episode = 3 Months Code 203
Present episode = 4 Years Code 304
PRIMARY PSYCHIATRIC DIAGNOSIS
indicate nosological system used 1 = DSM II
Code diagnosis from those listed in ECDEU Manual using 4 digits for
DSM II (Rows 15-19) or 3 digits for WHO (Rows 16-18)
Secondary psychiatric diagnosis Use same nosological system as 8a
If no secondary diagnosis, code field 0000
SIGNIFICANT CURRENT MEDICAL CONDITIONS?
If NO, 9b and 9c may be left blank
If YES, give ICD-8 code for illness (3 digits)
See Manual for ICD-8 list of diseases. Maximum of 2 conditions
may be entered at 9b and 9c
Second medical condition (3 digits) Code 000 if no 2nd conditic
10. ARE THE FOLLOWING ITEMS (11-15)
TO BE COMPLETED FOR THIS SUBJECT?
If YES, turn page and continue with item 71 on L— 10
1 = YES
2 = NO
9^
ADULT PERSONAL DATA INVENTORY
Continue marking on right half of scoring sheet on row specified
ROW
NO.
11. CURRENT CONDITION (Present Episode)
a. The current condition (present episode} is best characterized as:
' 1 = Indistinguishable from the past; continuation of long-standing
condition
2 = Exacerbation of chronic condition
3 = Recurrence of similar previous condition
4 = Significantly different from any previous condition
5 = First occurrence with no previous psychiatric illness
32
b. Onset of current condition was:
1 = Sudden - less than 4 weeks
2 = Gradual — one to several months
3 = Very gradual - one to several years
33
c. Precipitating external stress viras:
0 = Absent
1 = Probably present
2 = Definitely present
34
12. SUBJECT'S PSYCHIATRIC HISTORY
a. Age when first received any treatment for psychiatric illness 12 digits)
00 = Never treated
3536
b. Age when first hospitalized for psychiatric illness (2 digits)
00 = Never hospitalized
37-38
ROW
NO.
Mark on left half of scoring sheet on row specified 1
12. SUBJECTS PSYCHIATRIC HISTORY - Continued
1.3
c. Estimate total duration of ALL outpatient psychiatric treat
exclusive of present episode
mont-
Give time units: 0 = Days 1 = Weeks 2 = Months 3
Years
and duration (2 digits)
EXAMPLE: Subject's total treatment amounts to 10 months
C°<^^210 000 = No outpatient treatn
lent
4.6
d. Estimate total duration of ALL partial hospitalization — excl
of present episode
.sive
Give time units: 0 = Days 1 = Weeks 2 = Months 3
Years
and duration (2 digits) „„„ ^, . ,. , ,.
000 = No partial hospitahz
Btion
59
e. Estimate total duration of ALL hospitalizations (24 hour) —
exclusive of present episode
Give time units: 0 = Days 1 = Weeks 2 = Months 3
= Years
and duration (2 digits)
EXAMPLE: Subject's total hospitalization amounts to 4 years |
Code 304 ggg , ^^ hospitalizations
10
f. Number of hospitalizations
0-None, 1,2,3,4,5,6,7, 8 = 8 or more
9 = Not ascertained
g. Does subject have a history of:
0= No 2 = Yes, only within las
year
1 = Yes, but not within last year 3 - Yes, both in past an
d
last year
11
1. Excessive use of alcohol
12
2. Excessive use of Tobacco
13
3. Excessive use of Opiates
14
4. Excessive use of Marijuana
IS
5. ■ Excessive use of Sleeping pitis or Sedatives
16
6. Excessive use of Amphetamines/Stimulants
17
7. Excessive use of Hallucinogens
18
8. Excessive use of Other Drugs
19
9. Imprisonment
20
10. Sexual deviation
21
11. Suicidal attempts
22
12. Contributory physical illness or injury
95
ADULT PERSONAL DATA INVENTORY
ROW
NO.
Continue marking on left lialf of scoring sheet on row specified
ROW
NO.
Continue marldng on left half of scoring sheet on row specified
23
24
25
26
27
28
29
30
31
32
33
13. FAMILY PSYCHIATRIC HISTORY
Among family members (lineal and conjugal), has there been a
history of: (Mark all applicable on the appropriate rows!
0 = No history in any lineal or conjugal family members
36
15. ROLE PERFORMANCE
a. Subject's present occupational status is:
0= Not applicable
1 = Full time gainful employment
2 - Part time gainful employment
3= Unemployed
4 = Dependent spouse or student
5= Recipient of public or private assistance
9 = Not ascertained
LINEAL
CONJUGAL
1 = No history in parents or
siblings
2 = Mother
3= Father
4= Sibling/s
5 = No history in spouse or
children
6 = Spouse
7 = Children
urbance
37
b. In the past 3 years, subject has been gainfully employed:
1 = Briefly or not at all
2 = Less than 1/2 of the time
3 = Half of the time
4 = Most of the time
5 = Virtually all of the time
9 = Not ascertained
b. Manic-depressive disturbance
c. Other major affective disturbance
d. Schizophrenia
a. Other psychotic disturbance
f. Suicide
g. Hospitalized for any psychiatric illness
h. Mental deficiency
i. Excessive use of alcohol
j. Excessive use of drugs
k. Imprisonment
38
c. His/her employment has been limited primarily by:
0 = Not limited
1 = Going to school
2 = Household responsibilities
3 = Job market
4 = Retirement
5 = Physical illness
6 = Psychopathology
7 = Institutionalization
9 = Not ascertained
34
14. LIVING SITUATION
a. In the 3 years preceding the present episode, the subject's
residence has been:
1 = Primarily urban
2 = Primarily suburban
3= Primarily rural
39
d. The subject's work performance (whether in job, in household or
as student) during the past 3 years is best characterized as:
0 = Not applicable
1 = Marked decline in effectiveness
2 = Some decline in effectiveness
3 = Adequate with no change in effectiveness, static
4 = Some increase in effectiveness
5 = Variable, fluctuating in degree of effectiveness
35
b. Family type during this period has been:
1 = Parental or lineal — Patient does not carry major responsibility
for the home: it is either the home of his
family of origin or of his children. Code
foster home here.
2 = Conjugal - The patient or his spouse carries major
responsibility for the home; the household
may include his parents and/or children.
3 = Collateral - Home is not the responsibility of the
patient, his parents or children, but of a
sibling, aunt or some other non-linear
relative
4 = Alone - Patient maintains - wholly or in part - his
own quarters. Home may be shared with
others not related to the patient, or he may
live in a rooming house, dormitory, etc.
40
e. The subject's social functioning during the past 3 years is best
characterized ai:
1 = Marked decline in competence
2 = Some decline in competence
3 = Adequate with no change in competence, static
4 = Some increase in competence
5 = Marked increase in competence
6 = Variable, fluctuating in degree of competence
96
Developed within the ECDEU program, the Adult Personal Data Inventory (APDl)
is a 55-item scale formatted for use with the General Scoring Sheet. Its purpose
is to describe the social and demographic background of the subj-ect. Evolving
from the now obsolete Patient Personal Data Inventory, the APDl has been designed
to cover a greater diversity of subject types than its forbear. Most of the items
from the original inventory have been retained, although the majority have been
modified to increase their universality. Items numbered 1 through 10 constitute
the basic minimum of necessary demographic information. I terns numbered 11 through
15 are considered supplemental, although they represent the types of information
most investigators commonly collect.
APPLICABILITY -All adult populations
UTILIZATION —Once per subject
CARD FORMAT - ITEMS
CARD 01 = (19x, 12, 911, 13, M, 2|4, II, 213, k\]
I tern Column
1
20 - 21
2
22
3
23
k
2k
5a
25 - 26
5b
27 - 28
6a
29
b
30
7
31 - 33
8a
34
b
35 - 38
c
39 - k2
9a
43
b
hk - kS
c
kl - k3
212, 313,
911)
Item
Column
10
50
11a
51
b
52
c
53
12a
5k - 55
b
56 - 57
c
58 - 60
d
61 - 63
e
64 - 66
f
67
12g-l
68
2
69
3
70
k
71
5
72
6
73
7
74
8
75
97
12g-9
20
10
21
11
22
12
23
13a
2k - 25
b
26 - 27
c
28 - 29
d
30 - 31
e
32 - 33
f
3k - 35
g
36 - 37
CARD 02 = (19x, k\], 1112, k\] , I3, k\])
I tern Column I tern
13h 38 - 39
i kO - k\
j k2 - 43
k kk - k5
]ka ke
b 47
1 5a 48
b 49
c 50-52
d 53
e 54
Social class-Subject" 55
Head/Household-v 56
" - These items are calculated and punched on the card via programming.
SPECIAL INSTRUCTIONS
All items of the APDI are coded on one General Scoring Sheet. ITEMS NUMBERED
1 THROUGH 10 MUST BE COMPLETED. No data will be processed by the Biometric
Laboratory without completion of these 10 items for each subject. While data will
be processed without Items numbered 11 through 15, investigators are strongly
urged to complete the entire set of APDI items.
Item 1. Age - Encode the subject's age to the nearest whole year.
Examples: 25 years, 7 months. Encode as 26 years.
Exactly 25 years, 6 months. Encode as 25 years.
25 years, 4 months. Encode as 25 years.
Since "99" is employed as a "missing" or "not ascertained" code, no subject
can be 99 years of age - or, for that matter, any older - in this system.
Any bias introduced by halting time at 98, however, would appear acceptable,
I tern 2. Race - Subjects whose racial heritage is melanesoid, australoid or
mixed should be encoded as "Other"(3). In geographical areas where
these racial types are prevalent rater may encode melanesoid as 4;
australoid as 5 and mixed as 6. "Unknown" racial heritage should be
encoded as 9.
Item 4. Marital Status - The choice of categories is almost always straightforward.
In the event that the subject could be classified as b oth "3" and "4",
encode the most recent status, e.g., the subject's first marriage ended
in divorce, the second in the death of the spouse. Encode as 4 (widowed).
Code "5" may be used to designate common law relationships; i.e., living
in a conjugal situation without legal status.
98
6;=e:= ---^
-- z-.Z-.
-».
7-*. ..^
-. "»:
---X-
8=:©:- ----i
-. -.2^-.
"*=
9.^> ::]
z zztzz
----s^--
I terns Occupation and Education - Tliese 2 items require ratings of the
5a and subject AND/OR the Head of Household. if the subject is also
5b the Head of Household, only one actual rating is required - "0"
being encoded for both Head of Household's occupation (5a2) and
education (5b2) .
Example: The subject, owner of a small business and a high-
school graduate, is also the Head of Household.
Encode as follows:
"ir "fci z.Jzz ==8:r rr9:= QCC Upa t i On "S Ub j eC t
;:&= =:6:= i:3!:: -=8:= "9:: QCCUpa t i On "Hea d
::a:: "t: -.r.z "&= =:»:: Educa t i On "S ub j 60 t
..4. ..^- „jL. -g.. -jK. Educat ion-Head
The subject, a nuclear physicist prior to marriage,
has a Ph.D. Her husband, the Head of Household, is
a building contractor and has a 9th grade education.
Occupat ion-Subject
Occupation-Head
Educat ion -Subject
Educat ion-Head
A list of occupations - adapted from Hollingshead - are given in
Append ix I .
COMPUTATION OF SOCIAL CLASS - (See page 8o) .
I terns Treatment Status - While only one response may be encoded for 6a,
6a 'and a maximum of 3 responses may be encoded for Item 6b. The terms ■
6b "psychiatric treatment", "Outpatient", "partial hospitalization".
"24-hour hospitalization" - should be interpreted broadly.
Definitions for these terms are given on p. 84.
Example: The subject is presently in outpatient
treatment. In the past, she has received
treatment as an outpatient and in a day
hospital. Encode 2 on Row 10; 2 and 3 on
Row 1 1 .
6 ::a::
-4-
::2::
--Szz
::*:
-zSzz
::«::
::7::
:*:
-z9z
7::et:
::lr:
m^
-Szz
::4::
::S=:
::6::
::7::
:*:
:*
8::a::
mim
::2::
::3::
::4::
::&:
::6::
zzlzz
:*:
z^-
9:re::
::3::
::2::
zz3^z
zzA^z
.6.
::&:
::?::
:*:
::»:
z&z
zzbiz
::3!::
::&:
::St:
Present
-iz
::fc:
::?!::
::ft:
::9::
Prior
99
A coding system has been developed to reduce the possible multiple entries
in I tern 6b to a 1-digit field for card decks.
1 Card Code Response Position Description
0 9 Not Ascertained
1 4 24-hour hospitalization
2 3 Partial hospitalization
3 3,4 Partial and 24-hour
4 2 Outpatient
5 2,4 Outpatient and 24-hour
6 2,3 Outpatient and partial
7 2,3,4 Outpatient, partial and 24-hour
8 1 Never had treatment
item 1 . Duration of present episode - A 3-digit entry is required: one digit
to indicate the time unit; 2 digits for the numeric for duration.
Whichever time unit is employed, encode to the nearest whole unit.
Examples: When time unit is months: 11 weeks and 2 days is encoded
as 3 months .
When time unit is years: 1 year and 1 month is encoded
as 1 year.
Item 8a. Nosological System - The rater may use one of two nosological systems,
DSM II or ICD 8 (WHO), by the appropriate designation on Row 15. (Note
that this Row Number has erroneously been omitted in the packet). Codes
for both DSM II and WHO systems are listed in the Appendix 2, Certain
5-digit codes used in the official DSM II have been changed - for uni-
formity - to 4 digits.
Item 8b. Primary psychiatric diagnosis - Rows 16 through 19 - NOT 15 - 19 as
printed in the packet - are required for encoding a diagnosis under
BOTH systems. Item 8b should read:
Encode diagnosis from those 1 i.sted in Appendix 2 using
4 digits for both DSM II and WHO on Rows 16 - 19.
Examples: DSM II - Schizophrenia, chronic undifferentiated.
Encode 2959.
16-0:: --'.iz- 1.^ ^ ---iLZ
17:.fl:: "i: ==i; irir "*i
18"Q;= ::i= .z^z zzi: r;*l
\^zz(Szz z:ir =:i; ^3s =i4:r "i: -=fc= -zlzz ::fti lafc
WHO - Schizophrenia, paranoid type. Encode 2953.
16:*: ---y-z ■«■ ::3:: ::4:: ::*:: :=*:: -zlzz ::8:: ::»::
1 7 ::&:: ::!:: -^z zzizz zzAzz ::*: -Ztaz ::3t: ::8:: ^^
1 8 -zfyzz ::J:: zz^z zz^z zzizz mtm --(az ::?:: ::&:: zz9z.
1 9 zz&zz ::J:: zz3zz ^^m ::i:: ::S:: ::fc: -Zfzz ::8:: =*:
-&: z-kz zzfzz r:8:: =:Sb:
::5:: "fc: ::X: ::&: ute
laA. ::fc: -*: ::&: ::*:
100
Item 8c. Secondary psychiatric diagnosis - This item MUST be encoded in the
SAME NOSOLOGICAL SYSTEM as that used in I tern 8b. Leaving the field
blank or encoding "0000" will indicate no secondary diagnosis.
Item 9. Medical Conditions - If NO significant current medical conditions
are present, Items 9b and 9c may be left blank. No error citations
will occur since the "NO" response to I tern 9a is a programming sig-
nal. A "YES" response to the item requires that the rater then MUST
ENCODE RESPONSES FOR ITEMS 9a AND/OR 9b.
Item 9b. Medical Condition Number 1 - The rater selects the 3-digit code
appropriate to his diagnosis and encodes it in Rows 25 - 27. For
the comprehensive listing of diseases (and synonyms), refer to:
Eighth Revision, International Classification of Diseases, (lCD-8)
Public Health Service Publication No. 1693, Vol. 1 and 2, U.S.G.P.O.,
Washington, D. C. The ICD-8 codes may also be found in the Diagnos-
tic and Statistical Manual of Mental Disorders, American Psychiatric
Association, 1968, 3rd Edition.
Item 9c. Medical Condition Number 2 - Encoding a second significant current
medical condition is at the option of the rater. Leaving Rows 28-30
blank will be interpreted as the absence of a second medical condi-
tion.
Example: Subject has acute nasopharyngitis but no second
medical condition is rated. Encode 460 in
Rows 25 - 27 and leave Rows 28 - 30 blank.
25::e:i "Jz: r:2:i :i3:: .Urn
26-6:: =iaii z:2:= ;z3ti "<b=
27-ite :rJ:: zzSiz .z3zz z:<fc:
28r=e:r iiji: "ir zzir r:<t:
29:ze:z :=a=z zziz zziz zzdiz
SOzzttz zzJz: zziz zziz zztz
Item 10. This is a MANDATORY ITEM. It is a programming signal as well as a
statement of fact. In responding "YES", the rater commits himself
to respond to ALL of the remaining items (11 - 15).
Item 11a. Current condition - Only one response is permitted. Select the
category which best describes the subject's current condition.
1. Indistinguishable from the past - refers to those
conditions which have exhibited little - if any -
variation in intensity or floridity from the pre-
vious status.
2. Exacerbation of chronic condition - refers to an
intensification (flare-up) of a previously stable
(static) condition.
zzft: zzfcz
zzJrz
zziz
zzfcz
zzfcz
zzSbz -J
zzstz -1st Condition
zzStz _
zz&z zzfcz
zz?:z
zzfcz
zziz zzfcz
zzSz
zzfcz
zzStz — ■
--^- -2nd Condition
zzStz _
zzftz zzfcz
zzSrz zzfcz
zzJzz
zzjrz
zzfcz
zzfcz
101
3. Recurrence of similar previous condition - refers to
recurrent episodes of illness. Differs from 2 in
that there are symptom-free periods between episodes.
k. Significantly different from previous condition -
refers to a present condition which can be clearly
distinguished from any in the subject's past.
5. First occurrence - refers to the initial recognized
episode of psychopathology. Differs from k in that
there is no prior history of illness.
I tern 12. Subject's Psychiatric History - The several parts of this item
(12a - 12f) ask for the temporal aspects of some of the events in
the subject's history. The information necessary to answer the
items is not always complete or precise and the, rater is urged to
make the best estimates possible.
I terns These 2 items require a 2-digit code for age in years. Encode age
I2a and in the nearest whole year. Encode "99" if the subject is known to
12b. have been treated and/or hospitalized, but the age is "Not ascertained".
I terns Each of these items requires a 3-digit code: one digit to indicate the
12c- time unit and 2 digits to indicate the numeric for duration. To
12e Indicate that the subject has not received one or more of the treatments
the rater must encode "000". Do not leave blanks; rather encode "999"
when data is "not ascertained".
Example: The subject has received an aggregate of 2 years
of outpatient treatment; has never received
treatment in a partial hospitalization setting
and has had a total of 10 months of 24-hour
hospital ization.
1 "ft: "i: :r3:: ■•*
2i^ ::*: :=2:: =:*:
::5::
::6:: ::?:: :=&:
::&: =:3t: ::8::
::9::
::9::
Outpatient
3 "ft: "*: ^ "*:
::*:
::5::
::fc: "Jt: =:8::
::»:
i i ::*: -*: "*=
5«*- ::*:: ::»: ::*:
6^- "t: z-tz ::*:
::*:
zzt:z
::&:
::&:
::&:
::fc: ::7:: ::8::
::&: ::jt: ::8::
::&: ::?:: ::8::
::9::
::»:
:r9:: — —
Partial
7::ft: ::!=: -*> "*:
8::0:: -*■ ::*: --t^z
9<i«a "t: ::*: "»=:
1:4::
=:5::
::&:
::5::
::fc: zzfiz ::8::
::«:: ::3t: ::8:r
::t: ::3t: ::ft:
::*:
::9::
:=*: __
24-hour
102
Uem I2g Each of the items asks whether the event has been present in the
subject's recent (within the last year) and/or past (beyond the
last year) history. Do not leave blanks. Encode 9 for "Not
Ascerta ined".
I tern 13- Family Psychiatric History - This item gathers information on the
presence of a variety of psychiatric illnesses within both the
subject's lineal and conjugal families. For each of the items
(133 through 13k), record the presence or absence of the charac-
teristics among family members by marking ALL appropriate response
positions. The code "0" indicates the ABSENCE of the characteris-
tic in BOTH lineal and conjugal family members. The code "1" indi
cates the absence of the characteristic among the subject's lineal
family members ONLY,
1 ings . The code "5"
family members ONLY,
the subject's parents and/or his sib-
ndicates absence among the subject's conjugal
.e., the subject's spouse and/or his children,
Example: The subject's mother committed suicide following the
imprisonment of her alcoholic husband (the subject's
father). One of the subject's sisters is hospitalized
for heroin addiction. The subject's spouse, presently
hospitalized, has been diagnosed as schizophrenic.
The subject is presently taking care of the 10 children
one of whom has been diagnosed as mentally defective.
Encode as follows:
M F Sib
Sp Ch
23 ^P
==»:r =*r
1*1
==4==
==5=:
-re:
::f:r
-.*--
=r». a
24'-*r
==»== ;*=
I*:
==*=
==5==
=*=
-zT--.
==»'=
==»=b
25i*r
==»== :*:
i*r
==*=
==*=
==e:=
zzT--.
:rft:
==»= c
2*=*=
>*« ==fc=
:*r
--*'-
==S==
'^
zzT-z
==»=
==»=d
27a*K
"trr ::r-z
;:3;z
==*=
==s==
==e:=
"T:i
"»=
==»= e
n-:0^z
==»== M,^
==3==
--^-.
-*•
=*=
=:T:i
==»=
*. f
2»=«::
==!=: r=t=
i-J::
•*-
:=S==
«^
"T==
==»=
9 9
30=*=
:>*» ==«:=
==5==
==*=
==*:=
==«:=
-»1
==*=
==»=h
31=*^=
"J;: -:*::
«•>
=:*=
a«>
:*=
z:3t:
:*=
==»= 1
32=*=
~J=: :*:
:3=r
^^
•*•
==&=
z^r-z
==»=
==»=j
33=*=
:=t=i :*:
1*1
==*=
««E
==e=
zzT.z
==»=
==»=k
103
To conserve space on card decks, the possible multiple entries on items 13a
through 13k have been reduced to a 2-digit coding system - the first digit
referring to lineal history and the second to conjugal.
Lineal History
Card Code Response Positions Description
1 k Siblings
2 3 Father
3 3,k Father, s ibl ings
k 2 Mother
5 2,k Mother, s ibl ings
6 2,3 Mother, father
7 2,3,4 Mother, father, siblings
8 1 No 1 ineal history
9 0 No 1 i neal/conj uga 1
Conjugal History
Card Code Response Positions Description
1 7 Children
2 6 Spouse
3 6,7 Spouse, children
k 5 No conjugal history
9 0 No 1 i neal /conjuga 1
Examples: 99 = No lineal or conjugal history
62 = illness in mother, father, spouse
83'= No lineal history, illness in spouse, children
Item ]ka. Subject's residence - If the subject's residence has been split,
approximately 50% between 2 of the categories, encode the most
recent residence. Example: In the last 3 years, the subject
lived on a farm for the first 18 months and in a large city
thereafter. Encode the residence as "primarily urban" (1),
I tern ]kb. Family type - In circumstances analogous to those cited in Item l4a,
rncode the most recent family type.
Item 15a. Present occupational status - One or more responses may be encoded
up to a maximum of 2.
Example: Subject is currently unemployed and receiving public
assistance. Encode 3 and 5 on Row 36,
Unemployed Assistance
104
Rater s
hou
Id
If
he wishes
encode
these responses
6
2,5
7
3,5
8
^,5
A l-digit coding system has been developed for these multiple entries
and is as fol lows :
Descr ipt ion
Part-time employment and recipient
of ass istance
Unemployed and recipient of
ass istance
Dependent student/spouse and
recipient of assistance
Items 15b While only one response is permitted for Item 15b; a maximum
and 15c. of 2 may be encoded for Item 15c.
Example: During the past 3 years, the subject has been
gainfully employed for less than 1/2 the time.
Her employment has been limited by attendance
at school and household responsibilities. En-
code 2 in Row 37; 1 and 2 in Row 38.
37:*= ::l:: -*■ =:3:= zjUz riS: =:6:= "7:: :=8:= ::»:: AmOUnt Employed
38 =A: -*.. -a- ::3:: --4^- ==&: --b:-- -zT- ==8:r --9,- Limited
A 2-digit field is reserved for Item 15c on card decks. The codes are given
in Table 6.
105
TABLE 6
APDI (ITEM 15c - EMPLOYMENT LIMITATIONS)
— — O -M
_j
■i-i
o
o
o
o
to
o
o
O
—3
E
■I-I
to
u
\n
>-
Q-
0
o
>-
4-1
3
+-I
4-1
U1
c
0)
o
<
o
■z.
Response
Card Code
0
1
2
3
4
5
6
7
9
Pos i tions
00
X
9
01
X
7
02
X
6
03
X
X
6,7
Ok
X
5
05
X
X
5.7
06
X
X
5,6
07
X
k
08
X
X
k,l
09
X
X
k,G
10
X
X
k,5
11
X
3
12
X
X
3,7
13
X
X
3,6
14
X
X
3,5
15
X
X
3,4
16
X
2
17
X
X
2,7
18
X
X
2,6
19
X
X
2,5
20
X
X
l,k
21
X
X
2,3
22
X
1
23
X
X
1,7
2k
X
X
1,6
25
X
X
1,5
26
X
X
\,k
27
X
X
1,3
28
X
X
1,2
29
X
0
106
Examples: 29 = Not limited
11 = Job Market
10 = Retirement, physical illness
01 = Institutionalization
00 = Not ascertained
I terns 15d These items attempt to characterize the course of work performance
and 15e. and social functioning during the past 3 years by a "global judgment",
"Work performance" should be interpreted in a general way to include
effectiveness as a housekeeper or student as well as effectiveness in
gainful employment. For subjects who have been hospitalized for the
3-year period, rate their performance in industrial therapy, ward
assignments, etc. Similarly, the social functioning of inpatients
should be rated in the context of the hospital setting.
Example: The subject who has been hospitalized for the past
10 years has been a steady (unvarying) worker on
the ward. He has become markedly more isolated and
uncommunicative in relation to others, however.
Encode 3 on Row 39; 1 on Row kO .
39 :*:
z-.k-. -1.-- -.--&-. r:9:: -; ^o r k
-.-Mz z.Jzz ::B:= :;9::-< S OC I a !
Documentat ion
a. Raw score printout
b. Frequency tables
c. Cross-tabulations
107
046 PMR
PRIOR
MEDICATION
RECORD
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
PRIOR MEDICATION RECORD
PATIENT INITIALS
:Jt: :A: ::&: ::B:: :£: :f::
FIRST
:it: :±z: :M:: :it: :ft: :*::
INITIAL
:dd:: ::V:: :«: :Jt: ::Y:: :i:
::&: :it: ::!:: ::d::
:.-9:: :&: ::S:: ::T:r
NUMBER MALES 001-499 FEMALES 500-998
zSz: ::!:: z2zz :i: :*: zzi: ::&: zzT^z ::&: ::»:
PATIENT
:&: ::!:: :i: :i: :z4zz ::5z: z*: zzT^z ::&: ::*:
:&: ::!:: ::2z: :i: :z*:: :z5zz zz&: ::^: zzft: ::&:
:z4z: :&: ::€:: :A: :£:: :f::
SECOND
:&: :i:: :«:: :*t: :«:: :dP::
INITIAL
likz :?^:: :*: :dt: ::Y:: i:
:«:: z:H:: ::!:: ::<)::
:A: :i: :5zz zzTz:
:Sz: ::!:: :2z: zi: :z4:: :z5z:
RATER
:&: z:l:: zZzz ::3:: :^4:: ::5::
:*: ::7^: ::&: ::*:
:r6: ::^: ::ft: ::ft:
~
■-' -^ 'zzhz' zzZz: ziz zzftz' ■ ' zzS:;'
PERIOD
•Ac zztzz :2zz ziz zztz . z.-fc
Hourt Dayl Weeki
^dic zzlzz z:2:: ' zzSzz
zz6z ::7iz zzftz zzftz
zz&z zzTzz zzftz zzftz
- ," Montirt ■ - : '
■.'""' .zz4zz ■-■■','
—
j -4« FORM
[ NO.
_^
^
PLEASE USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
—
1. PRIOR PSYCHOTROPIC MEDICATION
a. Record the name/s and maximum total daily dose/s of the drug/s which
the subject received during the MONTH PRECEDING THE STUDY (prior
to any drying-oul period). If no drugs received, write "none". DO NOT
WRITE IN SHADED AREAS.
2. OTHER TREATMENTS RECEIVED PRIOR TO STUDY
Mark "YES" for all treatments which subject received in MONTH
PRECEDING THE STUDY (prior to ar^y drying-out period).
Mark NO for those not received.
^
1 . Drug Name — Confine writing within this block
a. DRUG
Analgesic-narcotic
Analgesic-non-narcotic
Anesthesia-general
Anesthesia-local
Antiallergenic
Anticoagulant
Anticonvulsant
Antifertility
Antihypertensive
Antimicrobial
Antiporkinson
Antitumor
Blood tonic
Bronchodilator
Cardiac medication
Cough and cold preparation
Dermatological preparation
Diabetic medication
Diet medication
Diuretic
Gastrointestinal preparation
Hormonal medication
Muscle relaxant
Sedative /hypnotic
Stimulant
Thyroid medication
Vitamin
b. NON-DRUG
Behavior modification
Electroconvulsive therapy
Milieu therapy
Physical therapy
Psychothera py-g roup
Psychotherapy-individual
Rehabilitation/occupational therapy
1 1 0 Remediol educational therapy
NO YES
zdObz zzlz:
zz&z zzlzz
zz&z zzlzz
zdftz zzlzz
zd&z zzlzz
zd&z zzlzz
zd&z zzlzz
zi&z zzlzz
zd&z zztzz
zSzz zzlzz
zfez zzlzz
zJ&z zzlzz
zflzz zzlzz
zd&z zzlzz
zftz zzlzz
zfizz zzlzz
z&z zzlzz
zfizz zzlzz
zd&z zzlzz
zdft: zzlzz
zfizz zztzz
zflzz zztzz
zd&: zztzz
zfiz: zzlz:
zfizz zztzz
zCzz zztzz
zfizz zzlzz
NO YES
zS:: zzlzz
zS:: zzlzz
zd&: zzlzz
zd&z zzlzz
zd&z zzlzz
zd&z zzlz:
:fe: zzlzz
zfizz zztzz
~~'
zflzr zzlzz zizz zz3- zz4zr zzSzz
z^. rrlr; --2zz zzSzr :-fc z^z
DRUG
zdBz: zzhz z£z-. zz3z: z*z zJSzz
CODE
=d9b= =J- z£ri zAr z*z zzStz
z&z zzizz' zJlzz zziz r*= zzSrz
zz&z :z7zz zzftz zAz
zzSzz zz7:z zzBz zzft:
zzfiri zz7:z zzft: zzSb
zzfc z:7- rrfc zzSzz
zz&z zzJzz zz&z zz&z
^
:^: ::.:: ::^: z3z: .:4^,,,„,„.^:
:ze:: ::):: :z2zz zz3zz zA: TOTAL :&;
DAILY
zAz zz):: :z2z: ::i: :z«z: DOSE IN ::&:
MILUGRAMS
:dt: flQt zflt: :J:: ::!:: :1Q:
:A: ::7:: ::&: ::ft:
zzfrz ::7:: ::&: ::»:
:*: ::7:: ::ft: ::&:
loa iQOfl
1
2. Drug Name — Confine wri(ing within this block
I^
zOzz zrtrz zSzz :A: z^tzz =Sz:
r&i ^rlzz rizz z3zz r*z ^*i
DRUG
zSzz ::tz: rizz r3:r -tr .rzSi;
CODE
ziSrz rrl- z£zz ziSzz :?i=z rdfc
r& ^1= ^£zz zzS:: rztz :i:
zz&z zJzz zdOzz -z9t=
=&: =7zz zzft: zA:
zz&z zr7=z zdfc =a=
zz&z zzT:; =B:: z3b:
CZ&: ,r£tr ziftz zzStz
^
:ft: :z.zz zzEzz z3zz -*-^^^,^^,^^-
:S:: ::!:: :5zz zz3zz zz4:: TOTAL -_J^,
DAILY
:fi:: ::l:: :i:: :i: :z4:: DOSE IN :z5z:
MILUGRAMS
:JL: iJQL zi31: :d:: r:lr: :1Q:
::6: :z7zz zzft: ::ft:
::&: ::7:: zzft: ::9:
:.-&: ::7r: :&: zziz
IQCt \QBQ
^
b. Estimate length of time subject has been receiving psychotropic medica-
tions. Mark appropriate time units and enter number. If "neveK' or "not
ascertained", leove number area blank.
E
Neuroleptic "?'?^ 1'^^.
:&: ::!:: :£:: ::3:: :4z: zzS;
z&z ::!:: z2zz zi: :A: zA:
Month Y«or Not Astortoinmi
zA; ::7:z zzft: ::ft:
zA: ::7:: :A: ::*:
^
Antidepressant *.'!?[ **'A
zfiz: zzlz: :2:: :3:: :.4:: zdSzz
:fi:: ::tz: :2z: :3:: zAzz zdSz:
Vonth Toor Not Auortoinxl
zz&z ::7:: z*: :A;
zz&z ::7:: :A: ::9::
—
Anxiolytic _"-'-'?'. *•_•>_
zQzz zzL:: :£:: zz3z: zAz zzSzz
:fl;z ::L:z z2zz z3zz :-4z: zirz
■ooth Teoi Not Asiinoinail
:&: ::7zz zz&z zAz
zz&z zz7zz zzft: z:*:
Other Psychotropic ."5.«?L J!nl
:0:: :zlzz ziz ::3:: zAzz ::5zz
z&: ::!:: :2z: zAz zz4zz zA:
Monlh Tior Not AKsrtoiiiiil
zz&z ::7zz zzft: zzftz
zz&z z:7zz :A: :Az
Developed with the ECDEU program, the Prior Medication Record (PMR) is a
single-page, 8 item form designed to capture information concerning the subject's
medication history prior to his entrance into the study. Responses are coded
directly on the form and the General Scoring Sheet is not utilized. The PMR
evolved from the now obsolete Drug Study Resume.
APPLICABILITY
UTILIZATION
TIME SPAN RATED
All research populations.
Once for each subject.
For I tern la, 11a and lib, one month prior to entrance
into study. For I tern lb, time span is dependent on
subject's psychotropic history.
CARD FORMAT ITEMS
CARD 01 = (I9x, 2(15, 1^) , ^13,2611)
Item Column
la - Drug Name No. I 20-24
Dose No. 1 25 - 28
Drug Name No. 2 29-33
Dose No. 2 3^-37
lb - Neuroleptic 38 - kO
Antidepressant k] - 43
Anxiolytic 44-46
Other psychotropic 47 - 49
2a - Other drug treatments (to Thyroid) 50 - 75
CARD 02 = (I9x, 9i 1)
2a - Other drug treatments (Vitamin) 20
2b - Other non-drug treatments 21-28
SPECIAL INSTRUCTIONS
1. Do not write in the shaded areas of the ID block. Both Form Number and
Period are pre-coded and need not be marked. (PERIOD for the PMR Is always
des ignated "000") .
ncorrect
Correct
\
'.A. zAzz
•A. zAzz
Hours
•A. zAzz
z2zz
■.-2zz
z-3r.z
Days
PERIOD
rA: r=fe:
Weeks
-Zu
1 '■'''■"
3*4- fORM
NO.
^
Montl^
111
2. Item 1 - When writing in the names of drugs, the rater MUST CONFINE ALL
WRITING WITHIN THE DESIGNATED AREAS. Failure to do so will result in processing
difficulties. Needless to say, the writing should be legible.
I ncorrect-
Drug Name — Conine »
riting v
vilhin this block
._ jy2P<i
yU4
^Uyi-<kJ^
5^ .:{..
--«-
— -
Correct
Drug Name — Confine writing wilhln this block
-t" ..izz -.-2r.-.
3. Item la - Note that "month preceding study" means prior' to any drying-out
period. Do not mark in the shaded area labeled DRUG CODE. Codes for drugs are
assigned by the Biometric Laboratory. A list of the ECDEU drug codes may be ob-
tained upon request from the Biometric Laboratory.
h. See pages 230-232 for instructions on encoding dosage. Note that
all dosages should be coded in miligrams.
5. Item lb - This item is NOT limited in time to the month prior to the study
but encompasses the subject's entire prior drug history. Estimate duration as an
aggregate total in those instances where intake has been intermittent. To encode
this ^-part item, the rater must designate the time unit and then encode in the
numerics for duration.
Example: Subject has received neuroleptics for h years; antidepressants
only for 2 months; never received anxiolytics and received a
stimulant for 3 weeks. These data should be encoded as follows:
Neuroleptic
Kner
*^.
Month
Teor
Not As(enoine<l
^ ::li: :2::
liz
z4zz
:i6::
zdBiz
:ir;:
"ft: lift:
ifi:: :zb: ri:
zjbzz
tA,
:*:
zzSzz
ri7i:
::&: ::&:
Antidepressant
Mtvir
Week
Month
Teor
Not AHOiloined
A^ ::tii :£:i
z3::
:4::
:5::
:*::
::?::
:A: 1:9::
zQzz ::br: .9.
:3ir
zAzz
:5-.:
:i6ci
:i7i:
:A: r:9::
Anxiolytic
Nev«r
WMk
Month
tent
Not Ascertoined
ifi:: ::l:: i£=:
idi:
:-»::
:5r--
rrfc:
"7i:
:A: :*:
:fi:-_ ::l:: :£==
=3::
:3»:r
:5z:
:*::
::7i:
i:ft: :r9::
Other Psychotropic
Never
*e.k
Month
Teor
Not Auertonied
jdM. :;li: z2zz
li:
::t:
r*:
1*1
:i7::
::&: ::ft„
!&: iitir z-2zz
■Ok
=4::
zJSnz
:r&:
::7::
:A: ::9::
6. I terns 2a and 2b - Contrary to the instructions printed on the form, raters
may mark positive responses (YES) and LEAVE NEGATIVE ONES (NO) BLANK.
DOCUMENTATION
a. Raw score printout
b. Frequency tables
112
THE
PSYCHIATRIC
PACKETS
There are two Psychiatrist Packets - one for pediatric and one for adult
populations. Each packet contains scales specific for the particular popula-
tion and three common or universal scales. The compositions of the packets are:
Children Adult
Children's Psychiatric Rating Scale Brief Psychiatric Rating Scale
Children's Diagnostic Scale Depression Status Inventory
Children's Diagnostic Classification Hamilton Depression Scale
Hamilton Anxiety Scale
Anxiety Status Inventory
Wittenborn Psychiatric Rating Scale
Universal (Conmon to both packets)
Clinical Global Impressions
Dosage Record and Treatment Emergent Symptoms
patient Termination Record
Manipulating the sections of the packet and inserting the General Scoring
Sheets may require some practice. The instructions on the back of the front
cover of the packets should, however, provide the information needed to develop
the necessary dexterity. It is important to state again, however, that the
rater ALWAYS USE THE ASSIGNED SHEET NUMBERS for the scales - EACH AND EVERY TIME
he uses them. Period Number changes, but Sheet Number never changes for a
particular instrument.
Although entitled "Psychiatrist Packets", these sets of scales may be rated
by members of other professional disciplines as well; e.g., clinical psychologists,
nonpsychiatric physicians, etc. The essential requirements for a rater are the
appropriate clinical experience to make competent judgments and a thorough
familiarity with these particular instruments and their uses. The selection of
rating scales for a specific study is at the discretion of the investigator.
Figures 8 to 12 present data matrices for each of the scales. These matrices
indicate the encoding location of each scale as well as the GSS sheet number upon
which it appears. These locations are FIXED and MAY NOT BE ALTERED. To do so will
render the data non-processable.
A maximum of 3 GSS is required at any given assessment with either packet.
Figures 13 and 1^ describe the manner in which Sheet Number is assigned to General
Scoring Sheets and show a typical usage of the scales.
114
ERRATA - Raters should make the following corrections in their packets.
PSYCHIATRIST PACKET - CHILD (GREEN)
1. On the cover, the word "PSYCHOPHARMACOLOGY" is misspelled.
2. Dosage Record and Treatment Emergent Symptoms (29-DOTES)
a) Page L-^, I tern 3. Should read "(No. 0 through 6)", NOT
"(No. 1 through 6)". Also on Adult (Gold) packet.
b) Page R-5 - I tern 5. The word "Tachycardia" is misspelled.
3. Clinical Global Impressions (28-CGl) - Page R-3. The word
"GLOBAL" is misspelled. Also on Adult (Gold) packet.
PSYCHIATRIST PACKET - ADULT (GOLD)
1. Depression Status Inventory (072-DSl)
a) All 20 items should be assessed using response positions
1 through 4. The "Not Assessed" category should NOT be
used as it would change the scoring structure.
b) Page L-3- Item k. Under Interview Guide, the item should
read: "Frequent and early AM wakings".
c) Page L-3- Item 7. Under Interview Guide, the item should
read: "Do you enjoy looking, talking or being with
attractive men/women?"
2. Hamilton Depression Scale (049-HAMD)
I tern 9 - Agitation - This item should be rated on a 5-point scale
as follows:
0 = None
1 = Fidgetiness
2 = Playing with hands, hair, etc.
3 = Moving about, can't sit still
k = Hand wringing, nail biting, hair-pulling,
b i t ing of 1 ips
3. Anxiety Status Inventory (051-ASl)
a) We regret that the author's name was inadvertently omitted
from the AS! header page.
b) The instructions given on the header page for the Depression
Status Inventory should be applied to the Anxiety Status
Inventory as follows:
MH-9-51 ANXIETY STATUS INVENTORY (AS I )
Wm. W. K. Zung
INSTRUCTIONS: Code 01 under Sheet Number on General Scoring Sheet
The data upon which the judgments are based come from the interview with the patient. The items in the
scale are to be quantified by using all the information available to the rater. This includes both clinical obser-
vation and the material reported by the patient.
Use of the Interview Guide below assures coverage of all the areas on which judgments are required. How-
ever, the rater has the flexibility of modifying the questions or probing for details, which makes possible a
smooth interview that does not sound like a question-answer examination. In rating the patient's current
status, an arbitrary period of 1 week prior to the evalutaion is adopted in order to standardize the data. In
order to reinforce this, the interviewer should occasionally precede questions with, "During the past week,
have you 7"
115
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
PATIENT INITIALS
NUMBER MALES 001 TO 499 NUMBER
FEMALES 500 TO
998
::A: rrfi: i^C: "D: "fc:
::F::
::«: ::H: --i"-
::*:
:*: ::l:: ::S:: rij:: ::4::
::£:
::fc:
::f::
::*:
::fc:
FIRST
PATIENT
r
~~
rrlfc: "t: zztAz :*t: ::0:
::P::
::Q:
::3:: :=*::
::5::
::fc:
::7::
::&:
::»::
^^
INITIAL
"tt: -zltz =A«: ::)t: i=Vi:
::£:
FIGUR
MATRICE
E 8 -_^, -^
::5::
::6::
::7::
::8::
::S::
—
S FOR ^ .
~~
:JC: "ft: ::£: ::£>= "&:
::?::
::©:
::3:: ::4::
::5::
::&::
::?::
::8::
::»::
SECOND
CHILDREN'S PSYCHIATRIC RATER
"^
i:K:r :rt: zMz :*t: :«:
::P::
-^ ACCCCCMCkfT crAi CC -^" =^"
::£:
::&:
::7::
::8::
::»::
~~
INITIAL
.:tt: "U: :*»: ::X: "¥::
::£:
Moo
1 J ur-\ i_ u 0
::3:: ::4::
::5::
::*::
::?::
::8::
::»::
—
E]
::3:: rri: ::9:: ::*: SHEET
::S:
::5:
::fe: r:^: ::»:
::&: ::S: ::&:
::9:
::a:
PERIOD
:*: ::}:: :*: :4:: ::*::
Hours Days
::&: ::t: ::2::
::5::
/Veeks
::a:
::&:
::?::
Months
::a::
::8::
::?::
—
::tt:
^1::a:: ::3:: ::±: NO.
Row
'G6mpitis-lVe==3:= ==*=
::S;:
::fc:(42^;
::ft:
::9:: Ro
' 1 :5tens4ton s: ----t-
§■■■■■
::5::
::&::
::7::
::8::
::»::
—
2H&t)itS 2:z ::3:: :=*:
::&:
::fc:(4*:
::&:
::*:
2iJfeder-pr«duotivse Speeali
r:6::
::f::
::8::
::»:i
"~"
3©fe=se*si^e --*- "*=
::5::
::fc:(4^5
::»:
::ft:
Sf'idgetSeSS ::*:
::5::
::fc:
::7::
::&:
::»::
^_
4g&^li«ary ==3:: ::*:
::S:
::fc:(4*;
::ft:
::9::
4 ^p eta G=e-i vi^ y
::5::
::6::
::7::
::8::
::*:
^
5Pe«r In^teeraeti^n
::S::
::fc:(4a:;
::ft:
::*:
SilypO&Cfcivity ::*:
::£:
::6::
::J::
:rS::
::«::
^_
6gfeTig ==*= 3^ ==*=
iiS::
::fc:(4:7:;
::»:
::*:
6 =MsG*^ae=tiMlity
::£:
::&::
::7::
::8::
:*:
^_
7Ft-gh«itig ==*= ==*=
::5::
::fr:(4g::
::8::
::9::
7^nGtma-l Rs^latttonsh
L:p:S
::fc:
::?::
:*:
:*:
^_
SBttlly ::2:: ::3:: ::*:
::&:
::«::( 4ft^
::»:
::St:
8 4fet t hiir a«a 1 ::*:
::£:
::fc:
::?::
:*:
:*:
^
'ftemp^T 3^ ==*: ::*:
::&:
::fc:(5#^
::ft:
::St:
9 #vertForaf ii=^nt^=*=
::5::
::6::
::7::
:*:
:*:
~
'"S^Fap^gcFat =*-■ ==*=
::&:
-^=(5*5
::ft:
::St:
10 4»egalfeiV«^ ::3:: :z4z:
:*:
::6::
::7::
:*:
:*:
IZ
'iL^ng ==2== ==3== ==*=
::&:
-t<52^^
::&:
::»::
1 1 ^BlgrJf :*: :*: :^:
::*:
::6::
::?::
::8::
::»::
"■"
i2Efepl«fit3tive ==*:
::5::
::fc:(5:>)
::ft:
::St:
12#ili^ :*: :=3:: :-t:
::5::
::6::
::?::
::8::
::«::
"^
"3l*abiii=ty c& fail asieep =(5#)
::&:
::Sk:
i3:@Gn£»3si:®n ^-- ^^
::S::
::fc:
::7::
::»:
::»::
~
"4S4«e^ di€fi^Hal=feies
:i5c:
-^<5#^
::ft:
::9t:
1 4 :M s o?ei ©«t afri oa -
::5::
::6::
::?::
::»::
::»::
^
l5BfedW*ttitag 3:: ::*:
ii5;:
-fc<5#^
::ft:
::9::
ISjSlingiag ::*: ::4::
i:S::
::6::
::?::
::8::
::»::
—
l6Rfefe*ei«fe ::3:: :=*:
:iS::
::*:(5:>)
::&:
::9t:
i6^feisp©Tifeane»as ::
::5::
::6::
::?::
::8::
::»::
_^
tJ'B^VSACVttSGTy .: ::*:
::&:
::fc:(5a^
::ft:
::»::
17 :gbiSpici«US:a€SS
::£:
::6::
::?::
::&:
::*:
^
i8?lFinMng Difeor4ers
::&:
::fc:(5*^
::ft:
::9::
l8:Bepi?fess*d ©emeanor
::S:
::6::
::?::
::8::
::9::
~
'9B<^lu#icFF*s ---^-- ==*=
::5::
==fc<6^)
::ft:
::*:
19:Munt-ed Affect
::S:
::6::
::?::
::«::
::8t:
^
JOHfel Ittc tflatifens:*:
::&:
::fc:(6±)
::ft:
::*:
20:liabitiey ---3== ==*=
::S:
::6::
::?::
::8::
::*:
—
MEteltaSl-ee a: ::*:
::&:
::fc:(6-l)
::ft:
::9::
21 -Sxes&urdiz cti spieech
::S:
::6::
::7::
::8::
::*:
—
Wtftck: of: insight:
::&:
::^:^6i^
::ft:
::St:
::*:
22 ^ee-eh ^^ev^lopftent
23 #feu£ifeertng ' ----^--
::5::
::5::
::6::
::6::
::?::
::?::
::8::
::8::
::»:
::5t:
—
23:*: ::!:: ::2:: :*: ::4::
::&:
^: ::^:
::ftr
^
24::ecr ::J:r rit: rii: rafcn
::&;
izflk ::7:: :ift:
::9::
24:Lgw *?oi«e --s^-- ==*:
::5::
::6::
::3i:
::»::
::9::
^
25::e:: =i3" =:St= :ilr r:4::
::5:r
::5::
:A:^
::£M?
::ft:
::9t:
25:lA3ud -V&iCe : ::4::
26 ^Misp^eoitanGiation
::S::
::»:
:i6::
::6::
::7::
::7:i
::8::
1=8::
::*:
::*:
~
26-6:: ::3" ::2:: zrl: rri::
::ft:
::*:'
.^
27::a:: ::tr rrii :n3c: z:i:n
::&:
::6:: ::3!:: iiBii
1=9::
27 #peefeh =iev#anGfie
::S::
::fr:
::Ji:
::»:
::St:
^
28 1:6:: i;ai: z:2:i ::3:: -"4::
:ift:
::&: :i3t; "ft:
::9::
28:^ytfenii=fe m^ioRS
::*:
zzlcz
::JI::
::»::
::»::
~
29::ft: ::3r: n:2:r -i: :=<t:
::&:
:;&: ::i: :*:
::S::
29 =laf e»ri<3*ity ==*=
::*:
zzifiz
::?::
::»:
::»::
"""
30-8:: zit: iiti ==lr :=4:r
::5::
::fc: nK: ::ft:
::9::
30 =^an«i(ySit5f -^-
::S::
::6::
::/::
::8::
::*:
—
31::a:= r:3rr "i: "i: "4::
::&:
::6:: ..J-.z ::ft:
::St:
31 =Miys»tcffl cSinplaints
::*:
::6::
::3t:
::&:
::*:
—
32::a:: ==ii: nil iii: ii4:=
::5::
lit: ::3I:: ::8::
::9t:
32 :QbeSjLty -- :*: ::4::
::S:
::6::
::^:
::&:
::*:
^
33=16:: ::!:: ::2:: :3:: :3d::
::&:
::6:: ::ft: ::ft:
::»::
33:Batifeg proMeiBS
::*:
::&:
::3t:
::8::
::*:
^
34:*: ::l:: :i: ::3:: :=*::
1=5::
::fc: ::J:: ::&:
::9b:
34:9epa»pafrion ansftety
::S:
::6::
::Jb:
::&:
::9::
*■"
35:*:: ::!:: :i: zJ:: :34::
::&:
::&: ::?:: ::ft:
::9l::
35 :BepFesffiDn ■ --*^-
::&:
::*::
::3b:
::8::
::9::
^
36 :A: ::5:: :i: ::3:: :d1::
Hi:
1:6:: ii3t: :*:
::*:
36:guph*5ri» =*: =*=
::S:
::6::
::Jii
::*:
::9::
^~
37::eiz
:ili: i:2:= ::3:: :d4::
::t: ::?::
:=8::
::St:
::9;:
37 :Sack :of enargy-:
38-^Snxi*et7 to^lcst=
::5::
::*:
::6::
::&:
::3t:
::3tr
::8::
::&:
::»:
::Sb:
^
38:*:
::!:: :i: :a:: SfevGrl
t^
::«c:(i).:
::ft:
~
39:*: ::!:: ::2:: :*:Impr OVetnfitll
40-*- -i- -±- ^flcacy Ii^c
: (2:>:
::ft:
::9t:
39 :&ep£»es s4ve top»ics
::*:
::S::
:i6::
::&:
::3t:
::3t:
::8::
::»:
=:»::
::»::
iX, 3
::t:
T!^
41:*i ::a~ =:2:: :*: :3l:: "
::5::
-4: ::!:: ::t:
.116
:,&:
lift::
::7::
::8::
79
::*:
20
a
ok: f
"3 — 3 — 4 &
T~
y g
ols: 11 12 13 14 IS
/6
77
18
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
PATIENT INITIALS
NUMBER MALES 001 TO 499 NUMBER
FEMALES 500 TO
998
z-Jkz
=:ft:
==J;=
==V=
:=e:
=da=
=a«=
::D=
==fct=
==)t=
==£::
FIRST
==o=
INITIAL
==>fc=
==p.=
==P:=
==Z:=
==©=
==Q=
=:H=
==4== ==*= zzOzz
FIGURE 9
MATRICES FOR
:HILDREN'S DIAGN
SCALES
==l== ==2:= =:3== =^= =
PATIENl
--'-- -"»- ::3=: ==4==
=:3== ==4==
==4=
==4=
==4=
==fc:
==4=
==4=
==?== ==4=
==f:= ==4=
::3t: ==4=
==4=
==4=
==4=
—
==ft:
==1;:
==e=
=:B=
==M=
==£:=
SECOND
==o=
INITIAL
==fc=
=:P::
=«=
OSTIC '*'" '^" RATER
==3== =^=
==4=
==i:
==4=
==4=
==?:= ==4:
==?== ==4=
==4=
==4=
.itl.
:=\t:
= 4W:
-Xz
==y:=
= :£=
==3== :=4==
PERIOD
:*: =:»=: ==2== ==3== ==*==
Hours Days
rift: :=4=: = = 2: =
==4=
==4=
Heeki
==3=
==6== ::7:: ==4 =
==4= ==f== ::4=
Months
==4=:
==4=
==4=
EL
=:3::
=:a==
::2: =
[3
"*: SHEET
==4:= NO.
=:»=
==5=
==»=
==&=
=:5t:
==i=
==8=
==a=
==a=
==a=
^
Row 1 ;:0::
==t=
==2:=
==»=
==*:
==&=
==&=
==7:=
==4=
==4= Row
1 Pgy<?hoCism 3:= ■>"
T^T*
=:6==
==7==
::4=
==4=
2::a-
==t=
==2:=
==»:
:=*:
==&=
==fc=
==7::
==4=
==Sb=
2A-ftxi*ty reafeti^n
==4=
=:t=
==?:=
==4=
==4=
~
3=:ft:
==t=
==*=
:=*:
:=*=
==a=
==fc=
==7:=
==4=
==*=
sWitl^drawal ■::"==4==
==4=
==fc:
==?==
==4=
==4=
4r:D::
=:t=
==2:=
==}:=
==*:
==&=
==fc=
==K:
==4=
==Sk=
4U*tsocializsd 3ggress:ion =6==
::?::
==4=
==4=
—
5::0::
==t=
==2::
==»=
==*=
==&=
==&=
==K=
==ft=
==9::
5S€Jcialt*ed aggfessio^f-
==6==
= =7=;
==4=
==4=
._
6::fti
==J==
==2:=
:=J:=
==*=
==&=
==6::
==7:=
==4=
==ft=
6E^l«3st*e 3^ ---^--
==i=
==4=
==7=:
==4=
==«==
—
7z:ftr
==J==
==i=
=:»=
==*:
:.&z
==& =
==3t=
:=4=
==4=
7 Hyperac-feivi ty ==4==
= =4:
==4=
==7=:
==4=
==»==
8==©::
==J==
==^=
==*=
==*=
==&=
==6:=
==3t=
==4=
==4:
8l«Bnatur=e ==3== ==4==
==4:
:=6=:
==7::
==4=
==4=
9==e:r
==J:=
==^=
==»:=
==*=
:=&:
:=«:=
zrS:
::»=
==4=
9Qcg3?t-iG iTnpair«ent
==4=
==6==
==?==
==t=
==4=
10 ==8::
==J::
==2:=
==J==
==4==
::&=
==6::
~3i:r
::a=
==4=
lOBeliriua =*= -^
==S=:
==6==
==7=:
==4=
==«==
1 1 ==e:i
==!==
==J==
==2:=
==2:=
==3==
==*:
==4==
==4==
==&=
==&=
==&=
==&=
==3!:=
==7:=
==4=
==4=
==4=
==4=
11 Mental retardation
==s=
==4=
==7=:
==4=
==4=
12=:e:=
l2Bi=agiiosis =<'a) :^-= ♦^
==4=
==fc::
==7: =:4=
= =4:
..^
13=*r
==J==
==2:
=*=
==4==
==&=
==6:=
=;3i=
==4=
==4=
13 ==4= ==H= ==2== =(%)==4==
==4=
==4=
==7:: ==4=
==4:
"~
14r=et=
:=3==
==2::
=:3b:
==*=
:=&=
==4=
==3i=
==ft=
==ft=
14==*== ==H= ==2:= =(-b) =^-^
==4=
==4=
==7= ==4=
==4:
15.:Q::
==J=:
==2: =
==&:
==*=
==5:=
==4=
==3!;=
==4=
==4=
15 ==4= :=J*= ==2=: =(t))==4==
==S=
==4=
==7i: ==4=
==4:
16==&:
==t=
==i=
==3:=
==*=
==&=
==4:
==7::
==4=
==4=
16 ==4= ==S?= ==2== =(b) ==4== 12
==S=
==4=
==7=: ==4=
==4:
17iitt=
==i=
==2:=
==3:=
==*=
==&=
=:fc:
==7:=
::4=
:=»:=
17 ==4= ==i5= ==2== =(Tg) -^=
==4=
==6::
:=7=: :=4=
==4:
18.-=&:
=r±=
::2:=
==1:
==*:
==&=
==4=
==J:=
==4=
==4=
18==e== ==5?= :=2== ={g) ==4=:
==4=
==4=
zzr-z =4=
==4:
—
19r:tt:
==i=
==2:=
==3::
==*=
==4=
==4=
==K=
==4=
==4=
19 ==4= -=S== ==2:: =(e) ==4==
==S=
==4=
==7== 4=
==4:
20i=&:
==±=
==±=
==2::
::2:=
==3: =
==3:=
==4=
==*=
==&=
==&=
==4=
==4=
==3!:=
==*:
==4=
==4:
==4=
:=4=
20 ==4= ==5J= ==2:= =(ig)==4==^J
==4=
==4=
==7== ==4=
==4:
21 ==a=
21 ==4=
No special SymptoHfe
i^)
=4=
==4=
22z=fi=
==±=
==2:=
==3:=
==*=
==&=
==4=
==31:=
:=4=
==4=
22 ==4=
&pee<?h <Jist-trbanc-e
im
==7:=
:4=
==4=
■^
23=zfc=
==J=:
=:2=:
==3==
==4==
==4=
==4=
==3!:=
==4=
==4=
23 ==4:
Learfting --Mz
==4=
4^)
==7==
:4=
==4=
^~
24==e:i
==a==
==2:=
==»:=
==4==
==&=
==4=
==*=
==4:
:=4=
24 ==4=
Tic r=2== ==3== ==4==
==S=
m
==7:=
:4=
==4=
25==e:=
==J:=
==2:=
==3==
==4==
==4=
::4=
==7:=
==4=
==4=
25 ==4=
VsychovaetoT- =
==&=
^£)
==7:=
:4=
==4=
^_
26r=a:.
:=!==
==2:=
==9==
==*=
==5:=
==4=
==3t=
==4=
==4=
26 ==4=
Sleep :=3== ---^--
==S=
i^)
zzrz ^i=
==4=
^_
27 ==6:=
==3==
==2:=
==9=:
:=*:=
==a=
==4=
==?:=
==4=
==4=
27 ==4=
F=eediag •== =*=
==*=
i^)
==7:=
=4=
==4=
^~
28 ..6:=
==J==
==2:=
==3==
==*=
==&=
==4=
==3t=
==4=
==4=
28 ==4=
Bnurfrsi^ --^-
==4=
i^)
==7:=
=4=
==4=
""
29==e:=
==3==
==2:=
==3b=
==*:=
==&=
==4=
==S=
==4=
==4=
29 ==4=
Encrdprscis =
==4=
i^)
==7:=
=4=
==4=
"^
30=:e:.
::1==
==t=
==i=
==2:=
==2:=
==2:=
==i=
==1=
==9:=
==*=
==*=
==*:
==5:=
==&=
==4=
==4=
==4=
==4=
==J:=
==?:=
==i:
==4=
==4=
==4=
==4=
==4=
::4=
30 ==4=
(Sephalalgia
==»=
iiS:)
=4=
==4=
==4=
^
31 zzfti
31 ==e== ==j== ==2== ==- CD£=
==&=
==4=
■^
32:re:=
32 ==4= ==J== ==2:= ==3== =^=
==5:=
==6:=
zzr-z ==4=
^~
33 3=6==
==»==
==2==
==3==
=:4==
==5:=
==4=
==J:=
==4=
==4=
33 ==4: ==J== ==2== ==3== ==4=:
==4=
=:6c=
==7:: ==4=
==4=
^
SA-dBzz
==!==
==2==
=J==
==d==
==i=
==4=
==?:=
==4=
==4=
34 ==4= =:J== ==2== =*= :^=
==*=
::ec:
==7:: ==4=
==4=
^
SS-ddzz
==!==
==2==
==3==
==*=:
==&=
==4=
==J:=
==4=
==4=
35 ==4= :=»:: ==2== ==3== ==4==
==4=
r:ec=
==7:= ==4=
==4=
-"
3b. Az
==!==
==2==
==3==
=d4==
==5:=
==4=
==?:=
==4=
==4=
36 ==4= :=»== ==2== ==3== ==4=:
==4=
==4=
==7t= ==4=
==4=
■~"
37=*=
==!==
==2==
==3==
==4==
==5:=
==4=
==3t=
==4=
==4=
37 ==4= zzUz =:2== =:3== =^=
==4=
==4=
==7:= ==4=
==4=
^
38==e==
==2==
==3==
==*==
==5:=
==4=
==J:=
=:4=
==4=
38 ==6== ==l== ==2== ==3== ==4==
==4=
==4=
==7:r =4=
==4=
^~
39==&=
==!==
zz3zz
:=3::
:d4:=
==5:=
==4=
==7==
==4=
==4=
39 ==4= ==!== ==2== =:3== ==4==
==4=
==4=
==7:= ==4=
==4=
40==ft:=
==2==
==3==
==*::
==5:=
==4=
==7:=
==4=
=='
==»== ==2== ==3== =*=
==*=
==6:=
==7:= ==4=
==4=
41==e==
==J==
==2==
==3==
==i==
==4=
==4:
==i=
==4=
==' 11
7 :=»:= ::2== =:3== =^=:
==4=
==4=
==7t= ==4=
==4=
Cols: 1
;>
3
4
K
6
7
S
9
7
72 13 14 IS
Tfi
17
18
19
20
j
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50GSS)
PATIENT INITIALS
NUMBER MALES 001 TO 499 NUMBER FEMALES 500 TO
998
—
::A; ::&: riC: "D: -fc: ::ft: r33: :
[== zzSzz ==4:: ==£: zzbzz
::7: =
==8:=
==9t=
FIRST
PATIENT
■"■
"K: rrt: zzIAz :i>t: :«: ::P:: :«: i
^ , ^ , ,r, r- 1 r, '" -^- -'■*-'- "5:: r:6::
==f: =
==8:=
==9::
^^
INITIAL
FIGURE 10
^
z.tlz :r!sf: zViz ::)t: :=V^= zzZ:= f^lA TR 1 C C TOR ^ '"^^ '"*'' '=*' "^'
:=7=:
::S: =
==9==
==*= ==^^ -e: .E.. ^=E. .^: .*: ADULT PSYCHIATRIC ^= -^-- =^== .^^ER ^=^= ^^'^^
==?==
==8: =
::9::
E
zztr :.t= --A*. :*t: :«: .:ft: ::£>: z: ASSESSMENT SCALES iz ==3.: r:4r: ::5:. ..&:
==7==
= =8==
==9==
—
INITIAL
:;tt- :rVi :i«: ::X: ::1|^: ::£:
:*: ::J:: :.^== ==3== =^== ==5== ==&=
=:7::
==8:=
=:9=:
—
Li.
:=3== ==2:= irl: ==*:
SHEET
::f:- rrf." -:7= : = S =
==5=
PERIOD
::©=: ==»=: ==2== ==3== =^=: ==5:= ==&==
Hours Doys Weeks
==ft= ==t= ==2= ::3=
==?==
Wonth
=i;==
==8==
==f==
—
-tt:
^1 =:2:= = = 3:: ==4:
NO.
=«= |==*=|^=l==a=
^L -
—
Row
' I>epresg^g<i =Meod
ATlxi=GUS^=^= ==a=
==9:= U
" iS&maedc Gortfeera -5:: ::»::
::7=
==8::
=:»::
—
2 (klilt ::2:: :::»: i:*;
F^ai^:' - ::S: ==&=
==9t=
2Aftxie=ty : =--3:= ==4== ==5:= ==6==
==?=
==8: =
==9==
—
3 &lieide ::3:: ::*:
P^ani^: ==s: =:ft:
iSt:
3Effiot=i«nal Wtthdrawal ^z ==6==
==7=
==8: =
= =?==
—
4 Barly Inrsonffila
D-isiii£egr=at;ion == |
4Gffincaptaal fiisarganizatifin
::7::
= =8:=
==9==
—
5 Mddle insoainia
A|iprflhen3S:iGja=
==9t=
sGtflila Faelistgs : ==5== ==6==
= =7=:
==8:=
=*:
—
6 Late InsoiHTtia t;
T^semorSzzT:: ==a:=
==9::
6Xens-l-on- ==3:= ==4== ==5== ==6==
= =7=:
==8==
==9=:
—
7 Work :=2:: ::?:: ::* =
Aahe=a^Pai=ns,8::
::ft:
jMenriftri^ss & Pasturing ..t.
==7=:
==8==
==9==
—
8 Retardation =^*^
E«ti^ue==s= ==ft=
==9:=
8Gtandiosity ----^-- ==5== ==6==
==7=:
==8==
==?==
—
9 Agitatien ^z*: -«:;
Rustles see s=s
==9b =
9Bepres s=ive ==Moo4 -' - ==6==
ioli®sti=li^ ==3== =^= *=!''**..==
==7=:
==8==
==9==
—
10 iteX:; PaydChiC ::* =
*l
Balpkitation
A
.=7=:
==8==
==9==
—
11 A¥ix==jSoma=ti« :*;
D=izz=inesB: ==&=
S
iiSaspicicftiSRass = "5== "fc=
::7:=
==8::
:=9==
—
12 Sytn^6omB= G=I ----^--
H
EairttnesE ==&=
« * =
I2li«llueiaat03f=y ftehavior ==6==
==7=:
==8==
==9:=
—
13 Symptoms Gane^
A
M
D^tspaea . ==&=
==9t=
l3Mffl£oH R&tard-ati=on ==5== ==4==
==7==
==8:=
==9:=
—
14 Srjnnpitomi: G^:!!!:^
D
Paraithestas ^ =
==9: =
i4U!ffiCQ0perativena:Ss ==5:= ==6==
::7=:
==8:=
==9:=
—
15 i%yp<3teh0fe=dr#asdte
Nausea ==3^-: ==&=
==ft =
isUmusiial Theaigh4 Gonteet ==6==
==7=:
==8:=
==*::
^^
16 lit. Leas. - ill-a£
U#inary=:Fre(|
==9:=
UMunfied Aff-feCt :=5:= =:*==
::7::
==8::
::9:=
X
I7 54t.- losi^A&txiss^
4I
Swea=6ing ==&=
==ft =
i7E«ciaem©nt ----^-- -5== ==&==
==?==
==8:=
==9:=
—
18 Insight : "Sb: ::*:;
19 Mu^nal-^Pr^s ==*=
E=Lusiied E-aez&z
lasoBKiia ==&=
==9t=
==9t=
isMsoBdea Cation -: ==5== ==*==
==7^:
==8:=
==8::
zzfzz
::9t:
—
I9liepre=ssed MeDd(l)
:=5:= z-dzz
:=jfc:
—
20 MurtiaL>-5e^ --iz
21 BepeiESOfial. . -i:
Nightaaarfes :,&=
==9t=
20&s=yiag ==2== ==»== =(2)
2lBiurnal==2== ==3== =(3)
-..Szz :=6:=
"S: ==6:=
:=Z:=
::^=
==8==
==8:=
=:St=
==St=
—
TkrPritened ==&=
4i;
—
22 Ba ratio i4 =:a= ==4:
Eare±K3diBbg ==&=
^2;
22S:leep ==2:: ==3:= =(4)
==5:= zzfsLz
:=7==
==8:=
==9:=
~
23:abS©SS/:£k3I^. ==4=:
H
Gi±il=t -=K= ==8:=
Aaaxieiyiij:: ==8::
23Appe&ite ==3== =(5)
24Wedgh;t isosa =(6)
==£= ==6:=
==5:= ==6:=
==7==
==7::
==8:=
==8:=
=:9t:
==9:=
—
24 Aiixious Moiad (zlz)
^^^^
25 5€nsion ==3=: (=2)
A
M
At.tea£io& ^
^5)
25ifibid© 3^ =*= :(?)
::S:: :=fc=
=:^=
==8::
:=9t=
^~
26 g«a=r-S r=2:= zri: (^S-)
A
S^rop-t-ems ^
m
26G«nseipat;iofi =(6)
=lS= ==6::
==7::
::8:=
--9zz
^~
27 ins£rmnia ::i= (-4)
G3^gaBic"^= t
if-)
z^Tsch^a^dia =^9)
::S= zzfszz
..r-z
==8:=
==9:=
^~
28 l¥lt«ile€tU*105)
P3*obi€ J^r =:&=
im
28F«tigse==2== ==3== (49)
^ D s 1
zzT-z
==8:=
==St=
"■■■
29 ®ep^-essfed (6)
Gfaiseseive: ==&:
i^)
29A-gica£iQn =*= (=ii)
==. . ..«::
==7::
==8:=
:=St=
ZI
30 S©matie-Mu#c(=?)
J
G<5mpQ4si^e ---^-
im
30Rfetaa?dation - (15)
:=S= ==fc=
==Jt:
==8::
==»:=
^~
31 9omatic-5etts(8)
l«de«isi^fe ==»=
a^-)
^leftnfU^ibff =*= (13)
==S= .z«.=
z=7:=
==8:=
:=9t=
^
32 Sym^tomfr-CV (9)
A'TOi^nee --^-
(m
32Eftpt3L¥iess =*= (14)
==S= z-t^z
==?::
==8:=
==*=
X
33 S:yTi^£oi^-RE(10)
Ra:tajrdatioita:=
(i^)
33H©peiessnes« (=15)
:=S:= "6::
==7:=
==8::
==9::
^~
34 Synif* t orafe- 6 1 ( 1 1 )
G:^?eraeti^-e ----^--
(i^)
Ml^deeisdve. (16)
=:S= r:6:=
-7i:
==8:=
==9:=
"^
35 gyTnptoraS:-GU(12)
I»re:leva»t ==8==
Ci^)
}5I«ri=ftabdlity (d?)
irS: ==6:=
==7:=
==8:=
==9::
~~
36 SymptoiBe-AfI(13)
Mis i¥iterpre*B( 1^)1
j6Mssa=EiBfae^ (18)
==&= ==6::
==7::
==8:=
==9::
"~"
37 ftehayiec (1=4=)
Ii*fliaeiiei6f --^^--
Liii
37BfevcEiBa«i-ofl (19)
JBSadcidai ==3== (3^)
::S:= ==6:=
:=S:: "6:=
::8:=
::8::
::8:=
:=8t:
==9:=
==9::
"^
38:A: iiJ:: ::ir ::3ri HA^fBTXty i<l)==I:--
39:A= =:hz :=2=: :=3 Jna^OVemeiLt ,l2).zJzz
==8:=
==9i:r
^
::*:
39 =*= ==}== =:a== ::3== ==4==
•4— c ti 1
iiS: ==6:=
40:16:= ==j=: ==2== Mfisacy ladej&.o <."?:= -fc
41 ==e== ==j== ==2== Eff iaacv ladexr ==?== ==8==
* 1
'" - I:: :=2== =:3== =*= ==»= ::6:=
iijbi
=:8::
==9::
-1
118 j== =:2== =:3:= =:4=: :=*= iifci
==7:=
78
1=8::
79
20
c
o)S?T"
2 5 4 5
6 7 8
9
10
2 13 14 IS 16 17
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
PATIENT INITIALS
::A: ::ft: riC: ::D: z-izz
FIRST
iiK: ::t: :**: -Mz :«r
INITIAL
::li; ::\t: zMz =iX: zzY.z
::F::
::P::
:i£:
:«:
::H: ::4:: ::*:
FIGUR
MATRIX
DOSAGE RE
TREATMENT EMER
SCAL
::3t: ::&: ::2: |
NUMBER MALES 001 TO 499 NUMBER
::«:: ::l:: ::2:: ::3:: -yt-z zzSoz
PATIENT
: ::«:: ::5::
Ell . :^:: ::£:
FEMALES 50(
::t: ::7::
:rfc: ::?::
::&: :iS:
) TO
::8::
::*:
::8::
998
::»::
::9::
::9t:
^_
iA= lift: r:e: "B: ::&=
SECONC
::lfc: ::t:: zMz :*t: :«:
::fc:
»
::P::
::£:
FOR . .^..
CORD AND "ATER
::4::
::5::
::5::
::6::
::&:
::7::
::8::
:*:
::»::
::9::
r:tt: :=Xt; :Wr "X: ::1ri:
rn . :^:: ::&:
'^^ PERIOD
: zzizz ::5::
Hours Doys Weeks
::0:: ::t: ::2:: ::3:
::6::
::fc:
Months
::4r:
:*:
:*:
:r9::
:*:
—
P^ r.J:: ::2:: rzS:: ::*:: SHEET
::»:
::5:
—
::a: :H::| ^1::^: .4: 'W'.
—
Row
'"Akafthisra"*= '*-
2::a: ::t^' r:^: ::»: ::4:r
::S:
::5::
"t:
::fc:
"S:
1-
::fc:
::8::
-^Ro,
::ft:
^ R€a3=*n ^=2^= ^ --*-
::5::
::fc:
::7::
::&:
::9::
2D«il^= DE?se-(2a>^
3::ft: ::K: ::2:: ::<:2a>=
4::a: ::^5: ::2:: ::<2a>
5::ftr ::«: ::2:: ::<:2a>=
6::e:i ::«= ::2:: -<2b>=
7::e:r ::«-- i.i: =K2fe>=
8::a:: ::«: ::2:: ::<:2b^
9::ft: ::H: ::J:: :.(:2bJ
lOLcmg Aceing<:2e=>=
11:*: ::J!: :*: -42e>:
12:*: ::J?: :*: :-42g>:
::S::
::S:--
ni:
::5::
::5::
::5::
:*:
:*:
:*:
:=S::
"S:
-.:&:
i:fc-.
::fc:
::6::
::6::
::&::
"6::
:*:
::6::
1=6:1
::6::
::f::
::?::
::7::
::7r:
::7::
::?::
::?::
::7::
"Iir
::?:=
rr^::
::8::
::8::
:*:
:*:
:*:
:*:
:*:
:*:
:*:
:=8::
::8::
::»::
:*:
:*:
:*:
:*:
:*:
:*:
z^.z
I*:
::»::
::»::
3=5ry Mouth *= "*-
4;:0:t ::j:V :z2:r ;:J:: z:l»zz
::S::
::S::
::6::
::R:
::8::
H
—
|::K:
::&:
::9::
5:«asFsii &&ng«sC*on
6::a: ::J:':' ::2:: rrj:: ::4::
::&:
::S:
::fc:
::&:
::f::
::&:
d
|::f::
::ft:
::9::
8:8:: ::)-^ ::2:: ::3:: ::*:
::&:
::&:
::&:
::fc:
::f::
::&:
;|
1-
::&:
::9::
9=€oiTatipati«n ^=*:
10::e:: ::jJ:' ::2:: ::}:: ::*:
::&:
::&:
::&:
::4:
::f::
::&:
"^
l::K:
::&:
::9::
12-6:: ::):':' ::2:: :*: ::*: ::5::
::fc:
::fc:
::K:
::&:
H
1-
::ft:
::9b:
14::eb: ::JJJ ::2:: zzizz ::*:
-a:
i:5::
"6::
::fc:
::K:
::&:
_d
l3Pres:crip:tieEn(3) |
::S:
::fc:
::?::
::»::
::»::
1
1-
::&:
::9t:
i4Ss^l3:tDmS P^«geft4:(4)
::S:
::&:
::?::
::&:
15 :$taij&ea/¥oiHitiT*g
16::ft: ::JJ:' ::2:: ::3:: ::*:
::&:
::5::
::fc:
::&:
::J::
::&:
H
16::©:: ::3:: :*: :*: :^: ::&:
2 <=5
::fc:
^:^:
::8::
::9::
1-
::&:
::ft:
'=-
::8::
::9::
18 ::£>:: ::±':' ::2:: ::3:: ::*:
::&:
::&:
::fc:
::6::
::?::
::ft:
::9bj
i7SKcitemsnt/Agifeation ^
18::a:; ::J:: rli: r*: :.4:: ::S::
::fc:
::t::
::?::
::»::
::»::
1 =
1-
::&:
::Sb:
::8::
::9:r
I9:gypoten«:ioft ^
20::fl:: ::i^:' ::i: ::3;: ::*:
::&:
::&:
::fc:
::fc:
::K:
::ft:
~n
i9DBepr^essa:ve Affect
20 ::a:: ::3:: ::!i: :*: ::*:
::&:
::&:
::6::
::6::
::?::
::«::
::»::
1-
::&:
::Sb:
::?::
::8::
::9::
21 rSyneope/DtazLiiess
22::fi: "i:' ::i: ::3:: ::*:
::&:
::&:
::fc:
::&:
::3t:
rift:
■q
21 i*tereas«d J^otor Acti^i
22::a:: ::J:: :^i: :--3:: ::*: ::*:
ty :
::6::
::?::
::8::
::»::
1-
::ft:
::9t:
-=
::*:
::*
23:¥acfeycardia -*-
24::e:: "3?^ ::2:: ::3:: ::4::
::&:
::&:
::fc:
::6::
;:ft:
::ft:
"^
23gecrfeas«d }«tetor Acti^^
24::e:: ::lr: :it: :*: ::*: ::*:
ty -
::6::
r:?::
::&:
::9::
1-
::&:
::9::
::7::
::8::
::*:
25:a:yp:©3?teftsi*n ==<t=
26::e:: ::J::' ::2:: "3c: ::<t:
::&:
::&:
-fc:
::fc:
"Kr
::ft:
::St:|
25=ifis0tenia ^*= ==*=
26 ::8:: ::!:: rc'i: :*: ::*:
::&:
::*:
::fc:
::6::
zzr-z
::»::
::*::
|::7::
::ft:
:r9t:
::?::
::«::
::*
27:BKG - ::2:: ::3b: ::4:
28::e:: ::3?:' ::2:: ::3:: -*:
::&:
::£:
::&:
::fc:
::3!::
::ft:
-d
27Bcowsdn*ss ==*:
28:*: ::3:: :*: :*: ::*:
::S:
::5::
::6::
::6::
:=?::
::8::
::9::
1-
::ft:
rrfti
h-
::8::
::»
29=Bemiatolog*e -*=
30::e:: -a!^ ::2:: ::3:: ::*::
::5::
::£:
::fc:
::fc:
::J::
:rft:
"1
29 AfenG tmai H^^ma t-e^l og i c=s:=
)0 :=e:: ::}:: :*: ::3:: ::4r: ::&:
::6::
::6::
::^:
::8::
::St:
3
|::7::
::ft:
:r9-
--^-
::»:
::9::
32::a:: ::3iJ ::2:: ::&: ;:d::
::5::
::6::
::fc:
::J::
::ft:
2*J
J2:*: ::»:: :S: ::3:: :U::
::&:
::S:
zztizz
::6::
::^:
::«::
::*:
i
li
r
1-
::ft:
::9t:
::?::
::«::
::r
33=Weight Los#^ =*==
34: A: r:J»J ::2:: ::3:: :=4::
::5::
::&:
::fc:
::fc:
::S:
::ft:
.-]
"Abnormal U*ine -
J4:*: ::5:: :*: :*: ::4::
::*:
::&:
::6::
::6::
::f::
::8::
::*:
|::S:
::fti
::9t:
::Jt:
::8::
::9t
35 Ano*exiA/Ddfcr-e*ased
36::e:: ::HJ :i: ::3:: :=*"
APP
::5::
et-i
::fc:
te
:=ft:
"3
36:*: ::l:: rSr: ::3r: ::4-:
::S::
::&:
::6::
::6::
::?::
::8::
::*:
h-
:=ft:
"9--
::?!::
::8::
::9t:
37 aea^acher- =^- =^-
38:*: ::l': :i: ::3:: :::4::
::&:
::£:
::fc:
-?:i
rrft:
"R
J7 ifreHSsT =2== ^ =^=
}8 :*: ::i:: ::¥:: ::3:: :=4::
::S::
::5::
zztnz
::6::
::jt:
::8::
::8::
::9t-
1-
lit:
==9t:
39 Tardive Dy#ki^esia
40::e:: ::Jr: ::2:r ::3:: ::i4:r
::£:
::S::
::fc:
::6::
::?::
::fti
i=9t^
59©yseein±-e S^ptsm
40:*: ::J:: :*: :4:: ::4::
::5::
::&:
::&:
::6::
::f::
::8::
::«::
::St:
1-
::ft:
i:*:
::St:
4i:Sev€git-»^
,J j
cSBTf
Distress:
b' y a
::t: ::*J
119
r2 13
::3:: ::«"
74 /5
16
::&:
J7
78 79 20I
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
PATIENT INITIALS
Z.A. Z--&. .-.C-. ---&-
rilfc: ==t= zMz zMz
-^z
NUMBER MALES 001 TO 499
NUMBER FEMALES 500 TO 998
"5:: ::fc: zzjzz "ft: :i9=:
:iU= zz\tz
.Mz ==X=
:ft=
r^e:
:=A:
-Ifc: iiti -vAA: i*t:
z.U. zz\tz zitiz ::>t:
-z&z
RATI
FIGURE 12
MATRIX FOR
ENT TERMINATION
RECORD
PATIENT
: ::3"
=:4=:
::&:
"fc:
==?:=
:;8::
::9::
"■"
-Z3-.
=:4::
:=S::
"fci
;:?::
=:ft:
=:9=:
i:3"
==fc:
RATER
"i:
::fc:
==?:=
:ift:
::9::
=:3::
lit:
:=5:=
z:fci
==S=
:it:
==9:=
~~
|=L
i-O-
r:2::
SHEET
I NO.
:*: :4r:
Days
-z2:z
PERIOD
^reorasho dilate c<^b)
3£ardiaC"i: (€ b^
SBermat; o i©g tea
%labe€ie ^
7@tet ==*=
85^ur-atiG
9g:I .z^rz :r2:.
iiMftBcle r«lax.
1 2P fty ch« t E op te^i
i3s«daGive ^i€b^
i^s^iiittilai* -^€5=)^
iSTfeyr-ddd = =r^:6 3=)
(|6b:)
1 7&&nf<*rmi.fcy < 7 a^) :
18e«nt.:RX ::<7b.)-:
i9Msp.-
In|;t <8a=>
0at-pt<6b=>
22 "fiz :;±
23 r A: =:a=
24:rft: "3:
25 "6:= -iz
26rre:= :=J=
27-6:: ::]=
28::a:r iH:
29=:e:: :Hr
30 -zOiz ;:J:
31 llftr 1=3:
::2:: "3::
::2:: ::3::
::2:-_ ::i:
::2:i iiil
rri: ::i:
32::ft: :it
33 1*1 ::
:: :i:
::3::
::4::
34::fc: :=
:: :i:
::3::
::*::
35 I A: ::
:: :i:
:*:
::4::
36:*:
-: ::2::
::3::
::«::
37:*: ::
:: :±:
:*:
:d4::
38:*: ::
:: ::2::
::3::
:d4:-
39:*: ::
:: :±:
:*:
::4:
40:*: ::
:: zziiz
:*:
::4:
41:*: ::
1:: :±:
:*:
::4:
Cols: 1 2 3
4
5
::»:
::St:
::S::
::»::
::Sb:
:3t:
::ft:
::Sb:
:J::
::ft:
::9::
:?::
::ft:
::i:
:3t:
::&:
::9t:
:i:
::&:
::S::
:3t:
::&:
::9::
-:*:
::ft:
::*:
::£:
::&:
::9::
::i:
:r8::
::9::
::K:
::ft:
::9t:
::3I::
::8:=
::»::
::i:
::ft:
::St:
::£:
::&:
::St:
::S:
::ft:
::9t:
ft:
::St:
ft:
::«::
ft:
::9t:
ft:
::9t:
ft:
::9b
ft:
::9:
:ft:
::9S
120
8::a::
9:*
10:*
II :*
i2StaratiGft -=*= <2a)
I3::e DairS in ::3:: <:2^)
14:*: &tLidy ::3:: <:^a)
l5P3;ema;t.Term., <-'2b)
iS^bjfect befere (la)
2Eteta seat iflb4-lb)
(=lc)
He)
ac)
nc)
tic)
:3:Pa4:iea£ <ic)
:,:: :*: ::3:: ^Ic)
i-- =S^inb€r9(lc)
3EeDE¥^ ==2:: ::£:
4::6:: ::3:: ::2:: ::3::
5::ft:StUdy : ::*:
6 ::ft: ::J:: ::J:: :*:
7 ::et: ::ani2:= =*=
::J:: ::2:: ::*:
::5:: ::&:
::5:: ::&:
::£: ::&::
::S:: ::&:
::5:: ::6::
::5:: ::6::
::5:: zztiz
:*:
:*r
16^-nt ervai Mst < § )
i7lton-dTug RX
l8Behav:ios Mod
19B6T-'" '-^- "^-
iOMilifeU ?:: :*:
21 i>hysi<;ai =*;
<4b)
<4b)
<^b)
^frb)
22 ifsyehotfeer=grp<=4b)
23 i^syGirotfeer-ind (:4b)
M S€hab=it*ta-e±on<=4b)
25Sdueatio:na:l: K^b)
26 family =*n -^er (=4c)
'7Sffigae-» =*- k#d)
:S:: ::fc:
:&: ::fc:
:S:: ::6::
:5:: ::fc:
t8 s^u^}:rLn^alc^= ^&)
29 Anciitla*y =Brug (=6a)
*o Analgesic 'ftare (=6b)
>1 Anaiges^-noBttia3?e(6b)
J2 Anestiie*iar-'gen<:6b)
'3 Anestlie*ia-ioe<=6b)
w -AntieFll£rgenie<=6b)
'5 Afttieoa^ul-lml|=^ C-6b)
'6 Anticonvulsant (6b)
»7 Antifertility (6b)
je Antihypertenl- (6b)
»9 =Ant±toie*ob4«l- ^6b)
to :iteiti^aE^in*on (6b)
11 :totd.fe\JinC-r :4:: I ::4-< 6b )
oETTt 72 /3 74 15
3=
::S:: ::6::
::»: --(nz
:Jb: ::8:: ::9t:
:3t: ::&: ::St
:^: ::ft: ::St:
:S: ::8:: ::»:
:Jt: ::&: ::»::
::&: ::fc: ::?:: ::ft: "»::
::S: ::6:: ::Jt: ::ft: ::9::
::&: ::fc:: ::7:: ::&: ::*:
76 77 78 79 20'
FIGURE 1 3
CHILDREN'S PSYCHIATRIST PACKET
Sequential Use of Scales and Assignment of
GSS Sheet Nxombers
INITIAL
RATING
INTERMEDIATE
RATINGS
FINAL
RATING
SHEET NO,
01
GPRS
CGI
I
SHEET NO.
02
DOTES
JZ.
SHEET NO.
03
CDS
CDC
SHEET NO.
01
GPRS
CGI
SHEET NO.
02
DOTES
SHEET NO.
01
GPRS
CGI
SHEET NO.
02
DOTES
121
FIGURE lU
ADULT PSYCHIATRIST PACKET
Sequential Use of Scales and Assignment of
GSS Sheet Numbers
INITIAL
RATING
SHEET NO
01
BPRS
DSI
HAMD
HAMA
AS I
WITT
CGI
I
SHEET NO,
02
DOTES
INTERMEDIATE
RATINGS
SHEET NO.
01
BPRS
DSI
HAMD
HAMA
AS I
WITT
CGI
SHEET NO,
02
DOTES
FINAL
RATING
SHEET NO,
01
BPRS
DSI
HAMD
HAMA
AS I
WITT
CGI
I
SHEET NO,
02
DOTES
122
027 CPRS
CHILDRENS
PSYCHIATRIC
RATING SCALE
c
MH.9-27 CHILDREN'S PSYCHIATRIC RATING SCALE p
1-73 S
INSTRUCTIONS: Insert General Scoring Sheet, Form 50, and Code 01 under Sheet Number.
Rate the first 28 items exclusively on the basis of direct observation during the interview.
Rate the last 34 items (29-63) on the basis of the child's verbal report of occurrence at the time
of the interview or during the past seven days. Do not use any other data, but that obtained in
the interview with the child.
Mark ?ll rows consecutively — do not skip any rows. Each row is numbered on the scoring sheet
and also on the page with the item to facilitate marking on the correct row.
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
NOT MOOER. EX NOT MODER- B(-
AS- NOT VE(^ MODER- AT^LY TREMELY AS- NOT VERY MODEH- ATtLY , ™BIELY
SESSED PRESErn MILO MILO ATE SEVERE SEVERE SEVERE SESSED PRESEffT MILD MILD ATE SEVERE SEVERE SEVERE
Mark on right half of scoring sheet on row specified
RQIft/
NO.
Continue marking on right half of scoring sheet on row specified
ROW
NO.
1. TENSION (Do not include fidgetinessi
Musculature appears taut, strained or tense. Fingers clothing, clenclnes jaws,
grips arms of chair, hands tremulous.
1
12. SILLY AFFECT
Clowning, inappropriately giddy, playful, silly behavior
12
13. CONFUSION
Confused, bewildered, perplexed in behavior or verbal expression.
13
2. UNDERPRODUCTIVE SPEECH (Rate antount of speech only, not rate or
relevance}
Fails 10 answer questions, monosyliabic. has to be pushed to gel an answer,
doesn't elaborate, blocked.
2
14. DISORIENTATION
Child is unaware of identity of surroundings after being told where he is.
Not aware of time discriminations. Doesn't know age or surname.
14
3. FIDGETINESS IDo not include tics)
Wriggles, squirms, moves or shifts restlessly in chair.
3
15. CLINGING BEHAVIOR
Clinging, in physical and verbal behavior with the examiner. Seeks physical
contact, demands constant direction.
15
4, HYPERACTIVITY
Has difficulty sitting in chair, gets up. moves fast, vigorously, impulsive
bursts of locomotion. Exclude slow ambling even if constant In rating
degree of overactivity, consider the ease with which the hyperactivity can
be controlled. ,
4
16. UNSPONTANEOUS RELATION TO EXAMINER
Responds to examiner, but does not initiate social or verbal overtures, nor
sustain conversation once begun. Lacks spontaneity. Restricted.
16
5. HYPOACTIVITY
Few or no spontaneous movements. Sluggish. tVlovements are slowed, feeble
or labored. Requires prompting for initiation of motor movements. Long
latencies of appropriate motor behavior.
5
17. SUSPICIOUS AFFECT
Expresses concern about the intent of the examination. Questions
instructions and good will of interviewer.
17
18. DEPRESSED DEMEANOR
Exhibits a dejection, depression in mood. Looks sad. Seems to be in
a state of painful dejection.
18
6. DISTRACTIBILITY
Distracted by usually minor, irrelevant stimuli. Shifts from one topic to
another. Interrupts thought or action abruptly.
6
,19. BLUNTED AFFECT
Restricted range and intensity of emotional expressions, blank or fixed
facial expression, monotonous voice.
19
7. -ABNORMAL OBJECT RELATIONSHIPS
Autistic use of objects with disregard for usual function. Stereotyped and
repetitive sequences or fragments of play. Aimless behavior without
organizing goal idea.
7
20. LABILITY OF AFFECT
Can suddenly vary from calm or silly to sullen mood, to screaming, crying,
loud complaining.
20
8. WITHDRAWAL
Oblivious of examiner, preoccupied. Facial expression and behavior do not
respond directly to examiner. Attention focus is oblique and vague in direc-
tion, with avoidance of eye contact. Responses are very delayed and require
forceful stimuli. (The fact that the child may have peculiar interest in
examiner, such as obsessive interest in parts of body or clothing does not
preclude a rating of withdrawal).
8
21. PRESSURE OF SPEECH
Speech is hurried, accelerated, pushed, difficult to interrupt.
21
22. LEVEL OF SPEECH DEVELOPMENT (Do not include diction, rate of
speech, or relevance of speech)
From age appropriate (1) to severely retarded (71 o I ?k^' q™!
speech development. Using your clinical judgment ^ '° ^^^
of verbal I.Q.. estimate the level of speech develop- 3 = 61 - 75%
ment (in percent) in relation to verbal l.Q. 4 > 46 - 60%
5 = 31- 45%
6= 15-30%
7= Less than 15%
22
9. OVERCOMPLIANT
Goes along with whatever examiner says in a passive fashion, even contra-
dicting self. Does not assert self in a reasonable manner.
9
10. NEGATIVE, UNCOOPERATIVE
Active opposition and resistance to examiner's initiative (differs from with-
drawal and oblique avoidance). Guarded, evasive replies, teasing, manipulative
or hostile refusal to cooperate. Child may remain silent in passive-aggressive
fashion.
10
23. STUTTERING
23
24. LOW VOICE
Voice weak, mumbling, whispering, almost inaudible.
24
n. ANGRY AFFECT
Irritable, touchy, erupts easily - shouts angrily, screams at examiner, overtly
and directly hostile.
11
124
25. LOUD VOICE
Voice loud, boisterous, shouting.
25
CHILDREN'S PSYCHIATRIC RATING SCALE
Continue marking on right half of scoring sheet on row specified
ROW
NO.
26. MISPRONUNCIATIONS
26
Lisping, mispronounces letters such as r, s. 1, etc. Unclear speech.
27. OTHER SPEECH DEVIANCE
27
Echolalia, question-like melody, neologisms; sentences fragmented,
unusual syntax.
28. RHYTHMIC MOTIONS (STEREOTYPE)
28
Rocking, whirling, head banging, rolling, repetitive jumping,
hand movements, alhetoid. twiddling, arm flapping
RA TE THE FOLLOWING 34 ITEMS ON THE BASIS OF THE CHILD'S
VERBAL REPORT OF OCCURRENCE AT THE TIME OF THE INTERVIEW
OR DURING THE PAST 7 DA VS. DO NOT USE ANY OTHER DA TA BUT
THAT OBTAINED IN INTERVIEW WITH THE CHILD.
29. EXPRESSED FEELINGS OF INFERIORITY
29
Describes feelings of inadequacy, inferiority, se!f<jeprecaling, self belillling
30. EXPRESSED FEELINGS OF GRANDIOSITY
30
Exaggerates own value, boasting. Unduly pleased with own achievement.
Says he is much better than others. Distorted sense of own capacity.
31. PHYSICAL COMPLAINTS
31
Somatic complaints of headaches, stomach aches, dizziness, not feeling well,
etc, {do not include fatigue).
32. OBESITY
32
Judge from child's appearance from normal physical appearance to severe
obesity.
33. OTHER EATING PROBLEMS
33
Picky, fussy, many dislikes, extremely restricted diet, peculiar food tastes.
34. SEPARATION ANXIETY
34
Ease with which child separates from mother or other significant people.
Extent of observed or reported anxiety {by child) experienced by child
when separated from mother or other significant people.
35. DEPRESSION
35
Admits feeling sad. lonely, feels like crying, expresses a despondent or
despairing attitude. Difficulty in anticipating success and enjoyment.
36. EUPHORIA - ELATION
36
States he feels terrific, great; elevation of mood, hypomanic state. "This is
the best of all possible worlds." Feels elated and wonderful. Nothing is
impossible.
37. LACK OF ENERGY
37
States he feels sluggish, fatigued. Everything is too much. Weary and feels
unable to make slightest effort. (Do not infer from motor retardation or
expressed indifferencei.
When you have completed this page (item 41), turn all pages
on this side and continue with text (item 42) on page Rl
38. PREOCCUPATION WITH TOPICS OF ANXIETY
Says he has nervous or scary feelings, concerns, apprehension, fears. Says
he worries about failure or other mishaps, thinks about something happening
to self or parents- illness, injury, death, loss or separation.
39. PREOCCUPATION WITH DEPRESSIVE TOPICS
Preoccupied with feelings of inadequacy and inferiority. Expresses feeling
that nothing can turn out all right. Preoccupied with feelings of uselessness
futility, and possibly guilt. Suicidal preoccupation.
40. SUICIDAL ATTEMPTS
0 = Not assessed
1 = None
2= Suicidal threat
3 = One minor gesture without danger
4 = A couple or several minor gestures without danger
5 = Dangerous gesture
6 = Infliction of life threatening damage to self
7 = Several life threatening attempts
41. FEARS AND PHOBIAS
Irrational morbid fears of specific objects, person, or situations, which, if
extreme, lead to avoidance behavior. Rate 6 or 7 only when fear is so
severe it leads to phobic avoidance.
125
CHILDREN'S PSYCHIATRIC RATING SCALE
ROW
NO.
Mark on left half of scoring sheet on row specified
ROW
NO.
Continue marking on left half of scoring sheet on row specified
1
42. COMPULSIVE ACTS
Acts or "habits" which are regarded as unreasonable by the child,
such as, counting, checking, rituals, excessive orderliness, and
cleanliness.
13
54. INABILITY TO FALL ASLEEP
Child reports a long time to fall asleep after going to bed.
1 = Not present 5 = 46 to 60 min.
2=10to15min. 6 = 60 to 90 min.
3= 16 to 30 min. 7 = Over 90 min.
4 = 31 to 45 min.
2
43. NERVOUS HABITS AND MANNERISMS
Stereotyped movements; rituals which are not perceived as
irrational. Facial tics or mannerisms. Biting nails, fingers, cuticles.
Sucking of objects or body parts (thumbs fingers^ hair, etc.);
Picking on skin, scabs, nose, twisting hair.
14
55. OTHER SLEEP DIFFICULTIES
Nightmares, early morning awakening, sleep walking, interrupted
sleep.
3
44. OBSESSIVE THINKING
Inability to "turn off" repetitive thought. Preoccupation, ruminations
about abstract problems or personal matters.
IB
56. BEDWETTING
Rating is for frequency of bedwelting for past 7 nights
1 = None 4 = 3 times 7 = 6 to 7 times
2 = One time 5 = 4 times
3 = 2 times 6=5 times
4
45. SOLITARY INTERESTS
Interested in activities which require little if any peer interaction,
such as stamp collecting, movie going, reading, school work,
solitary activities.
16
57. IDEAS OF REFERENCE
People are looking at him, following him, staring, etc.
Malevolent intent is not necessary but may occur.
5
46. LACK OF PEER INTERACTION
Isolated from other children. Has no friends or cannot name current
Close friend nor describe participation in play with peers. Lacks
interest in peers.
17
58. PERSECUTORY
Feels people have it in for him, try to hurt him. In the extreme
rating, the thinking has a delusional quality in that the belief is
impervious to change, rational arguments, or corrective experiences.
6
47. GANG ACTIVITY
Joins in antisocial activities along with a group of children (fighting,
trouble making, stealing) as a cooperating group against others.
18
59. OTHER THINKING DISORDERS
Irrelevant speech; or incoherent speech; or loose associations.
7
48. FIGHTING miTH PEERS
Says he frequently gets into fights - beats up other kids or gets
beaten up. Says he has a bad temper.
19
60. DELUSIONS
Delusional beliefs or convictions besides paranoia (58). i.e.
believes has introjected persons or objects in his body, has
a mission; is some other person or character, has unusual
powers; is guilty of some event.
8
49. BULLY
Says he's always the leader, winner; or says he teases, bullies
children, pushes children around; threatens them.
20
61. HALLUCINATIONS
The overall rating is a frequency rating reflecting the constancy
of the experience:
1 = Not present 5 = 4 to 5 times
2 = Once 6 = 5 to 6 times
3 = 2 times 7 = Daily recurrent phenomenon
4 = 3 times
9
50. TEMPER OUTBURSTS
Admits to feeling angry, irritable, touchy, admits he has a temper.
10
51 . SCAPEGOAT
Says he's picked on. teased, left out or pushed around, and bullied
by other children. May be called "sissy" or "baby".
21
62. PECULIAR FANTASIES
Morbid or bizarre fantasies and preoccupations, peculiar body
sensations, disturbances of body image experiences (not figure
drawings); preoccupation with flying, supernatural influences,
sadism, masochism.
11
52. LYING
Contradicts self in ways indicative of effort to hide the truth.
Reports telling tall stories, fibs, or admits he's accused of telling lies.
12
53. EXPLOITATIVE RELATIONSHIPS
Interested in other people insofar as he can get something out of it.
Callous and calculating in interpersonal activities.
22
B3. LACK OF INSIGHT
Is convinced of the reality of hallucinations or fantasies.
126
The Children's Psychiatric Rating Scale (CPRS) is an original scale
constructed by members of the Pediatric Psychopharmacology Workshop, It
is a comprehensive scale which endeavors to assess the broad spectrum of
psychopathology within this age group. As a consequence, items of the
CPRS will have varying degrees of relevance when assessing a circumscribed
diagnostic group. The CPRS is formatted for use with the General Scoring
Sheet and contains 63 items. A 7-point scale derived from the Adult Brief
Psychiatric Rating Scale is employed. The CPRS should be regarded as
experimental. Standardization procedures will be undertaken as soon as
sufficient data are accumulated.
APPLICABILITY
UTILIZATION
TIME SPAN RATED
CARD FORMAT - ITEMS
For children to age 15.
Once at pretreatment ; at least one pos tt reatment
assessment. Additional ratings are at the
discretion of the investigator.
The first 28 items are rated on the basis of direct
observation of behavior during the interview. The
last 3^ items are rated on the basis of the child's
report of occurrence during the interview or within
the past week.
CARD 01=(19x, k] II)
I tern Column Item
1
20
11
30
2
21
12
31
3
22
13
32
k
23
]k
33
5
2k
15
34
6
25
16
35
7
26
17
36
Bi
27
18
37
9
28
19
38
10
29
20
39
Col umn
I tem
Col umn
21
ko
31
50
22
41
32
51
23
42
33
52
Zk
43
34
53
25
kk
35
54
26
45
36
55
27
46
37
56
28
47
38
57
29
48
39
58
30
49
40
59
41
60
CARD 02=(19x, 2211)
tem
Col umn
Item
Column
Item
Column
1 tem
Col umn
1 tem
Col umn
42
20
47
25
52
30
57
35
43
21
48
26
53
31
58
36
44
22
49
27
54
32
59
37
45
23
50
28
55
33
60
38
46
24
51
29
56
34
61
62
63
39
40
41
127
CARD FORMAT - CLUSTERS CARD 51 = (19x, 9F6.2)
(Code "5" in Column 18 indicates a card containing factors, clusters or
other grouped scores) .
Cluster
1
Column
20-25
1 1
26-31
1 1 1
32-37
IV
38-43
V
kk-kS
:, 6F6.2,
,f4.o)
Cluster
Column
X
20-25
Xi
26-31
XI 1
32-37
uster
Col umn
VI
50-55
VI 1
56-61
VI 1 1
62-67
IX
68-73
Cluster
Col umn
XI 1 1
38-43
XIV
kk-ks
XV
50-55
Total Score
56-59
Cluster score = Sum of composite items cluster score range =1-7
Number of composite items
Total score = Sum of all items Total score range = 63 - 441
CLUSTER COMPOSITION - As a means of data reduction, the clusters have been
empirically derived for use in statistical analyses. It is planned to under-
take psychometric analyses of the CPRS when sufficient data are accumulated.
I . Psychotic IV. Anxiety
2. Underproduct i ve speech 1. Tension
7. Abnormal object relationships 15. Clinging behavior
19. Blunted Affect 34. Separation anxiety
27. Other speech deviance 38. Preoccupation - anxiety
28. Rhythmic motions (stereotypic) 41. Fears and phobias
57. Ideas of reference y_ Thought Disturbance
II. Hostile-Uncooperative 58. Persecutory ideation
10. Negative, uncooperative 59. Otherthinking disturbances
11. Angry affect ^0- Delusions
17. Suspicious affect ^2. Pecul ,ar _ fantas , es
50. Temper outbursts ^3. Lack of ins ight
III. Hyperactive VI. Neurotic
3. Fidgetiness 31. Physical complaints
4. Hyperactivity 42. Compulsive acts
6. Distractibi 1 ity 43. Nervous habits
20. Lability of affect 44. Obsessive thinking
128
CLUSTER COMPOSITION (cont'd.)
Vll. Depression X. Antisocial
VI I I
IX,
Dep
ress ion
5.
Hypoact ivi ty
18.
Depressed demeanor
Ik.
Low voice
29.
Expressed feelings of
infer ior i ty
35.
Depress ion
37.
Lack of energy
39.
Preoccupation with depressive
top ics
uo.
Suicidal attempts
Exc
■ ted mood
12.
Silly affect
21.
Pressure of speech
25.
Loud voice
30.
Expressed feelings of
grandios i ty
36.
Euphoria-elation
Withdrawal
8.
Wi thdrawal
9.
Overcompl iant
16.
Unspontaneous relation to
examiner
45.
Sol i tary interests
i+6.
Lack of peer interaction
51.
Scapegoat
kl . Gang activity
48. Fighting with peers
kS. Bully
52. Lying
53. Exploitative relationships
X I . Organic
1 3. Confus ion
\h. Disorientation
XII. Speech disturbance
22. Level of speech development
23. Stuttering
26. Mispronunciations
XIII. Sleep disturbance
54. Inability to fall asleep
55. Other sleep difficulties
XIV. Eating disturbance
32. Obesity
33. Other eating problem
XV. Enuresis
56. Bedwetting
SPECIAL INSTRUCTIONS - Cues for rating as well as specific instructions for each
item are printed on the scale. Strict adherence to these instructions is re-
qui red of al 1 raters .
Item 22 - Level of Speech Development - This item may be confusing. The rater
is asked to judge whether the level of speech development is appro-
priate to the child's verbal |Q. For example, response position k is
read as level of speech development is only 46 - 60% of Verbal jQ;
position 2 as level of speech development is 76 to 90% of Verbal IQ..
I tern 56 - Bedwetting and Item 61 - Hallucinations. Remember that these items
(as with all items from 29 to 63) refer to the past 7 days.
DOCUMENTATION
a. Raw score printout
b. Cluster score printout
c. Means and standard deviations for cluster scores
d. Cross tabulations
e. Variance analyses
030 CDS
CHILDRENS
DIAGNOSTIC
SCALE
CHILDREN'S DIAGNOSTIC SCALE
INSTRUCTIONS: Insert New General Scoring Sheet and Code. 03 under Sheet Nun^ber.
Responses should be based on overall psychiatric judgments utilizing all data sources integratively;
e.g., school reports, mother's reports, interview data, etc.
Rate current status only. Be sure to answer all items.
Complete at pretreatment only.
Mark each item on right half of scoring sheet on row specified
PSYCHOTICISM Gross
ronment.bizarfe inleracti.
responses appear markedl'
distinct thinking disorders
irrelevant or tangential coi
bizarre ideation; delusion
illogical or contradictory <
mpairment of relationship with people and envi-
n, extrei-ne preoccupation with internal stinnuli;
inappropriate to external stimuli and/or displays
neologisms, echolalia. incoherence: confused,
tent: or confused about reality or morbid or
, hallucinations, or permeated by loosening of
ANXIETY REACTION Expresses feelings of nervousness, anxiety,
unrealistic fears or worries; concern with feelings of inadequacy: infe
shyness, obsessions or compulsions.
WITHDRAWAL REACTION
detachment, inability to form
lose r
onships.
UNSOCIALIZED AGGRESSIVE BEHAVIOR Overtly negative, defiant,
hostile, and/or manipulative, evasive, guarded- Attempts to control others;
aggressive, antisocial: overwhelmingly selfish. Denial of anxiety and personal
responsibility for feelings and acts. Is in hostile conflict with the
environments in a variety of social settings (family, school) which do not
involve group expression of hostility.
SOCIALIZED AGGRESSIVE BEHAVIOR
conflict with the environment, primarily in j
gang, rarely on own.
EXPLOSIVE AGGRESSION Unable to control appropriately his
responses towards peers and/or adults. Physically aggressive, impulsive, often
reacts to others before understanding the meaning or motives of their words
or actions. Gets into numerous fights. Physically disruprive particularly in
classroom where he may hit out at others with little or no provocation.
CHRONIC HYPERACTIVITY High and conspi
activity in a variety of settings such as school, hon
level of gri
IMMATURE AND INADEQUATE BEHAVIOR Variable and poorly
organized personality characteristics and coping techniques.
PRESENCE OF GROSS ORGANIC IfVlPAIRMENT
Don
0= NO
ude impression of minimal brain damage, but use all
taminaiinnal riata Such as neurological tests, EEG. etc.
refers to findings which lead to a strong
■ganic diagnosis, e.g.. hemi-
Gross organic impa
paresis, cerebral palsy, epilepsy, etc
If YES, specify PSYCHIATRIC diagnosis (DSM II) in item 12b and/or
12c. Any neurologic diagnosis without associated psychopathology
nd Neurological Examination form
DELIRIUM Gross acute impairment of orientatio
place or person) and/or memory, with clouding of sen
Unlike Item 9, delirium should imply reversable organi
If YES, specify PSYCHIATRIC diagnosis (DSM II)
12c, Any neurologic diagnosis without associated psychopathology
should be specified on the Physical and Neurological Examination form
0= NO
1 = YES
12b and/or
PRESENCE OF GROSS MENTAL RETARDATION
Obvious to the examiner and/or found on psychometric tests.
If YES, specify diagnosis in item 12b and/or 12c.
0- NO
1 = YES
MOOER EX-
ArtLY SEVERE TREMELY
SEVERE SEVERE
Continue marking on right half of scoring sheet on specified row
12. DIAGNOSIS
(a) Specify ONE of the following diagnoses on row 12 OR record any
other DSM II diagnosis under lb) and/or (c) below.
1 -Schizophrenia, childhood (295,8)
2 -Overanxious reaction 1308,2)
3 - Unsocialized aggressive reaction (308,4)
4 - Hyperactive reaction (308,0)
5 -Withdrawal reaction (308,1)
6 - Diagnosis cannot be formulated but
significant psychopathology is preser
7 ■ No significant psychopathology (318,0)
(b) Other diagnosis #1 Mark on 4 n
(c) Other diagnosis #2 Marie on 4 n
13. SPECIAL SYMPTOMS
Check presence of a symptom by marking "0" on the proper row.
If no special symptoms present mark "0" on row 21 ,
A, No symptoms
B, Speech disturbance , . , ,
C, Specific learning disturbance .
D, Tic
E, Other psychomotor disorder .
F, Disorder of sleep
G, Feeding disturbance .
H. Enuresis
I. Encopresis
J. Cephalalgia
J 132
13 16
17-20
The Children's Diagnostic Scale (CDS) is a 13-item scale formatted for
use with the General Scoring Sheet. It is an original scale developed by
members of the Pediatric Psychopharmacology Workshop to explore and clarify
some of the nosological problems within this age group. The first 8 items
consist of behavioral syndromes to be evaluated on a 7-point scale derived
from the adult Brief Psychiatric Rating Scale (BPRS) . From the ratings ob-
tained on the eight syndromes, construction of more precise typological
entities may hopefully emerge. The remaining 5 items of the CDS are composed
of specific diagnostic questions.
REFERENCE
- Diagnostic and Statistical Manual of Mental Disorders
American Psych iatr ic Assoc iat ion , I968, 3rd Edition.
APPLICABILITY
Children to 15
UTILIZATION
Once at pretreatment . May be used at termination at the
discretion of the investigator.
TIME SPAN RATED - Current status only
CARD FORMAT - ITEMS (I9x, 1211, 2\k, 101 1)
I tem Col umn I tem
Col umn
1
2
3
k
5
6
7
8
9
10
11
20
21
22
23
2k
25
26
27
28
29
30
12a
12b
12c
13A
13B
13c
13D
13E
13F
13G
13H
131
13J
31
32-35
36-39
ko
k]
42
43
kk
kS
kS
hi
48
49
SPECIAL INSTRUCTIONS
Items 1 - 8 - Descriptions of each of the syndromes are printed on
the CDS. Raters should make their judgments within
these contexts.
I terns 9, 10, 1 1-These 3 items require a present (YES) or absent (NO)
judgment. Appropriate diagnoses should be encoded
under Items 12b and/or 12c.
133
Item 12a - The 7 most frequent diagnoses are printed on the CDS. Criteria
for these diagnoses are given in Table 1 . To enc9de any one of
them, the rater chooses the appropriate single-digit number and
enters it on Row 12.
Example: The rater has decided that the diagnosis is
Childhood Schizophrenia. She does NOT encode
the DSM-II code-295.8; rather she encodes 1
i n Row 1 2 .
1 2 :*: -«• rrt-- i:3r: --Al-- ::5:: "fc: ir?b: iiftir ri»::
items 12b- Diagnoses other than the 7 listed in item 12a are encoded here.
and 12c Codes for these additional diagnoses (4 digits) should be ob-
tained from Appendix 2. Some of the codes of the DSM-II have
been modified so that all diagnoses may be entered with h digits,
(The official DSM-II contains several 5 digit codes). Diagnoses
associated with the presence of organic impairment, delirium or
mental retardation (Items 9, 10, 11) should also be encoded here.
Item 13 - One or more of these Special Symptorirs may be recorded as
"Present" - regardless of the diagnosis - by encoding "0"
in the appropriate row. The code "0" in Row 21 indicates
that none of the 9 Special Symptoms are present.
Example: The child has both a speech disturbance
and enuresis. Encode as follows:
No symptoms ....
Speech disturbance •
Specific learning disturbance
Tic
Other psychomotor disorder
Disorder of sleep.
Feeding disturbance .
Enuresis
Encopresis
Cephalalgia
21
22
23
24
25
26
27
28
29
30
21
22
23
24
25
26
27
28.
29
30
DOCUMENTATION
a. Raw score printout
b. Frequency tables
c. Means and standard deviations
d. Variance analyses
13^
TABLE 7
DIAGNOSTIC CRITERIA - FORMULATED BY THE PEDIATRIC PSYCHOPHARMACOLOGY WORKSHOP
SCHIZOPHRENIA, CHILDHOOD TYPE
A, Necessary and Sufficient Symptoms
Autism - Gross impairment of relationships with people and the environment,
cons ist i ng of:
1. Avoidance of, or bizarre, human interaction
2. Behavior reflects lack of comprehension of social
or external situations, the ordinary meaning of
words or even the uses of ordinary objects,
and/or Thought Disorder
Austic vocabulary, neologisms, stereotyped echolalia,
incoherence, and/or disconnected, confused, irrelevant
or tangential content, and/or permeated by bizarre
fantasies which are ego-synotic, and/or lack of clear
recognition of the unreality of bizarre or morbid pre-
occupations (such as introjected bodies, hallucinations,
somatic delusions, persecutory delusions, delusions of
special reference or purpose.
B. Symptoms Commonly Associated, but not sufficient for Diagnosis
1. Extreme preoccupation with internal stimuli.
2. Responses appear to be dictated by inner impulses
and experiences, and appear inappropriate to ex-
ternal st imul i .
3. Treats other persons as interchangeable.
k. Rejects approaches or minimal initiative by other
persons; remains isolated in group setting.
5. Excessively diminished responses to sensory stimuli
or excessive responses to minor irrelevant stimuli.
6. Affect severely underrespons ive, out of harmony with
thought content, play or external context; exhibits
inappropriate, acute and unmodulated shifts to un-
differentiated excited, panicky or angry states, pre-
cipated by minimal change in the environment or aris-
ing without any apparent external stimulus.
7. Mutisim
8. Play is marked by one or more such features: stereotyped
behavior; repetitive use of objects; fragmentary, dis-
connected and illogical sequences.
9. Motility usually dyskinetic; may show posturing, manneris-
tic, choreo-athetot ic or tic-like movements, catatonic
rigidity, inert flaccid postures, or bursts of darting,
tiptoeing and whirling hyperactivity.
10. Is seen as "different", "queer", "crazy" or "sick" by
peers .
1 1 . Scapegoated.
135
TABLE 7 (Continued)
Disqua] if iers
1. Organic psychosis
2. Delirious or toxic states (such as acute drug reaction)
3. Q.uest ionable or "borderline" psychotic features.
OVERANXIOUS REACTION
A. Necessary and Sufficient Symptoms
Generally well patterned, well organized behavior marked by expressed
preoccupation with one or more of the following feelings of subjective
distress: anxiety, "nervousness", worries, unrealistic fears, tension.
B. Symptoms Commonly Associated, but not Sufficient for Diagnosis
1. Overconcern with performance.
2. Compliant; attempt to conform to external demands or
situations (including exam); dutiful, suggestible.
3. Seeks approval, protection and help from adults (includ-
ing examiner) and usually elicits sympathetic responses
as "n ice ch i Id".
4. Expresses feelings of unmet/unsatisfied needs for approv-
al, being cared for, helped, (which he/she may or may not
see as unrealistic).
5. Expresses preoccupation with guilt for his/her own real
or unreal demands on others, failures, misbehavior, imper-
fections .
6. Grossly self-conscious, lacking in self confidence, easily
flustered, inhibited.
7. Usually apprehensive in new situations; readily moved to
tears, upset or worried by inconsequential or imagined
failure, rejection, disappointment or loss of support by
others .
C. Disqual i f iers
1. Psychosis - If shows generally well organized behavior and
above preoccupation with anxiety, but language is so per-
meated by thought disorder, as defined under schizophrenia,
as to necessitate a diagnosis of psychosis, then classify
as Childhood Schizophrenia.
2, Denial of anxiety - Do not diagnose as overanxious, if
anxiety is not openly expressed as a preoccupation by child
on examination; e.g., if anxiety is only inferred from
physiological signs (tremors, muscle tension, fidgeting,
restlessness; sweating, vasomotor instability, irregular
respiration); or if anxiety is only inferred from history
of behavior which is interpreted as fearful by others (such
as insomnia, feeding disorders, poor attention and perse-
verance in school or other activities); or if anxiety and
fearfulness are diffuse and not fully articulated; or if
unrealistic fears, anxiety or tension do not dominate the
picture (upon exam or history) but are present only briefly,
136
TABLE 7 (Continued)
UNSOCIALIZED AGGRESSIVE REACTION
A. Necessary and Sufficient Symptoms
Generally well patterned, organized behavior marked by:
overt hostile disobedience, quarrelsomeness, physical
and/or verbal aggressiveness, vengeful ness and destruc-
tiveness in a variety of interpersonal contexts.
B. Symptoms Commonly Associated , but not Sufficient for Diagnosis
1. Tantrums, solitary stealing, lying and hostile
teasing of other children. Usually has no con-
sistent parental acceptance or discipline. Fre-
quently rationalizes and construes feelings and
actions in terms of external provocation. Denies
anxiety and personal responsibility for feelings
and acts.
2. Attempts to manipulate and control surroundings.
3. Expresses resentment at being controlled or placed
in an inferior position, or being exposed as in-
adequate or helpless.
4. Overtly negative, defiant, hostile, suspicious,
even belligerent with outbursts of anger and shout-
ing.
5. Manipulative, obliquely negative and saucy; oppor-
tunistically placating and ingratiating when faced
with superior strength or authority; bland, con-
trolled affective facade, with bravado and even
euphoria if feels in control of situation, becom-
ing guarded, calculated, evasive, suspicious only
if pressed in areas of personal concern.
6. Speech is guarded and calculated; capable of elabora-
tion but content limited, noncommital and evasive
about areas of personal concern.
7. Preoccupied with feeling restricted and threatened
by the control of others and with the need to assert
his/her own autonomy.
8. Denies feelings of needing support or approval from
others .
9. Denies personal responsibility for feelings and diffi-
cul t ies .
10. Domineering or exploitative with peers; aggressive if
challenged; respected, feared or resented by peers as
"tough" leader, "bossy" or "bully".
11. Resentment at being controlled or placed in inferior
position may lead to problems with authority figures
and to antisocial behavior.
12. Despite superficially confident facade, may refuse to
engage in any activity where unable to function ade-
quately or compete successfully, including learning
situations or peer group activity.
137
TABLE 7 (Continued)
D isqua 1 if iers
1. Psychosis - If shows generally well organized behayior with
denial of personal responsibility for feelings
and acts with negativism, hostility, suspicious-
ness and projection, as described above, but
language is so jDermeated by thought disorder, as
defined under childhood schizophrenia, as to
necessitate a diagnosis of psychosis, then classi-
fy as childhood schizophrenia.
2. Expressed preoccupation with anxiety and sadness which is per-
vasive, NOT transient.
HYPERACTIVE REACTION
A. Necessary and Sufficient Symptoms
Hyperactivity - with a high and conspicuous level of gross motor activity
(locomotion; or "rump" hyperactivity when seated, i.e.,
squirming, changing position and getting up and down fre-
quently; but not finger-hand twisting, picking or other
small muscle activity) occurring across environments in
situations in which sedentary or quiet behavior is appro-
priate for age;
and Disorder of attention - with higher distractab i 1 i ty and shorter atten-
tion span than appropriate for chronological age (not mental
age), especially in school or group situations.
B. Symptoms Commonly Associated but not Sufficient for Diagnosis
1. Poorly integrated and labile behavior, which gives the impression
of immaturity and of uneven but generally inadequate abilities.
2. Extremely variable relation to adults (including examiner), with
rapid fluctuation from attempts at compliance to silly clowning,
boisterous, mischievous or impertinent behavior, clinging and
demanding behavior and/or angry or sullen negativism.
3. Labile affect. Reacts with excessive irritability to any situa-
tion interpreted as rejecting, demanding or restricting, with
angry, suspicious, anxious, unhappy and silly clowning responses,
often associated with gross motor discharge, tantrums, destructive
or aggressive behavior.
k. Speech is often sparse and unelaborated with a tendency to evade
emotionally charged material.
5. Fantasy is usually expressed more clearly in play; concerned with
movement and aggression, diffuse fears of retaliation and loss of
love.
6. Motility usually variable, impulsive and poorly coordinated. Move-
ments are relatively undifferentiated for age; has difficulty
suppressing gross body movement when attempting isolated, finely
coordinated finger-hand or arm movements. Body manipulation
relatively uninhibited for age, chewing, sucking, nose picking,
masturbation.
138
TABLE 7 (Continued)
Unable to conform to demands of a group situation witii peers; often
becomes scapegoat and/or participates peripherally by provocative,
wily, teasing, aggressive, quarrelsome behavior; usually considered
"baby" and "pest" by peers.
Adults usually consider him/her immature, demanding, difficult to
manage. Has chronic and recurring difficulties in adapting to age-
appropriate social and educational demands.
Disqual if iers
1. Psychosis - If so permeated by autistic preoccupations or thought
disorder, as defined under schizophrenia, as to necessi-
tate a diagnosis of psychosis, then classify as Child-
hood Schizophrenia,
2. Expressed preoccupation with anxiety and sadness which is pervasive,
NOT transient.
3. Unsocial ized Aggressive Reaction with organized behavior pattern.
WITHDRAWAL REACTION
A. Necessary and Sufficient Symptoms
1. Generally well patterned, well organized behavior marked by shyness,
seclus iveness , withdrawal, detachment, and general inability to
form close interpersonal relationships.
2. Solitary "loner" or participant in group activities without zest,
reticent, aloof in a variety of settings.
B. Symptoms Commonly Associated, but not Sufficient for Diagnosis
1. Compliant; attempt to conform to external demands or situations
(including exam); dutiful, suggestible.
2. Expresses preoccupation with guilt for his/her own real or unreal
demands on others, failures, misbehavior, imperfections.
3. Grossly self-conscious, lacking in self-confidence, easily
- flustered,
k. Apprehensive in new situations; may be moved to tears, upset or
worried by inconsequential or imagined faflure, rejection, dis-
appointment or loss of support by others.
C. Disqual if iers
1. Psychosis - If shows generally wel 1 -organized behavior with above
withdrawal but language is so permeated by thought
disorder, as defined under schizophrenia so as to
necessitate a diagnosis of psychosis, then classify
as Childhood Schizophrenia.
2. Hostile - negative interaction with examiner.
3. Overtly expressed anxiety, worries and unrealistic fears.
4. Hyperactive Reaction.
5. Unsocial ized Aggressive Reaction.
139
031 CDC
CHILDRENS
DIAGNOSTIC
CLASSIFICATION
CHILDREN'S DIAGNOSTIC CLASSIFICATION
INSTRUCTIONS: ONE RESPONSE and only ONE is permitted. Mark that response on ROW 31 in the column specified.
Mark on General Scoring Sheet numbered 03.
Rate current status only. Follow the items until you reach the most appropriate classification for the child.
Mark that response and STOP.
Complete at pretreatment only.
MARK ON R0W31 ONLY
Proceed through sequence of YES-NO choice points and cho
Mark that response in specified RESPONSE POSITION.
ose ONE.
n
1 31
:=er:
1.
Is significant psychopathology present?
YES - Go to 2
Mark
0
and STOP
2
Is delirium present?
YES - Diagnose as ACUTE BRAIN SYNDROME . . .
NO - Go to 3
. Mark
and STOP
1
3.
Is autism and/or thought disorder present?
YES - Diagnose as SCHIZOPHRENIA CHILDHOOD TYPE
NO - Go to 4
. Mark
and STOP
2
4.
Is subjective distress (anxiety, worries, etc.) expressed?
YES - Diagnose as OVERANXIOUS REACTION . . .
NO - Go to 5
. Mark
and STOP
3
5.
Is there deliberate antisocial behavior and/or hostile conflict
with environment (not simply explosive reaction to frustration)?
YES - Diagnose as UNSOCIALIZED AGGRESSIVE
REACTION . . .
NO - Go to 6
. Mark
and STOP
4
6.
Is antisocial behavior predominantly in peer group (gang)
situation?
YES Diagnose as DYSSOCIAL REACTION
Mark
5
NO - Go to 7
and STOP
7.
Is hyperactivity /attention disorder present?
YES - Diagnose as HYPERACTIVE REACTION . . .
NO - Go to 8
Mark
and STOP
6
8
Is shyness-withdrawal the predominant behavior pattern?
YES - Diagnoseas WITHDRAWING REACTION . . .
. Mark
7
Mark
8
:J:: i*= ::3::
]kZ
The Children's Diagnostic Classification (CDC) is an alternative method
of arriving at a diagnosis. Developed by members of the Pediatric Psycho-
pharmacology Workshop, the CDC differs from the Children's Diagnostic Scale
in that it leads the rater through an ordered series of choice points until
a d iagnos is is made.
APPLICABILITY - Children to 15.
UTILIZATION Once at pretreatment . May be used at
termination at the discretion of the
invest igator.
TIME SPAN RATED Current status only
CARD FORMAT (19x, II)
CDC I tem Column 20
SPECIAL INSTRUCTIONS
Encoding the CDC is simple and direct. The rater proceeds through the
sequence of YES-NO choice points until one of his choices results in the
instruction to enter a number on the GSS. Having encoded this response on
Row 31, the rater STOPS. No other method of rating is permitted. Detailed
instructions for completing the CDC are given below.
DOCUMENTATION
The CDC item is displayed with the output of the Children's Diagnostic
Scale (030-CDS) .
a. Raw score
b. Frequency table
INSTRUCTIONS FOR THE CHILDREN'S DIAGNOSTIC CLASSIFICATION
John S. Werry, M.B., Ch.B.J
Department of Psychiatry
The University of Auckland
Like all diagnostic systems for children's psychiatric disorders, this one
is a compromise and it has some unsatisfactory features. However, if it is to
mean anything at all, it is important that the following rules be understood and
adhered to strictly. It is also important to realize that the best prediction
of drug action is likely to come from a multivariate analysis which includes
measures additional to diagnosis such as neurological status, birth history, IQ.
and so on. Thus, any shortcomings of the present classification should be
evaluated with the knowledge that such multivariate analyses will be done.
1
Drs. B. Fish, R. G i ttelman-Klein and D. Klein assisted in the development of
this classification.
1^3
It will be seen that a section of the DSM II Diagnostic classification of
the American Psychiatric Association (Behavior Disorders of Childhood and Adoles-
cence (308) and Schizophrenia, childhood type (295.8)) form the basis of the termi-
nology and symptomatolog ica 1 descriptions used since these appear to form the most
parsimonious and the best cross-validated categories as judged by a wide variety
of clinical and emp i r ica 1 -stat ist ical studies. However, there are important differ-
ences from the DSM II classification, notably the exclusion of etiology, severity
and mental deficiency as irrelevant to classification. The reason for so doing is
that these three variables are included in other parts of the evaluative battery
and it was felt, a) that they are more properly used in the context of a multi-
variate analysis, and b) that they are among the principal causes of obfuscation
in present nosology, c) Their separation from clinical symptomatology is consis-
tent with the proposed 9th revision of the International Classification of Diseases.
It is important again to emphasize that the importance of these excluded variables
is not denied in the present classification - it is simply felt that their contribu-
tion is better assessed by subsequent multivariate analyses on large numbers of sub-
jects. The number of categories is few (7) but it was felt that this number could
not only classify all children but would result in interjudge reliability of classi-
fication. Indeed it was also demonstrated in preliminary studies that assignment to
these categories could be made reliably across investigators.
The diagnostic process has been specified and is designed on a systems analysis
or pyramiding basis with each classification arranged in series and linked to the
previous one by a binary (yes/No) decision. While this injects a certain artificia-
lity it is designed to force a diagnostic decision and ensure comparability across
invest igators .
Rules of Procedure
1. Observe the stated data base from which to make the diagnosis. The format of the
clinical examination should follow that of Rutter and Graham, the instructions for
which are attached. Information not easily elicited in the examination and necessary
for certain categories should be taken from the standard teacher and/or parent rating
forms rather than based on each examiner's own rendering of these areas. This will en-
sure the use of a standard data base.
2. The diagnostic system must be purely symptomatolog ical . Parent and teacher reports
must be used only to establish the presence or absence of behavioral symptoms, their
severity and their persistence across different environments (notably the school and
peer group). The diagnostician must answer only two questions in classifying a child:
1) Is there clear evidence of abnormality? If so, 2) What is the symptomatolog ical
picture? Severity appears as a separate dimension and like CNS status is not denied
to be important but is more properly entered separately.
]kk
The following are to be specifically excluded from use in making the
diagnosis, a) Brain damage whether established by neurological tests, or
inferred from pre or perinatal history and/or psychological tests, b) Sever-
ity (except to make the distinction of normal v. abnormal) and prognosis em-
bodied in such distinctions as transient situational disturbance, behavior
disorder, personality disorder or neurosis, c) Intellectual level (IQ.) or
cognitive function and all psychological test data (learning disorder, per-
ceptual handicap, etc.). Of course, IQ. or more properly, mental age is nec-
essary for an accurate evaluation of the abnormality of behavior (such as
activity level) within a developmental context.
3. Symptoms must be seen by the examiner, explicitly reported by the patient
or detailed on the rating scales. Minimal inference must be made - in parti-
cular all psychodynamic formulations are specifically excluded. Extreme cau-
tion must be exercised in formulating affective states and only clear verbali-
zations and/or clear physiological evidence of such states may be used to make
such inferences as "anxiety" or "depression". It will be seen that with the
exception of overanxious-withdrawing disorder, all diagnoses are made on the
basis of a necessary externally observable or reportable symptom complex.
k. Symptomatology must be evaluated within a developmental and sociological
context; in particular, the peer group norm with reference to antisocial be-
havior. Thus, an appropriate question to ask is, what is the average child
of his age in his neighborhood like? This will prevent classifying the average
slum child as unsocial ized aggressive.
5. The diagnostic "flow sheet" (Figure 15) must be used with each case to en-
sure some minimal standardization across investigators. The diagnostician's
job is primarily to establish the presence or absence of symptoms. Once this
has been done the diagnostic flow sheet will make the diagnosis automatically.
6. Interjudge reliability of diagnosticians should be established by proper
independent evaluations. Diagnosticians need not be psychiatrists, particular-
ly when checking interjudge reliability. The categories are clear enough to be
made by anyone with some clinical experience who follows the instructions.
While it obviously is preferable to have every child independently diagnosed
by two judges, once the reliability of a diagnostician has been established he
may proceed to make unilateral diagnoses. Periodic checks of reliability should,
however, be made (say every 20th case).
7. Use the Diagnostic Criteria of the Children's Diagnostic Scale (Table 7) for
the interpretation of each diagnostic term.
145
FIGURE 15
DIAGNOSTIC FLOW CHART
BEGIN
1. Is significant psychopathology present?
(Q (no)
2. Is delirium present?
fNO) (fE^
3. Is autism and/or thought disorder present?
NO)
V
k. Is subjective distress (anxiety, worries, etc.)
expressed?
5. Is there deliberate antisocial behavior and/or
hostile conflict with environment (not simply
explosive reaction to frustration?
6. Is antisocial behavior predominantly in peer
group (gang) situation?
7. Is hyperact ivi ty/attent ion disorder present?
fNO) (fE^
8. Is shyness-withdrawal the predominant
behavior pattern?
DIAGNOSE AS;
-^ NORMAL
-|> ACUTE BRAIN SYNDROME
"O SCHIZOPHRENIA CHILDHOOD
TYPE
-O OVERANXIOUS REACTION
-|> UNSOCIALIZED AGGRESSIVE
REACTION
-{> DYSSOCIAL REACTION
-{> HYPERACTIVE REACTION
-C> WITHDRAWING REACTION
-[> UNDIAGNOSED
146
DIAGNOSIS FOR PSYCHOPHARMACOLOG I CAL STUDIES IN CHILDREN
John S. Werry, M.B., D ipl . Psych iat .
Dept. of Psychiatry, School of Medicine
University of Auckland, New Zealand
(Adapted from article appearing in Psychopharmacology Bulletin, Special Issue -
Pharmacotherapy of Children, 89 - 96, 1973)
In 1969 the Psychopharmacology Research Branch of the National Institute of
Mental Health brought together a group of clinicians and investigators interested
in children to develop a battery of measures for pediatric psychopharmacological
studies similar to those in the adult ECDEU test battery. The author was a member
of a subcommittee on psychiatric examination and diagnosis. This paper describes
the results of this subcommittee's deliberations but also provides some of the
background concepts and literature on diagnosis in child psychiatry as well as
some pilot work on the measures proposed.
Purposes of Diagnosis
We may arbitrarily draw a distinction between assessment and diagnosis: The
former is concerned principally with the idiographic or unique features of the
child; while the latter is an attempt to describe how this child resembles every
other child with a similar condition - in short, it is a nomothetic concept. Diag-
nosis is a process in which a child is assigned to a nosological category in order
to summarize statements about etiology, symptomatology, treatment, prognosis, and
prevention. Unfortunately, because of the present state of knowledge in child
psychiatry, this is likely to be less useful in dealing with the child as a patient
than would be a detailed dissection of his inner and soc iofami 1 ia 1 world.
However, as Dr. Fish (5) has argued, it is essential in psychopharmacological
studies as opposed to patient needs that the type of child who is studied is clearly
delineated so that others may interpret, replicate, and/or apply the findings In
addition, there is also reason to believe from the history of medicine that improbable
as it may seem at the moment, diagnosis may in the long run prove more heuristic than
the idiographic approach (3).
It may also be noted that diagnosis alone cannot adequately describe the sample
studied and that other identifying characteristics such as age, sex, socioeconomic,
and ethnic status are also necessary.
Diagnosis takes two main forms, discontinuous and continuous. In the first,
typical in medicine, the diagnostic condition (e.g., scarlet fever) is considered
qualitatively distinct from health or some other disease. In the continuous concept,
on the other hand, the condition is considered to be simply some arbitrary extreme
point along a continuum, e.g., in obesity, two standard deviations from the age mean
for triceps skin folds (9). There has been some debate in the mental health field
whether the discontinuous or continuous position is more valid (17). As an example,
some concepts of childhood psychosis, such as the Nine Points or Kanner's original
description of autism, are discontinuous; while others, particularly psychoanalytic
Drs. Barbara Fish, Rachel G i ttelman-Klein and Donald Klein participated in the
subcommittee, but the author is responsible for the opinions expressed herein.
1^7
views, reflect only a severe degree of psychopathology rather than anything
qualitatively different from other conditions (19). The epidemiological
approach (21), as typified in the works of Lapouse and Monk (8) and Rutter
and Graham (1^), which uses a statistical definition of abnormality but
then treats the children so diagnosed as "sick", is nevertheless more dis-
continuous than continuous.
Allied but not identical to these two concepts of discontinuity and
continuity of health and disease are those of nosological category and di-
mension. The first is a kind of "pigeon hole" into which a patient is fitted
along with other children with similar disorders. The dimensional approach,
on the other hand, assumes N dimensions of behavior or personality which like
physical dimensions, such as height, weight, hemoglobin level, and skin hue,
can be measured in any child. From this multidimensional space, diagnostic
categories can be developed by defining upper limits of normality on any num-
ber (1 through N) of the dimensions; e.g., an albino could be described in
terms of skin hue, while a dwarf could be described in terms of height and
weight. These differences may appear pedantic but they tend to be associated
with entirely different strategies in approaching a diagnosis.
The nosologist tends to employ the log ical -intuit ive or a priori tech-
nique - clinicians raise hypotheses which consider early infantile autism as
a distinct disease entity and suggest symptoms which distinguish it. They
then may or may not test the validity of their hypotheses. Depending on the
prestige of the proponent and the degree of clinician concensus, these hypo-
theses are likely to become incorporated untested into the lore of the pro-
fession. The history of medicine and of psychiatry in particular shows that
this technique may lead, as in nineteenth century European psychiatry, to a
plethora of nonexistent syndromes. A modern day example is that of the sym-
biotic child (18) or the Gilles de la Tourette syndrome which is only a severe
case of tics, as there is good reason to believe. However, in general, this
strategy despite its haphazard nature has served medicine well, certainly in
the pre-Vernard-V i rchow era.
The second strategy is the empirical-statistical or, as some might less
charitably call it, the serendipitous. Here the diagnostician makes few as-
sumptions about classification. He concerns himself with only the data domain
from which he believes classification will emerge. He then collects measure-
ments on large numbers of children after which he tries, usually by means of
multivariate statistical techniques, to group the children on a post hoc basis.
The works of Jenkins, Lessing, Dreger, Patterson, and Q.uay (12) are examples of
this approach. As might be expected, with the notable exception of Jenkins,
the empirical-statistical technique is more favored by psychologists than by
psychiatrists who tend to favour the a priori approach.
Diagnostic Examinations
Before a diagnostic category can be assigned, it is necessary to elicit
the data (or signs and symptoms) by which diagnosis is made. The first concept
germane to examination is the data domain of data base. This refers to the type
and amount of information available to the "diagnoser" for processing into a
diagnos is .
]kB
Data domains may be implicit or explicit. In psychiatry, a considerable
number of invalid assumptions are made about the implicit data domain from which
the diagnoser is operating. Thus, it is assumed that a competent child psychia-
trist will cover all necessary points in the child's history and examination to
arrive at a diagnosis. Though sporadic attempts have been made to systematize
history and examination (15), they have never really become popular. In sharp
contrast, psychologists have been almost obsessed with explicating the precise
details of how to elicit information and then how to score it, e.g., in the
standard intelligence tests. While this may inject some rigidity into the
diagnostic examination, child psychiatrists could well take a lesson from their
psychologist colleagues in the respect, since there is little doubt that the
unreliability of current diagnostic systems in child psychiatry stems at least
in part from the differing data domains of individual diagnosticians.
Diagnosis in child psychiatry is typically arrived at through a multifaceted
data domain, including a history taken from the mother, buttressed by school psy-
chometric reports, and confirmed by one or more psychiatric examinations of the
child. Methods, except psychological tests, tend to be informal and verbal; but
there is no good reason why they cannot be written, explicit (as in a questionnaire)
and based on less inferential techniques of observation, such as time sampling of
behavior (20) or measurement by electronic or other mechanical devices (16, 22).
Obviously, the technique and the source of elicitation will affect the data domain
sampled. It is also apparent that it will never be possible to sample the entire
potential data domain but that accuracy will be improved by sampling across ob-
servers (or informants), environments, and techniques, i.e., in the case of psycho-
pharmalogica 1 studies, until the precise cellular or system locale of the drug
action is known and can be measured. Even then its action is likely to be influenced
by social and other variables.
In summary, in order to understand the accuracy of a diagnosis, we really need
to know the scope and content of the techniques which elicit the information previous
to the diagnos is .
Logical Processes in Formulating a Diagnosis
Once information has been elicited, it must be processed to form a diagnosis.
The logical process can be judgmental or inexorable. Thus, once a psychologist has
administered the test items in a WISC, the actual |Q score is inexorably fixed. On
the other hand, a child psychiatrist in reviewing the data available to him from
many sources and of many types will have to exercise a considerable degree of judg-
ment in coming to a diagnosis. This is partly because different evidence is likely
to be conflicting (e.g., mother and teacher ratings) but principally because the
rules for assigning a child to one particular diagnostic category have never been
spelled out in unambiguous fashion. Even the "Nine Points" for diagnosing childhood
psychosis do not indicate which signs are necessary and how many are sufficient for
a diagnosis. Thus as a starter, someone has to specify these rules, however arbitrary,
so that assigning a diagnosis may become similar across different diagnosticians. Not
only is it necessary to specify what a condition is in terms of necessary and
1^+9
sufficient symptoms but also it must be indicated what it is not; in other words,
d isqual i f iers must be determined. Thus, no two diagnostic categories should have
the same set of necessary and sufficient signs or d isqua 1 if iers . There is only
one way to decide whether a system is reliable. Construct a decision tree or flow
chart, beloved of computer programmers, and then put the system to an-empirical
test with actual cases. No popular diagnostic system in child psychiatry present-
ly meets these criteria. Even if one did, it is not always easy to get psychia-
trists to abide by the logical rules as Overall and Hoi lister (10) have found.
Their solution was to use the unquestioning and obsessively logical computer to
make the diagnosis from the history and examination data.
Current Nosological Systems
One of the main obfuscating features of most current systems of nomenclature
is that they are conceptually impure being based on a mixture of severity, etiol-
ogy, intelligence, and behavioral symptomatology. This would be satisfactory if,
as with Fish and .Shapiro's (6) typology, it were a genuine multidimensional system
where each cell or nomenclature is defined by its position along each dimension.
Thus a true dimensional system would have the following possibilities: 1. Etio-
logical - organic/nonorgan ic , 2. Intellectual - retarded/normal. 3- Severity -
mild, moderate, and severe (replacing adjustment reaction, personality disorder,
and psychosis). 4. Symptomatolog ical - psychotic, antisocial, hyperkinetic,
anxious, withdrawing, and mixed. Thus a child would then be scored on each of
these dimensions. A child now described as psychotic, if one of Goldfarb's (7)
organic group, could be described as organic, retarded, severe, psychotic, and
not simply as of the schizophrenic-childhood type.
There are several popular systems available at the moment (12). The most wide-
ly used in North America is the APA's DSM li- which differs from the ICD S-- version
only by the interpolation in the section on Children's Behavior Disorders (308.0) of
a number of subcategories (such as, hyperkinetic reaction and withdrawing reaction)
which are actually derived from Jenkins' emp i r ical -stat ist ical system (12). The
GAP"~'~'' system is rather similar to the above except that in addition it categorizes
by "developmental level." Other systems are (a) by Rutter (13) which is part tradi-
tional and part empi r ical -stat ist ical and (b) a series of conceptually pure (i.e.,
behavioral only) empirical, statistical (mostly factor analytically derived),
dimensional systems of which the best worked out is certainly the four dimensional
one by Quay (12). Q.uay's dimensions are conduct problem, neurotic, immaturity-
inadequacy, and socialized (gang) delinquency. Unlike most other systems, Quay's
has a considerable amount of data on norms, reliability, predictive validity (e.g.,
outcome in delinquency), and discriminative power (normals vs. child guidance
populations). A weakness of Quay's system is that his original samples included
few psychotic children so that psychosis does not emerge. Dimensional systems like
Quay's are theoretically dimensional but not categorical. Yet, in practice it is
customary, as Quay does, to make categories by extreme scores, e.g., conduct-problem
type (equals unsocial ized aggressive reaction) for high scorers on that dimension,
"American Psychiatric Association's Diagnostic and Statistical Manual of Mental
Disorders-! I
v-'^orld Health Organization's International Classification of Diseases-8
*>WrGroup for the Advancement of Psychiatry
150
low scorers on the other three dimensions.
We may note that the idea of an emp i r ica 1 -stat ist ica 1 classification as
opposed to a logical intuitive one has won favor in the adult ECDEU battery
in Overall's classification based on the Brief Psychiatric Rating Scale (BPRS)
(11). What is remarkable about factor analytically derived systems is that
many different investigators have derived virtually the same dimensions, certain-
ly in so far as the more common ones are concerned (12), and it would, there-
fore, only be a matter of agreeing on the method of eliciting the information,
the cutoff scores, and combinations of dimensional scores for diagnostic entities
to have a good nosological system (in the scientific sense). The children's
ECDEU battery will include, in sections other than the psychiatric examination,
empirical statistical instruments and Conner's Teacher and Parent Rating Scales
(1) which could be used nosolog ica 1 1 y . This would perhaps make the psychiatric
examination and diagnosis unnecessary.
Characteristics of a Good System
When the committee came to consider its task, it had to define the charac-
teristics of a good system. The following characteristics appear to have emerged
not a priori but like termites out of the woodwork.
1. It should be acceptable to most investigators - simple, topical, compre-
hensible, accurate, and useful.
2. It should specify the data domain and the method of eliciting the data.
This domain should be wide enough to cover all conditions, including uncommon ones
1 ike psychos is .
3. The decision flow from data to diagnosis should be explicated.
k. Diagnoses should be mutually exclusive. This does not preclude making a
secondary diagnosis. It just means that one set of data should lead to a clear
terminal diagnostic point distinct from all others.
5. Diagnosis should be reliable across investigators.
6. Diagnosis should be valid in predicting drug responders and meaningful in
terms of current concepts and theory and in describing samples of children studied.
7- Diagnoses should be in a form suitable for statistical analysis, i.e.,
capable of being reduced to numbers or scales rather than a purely descriptive
statement.
How far the committee achieved these goals is a matter for future verification,
The System of Examination
The system consists of three parts: 1) A system of psychiatric examination,
2) a rating scale to be completed by the psychiatrist, and 3) a diagnostic section.
151
1. Developed by Dr. Fish from Rutter and Graham's (15) method of examination,
it describes the setting, conduct, and duration of the examination. While it is
specified to a certain extent, it is only a semistructured examination and much is
still assumed about the communal ity of operating assumptions, behavior, and the
competence of child psychiatrists. This apparent weakness need not bother us at
this time since reliability studies as well as other studies are planned. Further-
more, the complete children's ECDEU battery includes a number of other measures,
such as Conner's Parent and Teacher Scales (1) against which it can be validated.
Discrepancies will be difficult to interpret. Nevertheless, Conner's psychometri-
cally developed instruments together with their proven usefulness in drug studies
{k, 23) suggest that, opposed to the traditional position, the psychiatric rating
must be regarded as "not proven" rather than as a standard. This is particularly
the case since it is mainly based on a shorter sampling of the child's behavior and
one taken in a most unusual situation for the child in a one-to-one interview. In
the end, however, the acid test will come when its predictive ability to discrim-
inate between drug responders and nonresponders is tested rather than its descrip-
tive ability, important as the latter may be.
2. The Children's Psychiatric Rating Scale (CPRS) is a 63-item checklist to
be completed by the psychiatrist from his own observations and the child's verbaliza-
tions to him. Each symptom is defined in a manual and rated on a 7-point scale of
severity.
The reason for restricting it to interview material is so that it does not simply
parrot mothers' or teachers' reports but offers something unique. There was a differ-
ence of opinion in the committee as to how valid the result is likely to be. The
author was among those who felt that the yield from this restriction is not likely
to be high, but in the end the proof of the pudding is in the eating and the useful-
ness of the checklist can be tested empirically by consumer reaction, data reduction,
test construction, and other statistical analyses once sufficient numbers of observa-
tions have been accumulated in the ECDEU data bank.
Some initial work carried out by the author in the child psychiatry clinic of the
Auckland Hospital shows that a number of the items are nonoccurr ing , and only 20 per-
cent occurred with a frequency of 10 percent in the sample studied (N = 22). The
reason may have been (as might be expected from Dr. Fish's participation) that the
scale is overloaded with items reflecting severe psychopathology of the type found in
psychosis. Also, items in which the child reports his own psychopathology were very
infrequent, but this could reflect either the deficiencies of the Auckland examiners
or the sample of children seen there (a preponderance of unsoc ial ized , aggress ive , and
hyperkinetic reactions). If it should prove that many items are infrequent, a
decision would have to be made as to their value in the occasional case - decide
whether the instrument should remain wideranged or narrowed to a shortened version
as Conner has done with his Parent and Teacher Scales. A more satisfactory alterna-
tive in the author's opinion would be to use a "gating" system whereby one key question,
if positive, leads into a subset of related items (e.g., around psychotic behavior).
3. The diagnostic section consists of two scales - Children's Diagnostic Scale
and Children's Diagnostic Classification. As might be expected the committee spent
most of its time discussing this most contentious area. It was agreed that given the
chaotic state of diagnosis in child psychiatry, some arbitrary decisions would have
152
to be made simply to achieve some standardization. Knowledge cannot progress
until a common set of definitions and domains of study can be agreed upon. This
does not mean that the definitions or their underlying assumptions are valid but
that there can be no testing of their validity until this process has occurred.
The system below is offered then - not as a definitive system - but as a starting
point to be refined, extended, or even rejected - not a priori by armchair philoso-
phers - but by systematic empirical study of its worth. Unlike the CPRS, this
section is scored using information from al) sources and informants. It is sub-
divided into four parts: (See Children's Diagnostic Scale)
a. Symptomatic Dimension Ratings (Items 1 - 8) - This section is a symptoma-
tological or personality profile which is developed, as are all other parts of
this section, on the basis of all information available (except factor scores on
Conner's Parent and Teacher Scales). This is partly to see if psychiatrists can
validate the basic personality dimensions revealed by empirical statistical studies
(12) as Overall (11) has done with adult scales. It was mainly done though to pro-
vide a brief, readily comprehensible picture of the child's symptomatology or
personality profile. The latter cannot be done either by the APA diagnosis, ignor-
ing as it does all except the most prominent symptoms, nor by the 63-item Symptom
Checklist which is too cumbersome for summary statements. It is important to
realize that these are dimensions and not mutually exclusive diagnostic categories,
and thus a child must be rated on all dimensions on a scale of severity from 1 (not
present) through 7 (disabling). A preliminary test of the i nterexami ner reliability
of both (23) showed that a satisfactory degree of reliability can be attained in
both dimensional ratings and APA diagnoses.
b. Neurological and Intellectual Status (Items 9 - 11) -As discussed earlier,
the mixed etiological, intellectual status, severity, and symptomatolog ica 1 nature
of most diagnostic systems, such as the DSM II, presents insuperaole difficulties.
For this reason, the committee decided to separate out these areas, and all are
scored separately except that severity is assumed to apply to behavioral psychopathol -
ogy and scored there. There is provision elsewhere for rncluslon of the actual IQ.
or estimate of severity of retardation. Only major neurological signs (not history,
psychological tests, soft signs, etc.) permit a positive score for organic. Tnis
hard line position was decided upon in view of the elasticity with which the term
organic is often used, making it virtually worthless.
c. Modified APA Diagnosis (Item 12) - It was decided that the Behavior Dis-
order section in the DSM II was the most suitable because it is purely symp tomato logi-
cal, is derived from empirical -statistical studies, and has oeen repeatedly validated
in factor analytic (12) and clinical studies (b) . It was of course necessary to add
schizophrenia, childhood type to cover psychosis even though it has not emerged as a
symptom complex, no doubt oecause of its infrequency in the patient samples of Jenkins,
Peterson, Conners, and others. Some of Jenkins' categories which appear in this
section of the DSM II were, however, rejected on the grounds that they have not
appeared in other than his studies (e.g., runaway reaction). Also included are normal
and undiagnosable categories, the latter largely as a test of consumer acceptance.
153
d. Special Symptoms (item 13) - Provision is made for outstanding special
symptoms, such as enuresis or learning disability, but these do not preclude mak-
ing a modified APA diagnosis. Thus one could check enuresis and mark "normal"
overanxious reaction or something else. Attention is drawn to the exclusion of
juvenile delinquency of the gang-type which is considered to reflect social not
individual pathology (12). Only the true psychopath (i.e., unsocial ized aggress-
ive reaction) of the gang would be included and not because of his belonging to
a gang or because of severe antisocial behavior in accord with the gang's rules;
but because of such behavior as cheating on friends, general impulsivity (most
gangs require high degrees of discipline), exploitative relationships, and
ultimately nearly always rejection by the peer group.
Conclus ions
The above system is offered as a start to some degree of conformity in the
areas of psychiatric examination and diagnosis for pediatric psychopharmacological
studies. It is unlikely that it will become the definitive system, but it is
hoped that changes will be based primarily on an empirical test of the reliability,
validity, and predictive ability as far as the effects of medication are concerned.
Only field testing of the instrument by many investigators making the results avail-
able to NIMH's ECDEU will provide the necessary data for this empirical analysis.
Reliability studies require two independent examiners and thus more effort by the
investigators, but hopefully this will be done, too, and the children's ECDEU
battery will be off to a worthy start unusual for child psychiatry.
References
1. Conners , C. K. A teacher rating scale for use in drug studies with children.
Amer. J. Psychiat., 126: 152-156, 1969.
2. Conners, C. K. Symptom patterns in hyperkinetic, neurotic, and normal children,
Child Develop., 4l : 667-682, 1970.
3. Eisenberg, L. Psychotic disorders, I. Clinical features. In: Freedman, A.,
and Kaplan, H. (eds), A Comprehensive Textbook of Psychiatry. Baltimore:
Williams & Wilkins, I967, pp. 1^33-1^38.
k. Eisenberg, L., and Conners, C. K. Psychopharmacology in childhood. In:
Talbot, N., Kagan, J., and Eisenberg, L. Behavioral Science in Pediatric
Practice. Philadelphia: Saunders, 1971, pp. 397-^+23.
5. Fish, B. Methodology in child psychopharmacology. In: Efron, D., Cole, J.,
Levine, J . ,and Wittenborn, J. R. (eds), Psychopharmacology, A Review of
Progress, 1957-1967. Washington, D. C. USPHS Publication I836, I968,
pp. 939-1001.
6. Fish, B., and Shapiro, T. A typology of children's psychiatric disorders, I.
Its application to a controlled evaluation of treatment. J. Amer. Acad. Child
Psychiat., ^:32-52, 1965.
154
7. Goldfarb, W. Childhood Schizophrenia. Cambridge, Massachusetts; Harvard
University Press, I96I.
8. Lapouse, R., and Monk, M. An epidemiological study of behavior characteristics
in children. Amer. J. Pub. Health, ^+8: 11 3^-1 1^^, 1958.
9. Mayer, J. Some aspects of the problem of regulation of food intake and obesity.
New Eng. J. Med., 27^-610-673, 722-731, 1966.
10. Overall, J., and Hollister, L. Computer procedures for psychiatric classifica-
tion. J. Amer. Med. Assoc, 187:583-588, 1964.
11. Overall, J., and Klett, C. Applied Multivariate Analysis. New York: McGraw-
Hill, 1972.
12. Q.uay, H. Patterns of aggression, withdrawal and immaturity. In: Quay, H., and
Werry, J. (eds) , Psychopathological Disorders of Childhood. New York: Wiley,
1972.
13. Rutter, M. Classification and categorization in child psychiatry. J. Child
Psychol. Psychiat., 6:71-83, 1965.
]k. Rutter, M., and Graham, P. Psychiatric disorder in 10- and 11-year-old children.
Proceedings of the Royal Society of Medicine, 59:382-387, I966.
15. Rutter, M., and Graham, P. The reliability and validity of psychiatric assessment
of the child, I, Interview with the child. Brit. J. Psychiat., 114:653-659,
1968.
16. Schwi tzgebel , R. Survey of electromechanical devices for behavior modification.
Psychol. Bull., 70:444-459, 1968.
17. Ullmann, L., and Krasner, L. A Psychological Approach to Abnormal Behavior.
Englewood Cliffs, New Jersey: Prentice-Hall, I969, pp. 9-24.
18. Werry, J. Childhood psychosis. In: Q.uay, H., and Werry, J. (eds), Psycho-
pathological Disorders of Childhood. New York: Wiley, 1972a.
19. Werry, J. Psychosomatic disorders. Ibid., 1972b.
20. Werry J., and Quay, H. Observing the behavior of elementary school children.
Except. Child., 35:461-472, I969.
21. Werry, J., and Quay, H. The prevalence of behavior symptoms in younger
elementary school children. Amer. J. Orthopsych iat . , 41:136-143, 1971.
22. Werry, J., and Sprague, R. Hyperactivity. In: Costello, G. (ed.), Symptoms
of Psychopathology. New York: Wiley, 1970, pp. 397-417.
23. Werry, J., Sprague, R. et al. Methylphen idate in children - Effect of dosage.
Submitted for publication, 1972.
155
047 BPRS
BRIEF
PSYCHIATRIC
RATING SCALE
MH-9-47
6-73
BRIEF PSYCHIATRIC RATING SCALE (Overall and Gorham)
INSTRUCTIONS: Insert Genera/ Scoring Sheet and Code 01 Under Sheet Number.
This form consists of 18 symptom constructs, each to be rated on a 7-point scale of
severity ranging from "not present" to "extremely severe". If a specific symptom is
not rated, mark "0" = Not Assessed.
Mark the column headed by the term which best describes the patient's present condition.
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE
Mark on right half of scoring sheet on row specified
SOMATIC
CONCERN
EMOTIONAL
WITHDRAWAL
CONCEPTUAL
DISORGANI
ZATION
GUILT
FEELINGS
MANNERISMS
AND
POSTURING
GRANDIOSITY
DEPRESSIVE
MOOD
Degree
the pati
concern over present bodily health. Rate the
'vhich physical health is perceived as a problem by
t, whether complaints have a realistic basis or not.
Worry, fear, or over-concern for present or future
solely on the basis of verbal report of patient's ov
tive experiences. Do not infer anxiety from phys
or from neurotic defense mechanisms.
and t
Deficiency in relating to the intt
er situation. Rate only the degree to which the p.
the impression of failing to be in emotional conta
other people in the interview situation.
he i
Degree to which the thought processes are confused, dis-
connected or disorganized. Rate on the basis of integratiot
of the verbal products of the patient; do not rate on the
basis of patient's subjective impression of his own level of
functioning.
Over-concern or remorse for past behavior. Rate on the
basis of the patient's subjective experiences of guilt as
evidenced by verbal report with appropriate affect; do not
infer guilt feelings from depression, anxiety i
defenses.
and heightened activation level. Tension should be rated
solely on the basis of physical signs and motor behavior ar
not on the basis of subjective experiences of tension
reported by the patient.
Unusual and unnatural motor behavior, the type of motor
behavior which causes certain mental patients to stand out
in a crowd of normal people. Rate only abnormality of
movements; do not rate simple heightened motor activity
here.
Exaggerated self-opinion, conviction of un
powers. Rate only on the basis of patient'
demeanor in the interview situation.
Despondency in mood, sadness. Rate only degrt
despondency; do not rate on the basis of inferei
cerning depression based upon general retardatic
al ability t
mosity, contempt, belligeren
jide the interview situation.
verbal report of feelings and
o ope rat IV:
, disdain for other people
)te solely on the basis of
tionsof the patient towa
neurotic defenses.
Rale attitude toward
SUSPICIOUS-
NESS
Belief {delusional or otherwise} that others have now, or
e had in the past, malicious or discriminatory intent
(ard the patient. On the basis of verbal report, rate oi
se suspicions which are currently held whether they
cern past or present circumstances.
MODER- EX
ATILY TREMELY
SEVERE SEVERE SEVERE
Continue marking on right half of scoring sheet on row specified
ROW
NO.
12. HALLUCINA-
TORY
BEHAVIOR
Perceptions without normal external stimulus corre-
spondence. Rate only those experiences which are
reported to have occurred within the last week and which
are described as distinctly different from the thought and
imagery processes of normal people.
12
13. MOTOR
RETARDA-
TION
Reduction in energy level evidenced in slowed movements.
Rate on the basis of observed behavior of the patient only;
do not rate on basis of patient's subjective impression of
own energy level
13
14. UNCO-
OPE RATIVE-
NESS
Evidence of resistance, unfriendliness, resentment, and lack
of readiness to cooperate with the interviewer. Rate only on
the basis of the patient's attitude and responses to the
interviewer and the interview situation; do not rate on basis
of reported resentment or uncooperativeness outside the
interview situation.
14
15. UNUSUAL
THOUGHT
CONTENT
Unusual, odd, strange, or bizarre thought content. Rate
here the degree of unusualness, not the degree of disorgan-
ization of thought processes.
15
16. BLUNTED
AFFECT
Reduced emotional tone, apparent lack of normal feeling
16
17. EXCITEMENT
Heightened emotional tone, agitation, increased reactivity.
17
18. DISORIENT-
ATION
Confusion or lack of proper associationfor person, place
18
158
Developed by Overall and Gorham, the Brief Psychiatric Rating Scale (BPRS)
is formatted for use with the General Scoring Sheet and consists of the l8-item
version of the scale. Developed from the longer Lorr Multidimensional Scale for
Rating Psychiatric Patients (MSRPP) and Lorr Inpatient Multidimensional Psychiatric
Scale (imps), the BPRS provides a rapid and efficient evaluation of treatment
response in both clinical drug trials and routine clinical settings. Its focus
is primarily inpatient psychopathology . It has been employed in outpatient settings
to assess levels of anxiety and depression and to distinguish neurotic from more
severely disturbed patients; but the authors caution that the BPRS was not designed
to represent the fine distinctions between types of neurotic patients.
REFERENCES
1. Overall, J. E. and Gorham, D. R., The Brief Psychiatric Rating Scale,
Psychol. Rep., 10:799-812, 1962.
2. Overall, J. E., The Brief Psychiatric Rating Scale in Psychopharmacology
Research, Psychometric Laboratory Reports, No. 29, University of Texas,
Galveston, June, 1972.
APPLICABILITY Primarily for adult inpatient populations.
UTILIZATION Once at pretreatment; at least one post-treatment
assessment. The number and spacing of post-treatment
assessments are at the discretion of the investigator.
TIME SPAN RATED At a maximum, the interval since the last assessment.
At pretreatment, a span of one week is suggested.
CARD FORMAT - ITEMS CARD 01 = 19x, iSll)
I tern Column I tem Column
Hostility 29
Suspiciousness 30
Hallucinatory Behavior 31
Motor Retardation 32
Uncooperat i veness 33
Unusual Thought Content 3^
Blunted Affect 35
Excitement 36
Disorientation 37
1.
Somatic Concern
20
10.
2.
Anxiety
21
11.
3.
Emotional Withdrawal
22
12.
k.
Conceptual Disorganization
23
13.
5.
Guilt Feel ings
2k
14.
6.
Tens ion
25
15.
7.
Mannerisms
26
16.
8.
Grandios i ty
27
17.
9.
Depress ive Mood
28
18.
159
CARD FORMAT - FACTORS
CARD 51 = (19x, 5F6.2, F4.0)
Code "5" in Column 18 indicates card contain-
ing factor, cluster or derived scores.
Factor
Columns
1
20-25
II
26-31
III
32-37
IV
38-43
V
i+4-49
Total Score
50-53
Factor score = Sum of composite items pactor score range = 1
No. of composite items
Total score = Sum of all items
Total score range = 18 - 126
FACTOR COMPOSITION This factor structure is based on a I974
analysis of the pretreatment scores of 3596
subjects with diagnoses of schizophrenia. (Table 8).
I. Anxiety-Depression (ANDP)
1 . Somat ic Concern
2. Anxiety
5. Guilt Feel ings
9. Depressive Mood
I I . Anergia (ANER)
3. Emotional Withdrawal
13. Motor Retardation
16. Blunted Affect
18. Disorientation
IV. Activitation (ACTV)
6. Tension
7. Mannerisms & Posturing
17. Excitement
V. Hosti le-Suspiciousness (HOST)
10. Hostility
1 1 . Suspiciousness
14. Uncooperat iveness
Mi. Thought Disturbance (THOT)
4. Conceptual Disorganization
8. Grandiosity
12. Hallucinatory Behavior
15. Unusual Thought Content
160
TABLE 8
5-FACTOR VARIMAX SOLUTION OF 18-ITEM BRIEF PSYCHIATRIC RATING SCALE
Guy, W., Cleary, P. and Bonato, R. R., Methodological Implications of a Large
Central Data System, published in Proceedings of IXth Congress, CINP, Excerpta
Medica, Amsterdam, 1975.
ITEM
Somatic Concern
Anxiety
Emotional Withdrawal
Conceptual Disorganization
Gu i 1 1 Feel ings
Tens ions
Manner isms
Grand ios i ty
Depressive Mood
Hosti 1 ity
Susp ic iousness
Hallucinatory Behavior
Motor Retardation
Uncooperat i veness
Unusual Thought Content
Blunted Affect
Exci tement
Disor ientat ion
Contribution
of factor (V )
P
% Total Variance
% Common Variance
I I I
IV
-627
066
-164
030
-jkS
115
-073
293
156
-808
-139
157
019
-344
-640
280
-e^k
014
-055
013
-381
-040
-064
732
023
-463
.-216
568
004
208
-536
-027
-784
-116
099
-008
-208
036
-156
195
-346
078
-376
-020
-081
-147
-711
156
-337
-635
125
-198
078
-451
044
301
159
-027
-797
049
015
-793
-094
-077
-030
172
-210
744
227
-475
-330
300
2.58
14.3
22.8
2.48
13.8
21.1
2.30
12.8
20.3
10.5
16.7
V
Communal i t ies
014
425
127
677
073
726
052
610
074
491
161
712
-082
591
441
526
124
653
778
712
650
689
003
558
039
573
641
713
286
745
■032
645
319
729
208
519
1.94
11.29
10.8
62.7
17.
161
SPECIAL INSTRUCTIONS
Brief instructions for rating each item are printed on the scale itself.
To increase the degree of communal ity in interpretation, the items are defined
below in greater detail by Overall and Gorham, and the rater is urged to con-
fine his responses within these contexts.
A. Ratings Based Upon Observation of Patient
3. Emotional Withdrawal - This construct is defined solely in terms of the
ability of the patient to relate in the interpersonal interview situation.
Thus, an attempt is made to distinguish between motor aspects of general retarda-
tion, which are rated as "motor retardation" and the more menta 1 -emotional
aspects of withdrawal, even though ratings in the two areas may be expected to
covary to some extent. In the factor analyses of change in psychiatric ratings,
a "general retardation" factor has emerged in several different analyses, and
this general retardation factor has included both emotional and motor retarda-
tion items. It js difficult to identify the basis for rating of "ability to
relate"; however, initial work has indicated that raters achieve reasonably high
agreement in rating this quality. Emotional withdrawal is represented by the
feeling on the part of the rater that an invisible barrier exists between the
patient and other persons in the interview situation. It is suspected that eyes,
facial expression, voice quality and variability, and expressive movements all
enter into the evaluation of this important, but nebulous, quality of the patients.
6. Tension - It should be noted that the construct "tension" is restricted in the
Brief Scale to physical and motor signs commonly associated with anxiety. Tension
does not involve the subjective experience or mental state of the patient. Although
research psychologists in an effort to attain a high degree of objectivity
frequently define anxiety in terms of physical signs, in the Brief Scale observable
physical signs of tension and subjective experiences of anxiety are rated separately.
Although anxiety and tension tend to vary together, developmental resiearch with an
earlier form of the Brief Scale indicated that the degree of pathology in the two
areas may be quite different in specific patients. A patient, especially when under
the influence of a drug, may report extreme apprehension but give no external evi-
dence of tension whatsoever, or vice versa. |n rating the degree of tension, the
rater should attend to the number and nature of signs of abnormally heightened activa-
tion level such as nervousness, fidgeting, tremors, twitches, sweating, frequent
changing of posture, hypertonic! ty of movements, and heightened muscle tone.
7. Mannerisms and posturing - This symptom area includes the unusual and bizarre
motor behavior by which a mentally ill person can often be identified in a crowd of
normal persons. The severity of manner istic behavior depends both upon the nature
and number of unusual motor responses. However, it is the "unusualness", and not
simply the amount of movement, which is to be rated. Odd, indirect, repetitive
movements, or movements lacking normal coordination and integration, are rated on
this scale. Strained, distorted, abnormal postures which are maintained for ex-
tended periods are rated. Grimaces and unusual movements of lips, tongue, or eyes
are considered here also. Tics and twitches which are rated as signs of tension
are not rated as manneristic behavior.
162
13. Motor retardation - Motor retardation Involves the general slowing down and
weakening of voluntary motor responses. Symptomatology in this area is represented
by behavior which might be attributed to the loss of energy and vigor necessary to
perform voluntary acts in a normal manner. Voluntary acts which are especially
affected by reduced energy level include those related to speech as well as gross
muscular behavior. With increased "motor retardation" speech is slowed, weakened
in volume, and reduced in amount. Voluntary movements are slowed, weakened, and
less frequent.
]k. Uncooperat i veness - This is the term adopted to represent signs of hostility
and resistance to the interviewer and interview situation. It should be noted that
"uncooperat i veness" is judged on the basis of response of the patient to the inter-
view situation while "hostility" is rated on the basis of verbal reports of hostile
feelings or behavior toward others outside the interview situation. It was found
necessary to separate the two areas because of an occasional patient who refrained
from any reference to hostile feelings and who even denies them, while evidencing
strong hostility toward the Interviewer.
B. Ratings Based Primarily Upon Verbal Report
1. Somatic concern - The severity of physical complaints should be rated solely'
on the number and nature of complaints of bodily illness or malfunction, or
suspiciousness of same, alleged during the Interview period. The evaluation is of
the degree to which the patient perceives or suspects physical ailments to play an
important part In his total lack of well-being. No consideration of the probability
of true organic basis for the complaints is required. Only the frequency and
severity of complaints are rated.
2. Anxiety - Anxiety Is a term restricted to the subjective experience of worry,
overconcern, apprehension or fear. Rating of degree of anxiety should be based upon
verbal responses reporting such subjective experiences on the part of the patient.
Care should be taken to exclude from consideration In rating anxiety the physical
signs which are included in the concept of tension, as defined In the scale. The
sincerity of the report and the strength of the experience as indicated by the
involvement of the patient may be important in evaluating degree of anxiety.
k. Conceptual disorganization - Conceptual disorganization involves the disruption
of normal thought processes and Is evidenced in confusion. Irrelevance, Inconsistency,
disconnectedness, d Isjol ntedness , blocking, confabulation, autism, and unusual chain
of associating. Ratings should be based upon the patient's spontaneous verbal
products, especially those longer, spontaneous response sequences which are likely
to be elicited during the initial, non-»d I rect I ve portion of the Interview. Attention
to the facial expression of the patient during the verbal response may be helpful in
evaluating the degree of confusion or blocking.
5. Guilt feelings - The strength of guilt feelings should be judged from the
frequency and intensity of reported experiences of remorse for past behavior. The
strength of the guilt feelings must be judged in part from the involvement evidenced
by the patient In reporting such experiences. Care should be exercised not to infer
guilt feelings from signs of depression or generalized anxiety. Guilt feelings
relate to specific past behavior which the patient now believes to have been wrong
and the memory of which is a source of conscious concern.
163
8. Grandiosity - Grandiosity involves the reported feeling of unusual ability,
power, wealth, importance, or superiority. The degree of pathology should be
rated relative to the discrepancy between sel f-appra isa 1 • and reality. The
verbal report of the patient and not his demeanor in the interview situation
should provide the basis for evaluation of grandiosity. Care should be taken
not to infer grandiosity from suspicions of persecution or other unfounded
beliefs where no explicit reference to personal superiority as the basis for
persecution has been elicited. Ratings should be based upon opinions currently
held by the patient, even though the unfounded superiority may be claimed to
have existed in the past.
9. Depressive mood - Depressive mood includes only the affective component of
depression. it should be rated on the basis of expressions of discouragement,
pessimism, sadness, hopelessness, helplessness, and gloomy thema. Facial ex-
pression, weeping, moaning and other modes of communicating mood should be con-
sidered, but motor retardation, guilt, and somatic complaints, which are
commonly associated with the psychiatric syndrome of depression, should not be
considered in rating depressive mood.
10. Hostility - Hostility is a term reserved for reported feelings of animosity,
belligerence, contempt, or hatred toward other people outside the interview
situation. The rater may attend to the sincerity and affect present in reporting
of such experiences when he attempts to evaluate the severity of pathology in the
symptom area. It should be noted that evidences of hostility toward the inter-
viewer in the interview situation should be rated on the "Uncooperat iveness" item
and should not be considered in rating hostility as defined here.
11. Suspiciousness - Suspiciousness is a term which is used to designate a wide
range of mental experience in which the patient believes himself to have been
wronged by another person or believes that another person has, or has had, intent
to wrong. Since no information is usually available as a basis for evaluating
the objectivity of the more plausible suspicions, the term "accusations" might
be a more appropriate characterization of this area. The rating should reflect
the degree to which the patient tends to project blame and to accuse other people
or forces of malicious or discriminatory intent. The pathology in this symptom
area may range from mild suspiciousness through delusions of persecution or ideas
of reference.
12. Hallucinatory behavior - The evaluation of hallucinatory experiences frequent-
ly requires judgment on the part of the rater as to whether the reported experience
represents hallucination or merely vivid mental imagery. In general, unless the
rater is quite convinced that the experiences reported represent true deviations
from normal thought and imagery processes, hallucinatory behavior should be rated
as "not present".
15. Unusual thought content - This symptom area is concerned solely with the CONTENT
of the patient's verbalization; the extent to which it is unusual, odd, strange, or
bizarre. Notice that a delusional or paranoid patient may present bizarre or un-
believable ideas in a perfectly straightforward, clear, and organized fashion. Rate
only unusualness of content for this item, not degree of organization or disorganiza-
tion.
16. Blunted affect - This symptom area is recognized by reduced emotional tone and
apparent lack of normal feeling or involvement. Emotional expressions are apt to
164
be absent or of marked indifference and apathy. Attempted expressions of feeling
may appear to be mimetic and without sincerity.
DOCUMENTATION:
a. Raw score printout
b. Factor score printout
c. Means and standard deviations
d. Cross tabulations
e. Variance analyses
165
COMMENTS OF THE AUTHOR
THE BRIEF PSYCHIATRIC RATING SCALE IN PSYCHOPHARMACOLOG I C RESEARCH
John E. Overal 1 ^ Ph.D.
The Brief Psychiatric Rating Scale (BPRS) was originally developed to provide
an efficient and clinically valid means of assessing efficacy in psychopharmacolog ic
research.' Later research demonstrated its utility for descriptive class i ficat ion of
psychiatric patients according to profile pattern. ^'3 The BPRS consists of 18
(originally 16) symptom constructs, each to be rated on a 7-point scale of severity.
The ratings are coded 0-6-'- for the 7 categories of severity ranging from "not present"
to "extremely severe".
In most clinical research applications, the BPRS is completed immediately prior
to the start of drug treatment and again after a fixed period of time, usually k to
6 weeks. Ratings are based on information obtained in a clinical interview of about
20 minutes duration. It is recommended that each patient be interviewed and rated
independently by two professional observers to enhance the reliability of ratings,
although the advantage gained from duplicate independent ratings is not now considered
to be as great as it once was. A minimum of 35 to kO patients in each treatment group
should be included in any study in which the BPRS is used with two independent raters,
or approximately 45 to 50 patients per group if a single rater is used.^ These esti-
mates of sample size do not appear restricted to the BPRS and can be readily calculated
for any particular research setting. 5
The BPRS pre-treatment ratings can be used to describe the patient sample and to
classify patients into phenomenological homogeneous sub-types. Profile classification
has been found useful in reducing wi th in-treatment variability and in the study of
specific indications of psychotherapeutic drugs. Although earlier efforts at profile
classification using the BPRS were attempts to provide more objective methods for
assigning patients among standard diagnostic categories ,°»7, 8 more recent efforts have
centered about the use of cluster analysis and related empirical methods to identify
the most frequently occurring and thus most representative profile patterns .9, 1 0 jhe
results of these studies have produced a classification system consisting of six types
described as anxious depression, hostile depression, withdrawn-retarded depression,
paranoid host i le-susp iciousness syndrome, withdrawn-disorganized thinking disturbance
and florid thinking disorder.'' Most psychiatric patients can be recognized as hav-
ing symptom patterns fitting closely one of these six types. The six BPRS prototype
patterns, which depend upon only the original 16 items, are as follows.
ANXIOUS DEPRESSION
2.6 2.8 I.I 0.5 0.8 0.2 0.2 2.5 0.8 O.k 0.1 1.0 0.3 O.k 1.0
HOSTILE DEPRESSION
0.6 2.7 1.1 1.1 2.0 1.8 0.3 0.3 2.5 2.9 2.2 0.2 0.5 1.0 0.7 0.7
The ECDEU version of the BPRS is coded 1 - 7 rather than 0
166
}
WITHDRAWN-RETARDED DEPRESSION
1.4 1.7 3.0 1.2 0.7 1.1 0.6 0.1 3.4 0.5 0.5 0.3 2.2 0.8 0.4 2.7
PARANOID HOSTILE-SUSPICIOUSNESS SYNDROME
1.4 1.5 1.0 1.4 0.4 1.4 0.4 1.0 0.5 3.4 2.6 0.1 0.4 1.6 1.2 0.7
WITHDRAWN-DISORGANIZED THINKING DISTURBANCE
0.7 0.8 3.1 3.4 0.1 1.1 1.3 0.2 0.5 0.4 1.0 1.5 1.8 1.2 2.2 3.6
FLORID THINKING DISORDER
0.7 1.3 2.4 3.9 0.2 2.0 1.5 1.4 0.8 1.4 3.0 3.5 0.7 1.6 4.2 2.6
Patients can be classified among the six phenomenolog ical sub-groups by simply
calculating the sum of squared differences between individual profile elements
(scored 0-6 for single rater or average of two raters) and the corresponding proto-
type values, with the patient then being assigned to the group for which the simple
d^ is smallest. ^2 por studies involving only pre-screened clinically depressed
patients, only the first three profile patterns need be considered. Several more
complex profile analysis methods have been programmed for computer to classify
patients among the six types and can be obtained from J. E. Overall (University of
Texas Medical Branch, Galveston). Dr. Overall also has the facilities to process
profiles sent to him in punched cards and has agreed to do so for any ECDEU
invest igator .
Several composite scores derived from the BPRS are frequently used in evaluat-
ing treatment effects. Numerous factor analyses of BPRS ratings have consistently
revealed the presence of four major higher order factors which have been described
as thinking disturbance, wi thdrawa 1 -retardat ion , host i 1 e-susp ic iousness and anxious
depress ion. ' 3 Factor scores are obtained by summing ratings on the three BPRS items
most highly related to each factor.
THINKING DISTURBANCE - Conceptual Disorganization, Hallucinatory Behavior
and Unusual Thought Content.
W I THDRAWAL-RETARDAT I ON - Emotional Withdrawal, Motor Retardation and Blunted
Affect.
HOSTILE-SUSPICIOUSNESS - Hostility, Suspiciousness and Uncooperat i veness .
ANXIOUS DEPRESSION - Anxiety, Guilt Feelings, and Depressive Mood,
In addition to the four higher order factor scores, a "total pathology" score is used
to represent the total deviation from normality and to evaluate total change during
treatment. The total pathology score is the sum of ratings on all 18 rating constructs,
each scored on a 0-6 scale. Where patients have been grouped into distinctively
different profile types, the total pathology score is recommended for evaluation of
treatment outcome because specific symptom factors tend to be too highly related to
prof i le group.
167
Considerable effort has gone into the identification of extrinsic factors
which influence BPRS ratings. It is considered that these non-drug factors produce
variability in symptom patterns and treatment responses which should be controlled
experimentally or statistically jn order to improve the precision of clinical
psychopharmacologic research. Differences in initial symptom patterns are significant-
ly related to age, race, sex, age of onset, previous course of illness, marital status,
education, work achievement and a variety of other less important factors. 1^> '5, 16
Differences in treatment outcome have been found to depend significantly on pretreat-
ment level and type of symptomatology, age of onset, previous hospitalizations and/or
course of illness, marital status, presence of identifiable precipitating stress and
race.''' '° Where several different raters are involved in a project, systematic
rater differences are often very important.
While work is continuing along these lines, it appears obvious that a variety
of factors do influence BPRS evaluations of symptom pattern and treatment outcome,
and the above appear to be among the potentially most important. It is recommended
that these extrinsic factors be carefully recorded and that their effects then
should be removed by using somewhat more complex statistical analyses than have
been used in the past.''' Experimental control can be achieved by holding certain
of the extrinsic factors constant, such as age or sex, but this tends to restrict
the generality of conclusions that can be drawn.
A completely adequate experimental design involving BPRS evaluations should take
into account (a) pre-treatment profile type, (b) pre-treatment level of severity,
(c) demographic and sociocul tura 1 background characteristics of the patient which
may influence outcome independently of drugs, (d) experimentally introduced systematic
effects such as hospital differences, rater differences and the like, and (e) drug
treatments. Where patients are classified into distinct profile groups, the broad
measure of change in total pathology is recommended for evaluation of outcome with
differences in pre-treatment level of severity partial led out. In this brief summary,
an attempt has been made to provide the investigator with essential information con-
cerning sample size, scoring, patient classification and control variables that will
enable him to use the BPRS in as effective a manner as current methodology permits.
REFERENCES
1. Overall, J. E. and Gorham, D. R. The brief psychiatric rating scale. Psychol.
Rep., 1962, 10, 799-812,
2. Overall, J. E. and Gorham, D. R. A pattern probability model for classification
of psychiatric patients. Behavioral Science, 1963. 8, 108-116.
3. Overall, J. E. and Hollister, L. E. Computer procedures for classification of
psychiatric patients. J. Am. Med. Asso., 1963, I87, 583-588.
k. Overall, J. E., Hollister, L. E. and Dalai, S. N. Psychiatric drug research:
Sample size requirements for one vs. two raters. Arch. Gen. Psychiatry, 196?,
16, I52-I6I.
5. Overall, J. E. and Dalai, S, N. Empirical formulae for estimating appropriate
sample sizes for analysis of variance designs. Perceptual Motor Skills, I968,
27, 363-367.
168
6. Overall, J. E., Hollister, L. E., Meyer, F., Kimbell, I. Jr., and Shelton,
J., Imipramine and thioridazine in depressed and schizophrenic patients.
J. Am. Med. Asso., 1964, I89, 605-6IO.
7. Overall, J. E. and Hollister, L. E. Studies of quantitative approaches to
psychiatric classification. In the Role and Methodology of Classification
in Psychiatry and Psychopathol ogy . U. S. Dept. of Health, Education and
Welfare, PHS , U.S. Gov't. Printing Office.
8. Hollister, L. E., Overall, J. E., Bennett, L., Kimbell, I. Jr. and Shelton, J.
Triperidol in schizophrenia: Further evidence for specific patterns of action
of antipsychotic drugs. J. New Drugs, 1965, 5, 3^-42.
9. Overall, j. E., Hollister, L. E., Johnson, M. and Pennington V . Nosology of
depression and differential response to drugs. J. Am. Med. Asso., 1 966 , 195,
946-9^8.
10. Overall, j. E., Hollister, L. E., Shelton, Jr., Kimbell, I., Jr., and
Pennington, V. Broad-spectrum screening of psychotherapeutic drugs: Thiothixene
as an anti-psychotic and antidepressant. Clin. Pharm. and Therapeutics, I969,
10, 36-^+3.
11. Overall, J. E. Personal communication. To appear in Multivariate Methods for
Clinical Research by Overall and Klett. New York: McGraw-Hill, 1971.
12. Cronbach, L. J. and Gleser, G. C. Assessing similarities between profiles.
Psychol. Bull., 1953, 50, 456-473.
13. Overall, j, E., Hollister, L. E. and Pichot, P. Major psychiatric diso'-ders:
A four -dimensional model. Arch, of Gen. Psychiat., I967, 16, 146-151.
14. Overall, J. E. and Hollister, L. E. Controlling for extrinsic variability
associated with differences in background characteristics. Proceedings of
the VI International Congress of the C.I.N. P., I968. Excerpta Medica Inter-
national Congress Series, No. 180.
15. Pokorny, A. D. and Overall, J. E. Relationships of psychopathol ogy to age,
sex, ethnicity, education and marital status in state hospital patients.
J. Psychiat. Research, I969, 7, (Dec. Issue)
16. Overall, j. E. Historical and sociocul tural factors related to the phenomenology
of schizophrenia. |n Schizophrenia: Current Concepts and Research. D. V. Siva
Sankar (Ed.) PJD Publications LTD., Hicksville, New York, I968.
17. Overall, J. E. and Tupin, J. P., Investigation of clinical outcome in a doctor's
choice treatment setting. Dis. of Nerv. System, I969, 30, 305-313.
18. Overall, j. E., Hollister, L. E., Kimbell, I. Jr., and Shelton, J. Extrinsic
factors influencing responses to psychotherapeutic drugs. Arch, of Gen. Psychiat.
1969, 21, 89-94.
169
072 DS I
DEPRESSION
STATUS
INVENTORY
MH-9-72 DEPRESSION STATUS INVENTORY (bSI)
6-73 Wm.W.K.Zung
INSTRUCTIONS: Code 01 under Sheet Number on General Scoring Sheet
The data upon which the judgments are based come from theMnterview with the patient. The items in the
scale are to be quantified by using all the information available to the rater. This includes both clinical obser-
vation and the material reported by the patient.
Use of the Interview Guide below assures coverage of all the areas on which judgments are required. How-
ever, the rater has the flexibility of modifying the questions or probing for details, which makes possible a
smooth interview that does not sound like a question-answer examination. In rating the patient's current
status, an arbitrary period of 1 week prior to the evalutaion is adopted in order to standardize the data. In
order to reinforce this, the interviewer should occasionally precede questions with, "During the past week,
have you ?"
Mark on right half of scoring sheet on row specified
ROW
NO.
MODER-
NONE MILD ATE SEVERE
12 3 4
SIGNS AND SYMPTOMS
OF DEPRESSION
INTERVIEW GUIDE
1. Depressed Mood
Do you ever feel sad or depressed?
19
2. Crying Spells
Do you have crying spells or feel like it?
20
20 "3" "2:: rrS:: :Lt:
3. Diurnal Variation:
symptoms worse in a.m.
Is there any part of the day when you
feel worse? Best?
21
22 "3== ---2zz ::3:= ==4=-"
4. Steep Disturbance
Frequent and early AM wakings
22
24 i-J:: ==2:= :*: ==*=
5. Decreased Appetite
How is your appetite?
23
25 z-i- r=2:= ::3zr 4-"
26 ==):: ==2:= i*r =:4==
6. Weight Loss
Have you lost any weight?
24
27 zzl.z zziz. r=3:: z-tzz
28 "1:: ==2== :i3:: -zAzz
7. Decreased Libido J^/^^ ^"J^^ 1 ook i ng . ta 1 k i ng or
being with attractive men/women?
25
30 ::J:= "2=: ::3:: z-Azz
8. Constipation
Do you have trouble with constipation?
26
32 :i3" 1=2== ==3== 1=4==
9. Tachycardia
Have you had times when your heart
was beating faster than usual?
27
34 ==}:= ==2== ==3=1 --J\zz
35 ::i:= ==2== =*: ==4==
36 ==i== r=2== ==3== =-^-:
10. Fatigue
How easily do you get tired?
28
11. Psychomotor Agitation
Do you find yourself restless and
can't sit still?
29
37 :=l== ::2:: ==3== =-4=:
38 ==}=: ==2== ==3:= =i4==
Cols: 12 13 14 15
12. Psychomotor
Retardation
Do you feel slowed down in doing the
the things you usually do?
30
13. Confusion
Do you ever feel confused and have
trouble thinking?
31
14. Emptiness
Do you feel life is empty for you?
32
15. Hopelessness
How hopeful do you feel about the future?
33
16. Indecisiveness
How are you at making decisions?
34
17. Irritability
How easily do you get irritated?
35
18. Dissatisfaction
Do you still enjoy the things you used to?
36
19. Personal Devaluation
Do you ever ffeel useless and not wanted?
37
20. Suicidal Ruminations
Have you had thoughts about doing
away with yourself?
38
172
The Depression Status Inventory (DSl), developed by Zung, has been designed
as the professionally-rated analogue of the patient-rated Zung Depression Scale
(SDS) , With appropriate contextual changes, it consists of the same 20 items as
the SDS; and, based on 209 cases, the author reports a Pearson product moment
correlation of .87 between the 2 scales. The DSl provides a global measure of
the intensity of depressive symptomatology.
REFERENCE Zung, W. W. K., The Depression Status Inventory: An
Adjunct to the Self-Rating Depression Scale, J, Clin.
Psychol ., 28: 539-5^3, 1972.
APPLICABILITY Adults with depressive symptoms
UTILIZATION Once at pretreatment ; at least one posttreatment rating.
Additional ratings are at the discretion of the investigator,
TIME SPAN RATED Now or in the last week
CARD 01 = (19x, 2011 , lOx, \k)
Item Column
11 30
12 31
13 32
]k 33
15 3^
16 35
17 36
18 37
19 38
20 39
Z Score-'- 50-53
"The Z score is derived by dividing the sum of the raw item scores by the
maximum possible score (80) multiplied by 100. See Table 9 for the
Conversion of Interviewer-Rated Raw Scores to the DSl Z Scores. Zung has
provided the following mean DSl "Z" scores for various diagnostic groups:
Diagnos is
Depressive disorders
Schizophrenia
Anxiety disorder
Personality disorders
Transient situational disturbances
= Significantly different from other diagnostic groups (p. <[ .01)
CARD
FORMAT -
ITEMS CA
Item
1
Column
20
2
21
3
22
k
23
5
2k
6
25
7
26
8
27
9
28
10
29
Mean
N
DSl Z
Scores
96
6b'wV
25
kS
22
51
54
52
12
kk
173
TABLE 9 (from Zung)
THE CONVERSION OF I NTERV lEWfR-RATED RAW SCORES TO THE DS I Z SCORES
Raw
DSl
Raw
DSl
Raw
DSl
Score
Z Scores
Score
Z Scores
Score
Z Scores
20
25
40
50
60
75
21
26
41
51
61
76
22
28
42
53
62
78
23
29
^3
54
63
79
24
30
44
55
64
80
25
31
45
56
65
81
26
33
46
58
66
83
27
34
47
59
67
84
28
35
48
60
68
85
29
36
49
61
69
86
30
38
50
63
7b
88
31
39
51
64
71
89
32
40
52
65
72
90
33
41
53
66
73
91
34
43
54
68
74
92
35
44
55
69
75
94
36
45
56
70
76
95
37
46
57
71
77
96
38
48
58
73
78
98
39
49
59
IM
79
80
99
100
SPECIAL INSTRUCTIONS
The following rules and guidelines should be used in rating the patient's
psychopathology:
A. Each item should be rated independently as a unit in order to eliminate
the "halo" effect.
B. Each score should be the average of the full range of responses
observed or elicited, and not necessarily the extreme in severity.
174
C. The items are judged on a 4-point system that takes into account
Severity in terms of: intensity, duration and frequency. These
are defined as follows:
1 = none or insignificant in intensity or duration, present
none or a little of the time in frequency
2 = mild in intensity or duration, present some of the time
3 = of moderate severity, present a good part of the time
k = severe in intensity or duration, present most or all of
the time in frequency
To help establish severity, the following questions may be necessary:
Intensity: "How bad was it?", Duration: "How long did it last?", and
frequency: "How much of the time did you feel that way?"
D. An item is scored positive and present when (a) behavior is
observed, (b) behavior was described by a patient as having
occurred, and (c) patient admits that symptom is still a
problem.
E. An item is scored negative and not present when (a) symptom
has not occurred and not a problem or present, (b) response
is ambiguous even after suitable probing, or (c) patient
gives no information relevant to an item.
ERRATA
Rating of the items - The "Not Assessed" (0) position printed in
the packet should NOT be used. Use scale points 1 through h only.
Item 4 - The printed instructions should read "Frequent and early
AM wakings".
Item 7 - The printed instructions should read "Do you enjoy looking,
talking or being with attractive men/women?"
DOCUMENTATION:
a. Raw score printout
b. Z score printout
c. Z score means and standard deviations
d. Variance analyses
175
10. Zung, W.W.K.: Depression in the normal adult population, Psychosom. 12:
164-167, 1971.
11. Zung, W.W.K.: The differentiation of anxiety and depressive disorders:
A biometric approach, Psychosom. 12:380-384, 1971.
12. Zung, W.W.K.: A cross-cultural survey of depressive symptomatology in
normal adults, J. Cross-Cult. Psychol. 3:177-183, 1972.
13. Zung, W.W.K.: How normal is depression? Psychosom. 13:174-178, 1972.
14. Zung, W.W.K.: The Depression Status Inventory: An adjunct to the self-
rating depression scale, J. Clin. Psychol. 28:339-543, 1972.
15. Brown, G.L. & Zung, W.W.K.: Depression scales: Self- or physician-rating?
Comp. Psychiat. 13:361-367, 1972.
16. Zung, W.W.K.: From art to science: The diagnosis and treatment of depres-
sion. Arch. Gen. Psychiat. 29:328-337, 1973.
17. Zung, W.W.K. , van Praag, H.M., Dijkstra, P. and van Winzum, C: Cross-
cultural survey of symptoms in depressed and normal adults, in Itil, T. (Editor)
Transcul tural Psychopharmacology.
178
049 HAMD
HAMILTON
DEPRESSION
SCALE
MH-9-49
6-73
HAMILTON PSYCHIATRIC RATING SCALE FOR DEPRESSION
INSTRUCTIONS: Code 01 under Sheet Number on GSS.
For each item select the one "cue" which best characterizes the patient.
Be sure to record your answers in the appropriate spaces (positions 0 through 4),
Columns 1 - 5, on the left half of the General Scoring Sheet.
See Spec/a/ Instructiorts in Manual for Items 7, 16, 18, and 20.
Row 1 -Q:-
:=t:
:=2::
::3::
==*:
2:.ttr
r:t:
=:2::
==3:=
==*=
3:=ttr
::t:
r:2::
: t:
==4==
4:r0:r
"ti
z.Zz
"3::
==*=
5:=£t:
r:2::
::3:r
==*=
6==0: =
::2::
"3::
::*=
7. .ft:
;:2::
"*-
==4:=
8:re::
.Uz
"2::
::3::
::*:
9r:e::
::2::
::}::
==4==
lOz.a::
::2::
:*:
==4==
1 1 =:&=
::2::
"J::
==4::
n-.-e:-
=i2:=
:*:
::4=:
n-.-o:-.
"2:
zz3^z
==4i=
UzEbr
:;3::
-St;
"fc
==*=
ISrzEtz
rrJ::
:ri:
::2t-.
==*=
16;ifi:=
rrJ"
"3tr
-ar
::*:
17.:a::
:H=i
nil
1=3::
==*=
18.=a:
zzizz
iia:
==3:1
= :*=
19==a=
::i:
::2:
= = 3:=
==*=
20 -B:.
"±=
-i:
::3:=
==* =
21 ::ft=
=r±:
:ra:
::3::
==* =
22 --.&-.
r=±:
=:3ti
==3::
::*:
23. A.
::J;r
Ii2:=
==3==
=a!::
Cols: 1
2
3
4
5
ROW
NO.
Mark each item on left half of scoring sheet on row specified
Use marking positions 0 — 4, columns 1 — 5
1
1. DEPRESSED MOOD (Sadness, hopeless, helpless, worthless)
0 = Absent
1 - These feeling states indicated only on questioning
2 = These feeling states spontaneously reported verbally
3 = Communicates feeling states non-verbally - i.e., through facial
expression, posture, voice, and tendency to weep
4 = Patient reports VIRTUALLY ONLY these feeling states in hit
spontaneous verbal and non-verbal communication
2
2. FEELINGS OF GUILT
0 = Absent
1 = Self reproach, feels he has let people down
2 = Ideas of guilt or rumination over past errors or sinful deeds
3 = Present illness is a punishment. Delusions of guilt
4 = Hears accusatory or denunciatory voices and/or experiences
threatening visual hallucinations
3
3. SUICIDE
0 = Absent
1 = Feels life is not worth living
2 •" Wishes he were dead or any thoughts of possible death to self
3 = Suicide ideas or gesture
4 = Attempts at suicide (any serious attempt rates 4)
4
4. INSOMNIA EARLY
0 = No difficulty falling asleep
1 = Complains of occasional difficulty falling asleep — i.e., more than
Vs hour
2 = Complains of nightly difficulty falling asleep
5
5. INSOMNIA MIDDLE
0 = No difficulty
1 = Patient complains of being restless and disturbed during the night
2 = Waking during the night — any getting out of bed rates 2 (except
for purposes of voiding)
6
6. INSOMNIA LATE
0 = No difficulty
1 = Waking in early hours of the morning but goes back to sleep
2 = Unable to fall asleep again if he gets out of bed
7
7. WORK AND ACTIVITIES
0 = No difficulty
1 = Thoughts and feelings of incapacity, fatigue or weakness related to
activities; work or hobbies
2 = Loss of interest in activity; hobbies or work — either directly
reported by patient, or indirect in listlessness, indecision and
vacillation (feels he has to push self to work or activities)
3 = Decrease in actual time spent in activities or decrease in produc-
tivity. In hospital, rate 3 if patient does not spend at least three
hours a day in activities (hospital job or hobbies) exclusive of
ward chores
4 = Stopped working because of present illness. In hospital, rate 4 if
patient engages in no activities except ward chores, or if patient
fails to perform ward chores unassisted
180
HAMILTON PSYCHIATRIC RATING SCALE FOR DEPRESSION
ROW
NO.
Continue marking on left half of scoring sheet on row specified
8.
RETARDATION (Slowness of thought and speech: impaired ability
to concentrate: decreased motor activity)
0 = Normal speech and thought
8
1 = Slight retardation at interview
2 = Obvious retardation at interview
3 = Interview difficult
4 = Complete stupor
9.
AGITATION
0
= None
1
= Fidgetiness
2
= Playing with hands, hair, etc.
3
= Moving about, can't sit still
k
= Hand wringing, nail biting,
hair-pulling, biting of lips
10.
ANXIETY PSYCHIC
0= No difficulty
10
1 = Subjective tension and irritability
2 = Worrying about minor matters
3 = Apprehensive attitude apparent in face or speech
4 = Fears expressed without questioning
11.
ANXIETY SOMATIC
0 = Absent Physiological concomitants of anxiety, such as:
^ ~ l^'ld Gastro-intestinal — dry mouth, wind, indigestion.
11
2 = Moderate diarrhea, cramps, belching
3 = Severe Cardio-vascular — palpitations, headaches
4 = Incapacitating Respiratory - hyperventilation, sighing
Urinary frequency
Sweating
12.
SOMATIC SYMPTOMS GASTROINTESTINAL
0= None
12
1 = Loss of appetite but eating without staff encouragement. Heavy
feelings in abdomen
2 = Difficulty eating without staff urging. Requests or requires laxa-
tives or medication fpr bowels or medication for G.I. symptoms
13.
SOMATIC SYMPTOMS GENERAL
0= None
1 = Heaviness in limbs, back or head. Backaches, headache, muscle
aches. Loss of energy and fatigability
2 = Any clear-cut symptom rates 2
14.
GENITAL SYMPTOMS
14
0 = Absent Symptoms such as: Loss of libido
1 = Mild Menstrual
2 = Severe disturbances
15.
HYPOCHONDRIASIS
0 = Not present
1 = Self-absorption (bodily)
2 = Preoccupation with health
3 = Frequent complaints, requests for help, etc.
4= Hypochondriacal delusions
ROW
NO.
Continue marking on left half of scoring sheet on row specified 1
16.
LOSS OF WEIGHT Rate either A or B
A
When Rating By History:
16
0 = No weight loss
1 = Probable vreight loss associated with present illness
2 = Definite (according to patient) weight loss
3 = Not assessed
B.
On Weekly Ratings By Ward Psychiatrist. When Actual Weight Changes
Are Measured:
17
0 = Less than 1 lb. weight loss in week
1 = Greater than 1 lb. weight loss in week
2 = Greater than 2 lb. weight loss in week
3 = Not assessed
17.
INSIGHT
0 = Acknowledges being depressed and ill
18
1 = Acknowledges illness but attributes cause to bad food, climate,
overwork, virus, need for rest, etc.
2= Denies being ill at all
18.
DIURNAL VARIATION
A
Note whether symptoms are worse in morning or evening. If NO
19
diurnal variation, mark none
0 = No variation
1 = Worse in A.M.
2 = Worse in P.M.
B
When present, mark the severity of the variation. Mark "None" if NO
variation
20
0 = None
1 = Mild
2 = Severe
19.
DEPERSONALIZATION AND DEREALIZATION
0 = Absent Such as: Feelings of unreality
21
1 = Mild Nihilistic ideas
2 - Moderate
3 = Severe
4 = Incapacitating
20.
PARANOID SYMPTOMS
0= None
22
1 = Suspicious
2 = Ideas of reference
3 = Delusions of reference and persecution
21.
OBSESSIONAL AND COMPULSIVE SYMPTOM?
23
0 = Absent
1 = Mild
2 = Severe
181
Hamilton's Depression Scale (HAMD) is a 23-item (including two 2-part items)
scale formatted for use with tiie General Scoring Sheet. The scale points vary
from 3 to 5. The HAMD is one of the most widely used instruments for the clinical
assessment of depressive states. Unfortunately, the scale has been employed in a
number of different versions - creating considerable difficulty when attempting
to compare published findings. The present version is, we believe, the author's
vers ion.
REFERENCE
APPLICABILITY
UTILIZATION
TIME SPAN RATED
Now
CARD FORMAT - ITEMS
(i9x, ;
i tern
Col umn
1 Depressed Mood
20
2 Guilt
21
3 Suicide
22
k Insomnia - early
23
5 Insomnia - middle
2k
6 Insomnia - late
25
7 Work
26
8 Retardation
27
9 Agitation
28
10 Anxiety-Psychic
29
1 1 Anxiety-Somat ic
30
12 Somatic-GI
31
Hamilton, M., Development of a Rating Scale for
Primary Depressive Illness, Brit. J. Soc. Clin.
Psychol ., 1967, 6, 278-296.
Adults with depressive symptomatology
Once at pretreatment ; at least one posttreatment
rating. Additional ratings are at the discretion
of the investigator.
Now or within the last week
I tem
13 Somatic-General
14 Genital Symptoms
15 Hypochondriasis
16A Weight-History
16b Weight-Actual
17 Insight
Diurnal Variation-time
Diurnal Variation-severity
Depersonal ization
Paranoid
Obsess/Comp
Col umn
32
33
3^
35
36
37
38
39
ko
k]
kl
CARD FORMAT - FACTORS CARD 51 = (19x, 6f6.2, F4.0)
Code "5" in Col. 18 indicates card which contains
factor, cluster or derived scores.
Factor
1
2
3
k
Col umns
20-25
26-31
32-37
38-43
Factor
Columns
5
kh-kS
6
50-55
Total Score
56-59
Factor score = Sum of composite items
No. of composite items
Total Score = Sum of a 1 1 items." Total Score Range
in calculating Total Score, Only Item 18
Factor Score Range = 0
0-62.
not I 8A - is included.
182
FACTOR COMPOSITION
This factor structure based on a 1975 analysis of the pretreatment ratings
of ^80 subjects with diagnoses of neurotic depression. (Table 10).
Factor I - Anxiety/Somat izat ion Factor I V - Diurnal Variation
10. Anxiety, Psychic 18A. Diurnal Variation (Time)
11. Anxiety, Somatic B. Diurnal Variation (Severity)
12. Somatic Symptoms, Gastro- Intestinal
13. Somatic Symptoms, General Factor V - Retardation
15. Hypochondriasis
17. Insight 1. Depressed Mood
7. Work and Activities
Factor II -Weight 8. Retardation
]k. Genital Symptoms
16A. Loss of Weight (History)
16b. Loss of Weight (Actual Factor VI - Sleep Disturbance
Factor III - Cognitive Disturbance k. Insomnia, Early
5. Insomnia, Middle
2. Feelings of Guilt 6. Insomnia, Late
3. Suicide
9. Agitation
19. Depersonalization and Derealization
20. Paranoid Symptoms
21. Obsessional and Compulsive Symptoms
SPECIAL INSTRUCTIONS
I tern 7' Work and Activities - Rater may seek information from relatives or
ward personnel .
I tern 9. Agitation - This item - printed in the packet as a 3-point scale - should
be rated on a 5-point scale as follows:
0 = None
1 = Fidgetiness
2 = Playing with hands, hair, etc.
3 = Moving about, can't sit still
k = Hand wringing, nail biting, hair pulling, biting of lips
I tern 16. Loss of Weight - This is an "either/or" item requiring a response to only
part of the item, i.e., I6A or 16b. Actual Weight Changes (16b) is the
preferred choice - particularly during the course of a study. It is
suggested that Weight by History (I6A) be used only at the pretreatment
rating.
183
TABLE 10
6 - FACTOR VARIMAX SOLUTION OF 23-ITEM HAMILTON DEPRESSION SCALE
Cleary, P. and Guy, W., Factor Analyses of the Hamilton Depression Scale,
at the International Symposium on the Evaluation of New Drugs in Clinical
pharmacology, Pisa, September, 1975.
presented
Psycho-
Depressed Mood 1
Feel ings of Qui 1 1 2
Suicide 3
Insomnia (Early) k
Insomnia (Middle) 5
Insomnia (Late) 6
Work & Act ivi t ies 7
Retardation 8
Agitation 9
Anxiety Psychic 10
Anxiety Somatic 11
Somatic Symptoms G.I. 12
Somatic Symptoms - General 13
Genital Symptoms ]k
Hypochondriasis 15
Loss of Weight A 16
Loss of Weight B 17
Insight 18
Diurnal A.M. 19
D.iurnal P.M. 20
Depersonalization & Dualization 21
Paranoid 22
Obsess ional -Compuls ive Symptoms 23
Contribution
of factor (V )
% of Total Variance 11.43 8.91
% of Common Variance 20.06 15.63
F3
-213
-678
-429
-065
-194
-102
-167
-065
-465
-393
-158
-139
-211
-117
-070
025
-101
054
-121
-082
-556
-678
2.63 2.05 2.45
Fl
F2
077
052
012
006
009
237
091
367
058
109
105
084
184
103
167
000
420
144
448
233
720
155
462
293
601
002
340
083
731
076
086
746
262
8?8
513
-417
■015
109
084
064
119
235
173
-139
162
-022
10.65
18.68
F4
043
-068
163
052
104
119
-032
074
-196
117
-030
048
116
325
048
167
054
094
731
814
140
229
076
1.56
6.78
11.89
F5
709
152
366
105
223
244
602
645
-021
201
156
224
338
531
167
136
-040
-252
229
-030
223
-083
205
f6
100
090
157
585
709
708
261
222
295
030
109
326
284
004
■097
269
174
323
078
134
146
163
-051
2.33 2.09
10.13
17.77
9.08
15.94
Communa 1
it ies
57
50
43
50
62
60
50
50
54
46
60
48
61
52
58
68
92
62
62
70
47
59
47
13.11
56.9
184
Item 18. Diurnal Variation - When no variation is present, encode "0" for
Item A (Row 19) and leave 1 8b (Row 20) blank as follows:
19.^ ..t.. -^-- :*: :^: ] 8A
20:*: ::):: :*: :*: A^- 1 8B
When diurnal variation is present, encode the time of day when the
symptoms are worse in 1 8A and indicate the severity of variation;
i.e., the degree or amount of variation, in 1 8b . "Mild" should be
interpreted as doubtful or slight variation: "Severe" as clear or
marked variation.
Example: The patient's symptoms are clearly worse in the morning.
Encode 1 in Row 19 and 2 in Row 20.
19:0:: «^ ^^
:*:
:*:
ISA
20:*:: ::(:: -••
:*r
:*:
18b
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Means and standard deviations of factor scores
d. Crosstabulat ions
e. Variance analyses
185
COMMENTS OF THE AUTHOR - Adapted from "Development of a Rating Scale for Primary
Depressive Illness"; Brit. J. of Soc. Clin. Psychol., 1967, 6, 278-296
Max Hami 1 ton , M.D.
The scale provides a simple way of assessing the severity of a patient's condi-
tion quantitatively, and for showing changes in that condition. It should not be
used as a diagnostic instrument. A set of items to be so used should include not
only those which will show the presence of the symJDtoms that the patient has, but
also those which the patient has not, for a diagnosis not only includes the patient
within a certain category but also excludes him from others. It is possible that
the scale may have other uses, e.g.: predicting outcome and selection of treatment,
but these have not yet been worked out.
Ratings can be done in a number of ways, depending on the purpose, but whatever
this may be it must never be forgotten that the scores are merely a particular way
of recording the rater's judgment. Other things being equal, the value of the
ratings therefore depends entirely on the skill and experience of the rater and on
how adequate is the information available to him. This scale was devised for
recording the severity of symptoms of a patient C^part from minor and temporary
fluctuations) and therefore questioning should be directed to his condition in the
last few days or week. It is desirable to obtain additional information from rela-
tives, friends, nurses etc. and this should always be done whenever there is doubt
^bout the accuracy of the patient's answers. A question frequently asked concerns
the length of time required to make a rating, i.e. for how long should the patient
be interviewed in order to obtain sufficient information on which to base a judg-
ment. This will obviously depend on the skill of the rater and the condition of
the patient. Sick patients cannot think quickly and they should never be hurried.
An adequate interview will surely be not less than half an hour, for that gives an
average time of about two minutes per item, which is not really sufficient.
The following points about interviewing will be obvious to the skilled inter-
viewer, but it does no harm to emphasize them. The patient should not be pressed
and should be allowed sufficient time to say what he wants to say; but he should
not be allowed to wander too far from the point. The number of direct questions
should be kept to a minimum and such questions should be asked in d if ferent ways and,
in particular, both in positive and negative form, e.g. 'How badly do you sleep?'
and 'How well do you sleep?' Questions should be asked in language which the
patient understands and ordinary words should never be used in a technical sense.
It must not be forgotten that patients sometimes misuse technical words. Patients
should be helped and encouraged to admit to symptoms of which they are ashamed.
Normal people do not talk freely about themselves to strangers, and this is true of
patients; it is therefore helpful to delay a detailed assessment to a second intei-view.
When ratings are repeated they should be made independently. The interviewer
should not have previous ratings in front of him and should use a new fortti on each
occasion; this may seem a trivial matter but experience has shown that it is important.
As far as possible he should avoid asking questions relating to changes since the
previous interview. In order to increase the reliability of ratings, it is advisable
for two interviewers to be present, one of them conducting the interview and the
other asking supplementary questions at the end. The two raters should record scores
independently and then sum them after the interview to give the rating for the
patient. Discussion can take place after this. A discrepancy of one point on any
186
item is of no consequence, but a difference of two JDoints requires careful con-
sideration. Experience has shown that a preliminary training done on about a
dozen patients should produce close agreement. A difference of k points on the
total score is the maximum allowable, but in practice, the difference is rarely
more than 2 points. There is a great practical gain from having two raters:
occasionally one of them may not be available and then the other can do the
rating (and double his scores). With increasing experience, a rater can learn
to give half points, but summed scores from two raters should be converted into
integers for each item.
Symptoms are rated finely or coarsely; the former are on a five-point scale
(0-U) where the numbers are equivalent to absent, doubtful or trivial, mild,
moderate and severe. The latter are on a three-point scale (0-2) equivalent to
absent, doubtful or mild, and obvious, distinct or severe.
The Rating of Male Patients
1. Depression (0-4) - Depressed mood is not easy to assess. One looks for a
gloomy attitude, pessimism about the future, feelings of hopelessness and a
tendency to weep. As a guide, occasional weeping could count as 2, frequent
weeping as 3, and severe symptoms alloted k points. When patients are severely
depressed they may 'go beyond weeping'. It is important to remember that
patients interpret the word 'depression' in all sorts of strange ways. A use-
ful common phrase is 'lowering of spirits'.
2. Guilt (0-4) - This is fairly easy to assess but judgment is needed, for the
rating is concerned with pathological guilt. From the patient's point of view,
some action of his which precipitated a crisis may appear as a 'rational' basis
for self-blame, which persists even after recovering from his illness. For
example, he may have accepted a promotion, but the increased respons ibi 1 i ty
precipitated his breakdown. When he 'blames' himself for this, he is ascribing
a cause and not necessarily expressing pathological guilt. As a guide to rating,
feelings of self-reproach count 1, ideas of guilt 2, belief that the illness might
be a punishment 3, and delusions of guilt, with or without hallucinations, k points.
3.' Suicide (0-4) - The scoring ranges from feeling that life is not worth living 1,
wishing he were dead 2, suicidal ideas and half-hearted attempts 3. serious attempts
4. Judgment must be used when the patient is considered to be concealing this
symptom, or conversely, when he is using suicidal threats as a weapon, to intimidate
others, obtain help and so on.
4, 5, 6 Insomnia (initial, middle and delayed) (0-2) - Mild, trivial and infrequent
symptoms are given 1 point, obvious and severe symptoms are rated 2 points; both
severity and frequency should be taken into account. Middle insomnia (disturbed
sleep during the night) is the most difficult to assess, possibly because it is an
artifact of the system of rating. When insomnia is severe, it generally affects
all phases. Delayed insomnia (early morning wakening) tends not to be relieved by
hypnotic drugs and is not often present without other forms of insomnia.
7. Work and Interests (0-4) - It could be argued that the patient's loss of interest
in his work and activities should be rated separately from his decreased performance,
but it has been found too difficult to do so in practice. Care should be taken not
to include fat iguabi 1 i ty and lack of energy here; the rating is concerned with loss of
efficiency and the extra effort required to do anything. When the patient has to be
187
admitted to hospital because his symptoms render him unable to carry on, this
should be rated k points, but not if he has been admitted for investigation or
observation. When the patient improves he will eventually return to work, but
when he does so may depend on the nature of his work; judgment must be used here.
8. Retardation (0-4) - Severe forms of this symptom are rare, and the mild forms
are difficult to perceive. A slight flattening of affect and fixity of expression
rate as 1 , a monotonous voice, a delay in answering questions, a tendency to s i t
motionless count as 2. When retardation makes the interview extremely prolonged
and almost impossible, it is rated 3, and h is given when an interview is impossible
(and symptoms cannot be rated). Although some patients may say that their thinking
is slowed or their emotional responsiveness has been diminished, questions about
these manifestations usually produce misleading answers.
9. Agitation (0-4) - Severe agitation is extremely rare. Fidgetiness at interview
rates as 1, obvious restlessness with picking at hands and clothes should count as
2. If the patient has to get up during the interview he is given 3. and k points
are given when the interview has to be conducted 'on the run', with the patient
pacing up and down, picking at his face and hair and tearing at his clothes. Although
agitation and retardation may appear to be opposed forms of behavior, in mild form
•they can co-exist.
NOTE - The scale points printed on the original Adult packet are 0-2. Dr. Hamilton
states that the original range (0-4) was abandoned when severer forms of agitation
could not be found. He has since found that more severe cases of agitation do occur -
particularly in countries other than Great Britain. The author prefers the 0-4 range,
but the packet was printed before this instruction could be inserted. Subsequent
editions of the Adult Packet will contain the 5-point scale and raters are urged to
employ the 5-point scale for this item.
10. Anxiety (psychic symptoms) (0-4) - Many symptoms are included here, such as
tension and difficulty in relaxing, irritability, worrying over trivial matters,
apprehension and feelings of panic, fears, difficulty in concentration and forgetful-
ness, 'feeling jumpy'. The rating should be based on pathological changes that have
occurred during the illness and an effort should be made to discount the features of
a previous anxious disposition.
11. Anxiety (somatic symptoms) (0-4) - These consist of the wel 1 -recogn ized effects
of autonomic over-activity in the respiratory, cardiovascular, gas tro-intest ina 1 and
urinary systems. Patients may also complain of attacks of giddiness, blurring of
vision and tinnitus.
12. Gastro-intestinal symptoms (0-2) - The characteristic symptom in depression is
loss of appetite and this occurs very frequently. Constipation also occurs but is
relatively uncommon. On rare occasions patients will complain of 'heavy feelings' in
the abdomen. Symptoms of indigestion, wind and pain, etc. are rated under Anxiety.
13. General somatic symptoms (0-2) - These fall into two groups: the first is
fatiguabi 1 i ty , which may reach the point where the patients feel tired all the time.
In addition, patients complain of 'loss of energy' which appears to be related to
difficulty in starting up an activity. The other type of symptom consists of
diffuse muscular achings, ill-defined and often difficult to locate, but
frequently in the back and sometimes in the limbs; these may also feel 'heavy'.
]k. Loss of libido (1-2) - This is a common and characteristic symptom of
depression, but it is difficult to assess in older men and especially those,
e.g. unmarried, whose sexual activity is usually at a low level. The assess-
ment is based on a pathological change, i.e. a deterioration obviously related
to the patient's illness. Inadequate or no information should be rated as zero.
15. Hypochondriasis (0-4) - The severe states of this symptom, concerning
delusions and hallucinations of rotting and blockages, etc., which are extremely
uncommon in men, are rated as k. Strong convictions of the presence of some
organic disease which accounts for the patient's condition are rated 3. Much
preoccupation with physical symptoms and with thoughts of organic disease are
rated 2. Excessive preoccupation with bodily functions is the essence of a
hypochondriacal attitude and trivial or doubtful symptoms count as 1 point.
16. Loss of insight (0-2) - This is not necessarily present when the patient
denies that he is suffering from mental disorder. It may be that he is denying
that he is insane and may willingly recognize that he has a 'nervous' illness.
In case of doubt, enquiries should be directed to the patient's attitude to his
symptoms of Guilt and Hypochondriasis.
17. Loss of weight (0-2) - The simplest way to rate this would be to record the
amount of loss, but many patients do not know their normal weight. For this
reason, an obvious or severe loss is rated as 2 and a slight or doubtful loss as
I point.
18. Diurnal variation (0-2) - This symptom has been excluded from Hamilton's
factors as it indicates the type of illness, rather than presenting an addition
to the patient's disabilities. The commonest form consists of an increase of
symptoms in the morning, but this is only slightly greater than worsening in the
evening. A small number of patients insist that they feel worse in the afternoon.
The clear presence of diurnal variation is rated as 2 and the doubtful presence
is 1 point.
The following three symptoms were excluded from Hamilton's factors because
they occur with insufficient frequency, but they are of interest in research.
19. Derealization and Depersonalization (0-4) - The patient who has this symptom
quickly recognizes the questions asked of him; when he has difficulty in under-
standing the questions it usually signifies that the symptom is absent. When the
patient asserts that he has this symptom it is necessary to question him closely;
feelings of 'distance' usually mean nothing more than that the patient lacks
concentration or interest in his surroundings. It would appear that the severe
forms of this symptom are extremely rare in patients diagnosed as depressive.
189
admitted to hospital because his symptoms render him unable to carry on, this
should be rated k points, but not if he has been admitted for investigation or
observation. When the patient improves he will eventually return to work, but
when he does so may depend on the nature of his work; judgment must be used here.
8. Retardation (0-4) - Severe forms of this symptom are rare, and the mild forms
are difficult to perceive. A slight flattening of affect and fixity of expression
rate as 1 , a monotonous voice, a delay in answering questions, a tendency to sit
motionless count as 2. When retardation makes the interview extremely prolonged
and almost impossible, it is rated 3> and h is given when an interview is impossible
(and symptoms cannot be rated). Although some patients may say that their thinking
is slowed or their emotional responsiveness has been diminished, questions about
these manifestations usually produce misleading answers.
9. Agitation (0-4) - Severe agitation is extremely rare. Fidgetiness at interview
rates as 1, obvious restlessness with picking at hands and clothes should count as
2. If the patient has to get up during the interview he is given 3, and k points
are given when the interview has to be conducted 'on the run', with the patient
pacing up and down, picking at his face and hair and tearing at his clothes. Although
agitation and retardation may appear to be opposed forms of behavior, in mild form
■they can co-exist.
NOTE - The scale points printed on the original Adult packet are 0-2. Dr. Hamilton
states that the original range (0-4) was abandoned when severer forms of agitation
could not be found. He has since found that more severe cases of agitation do occur -
particularly in countries other than Great Britain. The author prefers the 0-4 range,
but the packet was printed before this instruction could be inserted. Subsequent
editions of the Adult Packet will contain the 5-point scale and raters are urged to
employ the 5-point scale for this item.
10. Anxiety (psychic symptoms) (0-4) - Many symptoms are included here, such as
tension and difficulty in relaxing, irritability, worrying over trivial matters,
apprehension and feelings of panic, fears, difficulty in concentration and forgetful-
ness , 'feeling jumpy'. The rating should be based on pathological changes that have
occurred during the illness and an effort should be made to discount the features of
a previous anxious disposition.
11. Anxiety (somatic symptoms) (0-4) - These consist of the wel 1 -recognized effects
of autonomic over-activity in the respiratory, cardiovascular, gas tro- intest ina 1 and
urinary systems. Patients may also complain of attacks of giddiness, blurring of
V is ion and t inn i tus .
12. Gastro-intest inal symptoms (0-2) - The characteristic symptom in depression is
loss of appetite and this occurs very frequently. Constipation also occurs but is
relatively uncommon. On rare occasions patients will complain of 'heavy feelings' in
the abdomen. Symptoms of indigestion, wind and pain, etc. are rated under Anxiety.
13. General somatic symptoms (0-2) - These fall into two groups: the first is
fatiguabi 1 i ty , which may reach the point where the patients feel tired all the time.
In addition, patients complain of 'loss of energy' which appears to be related to
difficulty in starting up an activity. The other type of symptom consists of
diffuse muscular achings, ill-defined and often difficult to locate, but
frequently in the back and sometimes in the limbs; these may also feel 'heavy'.
]k. Loss of libido (1-2) - This is a common and characteristic symptom of
depression, but it is difficult to assess in older men and especially those,
e.g. unmarried, whose sexual activity is usually at a low level. The assess-
ment is based on a pathological change, i.e. a deterioration obviously related
to the patient's illness. Inadequate or no information should be rated as zero.
15. Hypochondriasis (0-^) - The severe states of this symptom, concerning
delusions and hallucinations of rotting and blockages, etc., which are extremely
uncommon in men, are rated as k. Strong convictions of the presence of some
organic disease which accounts for the patient's condition are rated 3. Much
preoccupation with physical symptoms and with thoughts of organic disease are
rated 2. Excessive preoccupation with bodily functions is the essence of a
hypochondriacal attitude and trivial or doubtful symptoms count as 1 point.
16. Loss of insight (0-2) - This is not necessarily present when the patient
denies that he is suffering from mental disorder. It may be that he is denying
that he is insane and may willingly recognize that he has a 'nervous' illness.
In case of doubt, enquiries should be directed to the patient's attitude to his
symptoms of Guilt and Hypochondriasis.
17. Loss of weight (0-2) - The simplest way to rate this would be to record the
amount of loss, but many patients do not know their normal weight. For this
reason, an obvious or severe loss is rated as 2 and a slight or doubtful loss as
1 point.
18. Diurnal variation (0-2) - This symptom has been excluded from Hamilton's
factors as it indicates the type of illness, rather than presenting an addition
to the patient's disabilities. The commonest form consists of an increase of
symptoms in the morning, but this is only slightly greater than worsening in the
evening. A small number of patients insist that they feel worse in the afternoon.
The clear presence of diurnal variation is rated as 2 and the doubtful presence
is 1 point.
The following three symptoms were excluded from Hamilton's factors because
they occur with insufficient frequency, but they are of interest in research.
19. Derealization and Depersonalization (0-4) - The patient who has this symptom
quickly recognizes the questions asked of him; when he has difficulty in under-
standing the questions it usually signifies that the symptom is absent. When the
patient asserts that he has this symptom it is necessary to question him closely;
feelings of 'distance' usually mean nothing more than that the patient lacks
concentration or interest in his surroundings. It would appear that the severe
forms of this symptom are extremely rare in patients diagnosed as depressive.
189
20. Paranoid symptoms (0-4) - These are uncommon, and affirmative answers should
always be checked carefully. It is of no significance if the patient says that
others talk about him, since this is usually true. What is important in the mild
symptom is the patient's attitude of suspicion, and the malevolence imputed to
others. Doubtful or trivial suspicion rates as 1, thoughts that others wish him
harm rates as 2, delusions that others wish him harm or are trying to do so rates
as 3, and hallucinations are given k points. Care should be taken not to confuse
this symptom with that of guilt, e.g. 'people are saying that I am wicked'.
21. Obsessional symptoms (0-2) - These should be differentiated from preoccupations
with depressive thoughts, ideas of guilt, hypochondriacal preoccupations and
paranoid thinking. Patients usually have to be encouraged to admit to these
symptoms, but their statements should be checked carefully. True obsessional
thoughts are recognized by the patient as comrng from his own mind, as being alien
to his normal outlook and feelings, and as causing great anxiety; he always
struggles against them.
The Rating of Female Patients
The same general principles apply to the rating of women as of men, but there
are special problems which need to be considered in detail,
I. Depression {0-k) - It is generally believed that women weep more readily
than men, but there is little evidence that this is true in the case of depressive
illness. There is no reason to believe, at the moment, that an assessment of the
frequency of weeping could be misleading when rating the intensity of depression
in women.
7. Work and interests (0-4) - Most women are housewives and therefore their work
can be varied, both in quantity and intensity, to suit themselves. Women do not
often complain of work being an effort, byt they say they have to take things
easily, or neglect some of their work. Other members of the family may have to in-
crease the help they give. It is rare for a housewife to stop looking after her
home completely. If she has an additional job outside the home she may have to
change it to part-time, or reduce her hours of work or even give it up completely.
Women engage in hobbies less frequently than men. Loss of interest, therefore,
may not be as obvious. Patients may complain of inability to feel affection for
their families. This could be rated here, but it could be rated under other
symptoms, depending upon its meaning and setting. Care should be taken not to rate
it in two places. It is a very valuable and important symptom if the patient
mentions it spontaneously but could be very misleading as a reply to a question.
II. Anxiety (somatic) (0-4) - These last three symptoms appear to be more common
in women than in men.
13. Somatic symptoms (general) (0-2) - It is not uncommon for women to complain of
backache and to ascribe it to a pelvic disorder. This symptom requires careful
quest ioning ,
190
]k. Loss of libido (0-2) - In women whose sexual experience is satisfactory,
this symptom will appear as increasing frigidity, progressing to active dislike
of sexual intercourse. Women who are partially or completely frigid find that
their customary toleration of sex also changes to active dislike. It is diffi-
cult to rate this symptom in women who have had no sexual experience or, indeed,
in widows since loss of libido in women tends to appear not so much as a loss
of drive but as a loss of responsiveness. In the absence of adequate informa-
tion of a pathological change a zero rating should be given. Disturbed menstrua-
tion and amenorrhea have been described in women suffering from severe depression,
but they are very rare. Despite the difficulties in rating, it has been found
that the mean score for women is negligibly less than men.
REFERENCES
Robin, A. A., and Langley, G. E. A Controlled Trial of Imipramine. Brit. J.
Psychiat. 110: 419-^22, May, 1964
Doig, R. J., et al. Plasma Control Levels in Depression. Brit. J. Psychiat.
112: 1263-1267, Dec. I966
Davison, K., et al. Genetic Polymorphism in Metabolism of Phenelzine. Brit. J.
Psychiat. 112: 105, Jan. I966
Sutherland, S. S., et al. The Response to Treatment of Individual Patients in
a Drug Trial. Brit. J. Psychiat. 115: 1383-1385, Dec. I969
Martin, I. C. A., and Leahy, M. R. Prediction in Ant i -Depressant Therapy. Brit.
J. Psychiat. 114: 7^9-754, June I968
McDowell, R. W. T., et al. Subsequent Suicide in Depressed in-Patients. Brit.
J. Psychiat. 114: 74-9-754, June I968
Mendels, J., Electroconvulsive Therapy g- Depression in the Prognostic Significance
of Clinical Factors. Brit. J. Psychiat. Ill: 675-681, Aug. I965
Fernando, S. J. M. Depressive Illness in Jews and Non-Jews. Brit. J. Psychiat.
112: 991-996, Oct. 1966
Lascelles, R. G. Atypical Facial Pain and Depression. Brit. J. Psychiat. 112:
651-659, July I966
Halliday, A. M., et al, A Comparison of the Effects on Depression & Memory of
Bilat. E. C. T. & Unilat. E. C. T. to the Dominant & Non-Dominant Hemispheres.
Brit. J. Psychiat. 114: 997-1012, Aug. I968
Schwab, J. J. et al, Hamilton Rating Scale for Depression and Medical In-Patients.
Brit. J. Psychiat. 113: 83-88.- Jan. I967
191
Sandifer, M. G. et a], The Influence of Case Selection & Dosage in an Anti-
Depression Drug Trial. Brit. J. Psychiat. Ill: 142-148, Feb. I965
Mendels, J., Comparative Trial of Nortriptyline and Ami tr iptyl ine in 100
Depressed Patients. Am. J. Psyciiiat. 124, No. 8, Suppl . 59 - I968
Paykel , E. S. et al. A Comparative Trial of Imipramine and Chlorpromazi ne
in Depressed Patients. Brit. J. Psychiat. 114: 1287, Oct. I968
Stewart, J. A. and Mitchell, P. H. A Comparative Trial of Desipramine and
Nortriptyline in Depression. Brit. J. Psychiat. 114: 469-471, Apr. I968
Leahy, M. R. and Martin, I. C. A. Double-Blind Comparison of Nortriptyline
and Ami tr iptyl ine in Depressive Illness. Brit. J. Psychiat. 113: 1433-1434,
Dec. 1967
Rose, J. T. et al. A Comparison of Nortriptyline and Ami tr iptyl ine in
Depression. Brit. J. Psychiat. Ill: IIOI-IIO3, Nov. I965
Waldron, J., and Bates, T. J. N. The Management of Depression in Hospital.
A Comparative Trial of Desipramine and Imipramine. Brit. J. Psychiat. Ill-
511-516, June 1965
Richmond, P. W. and Roberts, A. H. A Comparative Trial of Imipramine,
Amitriptyl ine, Isocarboxazid, & Tranylcypromine in 0-P Depressive Illness.
Brit. J. Psychiat. 110: 846-850, Nov. 1964
Valentine, M., et al. A Comparison of Techniques in Electro-Convulsive
Therapy, Brit. J. Psychiat. 114: 989-996, Aug. I968
Lewis, A., and Hoghughi, M. An Evaluation of Depression as a Side Effect of
Oral Contraceptives, Brit. J. Psychiat. 115: 697-70I , June I969
Munro, A. Parental Deprivation in Depressive Patients, Brit. J. Psychiat.
112: 443-457, May I966
Hamilton, M., A Rating Scale for Depression, J. Neurol. Neurosurg. Psychiat.,
23, 56-62, i960
Hamilton, M., Comparison of Factors by Ahmavaara's Method, Brit. J. Math.
Stat. Psychol., 20, 1, IO7. May I967
Hamilton, M. Standardized Assessment and Recording of Depressive Symptoms.
Psychiat. Neurol. Neurochir., 72, 201-205, I969
192
048 HAM A
HAMILTON
ANXIETY
SCALE
MH-9-48 HAMILTON ANXIETY SCALE
6-73
INSTRUCTIONS: Code 01 under Sheet Number.
Be sure to record your answers in the appropriate spaces (positions 0 through 4),
Columns 1—5, on the left half of the General Scoring Sheet.
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
0 12 3 4
NOT MODER- VERY
PRESENT MILD ATE SEVERE SEVERE
ROW
NO.
Mark on left half of scoring sheet on row specified
Mark in response positions 0 — 4, columns 1—5. Follow
rating scale on header template.
24
0 = o °* . 1 = Mild 2 = Moderate 3 = Severe 4 = ^^'^^
Present Severe
24*1 r-azz ::2:= :*= ::4::
25z*r .:lz: :r2:: :=i= r:4c =
26:*= :raz= ::2:: r*: ::4cr
27 r*: rr3:: ::2:z :*r r:4c:
ANXIOUS MOOD
Worries, anticipation of the worst, fearful anticipation, irritability
25
TENSION
Feelings of tension, fatigability, startle response, moved to tears easily,
trembling, feelings of restlessness, inability to relax
29:*r ::arz ::2:r :*. :,4::
30:*: ::a:r ::£: ::a:z ::4::
26
FEARS
Of dark, of strangers, of being left alone, of animals, of traffic, of crowds
31 ::&: ::3:: ::2:: ::!: ::*:
32:6:: ::a:: ::2:: ::!: =:i:r
33:*: ::1:: :d2:: :3:: ::4r
27
INSOMNIA
Difficulty in falling asleep, broken sleep, unsatisfying sleep and fatigue on
waking, dreams, nightmares, night terrors
34:*: ::J:: :^:: :J:: ::4::
35:*: ::l:: :d2:: :J:: :.*::
36:*: ::J:: :i: :*: =.4::
37:*: ::J:: ::2:: =*= =,4:
28
INTELLECTUAL
Difficulty in concentration, poor memory
29
30
DEPRESSED MOOD
Loss of interest, lack of pleasure in hobbies, depression, early waking,
diurnal swing
Ct»#s: 12 3 4 5
SOMATIC (Muscular)
Pains and aches, twitchings, stiffness, myoclonic jerks, grinding of teeth,
unsteady voice, increased muscular tone
31
SOMATIC (Sensory)
Tinnitus, blurring of vision, hot and cold flushes, feelings of weakness,
pricking sensation
32
CARDIOVASCULAR SYMPTOMS
Tachycardia, palpitations, pain in chest, throbbing of vessels, fainting
feelings, sighing, dyspnea
33
RESPIRATORY SYMPTOMS
Pressure or constriction in chest, choking feelings, sighing, dyspnea
34
GASTROINTESTINAL SYMPTOMS
Difficulty in swallowing, wind, abdominal pain, burning sensations,
abdominal fullness, nausea, vomiting, borborygmi, looseness of bowels,
loss of weight, constipation
35
GENITOURINARY SYMPTOMS
Frequency of micturition, urgency of micturition, amenorrhea,
menorrhagia, development of frigidity, premature ejaculation, loss of
libido, impotence
36
AUTONOMIC SYMPTOMS
Dry mouth, flushing, pallor, tendency to sweat, giddiness, tension headache,
raising of hair
37
BEHAVIOR AT INTERVIEW
Fidgeting, restlessness or pacing, tremor of hands, furrowed brow, strained
face, sighing or rapid respiration, facial pallor, swallowing, etc.
19^
The Hamilton Anxiety Scale (HAMA) is a 1^-item scale formatted for use with
the General Scoring Sheet. The HAMA was designed by Hamilton and intended for
use with patients already diagnosed as suffering from neurotic anxiety states -
not for assessing anxiety in patients suffering from other disorders. Until the
contrary is proved, it must be regarded as invalid for the rating of anxiety in
any other setting. This limits the range of usefulness of the scale but, within
these limits, patients can be compared meaningfully. The scale places great
emphasis on the patient's subjective state. This follows from the medical bias
of the author. In treatment, the patient's subjective state takes first place
both as a criterion of illness, which brings the patient for treatment and as a
criterion of improvement.
REFERENCES
APPLICABILITY
UTILIZATION
TIME SPAN RATED
CARD FORMAT - ITEMS
1. Hamilton, M., The Assessment of Anxiety States by
Rating, Brit. J. Med. Psychol., 32, 50-55, 1959.
2. Hamilton, M., Diagnosis and Rating of Anxiety, in:
Studies of Anxiety, Lader, M. H., Brit. J. Psychiat.
Spec. Pub. 3, 76-79, 1969
Adults with diagnosis of anxiety neurosis
Once at pretreatment ; at least one posttreatment assess-
ment. Additional ratings are at the discretion of the
investigator.
Now or during the past week
CARD 01 = (19x, l4ll)
Item
1
Col.
20
2
21
3
22
k
23
5
2k
6
25
7
26
CARD FORMAT ■
■ FACTORS
CA
I tern
8
9
10
11
12
13
]k
Col .
27
28
29
30
31
32
33
CARD 51 = (I9x, 2F6.2, F4.0)
(Code "5" in Column 18 indicates card containing factor, cluster or other
derived scores) .
FACTOR
COLUMN
I - Somat ic Anxiety
I I - Psychic Anxiety
Total Score
20 - 25
26-31
32 - 35
Factor Score = Sum of composite items
No. of composite items
Total Score = Sum of all items
Factor score range =0-5
Total score range =0-70
195
FACTOR COMPOSITION
Hamilton has presented both centroid and orthogonal factor structures in
his 1959 article. Since other ECDEU factors are orthogonal and unipolar, this
structure - rather than the centroid one - will be employed for analyses. When
a sufficient sample is accumulated, factor analysis will be performed on ECDEU
data .
1 . Somat ic Anxiety
7 - Somatic, muscular
8 - Somatic, sensory
9 - Cardiovascular symptoms
10 - Respiratory symptoms
11 - Gastro-intest inal symptoms
12 - Gen i to-urinary symptoms
13 - Autonomic symptoms
I I . Psychic Anxiety
1 - Anxious mood
2 - Tens ion
3 - Fears
k - insomnia
5 - Intellectual
6 - Depressed mood
14 - Behavior at interview
SPECIAL INSTRUCTIONS
1. Assessments are made on a 5-point scale. In practice, however, the last scale
point (very severe, grossly disabling) is very rarely used for out-patients and
serves more as a marker, a method of delimiting the range, rather than as a grade
of practical use.
2. Each of the 14 items represents a set of symptoms grouped together according
to their nature or where clinical experience indicates that they were associated.
The symptom groups which serve as cues for the rater are:
1 . Anxious mood
3. Fears
Worries
Anticipation of the worst
Apprehension (fearful
ant icipat ion)
I rri tabi 1 i ty
2. Tension
Feelings of tension
Fat iguabi 1 i ty
Inabi 1 ity to relax
Startle response
Moved to tears easily
Trembl ing
Feelings of restlessness
Of Dark
Strangers
Being left alone
Large animals , etc.
Traffic
Crowds
Insomnia
Difficulty in falling asleep
Broken sleep
Unsatisfying sleep and
fatigue on waking
Dreams
Nightmares
Night terrors
196
5. Intellectual (cognitive)
11. Gastro-intestinal symptoms
Difficulty in concentration
Poor memory
6. Depressed mood
Loss of interest
Lack of pleasure in hobbies
Depress ion
Early waking
Diurnal swing
7. General somatic (muscular)
Muscular pains and aches
Muscular stiffness
Muscular twitchings
Clonic jerks
Grinding of teeth
Unsteady voice
8. General somatic (sensory)
Tinnitus
Blurring of vision
Hot and cold flushes
Feelings of weakness
Pricking sensations
9. Cardiovascular symptoms
Tachycardia
Pa 1 p i ta t i ons
Pain in chest
Throbbing of vessels
Fa inting feel ings
Missing beat
10. Respiratory symptoms
Pressure or constriction in
chest
Choking feel ings
S ighings
Dyspnoea
Difficulty in swallowing
Wind
Dyspeps ia:
pain before and after means
burning sensations
ful Iness
waterbrash
nausea
vomi ting
s inking feel ings
'Working' in abdomen
Borborygmi
Looseness of bowels
Loss of weight
Constipation
12. Gen i to-urinary symptoms
Frequency of micturition
Urgency of micturition
Amenorrhea
Menorrhagia
Development of frigidity
Ejaculatio praecox
Loss of erection
Impotence
13. Autonomic symptoms
Dry mouth
Flushing
Pallor
Tendency to sweat
G iddiness
Tension headache
Raising of hair
197
1^. Behavior at interview
a. General b. Physiological
Tense, not relaxed Swallowing
Fidgeting: hands, Belching
picking fingers. High resting pulse rate
clenching, tics Respiration rate over 20/min.
handkerchief Brisk tendon jerks
Restlessness: pacing Tremor
Tremor of hands Dilated pupils
Furrowed brow Exophthalmos
Strained face Sweating
increased muscular tone Eye-1 id^ twitching
Sighing respirations
Facial pallor
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Means and standard deviations of factor scores
d. Variance analyses
198
051 AS I
ANXIETY
STATUS
INVENTORY
ANXIETY STATUS INVENTORY
Wm.W.K.Zung
INSTRUCTIONS: Code 01 under Sheet Number on General Scoring Sheet
The data upon which the judgments are based come from the interview with the patient. The items in the
scale are to be quantified by using all the information available to the rater. This includes both clinical obser-
vation and the material reported by the patient.
Use of the Interview Guide below assures coverage of all the areas on which judgments are required. How-
ever, the rater has the flexibility of modifying the questions or probing for details, which makes possible a
smooth interview that does not sound like a question-answer examination. In rating the patient's current
status, an arbitrary period of 1 week prior to the evalutaion is adopted in order to standardize the data. In
order to reinforce this, the interviewer should occasionally precede questions with, "During the past week,
have you ?"
Se«r<t)r of Observed
or Reported Responses
5 6 7 F"
MODEIi
NONg MUD ATE SEVERE
Row 1
iiSi
::&=
==i:
zzOi.
2
:=5:=
-.-.b:--
"S:
"ft:
3
-z&z
----tz
=;*!
:=&:
4
==4:
-zdiz
=:*=
:=8:=
5
=:5::
==6:;
:=S=
:ra=
6
::5:=
rrfc:
::S=
:=8:i
7
-Sir
:=6:=
zzfzz
:r8:=
8
:i5:=
:=6::
::7::
izfti
9
"5:=
-zfcz
riT::
=:8:r
10
nil
==6:r
nil
=:8:r
11
"ir
=;&=
==3t:
:=&=
12
::&-.
zzb:z
==K:
:=8:=
13
----&-.
=:&=
==3!::
1=8::
14
z&z
=:&:
ri3t:
r:ft:
15
-S:--
:=t:
::*!
=:ft:
16
lft=
==t:
::J::
irft:
17
-.&--
:--6::
zzJiz
=:8:=
18
=&=
r=6:i
::3t_-
"ftr
19
:5:r
zzbiz
-S=
:=fti
20 :
--&-.
==fc=
list:
riftr
Cols:
6
7
8
9
Mark each Item on left half of scoring sheet on row specified.
Mark in response positions 5-8, columns 6 through 9.
Observe severity rating scale on header template
ROW
NO.
AFFECTIVE AND
SOMATIC SYMPTOMS
OF ANXIETY
INTERVIEW GUIDE
FOR
ANXIETY STATUS INVENTORY lASI)
1
Anxiousnest
Do you ever feel nervous and anxious?
2
Fear
Have you ever felt afraid?
3
Panic
How easily do you get upset? Ever have
panic spells or feel like it?
4
Mental
disintegration
Do you ever feel like you re falling apart?
Going to pieces?
S
Apprehension
Have you ever felt uneasy? Or that some-
thing terrible was going to happen?
6
Tremors
Have you had times w^en you felt
yourself trembling? Shaking?
7
Body aches
and pains
Do you have headaches? Neck or back
pains?
8 .
Easy fatigability
weakness
How easily do you get tired?
Ever have spells of weakness?
9
Hestlessness
Do you find yourself restless and can't
sit still?
10
Palpitation
Have you ever felt that your heart was
running away?
11
Dizziness
Do you ever have dizzy spells?
12
Faintness
Do you have fainting spells? Or feel like it?
13
Dyspnea
Evei have trouble with your breathing?
14
Paresthesias
Ever have feelings of numbness and tingling
in your fingertips? Or around your mouth?
15
Nausea and vomiting
Do you ever feel sick to your stoma* or
feel like vomiting?
16
Urinary frequency
How often do you need to empty your
bladder?
17
Sweating
Do you ever get wet, clammy hands?
18
Face flushing
Do you ever feel your face getting hot
and blushing?
19
Insomnia
How have you been steeping?
20
Nightmares
Do you have drean is that scare you?
200
Developed by Zung, the Anxiety Status Inventory (AS I ) is a 20-item scale
formatted for use witli the General Scoring Sheet, Employing a 4-point scale,
the AS I is the clinician-rated counterpart of the Self-Rating Anxiety Scale
(SAS) . The ASI along with the SAS were designed specifically for the assess-
ment of anxiety as a clinical disorder rather than as a trait or feeling state.
Zung reports a product-moment correlation of .7^ between the ASI and SAS for
patients with diagnoses of anxiety neurosis. (N = 22).
REFERENCE Zung, Wm. W.K,, A Rating Instrument for Anxiety
Disorders, Psychosomat ics , 12: 371-379, Nov. -Dec, 1971
APPLICABILITY Adults with diagnoses of anxiety neurosis
UTILIZATION Once at pretreatment ; at least one post-treatment rating.
Additional ratings are at the discretion of the investigator,
TIME SPAN RATED Now or in the week prior to evaluation
CARD FORMAT - ITEMS CARD 01 = (19x, 2011, lOx, \k)
Item Column
1 20
2 21
3 22
k 23
5 2k
6 25
7 26
8 27
9 28
10 29
'A- The Z score for the ASI is derived by dividing the sum of the raw item scores
by the maximum possible score (80) multiplied by 100. See Table 11 for the
conversion of raw scores to AS I and SAS indices. Zung has provided the following
mean Z scores and standard deviations for 5 diagnostic groups:
Diagnosis N MN
Anxiety Disorder
Schizophrenia
Depressive Disorder
Personality Disorder
Transient Situational
Disturbances 12 42.0 8.1
:-'■ Significantly different from other h groups (p = .05)
1 tem
Column
11
30
12
31
13
32
14
33
15
34
16
35
17
36
18
37
19
38
20
39
Z Score *
50-53
22
62.0
13.8V.'*
25
49.4
15.9
96
49.9
12.5
54
52.6
13.6
201
TABLE I 1
THE CONVERSION OF RAW SCORES TO
ASI AND SAS INDICES
AS I ASI ASI
& & &
Raw SAS Raw SAS Raw SAS
Score Index Score Index Score Index
20 25 ^0 50 60 75
21 26 k] 51 61 76
22 28 42 53 62 78
23 29 ^3 54 63 79
2k 30 kk 55 64 80
25 31 45 56 65 81
26 33 46 58 66 83
27 34 47 59 67 84
28 35 48 60 68 85
29 36 49 61 69 86
30 38 50 63 70 88
31 39 51 64 71 89
32 40 52 65 72 90
33 41 53 66 73 91
34 43 54 68 74 92
35 44 55 69 75 94
36 45 56 70 76 95
37 46 57 71 77 96
38 48 58 73 78 98
39 49 59 74 79 99
80 100
SPECIAL INSTRUCTIONS
The Interview Guide is printed in the packet to assist the rater in eliciting
the presence of a symptom. The items in the scale are to be quantified by using
all of the information available to the rater. This includes both clinical observa-
tions and the material reported by the patient. Use of the Interview Guide assures
coverage of all of the areas in which judgments are required. However, the rater
has the flexibility of interposing other questions or probing for details which allow
for a smooth interview without sounding like a question and answer examination.
In making judgments, the following rules should be observed:
1. Each item should be independently rated as a unit
by itself in order to eliminate any "halo" effect.
2. Each score should be the average of the full range
of responses observed or elicited, and not necessarily
the extreme in severity.
202
3. The items are judged on a four-point system, taking
into account Severity in terms of: intensity, dura-
tion, and frequency. These are defined as follows:
1 = none or insignificant in intensity or
duration, present none or a little of
the time in frequency
2 = mild in intensity or duration, present
some of the time in frequency
3 = of moderate severity, present a good
part of the time in frequency
k = severe in intensity or duration, present
most or all of the time in frequency
To help establish severity, the following questions may be necessary:
Intens i ty - "How bad was it?" Duration - "How long did it last?" Frequency -
"How much of the time did you feel that way?"
4. An item is scored positive and present when:
a. Behavior is observed
b. Behavior was described by the patient as having occurred
c. patient admits that symptom is still a problem
5. An item is scored negative and not present when:
a. Symptom has not occurred and not a problem or present
b. Patient gives no information relevant to an item
c. Response is ambiguous even after suitable probing
ERRATA
The instructions printed on the "header" for the AS I should be identical to
those printed on the "header" for the Depression Status Inventory. Raters are ad-
vised to duplicate these DS I instructions and paste them on the AS I "header".
Item 19 - Note that this item should be entitled "Insomnia-initial", NOT
simply "Insomnia".
DOCUMENTATION
a. Raw score printout
b. Index score printout
c. Means and standard deviations of index scores
d. Variance analyses
203
COMMENTS OF THE AUTHOR
ANXIETY STATUS INVENTORY
Will iam W. K. Zung, M. D,
In the construction of the present rating instrument the symptoms of the
illness were delineated by using the descriptive approach, since the basis of
definition and classification in psychiatric nosology continues to be based
upon presenting symptomatology. A review of the literature cited in the
original publication describing the anxiety scale (1) will indicate that al-
though anxiety as a disorder is discussed from several disparate frameworks
of psychiatric orientation, the diagnostic criteria used by the various schools
of thought are almost identical.
Anxiety Status Inventory (AS I )
As with the Depression Status Inventory (DSl) described elsewhere in this
manual, (p. 17^), the data upon which the judgments are based for the AS I come
from the interview with the patients. Thus, the following discussion is
applicable to both interviewer rated scales.
The items in the scale are to be quantified by using all of the information
available to the rater. This includes both clinical observations and the
material reported by the patient.
Use of the interview Guide assures coverage of all of the areas in which
judgments are required. However, the rater has the flexibility of Interposing
other questions or probing for details which allow for a smooth interview with-
out sounding like a question-answer examination. In rating the patient's cur-
rent status, an arbitrary period of one week prior to the evaluation is adopted
in order to standardize the data.
REFERENCES
1. Zung, W.W.K. and Green, R. L., Jr.: Detection of affective disorders in
the aged, in Eisdorfer, C. and Fann, W.E. (Editors): Psychopharmacology
and Aging, Plenum Press, New York, 1973.
2. Zung, W.W.K. : The differentiation of anxiety and depressive disorders:
A psychopharmacological approach, Psychosom. 15, 197^.
3. Zung, W.W.K.: The measurement of affects: Depression and anxiety, in
Pichot, P. (Editor): Psychological Measurements in Psychopharmacology,
Karger, Basel, 197^.
204
052 WITT
WITTENBORN
PSYCHIATRIC
RATING SCALE
MH-9-52
6-73
INSTRUCTIONS:
WITTENBORN PSYCHIATRIC RATING SCALES (Short Survey)
Code 01 under Sheet Number.
1. The statements in the Rating Scales are arranged in steps from 0 (no pathology) through 3 (extreme pathology).
2. For each scale, select the one statement which best describes the most extreme manifestation during the past week.
3. If the behavior is doubtful or variable, select the alternative which is nearer to 3.
4. Rate every item, but base the rating on the specified period of observation only.
5. Record your rating by marking the appropriate response position on the answer sheet.
Be sure to record your answers in the appropriate spaces (positions 5 — 8), columns 6 — 9, on the
left half of the General Scoring Sheet.
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
21
rrft:
zztiz
-r-
22
r=S::
zztnz
::?:
23
::S:;
::6:;
"S
24
rrS::
"4::
zzjz
25
r=S:=
:=6::
-^
26
-S:
::6:r
-7:
27
"5:=
==6:=
::^
28
-s^-
rrfc;
::?:
29
-Sp-
"fcr
z-r-
30
.-&.
-6::
z-r.
31
rrS:
::6::
:=7:
32
:zS::
zrfcr
;=?:
33
--&--
:rfc:
-^
34
::S::
zztnz
z-r-
35
::S:=
zzttz
-;?:
36
::&:
zifc:
lit
37
:S::
.-fer
-r.
Cols:
6
7
8
206
ROW
NO.
Mark each Item on left half of scoring sheet on row specified.
Mark in response positions 5 — 8, columns 6—9.
See rating instructions on header template.
I. ANXIETY
Threatened
by Task
Sense of
Foreboding
Subjective
Anxiety
0 = Does not express any feeling of anxiety when confronted
with a task, a test or a new situation
1 = When confronted with a task, a test or a i
the patient admits anxiety experiences
'■ When confronted with a task, a test or a new situation,
the patient admits anxiety experiences, and quality of
performance is adversely affected
3 = Feets threatened by a task, or new situation, and shows
failure and blocking
0 = Does not complain of premonitory experiences or any
sense of foreboding
1 = Has vague feelings of foreboding or misfortune
2 = Has definite feeling that something bad is going to happen
which will involve him or his family (but there is no
evidence upon which to base a prediction)
3 = Definite feelings of impending, inescapable, personal
doom or catastrophe (but there is no apparent basis for
this strong fear)
0 = No evidence that patient considers himself to be particu
larly unworthy or blameworthy
1 = Patient tends to blame himself or refer to his
unworthiness
2 = Patient blames and criticizes self to an unrealistic and
inappropriate degree
3 = Patient appears to have a delusional belief that he is i
extraordinarily evil, unworthy or guilty person
0 = No complaint of subjectively experienced anxiety
1 = Experiences at least minor feelings of anxiety
2 = Experiences anxiety which is strong enough to make
him express acutely uncomfortable feelings
3 = Is desperately distressed by his anxiety and considers it
to be intolerable
II. SOMATIC-HYSTERICAL
Attention
Demanding
0 = Does not appear to be attention-demanding
1 = In conversation, usually brings attention of others to
his own role
2 = Engages insistently in description of own role or
difficulties
3 = Dramatically attention-demanding
WITTENBORN PSYCHIATRIC RATING SCALES (Short Survey)
BOW
NO.
Continue marking on left half of scoring sheet on row specified 1
26
Uses
Symptoms
0 = No discernible psychological use made of phyiical
disease symptoms
1 = Use is made of physical disease symptoms to gain
attention or to dramatize self
2 = Use is made of physical disease symptoms for evading
responsibilities, justifying failures, etc.
27
Organic
Involvement
0 = Presents no complaint or symptoms of organic
pathology or malfunctioning
1 = Presents symptoms of organic pathology or malfunction-
ing which was not caused by emotional factors
2 = Presents organic pathology or malfunctioning which may
be caused in part or greatly aggravated by emotional
factors
3 = Presents organic pathology or malfunctioning which
probably was caused by emotional factors
28
III. OBSESSIVE-COMPULSIVEPHOBIC
Phobic
0 = No complaint of phobias or phobic reactions
(i.e., specific isolated, inappropriate fears)
1 = Patient experiences phobic reactions in certain situations
2 = Phobic reactions have affected patient's current behavior
3 = Patient's behavior is greatly disrupted or delimited by
his phobias
29
Obsessive
0 = No evidence for obsessional (repetitive, stereotyped}
thinking
1 = Obsessive thoughts recur but can be banished without
difficulty
2 = Patient is able to banish obsessive thoughts, but only
with difficulty
3 = Cannot banish or control obsessive thoughts
30
Compulsive
0 = No evidence of compulsive (repetitive, nonadaptive,
uneconomical) behavior
1 = Acts judged to be compulsive are performed from time to
time but not every day
2 = Compulsive acts occur daily
3 = Compulsive acts are practically continuous
31
IV. DEPRESSIVE RETARDATION
Indecisive
0 = No evidence of difficulty in making decisions
1 = Reports uncertainty and postponement of decisions
2 = Cannot make decisions without advice or pressure
3 = Cannot make decisions
ROW
NO.
Continue marl<ing on left half of scoring sheet on row specified |
32
Avoids
People
0 = No evidence of social withdrawal
1 = Does not appear to seek out the company of other
people
2 = Avoids many people
3 = Attempts to avoid almost all people
33
Motoric
Retardation
0 = No evidence of slowing of responses
1 = Actions have a deliberate quality. No evidence of haste
2 = Overt responses are slow and may appear to be delayed
3 = All overt activity is at a minimum. Patient loath to move
and all motions tend to be tediously slow
34
V. EXCITEMENT |
Overactive
0 = Is not particularly overactive
1 = Moderately overactive, e.g., toys with objects,
frequently changes his sitting position
2 = Noticeably restless
3 = In almost constant movement
35
Irrelevant
Words
0 = Does not use words in an obscure or irrelevant manner
1 = Words not always clearly relevant to recognizable idea
2 = Words used in such a manner that ideas seem unclear
and confused
3 = Words not relevant to any recognizable, logical idea
36
VI. PARANOIA 1
Misinterprets
Others
0 = No evidence that he misconstrues the intentions of others
1 = May exaggerate the intentions of others
2 = May seriously misinterpret the intentions of others
3 = Arbitrarily misinterprets the intentions of others,
apparently to conform with his delusional beliefs
37
Ideas of
Influence
0 = No evidence that patient feels that others seek to spy
upon or control his behavior or thought
1 = Wonders if others have a particular interest in.or desire
to know about his thoughts or behavior
2 = Wonders if others attempt to influence his behavior in
some unknown manner or attempt to control his thoughts
3 = Believes that others influence his behavior in some
strange manner or control his thoughts
207
Wittenborn's Psychiatric Rating Scale (WITT) is a ly-item scale formatted
for use with the General Scoring Sheet. The present ECDEU version was developed
from the longer 72-item Wittenborn scale in response to the need for a brief
assessment procedure to ascertain the rate and nature of symptomatic change.
With one exception, items are rated on a if-point scale.
REFERENCE Wittenborn, J. R., Manual: Wittenborn Psychiatric
Rating Scales, 1955, Psychological Corporation,
New York.
APPLICABILITY Inpatient and outpatient adult populations
UTILIZATION Once at pretreatment ; at least one posttreatment
rating. Additional ratings are at the discretion
of the principal investigator.
TIME SPAN RATED Now or during the past week
CARD FORMAT - ITEMS CARD 01 (19x. 1711)
Item Column Item Column
1 20 10 29
2 21 11 30
3 22 12 31
k 23 13 32
5 2k ^k 33
6 25 15 3^+
7 26 16 35
8 27 17 36
9 28
CARD FORMAT - FACTORS CARD 51 (19x, 6f6.2, F^f.O)
(Code "5" in Column 18 indicates card containing factor, cluster or derived score.)
Factor Column Factor Column
1
20-25
II
26-31
1 1 1
32-37
IV
38-i+3
V
kk-ks
VI
50-55
Total Score
56-59
Factor Score = Sum of composite items Factor score range = 0 - k
No. of composite items
Total Score = Sum of a 1 1 items Total score range =0-68
208
FACTOR COMPOSITION:
FACTOR I
ANXIETY
1. Threatened by task
2. Sense of foreboding
3. Guilt
k. Subjective anxiety
FACTOR II SOMATIC - HYSTERICAL
5. Attention demanding
6. Uses symptoms
7. Organic involvement
FACTOR I I I
8. Phobic
9. Obsessive
10. Compulsive
OBSESSIVE - COMPULSIVE - PHOBIC
FACTOR IV DEPRESSIVE RETARDATION
1 1 . Indecis ive
12. Avoids people
13. Motoric Retardation
FACTOR V
EXCITEMENT
14.
15.
Overactive
I rrelevant words
FACTOR VI PARANOIA
16. Misinterprets others
17. Ideas of influence
SPECIAL INSTRUCTIONS
See "Comments of the Author" (pp. 210-2)6 ) for detailed instructions.
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Means and standard deviations for factor scores
d. Cross Tabulations
e. Variance analyses
209
COMMENTS OF THE AUTHOR
Manual for Wittenborn Psychiatric Rating Scales
J. Richard Wittenborn, Ph.D., Rutgers University
I. CHARACTERISTICS OF SYMPTOM RATING SCALES
The development of research in psychiatry, clinical psychology, and clinical
psychopharmacology has been accompanied by the appearance of several psychiatric
symptom rating scales. Although these rating scales may all be used as criteria
for therapeutic efficacy, they may differ in several fundamental respects.
A. Content
There are many different patient characteristics which may be sampled by
rating scales. For example, it is possible for scales to reflect the strength
of certain aspects of the patient's personality. It is possible also for rating
scales to include aspects of the patient's clinical history. Some rating scales
include only currently discernible symptoms of psychopathology, and such scales
can be most sensitive to any change in the patient's status. Symptom rating
scales can be restricted to represent only certain limited psychopathological
deviations, such as depression, anxiety, or somatization, or they can attempt to
sample a broad spectrum of psychopathology so that change in target symptoms may
be seen in the context of a total symptom complex.
The WPRS samples a broad spectrum of commonly encountered psychopathology
and is restricted to currently discernible symptoms. It is not a diagnostic
device in any fundamental sense. Instead, it is intended to be sensitive to
change and to be sufficiently comprehensive to provide a common basis for compar-
ing a wide diversity of patients.
B. Referents
Many rating scales provide distinctions between patients on the basis of the
rater's general impression of the patient. Such scales do not refer directly to
the observational or factual basis for the judgments. As a consequence, a rating
based on such a judgmental scale may be as sensitive to rater characteristics as
it is to patient characteristics. A few other scales refer explicitly to verifiable
observations or other factual situations or events directly descriptive of the
patient and in this way minimize evaluative and interpretive judgments of the
rater. It is never possible to eliminate the influence of the rater's judgment
or to correct completely for the selective nature of his observation. Rating scales
do vary greatly, however, in the extent to which they involve the screening,
evaluative, and judgmental characteristics of the individual rater.
The WPRS emphasizes the use of verifiable observations as the basis for rating
and attempts to minimize the rater's judgmental involvement. For this reason, the
WPRS requires thorough and meticulous observation of the patient and does not rely
upon the interpretive acumen of the rater.
210
C. observational basis
The observational requirements for the proper use of a rating scale must be
related to its content. If historical considerations or aspects of the premorbid
personality are included in the ratings, the observational period cannot be rigidly
defined. Despite their possible diagnostic interest, ratings based on enduring
personal qualities or referring to indefinite time periods cannot be most sensitive
to the changes which are pertinent to current therapeutic effects.
Since the WPRS is designed to reveal changes, the obser-vat ional per iod on which
the ratings are based must be carefully defined. This period can be of any duration,
but it is necessary that firm limits be set so that old observations do not bias
current ratings and so that comparisons may be made between definite periods or
phases in the illness. Obviously, the selected rating period must be standard within
any sample of data submitted to common analysis.
For a sample of data submitted to common analysis, the observational setting
should be specified also. For the Long Form, the diversity of content requires an
in-patient setting. For the Short Form, however, the outpatient interview situation
(including the substance of the patient's verbalization) can provide an adequate
sett ing.
The provocative qualities of the observational setting remain an uncontrolled
factor in the ordinary use of rating scales. Certain settings, because of the
personnel or because of the qualities of the interview situation, can admittedly
be most provocative of psychopatholog ical reactions. For this reason, it is import-ant
for comparative purposes that the setting for a given patient remain constant, other-
wise the effect of any changes in the setting would be confounded with effects due to
treatment. in order to keep the "error variance" as small as possible, it is desirable
also that the settings be as uniform as possible among patients generating data for
a common analysis. Nevertheless, it is not recommended that ratings be based on a
standardized question and answer type of inquiry which is little more than a tour de
force of the items comprising the rating scale. Instead, it is recommended that the
observations and the interview be thorough and evocative with reasonable opportunity
for the expression of thoughts, sentiments, and reactions which are pertinent to the
patient's disorder and to the content of the rating scale.
The rater may either restrict the ratings to his own observations or decide to
incorporate the reports and observations of reliable informants , such as ward
personnel, family associates, etc. If ratings are to include the reports of informants,
it is obviously necessary that the informant be used in a consistent and standard
manner throughout any set of ratings required by an investigation. In many out-
patient §ituationSy particularly in work with juveniles and with character disorders,
it may be most helpful for the rater to have recourse to reliable informants.
The behavior of patients is ordinarily episodic and variable in its pathologic
quality. Accordingly, the interview itself provides, at best, a meager and, at
worst, a misleading sample of the patient's reactions. All other things equal.
211
the longer the observational period the greater the opportunities for pertinent
observation. For example, if the assessment period for which the rating is to
be descriptive is one week, the inadequate, untoward, or deviant behaviors during
that week are probably much more pertinent to the quality of the patient's current
functioning than are the qualities of behavior manifested during the period of one
interview. The limitation inherent in ratings based on the interview apply to any
rating scale, particularly any symptom rating scale which, by its nature, is con-
cerned with current manifestations of psychopathol ogy and not merely with those
qualities of behavior which may emerge in the course of one interview. Accordingly,
in the outpatient situation, the rater is particularly dependent on sel f-reports
and must rely on the patient's ability to recognize and willingness to describe
difficulties and deviations which have occurred during the period covered by the
assessment. This means, of course, that the rater must have excellent evocative
rapport with his outpatients.
In the evaluation of outpatient rating data based primarily on the intei —
view, it is important to recognize the special vulnerabilities of such data and
to remember that they are much more dependent upon both the rater's skill as an
interviewer and his interpretive acumen than are data which have a broader observa-
tional basis, e.g., data gathered in an inpatient situation.
D . Sea 1 ing cont i nua
The purpose of the rating scale is to record and systematize distinctions
which may be observed in the behavior of patients and which may be used to distinguish
between patients. These distinguishable qualities can be placed on continue to indi-
cate increasing levels of pathology or severity of disorder. The arrangement of
behavior qualities on such a continuum implies that a quality placed at any given
level of severity is more pathologically significant in its deviance than a quality
placed on the continuum at any lesser level of severity. The pertinence of such an
arrangement or continuum of behavior rests upon the consensual acceptance of experts
and is obviously dependent upon conventional concepts of pathological deviance.
Some arrangements or gradients which reflect increasing severity of pathological
deviation in our society may not be accepted as representing a gradient of deviation
in all other societies. It is possible also that certain individuals within our
society will challenge and perhaps reject an arrangement of items accepted by the
majority as an indication of progressing deviance.
Within any such a graded arrangement of behaviors, the distinctions between
successive behavioral qualities or conditions represent no uniform quantity. Regard-
less of their substance or format, behavior rating scales, like other measures of
behavior, do not offer a standard, equal unit (and are not based on an absolute
zero). Thus the increasing scores given to the successive rating scale positions
represent only the direction of the difference and not successive magnitudes in
any standard sense.
In some instances, behavioral qualities have been conceived to range from one
extreme through a point of indifference to some other extreme, e.g., from happiness
through a point of indifference to sadness, extroversion to introversion, love to
hate, honesty to dishonesty, etc. Unfortunately, human behavior seems not to
212
arrange itself according to the antonyms of the English language. In pathological
states particularly, it is possible to observe extremes of happiness and sadness
or love and hate concurrently, if not simultaneously, in the same individual. For
this reason, in bipolar continua which range from one extreme to another, a given
level of severity has no necessary implications for other levels of severity, i.e.,
a person might or might not be given an extreme position at both ends of the scale.
As a consequence, most symptom rating scales are now restricted to a unipolar for-
mat which begins with a point of indifference and proceeds in one direction through
a series of graded observations or circumstances to some one pathological extreme.
It must be acknowledged that rating scales which comprise an explicit arrange-
ment of verifiable behavior qualities or events require specific information for
their proper use. In addition, such scales place only minimal reliance on the rater's
own judgment of the severity of the symptomatic quality in question. Accordingly, a
set of rating scales, such as the WPRS, which relies on a graded series of verifiable
behaviors, may not be preferred by raters who have no specific information about
their patients. The use of the WPRS may be questioned also by raters who prefer to
indicate their own estimates of the severity of the disorder and do not feel satisfied
in expressing their evaluation in terms of a fixed series of graded qualities. For
this reason, most professionals will appreciate an opportunity to supplement their
standard objective ratings with a statement of their own estimate of the patient.
E. The Model of Psychopathology
Psychopathology can be assessed from the etiological, prognostic, dynamic, or
descriptive standpoint. The WPRS is a strictly descriptive instrument. It
represents no particular a priori dynamic or conceptual model. The separate scales
comprising the set represent the symptomatic facets which occur commonly and are
sensitive to the changing quality of psychopathology. These scales, each constructed
to reflect increasing levels of severity, may be combined to provide cluster scores
which represent the general severity of groups of interrelated symptoms. These
groups of interrelated symptoms do not necessarily reflect a priori considerations.
Instead, they indicate the natural symptom groupings which were found repeatedly by
factor analyses of data from samples of patients in the northeastern portion of the
United States. It is reassuring to find that these empirically determined groups of
symptoms tend to reflect familiar syndromes and are reminiscent of the traditional
descriptive concepts which have been in common usage since the days of Kraepelin.
II. THE RATING SCALE FORMS
The 1955 Form
The form copyrighted by the Psychological Corporation in 1955 was generated in
the course of a program of investigation initiated in 19^7. The symptom rating scales
that this form comprises were based on interviews with New England psychiatrists, and
the 52 items represent a consensual agreement concerning the tangible psychiatric
symptoms which, at that time, were considered to be important in newly admitted mental
hospital patients. This was a period prior to modern tranquilizers and one in which
a primary emphasis was placed on the newly admitted patient. Accordingly, the 1955
version includes florid symptomatic qualities which are not conspicuous in tranquil ized
patients or in chronic patients.
213
The 196^ Form
After 1955, patients appearing at psychiatric hospitals were usually to some
degree tranqui 1 ized , and as a consequence florid unmodulated symptomatic manifesta-
tions became unusual. In addition, the availability of tranquilizers generated a
substantial research and therapeutic interest in chronic patients. (As a matter
of fact, chronic patients appear to have been the subjects for most studies of the
effects of tranquilizers.) In order to accomodate to this shift in interest, the
original rating scales were extended and revised, and in 1964, a set of 72 symptom
rating scales was made available. Many of these scales were included for the
explicit purpose of revealing differences in and distinctions among chronic patients
and other patients whose manifestations were somewhat subdued in consequence of
tranqui 1 izat ion. In addition to the supplemental items, some of the original scales
were deleted, and others were revised. The ]SGk form has been applied to several
samples. Factor analyses of these data revealed distinctions in symptomatic patterns
not apparent in the factor analyses of the untranqui 1 ized , newly admitted patients
rated with the 1955 form.
The 1964 form is more versatile than the 1955 form in the sense that, in addition
to being descriptive of newly admitted patients, it reveals distinctions among chronic
patients. It should be noted that the 1964 form attempts to place a minimal reliance
on inferences of the rater. For example, there are no scales which rate the hallucina-
tory experience per se, but there are several scales which rate observable response
qualities that tend to accompany hallucinations.
The short form provides scores for six major factors or symptom clusters: anxiety
somatic-hysterical, obsessive-compulsive-phobic, depressive retardation, excitement,
and paranoia. The scales which contribute to these respective cluster scores were
selected on the basis of their appropriateness for outpatient use, their pertinence
to the factor to which they contribute, and their proven sensitivity to changes
accompanying treatment.
III. DIRECTIONS FOR USE
A. The Rating Procedure
1. It is necessary that the observational period on which the
ratings are based be scrupulously defined and that the
limits of this observational period be recorded in the
appropriate space on the face sheet.
2. It is necessary that a rating be Indicated for every scale.
If there is no information on which to base a rating, the
initial or least severe level is the appropriate rating.
3. The rating should always be the most pathological extreme
observed during the rating period. Ratings should not be
based on an average or general condition of the patient.
214
k. When informants are consulted as a basis for rating, the
identity or the role of the informant should be recorded.
5. Wherever possible, a diagnosis should be indicated in the
appropriate space. Because of the episodic and variable
nature of psychopathologica 1 manifestations, it is under-
stood that the diagnosis of the patient and the symptoms
which are rated as currently descriptive may not always be
cons istent .
B-. The Rater
1. Familiarity with the rating scales is an important determiner
of the speed and ease with which ratings may be made. The
rater should anticipate that his initial experiences with the
rating scales will seem tedious and time-consuming.
2. Most professionally trained raters, particularly psychiatrists,
psychologists, and social workers, will be able to use the
rating scales without personal instruction. In a research team,
where standardization can be critical, it is useful for beginners
to review their initial ratings with other members of the group.
3. Raters not professionally trained in psychopathology , e.g.,
occupational therapists, nursing personnel, or other ward
personnel, should have at least their first six rating forms
reviewed by a professionally trained person who shares their
knowledge of the patient. Although the language of the scales
is simple, it involves conceptual and terminological usages
which may be unfamiliar to nonprofessional raters, or at best
only partially understood by them.
k. Almost any careful observer can be trained to make satisfactory
ratings based on inpatient situations. Ordinarily, outpatient
ratings should be provided only by professionally trained
persons who are well acquainted with the patient.
C. The Observational Setting
Almost any standard observational setting can provide a useful basis for
symptom ratings. For interpretive purposes, however, it is important that the
observational setting be recorded on the face sheet of the form.
The observational setting which provides the most useful ratings will depend
upon the manner in which the setting is used and the purposes of the assessment.
In general, the ratings of psychiatrists and psychologists show very slight
average differences. The ratings of nurses tend to be consistently different from
those of psychiatrists, particularly in the sense that nurses' ratings will con-
tain fewer indications of affective or conceptual deviation, but will emphasize
matters relevant to ward routine, particularly matters concerning the patient's
cooperation and participation.
215
Ratings by different personnel will differ according to the observational
basis for the rating. Thus, ratings of the same patient by two different raters
should be expected to differ somewhat unless the two raters are observing at the
same time. Accordingly, differences between raters describing the same patient
have no necessary implications for either the validity or the reliability of the
scales and may reflect differences in the behavior sample on which the ratings
are based.
Where a fully comprehensive description is imperative, independent ratings
by the psychiatrist, the psychologist, and the nurse should be sought. Scale by
scale the different ratings from these persons may then be reconciled and com-
bined by selecting as most valid the one rating which shows the greatest pathologi-
cal extreme. The appropriateness of this procedure is based on the assumption that
the most pathological manifestation is the most pertinent basis for the rating and
on the further assumption that an observation of an extreme pathological manifesta-
tion is a valid basis for a descriptive rating regardless of whether the observa-
tion was made by the nurse, the psychologist, or the psychiatrist.
216
028 CGI
CLINICAL
GLOBAL
IMPRESSIONS
CLINICAL GLOBAL IMPRESSIONS
INSTRUCTIONS: Mark these items on General Scoring Sfieet coded 01.
Complete Item 1 -severity of illness at the Initial and subsequent assessments.
Items 2 and 3 may be omitted at the initial assessment by marking 0 - "Not Assessed'
Mark on the left half of the scoring sheet on rows 38-41.
38: A:
"1"
zdizz
:i:
r:4::
39:A=
::J"
==2i:
.-i3::
=:4i:
40rAr
::lr=
:±:
:J::
r:4r:
41rrfcr
z-Azz
zziiz
::3:r
==«::
Cols: 1
2
3
4
5
::^:
z.Jzz :ra:r
8
ROW
NO.
CLINICAL GLOBAL IMPRESSIONS
38
1. SEVERITY OF ILLNESS
B:: ::
a:r "
9::
9:i
9ri
9--
Considering your total clinical experience with this particular
population, how mentally ill Is the patient at this time?
0 = Not assessed 4 = Moderately ill
1 = Normal, not at all ill 5 = Markedly ill
9 70
2 = Borderline mentally ill 6 = Severely ill
_l
3 = Mildly ill 7 " Among the most extremely
ill patients
THE NEXT TWO ITEMS MA Y BE OMITTED A T THE INITIAL
ASSESSMENT BY MARKING "NOT ASSESSED" FOR BOTH ITEMS
39
2. GLOBAL IMPROVEMENT - Rate total improvement whether
in your judgment. It is due entirely to drug treatment.
or not.
Compared to his condition at admission to the project, how much
has he changed?
0 = Not assessed 4 = No change
1 = Very much improved 5 = Minimally worse
2 = Much improved 6 = Much worse
3 = Minimally improved 7 = Very much worse
40
&
3. EFFICACY INDEX - Rate this item on the basis of DRUG EFFECT
ONLY.
41
Select the terms which best describe the degrees of therapeutic
effect and side effects and record the number in the box where
the two items intersect.
EXAMPLE: Therapeutic effect is rated as "Moderate" and side
effects are judged "Do not significantly interfere with patient's
functioning". Record 06 in rows 40 and 41 .
SIDE EFFECTS
= I
c
c
THERAPEUTIC EFFECT
o
o
Z
1 ■$
— .CO
0.2 c
Lit
e5.i S
.1 &
3i
MARKED — Vast improvement. Complete
or nearly complete remission of all
symptoms
01
02
03
04
MODERATE — Decided improvement.
Partial remission of symptoms
05
06
07
08
MINIMAL — Slight improvement which
doesn't alter status of care of patient
09
10
11
12
UNCHANGED OR WORSE
13
14
15
16
Not Assessed = 00
218
Clinical Global Impressions (CGl), developed during the PRB collaborative
schizophrenic stud ies , cons is ts of 3 global scales (items) formatted for use
with the Genera] Scoring Sheet. Since the items are "universal", the CGI is
included in both the Pediatric and Adult packets. Two of the items, Severity
of Illness and Global Improvement, are rated on a 7-point scale; while the
third. Efficacy Index, requires a rating of the interaction of therapeutic
effectiveness and adverse reactions.
APPLICABILITY For all research populations
UTILIZATION For Severity of Illness: Once at pretreatment and
at least one post-treatment assessment. Additional
ratings are at the discretion of the investigator.
For Global Improvement and Efficacy Index: No
pretreatment (baseline) assessment is required. At
least one post-treatment assessment should be made.
Additional post-treatment ratings are at the discretion
of the investigator.
TIME SPAN RATED For Severity of Illness: Now or within the last week.
For Global Improvement: Since admission to the study.
For Efficacy Index: Now or within the last week.
CARD FORMAT - ITEMS CARD 01 = (19x, 211, 12)
I tern Col umn
Severity of I 1 Iness 20
Global Improvement 21
Efficacy Index 22 - 23
SPECIAL INSTRUCTIONS
The contexts under which the 3 CGI items are to be rated have been modified to
increase the reliability and precision of the items. Veteran ECDEU raters should be
alert to these new contexts.
I tern 1 - Severity of Illness - For this item, the modification for rating context is:
OLD Considering your total clinical experience,
how mentally ill is the patient at this time?
Considering your total clinical experience with this particular
NEW population, how mentally ill is the patient at this time?
The old version asked the rater to judge the severity of illness of a given subject
in the context of that rater's total experience with all types of patients; i.e.,
regardless of diagnosis, chronicity, age, etc. The present version restricts the
judgment within the range of the specific population under study. Thus, an anxious
neurotic subject is judged in the context of the rater's experience with anxious
219
neurotics - not, as was the case in the past - against a clinical background which
may have included schizophrenics, brain damaged, and depressive subjects as well as
anxious ones.
J tern 2 - Global Improvement - The modification here involves the relationship between
this item and Efficacy Index (item 3). In the past, no distinction between
TOTAL clinical improvement and that portion of the TOTAL which, in the
opinion of the rater, is the direct result of the drug administered. The
present contexts are:
Global Improvement
GLOBAL IMPROVEMENT — Rate total improvement whether or not,
in your judgment, it is due entirely to drufl treatment.
Efficacy Index
EFFICACY INDEX - Rate this Item on the basis of DRUG EFFECT
ONLY.
In many studies, of course, TOTAL improvement and improvement due to drug will be
one and the same; nevertheless, the new contexts allow a distinction to be made
when it is present.
Raters are cautioned to observe the unique time span rated for Global Improvement,
For most other ECDEU items, the time span to be rated is either a specified number of
days or since the last rating. The time span for Global Improvement - at each and
every rating - is "since admission to the project (study)" - NOT from the last rating
period.
Item 3 - Efficacy Index - In addition to the contextual modification mentioned above,
the matrix of therapeutic vs. side effects has been changed as follows:
THERAPEUTIC EFFECT
SIDE EFFECTS
m
c
O
Z
s .1
o^ c
III
C
"c
o
>-~ c
■5= 5 3
c « "^
a s M
40 .5 Q
8i
MARKED — Vast improvement. Complete
or nearly complete remission of all
symptoms
01
02
03
04
MODERATE - Decided improvement.
Partial remission of symptoms
05
06
07
08
MINIMAL — Slight improvement which
doesn't alter status of care of patient
09
10
11
12
UNCHANGED OR WORSE
13
14
15
16
Not Assessed = 00
220
The new matrix has been made symmetrical (k x 4) by combining 2 therapeutic
categories, "Unchanged" and "Worse" into one category. Category 4 of Side
Effects has also been reworded.
Efficacy Index is an attempt to relate therapeutic effects and side effects.
Therapeutic effect is regarded as gross profit; side effects as cost. The Index,
then, is analogous to net profit. The Index is derived by dividing therapeutic
effect score by side effect score as follows:
Side Effects
Eff
ect
Therapeut ic
None
1
No S ignif icant
Interference
2
Significant
Interference
3
Outweighs
k
k Marked
3 Moderate
2 Minimal
1 Unchanged
or
Worse
k . OOVr
3.00
2.00
1.00
2.00
1.50
1.00
0.50
1.33
1.00
0.67
0.33
1.00
0.75
0.50
0.25
Example:
Therapeutic Score (4)
Side Effect Score (1)
= Efficacy Index (4.00)
The transformation procedure for Efficacy Index (El) is;
Number Encoded = Transformed Score = El
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
00
41
42
43
44
31
32
33
34
21
22
23
24
11
12
13
14
00
4.00
2.00
1.33
1.00
3.00
1.50
1.00
0.75
2.00
1 .00
0.67
0.50
1 .00
0.50
0.33
0.25
0.00
221
Employing the cross tabulation scheme (page kjS) to interpret El, indices
falling on the diagonal CB would indicate that the therapeutic and toxic effects
of a treatment are equivalent. Those in the upper left quadrant would indicate
some degree of "profit" - the profit increasing as pole A is approached. The
converse is true of indices falling in the lower right quadrant and, in fact,
in all of the last column. The treatment with the. greatest efficacy fills the
cell at Pole A; the worst at Pole D. The cell at Pole C contains the "inert"
treatment. Pole B represents a paradoxical and "theoretical" cell - not one
likely to be encountered in the real world.
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Frequencies and crosstabulat ions
d. Variance analyses
222
029 DOTES
DOSAGE RECORD AND
TREATMENT EMERGENT
SYMPTOM SCALE
DOSAGE RECORD AND TREATMENT EMERGENT SYMPTOM SCALE
I NSTR UCTIONS: Insert New General Scoring Sheet and Code 02 for Sheet Number
Coding Dosage: Three rows are provided for the coding of the
numeric value and one row for the multiplier
Coding Symptom Judgments: The 3 judgments are coded
on 2 rows as follows:
INTENSITY RELATIONSHIP
NUMERIC
VALUE
MULTIPLIER-
■-O- "t" ■-■Z-- -^
«: ::«:: -.zZ.: ::S
::S:
"5:
::e:: "T:
r:S: ".T---
::e: --T.-
None Remoie Possible Piobable Dcimeil
:«: ::):: :*: -.:S:: ::*: INT-REL-J:: ::e: --T-: "ft: :■
::&: ::)- ::^: ::5:: ::4:: ACTION ::S: ::e:: ::T;: ::8: ::
.001
.1
■ «•*
The multiplier row designates the placement of the decimal point.
INSTRUCTIONS
TOTAL DAILY DOSE: To permit the coding of the widest range of
dosages and, at the same time, minimize the number of "marks" required
of the rater, the following 4— row schema has been constructed.
Examples:
2500 mg. = 250 X 10
250mg. = 250x 1
25mg. = 250x .1
2.5mg. = 250x .01
0.25 mg. = 250 x .001
code 2505
code 2504
code 2503
code 2502
code 2501
OR
25 X 100
25 x 10
25 X 1
25 X .1
25 X .01
code 0256
code 0255
code 0254
code 0253
code 0252
CATALOGUE OF SYMPTOMS - For each symptom cited (present), three (3)
judgments are required - intensity of the symptom, its relationship to the drug
and the action undertaken as a consequence of its presence,
1. INTENSITY - Generally, the levels of intensity are defined as follows:
0 - Not Assessed - Mark this category when NO assessment (rating) of a
specific symptom is made. Leave Relationship and Actions sections blank.
1 - Not Present — Mark tjiis category if symptom is assessed and is found
absent.
2 ■ Mild - The symptom does not hinder the subject's normal functioning
level, i.e., his level at pretreatment. An annoyance to the subject.
3 " Moilerate — The symptom produces some degree of impairment to
functioning but is not hazardous to health. Uncomfortable and/or
embarrassing to the subject.
4 - Severe - The symptom is a detmite hazard to well being. Significant
impairment of functioning or incapacitation.
b. RELATIONSHIP - A judgment of the degree of relationship between the
occurrence of the symptom and the drug rated on a 5— point scale.
5 " None - No relationship between symptom and drug
6 -Remote - Less than a 10% probability that symptom occurrence is
related to drug employed
7 - Possible - Probability between 10% and 50%
8 - Probable - Probability between 50% and 90%
9 'Defined - Greater than 90% probability that symptom is related to
drug employed
c. ACTION TAKEN - Refers to action taken as a consequence of the symptom's
appearance. Actions are arranged in order of increasing stringency. Only
ONE action — the most stringent — should be recorded as it is assumed that
less stringent actions may also be employed.
ACTION CODE: 0 ■= None
1 = Increased Surveillance
2 = Contraactive Rx
3 " Change Dose
224
4 = Change Dose plus Contra-
active Rx.
5 = Suspend Rx
6 = Discontinue Rx
DOSAGE RECORD AND TREATMENT EMERGENT SYMPTOM SCALE
Mark each item on right half of scoring sheet on row specified
I AfiW
REASON FOR COMPLETING SCALE On the DA Y recorded under
PERIOD, dosage was: (Mark ONE only)
0= Initialed (First Dose)
1 = Changed per protocol
2 = Changed due to ineffectiveness
3 = Changed due to toxicity
4 = Changed for titration (Test Dose)
5 = Discontinued/suspended
6 = Reinitiated following suspension
7 = Changeover point of
crossover design
8 = Not changed but treatment
emergent symptom/s
occurred
9 = Regular (fixed) TESS
assessment
2. TOTAL DAILY DOSE
a. Component (Use lor all single component drugs) .
b. Component (For combination drugs only) .
FOR STUDIES IIV WHICH RECORDING "TOTAL DAILY DOSE" IS
INAPPROPRIATE, E.G., LONG-ACTING DRUGS. DEPOT DRUGS.
VERY SHORT-ACTING DRUGS. ETC, enter amount of drug in 2 a (b)
and mark the length of time and time units over which the drug is pre
sumed to be effective. (See Manual for instructions)
Drug is presumed to be effective for (Code number) ....
Time Unit: 1 = Hours 3 = Weeks (Code one)
2 = Days 4 = Months
PRESCRIPTION
Dosage is
to be given:
Mark 2 responses — one for prescription
(No. 0 through 6) and one for proportions (No. 7 or 8)
1 =qd
2 = bid
3 = tid 4 = qid
6 = depot
7 = equal
8 = unequal proportions
TREATMENT EMERGENT SYMPTOMS At the previous dosage level (or
since the last assessment), were any significant physical signs, laboratory
findings or symptoms present? (For initial assessment, record presence or
absence at symptoms tor that day only) Mark one:
0 = NO (II NO. and ALL SYMPTOMS WERE ASSESSED, no further
responses necessary)
1 = YES, printed symptoms present but no "write-ins"
2 = YES, both printed and "write-in" symptoms present
3 = YES, only "write-ins" present. (Do not forget to complete Item 6
before proceeding to TWIS. TESS Write-In Scale)
CATALOGUE OF SYMPTOMS
Behavioral Toxicity:
(See Instructions on page R — 4)
Toxic confusional state .
Excitement/agitation
Depressive affect
Increased motor activity
Decreased motor activity
Insomnia
Drowsiness ....
Abnormal Laboratory Findings: Abnormal hematologic .
Abnormal liver
Abnormal urine .
Neurologic: Rigidity
Tremor
Dystonic symptoms .
ROW
NO
5-6
7-8
9-10
11-12
13-14
15-16
17-18
19-20
21-22
23-24
25-26
27-28
29-30
31-32
33-34
35-36
37-38
39-40
Mark each item on left half of sheet on row specified
5. CATALOGUE OF SYMPTOMS (Continued)
Neurologic: Akathisia
. Autonomic: Dry Mouth
Nasal Congestion
Blurred Vision
Constipation
Increased Salivation
Sweating
Nausea/Vomiting
Diarrhea
Cardiovascular: Hypotension
Syncope/Dizziness
Tachycardia
Hypertension
EKG Abnormality
Other: Dermatologic
Weight Gain
Weight Loss
Anorexia/Decreased Appetite
Headache
Tardive Dyskinesia
GLOBAL JUDGMENTS (Omit at Pretreatment)
u. Compared to other subjects in this study, how serious
have his/her treatment emergent symptoms been?
0 = Not at all
1 = Minimal
2 = Moderate
3 = Marked
4 = Not Ascertained
Compared to other subjects in this study, how much
distress has this subject expressed or attributed
to his symptoms?
5 = Not at all
6= Minimal
7 = Moderate
8 = Marked
9 = Not Ascertained
225
The Dosage Record and Treatment Emergent Symptom Scales (DOTES) is a 4l-item
scale formatted for use with the General Scoring Sheet. Processing experience
with the separate Dosage Record (DR) and Treatment Emergent Symptoms Scale (TESS)
revealed that subsequent collation of the data was frequently fraught with errors.
By combining the two scales, the rater is spared the tedium of redundant coding;
and, more importantly, the emergent symptoms can be related to a specific dosage.
Further, the combined scale is designed to capture judgments on the relationship
of a symptom to the drug and the action undertaken as well as the intensity of
that symptom. These three judgments - linked to a specific dosage - allow for a
more precise documentation of the adverse event. DOTES supersedes both 02-DR
Dosage Record and 03-TESS Treatment Emergent Symptom Scale. The scale is contained
in both the Children's and Adults' Psychiatrist Packets.
APPLICABILITY
UTILIZATION
Al 1 populat ions
Completed for every dosage change. A pretreatment
and terminal DOTES should always be completed.
ITEM FORMAT
CARD 01 (19x, II, 2\k, 13, 3H, 1313, 12) - Each symptom requires a 3-column
field. 1st column - Intensity; 2nd column = Relationship;
3rd column = Action.
tem
Column
I tem
Col umn
1
20
2a
21 - 2k
2b
25-28
2c
29 - 31
3a
32
3b
33
k
3k
5 Toxic
35 - 37
Exc i te.
38 - ko
Depress .
41 - 43
1 nc. Motor
44 - 46
CARD 02
(19x, 11, 1813, 11)
Item
Column
Akath (Action) 20
Mouth
21 - 23
Nasal
24 - 26
Bl.Vis.
27 - 29
Const ip .
30 - 32
Inc. Sal .
33 - 35
Sweating
36 - 38
Nausea
39 - 41
Dec .motor
I nsom.
Drows i ,
Abn.hemat ,
Abn .1 i ver
Abn.ur ine
Rigid
Tremor
Dyston,
I tem
Diarrhea
Hypoten.
Syncope
Tachycard .
Hyperten .
EKG
Dermat .
Wt.GaIn
Wt.Loss
Anorexia
Headache
Tard ive ( I ntens i ty)
47
50
53
56
49
52
55
58
59 - 61
62 - 64
65 - 67
68 - 70
71 - 73
Akath. (Intens/Rel) 74 - 75
Col umn
42
45
48
51
44
47
50
53
54 - 56
57 - 59
60 - 62
63 - 65
66 - 68
69 - 71
72 - 74
75
226
CARD 03
(19x, 12, 211
1 tern
Col umn
Tardive (Rel/Action)
20 - 21
6a Severity
22
6b Distress
23
FACTOR FORMAT - CARD 51 = (19x, 7F6.2, f4.0)
Code "5" in Column 18 indicates factor, cluster or other derived scores.
Factor
I I
I I I
IV
Col umn
20 - 25
26-31
32 - 37
38 - 43
Factor
Col
umn
V
kk
- kS
VI
50
- 55
VI 1
56
- 61
Total Score
62
- 65
Total Score = Sum of all symptoms (including TWIS)
FACTOR COMPOSITION
Six factors have been derived from a 197^ BLIPS analysis of 1963 pretreatment
TESS records. (Table 12). A seventh "factor" - actually an empirical cluster -
is composed of the 3 Abnormal Laboratory Findings.
I. Anti-chol inergic (ANT)
Drows i ness
Nasal Congestion
Dry Mouth
Blurred Vision
II. Central Nervous System (CNS)
Rigidi ty
Tremor
Dys tonic
Akathis ia
Increased Salivation
III. Neurotic (NEU)
I nsomn ia
Depress ion
Const ipat ion
Headache
Weight Loss
IV. Autonomic Nervous System (ANS)
Hypotens ion
Syncope/D i zz i ness*
Tachycardia
Nausea/Vomiting
Diarrhea
V,
VI
Mi seel laneous
Derma to log ic
Weight Gain
(MIS)
(DEL)
Del i r ium
Exc i tement
Toxic Conf us ion
VII. Abnormal Laboratory Findings (LAB)
Abnormal Hematologic
Abnormal Liver
Abnormal Urine
Symptoms not included in any factor
Increased motor activity
Decreased motor activity
Sweat ing
EKG Abnormal i ty
Anorexia/Decreased Appetite
Tardive Dyskinesia
Dizziness now combined with syncope
227
TABLE 12
6-FACTOR VARIMAX SOLUTION OF PRETREATMENT TESS
SCORES OF 1963 SCHIZOPHRENIC SUBJECTS ( Guy and Cleary)
tern
I I
I I I
Insomn ia
-on
032
-685
Drows iness
-482
018
-031
Exc i tement
-134
045
-040
Depress ion
007
-040
-733
Toxic Confusion
038
059
-107
Rig id i ty
-062
660
059
Tremor
-171
574
-121
Dystonia
162
578
073
Akathis ia
-019
708
-030
Hypotens ion
059
187
098
Syncope
-021
005
-029
Tachycard ia
-234
005
-220
Nasal Congestion
-713
014
083
Dry Mouth
-629
196
-251
1 ncr . Sal ivat ion
-217
328
128
Blurred Vision
-612
089
-105
Nausea
-261
-102
-095
Diarrhea
-129
-059
-145
Constipation
-307
172
-'?17
Derma t it is
-060
-078
047
Headache
-187
-116
-467
Dizziness
-282
-022
-454
Wt. Gain
065
070
-138
Wt. Loss
010
-088
-498
1.99 l.i
IV
-094
-025
-100
-201
036
143
049
-191
-003
-556
-653
-530
-072
-073
-109
-199
-358
-470
060
054
-295
-278
035
100
V
106
-092
-100
073
-007
-039
-075
124
-035
-050
-015
-076
081
007
182
-012
164
■059
090
743
178
-018
521
-216
VI
242
171
528
123
612
033
118
002
-099
-304
041
040
055
-123
206
-008
092
189
-301
-058
327
279
-036
-301
2J9 '-73 1.05 1.35
Percent Total Variance
Percent Common Variance
19.5
8.3
18.4
7.8
21.5
9.1
16.9
7.2
10.3
4.4
13.2
5.6
Communa 1 i t ies
549
272
320
600
392
466
395
418
514
452
430
391
530
517
259
434
251
301
493
570
493
442
302
402
10.19
42.5
228
SPECIAL INSTRUCTIONS
DOTES is the most difficult form to encode since the data are not as "fixed in
time" as are efficacy measures. The advent of side effects and the need for dosage
manipulations are much more idiosyncratic and not readily scheduled in a pre-determined
protocol. Raters should, therefore, pay particular attention to the following instruc-
t ions .
PERIOD - Whenever feasible, encode period in days since it will permit the more
precise delineation of effects.
I tern 1. Reason for completing scale - Preferably DOTES should be completed for
each dosage change and/or occurrence of treatment emergent symptoms.
The first 6 response positions are related directly to changes in dosage;
while the last three (7, 8, 9) are to be employed for unique situations.
Only one response is permitted for each DOTES.
1. "Per protocol" refers to all planned dosage changes established
prior to the study. The final (terminal) dose should be encoded
under "Per Protocol" and Total Daily Dose encoded as "0000".
2. Ineffectiveness - includes instances of increased psychopathology
(worsening) as well as instances where psychopatholog ical condition
is unchanged, unimproved or static.
3. Toxicity - refers to changes which in the judgment of the clinician
are the result of an untoward effect of the medication; i.e., to be
distinguished from ineffectiveness (2).
h. Titration - refers to changes which are made to enhance therapeutic
response in the individual subject; i.e., "test doses".
5. Discontinued/suspended - refers to unplanned interruptions in dosage
schedule. Encode "5" here and "0000" for Total Daily Dose.
6. Reinitiated - use this category when restarting medication following
suspens ions . (5)
7. "Changeover point" refers to planned switches of medication and is
for use only in crossover designs. Encode the dosage of the new
medication as usual.
8. "Not changed but treatment emergent symptom/s occurred" - Although
the dosage is unchanged from previous one, it should nevertheless be
encoded again rather than left blank.
9. "Regular TESS assessment" - Enter dosage whether or not the regular
TESS assessment coincides with an actual dosage change. "Regular
TESS assessment" refers to the use of the scale independent of dosage
change, i.e., using the DOTES in the manner of the original TESS, e.g.,
fixed periods of assessment which are scheduled prior to the start of
the study.
229
I tern II. Total Daily Dose - DOTES' time perspective requires the rater to be like
Janus - looking simultaneously in two directions, forward for dosage;
backward for symptoms. The dosage which he encodes is the dosage which
he is going to give - not the dosage which has been given. Conversely,
the symptoms which he cites have occurred under the previous dosage - not
the one actually encoded on the form.
Example: For the first 6 days of the study, the patient received a total
daily dose of 100 mg. of drug. On Day 007 - on which the patient
is still receiving 100 mg - the physician increases the dosage to
150 mg and records this new dosage on DOTES. He then encodes
nasal congestion and headache - two symptoms which have occurred
under the old (100 mg) dosage.
To permit the coding of the widest range of dosages and, at the same time, minimize
the number of "marks" required of the rater, the following U-row schema has been con-
structed. Three rows are provided for the coding of the numeric value and one row for
the mul t ipl ier .
NUMERIC
VALUE
MULTIPLIER-
r:0:r --.y.-. -.^--. ::5:: --A^- -.-S^-. ::&= --T-- -R: -»:
:«:: -.--t-- --Z-: :;5: "*: -S^- "6= -7^= "»= "-»-
-..(f-. z-.i-.- zzZ--. -z^z -z^z "5: r;e= -7^: "B- --»-
::0^: ril" :i2:: "Jr "4:: ;:5:: i.e: :;?; ::»: "S-
.001 .01 .1 1 10 100 1000
The multiplier row designates the placement of the decimal point
1 = .001; 2 = .01; 3 = . 1 ; ^ = 1 ; 5 = 10; 6 = 100; 7 = 1000,
Examples :
1. To enter 1750 mg; translate as 175 x 10
Encode 1 755
zzOiz -*■ ..3zz :r3:i :=*:
necr III:: zzizz zzSzz i:it:
r:et: ::!:: ::2:: ::*:: ::4::
zzQzz ::!:: lit: ::3:: ::4::
zi: ::6:: ::7:: -Szz :*:
zSzz ::&: -«■ :*: ==9::
■ft. ::6:: :i7:: :*: :*:
.4. zifc: "7:: =*= =*=
To enter 175 mg; translate as 175 x 1
Encode 175^
:2:: ::3:: -zizz ::*: -zftzz z.r-z ::8:: zz-n
z2:: zzSzz ::d:: zzSiz "fc: «*» "S:: ::*
i2:: :*: ::4:: -^ ~fc: -?=: -8:: I*
:2:: ::3:: "^ "*: ::6:= "?:: -*= "*
3. To enter 17.5 mg; translate as 175 x .1
Encode 1753
■rt: -i^ lit:
::3::
:i(ti
::5::
lit:
iiJ:i
:i8:i ::!
ifci ::!:: i:2:i
::!:
::d::
::5:i
::t:
«A>
i:8:: ::!
iiari III:: .z3zz
::3::
iufci
mim
lit:
i:3!::
::&: ::!
iitti ::!:: ::2::
1,^
::*:
::5::
i:fci
::S:
::&: ::!
230
To enter 1.75 mg; translate as 175 x .01
Encode 1752
-ft: m*^ iii: rri: ::*:
■.dO-.z -.zUz -..3zz z-2zT zzA.z
-.dOzz zzUz ;:2" :J:: r^i:;
'.Az "1" .^b> rJ:: :^::
:5:= :rt: "f:: iifti ::*;
:5:: ::&: — JU ::8t: ::»::
■te ;:t: r:S: "ft: ::ft::
:5:: ::fc: r:?:: ::&: ::»::
ALL FOUR ROWS MUST CONTAIN AN ENTRY. Blanks are not permitted and
will he "read" by the computer as missing data. Therefore, all lead-
ing and following zeros must be marked. For 1 mg . , code 0014,
NOT \k; for 100 mg . , code 1004, NOT 1 4.
For single drugs, i.e., drugs with one chemical component, com-
plete I tern l|a only. For combination drugs, encode Component A in Ma
and Component B in Mb. Even if the dosage for only one component of
the combination is being changed, encode BOTH the "changed" and
"unchanged" components. In a given study, always encode the components
in a consistent fashion, i.e., A in l|a, B in Mb.
Item lie. The sole purpose of this i.tem is to record dosage regimes which can not
be adequately described by Total Daily Dose. In all other circumstances,
it should be left blank.
Examples: A depot drug is presumed to be effective for 2 weeks.
The investigator plans to administer an initial dose
of 50 mg . He encodes as follows:
I. REASON FOR COMPLETING SCALE (0 = initiated)
Row 1 ^M. ::J:: z:Sr.z ::3:: :=«:: zzSzz :*: zzT-z :*: :*:
I I
TOTAL DAILY DOSE
a. Component
(50 mg)
J3*^ ==t
:: ::fc:
13::
:*:
zzSzz
:*:
::?;:
:*:
::»
y-:Ozz ::t
:: :«::
:a:r
:*:
«i«
:*:
::7t:
=*:
==»
A-^ =^i
:: :4::
:i=
:34::
:*--
::&:
::?::
:*:
::»
5--^-- ----t
:: :«::
:*:
mtm
l*=
:*:
::T::
:*:
--9:
b. Component Rows 6-9 omitted; i.e., left blank.
c. Drug is presumed to be effective for: (2 weeks)
10«*« =
t-z :«::
:*=
:34::
:*:
r*:
::7::
:*
!!:«:: :
t~ ««>.
:*:
:a)::
:*:
:*:
zzT-z
;*
1 = hours; 2 = days; 3 = weeks; k = months
]2:«:= ::(:: :*: mtm :*: :*: :*: ::7i: ::&: rrft:
231
At the end of 2 weeks, the investigator plans to administer another 50 mg
dose. He encodes as follows:
I. REASON (Marked as "1" - changed per protocol)
Row 1:0:: »4-> :«:: "i: :*: ::*:: :&: "Tr: :*: --:S:--
I . TOTAL DAILY DOSE (50 mg)
a. Component
:5--: :*r ::7:: i:&-- :A:
^4~ --:&. -iT--- zdB:-. -A.
ri: ::&: :.7:: ::ft: ::9t:
5:0:i .-:tr: :«:= *! -•• :i= ::&: "7:: ::a: ::9::
b. Component - Rows 6-9 omitted; i.e., left blank
c. Drug is presumed to be effective: (2 weeks)
2«e» ---.t
-.-. zSr-.
i3"
r*
3-iy-- ----t
z: :2::
:3::
:*
4>«« ----t
:- zrZ--.
:3-:
=*
10>«<^ :=l
(II zztzz
zzSzz
ZTtzZ
II&I
II&I
iiTii
1*1
lift
11 :0" :=l
t:: ^m
zzSzz
lAi
-ii
I*:
:i7ii
1*1
:*:
1 = hours; 2 = days; 3 = weeks; 4 = months
12 lO:: lit:: iS" ■•» -Az- llfrl i*! ii7:i :*: iifti
NOTE - For double-blind studies in which the rater is unaware of the actual dosage
administered, the number of capsules or other units may be encoded rather than dosage,
Later, when the data are processed, actual dosages can be calculated via computer.
Example: In a double-blind trial, the rater does not know the actual
dosage contained in identical capsules (one capsule contains
100 mg of Investigational Drug; the other capsule contains
10 mg of Control Drug). The rater changes dosage by adding
or subtracting the number of capsules given per day. To en-
code this information, he encodes the number of capsules in
the 3~digit field for numeric value and encodes "8" in the
multiplier. This will signal the computer that number of cap-
sules - not dosage - has been encoded,
III. Prescription - ERRATA: The phrase within the parentheses following the word
"prescription" should read "(No. 0 through 6)" NOT (No. 1 through 6). This
item requires 2 responses - one for prescription (0-6) and one for proportions
(7 and 8).
Example: The total daily dose of 300 mg is to be given "tid" in
equal proportions of 100 mg . each. Code as follows:
13 ;:6ll iijil llji ^ =l4i: -&z II&I mJm iiftr nil
232
IV
"Depot", which refers to a drug contained in a vehicle allowing for slow release
and long action, should always be coded as equal proportions. Similarly, QD, HS
and PRN are coded as equal proportions.
Example: The drug is prescribed "Q,D". Encode "1"AND. "7"
13 -.-.£t-. >^ z.i: -.-.a.-. ..*:. .&. -.-M-. .A. -.-.&z irSki
Presence/absence of symptoms - Since symptoms other than those printed on the
scale can occur and should be recorded, a separate "write-in" form has been
provided (033-TWIS). on DOTES, three "YES" positions are necessary as signals
to instruct the computer in its search for data. In the case where only write-
in symptoms are present, encode response 3 - leave all the catalogue of symptoms
blank (Item 5) - but be sure to answer Item 6, Global Judgments.
Catalogue of Symptoms - Originally it was thought desirable to have raters encode
some response for each and every symptom whether present or absent. Whatever the
merits of insisting on positive responses, the notion has been troublesome for
raters - as reflected in the high incidence of errors. Therefore, raters need
ENCODE ONLY THOSE SYMPTOMS PRESENT OR NOT ASSESSED. Leave the rest of the cata-
logue blank. Be extra careful, however, that you are encoding data on the
appropriate rows.
The rater should endeavor to make an assessment of all symptoms printed on
the scale as well as an inquiry into the occurrence of any other "non-printed"
symptoms. The extent to which symptoms may be monitored is - in part - dependent
upon the setting of the study, the sources of observation and the capacity of the
subject to report their occurrence. In making judgments, it is suggested that the
rater make use of all available sources of information, (nurses' observations,
family comments, subject's complaints, etc.) Whenever possible, objective verifica-
tion of the symptom should be attempted. General questions such as "How have you
been feeling physically?"; "How does the drug make you feel?" may be utilized to
elicit the occurrence of symptoms which are not directly observable or which have
not been brought to light from other sources.
NOTE - Raters may find it helpful to duplicate the "Instructions - Catalogue
of Symptoms" on page R-10 and paste copies on the backs of pages L-3 and
R-ll where they will be more accessible during rating.
For each symptom cited (present), three (3) judgments are required -
intensity of the symptom, its relationship to the drug and the action under-
taken as a consequence of its presence. The 3 judgments are coded on 2 rows
as fol lows :
Coding Symptom Judgments: The 3 judgments are coded
on 2 rows as follows:
RELATIONSHIP
NOT '
AS NOT MODER-
SESED PRESENT MILD ATE SEVERE NoiM Remote Possible Ptobabic Ocfiix
■-:0:-. --i" :*: :*: ::4::INT-REL::S:: ::S: -Ji: :*: ::»:
:*= "i.. ::2:r :i3:: i:*: ACTION r:*: ::«:: ::Jt: --»- -»-
233
Intens i ty
35:©:
::J" 2 >^ ::*=
36:*:
::J7= mOm. ..3o-. ..4:.
Action Taken
On the row labeled INT-REL, the rater makes a judgment of intensity -
using response positions 0 through <!+ and a judgment of relationship -
using 5 through 9. On the row labeled ACTION, the rater records the
action (if any) undertaken - using 0 through 6.
Example: The symptom "Rigidity" emerges and the rater judges
it to be moderate in intensity and probably related
to the drug employed. She prescribes an ant iparkinson
drug. Encoding is as follows:
Relationship
::5:: "fc: "3:z mm^m. r^St:
-zi-. -.-M-. -zj-.z ::8:: ;:»::
a. Intensity - Precise definition of the levels of intensity is complicated.
Many symptoms are subjective; i.e., not directly observable; and, further,
no established standards exist for rating intensity. (See NOTE below).
Generally, however, the 3 levels may be defined as:
2 = Mild the symptom does not hinder the subject's normal
functioning level, i.e., his level at pretreatment .
An annoyance to the subject. Evidence for the
presence of the symptom may be equivocal or based
entirely on subjective report.
3 = Moderate - the symptom produces some degree of impairment to
functioning but is not a hazard to life. Uncomfortable
and/or embarrassing to the subject. Evidence for the
presence of the symptom is clear-cut, i.e., directly
observable and/or deduced from the subject's behavior.
k = Severe Symptom is a definite hazard to well being.
Significant impairment of functioning or incapacitation.
Again, evidence is clearcut.
Intensity should be rated independently without regard to its relationship
to drug. Since there is a high degree of correlation between intensity
and the action undertaken as a consequence of a symptom, however, raters
may find that they differentiate intensity levels partially on the basis
of act ion.
b. Relationship - a judgment of the degree of relationship between the
occurrence of the symptom and the drug rated on a 5-point scale.
5 = None - no relationship.
6 = Remote - less than a 10% probability that symptom
occurrence is related tp drug employed.
7 = Possible - probability between 10% and 50%.
8 - Probable - probability between 50% and 90%.
9 = Defined - greater than 90% probability that symptom
occurrence is related to drug employed.
23^
c. Action Taken - refers to action taken as a consequence of the
symptom's appearance. Actions are arranged in order of increasing
stringency. Only ONE action - the most stringent - should be
recorded as it is assumed that less stringent actions may also
be employed.
0 = None - no action is taken; the symptom is simply cited
as present by the investigator.
1 = Increased surveillance . - Increased alertness over and
above routine observation is required by the professional
staff, the subject's relatives and/or the subject himself.
2 = Contraactive Rx - Remedial medication or treatment is pre-
scribed. Include all medications and treatments which, in
the opinion of the physician, are administered in response
to the presence of an adverse react ion/s.
3 = Change dose - Any non-protocol change (increase or decrease)
ordered as a consequence of adverse react ion/s.
4 = Change plus Contraactive Rx - A combination of actions 2 and
3 undertaken simultaneously.
5 = Suspend Rx - Cessation of treatment for a period of time as
a consequence of an adverse reaction. Be sure to encode
response 6 (item 1) when reinitiating medication.
6 = Discontinue Rx - A decision to stop medication completely
as a consequence of adverse reaction/s. Do not rate the
termination of treatment as planned in the protocol here.
Such "planned" termination is considered "Per Protocol'.'.
Item Vi. a. Global Severity. An overall judgment - similar to the widely used
efficacy judgment - of the extent to which treatment emergent symptoms
have affected the subject in comparison to all other subjects in the
study. Omit the item at the pre-treatment rating.
b. Degree of distress. An overall judgment of the subject's degree of
distress attributed by him to "adverse reactions" in comparison to
all other subjects in the study. The subject's degree of distress is
judged here - not the accuracy of his attributions. Omit the item at
pretreatment .
NOTE ON DEFINING INTENSITY
In the near future, it is planned to distribute a questionnaire among ECDEU
participants in an attempt to derive objective standards for the rating of intensity
levels of treatment emergent symptoms. This technique has been successful in the
past in obtaining consensual definitions - the new DOTES itself being a prime example,
In the interim, the following list of definitions is presented as guidelines for rat-
ing the intensity of symptoms in adults. The sources for these definitions are:
1. Vinai-, 0., Scale for Rating Side Effects during Psychiatric
Psychopharmacology, Activ. Nerv. Super. 8, k, 411-412, I966.
2. Schiele, B., Parkinson's Disease Rating Scale
3. McGlashan, T., Personal Communication
235
CATALOGUE OF SYMPTOMS
1. Toxic Confusional State (Vinar)
Moderate - Transitory toxic confusion during night
Severe - Toxic confusion lasting during daytime
2. Excitement/Agitation (McGlashan)
Mild - Expressed fear and anxiety
Moderate - Expressed fear and anxiety and frequent - but not constant -
agitated motor movements
Severe - Expressed fear and anxiety with constant agitated motor
movements; e.g., pacing, wringing of hands, etc.
3. Depress ive Affect (McGlashan)
Mild - Complains of depressed mood when questioned
Moderate - Volunteers feelings of depression and hopelessness. Cries easily.
Severe - Mimics full blown depressive episode with psychomotor retardation, etc.
k. Increased Motor Activity (McGlashan)
Mild - Increased - but not constant - activity which can be self controlled
Moderate - Constant activity but no external controls needed
Severe - Constant activity; external controls needed
5. Insomnia (McGlashan)
Mild - Loss of 2 hours from regular sleep pattern
Moderate - Loss of 3 - 6 hours
Severe - Loss of more than 6 hours
6. Drowsiness (McGlashan)
Mild - Dozing or sleeping the equivalent of 2 hours during daytime
Moderate - The equivalent of 2 - 8 hours/day
Severe - More than 8 hours; asleep most of the time but not comatose
7. Liver Functions (Vinar)
Moderate - Changes in the liver tests
Severe - Jaundice
236
8. Rigidity (Schiele)
Mild - Detectable rigidity in neck and shoulders. Activation phenomenon
is present. One or both arms show mild, negative, resting rigidity,
Moderate - Moderate rigidity in neck and shoulders. Resting rigidity is
positive when patient not on medication.
Severe - Severe rigidity in neck and shoulders. Resting rigidity cannot be
reversed by medication.
9a. Tremor (Schiele)
Mild
Moderate
Severe
9b. Tremor
11
- Less than one inch of peak-to-peak tremor movement observed in
limbs or head at rest or in either hand while walking or during
finger to nose testing.
- Maximum tremor envelope f a.i 1 s to exceed k inches. Tremor is
severe but not constant and patient retains some control of , hands .
- Tremor envelope exceeds k inches. Tremor is constant and severe.
Patient cannot get free of tremor while awake unless it is a pure
cerebellar type. Writing and feeding himself are impossiible.
(Vinar)
Mild - A feeling of inner tremble or tremor, which is not objectively
visible, unless a little when the arms are stretched in front
of the body and the eyes are closed.
Moderate - Clear, objectively visible tremor, not preventing the patient
from work (not even a fine work or writing)
Severe - Greater tremor, preventing the patient from precise manual work.
Big tremor, the patient cannot even eat.
10. Dystonic Symptoms (McGlashan)
Mild - Rigidity without impaired mobility
Moderate - Interferes with mobility but not incapacitating
Severe - Incapacitated (motoric mobility)
Akathisia (Vinar)
Mild - Subjectively felt "inner agitation", lack of patience; the
patient resists it.
Moderate - Lack of patience makes the patient stand up during conversation;
when working, he stands up now and then and walks a little. The
conversation, however, is not interrupted and the work is finished
in due time.
Severe - The patient cannot keep sitting even when consulting the doctor,
must walk along the room; his rate of work is substantially reduced,
cannot read even one page of a book without break. Impatience and
agitation prevent the. patient completely from any useful activity;
he must be walking continuously, cannot master himself.
237
12. Dry Mouth (Vinar)
Mild Mucuous membranes are dry; the patient complains of it.
Modt.-ate or Mucuous membranes are so dry that it can be seen by the
Severe observer clearly.
13. Nasal Congestion (Vinar)
Mild Feeling of stopped-up nose - or a very disagreeable feeling
of completely dry membrane in the nose.
Moderate or A stopped-up nose - it may be observed and proved (as the
Severe patient speaks, etc.)
]k. Blurred Vision (McGlashan)
Mild Complaints of blurriness but little if any sensory impairment
Moderate - Interferes with acuity
Severe Interferes with acuity and motor movements, e.g., bumps into things
15. Constipation (Vinar)
Mild Constipation for more than 36 hours
Moderate - Constipation for more than k days
Severe The patient needs to be given clysma
16. Increased Salivation (Vinar)
Moderate - More saliva, the patient manages to swallow it.
Severe - Sal iva flows out of the mouth.
'7- Sweating (Vinar)
Mild or He sweats more than usually or in fits
Moderate
Severe Facies oleosa
18. Nausea/Vomiting (Vinar)
Moderate - Nausea
Severe - Vomiting
19. Diarrhea (McG«1ashan)
Mild Two loose bowel movements per day
Moderate - 5 loose bowel movements/day
Severe - Over 5/day
238
20. Hypotension (Vinar)
Mild Blood pressure one tenth lower than before treatment
Moderate - Blood pressure two tenths lower
Severe - Blood pressure scarcely measurable
Note: This evaluation does not refer to subjective troubles
that may be in connection with hypotension. There is
only the question of objectively measured values of
blood pressure with mobile patients in sitting and
immobile patients in lying.
21 . Syncope/Dizz iness (McGlashan)
Mild Transient feelings of dizziness either standing or sitting
with no interference with equilibrium.
Moderate - Dizziness with disequilibrium. No unconsciousness.
Severe - Unconsciousness
22. Tachycardia (Vinar)
Mild The heart rate is between 90 and 100/min. in subjects where
it was under 80/min. before treatment.
Moderate - The heart rate is between 100 and 120/min.
Severe - The heart rate is over 120/min.
Note: The heart rate is recorded in the morning
before the patient leaves his bed.
23 . Hypertens ion McGlashan)
Mild Blood pressure 1^+0/90
Moderate - 160/100
Severe - 200/120
2k. Dermatologic (Vinar)
Mild Photosensitivity (the patient complains and/or is more sunburnt
than usual ) .
Moderate - Itch, rash, transitory
Severe - Dermatitis
25. Weight Gain (McGlashan)
Mild Gain of 5 pounds in one month
Moderate - Gain of 6 - 10 pounds/month
Severe - Over 10 pounds gain in one month
239
26. Weight Loss (McGlashan)
Mild - Loss of 5 pounds in one month
Moderate - Loss of 6 - 10 pounds /month
Severe - Over 10 pounds/month
27. Anorexia/Decreased Appet ite (McGlashan)
Mild - Subject consumes the equivalent of 2 meals/day
Moderate - The equivalent of 1 meal/day
Severe - Does not eat
28. Headache (McGlashan)
Mild - Subjective complaint with no impairment
Moderate - Sensory input painful but not incapacitating
Severe - Incapacitating
DOCUMENTATION
Since DOTES is a crucial element in the documentation, the data displays pro-
vided for it are extensive and, to a large extent, unique - requiring discussion
in deta i 1 ,
a. Raw score printout - Follows the schema given in the Documentation
section. (p. ^7^ ) .
b. Cumulative factor scores - Factor scores along with total score are
the variables employed in the quantitative analysis of DOTES. Unlike
most efficacy measures, however, DOTES is not necessarily completed
on a fixed schedule since differences in treatment response and/or
the emergence of adverse reactions among subjects are to be expected.
These individual differences produce variations in temporal order
which make nomethetic analyses extremely difficult. By restructuring
the DOTES data set, however, a temporal uniformity - necessary for
analysis - can be achieved. The method chosen involves accumulating
individual DOTES by time spans which correspond to those designated
in the protocol for the major efficacy measure/s. Factor scores along
with total score are first computed for each DOTES and then all DOTES
within the specified time span are added together to produce cumulative
scores. The display of these scores follows the schema for such data
given in the Documentation section, (p.kyh).
c. Individual summary - This display (Table 13) provides a detailed record
of events on an idiographic level. Emergent symptoms and their attri-
butes are linked directly to a given dosage level (total daily dose and
cumulative dose) so that the investigator can follow the treatment course
within the individual subject.
240
Dosage by groups - This display summarizes dosage events by group
and is organized by uniform time spans (Table \k) . Treatment groups
are juxtaposed so that the investigator can make direct comparisons.
All symptoms by group - A group summary of symptom events by uniform
t ime spans (Table 15) .
Drug-related emergent symptoms - This group display enumerates ONLY
those symptoms which meet the following criteria:
1. The symptom is not present in a subject at pretreatment .
2. Relationship is judged to be either "Probable" or "Defined".
3. Some action - excluding "None" - is recorded.
The display follows the schema given in Table 15.
Variance analyses - The format for these displays follows the schema
given in the Documentation section (p.if90).
241
Z CO n: I-
o — o —
I- 3: < Q
a. I— Q —
^ ^S ^
CO < X en
Q. ££ <P Q- ClI
O- Di LU t/) CJ —
s: o
ra o
o —
O CO
— z
1- o
Q. —
— \-
al Qi
o o
C/) Q.
LLl O
al c£.
Q. Q.
II n
(_)
CO Q-
: uj o
I cc: of
I a. a.
— s: o o
-5
X LU
^ to — 1
DC >
1- LU <
en
— CC —1
LU ro
q; H- 1- <
LU CO < X
> to
> — —
H Q
LU Q 1- Z
O LU
to o —
UJ UJ
< CO
h- z 3:
_J —1
CO QQ
^^
_l o
< LU II II
— <
Ixl
1- q:
CO -3
in CO
2:
z o
O CQ 1— Z
CO o
o
o z
_1 ^ O —
o cc
z
o —
t3 CO Z S
a. Q-
z
o
II
II II
II II
11 II
1-
CO o
1-
z
z cc
> CO
o C£.
o
o
o r)
LU —
Q. Q.
<
z
O CO
to O
LU I- < _
O Z Q O
< :3 o
CO O Qi ^
o z: LU
Q < Q-
2it2
<
-Z. LU
— >- _1
CO <:
< Q 00
UJ C3 I—
C3 <
< 00 CD
00 O Z
O Q — 2
Q Q
<; LU
LU OO I—
="^ <
O I
00 z I—
oo o —
o o z
Qi (/5 —
(_> — LU
1— OO Z
<C — LU
_J 31 00 Q LU Z
o CJ3 :^
< < _1
oo oo —
o o <
o o o
53
iL^
—
SL CC \-
o z 5
— z
X 1
z
— LU <
1- i- 2
Z X 1— < ^
z: S z 2:
_] 1- :^ 0
X
—
0 oj 1
LU
OJ LU — 1—
II
II Q O
<
0 u. 0 <•
H- Ll. — 2
*— >. ^-^
—
Z Z UJ II
S^ 5^
H-
-;: z q:
-;c < 1-
S5^^
0 LU X 1—
Qi Z 0 —
X X
s
r~- Q. <
z: s: II g~s
0. — 1- H-
X X
O 1/5 —
■ ■
Qi
O T.
II II >~
II II II II
h-
1 LU O
—1 n
LU
— S >-
z X — 2:
0 Ll. X 1-
*--** ^-^
Q£
O — OO
— < < ^
2: S Q 0
q: z 0 —
g5°5
Q.
O 1- Q-
Q- — h- 1-
X X
X X
< -^
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
< ^
O LU
— C3
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
X X
— CM I I
— CM I I —
243
Uj X X X
o
Z> X X X
«A
o
4. X X X
o
Z X X X X
o o
O O X X X
< o
a: X X X
(/)
o
Z X X X
UJ X X X
0£ X X X
X X
X X
X K
O X X X
o.
XXX
O X X X
X X
X X
X X
X X
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
> X X X
XXX
O X X X
XXX
— X X X
< =
<2 o
o oc
e §
o — o
oxooxo_o
I I- — I l_ _ p —
o<aco<«:xa.<a:
$ 2
^
^
^
2Mf
032 PTR
PATIENT
TERMINATION
RECORD
MH-9-32
1-73
PATIENT TERMINATION RECORD
INSTRUCTIONS: Insert New General Scoring Sheet and Code 04 for Sheet Number P
To be completed at the termination of the subject from the study. "
Mark on right half of scoring sheet on row specified
ROW
NO.
Continue marking on right half of scoring sheet on row specified
ROW
NO.
1. REPEATER
0= No
a. Has the patient ever been . _ „
a research subject before?
9 = Not Ascertained
1
4. NON-DRUG TREATMENT
a. Did the subject receive any non-drug 0 = No
treatments during the course of the study? ^ ^ yes
b. If YES, rate the effectiveness
of all treatments received: Mark row in appropriate column
17
b. If YES, was the patient a subject
in a study in which the data was 0 = No
sent to the Biometric Laboratory? 1 = Yes
9 = Not Ascertained
2
T.ea.mem
Efficacy
Unknown
Unsatis-
factory
Equivocal
Satis-
factory
Behavior modification ....
0
1
2
3
18
19
20
21
22
23
24
25
Milieu therapy
c. If YES, for the most recent
previous study, give:
1. ECDEU study number
2, Patient's number in that study .
3-8
9-11
P ^chothera" individual
Rehabilitation/occupational therapy
Remedial educational therapy .
2. DURATION
12-14
15
c. Did the subject's spouse/family receive therapy/coun- 0 = No
seling as part of the subject's overall treatment regime? i - v
26
b. Was patient prematurely terminated? (G/Ve major reason):
0 = Not prematurely terminated 5 = Intercurrent illness
1 = Did not return for treatment 6 - Found not to meet study
or refused treatment criteria
2 = Adverse reaction 7 = Dosage/Medication error or
violation
3 = Ineffectiveness or deterioration
4 = Improvement 8 = Administrative
d. If YES. rate the effectiveness of the therapy/counseling:
0 = Efficacy unknown 2 ' Equivocal
1 = Unsatisfactory 3 = Satisfactory
27
5. DRUG INTAKE
How well did the patient follow his drug regime?
0 = Not applicable, did not receive drugs
1 = Took study medication as prescribed
2 = Some irregularities but primarily took study medication as prescribed
3 = Suspected significant irregularities
4 = Confirmed significant irregularities
5 = Took additional medication in violation
9 = Not ascertained
28
3. INTERVAL HISTORY
During the course of the study, were there any significant events or changes -
external to treatment situation — in the subject's life situation?
0 = No significani events or changes
1 = Catastrophic event - fire, flood, financial disaster, accident, etc.
2 = Death of significant other
3 = Physical/mental illness of significant other
4 = Difficulties in relationships with relatives or peers — spouse,
children, family, lover.friends, fellow employees, etc.
5 = Decrease in status and/or responsibility - layoff, dismissal,
demotion or retirement from employment, school failure, loss of
hospital privileges, rejection by or dissolution of family unit by
divorce, separation or inability to perform household responsi-
bilities
6 = Improvement in relationships with relatives or peers
7 = Increase in status and/or responsibility - promotion in school or
employment, new employment, marriage or reuniting of family
unit, increased hospital privileges
8 = Pregnancy of subject (spouse or parents) and/or btrth of
child/sibling
16
6. ANCILLARY HflEDICATION
a. During the course of the study, did the subject receive 0 = No
any ancillary medication/s other than test/control drug/s? 1 = Yes
b. If YES, rate the effectiveness of all ancillary medication received:
29
Ancillary fvledication
Efficacy
Unknown
Unsatis-
factory
Equivocal
Satis-
factory
Analgesic-narcotic
Analgesic-non-narcotic ....
0
1
2
3
30
31
32
33
34
35
36
37
38
39
40
Antitumor
246
PATIENT TERMINATION RECORD
ROW
NO.
B. ANCILLARY MEDICATION (Continued) 1
Vark on left half of scoring
fleet on row specified
Efficacy
Unknown
Unsatis-
factory
Equivocal
Satis-
factory
1
Blood tonic
0
1
2
3
2 .
Bronchodilator
3 .
Cardiac medication
4 .
Cough & cold preparation
5 .
Dermatological preparation
6 .
Diabetic medication
7 .
Diet medication
8 .
Diuretic
9 .
Gastrointestinal preparation
10 .
Hormonal medication
11 .
Muscle relaxant
12 .
Psychotropic medication
(otfier ttan test or control
drug)
13 .
Sedative/hypnotic
14 .
Stimulant
15 .
Thyroid medication
16 .
Vitamin
7. GLOBAL ITEMS
a. Compared to other subjects, how well did this subject
conform to study requirements?
17
0 = Much below average
1 = Below average
2 = Average
3 = Above average
4 = Much above average
b. Given the choice, would you continue this subject
on his study medication?
0 = Definitely no
18
1 = Inclined to say no
2 = Undecided
3- Inclined to say yes
4 = Definitely yes
B. DISPOSITION AT TERMINATION Answer either "a" or "b"
a. Inpatients
0 = Elopement or discharge against medical advice
19
1 = Remains hospitalized and has lost privileges and/or work
assignments previously held, e.g., loss or decrease in passes, or
freedom of movement within hospital, loss of or decrease in
industrial therapy assignments, transfer to more closely
supervised wards
2 = Remains hospitalized and status is unchanged from pretreatment
3 = Remains hospitalized and has earned greater privileges and/or
work assignments, e.g., formal industrial therapy assignments,
day or night passes, transfers to wards with less supervision
Continue "Inpatients" on next page — R— 13
ROW
NO.
19
Cont.
Continue marking on left half of scoring sheet on row specified
Inpatients (continued)
4 = Paroled or discharged to a supervised living situation in
community, eg., foster home, halfway house, day hospital,
community mental health clinic, etc.
5 ^ Paroled or discharged to own custody or own family. Include
patients discharged with recommendation to continue treatment
with family physician; on OPD basis, etc.
6 = Transferred or discharged for reasons unrelated to present
treatment, e.g., intercurrent illness or accident, administrative
reasons, etc.
b. Outpatients
0 = Discharged against medical advice, e.g., refused treatment,
did not return for treatment, family uncooperative, etc.
1 = Hospitalized (transferred to inpatient status) because of^
exacerbation or deterioration of psychiatric condition
2 = Remains on outpatient status and treatment Is intensified
because of exacerbation or deterioration of psychiatric
condition, e.g., greater psychiatric supervision, partial
hospitalization such as day or night hospital, etc.
3 = Remains on outpatient status and status is unchanged from
pretreatment
4 = Remains on outpatient status and treatment is reduced
because of improvement of psychiatric condition; e.g., less
supervision, more widely spaced visits, etc.
5 = Discharged to own custody or own family. Include patients
discharged with recommendation to continue treatment with
family physician or to seek treatment independently.
6 = Transferred or discharged for reasons unrelated to present
treatment, e.g., intercurrent illness or accident, administrative
reasons, geographical relocation, etc.
247
Developed within the ECDEU program, the Patient Termination Record (PTR)
consists of 8 items and is formatted for use with the General Scoring Sheet.
The items of the PTR focus on the historical events of the study itself; e.g.,
the course and length of treatment, ancillary treatments, disposition of termlna*
tion, etc. The information elicited by the PTR is essential for the complete
documentation and evaluation of a study. The PTR evolved from and now replaces
the Drug Study Resume (OU-DSR) .
APPLICABILITY
UTILIZATION
TIME SPAN RATED
CARD FORMAT - ITEMS
Item Column
la
lb
Ic
2a
2b
3
20
21
22 - 30
31 - 33
3U
35 - 36
All research populations
Once per subject. Completed at the time of the
subject's termination from the study.
The length of the study; from entrance to termina-
tion.
CARD 01 = (19x, 211, 19, 13. M, 12, 3911)
I tem
Column
ka
37
kh
1 - 8
38 - kS
kc
ke
kd
hi
5
kZ
6a
hS
6b
1 - 26
50 - 75
CARD 02 = (19x. 611)
Item Column
6b27 20
6b28 21
7a 22
SPECIAL INSTRUCTIONS
Item
7b
8a
8b
Column
23
24
25
Item 1. Repeater - This item has been included on the PTR for technical reasons
rather than for its pertinence to termination status. (Translation - It didn't
fit no place elsel) The item enables BLIPS to Identify all individuals who have
been participants in more than one study and, further, to identify those who have
multiple data sets in the ECDEU data bank. If the subject has participated in
several previous studies, the rater should encode the identification data from
the most recent study. Identification of a repeater requires 9-digit code as
fol lows:
XXX
XXX
XXX
Unit #
Study #
Pat. #
Rows 3-5
6-8
9-11
If the subject has never been a repeater, leave items lb and Ic blank. If the
subject has been a repeater but does not have data in the ECDEU bank, leave
Item Ic blank.
2i»8
Item 2a. Duration - Duration is defined as the number of days from a subject's
entrance Into a study to his termination. Entrance into a study is defined as
the day of the initial assessment; termination as the day of the final assessment,
Total number of days in the study may or may not coincide with total number of
days under medication. Duration in studies in which a pretreatment drying-out
period and/or a follow-up period are encompassed (bracketed) by assessments, for
example, will exceed the actual duration of medication. (For detailed instruc-
tions, sec "Coding Duration, p. 25). Notice that duration MUST BE CODED IN DAYS.
Example: The subject was in the study for k weeks. Encode
0, 2, 8 in Rows 12 - 14. Note that 28 days - NOT
k weeks - is encoded and that the leading zero is
included.
12.*i
-..%-.-.
-.zT-.
:*:
"■4:--
::ft:
"fc-
"*:
::ft:
:rft:
13:*r
::!::
«»
:*:
■■*■-.
i:S-.
"fci
==*:
"ft:
::St:
U.A:
::fc:
"i:
-at:
"A:
---.i.:
-.-.k:
::J::
-«-
::Sb:
Item 2b. Premature Termination - Only ONE reason should be given. Definitions for
the categories are as follows:
1 = Did not return for treatment or refused treatment - includes
elopement; unauthorized leaves; rescinding of treatment per-
mission by parents, relatives or legal guardian; sporadic or
insufficient attendance of treatment appointments; refusal to
cooperate with assessment and/or other research procedures.
2 = Adverse reaction - Any reaction, side effect or treatment
emergent symptom which, in the opinion of the investigator,
requires termination of drug treatment.
3 •= Ineffectiveness or deterioration - Refers to lack of change
or exacerbation of psychiatric symptomatology which, in the
opinion of the investigator, is ethically unacceptable and,
therefore, requires termination.
h = Improvement - Refers to a degree of positive change (improvement)
in psychiatric symptomatology which, in the opinion of the
investigator, ethically requires release from treatment situation,
e.g., discharge or parole from hospital; discharge from clinic or
other agency.
5 = Intercurrent Illness - Refers to any non-treatment related illness
or medical condition requiring termination of treatment. Pregnancy
should be included here.
6 = Found not to meet study criteria - Refers to subjects erroneously
admitted to study, e.g., lacks required target symptoms; does not
fit age group; has a history incompatible with inclusion criteria.
249
7 = Dosage/medication error or violation - Includes errors or
violations by either the subject or the staff which necessi-
tate termination, e.g., "over" or "under dosing" by subject
himself or by his relatives; intake of medications prohibited
by protocol; dispensing errors in dosage and/or medication.
8 = Administrative - Includes transfers to other wards or hospi-
tals; subject moving from area; drug withdrawn by company;
personnel defections; protocol violations such as accidental
revelation of treatment assignment codes, improper assessment
procedures, introduction of services or activities prohibited
by protocol .
Item 3. Interval History - This item (and Item 8) is written in general terms so
that it might serve as wide a population as possible. Rather than specifying the
exact nature of the event, the rater is asked to judge the effect of the event
upon the subject. An external event or change is considered significant if, in
the opinion of the investigator, it has had a substantial effect on the course of
treatment .
I = Catastrophic event - refers to any natural disaster, economic
event, "act of God", etc.
k = Difficulties in relationship with relatives or peers - refers
to detrimental events or changes in the subject's emotional or
social interactions which do not appear to be primarily related
to treatment.
5 = Decrease In status and/or responsibility - includes any signifi-
cant event or change which reflects a diminution in the subject's
status or responsibility.
6 = Improvement in relationships with relatives or peers - non-
treatment related events or changes which reflect facilitation
of relat ionsh ips .
7 = Increase in status and/or responsibility - any events or changes
which enhance the subject's status or reflect increased responsibil'
i t ies .
A MAXIMUM OF 2 ENTRIES may be made for this item. On card decks, the entries
will be coded by a 2-digIt code. The legal codes are given in Table 16.
Examples: 00 = No significant events
10 = Difficulties in relationships
31 = Catastrophic event and decrease in status
250
TABLE 16
PTR - ITEM 3 INTERVAL HISTORY
< -I
LLl —I
O —
card
Response
Code
0
1
2
3
4
5
6
7
8
Pos it ions
00
X
0
01
X
8
02
X
7
03
X
X
7.8
04
X
6
05
X
X
6,8
06
X
X
6,7
07
X
5
08
X
X
5,8
09
X
X
5,6
10
X
4
11
X
X
4,8
12
X
X
4,7
13
X
X
^,5
14
X
3
15
X
X
3,8
16
X
X
3,7
17
X
X
3,6
18
X
X
3.5
19
X
X
3,4
20
X
2
21
X
X
2,8
22
X
X
2,7
23
X
X
2,6
24
X
X
2,5
25
X
X
2,4
26
X
X
2.3
27
X
1
28
X
X
1,8
29
X
X
1,7
30
X
X
1,6
31
X
X
1,5
32
X
X
1.^
33
X
X
1.3
34
X
X
1 .2
ILLEGAL OR IMPROBABLE CODES
251
Item ^43 and kb . Non-drug Treatments - If the answer to I tern ka Is "NO", Item kb
may be left blank. A "YES" response to ^a requires that EACH TREATMENT RECEIVED
must be evaluated.
Example: The subject did receive non-drug treatments.
(Encode 1 in Row 17). Her response to physi-
cal therapy was satisfactory (Encode 3 in
Row 21) while her response to individual psycho-
therapy was unknown. (Encode 0 in Row 23).
Leave the other non-drug treatments blank.
17 -.0^ .Jii -Sz- ..3c. -.-.*,-.
18 "ft: -t- "i. -.-.i:z ..*:-.
\9~.&. -.-.iz "ir rriz r:*:
20::a: r:i: ::i= ..Btz ..4zz
21 rifti :iir "li «A. "*=
22rrftr :=±r "ir zzStz z.4tz
23 .rf- r=3:: :ifc: rJ=: "i"
24i=a:r "3:: =:2:; rii: =al"
25 "t: rilr= "t: ==&; ::4:i
Note: Items 4c, kd, 6a and 6b are encoded in the same fashion.
I tern 5. Drug Intake - Only one response is permitted.
I tern 7a. This item requires a judgment of the behavior of the subject qua subject;
i.e., how well did he follow the "rules" of the study; did he miss appointments;
require surveillance; rebel against procedure; act as "guard -house lawyer"; etc.
I tern 7b. In double blind studies, it is crucial that this item be completed prior
to breaking the blind; i.e., revealing the exact nature of the treatment to the rater.
Item 8. Disposition at termination - As in I tern 3. this item endeavors to be universa
by stating the responses in general terms. The investigator must judge whether the
subject's treatment regime - as it existed at the beginning of the study - has been re
duced, intensified or altered substantially.
DOCUMENTATION
a. Raw score printout
b. Frequency tables
252
THE
NURSE
PACKET
Unlike the Psychiatrist packets which are focussed on specific populations,
the Nurse packet is "discipline oriented"; i.e., it contains all of the scales
which are rated by this profession. Spanning age from pediatric to geriatric,
the scales are:
Childrens Behavior Inventory (03^-CBl) - Pediatric
Nurses Observation Scale for inpatient Evaluation (039-NOSIE) -Adult
and Geriatric
Plutchik Geriatric Rating Scale (040-PLUT) - Geriatric
Nurses Global Impressions (042-NGl) - Universal
Although entitled "Nurse Packet", this set of scales may be rated by ward
personnel other than registered nurses (RN) ; e.g., licensed practical nurses (LPN)
psychiatric aides, attendants, orderlies, etc. The essential requirements are
that raters have appropriate clinical experience and that they be thoroughly
familiar with the rating instructions for each scale.
The selection of scales for any given study is at the discretion of the
investigator. Depending on the population involved, the most frequent selection
is one of the major scales - CBI, NOS I E or PLUT - in combination with the NG I .
Figure 16 shows the data matrices for each of the scales. These matrices
describe the encoding locations of the scales. Since all - or any combination -
of scales may be encoded on one GSS, the raters ALWAYS encodes Sheet Number as 10
each and every time he or she rates. Period number changes; but Sheet Number
always remains the same.
ERRATA - The authors' names were inadvertently omitted from the header for
039-NOSIE. The authors are:
Honigfeld, G., Gillis, R. D. and Klett, C. J.
25^
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (
50-GSS)
—
PATIENT INITIALS
1 NUMBER MALES 001 TO 499 NUMBER FEMALES 500 TO
998
—
:iA: ::ft: ::£: ::B:
"K: "ti :*»: 3*1=
::Lt: i:V6: rJW= =:)t:
::&:
FIRST
:«:
INITIAL
::¥::
::F:: ::©: ::tt:
::P:: :<):
::S:
::d:: ::±: 1 :A:: ::l::
FIGURE 16
MATRICES FOR
NURSES' ASSESSMENT
SCALES
:=»:: :4:: ::4:: ::&: ::fc: ::?:: ::»::
PATIENT
; :*: ::«:: ::&: ::6:: zzfzz ::8::
: ::3:: ::4:: ::5:: ::fc: :;3!:: ::8::
::9=:
::St:
::9t:
—
:A: ::ft: r-C: "B:
"It: "t: --*»: :*t:
::&:
SECONC
:«:
INITIAL
::ft: :«:
)
zzfzz zzQz
. ::3:: ::4::
RATER
::?:: :^:
::S: ::fc: ::?:: ::8::
::5:: ::fc: ::7:: ::*:
::8t:
:*:
=
^^
."U: zz\tz :*(: "X:
::y::
::£:
: ::3:: ::4::
::5:: ::&:: ::7:: ::«::
3
::5:: ::fc: ::?:: ::8::
:*:
:*:
^~
:tt: ^ f=n a
"*: SHEET
::4: NO.
::S: --ifz ::5t:
::»: ::»:
:*: ::»::
::2:: r:3::
PERIOI
—
1-:.] - - -
*i^>^l*l*
l*I^W
Y 1 V
':S'I N
'■^;i N
—
Row
2ifecGttttrtent
::2f :
SiOptpy ::?:: ::ft: (TJJ
Ro>
l::a(l:).:
■-^^^;^
-4::
'H7<^)^
4il8>
::»::
—
::*
ISipa£leat ::ft:(2j^
2::a(2=)±=
::^41:^:
::4::
---i80y
<-l-l^>
::»::
^_
3B»th?ing ^=
--XZ
==*■
6l?i&S= -S: ::ft:(3):
3::ft(3^d::
-^425^^
::4::
=»TOP=
<=12a>:
::9::
^
4Ffflling ^=
::»::
::*:
Activities J::(4):
4::e:(4:)3::
-^43!^^
::*:
=481=>:
U-21>
::«::
^
5W&lking i-
::»:
::*:
Si-ta : ::3t: ::8::(S>:
5::e:(5.)j-
::^44^:
::4::
::(82=>c:
ii:22^
:*:
^
6Vi.:si«n -*-
::»:
::*
A*igry -K: -ft: (6)=
6:*(6=)3-
::^43^:
::*:
==(83=)6c:
<=123V
::»::
^_
7H€FaFlng '=
::»::
::*
Heats TMngaC?):
7::ft(7^a::
■■^t^&r-
::4::
==(84=>:
4124>
:*:
^
SSl^eef^'NJLghfe ^
:*
Heat : ::Jt: ::ft:(8):
8::a:(8:)3-
--^hJT-
::4::
==(85=^
il25>
:*:
_
9Sl=eef^Day *
::*:
Fci&Bdl-y ::ft:(9):
9:*(9fja::
■■■■KA^r-
::4::
==<86=>=:
4126).^
:*:
—
lOResfelesS =*=
::4::
ypSet ::Jb: ::(41Q>=
10=:(10!J»-
==^49^
:al::
::<87=>=:
<U7h
:*:
—
"We-rg* Night •
:at:
Befiises do.: 4 11)=
n=ni^'"
=-t50^=
::al::
==(88=>=:
4i28>:
:*:
_^
12Ap:pe«r3nee -^i
::4::
:l4?riftabl« -412)=
12:9T0P»==
:<.51^:
::«::
■-■-iB9^-^-
ST=0PJ::
::9t:
—
13Mastiir hates -
:a|::
fiieme»b earing ^ 1 3):
13:<12:)J-
.:<52^:
::«::
■■--{90^
41=2 9>^
::*:
—
14e^nfi3sed- -at:
::«::
Sfefisfc-. s]^akU4)=
14:<i3=)>-
::<53^:
::4::
■.■-i9h)^
41=3 ©>:
::»::
^^^_
15Nftrne4 -tz ..tz
::4::
laughs ::S: :: 4 1 5)=
15:<:14:)J-
==4-54#==
::4::
==^92=)6c:
41^31^=
::|t:
'~~
1 6 e«miHwn ica t es
::*-
&ati*g -*= -416):
16:<:15:)J-
==<55^-=
::4::
::(93>=:
4i=32>:
::»t:
—
17ReaGts ^
::a::
::4::
e©nv#rs«s -.(-l5^>
17:<:16:)J-
--^5e^--
3
X
==<94>=:
41=33>=
::*:
—
IBElay:* ::St:
::a::
::*:
griue ==*= -n8)=
l8=tl7!J'-
■-^57r-
-(95:^:
4i.34>=
::*:
^
19R£ad:3 ::2::
::&:
::*:
i«te*es«-s 419^=
19:^18=)'-
■-^5sr-
==<9&>==
41=35>=
::»::
^~
20ifeifeiafc6^
::&:
::*:
S«es thd*igs^26^:
20=4:19=)3-
::<59^:
::^9^^:
^1=36>=
::*:
^
2Vniing
::*:
R-emlftde^ - ^2i>.:
21 :<20=)J-
-460^=
::4::
---{9&>
41=37^=
::St:
~~
22H€=lp3 - cKo¥esF*=
Slespps -3t: -422>=
22:<:21=)J-
-461^=
::*:
::<99^:
41=38>=
::*:
—
23:*:" -i-z _■ Oth«I
F«li-&w-s= -424^=
23::(22!^^-
24:<-23=>-
-^62r
::<::
(iDIi::
41=39^=
=9==
::*:
—
24Frieffids ^=
::i:
—
25T6lk* ::2::
::$::
::4c:
eempvTask ::i425)=
25:<.24=^5-
-464^=
:^:
ClD2)fc:
::*:
^
26W©Tk« =^2==
::9::
::*:
Mtonbies = -'4 2 6)=
26:<25=>-
==4^5^=
::4;:
(103>:
::*:
^
27BesfeTuctlve
::<t:
Sluggdsli ---ii^y
27:<tf26^1-
--^eey-
::4::
(i04>==
::»::
zz
28SlK)\rfeB -2=:
::3::
::*:
&lggles - -"^28^-
28:^2 7 JJ::
--xeir-
::4::
il05y-
::*:
—
29Steais ==2:=
::9b:
::*:
Fiy =©ff -- ---iin-
29:^28^1-
==K68^
::4::
aoey-
::*:
~
30T|jre^teFEte
31 friers Ba*Ti
::i:
::a::
::*:
::*:
::*:
:3l::
€ieafe= ^= -1430)=
30 :<:2^a-
31 :<e30=>J-
32:^3151::
33:<:32^»-
==46 9^
==470>=
■-^llf-
=^72>==
ZZl^Z
:a|r:
::«::
::4::
{W7r-
(108>=
Ci09>.=
(ilO>=
::8t:
::*:
::»:
■""
::&: ::fc: :*: ::&: ::»::
^_
32 ::&: ::t:^ ::2::
PLOT
33 :*: ::1:: ::2::
::!:
:a:r
::&: ::fc: :I: ::ft: ::9::
NOSIE
::&: ::fc: ::3I:: ::ft: ::9::
^
34:*: zzUz ::2r: r^::
:Di::
::&: ::&: ::?:: ::ft: ::9::
S4:<c33^J-
=<73^:
:a»::
(Jll:>=
::St:
^
35:=e=: :iJii zdSzz rir:
:Dd::
::&: ;:6:: ::7:: ::e:: ::*:
35:<34^»::
=^74^
zz4zz
(112>^=
::*:
ZI
36:*: ::J:: :i: ::3::
:Dd::
::&: ::6:: ::S: ::ft: ::»::
36:^35 J.::
==^75^
::4::
(113>=
::»::
~
37:*: ::J:: ::2:: :*:
:al::
::S:: ::&: ::J:: ::e:: ::9t:
37:<.36>i-
:^76)==
::<::
(M4>=
::*:
^
38:*: zzUz :±: ::3::
::>#■
izS: ::t: ::ft: ::8:: ::*:
38:^7^1::
=t-77?-
::4::
ai5>=
::>:
^
39:*: ::J:: :i: :*:
::5:: ::fc: ::7::
::8:: ::9!::
39:<^38^l-
40 zSToa-
=^-78^-
::4::
gTOPfc=
(il6)*==
::Jt: ::»::
::*:
40:*: ::!:: :±: SeVEerity
::^ ::fc: ::3t:
:*: ::S::
zzfzz
41:*: ::J:: :MpE-eVe*ent
::f- ::fc: ::!::
255
Wzf^qhlzz
:*: :4:: :=«::
73 74 IS
ai7.v=
::T:: ::»::
::*:
20
<
o/s; f ? T^*^
T^
A
18 19
034 CBI
CHILDRENS
BEHAVIOR
INVENTORY
CHILDREN'S BEHAVIOR INVENTORY
Eugene I. Burdock and Anne S. Hardesty
INSTRUCTIONS: Code 20 under sheet number on genera/ scoring sheet.
This inventory is applicable to children from 1 to 15
years of age. The items have been grouped according to
the ages at which the corresponding behaviors first
become significant of departure from developmental
norms. The behavior recorded should have occurred
during a specified interval of the observation day.
Always start at the beginning of the inventory and
proceed through the level corresponding to the child's
last birthday. A STOP signal is given at the end of each
age grouping. Mark "yes" when you reach the level
corresponding to the child's last birthday; "no" if you
are continuing to the next level.
For each item record your judgment by marking "yes" or
"no," All items within appropriate age groupings should
be answered.
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
Mark all items on this page in columns 11 & 12
AGES ONE TO THREE:
1. Responds to social stimulation (by talking, smiling, or reaching, etc.)
2. Is slow in his movements
3. Maintains a rigid posture when standing, sitting, lying or being held
4. Grinds teeth . . . :
5. Voice is flat and monotonous
6. Ignores toys or other objects around him
7. Repeatedly falls asleep
8. Bangs head on wall or other hard surface
9. Holds breath until face changes color
10. Responds to physical contact with limpness
11. Utters no sounds
STOP (mark "yes" or "no")
AGES THREE TO FIVE:
12. Soils bed or clothing with excrement
13. Acts apprehensive and afraid
14. Engages in rhythmic motions I'swoy/V)^, /7eotfro///>i^, efc.^
15. Says that he had a bad dream
16. Eats or drinks strange substance ^p/osfe/-, //Jit, e/c.^
17. Has attack of panic
18. Remains in one place unless directed into some activity
19. Has momentary lapse of consciousness
20. Complains of aches and pains or of physical distress
21. Picks at self (pulls out hair, picks at skin, face, buttocks, geriltals, etc.) .
22. Talks and talks or babbles and babbles ^pressure o/'speec/)^
23. Refuses to eat
24. Lisps
25. Hbz \\c Of Xv4'\\ch (distorts face, turns neck, blinks, etc.)
26. Gets angry or annoyed when addressed by adult
27. Has recurrent spells of nausea or vomiting
28. Appears listless and apathetic
29. Responds to own antisocial act with no sign of sorrow or remorse . .
30. Shows incongruous emotional response
31. Smears self and surroundings with food or feces
32. Acts perplexed or confused
33. Repeatedly gets irritated
34. Repeats some act over and over again as though driven
35. Wets bed or clothing (incontinent)
36. Is tense and anxious
37. Has a fixed grin
38. Speech is inarticulate
STOP (mark "yes" or "no")
AGES FIVE TO SEVEN:
39. Clings to adult
(Continue this age group on next page)
Mark all items on this page in columns 13 & 14
; FIVE TO SEVEN (Continued):
I. Keeps drooling
. Has temper tantrum
:. Slurs his speech
I. Uses baby talk
1. Keeps feeling the contours of objects within reach . . . .
i. Shifts attention in a restless manner
i. Becomes anxious when he cannot make things neat and orderly .
'. Has a dull expression
\. Maltreats younger child with deliberate cruelty
I. Complains of insomnia
I. Gets angry when interrupted at play by adult
, Displays excessive self-control and composure
'. Cries or looks hurt when criticized
I. Takes part in ongoing activity without being urged . . . .
.. Does not play with other children
t. Protests or resists directions of adult
I. Keeps asking for help in whatever he is doing
. Utterances consist of monosyllables or single words . . . .
1. Says he is going to kill himself
I, Shows understanding when given directions
I. Sucks thumb
. Acts nervous or agitated
'. Uses no gestures
:. Plays with genitals or masturbates
. Has a tight-tipped expression
I. Swears or uses bad language ' .
\. Speaks in a faint voice .
:lip
- table
Keeps slopping fodd c
Twists mouth
Has a mournful and downcast expressic
Walks on tiptoe
Stays by himself
Speech is slow and full of pauses .
Is hesitant and uncertain in making up his r
Gives excuse for breaking the rules .
Spills something or bumps into something
Talks about death and killing ....
258
(Continue this age group c
CHILDREN'S BEHAVIOR INVENTORY
Mark all items on this page in columns 16 & 17
ROW
NO.
Mark all items on this page in columns 18 & 19
ROW
NO.
AGES FIVE TO SEVEN (Continued):
1
2
3
AGES NINE TO ELEVEN (Continusd):
118. Giggles inappropriately
1
2
3
4
5
6
7
8
9
10
11
12
119. Weeps under slight provocation
STOP (mark "yes" or "no") .
120. Keeps demanding to be the leader
121. Says he feels sad . . .
AGES SEVEN TO NINE:
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
122. Has a scornful expression
123. Attention wanders ....
124, Gets angry when something does not suit
125. Hits or atiackj other child
him
126. Takes part in conversation
86. Twists or turns hands
127. Runs around or throws himself about in a
128. Grimaces or gestures grotesquely
wild and uncontrollable manner
STOP (mark "yei" or "no") .
AGES ELEVEN TO THIRTEEN:
129. Bullies younger child ....
13
14
15
16
17
18
19
91 . Says that he is bad, that he is in the wrong, or that he is ashamed of himself
130. Has a dirty appearance
131. Speaks in a jerky, uneven fashion
132. Acts friendly with another child . .
94. Eyes keep shifting
95. Acts as if he has a vision or talks about his vision
133, Shows pleasure at being talked to
134, Behaves in a sullen or argumentative man
er
STOP (mark "yes" or "no") .
97. Talks to his voices or acts as if he hears voices
AGES THIRTEEN TO FIFTEEN:
135, Shows difficulty in concentrating
20
21
22
23
24
99. Is impatient (will not wait for something to be given to him or to be done
136, Shows interest in the opposite sex (positii
137, Expresses feelings of inferiority .
138, Expresses a pessimistic outlook toward hi
139, Complains that an adult wants to kill him
e or negative feelings)
future accomplishments
102. Keeps eyes closed or averted or head bowed down
104. Walks with a cautious tread Cos //sfepp/n^ on e^^s,^
105. Shows suspicion or complains of unfair treatment .
106. Deliberately tears or breaks something
107. Tries to kill himself
110. Curses or sneers at other child ... . .
111. Attacks adult
112. Sets a fire
114. Keeps smiling
STOP (mark "yes" or "no") .
AGES NINE TO ELEVEN:
40
41
(Continue this age group on next page)
259
Burdock and Hardesty's Children's Behavior Inventory (CBl) is a 139-item,
2-point scale formatted for use with the General Scoring Sheet. The scale is
a technique for recording maladaptive behavior of children. The absence of
professional or technical jargon makes it possible for members of different pro-
fessions to carry out and record the relevant observations after brief training.
Experience with the method to date has demonstrated that with proper selection
and adequate training the CBl is equally reliable in the hands of nurses, teachers,
psychologists, psychiatrists and graduate students in psychology or special educa-
tion.
REFERENCES 1. Burdock, E. I. and Hardesty, A. S., A Children's Behavior
Diagnostic Inventory, Ann. New York Academy of Sciences,
105: 890-896, 1964.
2. Burdock, E. I., and Hardesty, A. S., Contrasting Behavior
Patterns of Mentally Retarded Children and Emotionally
Disturbed Children, in Psychopathology of Mental Develop-
ment, p. 370-386, Grune and Stratton, New York, I967.
APPLICABILITY
Chi Idren aged 1 to 15
UTILIZATION
TIME SPAN RATED
Once at pretreatment, at least one posttreatment assessment.
Additional ratings are at the discretion of the investigator.
Restricted to the period of observation
CARD FORMAT - ITEMS
CARD 01 = (I9x, 5611)
Item Column Item Column
2
3
k
5
6
7
8
9
10
11
20
11
21
12
22
13
23
\k
Ik
15
25
16
26
17
27
18
28
19
29
20
30
21
■stop 31
32
33
34
35
36
37
38
39
ko
h\
CARD 02 = (19x, 5611)
Item Column
55
56
57
58
59
60
61
62
63
(A
65
20
66
21
67
22
68
23
69
Ik
70
25
71
26
72
27
73
28
Ik
29
75
30
76
I tem
Column
Item Column
22
23
Ik
25
26
27
28
29
30
31
32
42
43
44
45
46
47
48
49
50
51
52
Item Column
31
77
42
87
53
32
78
43
88
54
33
79
44
89
55
34
80
45
90
56
35
80-
stop 46
91
57
36
81
47
92
58
37
82
48
93
59
38
83
49
94
60
39
84
50
95
61
40
85
51
96
62
41
86
52
97
63
Item Column
33
34
35
36
37
38
38-stop
39
40
41
42
53
54
55
56
57
58
59
60
61
62
63
Item Column
I tem
43
44
45
46
47
48
49
50
51
52
53
54
Item
98
99
100
101
102
103
104
105
106
107
108
109
Column
64
65
66
67
68
69
70
71
72
73
74
75
Column
64
65
66
67
68
69
70
71
72
73
74
75
260
CARD 03 = (I9x, 3311)
Item Column Item Column Item Column
no
20
111
21
112
22
113
23
]]k
2k
115
25
1 15-stop
26
116
27
117
28
118
29
119
30
120
31
121
32
122
33
123
3U
\2k
35
125
36
126
37
127
38
128
39
128-stop
^40
129
'tl
130
k2
131
43
132
kk
133
45
134
46
1 34-s top
47
135
48
136
49
137
50
138
51
139
52
Blanks on CBI cards indicate missing data only if they occur on items which are at or
below the child's age. Blanks on items over the child's age should be interpreted as
"not appl icable".
CARD FORMAT - SUBTESTS CARD 51 = (19x, 9F5.2, F3.0)
(Code "5" in column 18 indicates card containing factor, cluster or other grouped
scores) .
btest
Column
1
20 - 24
II
25 - 29
II 1
30 - 34
IV
35 - 39
V
40 - 44
Subtest
Column
VI
45 - 49
VII
50 - 54
VIM
55 - 59
IX
60 - 64
Total Score
65 - 67
Subtest Score - Sum of Composite Items
Total Score = Sum of all Items Total Score Range = 0-139
SUBTEST COMPOSITION
1. Anger-Hostility - Contains items describing verbal behavior,
attitudes and actions of an angry or hostile nature.
26
50
90
103
120
29
55
93
106
122
33
65
96
110
124
41
76
98
111
125
48
82
99
112
129
134
261
kl
85
hi
87-
h5
117
56
123
59,v
131
75
135
II. Conceptual Dysf unct ion Ing - Contains items reflecting
disturbances of speech, memory, or orientation.
11
19
22
Ik
32
38
" = I terns reflecting in scoring
II. Fear and Worry - Contains items describing verbal behavior
or actions reflecting fear and worry.
13 52
15 61
17 79
36 119
^6 121
IV. Incongruous Behavior. Indicates modes of behavior which are
either inconsistent with one another or with age norms, or
which are anomalous and unusual ways of doing things: head
banging, incontinence, walking on tiptoes, etc. The more
visual characteristics of psychological deviance are grouped
here .
k 35 69 104
8 37 71 108
9 39 72 109
12 40 77 113
14 44 81 114
16^ 60 86 115
21 63 89 116
25 64 94 118
31 67 100 127
34 68 101 128
130
V. Incongruous Ideation - Contains items indicative of bizarre
emotional and cognitive behaviors.
30
105
78
139
88
262
bv
28
62
2
47
66
5
51
70
6
53*
73
7
5k
74
18
57
83
VI. Lethargy-Dejection - Is reflected in both physical and emotional
behavior. A child may be reported to be slow in his movements,
to fall asleep repeatedly, or to have a voice that is flat or
monotonous; on the other hand, he may detach himself from his
environment by staying by himself, or by ignoring toys or other
objects around him.
84.V
102
126^v
132^v
133--'-
136-.V
" = I terns reflected in scoring
VII. Perceptual Dysfunct ion ing - I terns related to hallucinatory
exper iences .
95 97
VIM, Physical Complaints - Is concerned with such indicators as refusal
to eat, recurrent spells of vomiting, or responding to physical
contact with limpness.
3 27
10 49
20 92
23
IX. Self-Depreciation - is more dependent on verbal report than the
other subareas. However, deliberately hurting himself and trying
to kill himself are behavioral items included here in addition to
expressions of feeling of inferiority.
58 107
80 137
91 138
SPECIAL INSTRUCTIONS
1. Conduct of Observers - Whenever a study is. to be undertaken in a new setting
the observer should arrange to let himself be seen in the situation and by the
subjects before the beginning of the formal observations in order that his presence
lose its novelty. It is best when the child who is the focus of interest does not
perceive himself as such. The observer should give an impression of being interested
in the activities of the whole group. If a child inquires about the observer's role
or purpose, the observer may tell him, "I am watching because I am interested in
263
what children do here." There are two requirements which are essential if quantita-
tive or even only qualitative use is to be made of the instrument:
a. The observer must be able to maintain a friendly detachment from
the situation so that he neither manipulates nor purposely evokes
behavior that would not have occurred in his absence.
b. The observer must be closely attentive to the appearance, verbaliza-
tions, movements and gestures of the child.
2. Recording Observations - The CB I has 139 dichotomous items. The observer should
always start with the first item and proceed through all the items listed for the
age group of the child under observation. When the child's age "overlaps" two age
groupings, answer all items of the OLDER groupings and stop. (Example - if a child
is 5, complete age group "Five to Seven". If child is 7. complete group "Seven to
Nine".) The observer should mark "YES" when the child has displayed the behavior
noted and "NO" if he has not seen the relevant behaviors. The observer must be able
to set aside what he remembers or has heard from others about the child. His judg-
ments must be based solely on what he sees or hears from the child during the observa-
tion period. He must be sure to read every item carefully. Some items call for a
judgment of the presence of a behavior; other items require judgment that a particular
behavior is absent. Certain items describe behaviors which can be judged unequivocally
from a single event; others describe complex qualities whose presence may only be in-
ferred toward the end of the observational interval.
3. Time Interval - The most effective use of the CBI is achieved when it is possible
to observe an individual child in his normal activities over several behavioral sett-
ings. When the observer can give his undivided attention to the actions and reactions
of a single child, a period of two hours has been found to produce enough behavioral
diversity to be of discriminative significance. On the other hand, should service
obligations preclude such highly focussed observation, the behavior displayed over the
usual working shift of approximately eight hours will offer a reliable basis for judg-
ments provided observations are carried out consistently.
DOCUMENTATION
a. Raw score printout - item listings will end at each individual
subject's appropriate age group.
b. Subtest scores.
c. Means and standard deviations for subtests.
d. Crosstabulat ions of subtest scores.
e. Variance analyses.
26^
039 NOSIE
NURSES
OBSERVATION SCALE
FOR INPATIENT
EVALUATION
MM 939
1-73
NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION
Honigfeld, G., GMlis, R. D. and Klett, C. J.
INSTRUCTIONS: Code 20 under sheet number on general scoring sheet
For each of the 30 items below you are to rate this patient's behavior during the last THREE DAYS ONLY.
Indicate your choice by marking one response position for each item.
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
"^^ ?S!b' °"^ aTy ^"-"^^
Row 1
"5:=
=:fc:
"S:
::&:
::9:
2
::&:
::fc:
:r3i:
::&:
::Sb
3
----i-
"fc:
"f::
zzOiz
::St
4
:=&:
=:6::
riftr
::&:
::S:
5
iiS:
"fc:
r:R:
::ft:
::9:
6
"S:
lit:
"K:
::ft:
::»:
7
rrfer
::&:
::S:
"ft:
::9:
8
--Z&-.
=:6:r
"f::
::ft:
::9:
9
----&-
"fc:
::K.
::&:
rrSt
10
::&:
"fc:
"K:
:rft:
::9::
11
::&:
"fc:
:r?:r
::ft:
::9::
12
-:ft:
::6::
==7:r
::ftr
::9::
13
:5:r
::fc=
"3t:
::ft:
::ft:
14
iS:
:rfcr
::Jt:
::ft:
zzSiz
15
rS:
rrfc:
"?::
::a::
::ft:
16
=5::
=:fc:
r:3i:
zzOiz
::9::
17
:&:
rifci
::3i:
::ft:
::Sb:
18
li:
==6::
::?::
:rft:
::9b:
19
li;
"fc:
i:K:
::ft:
::9;:
20
zi.
::fc:
::?:r
::ft:
::9::
21
-.&-.
"fc:
"?::
::&:
::*:
22
ri:
r;6::
r:Jt:
::&:
::9b:
23
rS:
:rfc:
::?::
::fc:
::9b:
24
-&z
r:fc:
::f::
::&:
::St:
25
rSi
::fc=
"^:
;:ft:
::9t:
26
:S:
::fc:
"St:
::ft:
::*:
27
iSr
::6:=
"ft:
::&:
::ftr
28
:i:
::fc:
"ft:
::ft:
::9t:
29
iS:
z.biz
::ft:
::&:
::9t:
30
iS:
z.b:z
::ft:
::&:
::*:
ROW
NO.
A^arAr each item on row designated in columns 6—10
Is sloppy
Is impatient
Cries
Shows interest in activities around him
Sits, unless directed into activity
Gets angry or annoyed easily
Hears things that are not there
Keeps his clothes neat
Tries to be friendly with others
Becomes easily upset if something doesn't suit him
Refuses to do the ordinary things expected of him
Is irritable and grouchy
Has trouble remembering
Refuses to speak
Laughs or smiles at funny comments or events
Is messy in his eating habits
Starts up a conversation with others
Says he feels blue or depressed
Talks about his interests
Sees things that are not there
Has to be reminded what to do
Sleeps, unless directed into activity
Says that he is no good
Has to be told to follow hospital routine
Has difficulty completing even simple tasks on his own
Talks, mutters, or mumbles to himself
Is slow moving and sluggish
Giggles or smiles to himself without any apparent reason
Quick to fly off the handle
Keeps himself clean
Cols 6
10
266
Developed by Honigfeld, Gill is and Klett, the Nurses' Observation Scale (NOSIE)
is a 30-item scale formatted for use with the Genera] Scoring Sheet. Designed for
the assessment of ward behavior by nursing personnel, the NOSIE provides measures of
the patients' strengths as well as pathology. Employing a 5-point scale, the items
are written in simple language and ask for ratings based on the direct observation
of behavior. Since its introduction in 1965, the scale has been widely used and has
demonstrated its sensitivity to change.
REFERENCES
1. Honigfeld, G. and Klett, C, The Nurses' Observation
Scale for Inpatient Evaluation (NOSIE): A New Scale
for Measuring Improvement in Chronic Schizophrenia,
J. Clin. Psychol., 1965, 21: 65-71.
2. Honigfeld, G., NOSIE-30: History and Current Status
of Its Use in Pharmacopsych iatr ic Research, published
in Modern Problems in Pharmacopsychiatry: Psychological
Measurement, P. Pichot (Ed), Karger, Basle, 1973.
3. Guy, W. and Cleary, P., Factor Analyses of the NOSIE,
to be publ ished.
APPLICABILITY Adult and geriatric inpatients
UTILIZATION Once at pretreatment ; at least one post -treatment assessment.
Additional rating periods are at the discretion of the invest!'
gator.
TIME SPAN RATED
The span has been established by the author as "the last three
days only".
CARD FORMAT - ITEMS CARD 01 = (19x, 3011)
I tem
1
2
3
k
5
6
7
8
9
10
11
12
13
]k
15
Col umn
20
21
22
23
2k
25
26
27
28
29
30
31
32
33
34
I tem
16
17
18
19
20
21
22
23
2k
25
26
27
28
29
30
Column
35
36
37
38
39
ko
k]
k2
kl
kk
k5
kS
kl
48
kS
267
CARD FORMAT - FACTORS CARD 51 = (19x, 8F^.0)
(Code "5" in Column 18 indicates card containing factor, cluster or devised score.)
Factor Column Factor Column
I 20-23
II 24-27
V
36
- 39
VI
ko
- 43
VII
kk
- 47
Total Assets
48
- 51
III 28-31
IV 32 - 35
Factor Score = 2 X Sum of Composite Items
Total assets = 150 + total POSITIVE (I, II, III) - total NEGATIVE factors (IV.V.VI ,VI I) .
FACTOR COMPOSITION
This factor structure is based on a I975 analyses of the pretreatment ratings of
2415 subjects with diagnoses of schizophrenia. The factors derived are Identical with
the original Honigfeld factors except for addition of Factor VII - Depression. (Table 17)
POSITIVE FACTORS
1. Social Competence
"13 - Has trouble remembering
"14 - Refuses to speak
■*21 - Has to be reminded what to do
''f24 - Has to be told to follow hospital routine
*25 - Has difficulty completing even simple tasks on his own
I I . Social Interest
4 - Shows interest in activities around him
9 - Tries to be friendly with others
15 - Laughs or smiles at funny comments or events
17 - Starts up conversation with others
19 - Talks about his interests
III. Personal Neatness
*1 - Is sloppy
8 - Keeps his clothes neat
'-16 - Is messy in his eating habits
30 - Keeps himself clean
NEGATIVE FACTORS
IV. Irritability
2 - Is impatient
6 - Gets angry or annoyed easily
10 - Becomes easily upset if something doesn't suit him
11 - Refuses to do ordinary things expected of him
12 - Is irritable and grouchy
29 - Quick to fly off the handle
268
v. Manifest Psychosis
7 - Hears things that are not there
20 - Sees things that are not there
26 - Talks, mutters or mumbles to himself
28 - Giggles or smiles to himself without any apparent reason
Vl . Retardation
5 - Sits, unless directed into activity
22 - Sleeps, unless directed into activity
27 - is slow moving and sluggish
VII. Depress ion
3 - Cries
18 - Says he feels blue or depressed
23 - Says he is no good
* = I terns reflected in scoring
SPECIAL INSTRUCTIONS
Although most raters find it relatively easy to arrive at agreement on the
meaning of the items, confusions and misinterpretations do occur. It would be
prudent, therefore, to conduct training sessions for neophyte raters to reduce
any confusion which may exist.
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Means and standard deviations for factor scores
d. Cross-tabulation of factor scores
e. Variance Analyses
269
TABLE 17
7-FACTOR VARIMAX SOLUTION OF THE NURSES' OBSERVATION SCALE FOR INPATIENT EVALUATION
|tem
1
II
Ul
IV
V
VI
VII
Conmunal ities
1
-161
190
002
802
018
188
-257
807
2
052
780
-032
206
-087
140
-089
690
3
089
167
-059
-043
-612
032
-129
433
4
6??
-116
-217
-273
-028
-160
160
616
5
-383
043
?7?
024
-047
-005
-255
547
6
-062
90?
-045
076
-053
124
-096
858
7
-247
163
-150
135
-027
768
-155
743
8
230
-148
-023
-864
-024
-101
143
853
9
82^
oo4
-115
-689
-116
-032
-087
137
739
10
89?
-029
081
-120
091
-085
835
11
-087
567
128
226
-032
127
-441
608
12
-083
829
027
130
-090
124
-142
756
13
-106
024
M5
259
008
251
-686
627
]k
-312
167
oh
029
olo
035
-^36
532
15
7^?
-025
261
-131
-037
110
189
660
16
-032
119
114
567
029
263
-324
525
17
84?
047
-094
-075
-078
-107
149
777
18
154
067
147
-070
-797
-087
062
70I
19
704
-234
032
-175
-140
-222
-123
049
614
20
192
- 59
116
-042
725
-223
708
21
-195
256
85
400
Oil
192
-660
770
22
-014
024
862
076
-037
-027
020
752
23
032
036
08lf
050
-804
025
068
663
2k
-141
342
153
^81
010
161
-^17
712
25
-205
241
060
366
-028
235
-65^
721
26
-076
263
t014
238
-013
760
-111
-324
722
27
-107..
-141
?62
092
-174
-158
516
28
1?6
093
093
131
081
787
-094
685
29
-042
882
-Oil
058
-025
155
-098
817
30
2^5
-173
-073
-816
-025
-138
196
819
Contribution
of factor (V )
3.57
4.61
1.73
3.27
1.79
2.83
2.99
20.80
% Total Variance
11.9
15.4
5.8
10.9
6.0
9.4
9.9
69.3
% Comnon Variance
17.1
22.2
8.3
15.7
8.6
13.6
14.3
270
COMMENTS OF THE AUTHOR
The Nurses' Observation Scale for Inpatient Evaluation
Gilbert Honigfeld , Ph.D.
As a result of continued research with the NOSIE over the past several years
we have developed a revised scoring system based on a subset of 30 items from the
original 80-item scale. Our analyses show that this new version, the NOSIE-30, is
as reliable and valid as the parent scale and will be considered the definitive
scoring system in our future work. This research was based on an expanded norma-
tive sample of over 600 chronic schizophrenic patients aged 26 to 7k.
Five of the original 7 factors held up well under repeated factor analyses of
both pre-treatment and change score data. One factor, Cooperation, became obscured
because of its strong relationship with Social Competence and has since been dropped
as a separate factor.
Although potentially useful for describing patient status in a small number of
chronic schizophrenic men and of some usefulness in describing changes in behavior
over long time spans. Paranoid Depression has been dropped from the general scoring
system since it is of relatively little use in measuring patient change over custom-
ary experimental time spans. However, a new factor. Retardation, has been added
which is related to observable aspects of Depression, and which is quite sensitive
to changes over short time periods. Depression can still be scored using the NOSIE-
30, but for general purposes its use is not encouraged.
In addition a composite or overall score, Total Patient Assets, has been added
for the use of investigators who want a global estimate of patient status or change.
This score is simply the algebraic sum of the positive factors minus the negative
factors, with the addition of a constant to adjust the scale to a true zero-point.
A further addition to the scoring system involves the conversion of raw scores
to normalized T-scores. Similar to the MMPI a conversion table will be used to pro-
vide a rapid way of profiling patient scores, as well as giving immediate normative
comparisons. T-scores involve the conversion of raw scores to an adjusted mean of
50 and standard deviation of 10. Thus a patient's normalized T-score can be easily
interpreted as a centile rank by reference to a normal-curve t-able.
Regarding the validity of the scale, favorable evidence has been reported inde-
pendently by Lentz et al., (1971). Although based on a sample significantly younger
than the original norm group these authors reported (p. 75), "when compared to Honig-
feld's older, chronic geriatric group, the current sample was essentially at the mean
for Total Assets (T score=52) , and for all subscales (T score=49 or 50) except Social
Interest. On the latter subscale females were significantly higher than males in the
norm groups (T score=56) , and males in the current sample (T score (T score=5I)). For
frr itabi 1 ity, the other subscale on which sex differences were found, males were slight-
ly below the norm group (T=47) and females were slightly above (T=52) ."
271
In comparing the NOSIE with other scales, Ludwig and Marx (1969) reported a
correlation of +.90 between NOSIE Total Assets and a ward behavior form. Kish
(1970) reported that patients high on "sensation-seeking" (a measure of "Interest
in seeking stimulating activities") exhibited on the NOSIE-30 significantly less
retardation than patients low on "sensation-seeking".
p ve-^borg and Willenson (I969) compared NOSIE-30 scores for mentally retarded
Jb weil at mentally ill patients of both sexes. Very comparable scores obtained
across both diagnostic groups and both sexes with one major discrepancy - mentally
ill males scored significantly lower than all other groups on Social Interest. A
specific relationship was found between high scores on the irritability factor and
clinical categorizations of "hyperactive" classification.
Concerning the reliability of these scores, the report by Lentz et al, (1971).
showed high inter-rater reliabilities, as follows:
Factor Inter-rater Reliability
Total Assets (TOT) .95
Social Competence (COM) .86
Social Interest (INT) .95
Personal Neatness (NEA) .95
Irritability (IRR) .83
Manifest Psychosis (PSY) .82
Retardation (RET) .83
REFERENCES
1. Crumbaugh, J. C, Salzberg, H. C. and Agee, F. L., The Effects of Pool Therapy
on Aggression. Journal of Clinical Psychology, I969, 22, 235-237-
2. Hargreaves, W. A., Systematic Nursing Observation of Psychopathology. Archives
of General Psychiatry, I968, 18, 518-531.
3. Honigfeld, G. and Gill is, R. D., The Role of Institutionalization in the Natural
History of Schizophrenia. Diseases of the Nervous System, I967. 28, 66O-663.
k. Honigfeld, G., Gill is, R. D. and Klett, C. J., NOSIE-30: A Treatment-Sensitive
Ward Behavior Scale. Psychological Faports, I966, 19, 180-182.
5. Honigfeld, G., Rosenblum, M. P., Blumenthal, I. J., Lambert, H. L. and
Roberts, A. J., Behavioral Improvement in the Older Schizophrenic Patient: Drug
and Social Therapies. Journal of the American Geriatrics Society, 13, 57-72.
6. Lentz, R. J., Paul, G. L. and Calhoun, J. F., Reliability and Validity of Three
Measures of Functioning with "Hard-core" Chronic Mental Patients, J. Abn. Psychol.,
78, 69-76, 1971.
7. Marshall, G., Beer and Geriatrics, An Objective Study. Washington Brewers
Institute, Seattle, Washington, I965 (unpublished manuscript).
272
8. Ravensborg, M. R. and Willenson, D., Use of the NOSIE-30 Behavioral Rating
Scale in Hospitals for the Mentally ill and Retarded, J. Clin. Psychol.,
25: 453-^54, 1969.
9. Sugerman, A. A., Stolberg, H. and Herrman, J., A Pilot Study of P-46578 in
Chronic Schizophrenics. Current Therapeutic Research, 1965, 7, 310-314.
10. Taulbee, E. S., Overt Sexual Responses in Personal i ty Assessment and
Alcoholism. Veterans Administration Newsletter for Research in Psychology,
1968, 10, 22-23.
11. Wolpert, A., Sheppard, C. and Merlis, S., Method for Evaluation of Behavioral
Changes in Aged Hospital Patients During Anabol ic Steroid Therapy. Journal
of the American Geriatrics Society, 196?, 15, ^70-^3.
12. Wright, G. H. and Hambacher, W. D., Psycho-Social Problems of Shelter Occupancy,
Report No. 75111-F, HRB-Singer Inc., State College, Pennsylvania. I965.
273
040 PLUT
PLUTCHIK
GERIATRIC
RATING SCALE
MH 9-40
1-73
PLUTCHIK GERIATRIC RATING SCALE
INSTRUCTIONS: Code 20 under sheet number on general scoring sheet
Choose one response for each item and record in the appropriate spaces.
Row 1 :-(t-
"t;
::2:
2::ar
::*:
::a:
3::a:
-t:
::2:
4---.0:-.
::4::
::2:
5::tt:
::J=z
::J::
6::a=
"2:
7.(t.
::2::
Biittr
::)::
iij::
9::e::
.zh.
::2::
\0-.-.0:z
::!::
=:£.
1 1 ::e::
r:2:
12r:a::
-.--Zi
13::e::
::J::
----t:
14::a::
rli
\5.ft-.
iri
16::Q::
"i
17:-tt:
::i:
z-.i
18::ft:
::i:
-i
19::ft:
::i-.
::2:
20::£hr
"±:
"i
21 -M.
;:±=
::i
22::ft:
"±:
::*
23::e=:
:;2:
24::e::
::2:
25 ::&:
::2:
26::ft:
::2:
27::a:r
==2:
28:-e:r
::2:
29::Q::
:;2:
30r:a:
::3"
:r2:
31 r:0::
:H-
::2:
Cols: 1
ROW
NO.
yWar^ eac/» /fe/rj on row designated in columns 1—3
1. When eating, the patient requires:
0 = No assistance (feeds himself)
1 = A little assistance (needs encouragement)
2 = Considerable assistance (spoon feeding, etc.)
2. The patient is incontinent:
2
0 = Never
1 = Sometimes (once or twice per week)
2 = Often (three times per week or more)
3. When bathing or dressing, the patient needs:
3
0 = No assistance
1 = Some assistance
2 = Maximum assistance
4. The patient will fall from his bed or chair unless protected by
side rail:
4
0 = Never
1 = Sometimes
2 = Often
5. With regard to walking the patient:
5
0 = Has no difficulty
1 = Needs assistance in walking
2 = Does not walk
6. The patient's vision, with or without glasses, is:
0 = Apparently normal
1 = Somewhat impaired
2 = Extremely poor
7. The patient's hearing is:
7
0 = Apparently normal
1 = Somewhat impaired
2 = Extremely poor
8. With regard to sleep, the patient:
8
0 = Sleeps most of the night
1 = Is sometimes awake
2 = Is often awake
9. During the day, the patient sleeps:
9
0 = Sometimes
1 = Often
2 = Most of the day
10. With regard to restless behavior at night, the patient is:
10
0 = Seldom restless
1 = Sometimes restless
2 = Often restless
11. The patient's behavior is worse at night than in the daytime:
0 = Never
1 = Sometimes
2 = Often
276
PLUTCHIK GERIATRIC RATING SCALE
ROW
NO.
Mark each item on row designated in columns 1 — 3
12. When not helped by other people, the patient's appearanc
) is:
12
0 = Almost never sloppy
1 = Sometimes sloppy
2 = Almost always sloppy
13. The patient masturbates or exposes himself publicly:
13
0 = Never
1 = Sometimes
2 = Often
14. The patient is confused (unable to find his way around the ward,
loses his possessions, etc.):
14
0 = Almost never
1 = Sometimes
2 = Often
15. The patient knows the names of :
15
0 = More than one member of the staff
1 = Only one member of the staff
2 = None of the staff
16. The patient communicates in any manner (by speaking, writing, or
gestering) well enough to make himself easily understood:
16
0 = Almost always
1 = Sometimes
2 = Almost newer
17. The patient resets to his own name:
17
0 = Almost always
1 = Sometimes
2 = Almost never
18. The patient plays games, has hobbies, etc.:
18
0 = Often
1 = Sometimes
2 = Almost never
19. The patient reads books or magazines on the ward :
19
0 = Often
1 = Sometimes
2 = Almost never
20. The patient will bagin conversations with others:
20
0 = Often
1 = Sometimes
2 = Almost never
21. The patient is willing to do things asked of him:
■21
0 = Often
1 = Sometimes
2 = Almost never
22. The patient helps with chores on the ward:
22
0 = Often
1 = Sometimes
Mark each item on row designated in columns 1 — 3
23. Without being asked, the patient physically helps other patients:
0 = Often
1 = Sometimes
2 = Almost never
24. With regard to friends on the ward, the patient:
0 = Has several friends
1 = Has just one friend
2 = Has no friends
25. The patient talks with other people on the ward:
0 = Often
1 = Sometimes
2 = Almost never
26. The patient has a regular work assignment:
0 = Away from the ward
1 = On the ward
2 = No regular assignment
27. The patient is destructive of materials around him (breaks furniture,
tears up magazines, etc.)
0 = Never
1 = Sometimes
2 = Often
28. The patient disturbs other patients or staff by shouting or yelling:
0 = Never
1 = Sometimes
2 = Often
29. The patient steals from other patients or staff members:
0 = Never
1 = Sometimes
2 = Often
30. The patient verbally threatens to harm other patients or staff:
0 = Hever
1 = Sometimes
2 = Often
31. The patient physically tries to harm other patients or staff:
0 = Never
1 = Sometimes
2 = Often
277
Developed by Plutchik, Conte, Lieverman, Bakur, Grossman and Lehrman, the
Plutchik Geriatric Rating Scale (PLUT) is a 31-item scale formatted for use with
the General Scoring Sheet. The scale was designed to measure the degree to which
geriatric patients are able to function, both physically and socially, in an in-
tact, integrated manner. The items are rated on a 3-point scale and the ratings
are based on the direct observation of the patient's behavior.
REFERENCE
APPLICABILITY
UTILIZATION
TIME SPAN RATED
CARD FORMAT - ITEMS
I tern
1
2
3
k
5
6
7
8
9
10
11
12
13
14
15
16
1. Plutchik, R., Conte, H., Lieverman, M., Bakur, M.,
Grossman, J., and Lehrman, N., Reliability and
Validity of a Scale for the Assessing of Functioning
of Geriatric Patients, J. Amer. Geriat. Soc, 18,
6, 491-500, June, 1970.
2. Guy, W. and Cleary, P., Factor Analysis of the
Plutchik Geriatric Rating Scale, to be published.
Geriatric inpatients
Once at pretreatment; at least one post-treatment assess-
ment. Additional ratings are at the discretion of the
investigator.
None specified by authors; but it is suggested that the
time span be limited to now or within past week.
CARD 01 = (19x, 31 M)
Col umn
20
21
22
23
2k
25
26
27
28
29
30
31
32
33
34
35
I tem
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Col umn
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
278
CARD FORMAT - FACTORS CARD 51 = (19x, 7F6.2, F4.0)
(Code "5" in Column 18 indicates card containing factor, cluster or derived score.)
Column Factor Column
Factor
I
I I
I I I
IV
20-25
26-31
32-37
38-43
V
VI
VI I
Total Score
50-55
56-61
62-65
Factor Score = Sum of Composite I terns
No. of Composite Items
Factor Score Range =0-2
Total Score = Sum of all items
Total Score Range =0-62
FACTOR COMPOSITION
I. Overall Dysfunction
1 - Eating
2 - Incontinent
3 - Bathing and dressing
12 - Appearance
1 k - Confus ion
16 - Communicates easily
17 - Reacts to name
21 - Willing to do things
II. Aggressive Behavior
27 - Destructive
28 - Disturbs others
29 - Steals
30 - Verbally threatens
31 - Physically tries to harm
III. Sleep Disturbance
8 - Sleeps at night
10 - Restless at night
11 - Behavior worse at night
IV. Social Isolation
20 - Begins conversations
2k - Friends
25 - Talks with others
This factor structure Is based on a 1975
analysis of pretreatment scores from 260
geriatric subjects. (Table 18).
V. Sensory Impairment
6 - V is ion
7 - Hearing
VI. Work and Activities
18 - Games and hobbies
22 - Helps with chores
23 - Helps other patients
26 - Regular work assignment
VII. Motor Impairment
k - Falls
5 - Wal king
Items not included in any factor
9 - Sleep during day
13 - Masturbates
15 - Knows names of staff
19 - Reads
279
TABLE 18
7-FACTOR VARIMAX SOLUTION OF PLUTCHIK GERIATRIC RATING SCALE
Items I II J II )V V VI
1 58i -069 -024 -151 -076 -163
2 6^2 103 -077 -166 -051 -264
3 682 071 -026 -103 026 -294
if 269 -007 -008 -038 -144 -199
5 305 -049 054 004 -150 -237
6 -051 -026 -041 110 -547 -097
7 -022 -031 023 -109 ^7^8 018
8 -103 010 -815 035 Oil 013
9 249 -010 -013 -044 -394 318
10 -064 154 -809 091 031 -068
11 082 073 -770 003 -054 062
12 206 130 -097 -140 134 -033
13 033 289 -142 -371 -074 026
14 202 -Oil 045 -042 -088 -320
15 234 033 -039 -301 -268 -413
16 6^0 -023 105 -269 -054 -103
17 |o5 -061 187 -245 029 -114
18 260 058 014 -244 -127 -482
19 273 044 042 -223 -108 -403
20 331 -086 143 -719 014 -218
21 460 044 085 ^328 098 -416
22 295 -021 -043 -153 085 -686
23 170 -079 057 -477 047
24 225 025 -053 -653 -052 -219
25 242 -048 186 -790 049 -202
26 222 044 -014 "=055^ 073 -590
27 187 555 086 -182 273 143
28 137 5JL2. 194 -141 -037 -031
29 144 502 -072 088 193 092
30 -144 280 -096 079 -086 -109
31 -116 255 022 066 -048 -119
Contr ibut ion of
factor (Vp) 4.28 2.19 2.14 2.59 1.39 2.54
% Total Variance 13.8 7.1 6.9 8.4 4.5 8.2
7o Common Variance 25.7 13.1 12.8 15.5 8.3 15.2 9-3
VII
Communal ities
-333
518
-246
655
-245
631
-640
544
-6?4
604
-245
387
-008
605
014
677
-025
321
090
705
-073
618
-133
581
-104
260
006
607
246
451
066
578
-068
482
-032
380
-064
306
-042
703
-169
540
-269
663
-181
570
135
549
-056
767
-174
439
-196
517
-174
372
158
358
054
667
126
621
1.55
16.67
5.0
53,8
280
SPECIAL NOTE Plutchik et al have also provided percentile scores for
geriatric subjects. The following table "provides a
frame of reference against which future patients may be
evaluated for purposes of placement, selection, treat-
ment, and research".
PERCENTILE
DISTRIBUTION
OF
INDIVIDUAL
PLUTCHIK
SCORES
OF
GERIATRIC PATIENTS
Score
Percent! le
Score
Percent i le
0-4 1 25 55
5-6 2 26 59
7 3 27 62
8 5 28 65
9 8 29 68
10 10 30 71
11 12 31 73
12 15 32 76
13 19 33 80
\k 22 3^ 83
15 25 35 86
16 27 36 88
17 30 37 91
18 32 38 93
19 34 39 95
20 38 ho 96
21 k\ k] 97
22 k5 42-43 98
23 48 44-48 99
24 52 49-51 100
DOCUMENTATION:
a. Raw score printout
b. Factor score printout
c. Means and standard deviations of factor scores
d. Variance Analyses
281
042 NGI
NURSES
GLOBAL
IMPRESSIONS
MHB-43
1-73
NURSES' GLOBAL IMPRESSIONS
INSTRUCTIONS: Code 20 under sheet number on general scoring sheet.
Choose one response for each item.
USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE
40::0::
41 :A.
::>::
:i:
:J::
1.4::
-.-.&-.
::fc:
zzJzz
Cols: 1
2
3
4
5
6
7
8
ROW
NO.
Mark each item on row designated in columns 1 — 8
1. SEVERITY OF ILLNESS
Considering your total clinical experience with this particulir
population, how mentally III is the patient at this time?
0 >° Not assessed
1 ■= Normal, not at all
2 = Borderline mentally ill
3-= Mildly ill
4 = Moderately ill
5 •= Markedly ill
6 == Severely ill
7 = Among the most extremely ill patients
2. GLOBAL IMPROVEMENT
Compared to his condition at admission to the study,
how much has he changed?
(this item may be omitted at r/ie initial evaluation by marking
"0" - Not assessed)
0 = Not assessed
1 = Very much improved
2 = Much improved
3 = Minimally improved
4 " No change
5 = Minimally worse
6 " Much worse
7 = Very much worse
284
The Nurses' Global Impressions (NGl) was developed during the PRB collabora-
tive schizophrenia studies and is a 2-item scale for the assessment of global
clinical judgments and is formatted for use with the Genera] Scoring Sheet. These
two items correspond to the first 2 items of the Clinical Global Impressions. They
were previously attached as I terns 31 and 32 to the NOSIE but have now been formatted
independently so that they may be used with any combination of scales in the Nurses'
Packet.
APPLICABILITY
UTILIZATION
TIME SPAN RATED
CARD FORMAT - ITEMS
SPECIAL INSTRUCTIONS
Al 1 populations
Generally rated simultaneously with other Nurses'
scales. If used alone, the NGl should be rated
once at pretreatment and at least once at post-
treatment. Additional ratings of the NGl are at
the discretion of the investigator.
Now or within the past week
CARD 01 = (19x, 211)
Severity of Illness Column 20
Global Improvement Column 21
Severity of Illness - It should be noted that this item is rated in the context
of the particular population under study, e.g., in a study involving schizo-
phrenic subjects, the degree of illness should be assessed against the rater's
clinical experience with this type of subject. This represents a contextual
change from the original item in which the rater was asked to judge severity in
the context of total clinical experience with ALL populations. (See page 219).
Global Improvement - Change at any given rating should be compared to the sub-
ject's condition at pretreatment - NOT to his condition at the preceding rating.
This item should be rated in the same context as CGI Global Improvement; i.e.,
"Rate total improvement whether or not, in your judgment, it is due entirely to
drug treatment. "
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Frequencies
d. Crosstabulation
e. Variance analysis
285
035 TQ
TEACHER
QUESTIONNAIRE
MH-9-33
1-73
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE-PUBIIC HEALTH SERVICE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
CONNERS TEACHER QUESTIONNAIRE
PATIENT INITIALS
NUMBER MAl£S 001 TO 499; FEMALES
500 TO 998
—
:;A:: :*: :<:: :ft: :*::
HRST
:«:: :t:: :<*: :*: :*-
INITIAL
:«:: ::V:: :*: :«:: -rT-
:*::
:*::
:-Jt:
:ftr
:ft:
:*t:
:*:
::|::
:*:
::T::
ft: ::J:: :*: :i: :*:
ft: ::!:: ::fc: :i: :*:
ft: ::»:: :*:: :i: :.-*:
PATIENT
:i:
::&:
:*:
:*:
::&:
::!::
::J::
::3t:
-.-.&-.
-.--&-.
"&--
::»:
::»:
::»:
—
:*: :»: :«:: :ft: :«::
SECOND
:«:: :t:: :*»:: :«:: :«::
INITIAL
:»:: .it--- :1»: -*-- -■^--
:*::
:*:
:i::
:ft:
:*:
:«:
:*:
::!::
:*:
::*:
::T::
ft: ::»:: ::fc: :i: :*:
ft: ::»:: :i:: :*: ::*:
RATER
::S:
::&:
::ft:
::Jt:
::?i:
::ft:
::«:
::»:
::»:
^
ft: ::»:: ::£:: :*: ::*:
ft: ::»:: :*: :.5:: :=4::
Hours Days
ft: ::»:: ::t:
PERIOD
WMk>
:--*:
::a:
::&:
::?::
::J::
AAonthi
:*:
::a:
::»:
::S:
__
n
illll^^
!S9i
N
N
H
H
^
PLEASE USE A NO. 2 LEAD PENOL BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
—
Listed below ore descriptive terms of behavior. AAork in th
e column whi
ch best describes this child. ANSWER ALL ITEA^S.
^
1.
2.
CLASSROOM BEHAVIOR
Fidgeting
Hums and makes other odd noises
Not
•t
iUI
:ft:
:ft:
Jnl
UtHi
frelty
Much
:2::
:*:
V.ry
Mu(h
:*:
:i:
22.
GROUP PARTICIPATION
Isolates himself from other
children
Not
ct
All
:ft:
Just
•
imit
Ftitty
Huih
:2::
Very
Hucb
:3::
—
3'.
Demands must be met immediately;
gets frustrated
:ft:
:*::
:*:
23.
Appears to be unaccepted
by group
:ft:
::!::
:2::
=3::
^
4.
Coordination poor
:ft:
::»::
:*:
:i:
24.
Appears to be easily led
:ft:
::t::
:2z:
:*:
5.
Restless (overactive)
:ft:
::»::
I*:
:3::
25.
No sense of fair play
:ft:
::»::
:£::
:a::
6.
Excitable, impulsive
:ft:
:*:
:*:
26.
Appears to lack leadership
:ft:
::»::
:£::
:i:
7.
8.
9.
10.
11.
Inattentive, distractobie
Fails to finish things he starts
(short attention span)
Sensitive to criticism
Serious or sad
Daydreams
:*:
:ft:
:ft:
:ft:
:ft:
:*:
::fc:
I*:
:*:
:*:
:*:
:*:
:*:.
:*:
:3::
27.
28.
29.
Does not get along with
opposite sex
Does not get along with
same sex
Teases other children or
interferes with tfieir
activities
:ft:
:ft:
:ft:
::t::
::t::
::»::
:£::
:2::
:i:
:±:
:±:
:±:
^
12.
Sullen or sulky
:ft:
::t::
:*:
:*:
.^
.^
13.
Cries
:ft:
::»::•
:«::
:*:
ATTITUDE TOWARD AUTHORITY
14.
Disturbs other children
:ft:
:*::
:3::
30.
Submissive
:ft:
::t::
r2;:
:3::
15.
Quarrelsome
:ft:
::t::
:2::
:3::
31.
Defiant
-.&-.
::!::
:a::
r±:
16.
AAood changes quickly
:ft:
-.£=--
:3::
32.
Impudent
.&--
::L::
:2::
ri:
17.
Acts "smart"
:ft:
::»::
:2;:
:*:
33.
Shy
:ft-:
::t::
-2^
:±:
18.
Destructive
:ft:
:i:
:3::
34.
Fearful
:ft:
::L::
:2::
:i:
19.
20.
Steals
Ues
:ft:
:ft:
:*:
:*:
:3::
:*:
35.
^ Excessive demands for
teachers attention
rft:
-.-.U-.
:i:
zi:
^
21.
Temper outbursts (explosive ond
unpredictable behavior)
:ft:
::J.::
:*:
:*:
36.
37.
38.
39.
Stubborn
Anxious to please
Uncooperative
Attendance problem
:ft:
:ft:
:ft:
:ft:
z-A-.-.
::»::
::»:;
:*:
:*:
::2::
:*:
:ft:
:i:
:i:
:i:
3!
40.
Considering your total teaching experience with child
problem is th« child at this time?
ren of this age, how mu
chof
a
Nmi
:ft:
HiU
::!::
Hod-
•rcti
:*::
Sovira
:*:
=
Academic Achievement
Hwh
mprovw
IJM.
No
Clwngt
:i:
•iir
:=*:
HiKh
Won*
:ft:
—
41.
What changes have you observed in this child
(Omit this Htm at the initial rating)
since the start of the
Study?
Overall Behavior
Group Participation
=»::
:*:
:±:
:*:
:*:
:*:
—
Attitude Toward Authority
::,::
:*:
:*:
:*:
z*:
=
288
Developed by Conners, the Teacher Questionnaire (TQ.) is a single-page, 41-
item scale to be completed by the child's home-room teacher. It is an independent
form in that responses are coded directly on the form and the General Scoring
Sheet is not utilized. The first 39 4-point items are divided into 3 large groups:
classroom behavior, group participation, attitude toward authority. Item kO is a
4-point global judgment of the severity of the child's problem. Item k] consists
of four 5-point global judgments of improvement in the following areas: academic
achievement, overall behavior, group participation, attitude toward authority.
The TQ. was designed to tap the teacher's evaluations of the child's ability to
cope with his peers and with the demands of the school curriculum.
REFERENCE
Conners, C. K., A teacher rating scale for use in drug
studies with children. American Journal of Psychiatry,
1969, 126, 152-156.
APPLICABILITY Children to 15 years of age
UTILIZATION Once at pretrea tment . The 4l-item TQ. may be used for
repeated assessments; but frequently the 10-item Parent-
Teacher Questionnaire (PTQ) is substituted for ratings
subsequent to the initial rating. The number of assess-
ments is at the discretion of the investigator.
TIME SPAN RATED Now or within the past month.
CARD FORMAT - ITEMS CARD 01 = (19x, kk\\)
tem Column
1
20
2
21
3
22
k
23
5
2k
6
25
7
26
8
27
9
28
10
29
11
30
Item Column
CARD FORMAT - FACTORS
12
31
23
13
32
2k
]k
33
25
15
34
26
16
35
27
17
36
28
18
37
29
19
38
30
20
39
31
21
ko
32
22
k]
33
TORS
CARD 5
1 = (
I tem Col umn
k2
k3
kk
k5
kS
kl
k8
kS
50
51
52
I tem
Col umn
3^
53
35
5k
36
55
37
56
38
57
39
58
Sever i ty
59
Improvement
Academic
60
Overal 1
61
Participation
62
Attitude
63
19x, 5F6.2, F2.0, F^.O, 4F2.0)
(Code "5" in column ]i
scores) .
Factor
IV
V
indicates card containing factor, cluster or other grouped
Col umns
20 - 25
26-31
32 - 37
38 - k3
kk - ks
Item Columns
Severity 5'0 - 51
Total Score 52 - 55
Improvement, Academic 56 - 57
" Overal 1 58 ~ 59
" Part ic ipat ion 60 " 61
" Att i tude 6? - 63
289
Factor score = Sum of composite items
No. of composite items
Total Score = Sum of a 1 1 items
Factor Score Range =0-3
Total Score Range =0-117
FACTOR COMPOSITION
Conduct Problem
12 -
Sul len or sulky
]k -
Disturbs other children
15 -
Quarrelsome
17 -
Acts "smart"
18 -
Destructive
19 -
Steals
20 -
Lies
21 -
Temper outbursts
25 -
No sense of fair play
29 -
Teases other children
no -
Submiss ive
31 -
Defiant
32 -
Impudent
36 -
Stubborn
38 - Uncooperative
Inattentive -Pass ive
h - Coordination poor
7 - Inattentive
8 - Fails to finish things
1 1 - Daydreams
2k - Appears to be easily led
26 - Appears to lack leadership
Tens ion-Anxiety
9 - Sens i t i ve
10 - Serious or sad
30 - Submiss ive
33 - Shy
34 - Fearful
37 - Anxious to please
''39 - Attendance problem
Hyperactivity
1 - Fidgeting
2 - Hums and makes other odd noises
5 - Restless
6 - Excitable
14 - Disturbs other children
29 - Teases other children
35 - Excessive demands
37 ~ Anxious to please
Social Abi 1 ity
22 - Isolates himself
23 - Unaccepted by group
27 - Does not get along with opposite
sex
28 - Does not get along with same sex
Items not included in any factor: 3. 12, 16,
•'- = I terns subtracted from factor score
This factor analysis of the TQ. (Conners, I969) was based on a slightly reworded
version of the scale. The sample consisted of 82 boys and 21 girls (Mean age -
117.5 months; SD - 21.5 months) characterized by behavior disorders, hyperactivity
and poor attention spans associated with learning disorders. Only children for
whom drug therapy seemed specifically indicated were included. Factor 1 accounts
for 39 percent of the variance; Factor II for 16 percent; Factor III for 12 per-
cent; Factor IV for 19.6 percent and Factor V for 13-7 percent. The factors have
some degree of intercorrelat ion, especially between Factors I and IV.
SPECIAL INSTRUCTIONS
1. The investigator should make certain that teachers fully understand how to com-
plete the scale - particularly how to properly mark their responses. In checking
the completed scale, make sure that the encoded initials are the patient's, NOT the
teacher's. If the investigator wishes, teachers may complete the ID block. To do
so, however, they must be given patient numbers, their rating number and thorough
grounding in the encoding of PERIOD.
290
2. Do not write in the shaded area of the ID block. Form Number has been preceded.
f •*• FORM
Incorrect — ^ i NO. :*■ 35"
Correct — ^ I ■
DOCUMENTATION
a. Raw score printout
b. Factor score printout - including global items
c. Means and standard deviations for factor scores and global items. Ten-
item totals, in lieu of factor scores, will be displayed when the PTQ.
is substituted for repeated assessments.
d. Crosstabulat ion of factor scores - Displayed only when TQ. is used for
repeated assessments.
e. Variance analyses.
291
036 PQ
PARENT
QUESTIONNAIRE
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
CONNERS PARENT QUESTIONNAIRE
INSTRUCTIONS: Listed below are items concerning children's behavior or the problems
they sometimes have. Read each item carefully and decide how much
you think your child has been bothered by this problem during the
last month: NOT AT ALL, JUST A LIHLE, PRETTY MUCH, or VERY MUCH.
Indicate your choice by filling in the space |
column to the right of each item.
) in the appropriate
OBSERVATION
PROBLEMS OF EATING:
PROBLEMS OF SLEEP:
FEAR AND WORRIES:
MUSCULAR TENSION:
1 4 Shokes
SPEECH PROBLEMS:
•
WEHING:
BOWEL PROBLEMS:
19 Soiling self
COMPLAINS OF FOLLOWING
SYMPTOMS EVEN THOUGH
DOCTOR CAN FIND
NOTHING WRONG:
,
.
PROBLEMS OF SUCKING,
CHEWING or PICKING:
29, Picks at things such as hair, clothing, etc
CHILDISH OR lAAMATURE:
31 Cries
32. Wants help doing things he should do alone
34 Baby talk
TROUBLE WITH FEELINGS:
36. Lets himself get pushed around by other children.
37. Unhappy
38. Carries a chip on his shoulder
Pretty Very
much much
294
MH-9-36
1-73
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
CONNERS PARENT QUESTIONNAIRE
FORM APPROVED
0MB NO. 48R96
1
PATIENT
INITIALS
. :S::
: -.t::
: .itzz
rC:
HRST
zQzz :fi"
INITIAL
:fi:: -H.z z±-Z :Ji:
za.z :H:: :S:i :I::
NUMBER MALES 001 TO 499; FEMALES 500
:D:: ::L;i :£:: :3:: :4-: :*::
PATIENT
:0=: zdtzz :«:: :3:: :4:: =5"
:fi:: ::t:: :£:: :3:: r4:: :5::
TO 998
:&: ::7" =ft:
ifci ::7- idBci
:d6c: ::7" :dBb;
:A: 1
zA:
-A 1
:4:
:0"
-X-z
=E:: :i="
SECOND
INITIAL
:fir: :«" ::l:: :J::
ifl" :«:: :S:: "Tr:
:4:: :3::
RATER
:.4:: :*::
:&: -7" -Ai
i&= ::7:: :A:
:A:
:0::
:0::
M
:£::
F
:£::
:3:r
:3::
,
:0" ::l:; :£:: :3.:
:.4:: r3=.
PERIOD
:4r= liri
Weeks
r3::
:&: ::7:: :Ar
:&: ::7r: :*r
Months
:4r=
1
RS
|Rffi
i
P
^W^
1.
:0::
:0::
Hours
zizz
:£r:
r3::
Days
:2;:
OBSERVATION
OVER-ASSERTS
HIMSELF:
PROBLEMS MAKING
FRIENDS;
42. Shy
45. Has no friends
PROBLEMS WITH
BROTHERS AND
SISTERS:
47 Mean
48 Fights
PROBLEMS KEEPING
FRIENDS:
RESTLESS:
54. Falls to finish things he starts fshort afienlion span
TEMPER:
55. Temper outbursts, explosive and unpredictable
SEX:
PROBLEMS IN
SCHOOL:
LYING:
STEALING:
72. At school
FIRE-SEniNG:
74. Sets fires
TROUBLE WITH POLICE:
OBSERVATION 1
76. Everything must be
PERFECTIONISM:
77. Things must be
done same way
every time
78. Sets goals too high
79. Inattentive, easily
distracted
81 . Cannot be left alone.
82. Climbing; gets into
83. A very early riser .
84. Will run around
between mouthfuls
85. Demands must be
met immediately
— easily f rustroted
ADDITIONAL
PROBLEMS:
86. Cannot stand too
much excitement . .
87. Laces and zippers
88. Cries
89. Unable to stop a
repetitive activity .
90. Acts as if driven
by a motor
91. Mood changes
92. Poorly aware of
surroundings or
time of day
..-Ul._ A^ »»., think
295
94. How serious a problem do you think
your child has at this time? .
The Parent Questionnaire (PQ.) , developed by Conners, is a 93-item check list
of symptoms most commonly associated with behavior disorders of childhood. The
9^th item is a global judgment of the severity of the child's problem. Symptoms
are rated on a 4-point scale by either or both parents of the child. The PQ. is an
independent form and does not require a General Scoring Sheet.
REFERENCE
Conners, C. K. Symptom patterns in hyperkinetic,
neurotic and normal children, Child
Development, 1970, ^1, 667-682.
APPLICABILITY
UTILIZATION
Children to 15 years of age
Once at pretreatment . The 9^-item PQ may be used for
repeated assessments; but frequently the 10-item
Parent-Teacher Questionnaire (PTQ) is substituted for
ratings subsequent to the initial rating. The number
of assessments is at the discretion of the principal
invest igator .
TIME SPAN RATED
Now or within the last week.
CARD FORMAT - ITEMS
CARD 01 - (19x, 5611)
Item
Col umn
Item
Col umn
1 tem
Column
1 tem
Col umn
1
20
15
3k
29
48
43
62
2
21
16
35
30
49
44
63
3
22
17
36
31
50
45
64
k
23
18
37
32
51
46
65
5
2k
19
38
33
52
47
66
6
25
20
39
34
53
48
67
7
26
21
40
35
54
49
68
8
27
22
41
36
55
50
69
9
28
23
42
37
56
51
70
10
29
2k
43
38
57
52
71
It
30
25
44
39
58
53
72
12
31
26
45
40
59
54
73
13
32
27
46
41
60
55
74
]k
33
28
47
CARD 0
42
2 - (19x,
61
3811)
56
75
Item
Column
Item
Column
Item
Column
1 tem
Column
57
20
66
29
75
38
84
47
58
21
67
30
76
39
85
48
59
22
68
31
77
40
86
49
60
23
69
32
78
41
87
50
61
2k
70
33
79
42
88
51
62
25
71
34
80
43
89
52
63
26
72
35
81
44
90
53
64
27
73
36
82
45
91
54
65
28
7k
37
83
46
c
92
93
ever i ty
55
56
57
296
CARD FORMAT - FACTORS
CARD 51 = 19x, 8f6.2, F2.0, F4.0)
(Code "5" in Column 18 indicates card containing factor, cluster or other derived
scores .)
Factor
Column
Factor
Col umn
1
20 - 25
VI
50 - 55
II
26 - 31
VI 1
56 - 61
1 1 1
32 - 37
VI II
62 - 67
IV
38 - 43
Severity
68 - 69
V
kk - kS
Total Score
70 - 73
re - Sum
of
compos i te
items
Factor Score
Ranqe = 0 -
Factor score
No. of composite items
Total Score - Sum of 93 items
Total Score Range = 0 - 279
FACTOR COMPOSITION
I . Conduct Problem
39 - Bui lying
kO - Bragging and boasting
41 - Sassy to grown-ups
k7 - Mean
k8 - Fights constantly
51 - Picks on other children
69 - Blames others for his mistakes
11. Anxiety
8 - Afraid of new situations
9 - Afra id of people
10 - Afraid of being alone
11 - Worries about illness and death
k2 - Shy
43 - Afraid they (children) do not like
64 - Is afraid to go to school
III. Impulsive-Hyperactive
IV.
79 - Inattentive, easily distracted
80 - Constantly fidgeting
81 - Cannot be left alone
82 - Always climbing
83 - A very early riser
84 - Will run around between mouthfuls
89 - Unable to stop a repetitive activity
90 - Acts as if driven by a motor
Learning Problem
45 - Has no friends
62 - Is not learning
63 - Does not like to go to school
67 - Will not obey school rules
V. Psychosomatic
6 - Awakens at night
21 - Headaches
22 - Stomach aches
23 - Vomiting
24 - Aches and pains
VI . Perfectionism
76 - Everything must be just so
77 ~ Things must be done same way
78 - Sets goals too high
VII. Antisocial
71 - (Stealing) from parents
72 - (Stealing) at school
him 73 - (Stealing) from stores
75 - Gets into trouble with police
VIM. Muscular Tension
12 - Gets stiff and rigid
13 - Twitches, jerks, etc.
14 - Shakes
36 - Lets himself get pushed
around
Only 42 items are subsumed under the
8 factors; the other 52 items are not
utilized in the factor scoring.
297
This factor analysis is based on a sample of clinic outpatients and normal children
(N=683) and has been shown to give relatively stable factor structure across ages
and a wide social class range (Conners, 1970). These factor scores will be relative-
ly independent since items were selected so as to have minimal overlap in loadings
on other factors. However, some correlation among scales can be expected since only
factor scores derived by using actual loadings will be orthogonal to other factors.
Although similar patterns of symptomatology appear in normals and outpatients, the
severity of symptomatology is higher among the patient groups.
SPECIAL INSTRUCTIONS
1. For any scales which are filled out by "lay raters" (patient, parent, etc.) an
observer should be present, whenever possible, to make sure that the instructions
are understood and that the rater knows how to properly mark his/her responses.
Following completion of the scale, check to make certain that all items are completed
and that only one answer is given to each item. With the PQ., make certain that the
rater realizes that there are additional Items under the first fly leaf. If the
parent fills in the initials, check to see that they are the patient's initials, NOT
the parent's. The rest of the ID block is best completed by the observer.
2. Coding Rater - Code 1 1 (M) when mother or mother surrogate completes the scale;
code 22(F) when father or father surrogate completes the scale. Use any other 2
digits for other rater.
3. Do not write in the shaded area of the ID block. Form Number has been precoded.
ncorrect — » \ /L
' «/ Co NO.
I: ■ -*• FORM
Correct— * p ;,--■ i^_
DOCUMENTATION
a. Raw score printout
b. Factor score printout - including global item
c. Means and standard deviations for factor scores and severity. Ten item
totals, in lieu of factor scores, will be displayed when the PTQ. is
employed for repeated assessments.
d. Crosstabulat ion of factor scores - Displayed only when PQ. is used for
repeated assessments.
e. Variance analyses - When the PTQ is employed for ratings subsequent to
the initial one, the 10 comparable items extracted from the PQ •■■"' ^''■
used as for the initial rating.
298
037 PTQ
PARENT-TEACHER
QUESTIONNAIRE
DEPARTMENT OF HEALTH. EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
CONNERS PARENT-TEACHER QUESTIONNAIRE
PATIENT
:A:
-H:
:U:
INITIALS
:8::
:t::
. :«::
:C::
:M::
:*::
:0::
:«::
:X::
:£:: :J=::
RRST
:0:: :J>r:
INITIAL
:W:: r2:r
ifl::
ifl::
:H:: ::t::
:5J::
:I::
NUMBER
:0::
:0::
:0::
MALES 001 TO
::L:: :2:: :3::
r:t:: :2:: :3::
::L:: :«:: :3::
499; FEMALES 500
:*:: :*:
PATIENT
:*: :3::
:<:: :3::
TO
:*
:*
:*
998
::T::
::T::
::T::
-*:
:*:'
:*:
:*:
:*:
:*:
—
--A--
:K:
: :t::
: :«::
iCi:
:«::
:0::
:N::
:«::
:€:: :«::
SECOND
:0:: -ii-
INITIAL
zX". .2-z
:a::
:«::
:«:: :rt::
:«:: rS::
:J=:
::!?::
:0::
:0::
::L::
M
:*::
:2::
F
:2::
:3::
:3::
:<:: :*::
RATER
:*: :*:
:*
:*
::T::
::T::
:*:
:*:
:*:
:*:
^
-.V--
:0::
:0"
:0::
:4:: :«::
:i:: :«::
Houri
:*::
:3::
:3::
--:
:*: =3::
PERIOD
:<:: :*:
WMki
:3:r
:*
:*
::Tb:
::T::
Monthl
:*:
:*:
:*:
,
H
HI
— ~
Nii
""
PLEASE USE A NO. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
—
INSTRUCTIONS: Listed below are items concerning children's behavior or the problems they sometimes have.
Read each item carefully and decide how much you think this child has been bothered by
this problem of this time: NOT AT ALL, JUST A LIHLE, PRETTY MUCH, or VERY MUCH.
Indicate your choice by filling in the space (>••) in the appropriate column to the right
of each item.
ANSWER ALL ITEMS
Not Just
•I •
Ml tittli
htttr Vtry
Hsch Much
1 . Restless (overactive)
2. Excitable, impulsive
3. Disturbs other children
4. Foils to finish things he starts (short attention span)
5. Fidgeting
6. Inattentive, distractable
7. Demands must be met immediately; frustrated
8. Cries
9. Mood changes quickly
10. Temper outbursts (explosive and unpredictable behavior)
zfic: ::t:: :4:: i*:
:«:: irLi: :i::
:S:: ::»:: :2:: :i:
:fi:: ::!:: :£:: :i:
:fit: ::t:: :«:: :3::
riS:: "»:: =*:: :3:;
rfic: ::t:: :«:: :*:
:«:: ::»:: :*: ;*:
:«:: ::(:: :*:: :*:
:«:: ::J:: :*:: :*=
How serious a problem do you think this child has at this time?
:*:
300
The Conners Parent-Teacher Q,uest ionna i re (PTQ.) is an independently formatted
scale containing II items common to both the Parent (Questionnaire and Teacher
(Questionnaire. The PT(i per se is not so much an independent scale as it is a
device which reduces - by abbreviation - the burden of repeated assessments for
teachers and parents. The correspondence of items across the 3 scales is as
f o 1 1 ows :
PT(i Pd Td
1 52 5
2 53 6
3 kS ]k
k 54 8
5 80 1
6 79 7
7 85 3
8 88 13
9 91 16
10 55 21
Severity (11) Sk kO
APPLICABILITY Children to 15 years of age
UTILIZATION The PT(i must be used in conjunction with either the
Parent (Questionnaire or Teacher (Questionnaire.
TIME SPAN RATED Now or within the last week.
CARD FORMAT - ITEMS CARD 01 = (19x, 101 1, 12, ll)
I tern Column Item Column
1 20
2 21
3 22
k 23
5 2k
6 25
Total Score = Sum of Items 1 through 10. Total Score Range =0-30
SPECIAL INSTRUCTIONS
Either the full P(i or full T(i must be used for the initial assessment, even though
the investigator plans to use the abbreviated PT(i for subsequent ratings. This is
strongly recommended since a more detailed description of the subject prior to
treatment can be obtained by use of these longer scales. Although the brevity of
the PT(1 is a decided advantage for repeated ratings, it yields only a total score.
7
26
8
27
9
28
10
29
Total Score
30 - 31
Severity
32
301
Both the PQ and TQ provide factors which may permit scrutiny of specific drug
effects within circumscribed behavior areas. For investigators who wish a
more detailed measure of drug effect, it is suggested that the full PQ or full
TQ be used for all ratings.
Encoding Rater - Encode 11 (M) if mother completes the PTQ.; encode 22 (F) for
father. Use any other number for teacher; but, of course, use the same number
for a given rater throughout the study.
Shaded Area - Do not write in the shaded area of the ID block,
pre-coded .
Form Number is
incorrect-
Correct-
Monitoring - As with all forms used by lay raters, be sure that the rater fully
understands the instructions and how to properly mark his/her responses. When-
ever possible, the completed scale should be reviewed immediately for omissions
or multiple entries (more than one mark for an item). The ID block should also
be checked for accuracy if the lay rater has completed it. Make sure that the
patient's (child's) initials - NOT the rater's - are encoded.
DOCUMENTATION
a. Raw score printout
b. Total score means and standard deviations.
c. Variance analyses - When the longer PQ and TQ are used at the initial
rating, the 10 PTQ. items will be extracted from them for use in the
variance model .
302
RATING SCALES FOR USE IN DRUG STUDIES WITH CHILDREN*
C. Keith Conners, Ph.D.
The purpose of this report is to describe some rating scales for use in
children's drug studies. It seems eminently clear that no single choice of
scales is likely to meet the needs for the variety of populations, designs,
facilities and purposes of various research problems, and though I have chosen
to recommend certain scales for consideration, I have also presented alterna-
tives that may enrich the discussion and possibly be of use to investigators
unfamiliar with these alternatives.
A number of good sources are available regarding the technology of scale
construction and methodologic issues (1, 2, 3), 3nd reviews of rating scales in
psychiatric settings are available (4, 5). While there is indeed an elaborate
technology for producing "pure" psychometric instruments, most evidence seems
to indicate that the practical gains from elabora-te and sophisticated scaling
procedures is minimal (1), and I do not propose to deal with the many methodologic
issues raised in the use and construction of rating scales. Certain basic attri-
butes of reliability and validity need, of course, to be considered, and for the
most part I have not included a number of scales that look interesting but which
have no published reliability or validity data.
The choice of children's rating scales needs to be based on certain criteria
and working assumptions which will eliminate some scales from further consideration.
First, there is the source of the rating data. If the source of data is the
parent or teacher, then the scale must be non-technical, brief and easily filled
out. A clinician or trained observer on the other hand, may use much more detailed
and theoretically-oriented instruments. Since parent, teacher, and clinician have
different (though overlapping) behavior samples, the scales for different observers
almost certainly need to be different in content, though an overlap in some areas
would be des i rable.
Secondly, there is the question of level of observation. This can be very
molecular--where specific behavioral acts or sequences can be observed and time-
sampled--or the categories can be quite global, abstract or inferential. Most
people are agreed that ratings which require a great deal of inference about under-
lying processes tend to be unreliable; but descriptive global ratings that use
"middle level" inferences are often the most reliable. Unless the observer is high-
ly trained there is likely to be a loss of reliability for rating of molecular events,
We have, therefore, tended to assume that some middle level of abstraction, requiring
a minimum of inference, is preferable unless highly trained observers are available.
'-This material was written by Dr. Conners for presentation to the Pediatric
Psychopharmacology Workshop. It reflects the processes by wh'i'ch assessment
instruments were chosen for the ECDEU Pediatric Battery.
303
A related issue is whether one is interested in rating current behaviors,
symptoms or states; or whether the intent is to describe basic traits, disposi-
tions, or personality characteristics. While not mutually exclusive, these
approaches lead to somewhat different types of scales. I have assumed that a
symptom focus is most appropriate for our purposes, though the difference be-
tween a symptom and a trait is probably more a question of values as to
whether the behavior in question is normative or undesirable.
Whether one uses state or trait methods depends to some extent on the pur-
pose of using the ratings in the first place. A use for prediction might well
require more trait-disposition items, while symptoms would seem to be more appro-
priate for measuring change. Both types of items are appropriate for questions
of taxonomic classification. It is coneivable to me that all three purposes —
prediction, measurement of change, and class if icat ion--might be meaningfully
applied in drug studies. In general, I have recommended the use of behavior
items that are susceptible to short term change, but which can also be used in
conjunction with statistical techniques for prediction and classification.
The population under study clearly makes a difference in the type of scale
to be employed. It has seemed reasonable that separate instruments should be
employed for severe psychiatric disturbances (psychosis, retardation, autism,
etc.) as contrasted with the more frequent and typical patients found in out-
patient settings. Institutionalized children are usually more severely affected
by their illness, and many of their symptoms are of low frequency in outpatients
(e.g., hallucinations, autistic aloofness).
Finally, the format of the scale needs consideration. For most purposes a
scale with specific anchor points describing the behavior in question is most
likely to be reliable and valid. But such scales are also more cumbersome and
time-consuming to use. If the range of behavior to be sampled is broad, (as it
is likely to be in the screening phase of a study) then the items should be brief
and the rating procedure as simple as possible. This consideration has led me to
recommend the "chec-k-1 ist" type of scale, especially for parent ratings.
Teacher Rating Scales
1. Cattel 1 and Coan (6) administered a 38-item trait list of bipolar items
to teachers of 198 first and second grade pupils. This list was compiled to in-
clude the major "markers" from other personality research, as well as "useful
indicators of personality disturbance." Many of the items are probably irrelevant
for symptom-oriented studies (e.g., "aesthetically sensitive, aesthetically fastid-
ious, vs. lacking in artistic feeling"), but for those investigators interested in
predicting drug effect from personality traits, this might be a useful scale. They
identified some 15 factors by Cattel I's methods (oblique rotations), but the reliabil
ity of factor scores is not given, and the non- independence of the factors probably
makes them of little use as independent predictors in regression equations.
2. Peterson (7) used the referral problems of 427 cases at a guidance clinic
to select the 58 most common symptoms. The list was given to teachers of 831 kinder-
garten through sixth grade pupils for ratings. Two major factors (conduct problem
and personality problem) emerged with considerable consistency across the whole age
range. Interrater reliabilities (for the Kg sample) were .77 and .75 for factor
304
scores for the two factors. Quite similar factors have emerged in a number of
studies by Quay and associates (8) for various populations, from sources as dis-
parate as case history ratings, questionnaires, standard ratings, and by a vari-
ety of factor extraction methods.
However, several questions can be raised about these results. The presence
of only two (sometimes three) factors suggests that either the repertoire of items
is so restricted as to guarantee a small number of independent factors or the meth-
od of analysis produces few factors. Secondly, the two factors appear to subsume
some very disparate behaviors which intuitively seem distinct. Thirdly, many of
the items, particularly conduct problem items, are essentially synonyms, guarantee-
ing that a strong factor will emerge. Some of the items are symptomatic (e.g.
fighting), while some are essentially trait names (e.g. nervousness, aloofness).
Nevertheless, similar factors emerge in some form or other in many other studies,
and it is probably safe fo assume that there are at least two important dimensions,
or causally independent factors, that could be extremely useful in basic classifi-
cation, prediction, and possibly measurement of change in drug studies.
3. A comprehensive classroom behavior and personality instrument has been
developed by Shaeffer and colleagues at the Laboratory of Psychology of NIMH. The
items were selected from a theoretical model of child behavior, have been extensive-
ly analyzed for factor structure and reliability, and tested in the U.S. and
Scandinavia. Specific classroom behaviors are organized into traits, and the traits
are organized into factors and arranged in a "circumplex" model. Figure 17 shows
the conceptualization of the item-trait-factor derivation, and Figure 18 is an
example of the ordering of traits on a circumplex. 1 The major difficulty with this
instrument seems to be its length. The 320 items in the scale seem prohibitively
time-consuming for volunteer reporting by teachers. However, the excellent pool
of items, and the extensive analytic work on sub-scales might be useful in some
sett ings .
4. The Devereux Elementary School Behavior Rating Scale (9) is a ^y-item
anchored scale for teachers, with items easily grouped into 11 behavior factors.
Normative data is available on 809 normal children in kindergarten through 6th
grades. Test-retest factor scale reliabilities range from .71 to .91. with small
standard errors of measurement, and median reliability of .87. The factor structure
is quite similar across grade levels. In general the scale meets most of the require-
ments for an instrument in drug studies, though I know of no demonstration that it is
"drug-sensitive". This scale has a high priority for use as a standardized data-
gathering instrument.
5. A 39-item Teacher Symptom Checkl ist ,or iginal ly developed by Eisenberg and
colleagues has been used in several drug studies and recently factor analyzed by
Conners (10). The five factors are highly reliable on test-retest, and appear to
be quite sensitive to changes due to drug, with relatively little placebo influence.
Test-retest reliabilities over a one-month period ranged from .72 to .91. The five
These data are from an unpublished manuscript by Shaeffer, Droppelman, and
Kalverboer. Unfortunately, at the time of this preparation I did not have
available Dr. Shaeffer's more recent extensive work.
305
/N
a: >
O 1-
— (0
> E
LLl Q.
O »-
O ID
a: LLl
(/)
(/) o
o —
o
LLl O
I- o
(U Ll.
E
— m
E
O
— c
< —
,-^
.—
5
C
l/l
V)
in
(T>
t/l
U)
<u
tf)
in
1-
3
4->
1—
(U
0)
T3
o
• —
(D
1-
c
^
(0
U
Q.
in
+-1
o
L.
to
X
3
—
If)
o
o
(D
l/l
c
c in
>4-
— L.
^—
o
o <u
3
—l-C
M-
>
•^J
0)
-l-J
>~ o
L.
—
< —
(D
>
0) -C
O
1- +->
■(->
nj —
in
o
oc S
— '
(D
T3
o
c
in
^
^
—
(U
(U
4^
+-1
o
4-'
c
•—
—
in
(D
^-
>^
3
c
1-
in
3
•—
o
(U
in
l^
^
F^
o
•u
<U
■M
nj
(D
1
■—
c
C
—
M-
in
■o
0)
■—
O
1 —
c
c
in
u
o
0)
o
(U
L.
I/)
uv
o
i^
□::
s >■
o
■D
^
■M
lU
CD E
^
C O
in
in
— >_
-:<:
■M M-
o
c
in
— Q.
0) CD (13
1- C ^
Ll. — U
c
J-"
> jS
ro
(D
L.
L.
+-> +->
0)
■M
u o
>
c
(D (0
(U
<u
1- 1-
in
u
0) ■!->
L.
c
Ql in
OJ
o
> —
Q.
o
a: Q-
306
in
Z
</i
■u
0)
c
S
^
3
M
4-
Q.
3
(U
a
I
<
>
o
1
ro
■:^ *>2
4-O0
— -^^
z
2 o
S 2
c
— 4-1
— o
■? <
I — I — I-
\
..O
s f /t
C 1/1 / Q.
H ^ h
— >_o <u
in i/i •—
in
-C
<U
1/1
c
L_
—
(U
Q.
■D
Q.
ITJ
c (Daj-t-" +JO--
(U c — — o
> — 1- -D (13
0 O en
Q 1_ .-
1 a. o£
ID
V
^ < -- (
(/I i/i »—
\
/
— ^
« e
o
7^
' o
•M
ID
O^
>-
*o
• —
1 :3
»—
- u.
XI
nj
^
4-J
-2°
1-
'♦
T
0
0
/
(/I •— —
T> — <->
H 1 1 1-
Z'
o 2
% S
Q. C 4->
Ul O O
3 — 3
CO ■!->.—
*0 I ^^
307
factors were labeled "aggressive conduct", "day-dreaming-inattent i ve" , "anxious-
fearful", "hyperactivity", "sociable-cooperative". (A newer, slightly modified
form has been developed which contains 10 items that overlap with the symptom
checklist for parents, described below. This allows one to compare ratings from
both sources on a common core of items.)
6. Two excellent teacher scales should be mentioned. Both are more appro-
priate for identification of learning disorders and children with developmental
deviations than for measuring change, but in view of the likelihood of increased
interest in drug studies of learning disorders, the scales are important to keep
in mind where large scale screening may be needed to identify potential candidates
for drug studies. The first is a 24-item anchored scale by Myklebust (11). The
items are grouped into five areas: auditory comprehension and learning, spoken
language, orientation (time, space, relationship), behavior, and motor. The scale
was used to identify children with minimal cerebral dysfunction in a sample of
2767 third and fourth graders. Excellent discriminative power and validity were
shown with the scale, though reliabilities are not reported.
The Classroom Screening Inventory developed by the Rocky Mountain Educational
Laboratory (12) is an 80-item scale that is divided into 14 sub-scales focused on
classroom learning and behavior. A very thorough item analysis, factor analysis,
reliability and validity studies are reported. The instrument was used in a study
of a stratified random sample of 2400 children in the Rocky Mountain area. jnter-
rater reliability was .85. A validity study showed that the screening produced no
false positives and very few false negatives. This instrument though still being
developed is the best of its kind known to this writer.
In summary, the Devereux Elementary School Behavior Rating Scale appears to
meet most of the requisites for a brief, reliable scale for children's drug studies.
As an alternative, the Conners scale is probably easier to use and less likely to
be resisted by the busy teacher because of its checklist format. However, the more
extensive published research on the Devereux Scale makes it appear as the best bet
at this time.
Parent Rating Scales
A number of studies of the dimensions of symptom behavior in young children
have been made during the past several years. Jenkins and Hewitt (13) described
three clusters of traits identified from case records of 500 children rated on 90
symptoms. More recently, Jenkins (14) identified 5 clusters which he labelled
"shy-seclus ive", "overanxious-neurotic", "hyperactivity with poor concentration",
"undomesticated", and "socialized delinquent". These clusters fell into two broad
categories of inhibited and aggressive children. Peterson (15) identified two
dimensions from parent and teacher ratings which he labelled "conduct disorder"
and "personality disorder". These patterns have emerged in several other studies
by Quay (16), Dreger, et al. (I7), and Borgatta and Fanshel (18). The latter study
produced 12 factors: defiance, unsoc ia] ized, tension-anxiety, lack of affection,
infantilism, overcleanl iness , sex precoc iousness , sex inhibition, learning diffi-
culty, (a and b) , likeability, responsibility. A second-order factor analysis
308
produced six factors including an "acting-out" factor, developmental immaturity,
inhibited behavior, learning disorder, and sociable-responsible. Reliabilities
of factor scales are not given, but individual item reliability ranges from .60
to .77, suggesting that factor scales are likely to be highly reliable. These
studies and others mentioned below provide a substantia] base of knowledge for
purposes of prediction and classification.
An anchored rating scale for nonprofessionals was developed by Spivack and
Spotts (19) at the Devereux Foundation. Good norms are available for the 17 sub-
scales of the 97~item scale. Like the teacher's version, this scale is thorough-
ly researched, easy to use and score, and covers a bro^d range of psychopathology .
The Missouri Children's Behavior Checklist (20) is a similar 70-item yes-no
checklist of symptoms. The factors of aggression, inhibition, activity level,
sleep disturbance, somatization and sociability have odd-even reliabilities rang-
ing from .67 to .86. Inter-parent agreement on individual items ranged from 53%
to 9k%. Validity studies of clinic versus controls showed significant discrimina-
tion of all factors except somatization and sleep disturbance.
Conners (21) has described a 93-item parent symptom checklist that was factor-
analyzed on 316 clinic patients between the ages of 6 and \k, and 367 normal con-
trols of the same age. Twenty-four categories of symptoms (sleep, learning, socia-
bility, etc.) were factor analyzed. Six factors were identified by principal com-
ponents analysis and labelled aggressive conduct disorder, anxious-inhibited, anti-
social, enures is-encopres is , psychosomatic, and anxious-immature. Discriminant
function analysis showed that 83% of controls and 70% of clinic patients could be
correctly classified from factor scores. Neurotic and hyperkinetic children were
also correctly identified in 77% and 7^% of the cases, respectively. Mother-father
agreement averaged .85 on total scores, but factor scale agreement is not reported
as yet. The first two factors (conduct disorder and anxious-inhibited) have been
used in drug studies and show significant drug-placebo interactions. A recently
modified version employs a 10-item scale to overlap with teacher ratings for repeated
measures in drug studies.
A factor analysis was also completed on individual items for the total sample
of 683 subjects (previous analyses had shown close similarity in factor structure
for different social classes, different age ranges, and for the sexes). Factor load-
ings on each of the seven factors are very similar to the factors reported bv
Achenbach, Borgatta and Fanshel (18), and several others.
One drawback of the scales described here is that none includes symptoms of
severe psychopathology such as psychotic manifestations. A rather extensive study
on children's psychiatric symptoms by Achenbach (22) includes more of such symptoms.
The large, first principal component factor appeared to be a bipolar "internalizing
vs. externalizing" factor, and the second large component was identified as a uni-
polar "diffuse psychopathology" factor. Eight rotated factors were identified as:
somatic complaints, delinquent behavior, obsessions, compulsions and phobias; sexual
problems; schizoid thinking; unsocial ized aggression; hyperactivity; and one minor
factor. The main problem with this scale is that it is designed for professionals
309
or semi-professionals, so that various items would be difficult for parents to
use (such as diplopia, compulsions, etc.). This is an excellent list, however,
for rating of case records or other symptom rating in a clinical context.
In summary, both the Conners and Devereux scales appear to be feasible in
drug studies, with the latter scale being more thoroughly standardized.
Cl inician's Ratings
1. Very few standardized child-psychiatry rating scales are available. The
brief standardized rating procedure described by Rutter and Graham (23) appears
to have both good inter-examiner reliability and validity. A somewhat more com-
prehensive rating scale for psychiatrists has been provided by Drs. Klein from
the Hillside Hospital but standardization procedures are not available at this
t ime.
2. A valuable source of observation, particularly for measuring change in
drug studies, is a behavior rating by the psychologist on the basis of observa-
tions made during psychological testing. I am unaware of any standardized forms
for this purpose, but the rating scale used by the NINDS Collaborative Perinatal
project appears to be excellent for most purposes.
Inpatients and Retarded
The Children's Behavior Inventory by Burdock and Hardesty (24) is a 139-item
yes-no scale with items grouped by age-appropriateness. Extensive reliability and
validity studies have been done, and the results indicate sufficient discriminative
power and stability to warrant using the inventory in settings where a moderate
amount of training of observers is possible. The items are rationally grouped into
categories of vegetative function, appearance and mannerisms, speech and voice,
emotional display, socialization and thought processes. Drug studies have not yet
been reported with this instrument.
A much briefer scale has been reported by Davis, Sprague and Werry (25) for
time-sampling measurement of stereotyped behavior in retardates. Interjudge relia-
bilities ranged from .61 to .88 for the 7 categories. The scale showed sensitivity
to drug treatment, and would appear to be an excellent measure for this relatively
restricted (but common) set of behaviors in retardates or other severely disturbed
inpatients .
REFERENCES
1. Chronbach, L. J. Essentials of Psychological Testing. Harper, I960 (New York),
2nd Ed.
2. Lyerly, S. B. and Abbott, P. S., Handbook of Psychiatric Rating Scales (1959-
1964). USPHS Publication # 1495.
3. Guilford, J. P., Psychometric Methods, McGraw Hill, 1954 (New York), 2nd Ed.
310
k. Norton, W. A., Review of Psychiatric Rating Scales, Canad. Psychiatric
Assoc. Journal. I967, 12 (6), 563-7^.
5. Doty, D., Rating scales used in children's drug research: a review of
the literature. In Survey of research on psychopharmacology of children,
by R. Sprague and J. Werry and Students (Children's Research Center,
U. of 111 inois) .
6. Cattell, R., and Coan, R. W., Child personality structure as revealed by
teachers' behavior ratings. J. Clin. Psychol., 1957, 13, 315-327.
7. Peterson, D. R., Behavior problems in middle childhood, J. Consult.
Psychol., 1961, 25, 205-209.
8. Quay, H. C. Personality dimensions in delinquent males as inferred from
the factor analysis of behavior ratings. J. Research in Crime and
Delinquency, 1964, 1, 33-37.
9. Spivack, G. and Swift, M. The Devereux Elementary School Behavior Rating
Scale. Devereux Foundation, Devon, Pennsylvania.
Spivack and Levine, M. The Devereux Child Behavior Rating Scales: a study
of symptom behavior in latency age atypical children. Amer. J. Ment. Def.,
1964, 68, 700-717.
10. Conners, C. K. A teacher rating scale for use in drug studies with
children. Amer. J. Psychiatry, I969, 126, 884-888.
11. Myklebust, H., Minimal Brain Damage in Children. Final report to USPHS
Contract #108-65-142,
12. Rocky Mountain Educational Laboratory Classroom Screening instrument.
RMEL, 1620 Reservoir R., Greeley, Colo. 8O63I.
13. Jenkins, R. L., and Hewitt, L., Types of personality encountered in child
guidance clinics. Amer. J. Orthopsychiatry, 1944, 14, 84-94.
14. Jenkins, R., Psychiatric syndromes in children and their relation to
family background. Amer. J. Orthopsychiatry, 1966, 36, 450-457-
15. Peterson, D. R., op. cit.
16. Quay, H. C, op. cit.
17. Dreger, R. M., et al. Behavioral classification project. J. Consult.
Psychol., 1964, 28, 1-1 3.
311
18. Borgatta, E. F. and Fanshel , D. Behavioral characteristics of children
known to psychiatric outpatient clinics. Child Welfare League of America, |
1965, (Library of Congress, 65-197^6). '
19. Spivack, G. and Spotts, The Devereux Child Behavior Rating Scale.
Devereux Foundation, Devon, Pa.
20. Sines, J. 0., Pauker, J. D., Sines, L. K. and Owen, D. R., Identification
of clinically relevant dimensions of children's behavior, J. Consult. &
Clin. Psychol., I969, 33, 728-73^.
21. Conners, C. K., Symptom patterns in hyperkinetic Neurotic and Normal
Children. Child Devel . (in press).
22. Achenbach, T. M. The classification of children's psychiatric symptoms:
a factor analytic study. Psychological Monographs, I966, 80, No. 6.
23. Rutter, M. and Graham, P. The reliability and validity of a psychiatric
interview for children. Brit. J. Psychiat. ,' I968, 114, 563-579-
2k. Burdock, E. L., and Hardesty, Anne S., A children's behavior diagnostic
inventory. Ann. N. Y. Acad. Sci., 1964, 105, 89O-896.
25. Davis, K. v., Sprague, R. and Werry, J. Stereotyped behavior and
activity level in severe retardates: the effect of drugs. Amer. J. Ment.
Def., 1969, 73, 721-727.
26. Alderton, H. R. & Hoddinot, B. A., A controlled study of the use of
thioridazine in the treatment of hyperactive and aggressive children in
a children's psychiatric hospital. Canad. Psychiat. Assoc. J., 1964,
9, 120-130.
27. Pritchard, M. Observation of children in a psychiatric inpatient unit:
design of a behavioral rating scale for nursing staff. Brit. J. Psychiat.,
1963, 109. 572-578.
312
053 SCL-90
SELF-REPORT
SYMPTOM
INVENTORY
SCL-90
Below is a list of problems and complaints that people sometimes have. Please read each
one carefully. After you have done so, please fill in one of the numbered spaces to the
right that best describes HOW MUCH THAT PROBLEM HAS BOTHERED OR DIS-
TRESSED YOU DURING THE PAST WEEK INCLUDING TODAY. Mark only one
numbered space for each problem and do not skip any items. Make your marks care-
fully using a No. 2 pencil. DO NOT USE A BALLPOINT PEN. If you change your mind,
erase your first mark carefully. Please do not make any extra marks on the sheet. Please
read the example below before beginning.
HOW MUCH WERE YOU
BOTHERED BY:
1. Backaches
HOW MUCH WERE YOU BOTHERED BY;
1. Headaches
2. Nervousness or shakiness mside
3. Unwanted thoughts, words, or ideas that won't leave your mir
4. Faintness or dizziness
5. Loss of sexual interest or pleasure
6. Feeling critical of others
7- The idea that someone else can control your thoughts ....
8. Feeling others are to blame for most of your troubles ....
9. Trouble remembering things
10. Worried about sloppiness or carelessness
11. Feeling easily annoyed or irritated
12. Pains in heart or chest
13. Feeling afraid in open spaces or on the streets
14. Feeling low in energy or slowed down
15. Thoughts of ending your life
16. Hearing voices that other people do not hear
17. Trembling
18. Feeling that most people cannot be trusted
19. Poor appetite ,
20. Crying easily
21. Feeling shy or uneasy with the opposite sex
22. Feeling of being trapped or caught
23. Suddenly scared for no reason
24. Temper outbursts that you could not control
25. Feeling afraid to go out of your house alone ,
26. Blaming yourself for things
27. Pains in lower back
28. Feeling blocked in getting things done
29. Feeling lonely ,
30. Feeling blue
31. Worrying too much about things
32. Feeling no interest in things , . . .
33. Feeling fearful
34. Your feelings being easily hurt
35. Other people being aware of your private thoughts
36. Feeling others do not understand you or are unsympathetic. ,
37. Feeling that people are unfriendly or dislike you
38. Having to do things very slowly to insure correctness
314
MH 9-53
5-73
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
NATIONAL INSTITUTE OF MENTAL HEALTH
SCL - 90
PATIENT INITIALS
FIRST
INITIAL
NUMBER MALES 001 to 499; FEMALES 500 to 998
6
PATIENT
SECOND
INITIAL
Day
1
HOW MUCH WERE YOU BOTHERED BY:
Heart pounding or racing
Nausea or upset stomach
Feeling inferior to others
Soreness of your muscles
Feeling that you are watched or Talked about by others
Trouble falling asleep
Having to check and double-check what you do ... .
Difficulty making decisions
Feeling afraid to travel on buses, subways, or trains . .
Trouble getting your breath
Hot or cold spells
Having to avoid certain things, places, or activities
because they frighten you
Your mind going blank
Numbness or tingling in parts of your body
A lump in your throat
Feeling hopeless about the future
Trouble concentrating
Feeling weak in parts of your body . . . .
Feeling tense or keyed up
Heavy feelings in your arms or legs
Thoughts of death or dying
Overeating
Feeling uneasy when people are watching or talking
about you
Having thoughts that are not your own ....
Having urges to beat, injure, or harm someone
Awakening in the early morning ,
Having to repeat the same actions such as touching,
counting, washing
Sleep that is restless or disturbed
Having urges to break or smash things
Having ideas or beliefs that others do not share
Feeling very self-conscious with others
Feeling uneasy in crowds, such as shopping or at a movie
Feeling everything is an effort
Spells of terror or panic
Feeling uncomfortable about eating or drinking in public
AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE
HOW MUCH WERE YOU
BOTHERED BY:
74.
Getting into frequent arguments
75.
Feeling nervous when you
76.
Others not giving you proper
credit for your achievements .
77.
Feeling lonely even when
you are with people
78.
79.
Feeling so restless you couldn't
sit still
Feelings of worthlessness . . .
80.
Feeling that familiar things
are strange or unreal
81.
Shouting or throwing things . .
82.
Feeling afraid you will
83.
Feeling that people will take
advantage of you if you let therr
84.
Having thoughts about sex
that bother you a lot
85.
The idea that you should be
punished for your sins
86.
Feeling pushed to get things
87.
The idea that something
serious is wrong with your body
88.
Never feeling close to
another person
89.
Feelings of guilt
90.
The idea that something is
wrong with your mind
315
Developed by Derogatis, Lipman and Cov i , the Self-Report Symptom Inventory
(SCL-90) is an independently formatted form and does not require a General Scor-
ing Sheet. The SCL-90 is composed of 90 items - each rated on a 5-point scale
of distress. Evolving from the earlier Hopkins Symptom Checklist, the SCL-90
was designed primarily as a general measure of psychiatric outpatient symptoma-
tology in both clinical and research situations.
APPLICABILITY
Adults in psych iatr ic, and nonpsychiatr ic
outpatient settings.
UTILIZATION
Once at pretreatment ; at least one post-
treatment rating. Additional ratings are
at the discretion of the investigator.
TIME SPAN RATED
Now or in the last week.
CARD FORMAT - ITEMS CARD 01 = (19x, 56ll)
Item Column Item Column
I tern
Column
1
20
2
21
3
22
4
23
5
2k
6
25
7
26
8
27
9
28
10
29
11
30
12
31
13
32
]k
33
15
34
16
35
17
36
18
37
19
38
20
39
21
ko
22
k]
23
k2
2k
k3
25
kk
26
k5
27
ke
28
kl
29
48
30
49
31
50
32
51
33
52
3k
53
35
54
36
55
37
56
38
57
39
58
40
59
41
60
42
61
43
62
44
63
45
64
46
65
47
66
48
67
49
68
50
69
51
70
52
71
53
72
54
73
55
74
56
75
CARD 02 = (19x, 34ll)
I tern
Column
I tern
Column
I tem
Column
I tem
Column
57
58
59
60
61
62
63
64
65
20
21
22
23
24
25
26
27
28
66
67
68
69
70
71
72
73
74
29
30
31
32
33
34
35
36
37
75
76
77
78
79
80
81
82
83
38
39
40
41
42
43
44
45
46
84
85
86
87
88
89
90
47
48
49
50
51
52
53
316
CARD FORMAT ■
- DIMENSIONS
CARD
51-"-
= (19x, 9F6.2)
D imens
on
Column
D imens ion
Col
umn
1
20 - 25
VI
50
- 55
II
26-31
VI 1
56
- 61
1 1 1
32 - 37
VI 1 1
62
- 67
IV
38 - k3
IX
68
- 73
V
kk - ks
CARD 52-.'- = (19x, 3F6.2)
Global Scores Column
GSI 20 - 25
PS! 26-31
PSD! 32 - 37
General Symptomatic Index (GS I ) = Sum of all Items
No. of I terns
Positive Symptom Total (PSI) = No. of items rated positively; i.e., rated
1 , 2, 3 or 4.
Positive Symptom Distress Index (PSDl) = Sum of a 11 items
PST
" Code "5" in Column 18 indicates card containing factor, cluster or derived scores
DIMENSION COMPOSITION - Dimensions I - V have been validated on samples involving
over 2500 patients. Dimensions VI - IX are presently
assigned provisional status since validation studies for
them are still in progress.
I. Somatization Ml. Interpersonal Sensitivity
Somat
zat ion
1
48
k
49
12
52
27
53
40
56
k2
58
IV.
II. Obsessive-Compulsive
3
45
9
46
10
51
28
55
38
65
6
41
21
61
34
69
36
73
37
Depress ion
5
30
14
31
15
32
20
54
22
71
26
79
29
317
v. Anxiety
VIM. Paranoid Ideation
VI
2 57
17 72
23 78
33 80
39 86
Anger-Host i 1 i ty
11 67
2k Ih
63 81
VII. Phobic Anxiety
13
70
25
75
hi
82
50
8 68
18 76
43 83
IX. Psychoticism
7 84
16 85
35 8?
62 88
77 90
I terns Not Included in any Factor
19 64
kk 66
59 ?9
60
SPECIAL INSTRUCTIONS
The SCL-90 is normally completed by the patient, with administration and
monitoring being performed by a technician familiar with the procedure. Usually
about 15 minutes of patient time and about 5 minutes of technician time are re-
quired. In instances where someone other thap the patient is doing the rating,
(e.g., doctor, nurse, etc.) the technician's primary involvement is in verifying
the accuracy for identifying information. The SCL-90 may be introduced to the
patient as part of the facility's attempt to understand the problems of the pa-
tient, or it may be explained directly as part of a research project for which
the patient's assistance is requested. Both methods have proven quite success-
ful. Stress completion of ALL items as quickly as possible. The patient should
also work independently without discussing the items with spouse, family members,
etc. The instructions should be read and carefully explained to the patient by
the technician/administrator, with particular attention being given to an explana-
tion of the Example printed on the form and the definitions of the scale points
given below.
Definition of Scale Points - To be explained to the subject and to be used by
raters other than the subject.
0 - Not At All Patient reports no distress associated with the
particular symptom.
1 - A Little Bit = Patient is aware of some distress associated with the
symptom, but it is infrequent and of low intensity.
2 - Moderately = Patient experiences distress associated with the symptom
in a somewhat regular manner and it is of mild or
moderate intensity.
318
3 - Quite A Bit = Patient experiences distress associated witii the symptom
with regularity, and it is of moderate to high intensity.
k - Extremely = Patient experiences extreme distress associated with the
symptom, due to frequency, intensity, or a combination of
both.
RATER CODE - The code "00" is reserved for the subject; i.e., it indicates that the
scale has been self-rated. Any other number may be used to designate a rater other
than the subject.
FORM NUMBER - The SCL-90 has the Form Number preprinted and it is not necessary -
in fact it is prohibited - to encode this number.
Example: Writing in the form number may trigger multiple opscan punches.
Incorrect-
^ I
Correct
DOCUMENTATION
a. Raw score printout
b. Dimension printout
c. Means and standard deviations of dimensions and global scores
d. Cross-tabulation of dimensions
e. Variance analyses
319
COMMENTS OF THE AUTHORS
SCL-90: /* -) Outpatient Psychiatric Rating Scale: Preliminary Report
Leonard R. Derogatis, Ph.D. J Ronald S. Lipman, Ph.D.,^ and
Lino Covi , M.D. '
The •" ; 90 ■ a self-report clinical rating scale oriented toward the symptoma-
tic behavior of psychiatric outpatients. It is comprised of 90 items which reflect
9 primary symptom dimensions believed to underly the large majority of symptom behav-
iors observed in this class of patients. A number of additional scales are included
outside the principal dimensional framework to assess disturbances in appetite and
sleep. The primary symptom dimensions are:
I. Somatization Vi. Hostility
II. Obsessive-Compulsive VII. Phobic Anxiety
III. Interpersonal Sensitivity VIM. Paranoid Ideation
IV. Depression IX. Psychoticism
V. Anxiety
Dimensions I -V have been empirically established and validated in the context of
the Hopkins Symptom Checklist on samples involving over 2,500 patients. Major studies
in this series are listed in the Bibliography. Assessments of the various forms of
reliability, validity and factorial invariance of these dimensions have been presented
in Derogatis et al. (1) (2^). Dimensions VI-IX represent "new" dimensions that have
been integrated with the five previous measures to provide a more complete representa-
tion of the outpatient symptomatic domain.
A brief description of the symptom constructs defined by these dimensions and, in
several cases, a short synopsis of the development and rationale basic to each follow
below. This is given so that the user may gain a better appreciation of the range and
meaning of the SCL-90 clinical profile.
I. Somatization - Reflects distress arising from perceptions of bodily dysfunc-
tion. Complaints focused on cardiovascular, gastro-intestinal , respiratory,
and other systems with strong autonomic mediation are included. Headaches,
backaches, and pain and discomfort localized in the gross musculature are
also components, as are other somatic equivalents of anxiety.
II. Obsessive-Compulsive - Reflects ehaviors that are closely identified with
the clinical syndrome of the same name. The focus of this measure is on
thoughts, impulses and actions that are experienced as unremitting and
irresistible by the individual but are of an ego-alien or unwanted nature.
Behaviors indicative of a more general cognitive difficulty (e.g., "mind
going blank", "trouble remembering") also load on this dimension.
III. Interpersonal Sensitivity - Focuses on feelings of personal inadequacy and
inferiority, particularly in comparison with other individuals. Self-
deprecation, feelings of uneasiness, and marked discomfort during inter-
personal Interactions are characteristic of persons showing high levels of
1. School of Medicine, Johns Hopkins University
2. Psychopharmacology Research Branch, NIMH
320
I.S. Feelings of sel f-consciousness and negative expectancies regarding
interpersonal communications are also typical sources of distress.
IV. Depression - Reflects a broad range of the concomitants of the clinical
depressive syndrome. Symptoms of dysphoric affect and mood are represented,
as are signs of withdrawal of interest in life events, lack of motivation,
and loss of vital energy. The dimension mirrors feelings of hopelessness
and futility as well as other cognitive and somatic correlates of depres-
sion. Several items are included concerning thoughts of death and suicidal
ideation.
v. Anxiety - Subsumes a set of symptoms and experiences usually associated
clinically with high manifest anxiety. General indicators such as restless-
ness, nervousness, and tension are included here as are additional somatic
signs (e.g. "trembling"). Scales measuring free floating anxiety and panic
attacks are an integral aspect of this dimension, and an item on feelings of
dissociation is included. The SCL-90 Anxiety dimension has been augmented
beyond the item set used with the previous HSCL.
VI. Hostility - The consistent observation that the presence of anger and hostile
behavior function as important determinants in a variety of clinical decisions
with psychiatric outpatients (e.g. diagnosis, treatment assignment, disposi-
tion, etc.) has led to the development of a formal Hostility dimension. This
dimension is organized around three categories of hostile behavior: thoughts,
feelings, and actions. Items range from feelings of annoyance and urges to
break things, through arguments and uncontrollable temper outbursts.
Vll. Phobic Anxiety - Reflects symptoms that have been observed with high inci-
dence in conditions termed phobic anxiety state or agoraphobia (Marks 2,3).
Fears of a phobic nature oriented towards travel away from home, open spaces,
crowds, or public places and conveyances are represented by this measure.
In addition, several scales representing social phobic behavior have been
included .
/III. Paranoid Ideation - Derives from the notion that paranoid behavior is best
considered from a syndromal point of view. The authors have adopted the
position put forth by Swanson, Bohnert, & Smith (k) that paranoid phenomena
are most effectively conceived as a mode of thinking. Accordingly, scales
have been developed around the primary characteristics of paranoid thought.
Swanson, et al. (k) list projective thinking, hostility, suspiciousness,
central ity, delusions, loss of autonomy, and grandiosity as cardinal para-
noid characteristics. Within the limitations imposed by a self-report format,
scales were designed to reflect these manifestations.
IX. Psychoticism - Since psychotic behaviors are observed in the out-patient
setting, and play a critical role in administrative and treatment decisions
when manifest, a psychoticism dimension was integrated into the SCL-90.
The approach taken in building this scale involved sampling from the full
321
continuum of psychotic behaviors. Thus, florid, acute symptomatology,
as well as behaviors typically viewed as more oblique, less definitive,
indicators of psychotic process are represented. Four items reflect
Schneiderian first-rank symptoms of schizophrenia: auditory hallucina-
tions, thought broadcasting, external thought control, and external
thought insertion (Schneider, (5); Mellor, (6); Taylor, (7) ). In
addition secondary signs of psychotic behavior, as well as indications
of a schizoid life style, are also represented. This combination
approach is believed to have the greatest potential validity within
the self-report format of the instrument.
Areas of Utilization - Due to the ease of administration and broad range of symptoms
reviewed in the SCL-90, it should find ideal utilization as a clinical screening
instrument in numerous outpatient psychiatric settings. Outpatient departments,
emergency services, acute treatment centers, and like facilities are potential pri-
mary users. The graphic presentation of the SCL-90 Symptomatic Profile, coupled
with the 9 dimensional symptom scores and the three global indices, provides a con-
cise, relevant statement of the patient's immediate symptom status (Figures 19 and
IQ) . A brief clinical narrative may also be appended to the SCL-90 Symptomatic
Profile to provide a verbal description of the symptom picture in greater depth.
Clinical utilization may be found particularly effective in situations where the
patient/professional staff ratio is high and para-medical staff are employed in a
screening role.
The SCL-90 should also find effective utilization as an efficient means of ob-
taining symptomatic information in non-psychiatric settings: Counseling centers,
student health facilities and medical clinics with a primary orientation toward
psychosomatic conditions should find the scales highly relevant. In addition, general
medical and surgical facilities are increasingly incorporating information on the
psychological status and psychiatric symptomatology of their patients to aid in mak-
ing decisions about adequate treatment regimens and case dispositions. The scale
provides a ready means of evaluating the interactive potential that the psychological
status of the individual may have on both primary physical conditions, and on the
outcome of procedures designed to alleviate or treat those conditions.
Although designed primarily for use with outpatients, the SCL-90 may also be
found valid and useful in certain specified inpatient settings. Raskin et al. (8)
found a modified version of the HSCL to be a sensitive indicator in the NIMH-PRB
inpatient studies of depression. Validation studies with inpatients are presently
examining its feasibility in this regard. Modified administrative formats (e.g.
interview presentation) are being assessed concomitantly.
In research contexts, the SCL-90 is an excellent instrument for inclusion in
protocols where the major criterion of interest involves assessment of an outpatient
symptomatic configuration. Relative brevity and ease of administration allow the
SCL-90 to be efficiently utilized in treatment studies which involve repeated assess-
ments of the symptom picture across time. The high test-retest and inter-rater
reliabilities of Dimensions I -V (1), {2k) are expected to extend to the new dimen-
sions, thereby providing the clinical investigator with a consistent basis for
evaluating treatment differences.
322
un r^
o
J-
r~^
LA
r^
LA
CTv
r^
LA
CM
'
0^
CSI
'
'
(_)
II
CSI
II
-z.
tn
I-'
2:
— .
X
o
2
•
s
CO
t-
LU
—
LU
2
X
—
^
Q
2:
1-
to
o
>-
z
Q
o
Z
0
N Q.
—
\-
<
—
—
o
—
K
X
CO
>-
—
1-
^-
Q.
LU
— X
Q.
CO
1—
-J
o
•
o
a.
S
0
t- o
Qc:
LU
LU
—
—
12
I
2:
^
Z
$v
LU
X
1—
00
DQ
O
^
o
>-
>-
CO
CO
o m
■z.
LU
-z.
o
3:
<
CO
LU
CO
00 o
O
<
3:
Q.
H:
Q-
_J
>
1—
CO
LU
•^ —
^
>
>
•^
—
^
X
LU
—
t-
—
^
^
>
^
^
—
Z
CO
00
~
>
>
LU
C3
0
a.
Q
I — I — I — i — I— I — I — I
a
— (_>
0
. —
>
0
in
a>
c
0)
c
(D
•—
in
E
Ql
(U
nj
U
U1
•—
0
0
E
(D
—
V)
Q.
■(-J
X
■i-j
E
(/)
<U
0)
Q.
c
in
0
>~
L.
E
M-
0)
—
i_
x:
Q. -I-J
>~
0
in
0)
4-
Q.
OJ
C
in
(U
>
-0
0)
in
1-
lU
■D
fO
Ml
>-
cn
<U
(0
0)
i_
c
4_l
1-
L.
1-
(D
•—
in
^
l-
0
in
Q.
_E
r—
0)
•l-J
(U
4-
■M
0)
4-
(U
M-
</l
<u
1-
tu
••—
(U
>-
<u
-C
Q.
4-
c
X
1_
»—
en
4-J
(D
c
^—
CD
■0
E
«J
in
(D
3
•»
•
(U
(D
•—
in
+J
0)
-Y
■0
x:
S
■!->
c
4-1
1_
c
C71
• —
S
Q)
3
(0
ID
•— .
(U
c
0)
0
E
-C
t~
•—
•—
■i-i
(D
A
(D
>
03
x:
in
^
8
c
1-
Q.
>
4-1
■M
0)
Q)
0)
• —
j:
. —
I+-
a;
•M
l/l
<U
3
CD
03
</i
c
• —
>
3
L.
(U
•—
^
•—
4->
0
0)
•M
</)
J-*
4->
0
x:
c
—
(TJ
J^
(D
(U
■M
D
£
2
O)
L.
'—
4-
ai
2
D
0
0)
4-
^^
OJ
0
4-
1_
(D
03
-D
0
•«
J=
j:
T3
c
0)
T3
U1
■M
~
in
0
«—
03
u
—
^
Q)
(0
•—
0
c
0
0)
<
M-
1-
•—
in
03
1-
•—
■a
0
3
^
T3
Q)
^-
0)
x:
in
0
1-
x:
•
XI
Q.
03
">
>•
S
c
M-
•—
in
•»
■t-i
0)
0
0
u
>
in
•i-i
JD
0)
•—
0
T3
in
03
c
IN
0
■l-J
0)
in
OJ
•—
•—
•—
*— -
0)
0)
c
0
V)
>
-a
:^-o
>
in
0
—
L.
c
■!->
r^
in
c
in
^
0)
0
in
in
0
lU
03
f-
c«
0
-
—
>
—
Q.
03
i3A3n ss3yisia
323
ri o CM
00
CTi O
LA
O
CNI
-3-^
—
-4 (V\ CM
'
CM
CM
CVJ
CS
CO
0
CSJ
II
II
CSI
CO
II
^ to
I-'
2:
-^
X
3 -Z.
s
CO
1—
LU
LU
z
X
^
Q
z:
z:
CO
o
>-
-z.
Q
0
Z
0
0
c
—
H
<
—
—
0
—
1-
X
1-
si Q. •
00
>-
—
h-
1-
Q.
LU
a.
- s: Q.
CO
1-
_J
CJ
0
a.
X.
0
s:
- o a:
LU
LlI
—
-z.
X
2:
>■
Z
>
r o uj
a:
-^
1-
OQ
^
0
>-
</)
—
CO
- 1 1-
Q.
X
co
O
>-
CO
D CQ z:
LU
-z.
o
x:
<
CO
LU
CO
LU
0 o —
o
<
T.
Q.
a:
Q.
_J
>
to
LU
>
•
•
1—
Qi
h- -1
_ —
>
>
—
^
—
X
LU
^
1-
— <
—
>
—
—
—
2
CO
co
00 P
~
>
>
LU
C3
0
0
0 0
Q- 1-
3
3
—
f—
^—
J3
1
0)
»^
0)
0
QJ
>
m
u
X)
^
u
(U
4-J
^
+j
0)
Q.
Q.
J3
(D
M-
(D
j:
"a
in
fO
0
■i->
c
—
+J
0
0
fO
0
0
in
t/1
tJ
c
c
1/1
c
■t-»
C7)
f^
1/1
0
c
c
^
m
•—
• —
.—
■M
4-i
+j
l/l
4-1
m
—
■0
m
C
T3
nj
!U
5
c
0
1_
<U
0
-0
(n
• —
0)
•M
»—
•—
in
■0
4-i
ro
M-
C C — (D O 0) —
0) O 1- +-> O "4- (0
1- •- (D -C O
I i I I — I— I — I — V
Q.
+j
cn
c
j:
m
0
OJ
3
•—
+J
Cl-
(U
C
&-
0
0
1 —
3
0)
-C
>--Q
(T)
M-
-C
4->
1—
E
4-1
-Q
14-
in
•
0)
0)
—
<D
0
<u
W-
>
•»
(D
-Q
<u
0)
. —
c
C
0
in
>
L.
-ii:
4-)
0
0
s_
c
tt)
CD
u
—
•—
Q.
0
lU
<ti
c
4-1
in
•—
■a
en
.—
3
■a
4-1
■0
^
0
-D
.•^
c
in
0)
<u
u
13
<u
(D
(U
4-1
4-1
•»
(0
■0
Ol
(D
(D
T3
c
-C
in
>
1-
• —
C
^
ai
3
<u
d)
"o
^
4-1
•—
in
-a
U)
. —
-C
(U
0
•
0)
3
-C
E
1-
0
•
in
4-1
4-1
>
c
in
in
•—
.—
(0
(0
(D
0)
c
2
-d-
J3
in
0
c
>■
0
CM
1-
in
1-
■s
4-1
+-'
3
(U
4-1
<u
in
0)
(/I
4-1
0
ID
0
c
4-J
•—
in
0
C
c
0
X
c
^
• —
1-
•—
0
•—
c
(U
1-
■D
Q.
0
0
in
<D
in
Ll- O
O Z
Z LU
:3 oc
x:
— O
Z M
O —
■^
to
CO
2
0
CO
—
0
1—
z
LU
LU
<
t3
Z
1-
0
<
g
0
_J
o
13A31 SSiyiSIQ
324
More specifically, the SCL-90 is expected to be particularly valid as a
criterion measure in clinical drug trials where the principal focus is on the
relative efficacy of psychoactive agents. Dimensions I -V have been repeatedly
shown to be sensitive indicators of treatment effects with a wide range of
psychoactive drugs (1), (Ik). The refinements in these scales, coupled with
the supplementation provided by Dimensions VI-IX, results in a marked extension
of the instrument's sensitivity to drug effects. Beyond the validity revealed
for this specific utilization. Dimensions I -V have been shown to be sensitive
to a wide variety of non-pharmacolog ic factors in the treatment setting (1),
(24). It is expected that the methodological revisions and substantive extensions
incorporated into the SCL-90 will function to enhance this sensitivity to drug-
extrinsic influences as well.
Scale Characteristics - The SCL-90 is comprised of 90 distinct items each of
which is rated on a 5-point scale of distress ranging from "not-at-all" to
"extremely". Under conditions of typical administration, the patient is instructed
by the technician as to how to fill out the form. Questions concerning procedure
or interpretation are resolved by the technician; however, the technician in no
way interferes with the self-rating characteristics of the procedure.
In those instances when the rater is other than the patient, (e.g.
doctor, social worker, psychiatric nurse, etc.) ratings should be made in terms of
manifest behaviors and/or complaints. Inferences about symptoms or distress,
where there is no explicit behavioral or verbal referent on the part of the patient,
should be minimized.
The SCL-90 has been provided with a flexible time context so that different
temporal limits may be utilized with the instrument. This feature also greatly
facilitates research on the effects of different temporal referents on the nature
of the symptomatic picture. Normally, however, the time context used with the
SCL-90 is 7 days. Numerous other rating scales use the one-week rating period as
standard, and a more extensive rationale for selection of this period is given by
Hamilton (9).
In developing the items, care was taken to use very fundamental phrasing; an
attempt was made to select the most basic word levels possible that would still be
consistent with the meaning of the item. Toward this end, the Thornd i ke-Lorge
Word Book of 30,000 Words (10) was employed to equate the vocabulary levels of the
9 dimensions and the overall verba] level of the instrument. Even with this con-
sideration, some patients' literacy levels will be insufficient to allow them to
validly complete the SCL-90. In cases of marginal literacy, care must be taken in
making interpretations; profiles developed under such conditions are probably best
assigned a tentative status.
The selection of 5-point rating scales for each symptom reflect the well-
documented observation - from both psychometric theory (11) and information theory
(12) - that the reliability of rating scales tends to be proportional to the number
of scale points provided (within certain limits). Also, the minimum number of
items subsumed under any one of the primary dimensions is six, in keeping with
recent observations about the relationship between factorial invariance and the
number of items per factor (13).
325
Developmental History - The immediate precursor to the SCL-90 was a rating scale
termed the Hopi<ins Symptom Checklist (HSCL) . This rating scale is comprised of
58 items which tend to focus on conventional neurotic symptoms, and are rated on
a 4-point scale of distress. A series of factor-analytic studies of both psychia-
trist's ratings (14) and patient self-ratings (15) on the HSCL isolated five
primary symptom dimensions underlying the scale. Construct validity has been demon-
strated for these dimensions (I6), and factorial invariance has been shown for
this dimensional set regarding patient social status, doctor rating versus patient
rating, and diagnostic class (see Bibliography).
The SCL was developed principally as a criterion measure in psychoactive drug
trials. It has been shown to have high sensitivity and predictive validity in
this regard (17, 18, 19). In addition, numerous "extrinsic" factors (e.g. doctor
medication attitude, patient perception of doctor warmth, etc.) have been reflected
by scores on the primary HSCL dimensions (see Bibliography). A consistent typology
of "anxious neurotic" patients (20) has also been developed in terms of the HSCL
symptom scales .
Slight variations in the number and content of the scales have resulted in
several similar versions of the HSCL (8, 21). These scales have very similar for-
mats and tend to be highly compatible regarding the underlying dimensions they re-
flect. Also, there is a brief version (35-item) of the HSCL that has been utilized
primarily by investigators in the Early Clinical Drug Evaluation Units (ECDEU) spon-
sored by Psychopharmacology Research Branch of NIMH. Most of these alternate
versions may be traced back to a prototype "Discomfort Scale" developed by Parloff
(22), and further elaborated by Frank (23). The Discomfort Scale was based to an
appreciable extent on symptoms taken from the Cornell Medical Index, and has been
used as a criterion measure in studies of psychotherapy.
A bibliography documenting much of the recent research done with the Hopkins
Symptom Checklist (HSCL) has been appended. In addition several thorough reviews
of this work have recently become available (1), (2^+) .
REFERENCES
1. Derogatis, L. R., Lipman, R. S., Rickels, K., The Hopkins Symptom Checklist
(HSCL): A Measure of Primary Symptom Dimensions in Psychological Measurement:
Modern Problems in Pharmacopsychiatry. P. Pichot (Ed.) Karger, Basle,
Switzerland; 1973-
2. Marks, I. M. Fears & Phobias, Academic Press, New York, I969.
3. Marks, I. M. The classification of phobic disorders. Brit. J. Psychiat.,
116:377-386, 1970.
4. Swanson, D. W., Bohnert, P. J., and Smith, J. A., The Paranoid, Little, Brown
and Company, Boston, 1970.
5. Schneider, K. Clinical Psychopathology , M. W. Hamilton (trans.), Grune &
Stratton, Inc., New York, 1959.
326
6. Mellor, C. S. First rank symptoms of schizophrenia. Brit. J. Psychiat.,'
117:15-23, 1970.
7. Taylor, M. A. Schne ider ian first-rank symptoms and clinical prognostic
features in schizophrenia. Arch. Gen. Psychiat., 26:6U-67, 1972.
8. Raskin, A., Schul terbrandt , J. G., Reatig, N. & McKeon, J. J. Differential
response to chlorpromaz i ne, imipramine and placebo. Arch. Gen. Psychiat.,
23:16^-173, 1970.
9. Hamilton, M. The Hamilton Depression Scale, In: Guy, W., & Bonato, R.,
ECDEU Assessment Manual, NIMH, Md . , O8-7, 1970.
10. Thorndike, E. L., and Lorge, I. The Teacher's Word Book of 30,000 Words.
Bureau of Publications, New York, 19^^.
11. Guilford, J. P. Psychometric Methods. McGraw-Hill, New York, 195^.
12. Garner, W. R. Rating scales, d iscr imi nab i 1 i ty , and information transmission.
Psychol. Rev., 67:3^3-352, I96O.
13. Gorsuch, R. L. A comparison of biquartimin maxplane, promax, & varimax.
Educa. & Psychol. Meas . , 30:861-872, 1970.
l^t. Lipman, R. S., Rickels, K., Covi, L., et al. Factors of symptoms distress:
Doctor ratings of anxious neurotic patients. Arch. Gen. Psychiat., 21, I969.
15. Derogatis, L. R., Lipman, R. S., Covi, L., et al. Neurotic symptom dimensions
as perceived by psychiatrists and patients of various social classes. Arch.
Gen. Psychiat. , 2k, 1971 .
16. Derogatis, L. R., Lipman, R. S., Covi, L., et al. Dimensions of outpatient
neurotic pathology: Comparison of a clinical vs. an empirical assessment.
J. Consult. & Clin. Psychol., 3^, 1970.
17. Uhlenhuth', E. H., Rickels, K., Fisher, S., et al. Drug, doctor's verbal
attitude and clinical setting in the symptomatic response to pharmacotherapy.
Psychopharmacolog ia (Berl.), 9, 1966.
18. Lipman, R. S., Park, L. C. & Rickels, K. Paradoxical influence of a thera-
peutic side-effect interpretation. Arch. Gen. Psychiat., 15, 1966.
19. Rickels, K., Lipman, R. S., Park, L. C, et al. Drug, doctor warmth £- clinic
setting in the symptomatic response to minor tranquilizers. Psychopharmacolog ia
(Ber.), 20, 1971.
20. Derogatis, L. R., Lipman, R. S. & Covi, L. A typology of anxious neurotics,
paper presented at the Eastern Psychological Associat ion Annual Meeting,
Boston, 1972.
327
21. Rickels, K., Lipman, R. S., Garcia, C. R., et al. Evaluating clinical
improvement in anxious outpatients: A comparison of normal and treated
neurotic patients. Amer. J. Psychiat., 128, 1972.
22. Parloff, M, B., Kelman, H. C. & Frank, J. D. Comfort, effectiveness and
self-awareness as criteria of improvement in psychotherapy. Amer. J.
Psychiat., 111:3^3-351, 195^.
23. Frank, J. D., Gliedman, L. H., Imber, S. D., Nash, E. H. and Stone, A. R.
Why patients leave psychotherapy. A.M.A. Arch. Neur. & Psychiat., 77:
283-299, 1957.
2k. Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H. & Covi, L.
The Hopkins Symptom Checklist (HSCL) : A Self-R«Dort Symptom Inventory.
Behav, Sci. (In press - March, 197^).
BIBLIOGRAPHY
A. SCALE EVOLUTION
1. Derogatis, L. R., Lipman, R. S., Covi, L., et al: Neurotic symptom
dimensions as perceived by psychiatrists and patients of various social
classes. Arch. Gen. Psychiat., 2k, 1971.
2. Derogatis, L. R., Lipman, R. S., Covi, L., et al: Dimensions of out-
patient neurotic pathology: Comparison of a clinical vs. an empirical
assessment. J. Consult. & Clin. Psychol., 34:2, 1970.
3. Lipman, R. S., Rickels, K., Covi, L., et al: Factors of symptom distress:
Doctor ratings of anxious neurotic outpatients. Arch. Gen. Psychiat.,
21, 1969.
k. Lipman, R. S., Covi, L., Rickels, K., et al: Selected measures of change
in outpatient drug evaluation. Psychopharmacology: A Review of Progress
1957-1967. PHS Pub. No. I836, U. S. Gov't, Printing Office, Washington,
D. C, 1968.
5. Williams, H. V., Lipman, R. S., Rickels, K., et al: Replication of symptom
distress factors in anxious neurotic outpatients. Multivar. Behav. Research,
3. 1968.
6. Mattsson, N. B., Williams, H. V., Rickels, K., et al: Dimensions of symptom
distress in anxious neurotic outpatients. Psychopharm. Bull. 5 (Jan.), I969.
B. DRUG SENSITIVITY
1. Rickels, K., Lipman, R. S., Park, L. C. , et al: Drug, doctor warmth and
clinic setting in the symptomatic response to minor tranquilizers.
Psychopharmacologia (Berl), 20, 1971.
328
2, Lipman, R. S., Park, L. C, & Rickels, K.: Paradoxical influence of a
therapeutic side-effect interpretation. Arch. Gen. Psychiat., 15, I966.
3. Uhlenhuth, E. H., Rickels, K., Fisher, S., et al: Drug, Doctor's verbal
attitude and clinic setting on the symptomatic response to pharmacotherapy.
Psychopharmacologia (Berl.), 9, 1966.
k. Covi, L., Lipman, R. S., Pattison, J. H., et al: Length of treatment with
chlord iazepoxide and response to its sudden withdrawal. (in press,
Psychopharmacologia) .
5. Hesbacher, P. T., Rickels, K., Hutchison, J., et al: Setting, patient, and
doctor effects on drug response in neurotic patients: II. Differential
improvement. Psychopharmacologia (Berl.), 18, 1970.
6. Covi, L., Park, L. C, Lipman, R. S., et al: Withdrawal of meprobamate and
chlord iazepoxide in anxious outpatients. In Cole, J. 0. 5- Wittenborn,
J. R., (Eds.), Drug Abuse: Social and Psychopharmacolog ical Aspects.
C. C. Thomas, Springfield, 111., I969.
7. Rickels, K.: Drugs in the treatment of neurotic anxiety and tension:
Controlled studies. Psychiatric Drugs, Grune and Stratton, Inc., U.S.A.,
1966.
C. SENSITIVITY TO EXTRINSIC FACTORS (NON-DRUG)
1. Derogatis, L. R., Covi, L., Lipman, R. S., et al: Social Class and race
as mediator variables in neurotic symptomatology. Arch. Gen. Psychiat.,
25, 1971.
2. Hesbacher, P. T., Rickels, K., £• Goldberg, D.: Neurotic symptoms in
general practice: Clarification of the relationships of sex, race, and
social class. In press.
3. Hesbacher, P. T., Rickels, K., Hutchinson, J., et al: Setting, patient,
and doctor effects on drug response in neurotic patients: II. Differential
improvement, Psychopharmacologia (Berl.), 18, 1970.
k. Lipman, R. S., Uhlenhuth, E. H., Rickels, K., et al: Medication attitudes
and drugs response. Dis. Nerv. Sys., 30, 1969.
5. Uhlenhuth, E. H., & Covi, L.: Subjective change with initial interview.
Amer. J. Psychother., 23:3, 1969.
6. McNair, D. M., Kahn, R. J., & Droppleman, L. F.: Patient acquiescence and
drug effects. In Rickels, K. (Ed.), Non-Specific Factors in Drug Therapy.
C. C. Thomas, Springfield, 111., I968.
7. Rickels, K., & Anderson, F. L.: Attrited and completed lower socioeconomic
class clinic patients in psychiatric drug therapy. Comp. Psychiat., 8:2,
1967.
329
8. Lipman, R. S., Rickels, K., Uhlenhuth, E. H., et al: Neurotics who fail
to take their drugs. Brit. J. Psychiat., Ill, 1965.
9. Rickels, K.: Some comments on non-drug factors in psychiatric drug-therapy,
Psychosomat ics , 6, 1965-
10. Uhlenhuth, E. H., Park, L. C, Lipman, R. S., et al: Dosage deviation and
drug effects in drug trials. J. Nerv. & Ment. Dis., I4l:l, 1965.
11. Fisher, S., Cole, J. 0., Rickels, K., et al: Drug-set interaction: The
effect of expectations on drug response in outpatients. Neuropsychopharm.
3, 196it.
D. CONTENT VALIDITY
1. Derogatis, L. R., Lipman, R. S., Covi, L., et al: Dimensions of outpatient
neurotic pathology: Comparison of a clinical vs. an empirical assessment.
J. Consult. & Clin. Psychol., 3^:2, 1970.
E. CONSTRUCT VALIDITY
1. Rickels, K., Lipman, R. S., Garcia, C. R., et al: Evaluating clinical
improvement in anxious outpatients: A comparison of normal and treated
neurotic patients. Amer. J. Psychiat., 128:8, 1972.
2. Rickels, K-, Garcia, C. R., & Fisher, E.: A measure of emotional distress
in private gynecologic practice. Ob-Gyn., 38:1, 197'.
3. Derogatis, L. R., Lipman, R. S., Covi, L., et al: Dimensions of out-
patient neurotic pathology: Comparison of a clinical vs. an empirical
assessment. J. Consult. & Clin. Psychol., 3^:2, 1970.
k. Park, L. C, Uhlenhuth, E. H., Lipman, R. S., et al: A comparison of
doctor and patient improvement ratings in a drug (meprobamate) trial.
Brit. J. Psychiat., ill, I965.
F. RELIABILITY
1. Derogatis, L. R., Lipman, R. S., Rickels, K., Uhlenhuth, E. H. & Covi, L.:
The Hopkins Symptom Checklist (HSCL): A measure of primary symptom
dimensions. In P. Pichot (Ed.). Psychological Measurement: Modern
Problems in Pharmacopsychiatry. S. Karger, Basel, Switzerland, 1973.
G. FACTORIAL INVARIANCE
1. Derogatis, L. R., Lipman, R. S., Covi, L., et al: Factorial in\/ariance
of neurotic symptom dimensions in anxious and depressive neuroses.
Arch. Gen. Psychiat. 155, 1972.
2. Derogatis, L. R., Lipman, R. S., Covi, L., et al: Neurotic symptom
dimensions as perceived by psychiatrists and patients of various social
classes. Arch. Gen. Psychiat., 2k, 1971.
330
H. ADDITIONAL STUDIES
1. Derogatis, L. R., Lipman, R. S. & Covi, L.: A typology of anxious
neurotics. Paper read at the 43rd Annual Meeting of the Eastern
Psychological Association, Boston, April 27-29, 1972.
2. Yevzeroff, H., Derogatis, L. R., Lipman, R. S. & Covi, L.: Constancy
of neurotic symptom dimensions among psychiatric outpatients. Paper
read at the 44th Annual Meeting of the Eastern Psychological Associa-
tion, Washington, D. C. May 5, 1973.
331
073 SDS
SELF-RATING
DEPRESSION
SCALE
MH t73
6-73
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
PUBLIC HEALTH SERVICE
NATIONAL INSTITUTE OF MENTAL HEALTH
ZUNG SDS
FO«M APPROVED
OM6 NO MII953
PATIENT INITIALS
:A:: -&■-
:«:: :±;:
:U:: :W::
:£: :H::
FIRST
:0: :!?::
INITIAL
-.Hz ::»:
rj::
:fr::
NUMBER MALES 001 to 499; FEMALES SCO to 998
rO:: ::t:: .:Z:z z-3:z ::4:^ =5" -&z if?:: :«:: :*:
PATIENT
:0:: ::t:: -^- :3:: :^: :5" rfi:: if?:: :«:: :S::
:0:: ::t:: =2:: 3:: ::*: =5:: :«: :i7;: ;»:: :«:
; J4 :
SECOND
INITIAL
:&..
-.&-.
zhtz :rl:
Sfc*- :;..- -:i\-- ,.' ' : RATER
:i J
0:: -:t-z .3z. -3zz lat: :5i: :«:
PERIOD
O:: ::t:: :2:: :3:: :^: :S== :«:
Houn Days Weeks
::7t: rft: i®:
I
■"•«■
FORM
NO.
::?:: :«: :«=
AAonthi
PLEA";.'- Mr.
-: !\ HO
. 2 LEAD PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
INSTRUCTIONS
Listed below are 20 statements. Please read each one carefully and decide how much of the statement describes how you have
been feeling during the past week. Decide whether the statement applies to you for NONE OR A LITTLE OF THE TIME, SOME
OF THE TIME, A GOOD PART OF THE TIME, OR MOST OR ALL OF THE TIME. Mark the appropriate column for each statement.
EXAMPLE 1
NONE 01
« LinLE
STATEMENT "{jf'
SOME
OF THE
TIHE
AEOOD
tAII OF
THE TINE
MOST
01 Alt
OF THE
TIME
1 feel nervous -'^'-'-
--2^z
•*•
ijjrr
If the statement "1 feel nervous" describes the way you have felt
"A GOOD PART OF THE TIME", you would mark column 3
"A GOOD PART OF THE TIME" as shown.
STATEMENT
HONE 01
A LiniE
OF THE
TIME
SOME
OF THE
TIME
A eooD
PAIT OF
THE TIME
MOST
01 All
OF THE
TIME
"J::
z2^z
.■3iz
:lJ::
III"
-Z^z
z-3:z
lit:
III"
rSi
--3:z
:ltr
III"
=2:--
z-3:z
:4::
zzl"
=2::
z-3zz
:A:
izlii
z-2^z
Z-3ZZ
:A:
r:t;:
--2zz
z-3zz
-Az
irli;
=2::
Z-3ZZ
:2t:
lit"
-S^z
=3::
:4:=
=;t"
-S^z
:3:r
:2j:=
Z^II
=«::
:3::
:3t::
izlii
=2::
:3c:
:l4::
zAzz
z-2zz
:a::
:3t:
"t=:
=2::
:-3::
:Jt:
zitii
-S^z
:3::
:4::
r4::
-Sr-
:3::
.-21;:
zzXzz
-S^z
:3::
:4::
:rjri
-S;z
:3::
;2l::
i:t"
-S^z
:3:=
:*:
"J"
13::
:*:
:2);:
1 . I feel downhearted and blue
2. Morning is when I feel the best
3. I have crying spells or feel like it
4. J have trouble sleeping at night
5. I ea*. as much as I used to
6. I still enjoy sex
7. I notice that I am losing weight
8. I have trouble with constipation
9. My heort beats faster than usual
1 0. I get tired for no reason
1 1 . My mind is as clear as It used to be
12. I find it easy to do the things I used to do
13. I am restless and can't keep still
14. I feel hopeful about the future
15. I am more Irritable than usual
16. I find it easy to make decisions
17. I feel that I am useful and needed
18. My life is pretty full
19. I feel that others would be better off if I were dead
20. I still enjoy the things I used to do
334
Zung's Self-Rating Depression Scale (SDS) is a 20-item independently
formatted scale in which the subject rates his symptomatology on a ^t-point scale
of severity. This version of the SDS replaces the original Zung Depression Scale
(Form 09). The identification block has been changed and the wording of 2 of
the scale points has been altered in the present version. The SDS is the patient-
rated version of the Depression Status Inventory.
REFERENCE Zung, W. W. K., A Self-Rating Depression Scale, Arch. Gen.
Psychiat,, 12, 63-7O, 1965
Zung, W. W. K., Factors Influencing the Self-Rating
Depression Scale, Arch. Gen. Psychiat., 16, 5^3-5^7, I967.
APPLICABILITY Adults with depressive symptoms
UTILIZATION Once at pretreatment ; at least one post-treatment rating.
Additional ratings are at the discretion of the investigator.
TIME SPAN RATED Now or within the past week
CARD FORMAT - ITEMS CARD 01 = (19x, 2011, lOx, l4)
Item Column Item Column
1 20 11 -A- 30
2* 21 12-.V 31
3 22 13 32
k 23 14-A- 33
5* 2k 15 34
6^^ 25 16-A- 35
7 26 17-A- 36
8 27 18-.V 37
9 28 19 38
10 29 20-'- 39
Index Score 50 - 53
^v Items reflected in scoring.
Table 9 gives the conversion of SDS raw scores into Index scores, (p. ]yk )'.
The following table from Zung presents mean index scores for 5 diagnostic groups:
Mean
Diagnosis N SDS
I ndex
Depressive disorders 96 65"
Schizophrenia 25 51
Anxiety disorder 22 53
Personality disorders 5^ 56
Transient situational disturbances 12 48
" Significantly different from other 4 groups (p <^ .01).
335
SPECIAL INSTRUCTIONS
The rater should make certain that the subject fully understands the task
and the correct method of recording his responses. When the subject finishes,
the rater should check all items for omissions or multiple marks. Unless
clinically inadvisable, the rater should urge subject to complete all items.
The rater should also encode patient and period numbers within the identifica-
tion block. Rater number is precoded and need not be filled in. The patient's
initials may be encoded by either the subject or rater.
Both Form and Rater Numbers are precoded and no entries are required - or
indeed permitted - in these shaded areas.
Example: Writing in Form and/or Rater Number is incorrect and
may trigger multiple opscan punches.
lis/::
rfrt:
:W:
vt:
:^:t i-^z
:0-
:rt::
zisr-z -3zz
:4: :5::
:«::
::?:: =8=:
-l»z
zEtz
--tiz
:3t:
:£:: :H::
SECOND
:©:: :P::
INITIAL
zifzi :*:
:e:: -Hz ::l:: :d::
:ar -Szz :S:: ::T::
. .0.C
:.^:r
zSr^z3=
RATER
' :t±c
:0"
:0==
:0::
Hours .
:« :3::
/Sr-z :3::
r Day*
:2r:
:*: rS-:
PERIOD
::*: -^z
Weeks
:3^:
:«::
::?tr :«::
::7t: :«::
Months
zzUzz
-r&^z
'
t'^'
'>«>
FORM
NO.
::©::
\
This is incorrect,
DOCUMENTATION:
a. Raw score printout
b. Index score printout
c. Means and standard deviations for index scores
d. Variance analyses
336
054 SAS
SELF-RATING
ANXIETY
SCALE
DEPARTMENT OF HEALTH. EDUCATION, AND WELFARE
NATIONAL INSTITUTE OF MENTAL HEALTH
S A S
William W.K.Zung.M.D.
PATIENT
INITIALS
NUMBER MALES 001 TO 499
NUMBER FEMALES 500 TO 998
A
B
■x>
-D
E
FIRST
:*::
:«:
:-H
::(::
::J::
:»:
::1::
::2::
-3
:*
:*:
:*:
.7:.
::a:
::9
fATIENT
(}
K
t
■■*A
n
ti
:»>::
:Q:
:«;
:«::
.^..
:«:
::J::
::?:
:.S
4
::6:
::J::
»
INITIAL
^~
\f
V
■W
-.JC-:
:y:
:rZ:
^
::!::
::2:
::3:
:«
:*:
::6:
::?^:
::a:
::9:
^~
:A::
:fl::
:£:
:&:
-£:
SECOND
:f::
:S:
:±t:
-i::
:J::
, = •-
-II-.-
,^'
"»:
:♦:
RATER
:*;
:*-.
>A:
-.-A:
^
:«:
:*,:
-.M:
:il»:
:.0
INITIAL
:f::
rQ
::R:
:*:
::T-
= •■
"J.-=
:«.
,-■=*.:,.■
:*-•
M.^S;:*'.
-*:
„„_^;.,
^:
:«:
^~
:«;-
:V:
vt
X
Y
:Z.
:*:
::J::
"2::
::$:
4
::6::
::B:
::?:
::8:
:;9
—
PERIOD
FORM
-^
::&:
Hours
.2..
:r3
Days
:4:
Weeks
-S^-
::7::
Months
::8:
: 9:
-_
::&:
r:^:
r
:3::
:*
^
INSTRUCTIONS: Ljsted below are 20 statements. Please read each one carefully and decide how much of the statement
describes how you have been feeling during the past week. Decide whether the statement applies to you
NONE OR A LITTLE OF THE TIME, SOME OF THE TIME, A GOOD PART OF THE TIME, OR MOST
OR ALL OF THE TIME. Mark the appropriate column for each statement.
PLEASE USE A N0.2 PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
None
or
a little of
the time
1 . I feel more nervous and anxious than usual ::j::
2. I feel afraid for no reason at all "1;:
3. I get upset easily or feel panicky ::1::
4. I feel like I'm falling apart and going to pieces r:l::
5. I feel that everything is all right and nothing bad w/ill happen ::1:;
6. My arms and legs shake and tremble ---.%-.:
7. I am bothered by headaches, neck and back pains ::!::
8. I feel weak and get tired easily "1::
9. I feel calm and can sit still easily :;1::
10. I can feel my heart beating fast -.-.r--.
11. I am bothered by dizzy spells z-.t.-.
12. I have fainting spells or feel like it z:y.:
13. I can breathe in and out easily ::]::
14. I get feelings of numbness and tingling in my fingers, toes z.^-
15. I am bothered by stomachaches or indigestion "1::
16. i have to empty my bladder often -l-
17. My hands are usually dry and warm z.y.z
18. My face gets hot and blushes zzy.z
19. I fall asleep easily and get a good night's rest -I::
20. I have nightmares ..y.z
Some
of the
time
::2::
A good
part of
the time
Most
or
ALL of
the time
::2::
-3::
::*:
::2::
:*:
:^r
::?::
::»:
::*:
::2:
-^
:34::
::2:
-^
::*:
::2:
-^
--4:-
::2:
-:»
:i4;:
i:2::
-^
::*:
"2:
r-
::*:
::2::
.<sr-
=4::
::2:
-^--.
::*:
::2::
:3::
:=*:
::2::
-^
--A:-
::2:
-^■
--^z
-2::
^
:^i
.:2:
:3=r
::4::
;:2::
:3::
:^:
::2:
:3:r
-^.
::2:
--»:
:at:
338
Zung's Self-Rating Anxiety Scale (SAS) is a 20-item scale in which the
subject rates his symptomatology on a 4-point scale of severity. The SAS is
self-contained and does not utilize the General Scoring Sheet. The comparable
clinician-rated version (AS I ) is described on pages
REFERENCE Zung , Wm . W. K., A Rating Instrument for Anxiety
Disorders, Psychosomat ics , 12, 371-379, Nov ./Dec , 1971 .
APPLICABILITY Adults with symptoms of anxiety
UTILIZATION Once at pretreatment ; at least one post-treatment assess-
ment. Additional ratings are at the discretion of the
i nvest i gator .
TIME SPAN RATED One week prior to rating
CARD FORMAT - ITEMS CARD 01 = (19x, 2011, llx, \k) .
I tern Column I tern Column
1 20 11 30
2- 21 12 31
3 22 13" 32
k 23 ]k 33
5-'- 2k 15 3h
6 25 16 35
7 26 17--'^ 36
8 27 18 37
9-'-- 28 19" 38
10 29 20 39
I ndex Score 50 - 53
" = Scores on these items are reflected when computing total raw score.
Table 11 gives the conversion of SAS raw scores into Index scores, (p. 202)
The following table from Zung presents mean index scores and standard deviations
for 5 diagnostic groups:
SAS Index
Diagnosis N Mean S.D.
Anxiety Disorder
Sch izophren ia
Depressive Disorder
Personality Disorder
Transient Situational
D isturbances
Controls (Normals)
" = Significantly different from other 4 diagnostic groups (p = .05)
''"" = Significantly different from all diagnostic groups (p = .01)
22
58.7
13.5--<
25
46.4
12.9
96
50.7
13.4
54
51.2
13.2
12
45.8
11.9
00
33.8
5.9--'
339
SPECIAL INSTRUCTIONS:
The rater should make certain that the subject fully understands the task
and the correct method of recording his responses. When the subject finishes,
the rater should check all items for omissions or multiple marks. Unless clin-
ically inadvisable, the rater should urge subject to complete all items. The
rater should also encode patient and period numbers within the identification
block. Rater number is precoded and need not be filled in. The patient's
initials may be encoded by either the subject or rater.
Both Form and Rater Numbers are precoded and no entries are required - or
indeed permitted - in these shaded areas. (See page 336 ).
DOCUMENTATION:
a. Raw score printout
b. Index score printout
c. Means and standard deviations for Index scores
d. Variance analyses
COMMENTS OF THE AUTHOR
Wi 1 1 iam W. K. Zung, M.D.
The SAS is based on the same 20 diagnostic criteria as the observer rated
Anxiety Status Inventory. So that the patient is less able to discern a trend
in his answers, the scale was devised so that of the 20 items used, some of the
items were worded symptomat ical 1 y positive, and others symptomat ical ly negative,
depending upon their suitability and usage. In addition, an even-number of
columns were used to eliminate the possibility of a patient checking middle and
extreme columns.
Cumulative data on the SAS from several completed studies of psychiatric and
normal subjects indicate that a morbidity cut-off score on this scale would be at
kS. Thus, patients with scores of k5 and above on the SAS would be considered by
most clinicians to have anxiety symptoms of significant severity. Complete corre-
lation with clinical global impressions and the SAS indices and other anxiety
scales will ^^° available at a later date.
340
033 TWIS
TESS
WRITE-IN
SCALE
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
TREATMENT EMERGENT SYMPTOMS SCALE— WRITE-IN
PATIENT
INITIALS
-v----
--U:--
RRST
INITIAL
z-J-.-.
NUMBER MALES 001
rO:: riL:: i£=:
:Oi: =:L:: =£.-:
:Oi: ::l;r :fcr
TO
i3i=
499; FEMALES 500
.^- PATIENT ...
'" NUMBER
TO 998
r&= ::7:=
r&.- "7=r
:&: r:7:r
:*=
=:&=
:A=
':A=
=d9:=
:*:-
:«::
-M----
-x---
SECOND
-.0-.-. :*--:
INIHAL
:«;:
:«::
-it-- ".i-.-
-a---- zs---
r:Lr:
"L:i
^^^ RATER ;±:
. NUMBER
::7:=
=dB:=
==&=
:A=
==&:
-.It-.-.
:iL:=
Noun
iiLii
:3ir
I*:
Oayi
PERIOD
Wnki
=:&=
=&=
==7"
zzTzz
=*r'
==&=
==ft=
==ft:
==»:
m
H
M
H
Pt£ASE USE A NO. 2 LEAD PENQL BE SURE TO MAKE MARKS HEAVY AND DARK.
ERASE COMPLETaY ANY MARKS YOU WISH TO CHANGE.
INSTRUCTIONS: This scale MUST be used in conjunction with the DOTES. Be sure that the PERIOD designation matches the
proper DOTES. Make three judgnoents for each symptom and confine all writing wUhin the box provided.
DO NOT MARK IN SHADED AREAS
1. OTHER SYMPTOM (Conhntwriling within Iha block)
MOO-
==t== =4=:
RELATIONSHIP
ACTION
NoM iMHti FKiibh hokobh MimI
TAKEN:
=«:i =:»== =*= :*: :a*=
2. OTHER SYMPTOM (ConHn« wrHing within thii bhck)
HIU ^^ SE«Bf
=:»:z :i:: ==Sr
3. OTHER SYAAPTOM (Conhnt writing within thii blocki
HOO-
"""l BAH
SEVBE
==3:=
RELATIONSHIP
N«M laintt rtsaM* htlnlil« Mmi
;«:= ==J== =fcr =i: =*:
4. OTHER SYMPTOM (ConKnt writing within thit block)
WID
=:t=:
HOO-
HATt ««K
:4=r :*:
RELATIONSHIP
NoM laiwti r«aU< Pnbtfi MmJ
:«:: ::»:= :«:= ==3== :*:
5. OTHER SYMPTOM (Confin* writing within this block)
MOO-
wiii j„„ stvai
==t=: =S=; ==3::
RELATIONSHIP
NoM iMwta PesaU* rrobibh MmJ
=«:: ==J" =*= zzi: =*=
6. OTHER SYMPTOM (Confint writing within this block)
MOD-
Eun
SEVBt
==5::
RELATIONSHIP
N«M Imnti Possflih PrekobI* MUmJ
::©:= ==J:= ==fc= :=»= ==*=
RELATIONSHIP
ACTION
NoM Innati PosiiUt Prekabb DtfiMd
TAKEN:
=*: 1=1" :S;= =i= ==•:=
ACTION
TAKEN:
• ^A /yt^VX
=fi:= ==Ji= =£== =3c= =*: ==5== :=&=
^
^/ /•^^/t^
Developed within the ECDEU program, the TESS Write-In Scale (TWIS) is an
independently formatted 6-item scale to be used in conjunction with the Dosage
Record and Treatment Emergent Symptoms (DOTES). Since writing of any sort is
absolutely prohibited on the General Scoring Sheet, a separate scale had to be
designed to allow the rater to record the presence of any treatment emergent
symptoms whose names were not printed on DOTES.
APPLICABILITY
UTILIZATION
For all research populations
Used in conjunction with DOTES whenever it is
necessary to record the presence of a symptom
not printed on DOTES
TIME SPAN RATED Same as the referent DOTES
CARD FORMAT - ITEMS CARD 01 = (19x, 6(13, 311) )
Symptom
Col umns
20 - 25
26 - 31
32 - 37
Symptom
k
5
6
Col umns
38 - k3
kk - i+9
50 - 55
The length of the data field will vary with the number of "write-ins". The field
for each "write-in" is |6 and is coded as follows:
Symptom code
I ntens i ty
Relat ionship
Act ion
First 3 columns
'4th column
5th column
6th column
SPECIAL INSTRUCTIONS
Identification Block (ID) - It is essential that the ENTIRE ID BLOCK coded on TWIS
MATCH EXACTLY the ID block of the corresponding DOTES. Example - While rating the
DOTES at Day 2k, the rater observes that - in addition to tremor and increased sali-
vation (printed symptoms) - the subject is grinding his teeth. On Item k of DOTES,
he codes "2 = yes, both printed and write-ins present" and then proceeds to code his
judgments of "tremor" and "increased salivation". He next fills out the TWIS by com-
pleting the ID block exactly as it appears on DOTES. Finally, he writes in "grinding
teeth" and makes his 3 judgments of the symptom.
- -t:: :«:: :a.- :«:: ::l:: :J::
SECOND
:X:: :t:: :*»:: -H"- -O-- :«:: :«:: -Ji-- -S- ::T::
.«. -A'- 2- :3:: A- RATER ^ *^- ^
NUMBER
:fl:: .rii. :2:: :3:: .A. :i: :*: ::7::
::a:
::&:
::»:
:«:: :V:: -ift- ^X-- V ■•»
:fl:: ::!:: «^ :3:: -A- :i: -A- ::7::
PERIOD
:fl:: ::t:: :2:: -2- .4- :*: :*: ::7::
Hours Days Weelts Months
:fl:: ::t:: ^^ :i: :*:
::&:
::a:
::*:
::*:
>*- FORM
,«. NO.
PLEASE USE A NO. 7 LEAD PENCIL BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
INSTRUCTIONS: This scale MUST be used in conjunction with the DOTES. Be sure that the PERIOD designation matches the
proper DOTES. Make three judgments for each symptom and confine o// writing within the box provided.
DO NOT MARK IN SHADED AREAS
1. OTHER SYMPTOM (Confine wri/ing w.lhin (/..s Wocic)
:©:: ::t:: :£:: :3:: -A- :3:: :&: ::7::
:fl:: ::t:: :2:: :3:: :^r: :i:: :*: ::7::
:fl:: ::t:: :2:: :3i: -A.-- li:: :*: ::7:-
:A:
:Al
3^3
Notice in the above example that NO marks have been made in the shaded areas of
either the ID block or text of the scale. The code for "grinding teeth" will
be inserted by BLIPS editors.
Form Number - This number is preprinted on the form and need not - indeed must
not - be encoded again. (See page 336).
Items 1 - 6. Other Symptom - When writing in a symptom, the rater must make
judgments of intensity, relationship and action undertaken exactly as he does
for DOTES. He must also confine his writing ENTIRELY within the blocks pro-
vided. Failure to do so may cause the optical reader to misinterpret signals
and cause processing delays,
Exampl es :
OTHER SYMPTOM (Conlir
'iting within this block)
None (emote foiMf/tiobMt Defined
ACTIO
TAKEN
INCORRECT - May cause multiple codes in Intensity and/or Relationship,
OTHER SYMPTOM (Confine writing within this block)
•*""■ SEVERE
None Remote Possible Probable Defined
r:©:: ^.4» :i:r :ii lA:
INCORRECT - Requires erasure before symptom code can be inserted,
OTHER SYMPTOM (Confine writing within this block)
RELATIONSHIP
None Remote Possible Probable Defined
=«:r :■!> :5:i -zS^z z=«:i
ACTION
TAKEN:
CORRECT - No opscan problems,
3^+4
Symptom Code - A 3-digit numeric code for the "write-in" permits documentation
of "write-ins" by name. A list of these treatment emergent symptom codes will
be provided upon request to the Biometric Laboratory.
Intensity, Relationship, Action - These 3 judgments are rated in the same manner
as described in DOTES.
DOCUMENTATION
a. Raw score printout
b. "Write-ins" will be incorporated within the documentation provided
for DOTES.
345
038 STESS
SUBJECTS
TREATMENT EMERGENT
SYMPTOM SCALE
MH-9-38
1-73
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
STESS
PATIENT INITIALS
NUMBER MALES 001 TO 499; FEMALES 500 TO 998
~
zC-.-. :«::
HRST
INITIAL
:«;: -S-z
zziz
:0:: ::►:: :*::
:0:: "t" :4::
:Or: Z.U-. :4=:
:*: :*; :*: :;Ti: =*: :*:
PATIENT
I*: :*; :*: :=T:r =*: rAr
I*: I*: :*: zzTzz i*: r*:
^
:C:: :«r:
--M:-. --n-.z
SECOND
INITIAL
zziz
:0::
S
M
F
:3"
:*: :*i :*: ::Ti: i*: :*:
RATER
-.*: r*r r*: riT:= i*: ;*r
^
:«" :V"
=0--: t:L:: :*::
Doyi
:*: :*r r*- ==T:: :*: :*-"
PERIOD
:*: :*r :*: idT: :*: ::*:
WhIci «Aon«ht
—
WM
^^^Hi
m "^ ffi '^"
~
PIEASE USE A NO. 2 LEAD PENQL BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
—
INSTRUCTIONS:
Since the
you been
filling out
mark "Dor
ast time here, hove you been bothered with or had trouble with any of the items listed below? If this is your first visit, have
>othered by any of these items in the last week? Mark the number which best tells how much you were bothered. When
form for the child, mark on the basis of what you have seen or what the child has complained about. If you are unsure,
't know".
^
EXAMPLE
Cram
Ncl Just ^
et . '"""
All Unh ""■'"
pS? :«:: i;t:r i«.
Vtry
Hgcb
Don't
Kiww
—
Hova you hoc
trouble with: ITEM
1 . Eating?
«ii imi. "«''
:«:= :rj=-. z±:z
Vtry
Much
Don't
Know
^
2.
Drinking?
:«:: "»" l*r
:*;
=*=
—
3.
Dry mouth and lips?
r*; r:J" t:^:
:*:
t*:
—
4.
Wetness in mouth?
:«:: =:»:: I*:
=*:
=*:
—
5.
Fewer bowel movements (constipation)?
:«:: =:):: i*:
"-*:
---^z
—
6.
AAore bowel movements (diarrhea)?
!«:= =.-»=: I*:
=*:
-z^z
—
7.
Stomach aches?
=«:: :rj=: =*i
I*:
=*-
—
8.
AAuscle cramps?
:«:: "J:r =*r
1*:
r:*:
—
9.
Being sick to your stomach?
I*: =:»:: -ztzz
I*:
i^i
10.
Wetting the bed?
=«:: i:t" =*r
z*:
=*=
11.
Urinating?
iS:: ::>:: :*:
zzizz
!=<;=
12.
hchy or scratchy skin?
=«:: :=»=: =*:
z*r
=*:
~
13.
Rashes?
=«:: "t" z:ar--
r3--=
1=411
14.
Colds or sniffles?
!«:: "t" :*:
=*:
i=4;r
—
15.
Headache?
z&i r:J:: ii:
:*:
=*=
—
16.
Dizziness?
zrBiz =rhi ;£:.
;i=
I*:
17.
Playing sports?
=St; :rl:: z:2zz
:i:
=*:
—
18.
Shokiness?
rfi:: r:l=: ri:
;i:
=*:
—
19.
Pronouncing words?
=flc: =i»=r zir
l*r
=*:
—
20.
Doing things vnth your hands?
ifti "1:: :i:
:*:
I*:
—
21.
Sitting still?
ifi:: :ij=: li:
:i:
-v*-
22.
Tiredness?
ifit: ."Ir: z:2zz
:*:
:*;
—
23.
Feeling sleepy?
=«:: :r»:: :*::
r3c:
r*r
24.
Trouble getting or staying as
leep?
:£t: :iJ:: :i:
=ii:
:i4:i
25.
Bad dreams?
idSt: ::l" ii:
:i=
:A:
26.
Getting olong with parents?
:dBt: ;rl:: :ii
III;
iztr
—
27.
Getting along with other kids?
idBk: ::!:: .2zz
iii:
rrt:
28.
Crying?
lAr irh: =i:
"ir
:A:
29.
Getting mad?
:A: "1" i=fc:
:i:
:A:
—
30.
Not being happy?
:Ar rrhz ri::
li:
:*:
31.
Being sad?
:fib: ::!:: =i:
;ii
-=4:=
32.
Paying attention?
348 .
lA: "J:: :i::
;*:
;:«:: !>. H»>.>
The Subject's Treatment Emergent Symptom Scale (STESS) was developed within
the ECDEU program and is an independently formatted 32-item scale designed to
elicit information on the presence and degree of physical complaints. It may be
completed by the child, parent or other knowledgeable adult. Although focussed
on possible treatment emergent symptoms, STESS does not ask the rater to judge
the relationship of his "symptoms" to the drug he is taking. A ^t-point scale of
severity is used with an additional response position for "Don't Know".
APPLICABILITY
UTILIZATION
TIME SPAN RATED
CARD FORMAT - ITEMS
Item Column Item
20
21
22
23
2k
25
26
27
Children to the age of 15
Once at pretreatment ; at least one post-treatment
assessment. Additional ratings are at the discre-
tion of the investigator.
Now or within the past week.
CARD 01 = (19x, 3211 , 12)
Column I tern Column Item
9
10
11
12
13
14
15
16
28
29
30
31
32
33
34
35
17
18
19
20
21
22
23
24
36
37
38
39
40
41
42
43
25
26
27
28
29
30
31
32
Col umn
44
45
46
^7
48
^9
50
51
Total Score-'- 52-53
* Total Score = Sum of all items,
SPECIAL INSTRUCTIONS
Total Score Range =0-96
1. Coding Rater - When the child completes STESS, Code 00 (S) ; for mother or
mother surrogate, encode 11; for father or father surrogate, encode 22. Use
any other numbers for other adult raters. Do not intermix raters for a given
subject; e.g., mother at one rating; father at the next; self at the next. Use
the same rater throughout the study; e.g., self at every rating; mother at every
rating, etc. Concurrent ratings may, of course, be used; e.g., self ratings
along with mother and/or father.
2. Do not write in the shaded area of the ID block. Form Num.ber has been preceded,
Incorrect
FOKM
"<S r:-:^'S^: 1
Cprrect-
349
3. STESS may be used as an independent scale for the periodic evaluation of
treatment emergent symptoms (physical complaints) as:
a. perceived by the subject
b. observed by one or both parents or parent surrogates
c. observed by other raters, e.g., nurses, counselors, aides, etc.
Along with its use as an independent measure, the completed scale may also be
referred to by the physician as a screening device in his assessments of treat-
ment emergent symptoms.
k. As with all scales filled in by lay raters (patient, parent, etc.) be certain
that the rater understands the instructions and knows how to marl< his responses.
Immediate monitoring of the completed form is suggested whenever possible to
check that each item has been marked properly and that there are no multiple
answers .
DOCUMENTATION
a. Raw score printout including total score
b. Total score means and standard deviations by period and rater where
appl icable.
c. Symptom frequencies by period and rater where applicable
d. Variance analyses - Rater may be included as a factor if the
investigator chooses. When sufficient sample is available,
factor analysis will be performed on the STESS.
350
055 LAB
LABORATORY
DATA
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALYH
PSYCHOPHARMACOLOGY RESEARCH BRANCH
LABORATORY DATA
INSTRUCTIONS
LABORATORY STANDARDS - If Laboratory Standards {normal limits) are not
already established for your unit, i.e., in the ECDEU
Data File or if you wish to employ different
standards for analyses, please include such Standards
with data.
PERIOD - Laboratory tests MUST be encoded PERIOD BY PERIOD, i.e., do not encode laboratory data
from different assessment periods on the same General Scoring Sheet (GSS).
Record PERIOD in DAYS from initial (first) rating regardless of initiation of medication.
For example, if ratings are made at the start and end of a 2-week drying out period; every week
during a 4-week course of medication and finally 2 weeks after the cess^^tion of medication,
PERIOD would be recorded as follows:
Rating
1
2
3
4
5
6
7
Day
00
14
21
28
35
42
56
Dry
Drug
Followup
While a set of laboratory tests may actually be collected in 2 days, code the entire set under one
PERIOD if they were meant to constitute a single assessment. When a test requires verification,
i.e., repeated to check result, ONLY THE VERIFIED VALUE should be encoded.
For each laboratory test encoded, the rater must make 4 entries:
1 . The numeric value
2. A clinical judgment of abnormality
3. A clinical judgment of relationship to drug
4. The action undertaken as a consequence of the finding
VALUE — Refers to the numeric value obtained from the test.
For the preprinted tests, the number of "x's" indicates the number of digits required. Raters must
fill in ALL required rows - including leading and following zeros.
EXAMPLE - Obtained White Blood Count (WBC) was JfiOO/mirfl.
Correct coding ~
«*• :il:: =2i: .^-. z^:
WBC ^ ^
:0= zA--- :»- :*: =4- :«== =*■
xx.x thousandt/mm3
zfl"
r2ri :*:
«=- =9"
r«:: r:7" =«- =*:
:0:: ::»" =8" =*= --^^
; xx.x th
lAi "t: -az: -.i^z z*zr.
=«:: ::t: ra^: :*= ==«::
:i7" ::»: =9"
:*: :«ir «■» r«~ =«"
i^i :«:: z:?:: =«:i rfl::
MH 9-55
6-73
352
FORM APPROVED
OMB NO. 68-R955
CLINICAL
JUDGMENTS — For each laboratory test, 3 clinical judgments are made: abnormality (ABN), relationship (RED
and ACTION.
a. ABNORMAL Abnormal refers to a clinical judgment of abnormality - regardless of
numerical value.
N = No, Not abnormal
7 = Questionably abnormal
Y = Yes, Clinically abnormal
A = Alert, an extreme abnormality
b. RELATIONSHIP - a judgment of the degree of relationship between the test abnormality
and the drug rated on a 5-point scale.
N = None, - no relationship
R = Remote, - less than a 10% probability that symptom
occurrence is related to drug employed.
PC = Possible, - probability between 10% and 50%.
PR = Probable, - probability between 50% and 90%.
D = Defined, - greater than 90% probability that symptom
occurrence is related to drug employed.
c. ACTION TAKEN - refers to action taken as a consequence of the symptom's appearance.
Actions are arranged in order of increasing stringency. Only ONE action
- the most stringent - should be recorded as it is assumed that less
stringent actions may also be employed.
ACTION CODE:
NO = None
CH+ =
= Change plus
SR = Increased Surveillance
Contraactive Rx
CO = Contraactive Rx
SU =
= Suspend Rx
CH = Change Dose
Dl
= Discontinue Rx
EXAMPLE: A BUN value of 42mg/100 ml is obtained on a young schizophrenic male. The investigator considers
the result abnormal; feels it is probably due to drug and suspends medication. Coding is as follows:
:*::
:*-
==»:
XX mg/100 rnl
:«ii
:^:--
-9-
:*:
-ttz-
::?r:
^f^
.ZfifZ
-n-
:ff-
:*----
^^
-s^--
-A-.z -.S-.Z
r*=
i3:i
:«::
=:»:
«&
SSi
CO:
Gtt:
ei**
Wt0
Gtz-
Unlisted tests may be encoded on pages 3 and 4 - either in conjunction with listed tests or by themselves by using
Page 4 as an "independent scale." See Manual for Instructions.
If you obtain data from a laboratory test using units other than those preprinted on the form, do not encode the
data in the preprinted section. Record the data in one of the sections under "Additional Laboratory Tests."
IMPORTANT - PLEASE READ CAREFULLY BEFORE MARKING THIS FORM.
INSTRUCTIONS FOR COMPLETION OF MULTIPLE PAGE FORMS
1. Complete page 1.
2. Following completion of page 1 carefully tear out and remove the pink protective sheet lying between the carbon
and your copy of page 2. Follow this procedure for each subsequent page. You must do this to obtain a copy of
the data for your files.
CAUTION:
DO NOT REMOVE PINK PROTECTIVE SHEETS OTHER THAN THE ONE LYING BETWEEN
CARBON AND COPY OF THE PAGE YOU ARE ABOUT TO COMPLETE,
When you have completed all pages of the form, carefully tear out and remove carbon papers and your copy
pages. The machine scannable pages should be left In booklet form for shipment to the Biometric Laboratory
in packages prepared according to instructions received from the Biometric Laboratory.
353
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
NATIONAL INSTITUTE OF MENTAL HEALTH
LABORATORY DATA
PATIENT INITIALS
NUMBER MALES 001 TO 499
NUMBER FEMALES 500 TO 998
—
---J<--
:*:
z:C:-.
:©::
:*:
FIRST
zzfzz
:«:
:»=
:.,::
i-.Jzr
--^-
:;1"
:«::
:*-
;>*:
PATIEN1
--^--
--«::
:i7::
:«:
-:&z
:«::
"t::
-tit-.
--*t-
=o
INITIAL
:*--:
-O:
:*:
:*:
::T==
:©:
::1z:
-:2::
--:»--
zA:z
--:&--
:©=
:=7:;
:«:
::&:
:«::
::V:;
-vt--
=*--
::V:
:i::
-«::
:i1:r
zz^z
-.^--
-Jt:--
!:&:
:«::
::?::
:«:
::»:
-A--
:*-
r«zr
:*-
=*
SECOND
zzfzz
:«:
:«:
::t::
"Jz:
:©:
::1::
--:&--
--^--
z-Az:
RATER
--:&--
=*=
r:7:i
=«::
;:»:
—
:*:
-^----
-Mf-
--*»:--
:©:
:*:
:0:
:*:
--^--
"T:;
--:&--
::1r:
z:S^z
--:»--
:=*:
--^-
-?
:r7::
=«:
::»:
—
INITIAL
:#=
:dV::
--W--
:*:
zif:
r:Zr:
--:&--
==1"
=:g:=
--^--
::4:;
PERIOD
:«::
r«::
zzT-z
::&:
::&--
^£^
FORM
ifiii
--:&--
:r1::
r^r
=:»=
---^z
-^-
=«:
::?::
zz&z
::»:
Hours
Days
Weeks
Months
^~
NO.
^^j
:©:
::1::
:*:
--:»-
:^r
__
PLEASE USE A NO. 2 PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE. —
HGB "
;:1::
-.:1"
rig::
rrg:;
-zAz rig::
xx.x gm/lOD ml
= «::
"Ti:
zzfzz
=©:
::1r:
=:g:r
zz^z
--4= i©=
= «:=
=:7::
:«:=
zrSz
33a
WBC
:«:.- :r1:= rrg:
=r1" ::2:r
:r1:
z«:: ::1i: =:S:=
::3:: ::4:: =©::
xx.x thousand/mm 3
1:3:: :-4: ::§::
:©:r :;^: iig::
NA +
!«:: ==1" =:g:i
::3:: :4: :«:=
XXX mvg/L
::3:: :!*= -meq ::§::
«:;
iiTii
-^
«:=
iiTti
=«:
©:
r:7:=
:«^
*IO rSS: «©:
;:Ar
:€» Gtt*
*& :P«:
-«e=
= r1r:
zzS-z
^-
z-A^z
::»:
=«::
zzT-z
-»-
:«:=
=«=
:r9i:
::V:;
:A::
=*t:
:*:
*©:
=P«:
=©::
HCT
XX %
:©:
::1::
zz^.z
-:»--
---■4:--
r®:
:©:
:=7ii
--»:
:«::
-NO^
:S«:
<»
:«*
G»*
=S0:
:01:
».;.*'
::1ri
zz^.z
-^--
:4:
::&"
:©:
=:7^:
i«:i
:«::
-tt--
:=?::
iitii
=5ft::
=«:
:*=
*&
:{«:
=©=
RBC
X.X IT
illions/
mm'J
-^-
::1::
i:g:i
^
=4=
zz^iz
:©=
iiT^z
=«=
=«:
«©
:SR:
«3:
aC*t
C»*
=so=
=«:
zjzz
-^-
:«::
=*»::
:r?::
:i»i=
z-J^z
;*t:
:*:
*&
:T--
:«:=
= «::
*IO
-SR:
<»
^ett
a**
i$0=
lOl:
zfzz
=*:
:«::
::©: :=1::
::S::
:*=
zz4:z
:*:
:«:i
zzT-z
:«:
=«:=
=*t;
::?::
ziYii
:;*:
:*)::
:*:
*&
:Pt=
:*:
Neutrophiles
XX%
:©: :=1:r
::g:=
=:»:
z-AiZ
=:&=
r«:r
z:^:
:«:=
=«:=
*to
=SK:
=£©
zCh:
ew*
:SU:
;01:
. =:&= :i1zz
::2::
=:»=
:=*=
--^--
:«::
:;7t=
;«:=
:«:i
:*tz
::?::
ii>i:
z-J^z
=*»::
I*:
*&
:Pg=
:«:=
Lymphocytes
xx%
r©: zzlzr
:*i
--^--
:=*:
:*:
=«::
zzT-z
:«::
:«:=
*IO
=S«=
3C©
zCHt
cw*
lSU=
:01:
:©: ijl::
=S:
--:»--
::*:
:S=
:©=
1=7::
:«:
-:&z
:*t:
rr?:i
==>t=
zzAzz
:«:
:*:
*&
=H»:
zzStz
Eosinophiles
xx%
:<t: r:1::
=«::
--:»--
::*:
=:fef:
-^-
i:7i:
=©:
=«::
*»o
=S8:
ac©
:C»
c»*
=SU:
:01:
©: ilrz
=:g:=
-:»--
z-A^z
:©:
--:&--
::7t;
:*=
r:©::
:«:
:;?::
"¥::
zzPiZ
:*J:r
:*:
*&
-mz
-:&z
Monocytes
xx%
raS:: -"1=:
rig:
-:»-
zzAzz
:©:
-:&--
==7^=
:*:
:«::
«o
:SR:
«ec
aCtt
Cttt
zSO:
:01:
:«:= ;=1==
::2::
::»=
-A^-
ir&r.
--:&-
"7t=
--:&-
:«::
-zUz
-:?::
-y^i
=;*::
=*t:
=*:
*0:
-f*-
-^--
Bosophiies
x.x%
:«:: "Irr
::g:r
.:»z
Z-4-.
=*f=
-^-
::7i:
-^
:«:=
*to
=SR:
<»
=ew
CM*
iSU:
rOJ:
:©: ::1r:
rigrr
-^-
--A--
:*i::
--zQzz
=:7i:
-^
= «:=
:*)::
I!*:
:dyi:
=A:
:*t:
:*=
*&
:«»=
:«=
Sedimentation Rate
XX mm/h
:«:i r=1::
::g:z
-^-
=4=
:©:
--:&--
r:7i=
-^-
:«::
*t©
:S8:
<»
=0*
cw*
=S0=
=01=
::3:i :4= ::§::
X.X meq/L
::3:r ::*: iig::
irTt:
z=7t=
«3: iCW G»*
CL-
r«:i "
:: zzS.z
rz ::S:
:^r
=:*=
XXX
-Ai--
meq/L
:«::
=«:=
r«::
=«:r r=
z: =:g:z
=:»:
---■A-
i«:r
:«::
rrT::
:«::
=S:
«0 :SR: <» ^O* G»*
n*t= =:|t: *& =«t
rSO: :«:
=«::
=*=
::»=
13*:
=«:=
:©:
::?::
:«::
:«::
=«::
::»::
::>r::
:;*:
=W=
"R:=
*©:
:«t
:©:
CA + +
XX
mg/100 ml
:<r=
=«:
-.:»--
:a*::
:*=
:«::
::7:r
:«-
:«::
«IO
=SR=
<»
=€»
GK»
=S0=
:0»:
:«::
::1"
:«:
■-:»--
:=*:
-:&=
:«::
::jt:
=«:
:«::
:«:
::*:
:^:
:;A::
=W=
==lt:
*&
:PR:
:«:l
P04 =
X.X
mg/100 ml
:©:
=*:
--^--
:=*:
=^=
=«:--
::7::
:«=
-^-
*to
:SR:
3SO:
aC»
GW*
=S0=
:OJ:
=«::
:;5:=
-rS^-
--:»--
zAz
:©=
:«::
zzT-z
:«::
-z&z
:«::
::?::
::y^:
:Vt:
=*)::
:*=
*©:
:Wt
:©:
MC++
X.X meq/L
■■:&■--
::!:;
=*:
1:3:=
::*:
::&=
:«::
::7tr
:*:
-zSzz
*l©
:S«:
«&
=€»
e»*
=SOt
:01:
-:&--
"1"
:*:
=:3::
::*:
::&:
:«::
::?::
:«:
:«::
:«:
::*:
:iVi-
---Af--
:*t=
:*:
*©:
:|*
=©=
Li +
X.X meq/L
:©:
:r1::
:*:
:*:
::*:
=:&:
--:&--
::?::
:«::
:*:
*to
:S«:
«&
«*:
G»«
=S0=
:«:
:©- ::1:: ::2:r
SGOT
:©: ::1:: :3::
::&: :=*: ::&: :
XX Kormen U./100 ml
::3:: ::*: ::§:: :
■.zT-z :«:
::?:: r*:
354
«© :SR: 3»3: :€«: Gtt*
:«:: :*: *& :P«:
:S0= =OJ:
LABORATORY DATA
PAGE 2
—
NUMBER MALES 001
to 499
NUMBER FEMALES 500 to 998
—
:«::
zzy.z
:S::
:*:
:--*:
:«^:
:«:
::?::
:«:
:«::
BE SURE TO AAARK IN PATIENT, RATER AND PERIOD NUMBERS
:©:
z.y.z
::2::
:S3::
PATIENT
::*: ::&:
:©:
zzT-Z
:«:
::»:
:©:
z.y-z
:*:
::3::
::*:
:©:
:©:
::7t:
:«:
::St:
:©:
::1::
::§::
::3:=
::*:
=:&:
:«::
::?::
:«:
::&:
«ATER
:«::
::1::
:«:=
:S3:=
::*:
;*=
:«::
::7i:
:«::
:i*:
:©:
zzy.z
::2::
:S3::
:=*:
::&:
:*:
::7t:
:«:
::©:
zz
■rtn
•«■
zzQzz
::J::
Hours
::1::
:S::
:i3::
Days
::2::
::*:
Weeks
:*::
::?-.:
Months
:3t:
zz&z
::a:
^
:&-- A-
:^:
^z
::*:
:ri::
:«::
::?::
:®:
:«::
:«::
::?::
::y::
:A:
:W:
:*:
*0:
:PS:
:«::
—
SGPT
XX units/10(
ml
:©: -U-
:S::
^z
::*:
:«::
:©:
zzT-z
:«::
::&:
«&
:SR:
3sec
aa*
c««
:SU:
rO»:
—
:©: -zV.-.
:^.:
=3::
:4:
::-i::
=©=
zzT-z
:«::
:«::
:*t:
:A:
:::r::
:A:
:«:
:*:
*CC
:PS:
:»:
—
LDH
XXX
units/ 100 ml
_
:©i r:1ri
:S::
=3::
::*:
::Sf:
:«:
zzr-z
:«:
:«::
ttet
:S«:
«et
aa*
Cttt
:SU:
ziiiz
—
-.:&-. ::1::
r:2::
=3::
::*:
:«::
:«::
::7t:
:©:
-:»z
^
:©: ::1:r
11?:=
:3::
:vt:
::»:
:«::
::7i:
=«=
:®:
:*t:
::?::
::Y::
:^:
:«:
::R:r
*Cc
:PS:
:»:
—
Amylase
XXX Somogyi units/100
ml
_
:©:: ::1=:
iriti
:3::
"-*:
:«::
:©::
r:^:
:«::
::&:
«©
:S«:
a^ec
zatz
cw*
:S0--
ziiiz
—
:©: "1=:
::2::
^z
::*:
:«::
:©:
::T-:
:«::
:«;:
~
.:»-. -V-
::?::
:a::
::*:
zzSfz
:©:
zzT-z
::«::
::&:
:«:
::?::
riT::
::a^:
:«:
"R::
*Gc
:P«:
:«:
—
Alkaline P'tase
xx.x K
ng-Armstrong
units/ 100 ml
...
:«:: ::1:--
:S!::
::3::
::*:
:«::
:©:
zzr-z
:«:
:«::
WO
:SR:
ze&
aa*
GWt
:SW:
:«4:
—
:©i "1::
::2::
:«:;
::4::
:«::
:©=
-zT-z
:«::
:®:
:©: "1::
::Pzz
:^:
::*:
::«::
:©:
zzr-z
:«::
:«::
:3a::
::?::
zttzz
::«i:
:W:
:*:
*©:
:P8:
:©:
—
BUN
XX
mg/100
ml
raSti ::1::
lit:
:®:
:^:
::&:
-ezz
zzr-z
:«::
:«::
«©
:SR:
ZGO:
aa*
CW-t
z%A3--
:Ut:
—
= ©= ::1: =
::?:i
::3::
::*:
=«::
:®:
zzT-z
:«::
:«::
:«::
irS::
:^::
:A:
:«:
iiRi:
*Cc
:Pe:
:©:
—
Creatinine
X.X
mg/lOO
ml
--:&-. :r1::
::2::
::3::
::>*:
::&:
:«:=
z-r-z
:«::
:*:
«©
:SR:
«©:
3E»
CtHit
:$«:
:«!:
—
:©: =:1--:
:5t:
-zSzz
::*:
::S:=
:«::
zzT-z
:«:
:«;:
:**:
::?::
:fr::
::A^:
:«::
::R::
«5:
:PS:
:ft:
—
Uric Acid
X X
mg/lOO
ml
=«t: =r1"
rrSt:
::3::
::*:
::§::
=«:--
z-r-z
:«::
:«::
*t©
:S8:
:£©:
3E«
c»*
:SO:
:«):
:«:: ii1=:
::5ti
:<§::
::*:
:*:
:«::
zzT-z
:«::
:«::
:«:
:A:
::Y::
:A::
:**:
::g::
*&
:PS:
:©:
—
Total Bilirubin
X.X
mg/100 ml
i«:r :r5:i
izgir
=<§:=
::*:
::&::
:«::
z-r-z
=«:
::©::
W&
:SR:
:£©:
ze»z
C«t
=S«:
:Ui:
—
:©: :=1::
::?:z
::3:=
::*:
:«:
:«::
-zT-z
=«=
-:»z
=*!:-
::9::
:^::
:=*::
:«:
:*:
*0:
:P8:
:*:
—
Direct Bilirubin
X XX
mg/lOQ
ml
^^
:«:: ::1::
=S::
:<g::
::*:
::§::
=«::
zzr-z
--«::
:*:
*t©
rSS:
3EO:
33*
C«t
:S«:
:U4:
—
=©: :=1r:
r^::
:::3::
:3t:
r®:
:©=
-zT-z
:«::
:«::
__
:«:: -1=:
=^=
::§::
::*:
zz^izz
:«:=-
z:7i:
:«:
=«::
:«:
::?::
:^:
:A::
:«::
:*:
*CC
:PS:
:«::
—
Total Protein
X.X
gm/100
ml
--:&:-. -y-
::S:=
::3::
::*:
:*j::
=«::
zzr-z
=«:
:«::
W©
:S8=
:«©:
33*
GW*
:S»:
:«l:
.^
:©: .--V-
=:?t=
:*:
=4:
::&::
:©::
zzr-z
zzQiz
::&:
:»:
::?::
::Y::
::A::
:«:
::?::
*Gc
:PS: •
:*::
—
Blood Albumin
X X
gm/100
ml
;53:; rrl::
r:2::
::§::
:--*:
::&::
:®:
z-r-z
:«:--
:«::
W©
:SR=
3KC
«*
G«*
:SO:
= 131:
—
:«:= -=1rr
==?^=
::§::
:=*:
::&:
:®:
-zT-z
:«::
:*:
:*t:
::?::
::Y::
:^:
:«::
"R::
*Gc
:P8:
:«::
—
PBS
XXX
mg/100
ml
rJ3:: i:1::
:5(:r
::§::
i^r
::»::
:«::
zzr-z
-«::
::©::
*t©
:Sfi:
X.&
3S*
G««
:S«:
:Ui:
—
=«:; "1r:
::2::
::3::
::*:
::&:
:«::
zzr-z
:«::
--:&:
_
;«:= :=1:=
::5tr
::3l:
r=ti
z^z
:«::
zzT-z
:*:
:«::
:*t:
::?::
:^::
:at:
:«:
:*:
*Cc
:P8:
:*:
—
Cholesterol
XXX
mg/100
ml
--:&-- :i1r:
;S:=
::§::
:^:
::&::
:«::
zzr-z
:«::
::&:
«©
:S«:
:£©:
«*
G»«
:S«:
:«*:
—
:«:: r:1r:
r:2:=
::g::
:=*:
::§::
:©:
zzT-z
:«::
:*:
"""
:«:= ---y-
::$^:
:^:
::*:
:«::
:«::
r:7i:
:«::
:«::
:«:
::?::
::y::
::*;:
:«::
:*:
*©:
:P8:
:*:
—
PBI
X.X
meg/ IOC
ml
:©: ==1::
=:2:i
::3::
:^:
:*>::
:«::
zzr-z
r:©::
:«::
«©
:SS:
ze&
ati*
G***
:S«:
:«1:
__
r©: z-y-
irftr
::3::
r^:
:«::
:«::
::7i:
:*:
::©::
:*t::
::?::
::y::
:;4^:
:«:
:*:
*ec
:PS:
:«::
—
Triglycerides
XXX
mg/100 ml
:©r ==1:=
=5f=
::3:r
:^:
::!=(::
:«::
::^:
:«::
::9::
«©
:SR:
«&
as*
GH:«
:S«:
=431:
:::::
—
:©::: -zy.z
=:g::
::§::
::*:
::§::
:«::
:r7i:
=«:=
::©::
~~
Specific Gravit]
::2:i
=:§::
:4:
:«::
:«::
-7::
:*:
;:©::
:«:
irfcz
:3r^:
::A::
:*(::
:*::
*»
:PS:
:*:
—
f (Urine)
l.xxx
:«:: i:1r:
1:2::
:=§::
::*:
=:fe:=
:«::
zzr-z
:©:
:S::
«©
:SR:
«©
=3*
GH:*
:SU:
:«):
—
:©: ;:1r;
zz^.z
::§::
::*:
::&:
r©:
-zT-z
:«::
zzQiz
355
^
LABORATORY DATA
PAGES
—
NUMBER MALES 001
to 4-»9
FEMALES 500 to 998
—
:©:
zzizz
zazz
zO::
zz4zz
zr&z
:«::
zzTzz
:«::
z«:z
—
BESURETOAAARKINPAT
ON THIS PAGE EXACTLY
lENT, RATER AND PER
AS YOU DID ON PAGE
ODNL
MBER
S
zzizz
zzizz
zS:--
zzg::
PATIENT
z^z z^zz
Z-Azz zigzz
=«::
:«::
zz7:z
zzT^z
z«:z
zzS::
^~
zzizz
zzizz
z:g:z
z^z
::3::
:z4:z
z^z
RATER
:«::
:«::
zzTiz
zzTiz
z«:z
^
zzizz
zziz:
Hours
z^zz
z:g:z
::2:z
Days
z:2:z
ZZ4ZZ zrgzz
PERIOD
zAzz zSzz
Weeks
z«:z
zzT^z
zzTz:
Month
zz4z
:«::
:«::
z«:z
zdt
__
■Ac
•^
^
Albumin (Urine)
(None
or trace
zzizz
z^zz
(4
-<Szz
or 4+)
z-Azz
zitz
zz?zz
zSRz
zzYz:
£0:
zzfcz
zO*
CH*
:*t=
zzRzz
zO»:
*Cc
:PS:
rtcz
^
Sugar (Urine)
(None
or trace
-r&z
zzizz
zzgzz
(4
=0::
or 4+)
zz^zz
z*tz'
wet
zz?zz
zSRz
ziYzz
«0:
z=ft:z
zCHz
CH*
=S«=
zO):
*0:
zP«:
=*:
^
:«:: -z^.z i^:: =0==
RBC (Urine)
:«:: ::,:: i^:: =3::
zAzz zig::
xx/HPF
:^: z:gzz
z«:z
zzT^z
zzTiz
z«:z
:S:z
z«:z
zzfzz
zSSz
zet'zz
zz4zz
zCHz
CW*
==R=:
zt5»z
*©:
=PR:
:©:
^
:©: III" ::2:: :3::
WBC (Urine)
:©: :r1:: zzg:: r:3::
zz*: :®:
xxx/HPF
:«:;
:«::
zzT^z
zzTzz
z«::
z«:z
zSzz
z«:z
zz?zz
iSR:
zzVz:
zOSz
zAz
aa*
C«:*
:S0:
--z9r-z
:0»=
*©:
zPS:
:©::
^
:©:: :i1:: r^:: :3=
:z4zz z:§::
^z
zzT^z
z«:z
:*:
__
ADDITIONAL LABORATORY TESTS
_^
Spaces are provided below for the encoding and rating of laboratory tests not printed
above. Write in the name of test in the space provided (PLEASE CONFINE WRITING
TO THAT SPACE) and then code in value and make the clinical judgments as usual.
As they serve as essential processing signals, ALWAYS BE SURE TO ANSWER THE
FOLLOWING TWO QUESTIONS:
~
NO
YES
—
Have you encoded non
-listed tests on
page
3?
zz
NO
YES
.^
Have yc
u encoded non
-listed tests on
page
4?
^
Name of Test and Units
=«:=
-4-
I^ZZ
=:3^
z-Azz
rzg::
^*:
ripz
=«:
ziQiz
"■■"
=1-
irlzz
;;S:z
--zA=
z«:z
zzTtz
zzTiz
~
:©: irl;: =-5:; 1:3::
z=<1zz z^z
z-Azz VALUE =«:=
z«:z
zzTtz
zzTtz
zzgz
z«:z
-zQzz
-:»z
IZ
=©:: 1:1=1 :-2:: i^::
=«:-
:i?zz
zzTzz
z:A:z
:»:
::R::
TGC
:PS=
z«::
ZI
:©:: :r1r: i^:; =3:=
ZZ4ZZ =:&"
=«:=
zzT^z
r«:z
-z^z
«©
=SR=
«3:
«*
G»*
=su;
=01z
■^
Name of Test and Units
=«:=
=*:
=©:-
=3=
=3tr
rzS^r
^^-
=:?:=
^*:
=«:^
■■■
^«:=
--:&--
.-r1=
z:iz:
=3=
=2jzz
z«:z
■""
r«:: :r1:i zig:: 1:3::
z^z zrgzz
^^: VALUE :®::
:«::
:«:=
z^z
z^z
zzSzz
z©:z
~~
:©:: ir^:: .:^.z i:^::
:W:
zzSzz
zzttz
zzfifz
=W=
:=R==
zPOz
:PR:
:«:=
~~
:©:: zz^zz z^:: zi^iz
ZZ4ZZ zgzz
z6:z
.:T-z
z«:z
=*=
W©
=SR:
aKt
^Gt*
GW*
=SU:
:01:
^^
Name of Test and Units
=«:=
=1=-
ziSiz
z:3:r
:=4=
z:S:z
-«=
^^.
=»=
=©:;
;=1x:
:=*:
^^4=
ZZ^Z
=«:^
:«:^
r^z
zzQiz
zzgiz
z©:z zrlz: i^:: 1:3:=
z-Azz VALUE :«-:
=«:=
=«:=
ztr-z
ziT^z
:«:z
z«:z
z:©:z zzl" zig:: r:3:=
:W:
ZISZZ
z^z
ziA::
ZZffZ
:=R=:
=PG>:
:PR=
zz&z
z:©:: z.-Jzz z:2:= :*:
::*: :©::
=«:-
z^z
z«:z
=«::
«o
-Sfiz
«3:
^Gff
G»»
-93-
zW;
zzzzz
zzzz:
Name of Test and Units
;«:z
r^=
=s=
=3=
za^zz
=5=
=*:
-.tj=
-^-
-zQr.
;«:;
^«^
r:1=
=3=
=8=
zzrrz
z«:z
!«:: zzizz z-J:: zzg::
z^z zzgzz
=^= VALUE =«::
z«:z
ziT^z
z^z
z©: zzizz z.^z z:3:z
W=
zz?==
z^z
ZZfifZ
=W:
=zR:=
zptSz
=PfP
-^■-
:«:z zzizz z:S:z zigzz
zz4:= =«:^
z«:z
z^z
:«::
=«:=
3i)b ^
:SS:
«©:
=G«:
G»»
:S«=
=01=
MH't'SS
DEPARTMENT OF HEALTH, EDUCATION,
AND WELFARE
FORM APPROVED
NATIONAL INSTITUTE OF MENTAL HEALTH
OMB NO 68'R9SS
—
LABORATORY DATA
PAGE 4
—
PATIENT INITIALS
NUMBER MALES 001 to 499
NUMBER FEAAALES SOO to 996
—
:-Jf-.
-*:
.-«::
=©:
=*
FIRST
zzf-.-.
:«:
=*=
-«-
::*:
:«::
r:1i:
:«:
=:»:
rat:
PATIENT
--«:--
r=7:r
:«:
:4t:
—
:*;
::t::
i*fti
:*t:
:0
INITIAL
--*----
--^--
:*:
:*:
::T=:
:«:
::1::
:*:
:*:
:=*:
:*-
;*t:
:-.?::
:«::
:«:
—
r*t:
zitt.-
:««:
:«:
riV:
:*:
:«:
::1::
:*=
=*=
r:*:
z:^-.
:«::
"7::
:«:
=:»:
,
:A:
--*--
:«::
:©:
:*
SECOND
zzf-.z
:«=
--*--
i:t"
"*=
=«=
==1"
:«:
:*:
:=*:
RATER
=«::
::?::
:«:
::»=
—
:*:
"t"
:Mr
-M-
:©
INITIAL
-.*■---
:«:
:*:
=*:
=:!::
:«:
r:1r:
:*:
:*=
:^:
--^--
=«=
:=?::
:«:
-:$t.z
:«:=
:V::
:W:
:*;
:-lri
-.it.-.
=©:
"1::
:*=
=*=
==*;
:*=
:«:-
=:7::
:«::
::a:
PERIOD
-i-
/
"1:-.
Hour*
:*=
Days
rat:
Weeks
:*:
Months
«:
-«;i
If the laboratory dota you wish to encode consist ONLY OF TESTS NOT PRINT-
ED ON PAGES 1-3, this poge (4) may be used independently, i.e., by itself.
Fill in patient's initials, patient, rater and period numbers and AAARK HERE
Discorc
pages
1-3.
Name
of Test and Unit*
z:0=
z4-
:*r
^:
zat:
zz^-
-^^
ziTtz
=«::
^*r
zzlz:
z*z
z:3=
zz*z
z:4=
z®z
z:S:r
ziTtz
zzjirz
zzgiz
I*:
z:3:z
zz4:z
zz4:z
VALUE
zzTiz
zzT::
-rSiz
z*z
z-^z
:«z
zz»z;
zzttz
zzfcz
zWz
zzlt:
*©:
zP8z
:©:
=«:
"1::
=«z
z3:z
:at:
:*z
=*=
-zT::
:«:
z*:
*t©
zS«z
«et
zCHz
CH«
zSOz
zOlz
Name
of Te*t
and Unit*
--«=
zzjzr
::8:z
=»:
zz*z
rSiz
:«=
z:7:z
=^»=
=#=
=4=
=3::
zatz
z«::
z*z
r*z
-.«::
zSz
z«:
z:3:z
z=*z
zz4:z
VALUE
:*z
z:7i:
zz?:z
z«:z
z*z
z*:
z«z
:<t=
:**:
zz?zz
zzYiz
zzAzz
=w=
::R:=
:PO:
:PR=
zzEtz
=«:=
Z*I
:*z
=*:
zz*z
=*=
=«:
zzT-z
-«:
z«z
**©
zS«z
ze&
zO*
Gtt*
=su=
=C«:
Nam* of Teit and Unit*
=©=
=1=
:«=
-*:
:=*=
:«=
=*=
:^:
z«:z
zz&rz
:«:z
=1=
=7=
=7zz
:#z
=8=
--»z
z*r
:*:
z«:z
zz4:z
z=*z
VALUE
zzTtz
zzTtz
r*z
z*z
:«:=
z*J:z
zz?zz
z:^:
zUtz
zWz
zzRiz
*©:
:PS:
:«:=
=*=
z=1=r
zSiz
z*z
zz*z
:«:
=©:
zzTiz
:*:
:«:z
*to
zS«z
ze&
zOtz
C«*
:saz
ZOI:
Nam* of T*sl and Unit*
:«r
=1=
ran
=»:
=*:
=©:^
=&^
=T=
=*=
=»:
=3=
=8=
zrsn:
;*;
^*^
:«:
:^zz
z«:z
zSrz
==*z
zz4:z
VALUE
z«;z
zzTiz
zzTiz
:«:
z*tz
ZZJZZ
zzttz
zA:z
:«=
z:R:z
*©:
:«t
zzfr:
-.■&Z
zzlzz
=*:
=*=
z:4:z
z«:z
-*:
zzTiz
:«:
:«z
*JO
zS«z
zCO:
rett
C»*
-StJ:
zOlz
NOTE THAT 4 ROWS ARE PROVIDED FOR VALUE IN THE NEXT 2 BLOCKS.
Nam* of Test and Unit*
,:.,-^
=*=,
=a=
=»=
:=4=
=«=
:«=
zzT=
=*=.
=*^
=4=
ZZ4Z5: :
z«zz
zz?:r
=*;
:«:
-^--
:::1zz
:*z
rztzz
zz4:z
zz*:
VALUE
z«:z
zzTtz
zzTiz
z*z
:*tz
*to
zz?zz
zfr:z
z:Az
c«*
z*|:z
=PO:
zPRz
-z»z
:«:i
z:iz:
z*z
--rSzz
:z4:z
:«::
:*:
zz7i:z
:«=.
:*:
Nam* of T*st and Units
=*:
:*:
r*:
=*r
=4=
=«=
=«=
zzfz
:*=
=»--
=3=
=3=
rz4=
z«=
:«:
z^z:
zzizz
zzizz
:*z
=*=
:*z
zz*:
zz4:z
VALUE
z«:z
z«:z
z«:z
zzTtz
ziTiz
r*z
:*=
:«z
z«z
«©
zztzz
za«z
ZI^Z
Z3fc:z
Ot*
zttz
zztC:
zOtz
*0:
zPRz
:*z
:«:
=1zz
r*r
:*:
lat:
:«::
=«=
ziTiz
:*-
:«:
357
Developed within tine ECDEU program, Laboratory Data (LAB) is an independently
formatted 52-item form for the recording of results from clinical laboratory tests,
It is in op-scan format and replaces the earlier l<ey-punch versions of Laboratory
Data (05-LD Regular, 05-LD Special),
APPLICABILITY All populations
UTILIZATION Once at pretreatment ; at least once at postt reatment .
Additional assessments are at the discretion of the
i nvest i gator .
TIME SPAN RATED By their nature, laboratory tests are "point in time"
assessments .
CARD FORMAT - ITEMS
CARD 01 = (19x, 16, 215, l6, 6l5 , 13, M)
Item Col . I tem Col .
Hgb^v
20-25
Hot
26-30
RBC
31-35
WBC
36-41
Neut
42-46
Na (Act)
20
Na (Rel)
21
K
22-26
CI
27-32
Ca
33-37
P04
38-42
Lymph
47-51
Eos in
52-56
Mono
57-61
Baso
62-66
Sed.Rate
67-71
Na (Value)
72-74
Na (Abn)
75
"The format for each "printed" test is:
Value = up to 3 columns
Abnormal = 1 column
Action = 1 column
Relation = 1 column
CARD 02 = (19x, 12, 715)
I tem Col . I tem Col
Mg
43-47
Li
48-52
SCOT
53-57
358
CARD 03=(19x, 15, 316, 4l5, I6, 15, 12)
I tern Col .
SGPT 20-2^
LDH 25-30
Amal 31-36
Alk.Phosp. 37-'^2
BUN 43-^7
Creat 48-52
Uric 53-57
CARD Ok = (19x, 13, 216, 15, 216)
1 tern
Col
Bl .Album. (Abn.) 20
81 .Album. (Act.) 21
81 .Album. (Rel .) 22
FBS 23-28
CARD 05 = (19x, 2l4, 15, 16,12, 319, 18)
1 tem Col .
Alb. (Urine)
20-23
Sugar (Urine)
2i+-27
RBC (Urine)
2a-32
W8C (Urine)
33-38
CARD 06 = (19x, 11)
1 tem Col .
Write-in 4(Rel) 20
CARD 07 = (19x, II , k\3, 110, 19)
1 tem
Col
Page k (Used)
20
Write-in 5
21-29
Write-in 6
30-38
Write-in 7
39-47
CARD 08 = (19x, 1 1)
1 tem Col ,
Write-in lO(Rel) 20
Item
Tot.Bi 1 i
Dir.Bil i
Tot.Prot.
Bl .Alb. (Value)
I tem
Choi
PBl
Tri .
S.G.
(Urine)
tem
I tem
Col .
58-62
63-68
69-73
74-75
Col .
23-34
35-39
40-45
46-51
Col
Page 3 Used
39-40
Write-in 1
41-49
Write-in 2
50-58
Write-in 3
59-67
Write-in 4
68-75
Col
Wr i te-i n 8
48-56
Write-in 9
'57-66
Write-in 10
67-75
359
"Write-in" tests have the following format:
Test Code No.- 3 columns
Value 3 columns (4 for No. k and 5, p.^)
Abnorm 1 column
Action 1 column
Relation 1 column
"Three-digit codes for "write-in" LAB tests are assigned by the Biometric
Laboratory. A list of LAB codes will be provided upon request.
SPECIAL INSTRUCTIONS
Detailed instructions are printed directly upon the form and should be read
carefully by the rater.
1. STANDARDS refer to the limits of normality set by the investigator
for his laboratory data. These standards MUST be sent to the
Biometric Laboratory - otherwise processing cannot proceed. In
subsequent BLIPS processing, each investigator's standards will be
used as the basis of analyses for his data. Investigators may
utilize more than one set of standards if they desire. For a given
study, however, the investigator must specify which set of standards
is to be used in the analyses.
2. The new LAB form differs from the older key-punch version in one
major way. ONLY DATA FROM A SINGLE PERIOD CAN BE ENCODED ON A SINGLE
FORM. The older version permitted the encoding of data from several
periods (assessments) on a single form. While this feature was popular
among investigators, it created significant processing problems. Error
rates for both the investigator and BLIPS staff were excessive and,
consequently, much valuable data were lost.
3. In assigning PERIOD to a set of LAB tests, ALWAYS encode the day on
which the set of tests was actually obtained - not the day the report
of results was obtained. Since the LAB usually requires transcription
from hospital laboratory slips, this post-dating should not be any
great problem.
k. When a given test value requires verification (repeating the test),
ENCODE THE "VERIFIED" VALUE ONLY: i.e., the value the investigator con-
siders correct.
5. If one of the LAB tests printed on the form employs UNITS OTHER THAN
THOSE INDICATED, the test must be encoded as a write-in and the units
indicated; e.g., SGOT values are obtained in Frankel units - not Karmen
units. The investigator codes SGOT in one of the "write-in" blocks -
not in the SGOT block printed on the form.
360
6. In instances where the obtained value of a test exceeds the number
of rows provided for that test, use one of the "write-in" blocks;
e.g., a BUN value of 100 is obtained and, as this exceeds the 2
rows provided, the investigator uses one of the "write-in" blocKS.
ENCODING TESTS NOT LISTED ON THE SCALE
1. Encoding non-listed tests in conjunction with listed tests - When
the investigator wishes to encode both listed and unlisted tests
at a given assessment period, he MUST so indicate by answering the
2 questions on page 3- He then may encode a maximum of 10 addition-
al tests on pages 3 and k.
2. Encoding non-listed tests only - When the investigator's data consist
ONLY of unlisted tests, he MUST use page k - NOT page 3 - and so indi-
cate by marking the specified location on page k. In this case, Page k
becomes an "independent scale" - the first 3 pages can be discarded.
When using Page k as an independent scale, the investigator MUST COMPLETE
THE ENTIRE IDENTIFICATION BLOCK ON PAGE k.
3. Note that the last 2 sections of Page h contain k rows of digits under
VALUE rather than 3 rows. This provides for the encoding of test values
which may require the extra digit.
DOCUMENTATION
a. Standards printout - it is the investigator's prerogative as to the
set of standards employed.
b. I ntra-subject display of test values and judgments. (Figure 21).
c. Group summaries by test. (Figure 22),
d. Cross-tabulation of tests/actions, ^Figure 23).
e. Variance analyses
For each subject, the events occurring throughout the study are described
test by test. The daily and cumulative dosages, the actual value and its
position in regard to limits and judgments of abnormality and drug related-
ness are given. Similar data are summarized by treatment group. Finally,
a cross-tabulation of actions undertaken by test are displayed for each
treatment group.
361
^ ^
=tfc
^
362
— O
O ^
^ o o o
J-
o
I I I I
O O CO — ^D
O O O O —
O I- -I
CO — UJ
< 3 CO
LU o a: UJ o
Q Q. a. a£ z
^ ^
> 3
z a:
— Q
^
^
363
— I
v»
I I I
+ • I
^
I I I
o i I I
< CO o
c o
364
CLINICAL LABORATORY STANDARDS IN PEDIATRIC PSYCHOPHARMACOLOGY---
Samuel Gershon, M.D., NYU Medical Center
Clinical laboratory data at baseline and changes with treatment are an integral
part of the assessment of the effects of new drugs. Former speakers have presented
certain piroblems in this area in regard to studies in adults and to the applicability
of textbook normative data for psychiatric populations (3) •
Whatever the magnitude of the problem with adults, the situation in regard to
children is far worse. First, the same problems, as mentioned above, will certainly
arise, i.e., in the applicability of medical textbook norms to a population of mentally
ill children. Second, they will arise also in regard to the vagueness of some of the
child norms, i.e., when an adult normative figure is given and is followed by the state-
ment: "higher in children" or "lower in children" without additional qualifications (1).
Third, another problem which arises with children is the distinction between child and
adult. This distinction is in itself somewhat arbitrary and still inadequate. More
particulate divisions ought to be made in grouping children by age, e.g., norms for
three years may not be applicable to norms for six years. In addition to such age sub-
divisions, another parameter of maturat ional , physical, and mental levels may cut across
such age levels. This issue of physical and mental levels of maturation may be even
more marked in child psychiatric populations. Fourth, there is the problem of the ef-
fect of manifest or covert intercurrent infection or physical disease on the clinical
chemistry data. Admittedly, such situations can and do occur in studies with adult psy-
chiatric populations, but they are more frequent and prevalent in institutions housing
child psychiatric populations. The influence of such a variable may be of much greater
magnitude than the possible effect of the drug under investigation. Fifth, laboratory
measurements may indeed be the greatest source of error under adverse conditions.
In this discussion, we will present some of the norms currently available in the
literature, a brief analysis of some of the laboratory data obtained from the child psy-
chiatric studies at New York University, and then conclude with a review of this material
and proposals for consideration by this group.
NORMS FROM REFERENCE SOURCES
It can readily be seen that most of the information available is on hematology and
that the normative data show variance at the different age levels. Also, there are
differences in these values from one source to another. Other areas are not that well
covered, e.g., liver function tests.
" Presented at the Pediatric Psychopharmacology Conference, November 13-1^, 1969.
Wash,ington, D. C. Sponsored by the Psychopharmacology Research Branch, Division
of Extramural Research Programs, National Institute of Mental Health.
'<■ Reprinted from Psychopharmacology Bulletin, Special Issue, Pharmacotherapy
of Children, 1973-
365
DISCUSSION
This review of laboratory findings was undertaken to explore the possibility
that such data might show variation from recognized normal values derived from a
nonpsychiatr ic population. Recognition of this problem in adult psychiatric popula-
tions has resulted in exploratory studies which have tended to confirm the diver-
gence of findings from textbook norms in this special population.
The report by Gonzales et al. (3), Table 22, on hemogram studies in a psychiatric
population showed that in the case of white blood cell (WBC) counts and if an upper
normal limit of 7>000/cu mm is used as proposed by some reference sources, then 50.2
percent of the values fell above 7,000 and ]k percent above 8,500. In regard to hemo-
globin values in males, ]k percent fell below the norma] range of 14-18 grams.
The findings for hematocrit were: 26.2 percent of determinations fell below and
11.0 percent above the normal range of 42 to 50. When broken down by sex, 44.1 per-
cent of hematocrit determinations in males fell outside these limits and for females
42 percent were abnormal.
Sedimentation rate determinations for. males showed that 77-2 percent were above
the normal range of 0 to 9.
These findings would strongly suggest that it may be necessary to redefine limits
of normal values for specialized patient groups.
Hoi lister et al. (5) have commented on this same problem in adult psychiatric
populations. These workers reported that 97 of 475 patients prior to treatment ex-
hibited counts greater than 10,000/cu mm. There were 19 instances of serum glutamate
oxalecetate transaminase (SCOT) estimations over 40 units in 154 patients in the same
study. A study by Holden et al. (4) in a similar population produced similar findings
and corroborated the previous reports that clinical laboratory data in adult chronic
psychiatric populations exceed established textbook standards. Here again the great-
est discrepancies were: 31 percent of erythrocyte sedimentation rate (ESR) in males
and 70 percent in females were beyond the normal range, almost 30 percent of WBC were
beyond the normal range and 15 percent of the differential counts.
To date we do not have any such studies to compare results in a child psychiatric
population with textbook norms.
Looking at the very limited data obtained to date at New York University (2) on
Dr. Fish'S" nursery children (to six years), it is exceedingly likely that a similar
discrepancy will result as has been observed in the adult psychiatric population.
The laboratories themselves may contribute markedly to errors. Variation in the
methods or the time of day for the collection of blood can account for differences in
results greater than those produced by standard laboratory methods. There are also
variations which can be attributed to laboratory personnel. Clinical laboratory estima-
tions of hemoglobin by two observers differed by more than 10 percent in 17 percent of
measurements using the same laboratory facilities and methods. In a special study (10)
of errors i/i measurement of serum electrolytes, it was found that for the same sample
of blood the serum sodium, potassium, and chloride values varied widely among four
*Now at: Department of Psychiatry, University of California (UCLA), Los Angeles,
Cal ifornia.
366
hospital laboratories. The standard deviations of the results in three of the
laboratories are approximately twice those obtained by the authors. The hospital
results on normal sera were frequently outside the quoted normal ranges. This
occurred for k8 percent of the sodium results from one laboratory and 55 percent
of the chloride results from another.
Thus, there is enough evidence to suggest that new normative clinical chemistry
data will need to be obtained for a child psychiatric population. This issue is
further compounded when the investigation of an experimental pharmacological com-
pound is addecj. The question then becomes: How much deviation from normal labora-
tory norms is allowed before attributing the "abnormal" findings to the experimental
med i cat ion?
PROPOSALS
1. It will be necessary to establish new norms for laboratory data in this popu-
lation and ranges for each age level. In few of the evaluations of new psychotropic
compounds have parallel clinical and laboratory studies in control populations living
under similar environmental conditions been reported. Reliance is most often placed
on published standards of normality. It is most fortunate that the Biometric Labora-
tory of the George Washington University, Kensington, Maryland, now has procedures
available for the collection of such data and the provision of such norms. This should
provide the sorely needed normative lab data for this special population and enable the
better interpretation of drug effects in regard to clinical chemistry.
2. Special care will be required in regard to quality control in each laboratory
to avoid the possibility that laboratory errors alone may obliterate drug-induced changes,
REFERENCES
1. Cecil-Loeb Textbook of Medicine, P. B. Beeson and W. McDermott (eds.), Vol. 1 and
II. Philadelphia: W. B. Saunders Company, 1963.
2. Fish, B. Personal Communication. New York University, New York, New York.
3. Gonzales, R. G., Bishop, M. P., and Gallant, D. M. Hemogram abnormalities in
chronic schizophrenics used as placebo controls. Psychopharm. Serv. Cent. Bull.,
3:29. 1965.
k. Holden, J. M. C, Itil, T., Simeon, J., and Fink, M. Clinical laboratory test
standards in new drug trials. J. Clin. Pharmacol., 7:1, 1967-
5. Hollister, L. E., Caffey, E., and Klett, C. J. Abnormal symptoms, signs, and
laboratory tests during treatment with phenoth iazine derivatives. Clin. Pharmacol.
Ther., l:28if, I96O.
6. Nelson, W. E., VaUghan, V. C, III, and McKay, R. J. Textbook of Pediatrics.
Philadelphia: W. B. Saunders Company, I969.
7. O'Brien, D., Ibbott, F. A., and Rodgerson, D. 0. Laboratory Manual of Pediatric
Micro-Biochemical Techniques, 4th Ed. New York: Harper and Row, I968.
8. Slobody, L. B. and Wasserman, E. Survey of Clinical Pediatrics. New York:
McGraw-Hill, I968.
9. Smith, C. H. Blood Diseases of Infancy and Childhood. St. Louis: The C. V.
Mosby Co. , 1966.
10. Thompson, Gi S. and Jones, E. S. Errors in the measurement of serum electrolytes.
J. Clin. Path., 18:443, 1965.
11. Wintrobe, M. M. Clinical Hematology. Philadelphia: Lea and Febiger, I967.
367
Hemogic
^^ (7)
5 yrs.
8-13 yrs.
RBC 3,800,000-5.400,000
Hematocrit
A.
(11)
4 yrs.
- 33-37
6 "
- 34-38
8 "
- 35-39
12 "
- 35-40
B.
(7)
4-10 yrs. - 37% ±6%
WBC Count (11)
4
yrs. - 5,500-15,500
6
- 5,000-14,500
8
- 4,500-13,500
10
" - 4,500-13,500
12
- 4,500-13,500
Table 19
Childrens
Laboratory Norms
(Aver. 9,100)
8,500
8,300
8,100
8,000
WBC Differential (11)
Ago Segmented Neut.
12 1/2-15 gms. (Aver. 13 1/2)
13-15 1/2 gms. (Aver. 14)
Lymphos
4 yrs.
29-49%
1-5%
35-65%
5%
(Av.)
2.8% (Av.)
.6% (Aver.)
6 "
38-58%
1-5%
28-57%
4.7%
"
2.7% "
.6% "
8 "
40-60%
1-5%
24-54%
4.2%
"
2.4% "
.6% "
10 "
36-66%
1-5%
28-48%
4.3%
"
2.4% "
.5% "
12 "
37-67%
1-5%
28-48%
4.4%
"
2.5% "
.5% "
Tr' i 20*
Differential
Hgb'
Hct'
RBC"
WBC*
Neutroi
Lymphos
Monos
Eoi
Bo SOI
Plate lat>
1 yr.
2 yrs.
3 yrs.
10-12.5
36%
40%
4.6 mil
1 2,000
30%
60%
5'
^
2-
3%
0.
5%
250,
350,
000
000
4 yrs.
8,000-
40%
50%
5 yrs.
13-13.5
10,000
6 yrs.
7,500
55-
60%
40%
^
'
1
'
1
T
^
r
•Relevont data extracted from text (9).
Hemoglobin.
Hematocrit.
' Red Blood Celli.
* White Blood Cells.
368
4
o
<
u
a
■D
o
o
•u
c
D
o
>
o
o
>00>a>->r<oro<o>Oi— •— csM
rv>ocscx)0>o>o>>— ooo>i^o>— o
CNCN0><0O<0O>-;C>r>.^>000C0-^
o <N tv o
f^ r-r O' rs:
<N
o
o <o
as
CO
c4
ci
-*' cs
pi
^ <^
oi
c>i ci
ri
M "O €>> <0
o o o o
o o o o
OO 00 ■* <o
p>«>ooooooo-*r-h»o>>0
I I I I I I I I I I I
0.10-*'0>— 0>'00000
». <0 «0 CI
l>x IV 00 1^
00 o> o
CO
CO
in ■— •— 00
CO -* CO -^
O Is. tv <0
<o "o c< « f— Ci
'^ o hx
CO CO CO to iv <o L;
rv •— «o 00 >o
I I I I I
lO "O >o c^« •—
CO IV C< (>• CN
«t tt ^
c .E .c c ^
15 15 15 ^ 'c
_0 _0 _o _0 y
09 a> g> □> '2
d o 6 o o
E E E E E
<D O O O 4f
I X X I I
«
«
c
C
tt
tt:
o
c
c
It
(t
o
O
o
o
o
o
o
o
^
a«5
JS
-a
a
X
c
E
o
o
X
c c It tt
o o o o
s ?
369
Table 22 Summary pf Laboratory Findings for 65 Chronic Schizophrenics on Placebo (3)
Percent Percent Total
Number of below above Percent
Test Normal limits* Determination Mean S.D. normal normal "abnormal"
Red blood count 4.2-5.5 mill. 244 4.6 mill. 0.3 mill. 6.4 1.6 8.0
White blood count 5,000-10,000 342 7,090 1,200 2.0 1.8 3.8
Hemoglobin :
(Males) 14-18 grams 178 14.9 1.6 14.0 0.0 14.0
(Females) 12-16 grams 134 13.9 1.5 1.5 2.2 3.7
Hematocrit** 42-50 345 45.8 5.2 26.2 11.0 37.2
(Males) 47±7% 195 47.0 4.1 26.7 17.4 44.1
(Females) 42±:5% 150 43.8 4.5 10.7 31.3 42.0
Sed. Rate (Wintrobe) :
(Males) 0-9 145 12.3 7.6 — 77.2 77.2
(Females) " 0-20 134 21.4 7.7 — 49.2 49.2
• From Sunderman, F. W. and Boerner, F. Normal Values in Clinical Medicine. Philadelphia : W. B. Satinders
Co., 1949.
• Normal limits of 42-50 for hematocrit from reference above. Additional separate norms for males and females
from Merck Manual of Diagnosis and Therapy, 10th Edition, 1961.
370
NORMAL BLOOD VALUES
TABLE 23 Chemical Constituents of Blood
ACID-BASE CONSTITUENTS
Total fixed cations (Na + K + Ca + Mg) (serum) 150-155 mEq./liter
By methods of Hald and Sunderman, normal
values tend to be lower 143-150 mEq./liter
Sodium* (serum) ...136-143 mEq./liter
Potassium* (serum) 4.1-5 6 mEq./liter
Calcium* (serum) 10-12 mg./lOO ml.
5-6 mEq./hter
Calcium,* diffusible (ionized Ca) (serum) 5-5.5 mg./lOO ml.
Magnesium* (serum) 2-3 mg./lOO ml.
In the newborn a value as low as 1.3 mEq./liter 1.65-2.5 mEq./liter
would be considered normal
Chlorides* (CD (serum) 98-106 mEq./liter
At birth and during early infancy the plasma
(serum) chloride is 6-10 m.Eq. /liter higher than
that of older infants and children 585-620 mg./lOO ml.
Phosphorus, inorganic, as P (serum) 4.0-6.5 mg./lOO ml.
Slightly higher in the newborn (in infants,-up
to 8 mg./lOO ml. considered normal) : 1.29-2.1 mM./liter
HPO4— /H^POr (average valence 1.8 at pH 7.4) 2.3-3.8 mEq./liter
Serum protein cation-binding power (serum) 15.5-18.0 mEq./liter
Bicarbonate cation-binding power (serum) 19-30 mEq./liter
The above two constitute a major portion of the
buffer base (Hastings and Singer) of serum
Standard bicarbonate (Astrup)t (plasma) 21-25 mEq./liter
Buffer base.(BBlb (blood) 46-52 mEq./liter
Base excess [BEJh (blood) -2.3 to -1-2.3 mEq./liter
Sulfates, inorganic, as SOj"" (serum) 0.5-1.0 mEq./liter
2.5-5.0 mg./lOO ml.
Sulfates, ethereal (serum) 0.1-1.0 mg./lOO ml.
Sulfur, neutral (serum) 1.7-3.5 mg./lOO ml.
Lactic acid (serum) 10-20 mg./lOO ml.
pHat38°C. (blood, plasma or
serum) 7.3-7.45
The sample must be protected against loss of
CO2 and determination made as soon as pos-
sible. Arterial blood in a resting person is about
0.03 pH unit higher than venous blood.
pH at 38° C. (serum from arterial
blood)
(Data from Cassels and Morse)
1.5- 3.4 years 7.30-7.40
3.5- 5.4 years 7.35-7.43
5.5-12.4 years 7.37-7.43
12.5-17.4 years , 7.35-7.41
• In human red blood cells an average concentration of sodium would be about 21 ipEq./liter of red blood cells; of potassium about
86 mEq./liter.
The level of calcium in serum is influenced by the concentration of serum protein because part of the calcium is associated with or
bound to the protein. Practically all the calcium in blood is in the plasma.
The chloride concentration of whole blood depends largely on the cell volume, since the erythrocyte contains approximately half
as much chloride as serum.
t Concentration of bicarbonate in plasma which is separated from the cells with the hemoglobin completely oxygenated, at a
pCO, = 40 mm. Hg and at a temperature of 38° C.
371
TABLE 23 I Continued/
ACID BASE CONSTITUENTS
Carbon dioxide content (serum from venous
blood I 45-70 vol. per cent
20.3-31.5 mM /liter
The CO-, content is lower at birth and rises
slightly during the first 4 days of life
Carbon dioxide content (whole venous blood) 40-60 vol. per cent
18-27 mM. /liter
Carbon dioxide content (arterial blood)
(Data from Cassels and Morse)
1.5- 3.4 years 15.5-20 5 mM. /liter
3.5- 6.4 years 18.7-21.2 mM. /liter
6.5-11.4 years 19.3-21.6 mM./liler
11 5-14 4 years 19.9-22.2 mM./liler
14.5-17 4 years 20.4-22.4 mM./liter
Carbon dioxide tension (arterial blood)
(Data from Cassels and Morse)
15- 6 4 years 33.5-41.1 mm. Hg
6.5-12.4 years 35.4-40.6 mm. Hg
12.5-17.4 years 38.3-44.4 mm. Hg
Oxygen tension P„. (arterial blood) 85-100 mm. Hg
Oxygen capacity* (whole blood) 19-22 vol. percent
Oxygen saturation (whole venous blood) 60-85 per cent
Blood of newborn 30-80 per cent
Hemoglobin
At birth (whole blood) 17-20 gm./lOO ml.
3 months 10.5-12 gm./lOO ml.
1 year 11-12.5 gm./lOO ml.
5 years-.. 12-13 gm./lOO ml.
10 years 13-14 gm/100 ml.
Above 1 0 years 14-16 gm. /1 00 ml.
Methemoglobin (whole blood) 0.0-0.3 gm./lOO ml.
Premature infants at higher level (0 4)
Carbon monoxide hemoglobin (whole blood) up to 5'"/( of total hemoglobin
Haptoglobin (serum) 40-170 mg. ""/i as hemoglobin-binding capacity
Water (whole blood) 79-81 gm./lOO ml
(serum) 91-92 gm./lOO ml.
(red blood cells) 64-65 gm/100 ml
The oxygen capacity and iron content of blood are directly related to the hemoglobin content of the blood 1 1 335 ml. O./gm of
hemoglobin).
CARBOHYDRATES, LIPIDS AND PIGMENTS
Sugar, fasting
(Somogyi-Nelson) (blood) 60-90 mg./lOO ml.
Under fasting conditions capillary or arterial
blood and venous blood are nearly the same
Sugar, fasting arterial (Folin-Wu) (blood) 80-120 mg./lOO ml.
fasting venous (Folin-Wu) (blood) 70-100 mg./lOO ml.
Lactic acid. See Acid-Base Constituents
Pyruvic acid, fasting (blood) 0.7-1.2 mg./lOO ml.
Citric acid (blood) 1.3-2.3 mg./lOO ml.
Citric acid (plasma) 1.6-2.7 mg./lOO ml.
a-Ketoglutaric acid (blood) 8-10 mg./lOO ml.
Acetone bodies (as acetone) (serum) 1-6 mg./lOO ml.
Total cholesterol (over 6 yr.) (serum) 150-250 mg./lOO ml.
Infants 70-125 mg./lOO ml.
Newborn 50-100 mg./lOO ml.
Cholesterol esters 125-180 mg./lOO ml.
17-Hydroxycorticosteroids (plasma) 10-13.5 microgm./lOO ml.
Total lipids
(Rafsted) 2-14 years (serum) 490-1000 mg./lOO ml.
3 days-1 year...., 240-800 mg./lOO ml.
372
TABIE 23 (Continued)
CARBOHYDRATES, LIPIDS AND PIGMENTS
3 days-10 days 430-760 mg./lOO ml.
Newborn 170-450 mg./lOO ml.
Free fatty acids (serum) 230-380 microgm./ml
More variable in young children
Phosphatides (lipid P x 25) (plasma)
Children 180-295 mg./lOO ml.
Up to 1 year 100-275 mg./lOO ml.
Newborn 75-170 mg/100 ml.
Bilirubin (total) (serum) 0.2-0.8 mg./lOO ml.
Higher in newborn 1.0 or more
Conjugated bilirubin (direct) 0-0.3 mg./lOO ml.
Icterus index 4-6 units
Total protein (from nitrogen determination) (serum) 6.5-7.5 gm./lOO ml.
At birth the protein is slightly lower
Albumin* [globulins precipitated by Nai.SOj-Nai,SO.i
mixture (20.8'X Na.,SO< + 7.0'2 Na.SO.i)] (serum) 3.9-4.5 gm./lOO ml.
Globulins (by difference) 2.3-3.5 gm./lOO ml.
A/G ratio 1.2-1.9 gm./lOO ml.
Protein values vary slightly with age. The follow-
ing values for plasma are adapted from the
paper of Metcoff and Stare (New England J.
Med.. 1947)
Total protein (plasma)
Premature infant 4.55 ±0.59 gm./lOO ml.
Full-term infant 5.11-5.70 gm./lOO ml.
Birth to 1 year 6.10 ± 0.29 gm./lOO ml.
1-4 years 6.94 ± 0.47 gm./lOO ml.
5-12 years 7.30 i: 0.59 gm./lOO ml.
12 years and above 7.16 gm./lOO ml.
Albumin (plasma) (globulin precipitation by 22*;^ Na^SO^; Howe)
Premature infant 3.55 ± 0.65 gm./lOO ml.
Full-term infant 3.76-3.79 gm./lOO ml.
Birth tol year 4.97 ± 0.73 gm./lOO ml.
1-4 years 4.59-4.83 gm./lOO ml.
5-12 years 5.0 ± 0.78 gm./lOO ml.
12-15 years 4.72 gm./lOO ml.
Globulin (plasma)
Premature infant 1.01 ± 0.45 gm./lOO ml.
Full-term infant 1.34-1.66 gm./lOO ml.
Birth to 1 year 1.38 ± 0.68 gm./lOO ml.
1-4 years 2.03 ±0.34 gm./lOO ml.
5-12 years 2.4 ± 0.74 gm./lOO ml.
12-15 years 2.49 gm./lOO ml.
Fibrinogen (plasma) 0.2-0.4 gm./lOO ml.
Gamma globulin 10-15?t of total protein
0.7-1.2 gm./lOO ml.
At birth values approximate adult levels, owing to passive transfer from the mother; during the ensuing weeks
there is a decrease, the "low point" being reached between the second and fourth months. After this there is a
gradual increase to the "adult level" by about the second year of life.
Ceruloplasmin (serum) 16-33 mg./lOO ml.
Mucoprotein (serum) 45-105 mg./lOO ml.
Mucoprotein tyrosine (serum) 2-4.5 mg./lOO ml.
Serum protein partition by paper electrophoresis (Durnim)
5f of total protein
Albumin 50-60%
a, -globulin 5-89t
a,-globulin 8-13%
/3-globulin 11-17%
y-globulin 15-25%
•When the globulin is precipitated with the Na.SO^-Na.SOj mixture, the albumin values agree with those obtained by
electrophoresis.
373
TABLE 23 Continued)
NITROGEN CONSTITUENTS
Nonprotein nitrogen (whole blood) 25-40 mg./lOO ml.
(Tungstic acid filtrate; zinc hydroxide filtrates
give lower values because more small molecule
nitrogenous compounds are precipitated) (plasma) 18-30 mg./lOO ml.
Urea nitrogen (whole blood) 7-15 mg./lOO ml.
(plasma).. 10-17 mg./lOO ml.
Creatinine (serum) 0.4-1.2 mg./lOO ml.
Absorption by Lloyd's reagent (whole blood) 0.5-2.0 mg./lOO ml.
Creatine + creatinine (whole blood) 5-8 mg./lOO ml.
Concentration of creatine is low in plasma
Uric acid (serum).. 2-6 mg./lOO ml.
At birth the uric acid concentration of the blood
of the infant is identical with that of the
mother
Ammonia (whole blood) 0.1-0.3 mg./lOO ml.
Amino acid nitrogen (plasma) 3.5-5.5 mg./lOO ml.
Serum gives slightly lower value than plasma
Phenylalanine (serum) 0.7-4.0 mg./lOO ml.
Proline (fasting) (plasma) 13.8-32.5 microgm./liter
Glutamine (plasma) 6-12 mg./lOO ml.
Citrulline (plasma) 0.3-1 mg./lOO ml.
Amylase (plasma or serum) 70-200 Somogyi units
6-33 Close-Street units
Aldolase (serum) 0.15-0.8 units (micromoles of fructose diphos-
phate split/per ml, serum/hour)
Alkaline phosphatase
Infants (serum) 5-10 Bodansky units
Children (2-15 years) 3-13 Bodansky units
The values by the Shinowara Jones and Rein-
hardt method are about V3 higher, owing to
incubation at pH 9.3 instead of 8.6
Infants 4-14 Bessey-Lowry-Brock units (substrate p-
nitrophenol-phosphate) (Sigma units)
Children 3.4-9 B.L.B. units
Children 10-20 King-Armstrong units (Substrate di-
sodium phenyl-phosphate)
Infants 3.8-11 Klein-Babson-Reed units
Children 2-15 (Substrate buffered sodium phenolph-
thalein phosphate); 1 unit of activity liber-
ates 1.0 mg. phenolphthalein in 30 minutes
at37°C.
Phosphatase, acid (serum) 1-5 King- Armstrong units
Creatine phosphokinase (CPK) (serum) to -0.72 milliuniU (Bergmeyer)
Lactic acid dehydrogenase (serum). 30-120 units
(Snodgrass method)
Copper oxidase (Ravin method) (ceruloplasmin) (serum) 0.14-0.57 O.D. units
Lipase (serum) < 1 unit/ml. Sigma-Tietz unit (ml. of 0.05 N
NaOH to neutralize free fatty acid during
6-hr. incubation period)
Transaminase (children) (serum-glutamate-
oxalacetate)
SCO, spectrophotometric method 4-40 units (higher in infante)
Serum glutamate pyruvate 1-45 unite
MISCELLANEOUS
Ascorbic acid (serum) 0.4-1.5 mg./lOO ml.
Vitamin A (seruni) 15-60 microgm./lOO ml
Carotenoids (serum) 40-400 microgm./lOO ml.
Iron 0.04-0.18 mg./lOO ml.
37^
TABLE 23 (Continued)
MISCELLANEOUS
Iron-binding capacity (serum) 0.187-0.65 mg./lOO ml.
Transferrin (serum) 0.2-0.3 gm./lOO ml.
Copper (serum) 0.08-0.235 mg./lOO ml.
Lead (serum) 0.001-0.003 mg/100 ml.
Lead (blood) 0.01-0 06 mg/100 ml.
Bromine (serum) 0.7-1 microgm./lOO ml.
Iodine, protein-bound (serum) 0.003-0 008 mg./lOO ml.
Iodine, butanol extractable 0.003-0.0065 mg./lOO ml.
Potassium (erythrocytes) 86-104 mEq. /liter of red blood cells
Thiamine (blood) 5.5-9.5 microgm./lOO ml.
Tocopherols (serum) 0.6-1.2 mg./lOO ml.
Lower in the newborn
PHYSICAL MEASUREMENTS
Specific gravity (whole blood) 1.048-1.05
Newborn infants: falls rapidly during first 2 1.06—1.085
weeks and continues to decrease until second
or third year (plasma) 1.025-1.03
Prothrombin time (Quick) (plasma) 12-15 seconds
This determination should always be con-
trolled by a determination on a normal blood,
since the activity of the thromboplastin prep-
arations may vary greatly
Bleeding time 1-3 minutes
Coagulation time (test tube method) , 3-9 minutes
Cephalin flocculation (serum) 0-1+ units
During first 6 months of life this test may be
negative in the presence of liver disease
Thymol turbidity (serum) 0-4 Maclagan units
Zinc sulfate turbidity (serum) 2-8 Maclagan units
Viscosity, compared to water as unity (whole blood) 4.5-5.5
(serum) 1.7-2.1
Corrected erythrocyte sedimentation rate
(Rourke-Ernstene) 0.1-0.35 mm./min.
Cutler method 2-10 mm./hr.
The rate is slower in the neonatal period
Freezing point depression (serum) —0.535°-(— 0.555°) C.
Osmolality (plasma) 270-285 milliosmoles/liter plasma water
Refractive index, 20° C 1.3485-1.3505
375
NORMAL CEREBROSPINAL FLUID VALUES
TABLE 2k
Amount in the newborn Up to 5 ml.
Increases with age to adult (igure 100-150 ml.
Initial pressure 70-200 mm. H.O
Cell count
Under 1 year Up to 10 cells/mm.'
1-4 years Up to 8 cells/mm."
5 years to puberty 0-5 cells/mm,'
Specific gravity 1.005-1.009
Freezing point depression — 0.56-(-0.60)''C.
Rerractive index at 20°C 1.33554
pH 38°C. (protected against loss of CO.) 7.33-7.42
Fluid exposed to air becomes alkaline
Carbon dioxide-combining power.. 40-70 vol. per cent
18-31 m.Eq./Iiter
Chloride
7 days-3 months 108.8-122.5 mEq./liter
4-12 months 112.7-128.5 mEq./liter
13 months-12 years 116.8-130.5 mEq./liter
Cholesterol ^ Trace-0.22 mg./lOO ml.
Glucose, 6 months-10 years 71-90 mg./lOO ml.
over 10 years 50-80 mg./lOO ml.
The glucose level is less than, and varies proportionally with, the rise and
fall or the plasma glucose level
ToUl fixed cations About 155 mEq./liter
Sodium 130-165 mEq./liter
Potassium 2.8-4.1 mEq./liter
Calcium 4.5-5.5 mg./lOO ml.
Magnesium 2.8-3.3 mg./lOO ml.
Phosphorus, inorganic 1.5-3.0 mg./lOO ml.
3 mg. first day of life
Lactic acid Trace
Fluid on standing may increase in concentration with disappearance
of glucose
Protein 15-40 mg./lOO ml.
The ventricular fluid contains much less protein than does lumbar fluid.
Fluid from the cistema magna contains more protein than that from the
ventricle and less than that from lumbar region. The range is greater in
the newborn and during the first month of life (20-120 mg./lOO ml.)
Albumin 809 of toUl protein
Globulin 209 of total protein
Fibrinogen None
Pandy reaction'. No precipitate
Urea nitrogen 7-15 mg./lOO ml.
Nonprotein nitrogen 8.5-20 mg./lOO ml.
Creatinine _. ..i... 0.45-1.9 mg./lOO ml.
Uric acid 0.3-1.5 mg./lOO ml.
Amino acid nitrogen 1.5-3 mg./lOO ml.
Ammonia nitrogen 0-0.015 mg./lOO ml.
Bilirubin None
Iodine Trace
Transaminase (GOT) 2-20 units (about Vi the
value of SGOTi
Co(,loidal gold number (Wuth and Faupel) 0000000000
Dilutions l-IO to 1-5120 with 0.49 NaCI solution
376
TABLE 25
Hormal laboratory Ooto
Blood:
F4onprot«;n nitrogefl 25-40 mg/100 ml
Ureo nitrogen 10-1 J mg/lOO ml
Uric odd 2-3 mg/lOO ml
Oeotin;n« 1-2 mg/100 ml
Oeoline 5-7 mg/1 00 ml
Glucoie 60-120 mg/100 ml
Cholnterol 120-250 mg/100 ml
EiJen 100-150 mg/100 ml
Fre« 50-100 mg/lOO ml
Bilirubin 0.2-1.0 mg/100 ml
lct«rvi indox 3—5 ikmIi
Qtlondes (exprexied as NoClh
Wbola blood 450-500 mg/100 ml (70-85 mEq/liter)
Sorum 585-420 mg/100 ml (I0O-106 mEq/nier)
Sodium — MTum 310-330 mg/100 ml (133-143 mEq/ntar)
Potoxsium — terum 1 6-22 mg/1 00 ml (4.0-5.5 mEq/Dlm-)
Phosphonn — >«rum 3.5-5.0 mg/l 00 ml (2.0-3.0 mEq/litar)
Coldum — i»rum 9-1 2 mg/1 00 ml (4.5-6 mEq/Clar)
COi eontanl — »er«m 45-70 vol % (20.3-31.5 mEq/lilw)
Servm albumin 4.5-5.5 gm/100 ml
S«mim globuPm 1.8-2.7 gm/100 ml
Sedimentation rate;
Micro 4-10 mm/hr
Weitergren 5-20 mm/hr
Coagulotton time;
Copillary 3—4 min
VetMMn 4-10 min
Bleeding time 1—3 min
Frogirity test ^ 0.46-0.30% Kinna
Prothrombin time (Ouidc test):
Plasma 12-15 sec
Urine:
Albumin Negative (trace is often of no signiRcance)
Sugar Negative
Acetone bodies. Negative
Speoflc gravity 1.005-1.030
Urobilinogen Positive in dilution 1:20
BHirubin.... Negative
Red blood celb Absent (centrifuged)
White blood celb ,. 0-2 HPF* (centrifuged)
Cosh. ............................. Absent (few hyaline costs are often not
signiRcantl
Spinal fluid:t
Pressure 70-200 mm water
Cell count. 0-10 (chiefly lymphocytes)
Protein 20-40 mg/100 ml
Sugar. 50-90 mg/100 ml
Chlorides (expressed os NoQ) 650-750 mg/100 ml (1 1 1-128 mEq/nter)
* HPF: high-power field.
I Amount in newborn infonts ranges from 30 to 60 ml; in a child of 10 yr, there may be up to 200 nU
377
TABLE 26 A,
Blood Cell Voluet during Infancy ond Childhood*
Cell!
Binh
2 days
2 weeks
3 montht
I yeor
5 yeor.
10 yean
Red blood cellj, million, per cu mm
4.9-5.5
5.3-6.5
4,5-5.5
3.9-4.8
4.5-5.0
4.7-5.3
4.8-5.5
Hemoglobin, gm per 100 ml
16-20
18-22
14-17
10.5-11.5
12-13
12.5-13.5
12.5-14.5
Rellculocylei, %
3-5
1-5
1-2
0.2-1.0
0.1-1.5
0.1-1.5
0.1-1.5
Nucleated red blood celli, per 100
while celli
2-10
0-5
0-2
0
0
0
0
White blood celli, Ihoujondi per cu mm
10-20
12-22
8-12
5-9
6-10
6-10
6-10
Neutrophil,, %
45-55
50-65
30-45
30-40
35-45
40-50
45-55
Lymphocytei, %
45-30
40-20
55-45
65-50
60-50
55-45
50-45
Others, % — monocytei, eojinophili.
10-15
10-15
15-10
5-10
5
5
5
boiophllj
Occaiionol myelocyte!
Plateleti, Ihouiondi per cu mm
350
450
350
200-300
250-350
250-350
250-350
• Dete
In dehyd
hond.
hile
ell
otion of the
peripheral
jn, for exo
nple, when t
lasmo and
ed blood ce
er the blee
ding has slov
hange in si
e of the circ
ted by the
peripheral n
3ted for about 2 weeks.
ed cell count or hemoglobin reflects the true size of the circulcsling red blood cell mass only when the blood volume is normal.
"le plasma volume is greatly reduced, perlpherol measurements give falsely high values. In brisk hemorrhoge, on the otfier
I volumes ore being proportionately reduced, peripheral measurements early do not reflect the true reduction of total red blood
ved or stopped and plasma volume has been restored from the extrovascular fluids, red cell and hemoglobin concentrations
flatlng red blood cell moss. In chronic anemia, the total blood volume is usually unchanged; thff total circulating red blood cell
'alues. Several hours after birth, the total erythrocyte, plasma, and blood volume incroaies by as much as 20 per cent ond
TABLE 27 N'oiniiil bloinl viiliici sigiiili(;iiil in diiignosis ol Hnenii^s
in iiihiiicy iiiul tliiklliood*
ll.nu.Klol.in
First day
2 weeks
Kirst and second years
:! lo ."> years
.'> to 10 years
10 years
Red blood cells
Ursl day
Second week
Older infant and child
20 gm. (18 10 22 gm.)
17 gm.
II gm. (10 to 12.5 gm.)
12..') to 13 gm.
i:t 10 1S.5 gm.
1-1.5 gm.
5.500,000 (5 to C million)
5,000,000
4,000,000 per cubic milliiiieicr
lower limit of normal
.Nmlialcd red cells
-Average— 3 to 10 per 100 while cells (birth to 4 days of life)
Rclirnlocylcs
0.5 lo 1.5% (6% upper limit of normal— fioiii birth to 4 days of life)
(Iklow 0.5% in aplastic and hypoplastic anemia; increased in hemolytic anemia:
in deficiency anemia rise from low to high levels with tiealment)
\ ohniie of packed red cells (hematocrit)
Infants 1 month to 2 years
Childien 2 years to 12 years
Older children
34%
36%
40%
Serum bilirubin
Newborn full-leriu infants 2 lo 8 mg.%
Newborn picmalure infants I to 15 mg.%
(Values given for both full term and premanue newborn infants are the low vahie.s
at birth rising to maximum during liisi week of life)
Normal infants and children l.'nder 1 mg.%
(Hemolytic anemias-elevalcd total bilirubin |)ii(loniinantly indirect fraction)
I'ragility lest
Normal range 0.425 to 0.325% sodium chlo-
ride
(Increased fragility in hereditary spherocytosis and in some cases of acute hemo-
lytic anemia; decreased fragility in sickle cell anemia, thalassemia [major and
minor], and in iron-deficiency anemia)
•lioni Smith, C. H.: Anemias in infancy and childhood; diagnostic and therapeutic considerations
null. New York Acad. Med. 30:155, 1954.
378
CLINICAL LABORATORY TEST STANDARDS FOR SCHIZOPHRENIC RESEARCH SUBJECTS
T. H. McGlashan, M.D. and P. deary, M.S.
Standards for 15 clinical laboratory tests have been developed from data
obtained from pretreatment blood samples of subjects who were participants in
22 clinical psychotropic drug trials conducted in collaboration with the ECDEU
Program at nine different research centers in the United States and Canada be-
tween 1969 and 1972. A final sample of 325 research subjects was selected on
the cr i ter ia :
a) Diagnosis of schizophrenia (regardless of subtype)
b) Adult (18 years or more)
c) No significant concurrent medical conditions
d) Non-repeating research subject (i.e., if a patient participated
in more than one research project in which laboratory values
were recorded, only his first test results were included in the
f inal sample) .
e) Complete data on age, sex, and race (i.e., if any of this demo-
graphic information was missing, the subject was excluded).
Demographic characteristics of the sample are given in Table 28. Both
parametric means and ranges (mean + 2 standard deviations) and non-parametric
medians and percentile ranges (2.5 and 97.5 percentiles) are reported in
Tables 29 and30. The results generally confirm the finding of increased
variability in schizophrenic laboratory test data noted in the past. This,
and implications of the method, are discussed more fully in a paper entitled
"Clinical Laboratory Test Standards for a Sample of Schizophrenics", Psycho-
pharmacologia, kk, 281-285, 1975.
37.9
TABLE 28
POPULATION DEMOGRAPHIC CHARACTERISTICS
N=325-'-'
CHARACTERISTIC
Sex
Male
Fema le
Race
White
Black
Other
Marital
Status
Ever married
Never
marr ied
Previous Treatment for Mental Illness (total time)
None
Less than two years
More than two years
Duration of Present Hospitalization
Outpat ient
Less than one month
One month to two years
More than two years
Sch izoid L i f e Style
Definitely characteristic
Somewhat characteristic
Not characteristic
Occupational - Role Adjustment
Adequate
Marg ina 1
I nadequate
FREQUENCY
PERCENT
170
155
52
48
271
^7
7
83
14
3
138
185
43
57
28
72
212
9
23
68
45
113
33
143
14
32
10
44
128
112
51
44
38
18
134
136
14
43
43
MEAN
Present Age 40
Age First Hospitalization 25
S.D.
RANGE
11
18 - 77
8
11-56
"Missing data existed for many of the demographic characteristics other than age,
sex and race. Therefore, the N's listed under Frequency do not always sum to 325.
380
TABLE 29
PARAMETRIC NORMAL RANGE ESTIMATES
FOR 15 CLINICAL LABORATORY TESTS:
SCHIZOPHRENIC SAMPLE AND TEXTBOOK NORMALS-^
TEST
SCHIZOPHRENICS
TEXTBOOK NORMAL RANGE
Sample
N
Mean
Range (Mean ± 2 SD)
Hemoglobin
male
149
15.2
12.8 - 17.6
14 - 18
gm/lOO ml
female
153
13.8
11.6 - 16.0
12 - 16
Hematocrit
male
166
46
40 - 52
40 - 54
%
f ema 1 e
150
41
35 - 47
37 - 47
Red Blood Count
male
51
5.0
4.0 - 6.0
4.6 - 6.2
mill ions/cumm
female
56
4.5
3.7 - 5.3
4.2 - 5.4
Sedimentation Rate
male
22
17
1 - 33
0-20
mm/hr
female
31
28
0-60
0-30
White Blood Count
total
320
8.4
3.2 - 13.6
5 - 10
thousands/cumm
Differential Count
total
268
% neutrophi les
61
41 - 81
% lymphocytes
33
13 - 53
% eos inophi les
3
0 - 9
% monocytes
4
0 - 8
% basophi les
0.4
0 - 1.8
Blood Urea Nitrogen
total
274
12
2-22
8-20
mg/lOO ml
Sodi urn
total
65
139
131 - 147
136 - 142
meq/1 iter
Potass ium
total
64
4.3
3.1 - 5.5
4.0 - 4.8
meq/1 i ter
Creat inine
total
53
1.0
0.6 - 1.4
0.5 - 1.2
mg/100 ml
Di rect Bill rub in
total
124
0.2
0 - 0.4
0 - 0.4
mg/100 ml
Total Bill rub in
total
196
0.6
0 - 1.2
0.5 - 1.4
mg/100 ml
Total Protein
total
58
7.5
6.5 - 8.5
6.0 - 7.8
gm/ 1 00
Blood Albumin
total
49
4.8
3.8 - 5.8
3.2 - 4.5
gm/100 ml
Fasting Blood Sugar
total
103
98
62-134
60-100
mg/100 ml
Chplesterol
total
131
207
113 - 301
150 - 250
mq/100 ml
*Taken from: Clinical Diagnosis By Laboratory Methods
Davidsohn and Henry, I969
l4th Edition, W. B. Saunders Co.
381
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
PHYSICAL AND NEUROLOGICAL EXAMINATION FOR SOFT SIGNS
The Physical and Neurological Examination for Soft Signs (MH-9-41 PANESS) is a 4-page form for the
assessment of physical status (pages 1 and 2) and soft neurological signs (pages 3 and 4) in pediatric popu-
lations. BEFORE ATTEMPTING TO COMPLETE THE FORMS, RATERS SHOULD BE FAMILIAR WITH THE
INSTRUCTIONS GIVEN IN THE ECDEU ASSESSMENT MANUAL. THIS IS PARTICULARLY CRUCIAL FOR
THE EXAMINATION OF SOFT NEUROLOGICAL SIGNS.
The neurological examination for soft signs has been developed and copyrighted by Abbott Laboratories
and their permission to use it is gratefully acknowledged.
IMPORTANT - PLEASE READ CAREFULLY BEFORE MARKING THIS FORM.
INSTRUCTIONS FOR COMPLETION OF MULTIPLE PAGE FORMS
1. Complete page 1.
2. Following completion of page 1 carefully tear out and remove the pink protective sheet lying between the carbon and
your copy of page 2. Follow this procedure for each subsequent page. You must do this to obtain a copy of the data
for your files.
CAUTION: DO NOT REMOVE PINK PROTECTIVE SHEETS OTHER THAN THE ONE LYING BETWEEN
CARBON AND COPY OF THE PAGE YOU ARE ABOUT TO COMPLETE.
3. When you have completed all pages of the form, carefully tear out and remove carbon papers and your copy pages. The
machine scannable pages should be left in booklet form for shipment to the Biometric Laboratory in packages prepared
according to instructions received from the Biometric Laboratory.
MARKING INSTRUCTIONS
Read each item and its numbered responses. When you have decided which response is
correct, blacken the corresponding space on the page with a No. 2 pencil. Do not use
a ball point pen. Make your mark as long as the pair of lines, and completely fill the area
between the pair of lines. If you change your mind, erase your first mark COMPLETELY.
EXAMPLE: The child is 56 months old. Code as follows:
1. AGE Coded in: Months
:©: ::1:r z:g:= z:^: zA:
i©= zzi-.z :^.z .:^z zj^z
:«::
Years :::::
zll-z =:§: =
Mark a field of 9's if an item is unanswered or Not Ascertained.
EXAMPLE: Blood pressure was not taken; the rater codes as follows:
6. •BLOOD PRESSURE
zS^z :=1 = :
= ©:: A-Z
5::
-<^z
-i^z
SVSTOLIC
= €::
-^z
z^z
-Qzz =^==
=5==
:3::
:=1.-: :5:=
-^z
rr7=r
z^z
•^
zQzz i\z
zQzz
:3-:
A^z ,5::
=€=:
=«:=
z:7=:
--&: =^::
:5=:
0==
-A^z =5: =
^z
::7::
:*:
■«-
MH-9-41 (1-73)
38it
NATIONAL INSTITUTE OF MENTAL HEALTH
PHYSICAL AND NEUROLOGIC EXAMINATION FOR SOFT SIGNS
"ATIENT INITIALS
NUMBER MALES 001-
499
FEMALES SOO-998
-A-
■e
:0:
--&■■
:g::
r^E::
:©:
-n-
::(::
-.-4-.Z
:#: ::1::
-zS-.z
:*:
::4::
::5::
:*:
::7::
:*:
:*:
llCi-
:4:::
■m-
■H:
:©:
INITIAL
r:P::
:©:
:}^:
:«::
::T::
:*: ::1::
:5::
:*:
::4::
PATIENT
:*:
:*:
::7::
:*:
:*:
-iii:
-.it-.
--W-
:*:
:fr::
-.-.Izz
:*: ::J::
zzS-.z
:*:
::4::
:*:
:*"
::7::
:*:
:*:
--A--
:&-.
r©:
:&:
:g::
::p:::
:&:
:«::
::(::
:^::
zzQzz ::1::
:z3-:
:*:
::4::
:*:
:*:
::7::
:*:
:*:
rX::
-.if.
-W-
:©:
SECOND
INITIAL
::P::
:0:
:«::
:«::
::T::
::©:: ::}::
::2::
:*:
z-Jtzz
RATER
:*:
--^-
::7::
:*:
:*:
•-1?:
:«:: ::1::
zzQzz ::1::
ZZ2-.Z
::2::
::*:
:*:
zzAzz
:--4;:
PERIOD
:*:
::§::
:*:
::7::
::7::
:*:
:*:
:*:
:*:
,^m
-^
FORM
=^
NUMBER
Hours
zOzz :rt::
Days
:2::
Weeks
:3::
Monlhs
:=»::
PLEASE USE A NO 2 PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
1. AGE
Coded in
Months
Years
7
-VISUAL ACUITY
Code
numerator only
-^-
-.-.U-.
-:S-.-.
;*:
::4::
::5--:
:*:
1:7:1
:*:
:*:
:*: ::1::
:*:
:*:
::4::
:*:
:«::
::7::
:*:
:*:
--^--
-.-.i-.-.
zti..
:=*:
;:4::
:=5-"
:*:
::;::
:*:
:*:
:«:: ::J::
:#: ::1::
::2::
:*:
:*:
:--*:
::*:
::4::
RIGHT
:*:
::&::
:*:
::7::
::7::
:*:
:*:
ZZSZZ
:*:
:«:: ::!::
::2::
:*:
::*:
:*:
::6::
::7::
:*:
:*:
2. -HEIGHT
Coded in
Inches
Cer
limeters
:«:: ::1::
::S::
:*:
::4::
LEFT
::&::
:*:
::7::
:*:
:*:
:zU-.
.^z
::4::
zzAzz
zzAzz
1=5::
-.-.Szz
:-§::
:«::
:*:
:*:
::7::
::7::
-.r.z
:*:
:*:
:*:
:*:
:*:
:*:
::©:: ::!::
zzS-z
:*:
Z-.4ZZ
::§::
:«::
::7::
:*:
:*:
::!::
S
-OPHTHALMOSCOPIC
Normal
:*:
Abnormal
::!::
NA
:*:
3. -WEIGHT
Coded in:
Lbs
Kg
9
-AUDIOGRAM
Normal
:«::
Abnormal
::1::
NA
:*:
:*:
::J"
.-:2"
"3:=
-.-J(iz
:*:
:«::
::7::
:*:
:*:
Right
Lett
Mixed
NA
:«::
"1::
zz^zz
-^
z-J;zz
"§::
:«::
::7::
:*:
:*:
•HANDEDNESS
::!::
:*:
:*:
:*:
:*:
::li:
::3::
--^-
::4::
:*:
:*:
::7::
:*:
:*:
'Specify abnormalities under Item
r4
4. -HEAD CIRCUMFERENCE
Inches
Cm
11
PHYSICAL EXAMINATION
under Item 14
— Spec//y any abnormal Imdmgs
--*=
.rl"
zzSzz
= *:
::4=:
::§::
:«::
::7::
:*:
:*:
Normal
Abnormal
NA
:#:
::1::
::2::
;*:
riO^:
::§::
::§::
::7::
:*:
:*:
A
B
HEENT
NECK
:*:
::l:z
i;t::
S. 'PULSE
Code
Per
minute'
C
CARDIOVASCULAR
=*=
-Jiz
z*z
--^--
"1"
::2"
^-
::j)i:
::§::
:*:
::7::
:*:
:*:
D
PULMONARY
:#:
-.zi-.-.
:*:
:=S==
=:)::
=:2=r
3^
rup:
::5::
::§::
::7::
-^--
-^--
E,
LIVER
=«:=
zzUz
=--9::
--^-
zU.
zz^.z
-^
z-Ji^z
::§::
:*:
::7::
:*:
:*:
F
KIDNEY
lie:;
::1:;
:*:
Regular
--^--
Irregular
::1:;
G
SPLEEN
=:&=
ziliz
:*:
H
OTHER ABDOMINAL
:*:
::!::
=*:
6. -BLOOD PRESSURE
1
MUSCULOSKELETAL
=*=
zilzz
:*:
--^-
..,..
= ^==
==*=
::4==
==§::
:*:
::7::
:*:
:*:
J.
GROSS NEUROLOGIC
:*:
::3::
=*:
;#:
:*=
--^-
=:4==
SYSTOLIC
::§::
:*:
::?::
:*:
:*:
K
SKIN
=*=
zzjzz
=*:
:*:
::gri
-^--
:i4=r
==5::
:*:
::?::
:*:
:*:
L.
M
LYMPHATICS
GU
:*:
zzjzz
::J::
:*:
-.-.i.z
-zS-z
-zSzz
DIASTOLIC
==5:=
I*:
1:5::
:*:
:*:
::«::
::?::
::?::
::?::
:*:
:*:
:*:
:*:
:*:
:*:
"1"
12
. Was the neurological examination for soft signs conducted
and coded on pages 3 and 4 of this form?
NO
YES
:*:
::t:z
385
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
HEALTH SERVICES AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
PHYSICAL AND NEUROLOGICAL EXAMINATION FOR SOFT SIGNS
The Physical and Neurological Examination for Soft Signs (MH-9-41 PANESS) is a 4-page form for the
assessment of physical status (pages 1 and 2) and soft neurological signs (pages 3 and 4) in pediatric popu-
lations. BEFORE ATTEMPTING TO COMPLETE THE FORMS, RATERS SHOULD BE FAMILIAR WITH THE
INSTRUCTIONS GIVEN IN THE ECDEU ASSESSMENT MANUAL. THIS IS PARTICULARLY CRUCIAL FOR
THE EXAMINATION OF SOFT NEUROLOGICAL SIGNS.
The neurological examination for soft signs has been developed and copyrighted by Abbott Laboratories
and their permission to use it is gratefully acknowledged.
IMPORTANT - PLEASE READ CAREFULLY BEFORE MARKING THIS FORM.
INSTRUCTIONS FOR COMPLETION OF MULTIPLE PAGE FORMS
1. Complete page 1.
Following completion of page 1 carefully tear out and remove the pink protective sheet lying between the carbon and
your copy of page 2. Follow this procedure for each subsequent page. You must do this to obtain a copy of the data
for your files.
CAUTION:
DO NOT REMOVE PINK PROTECTIVE SHEETS OTHER THAN THE ONE LYING BETWEEN
CARBON AND COPY OF THE PAGE YOU ARE ABOUT TO COMPLETE.
When you have completed all pages of the form, carefully tear out and remove carbon papers and your copy pages. The
machine scannable pages should be left in booklet form for shipment to the Biometric Laboratory in packages prepared
according to instructions received from the Biometric Laboratory.
MARKING INSTRUCTIONS
Read each item and its numbered responses. When you have decided which response is
correct, blacken the corresponding space on the page with a No. 2 pencil. Do not use
a ball point pen. Make your. mark as long as the pair of lines, and completely fill the area
between the pair of lines. If you change your mind, erase your first mark COMPLETELY.
EXAMPLE: The child is 56 months old
Code as follows:
1. AGE Coded in:
Months m^
Years
:#= ==1=: .:^.. Z^^.
-.4-. -*- --^--
--J.Z
:«:r
--^--
.:&. .:1:: .dSr-. ::&:
-..4^-. =5:: -^
zzj.z
= # =
--^-
Mark a field of 9's if an item is unanswered or Not Ascertained.
EXAMPLE: Blood pressure was not taken; the rater codes as follows:
6. •BLOOD PRESSURE
zQzz :^::
ZZ2ZZ
:4^: :5::
SYSTOLIC
4^: =5^:
-^--
--^--
rr7:r
--^-
--^--
•^
-^^•
r©:r zz^rz
:5--:
=0==
-A^z :5: =
--^--
rr7=:
:€::
•«-
z2zz
DI/SSTOLIC
r©::
-^--
:7::
=7:
--^--
S =
:0:: :^::
zit-z
.0==
:4^= :5::
=€--:
::7r:
-^-
^-
MH-9-41 (1-73)
384
NATIONAL INSTITUTE OF MENTAL HEALTH
PHYSICAL AND NEUROLOGIC EXAMINATION FOR SOFT SIGNS
J NO 6B-Re55
PATIENT INITIALS
NUMBER MALES 001-499
FEMALES SOO-998
--i^--
:t::
"X"
:©:
::V::
FIRST
INITIAL
:4r::
:0:
■n-
:ft:
=«:=
::T::
zzOzz zzUz
rij::
-za-z
-zSzz
::4::
r;4=:
::4;:
PATIENT
::6::
:--5::
z.r-z
z-r.z
=:7:i
■A-
rV::
-W-
:©:
z.Y::
SECOND
INITIAL
-:3-Z
zzSzz
zu^zz
RATER
-z^z
-*-
"7"
^<*=
::2::
::2::
zzSzz
Days
::3::
zzAzz
::4::
PERIOD
::5::
:*:
Weeks
r3::
::7::
Months
:4-
■*-
ui-
"*•
FORM
NUMBER
PLEASE USE A NO. 2 PENCIL. BE SURE TO MAKE MARKS HEAVY AND DARK. ERASE COMPLETELY ANY MARKS YOU WISH TO CHANGE.
1. AGE
Coded in
Months
Years
7. -VISUAL ACUITY
Code
numerator only
=*=
::J::
:i2::
-^-
::4::
::5--:
zz^z
:;7::
--^-
:*:
i:©:-. ::J::
=*:
*:
zzJ^z
-5--:
:*:
::7"
:*:
:*:
:*:
"'"
i:2::
z-S^-.
::4::
:*:
--^--
::7::
-^
:*:
-:2"
-zS-z
-zSzz
zzAzz
RIGHT
zzSzz
::5::
::7"
= *: :=lz:
=:g::
:*:
zzAzz
zz.^zz
-*=
:i7::
:*:
:*:
2. -HEIGHT
Coded in
Inches
Ce
limeters
:#: i:l; =
=*:
---3^--
ZZl^iZZ
LEFT
::&::
--^--
zzr-z
:*=
:*:
::J:-.
.:2::
::2::
::2"
1:4::
::4::
::7::
r:7::
"7::
::©:: iilri
-z2-z
"*:
zzAzz
::§::
^--
::7i:
=*:
= *:
::!::
8. -OPHTHALMOSCOPIC
Normal
Abnormal
NA
3 •WEIGHT
Coded in
Lbs
Kg
9. -AUDIOGRAM
Normal
Abnormal
rrl"
NA
"1: =
.12::
"3:=
==3=:
::4::
:=4::
zz^z
:;7"
:i7"
-HANDEDNESS
Right
Left
Mixed
NA
-^
i:l;:
= :2::
-^
1:4::
I*:
:*:
::7::
:*:
=*:
'Specify abnormalities under Item
14
A. -HEAD CIRCUMFERENCE
r:©:: "1" -rS-- ::3::
r:©:: "1=; --^---- :*:
r:4;:
Inches
::g::
Cm
:i7::
-7::
11. PHYSICAL EXAMINATION
under Item 14
A HEENT
— Specify any abnormal lindmgs
Normal Abnormal
::©:: -zUz
NA
B NECK
:#=
==t==
:*=
S. 'PULSE
Code
Per
minute ■
C CARDIOVASCULAR
=#=
==li=
=*:
=«:=
rrj:=
=:3ir
=^3:-
zzAzz
!=§::
=*:
=:7::
--^--
:*:
D PULMONARY
:*:
::}::
:*:
-^--
=:Ji=
zzSzz
"3==
zztizz
=15:=
=*:
::7r:
=*=
=*=
E LIVER
==©:=
==J=:
:=»=
--^--
;:J::
zz^z
^
:i4::
:*=
=*;
::7::
:*:
:*=
F KIDNEY
:*:
=il;i
--^-
Regular
-^z
Irregular
i:1::
G SPLEEN
--^--
=zl==
--^--
H OTHER ABDOMINAL
1 MUSCULOSKELETAL
ZZ^LZ
6. -BLOOD PRESSURE
-^--
zzizz
:=3:--
zzAzz
1=5::
:*:
::T::
:*:
:*:
J. GROSS NEUROLOGIC
=*:
;:1::
:*:
-«:=
■■*:
--^--
lut:
SYSTOLIC
::§::
:*:
==7::
=*:
=*=
K SKIN
=*=
=zjz=
Z.-9::
=*=
::2::
:*:
::*:
:*:
:*:
r:7:=
-zSzz
=*:
L. LYMPHATICS
M GU
zzjr:
::4::
DIASTOLIC
::5::
:i5::
=*:
=:7::
::7"
==7:=
=*:
12. Was the neurological examination for soft signs conducted
and coded on pages 3 and 4 of this form?
NO
YES
385
PHYSICAL AND NEUROLOGIC EXAMINATION FOR SOFT SIGNS (PANESS)
NUMBER MALES 001
499
FEMALES 500-998
:a3:: ::
1;: ::?:;
:*:
:iit:
::5::
:*:
::?::
:*:
:*:
BE SURE TO MARK IN PATIENT, RATER AND PERIOD
NUMBERS ON THIS PAGE EXACTLY AS YOU DID ON
1" r:f::
1:: ::?::
::3::
"-3::
:-^:
:l4i:
PATIENT
::5::
r:5::
::7r:
:;7::
P'^'^E 1 fci
1:: ::g.:
1:: ::?:--
:l4=:
::4;r
RATER
::7"
■-*:
):: ::2::
):: ::2:i
::3::
:*:
Days
r:2::
:l4::
PERIOD
::5::
z-S^z
Weeks
3::
:*:
:«::
r:7:r
:--7"
Months
:*:
::S::
:*:
■*" "^^ FORM
i„,|, NUMBER
13 PAST MEDICAL HISTORY - Desciibe only CONTRIBUTORY
illness accidenls operations, elc
i:: :5::
1" ::2::
---4;:
::4-"
;:5::
:-5::
:«::
:«::
::T::
::7::
zzSzz
::&: =:
1:: :5::
:--3-:
:-^:
:=5-:
■«"
;:7::
:*:
:* =
::©:: -"
Jr: ::2;:
::3=:
::4."
--rS::
:* =
:;7::
:*:
= *r
r:©:; ::
1r: r:2r:
:* =
::4::
ri&r
::«::
-7::
:*:
I*:
:^-. '.-.
1:: :3:;
;3::
:L4:r
:* =
= *"
::7"
:*:
= *=
-.:^z -.-.
In :i2:i
:=3=:
::4=:
:*:
:«=:
::7==
:«=:
::r-i
-.:Qii -.-.
i;: ::2;-
:*:
r:4=:
:*:
:«::
::7r:
^z
1*:
:#= r:
):: :;2::
r-^:
;r4;i
:=§-:
;*-=
"7"
-^-
:*:
::Q=: r:
" ::2zr
:-3-r
r:4:i
-5::
:*:
r:7ri
--*:
= *:
-i^r. ::
:; :5::
--*r
zz4zz
= * =
=*--
:;7:-
*:
::t::
:*: i:
:: ::2r:
::*:
zzizz
1:6::
:*:
1:7--:
■*:
:*:
:«:: ::
:: ::2::
::3::'
::4--:
DO
-z^-
:*:
::?::
r*:
:*:
::8:: ::
:: ::2::
:*:
;:4rr
z-^z
:«=:
::7::
=*;
:*:
14, ABNORMAL PHYSICAL FINDINGS - Specify all abnormalities
noted on physical ana GROSS neurologic examination (Item 11)
(Soft signs are coded on page 3 and 4 j
I*: ::
:: .z2zz
:: z:2:l
::3::
"4;:
::4;:
NOT
--*:
= * =
i:7:.
:*: "
:: r^r:
-*:
r:4: =
::5::
:*:
::7:r
*:
r*:
::©:: =r
:: .:2=:
::3=-
:at:
::6::
:*:
-7"
:*;
;*:
:*i ;:
rr ::2::
:*:
:iit:
MARK
r*:
:*:
:i7:.-
:*:
:*:
:*: r:
:: :2::
:*:
r:4;:
::*:
:*:
:;?::
:*:
I*:
:: ;:2::
:i :i2=:
"-3::
:-Jt:
r:4-"
OR
:i5::
:i5::
::7::
::e=: ==
r: r:2_-_
:=3=:
r=4;:
= :&::
:«=:
:i7::
:*:
:* =
:#: --:
r: =5r:
::*:
r:4;:
WRITE
:*:
:«:=
=r7"
= *-
:*=
:«:: "
=: r:2=-
= *:
r:4; =
=*i
:*:
::7::
:*:
= *:
:«:: ::
:: :5::
::3::
:3tr
: 5:-
-*:
zzjzz
:*:
:*:
::©:: ::
.. r:2"
:*:
:Kt:
IN
r:5::
:*:
::7i:
:*:
:*:
= «:-- =r
r. :;2_-:
r*:
"4;:
:i5=:
:*:
:i7-
^-
:*:
15. DIAGNOSIS - Soecily all physical and neurological diagnoses here
Please use ICD-8 classifications
;; .z2zz
:: :3r:
::4=:
::4::
THIS
:*r
=r7==
"7: =
=:©:: ^
=: =:2r=
:*-
i:4:=
rifri
:*:
::7rr
:*:
:*:
-.:&:-- -.-.
:: ;:2::
:.3::
::4r=
AREA
rrg::
:*:
r:7=:
:*:
:*:
1:8:1 r:
:: zzSzz
r=3=:
::4;:
:*=
::«==
==7=:
:*:
1*-
:*: r:l
" :3:--
-■Sz-
::4;;
:* =
:«--
:n7:r
=*r
:*:
■.:&:-. Z-.
i: ::2::
:*:
::4::
:*:
= *:
::7::
= *:
I*:
z:Qiz :i
=: rigr:
:*:
Z-4ZZ
= :&;:
:*::
-7=:
:*:
:*:
zzQzz z:
:r ::2=r
:*r
::4::
:*=
:*:
:i7=:
:*=
:*:
zzQzz ;:J
:: ::2-
:*:
i:4;=
:*i
:«::
"7r:
:*:
:*:
--:©:: ril
- _-z2"
zz3zz
"4::
:*r
:*:
r:7::
:*:
:*:
r:©:: ==1
=1 r^::
:*-
zr4::
;*:
:«=:
rr7:r
:*:
:*:
386
;*; :i)
:= ;:2::
r*:
:=4:r
"-6::
:*:
::7r.-
:*:
:*:
PHYSICAL AND NEUROLOGIC EXAMINATION FOR SOFT SIGNS (PANESS)
NUMBER MALES 001-499 FEMALES 500-998
zzQzz ::J:: ::2:: ::3;; ^4::
::5::
:«--:
::7::
:*:
:*:
BE SURE TO MARK IN PATIENT, RATER AND PERIOD
NUMBERS ON THIS PAGE EXACTLY AS YOU DID ON
::©:: ::!:: ::2:: zz^z :l4:: PATIENT
zzHz: ::l:i :4:: :*: :=4=:
::§::
::§::
::7::
::7::
zzQzz ::!:: ::g:: ::3:: zzAzz
RATER
::©:: ::!:: zzS-Z i:^:: zjHiz
::5::
z-Szz
::T::
zzQzz ::!:: ::2:: ::3:: ^4::
PERIOD
;:©:: ::!:: iig:: llS:- zzAzz
zzQzz :?l":? .^X
::§::
::§::
Weeks
3::
::7-
zzj.z
zAz!^
:*:
i t^m m^ FORM
' NUMBER
USE THIS CODE FOR ITEMS 1-20 • SEE INSTRUCTIONS IN ASSESSMENT MANUAL FOR DETAILS
1 - Performed correctly
2 — Performed but not well
3 — Performed poorly or only after repeated instruction and demonstration
4 — Unsuccessful even after repeated demonstration
9 — Not done or not ascertained
1. Touch your finger to your nose ::1:; zzSzz ::3:: ::4:: ::9:--
5, Touch one heel to your other leg
::!::
::2r:
zzSzz
::*::
:*:
2. Touch your other linger to your nose ;;J:: ::2:: :;3:i :l4i: :r9::
6, Do the same with your other heel
::!::
::2"
zz^zz
::4;:
:*:
3. Close your eyes and touch your ;:J:: iijr: ::3:: ::4r: irg::
finger to your nose
7. Close your eyes and do it again
::!::
::2"
-^--
::4::
:*:
4 Close your eyes and touch your ::J:: zzSzz :-^: ::4;: irg::
other finger to your nose
8. Now the other heel
::J::
ZZS.ZZ
■^-
::4r:
:*:
Child writes name at the top of separate sheet of paper. Trace a "6" in each palm and identify it for the child. Figure
In palm as child would see it. "Close your eyes and 1 will draw a mark on your hand. Now open your eyes and draw it
is drawn
on paper."
9. n Right Hand nj- .zS.z i:*: :i4^: ::t::
13. X Right Hand
::!::
zz^zz
:*:
114;:
:* =
10. X Left Hand -I:; zS.z ::3:: "-4=: =*:
14. 3 Left Hand
::1::
::2::
:*:
:liI::
::9::
11 O Right Hand -]:: ::2:: ::3:: :ii)i: zz^zz
15, O Right Hand
::!::
::§::
:*:
::4;:
::§::
12 D Lett Hand -l- ::2:: zzSiz :=4:: =*:
16. 3 Left Hand
::!::
=:2=:
==3=:
1:4::
::&:
"Close your eyes and tell me what I'm putting in your hand." [
17. Com Right Hand ::!:: zzS-z ::3:: zziizz ::§::
19, Safety Pin Right Hand
::1::
::2::
:*:
::4=:
:*:
18, Ring Left Hand ::!:: :5ri ::3:: ii4;: .-:§::
20. Key Left Hand
::J::
zzi-z
:*:
::4;:
:*:
SCORING: Count number of errors (more than 3 scored as three). An error is
definite deviation from the line or steps incorrectly done
21. Walk the line to the end on your toes zzQzz ::j:: .zS.z :=3:i :=g::
24, Now hop back on the other foot
:#:
::J::
:*
-=3::
:*:
22. Walk back on your heels ::©:: :ij:: .zSzz ::3:: ir§::
25. Walk to the end this way (show tandem)
:*=
::1::
= =2::
:^:
:*:
23. Hop on one foot to the end of the line zzQiz :r1r: ::g:: zzSzz ::9::
26 Now walk backwards the same
way (6 steps)
:*=
III::
zzSr-Z
:=»:
:*:
27. FACE — HAND Brush face and/or hand gently with equal stroke (patients eye
s closed)
--^--
::1::
zz2zz
-^-■
::*:
28. FACE— NOISE Brush face and/or click toy cricket ipsilateral ear (patients eys
>s closed)
:*=
iij::
:*:
zzSzz
:*:
29. Two point discrimination. 1 cm. separation, dorsum of digiti minimi.
zzQzz
::J::
::2::
z^--
:*:
PERSISTENCE MEASUREMENTS - Period of uninterrupted success (stopwatch)
SECONDS
20 15-19 10-14 0-9
30. Stick out your tongue until 1
tell you to stop ::1;; ::g=: rig:: 1:4;: r:^::
31. Raise your arms out in front of
you until 1 tell you to stop ::!:: ::2:r 1:3:: zzAzz ::§::
35. Close your eyes and stand still
until 1 tell you to stop
Tendency to fall''
20
::!::
SECONDS
15-19 10-14 0-9
zz^zz ::3:: 1.4::
NO YES
::©:: ::1"
32. Close your eyes until 1 tell you ::1:r ::2:: zzSzz zzJizz rrg::
to open them
33. Stand on one foot until 1 tell you to stop ::1:: ;:grr zz^z zzAzz ::9::
36. Now do it again like this
(Demonstrate tandem)
Tendency to fall'
::!::
-zi-z
NO
:*:
::4_-r
YES
::1::
zzSzz
34. Now stand on the other ..i.z ::2:: zz^z ::4:: iig::
387
PHYSICAL AND NEUROLOGIC EXAMINATION FOR SOFT SIGNS (PANESS)
NUMBER MALES 001
-499
FEMALES 500-998
:*:
z:3.z
:*:
zzAzz
"-5::
:*:
z-r-z
:*:
:*:
BE SURE TO MARK IN PATIENT. RATER AND PERIOD
NUMBERS ON THIS PAGE EXACTLY AS YOU DID ON
zzSzz
:--3::
zzHii
::4::
PATIENT
::5-:
::7::
zzr-z
--J--
::2r:
-:S-z
::4;:
::4::
RATER
r:5:=
z-r-z
-zj-z
--^■-
zt)zz
Hours
::a::
Days
rut:
::4::
PERIOD
::5::
rig::
Weeks
3::
:«:: ::7"
:*: ::T::
Months
:24r:
"^ *"*" FORM
^ NUMBER
USE THIS CODE FOR THE QUALITY SECTION OF ITEMS 37-42 • SEE INSTRUCTIONS IN ASSESSMENT MANUAL FOR DETAILS
1 — Performed correctly
2 — Performed but not well
3 — Performed poorly or only after repeated instruction and demonstration
4 -
9 -
Unsuccessful even after
Not done or not ascerta
repeated demonstration
ned
SCORING: These are 5 second tests Always dennonstrate with a 4/second beat
Three
scores are
recorded for each test.
TEST
NUMBER OF TAPS
NUMBER OF MOVEMENTS
(II greater ttian 4. mark 4 )
QUALITY 1
20 15-19 10-14 0-9
37 Tap this fast witti your finger Left
::!:: zzS.-. :*r ::4:: -z^zz
"1=:
1*:
zzSzz
::4;:
--*:
irlri
-:2::
z^--
r:*:
:*:
38 Rigtit
zzUz :5=: :*: -zAzz :*:
::!::
-:i-z
:*:
:-.4::
:*:
::J::
-3"
:*:
::4::
:*:
39 Tap this fast with your foot Left
zzUz -:2zz :*: ::4:: :*:
:zj::
r*r
:*:
:^-:
::9::
::lr:
r:2=i
--^--
n*:
=*:
40 Right
::!:: zz2zz :*= :^: ::9::
::1"
-ri-z
:*:
Z.AZZ
-zSzz
::1::
:a::
:*:
:i4::
:*:
41 Tap with your finger and fool Left
"1:: i3=: =*: ::4:: =* =
::1=:
:a::
--^-
zzAiz
-*:
:-.1::
-rS-z
:*:
::4::
=*:
42 Right
::!:: r^" :*: :^: =*:
::1::
:a::
:*:
zzAzz
:*:
::1=:
zzSzz
:*:
r:4;:
:*:
43 STRING TEST
ti/larl< the number of times child successfully
followed the five motions To the righ
"1"
zzAzz
Z.AZZ
:=fr:
".5::
No
zzUz
Present
::1::
NYSTAGIWUS
zzS-z I*:
Right LeII
zzSzz -zSiz
44 GLOBAL IMPROVEMENT Rate degree of improvement since ad
mission to the study
Mini- Mini-
Uuch many No mally Much
Improved Improved Change Worse Worse
11
sessed
(At initial rating, mark "Not Assessed") zzUz rij:: :*: :*= =*:
;*:
45 The conditions of the examination were: Satisfacfc
)ry ::li:
Unsatisfactory
::2::
388
The Physical and Neurological Examination for Soft Signs (PANESS) is a
multipage form which is independently formatted and does not require the use
of a General Scoring Sheet. The first 2 pages contain the section relating
to the physical examination; while the last 2 pages contain the scored neuro-
logical examination for soft signs. Investigators may employ one or both
sections of PANESS in their studies. The content of the physical examination
section - though new to the ECDEU battery - should be very familiar to
physicians. The neurological section, on the other hand, attempts to "quantify'
a number of standard clinical procedures and may require additional training.
The physical examination section has been developed within the ECDEU program;
while the neurological section has been developed by Abbott Laboratories and
Dr. Close.
APPLICABILITY
UTILIZATION
Chi Idren to Age 15
Once at pretreatment ; at least one post-
treatment assessment. Additional ratings
are at the discretion of the investigator.
TIME SPAN RATED
Present status
CARD FORMAT
ITEMS
CARD 01 = (I9x, 13, 2|4, 13, |4, 4i3, 171I)
I tem Col umn I tern
Col umn
Age
20 - 22
Height
23 - 26
Weight
27 - 30
C i rcumference
31 - 33
Pulse
3^ - 37
Systo) ic BP
38 - 40
Diastol ic BP
41 - 43
Visual acuity-
■R
44 - 46
Visual acuity-
•L
47 - 49
Opthal
50
Aud iogram
51
Handedness
52
HEENT
53
CARD 02 - Oper
i-en(
ded. Depi
Neck
54
Card iovascular
55
Pulmonary
56
L iver
57
Kidney
58
Spleen
59
Other Abdom.
60
Musculoskeletal
61
Gross Neur.
62
Skin
63
Lymphat ic
64
6U
65
Neuro. Exam
66
Dependent upon number of "write-ins" under I terns 13, 1^
and 15. Using 3-digit ICD-8 codes, "write-ins" will be
encoded by the Biometric Laboratory as follows:
13. Past Medical History
14. Abnormal Findings
15. Diagnoses
Columns 20 - 31
Columns 32 - 43
Columns 44 - 55
389
CARD 03 = (19x, 3811)
I tern Column I tern Column
I tem
Column
1
20
13
32
24
43
2
21
\k
33
25
kk
3
22
15
34
26
hS
k
23
16
35
27
46
5
2k
17
36
28
47
6
25
18
37
29
48
7
26
19
38
30
49
8
27
20
39
31
50
9
28
21
ko
32
51
10
29
22
k\
33
52
11
30
23
k2
34
53
12
31
35
35
36
36
(Sec)
(Fall)
(Sec)
(Fall)
54
55
56
57
CARD 04 = (19x, 613, 212, 211)
I tem
Column
I tem
Column
37 (Tap)
20
43 Left String
38 - 39
37 (Move)
21
43 Right String
40 - 41
37 (aual)
22
44 G 1 ob . 1 mp .
42
38
23 - 25
45 Exam
43
39
26 - 28
40
29 - 31
41
32 - 34
42
35 - 37
CARD FORMAT - CLUSTERS CARD 51 = (19x, 1512, 13)
Code "5" in Column 18 indicates card with factor, cluster or other derived score
Cluster
1
2
3
4
5
6
7
8
Column
Cluster
Column
20
22
24
26
28
30
21
23
25
27
29
31
32 - 33
34 - 35
9
36 - 37
lb
38 - 39
11
40 - 41
12
42 - 43
13
44 - 45
14
46 - 47
15
48 - 49
Total Score
50 - 52
390
CLUSTER COMPOSITION
CLUSTER
ITEMS
1 - Synergy
1-8
2 - Graphesthes ia (Right)
9,11,13,15
3 - Graphesthes ia (Left)
10,12,14,16
k - Graphesthes ia (Both
9 - 16
5 - Stereognosis (Right)
17,19
6 - Stereognosis (Left)
18,20
7 - Stereognosis (Both
17-20
8 - Gait
21 - 26
9 - Topognos is
27 - 29
10 - Persistence
30 - 36
11 - Rapid Movements (Left)
37,39,41
12 - Rapid Movements (Right)
38,40,42
13 - Rapid Movements (Both)
37 - 42
14 - String (Left)
43a
15 - String (Right)
43b
Total Score
All
CLUSTER SCORE RANGE
8-32
4-16
4 - 16
8-32
2-8
2 - 8
4-16
0-18
0 - 9
7 - 30*
9-36
9-36
18-72
2 - 5**
2 - 5^-^^
-'cScore = Sum of Items 30 - 36 + 35b + 36b
-'-"Score = No. of Movements + (Absence (1) or Presence (2,3) of Nystagmus)
SPECIAL INSTRUCTIONS
Identification block (ID) - Patient, rater and period numbers MUST be encoded
on ALL pages used. Form and Page Numbers are preceded and no marks are required -
indeed none are permitted - in these shaded areas.
Multipage forms - The pink sheets inserted after the carbons of pages 2, 3 and 4
prevent fnarks from passing through to the sheets below. Each pink sheet must be
removed before you compilete the page before it; e.g., remove the pink sheet between
white page 2 and yellow page 2 BEFORE filling in page 2. Exercise care in tearing
but pink sheets so as not to mutilate white sheets.
Physical Examination - This section of PANESS comprises pages 1 and 2. It may be
used independently or in conjunction with the neurological examination for soft
signs. All items should be "filled in" - whether or not all items (examinations),
were conducted. For those examinations not done, code a field of "9's". (See ex-
ample on face sheet of PANESS).
NOTE - Although the physical examination section was designed specifically
for children, the items - with the exception of Item 4, perhaps, are
applicable for all populations. Investigators with adult populations
may use this section of PANESS to submit medical data for BLIPS
process Ing.
Item 12 - This item MUST BE COMPLETED. It is a necessary signal - the absence of
which will produce "severe persever i t is" in the computer; i.e., the computer will
search endlessly for further data.
391
Page 2 - ONLY the left side of this page is for "write-ins"; the right side for
encoding of "write-ins".
EXAMPLE
NCORRECT
13. PAST MEDICAL HISTORY - Describe only CONTRIBUTORY
illness, accidents, operations, etc
Qi c^uX^ l\f aAJ2?^iAji^^.y^^ iZit'
CORRECT
CiCiX:^ N^^-^O^c^-r^-y^C^
Page 2 should always contain written entries if any abnormalities are cited on
page 1. If the physical examination is completely "normal" and there are no
"write-ins" to enter, page 2 may be omitted. The omission of page 2 under these
circumstances may occur whether or not the neurological examination (pages 3 and
h) is completed.
Items 13, 1^ and 15 - Write-ins must be legible. Use ICD-8 terminology whenever
possible to describe illness. The ICD-8 List of Major Disease Categories is given
in the Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric
Association, 1968, 3rd Edition. Raters may write in the appropriate 3-digit codes
in lieu of the written words.
Pages 3 and k - Neurological Examination for Soft Signs - EXAMINERS MUST BE THOROUGH-
LY FAMILIAR WITH THE PROCEDURES FOR CONDUCTING THIS EXAMINATION GIVEN IN THE SECTION
"SCORED NEUROLOGICAL EXAMINATION". DO NOT ALTER OR MODIFY THE MANNER IN WHICH THE
TESTS ARE TO BE GIVEN.
I tern 17 - The child need not name the correct denomination of the coin - merely
recognize it as a coin.
I tern 18 - The response "circle" is acceptable for "ring".
Items 27 and 28 - These tests are performed only ips i latera 1 ly .
I terns 30 and 34 - The scale points for these items are in time intervals rather
than quality of performance. No second chances are given with these items.
Item 32 - Use clinical judgment as to whether eyes are closed tightly.
Items 35 - 36 - These 2 items require judgments on the subject's tendency to fall
in addition to recording time intervals. No second chances are given with these
i tems .
392
I terns 37 - hi - Each of these items requires 3 judgments: number of taps,
number of adventitious movements and quality of performance.
Example - Subject taps 12 times; makes 2 adventitious movements and
the quality is judged as poor. Code as follows:
SCORING: These are 5 second tests Always demonstrate with a 4/second beat. Three scores are recorded for each test.
TEST
37 Tap this fast wilti your finger
NUMBER OF TAPS
20 15-19 10-14 0-9
::li: i^:: <*• --Az-- :*:
NUIV1BER OF rviOVEfVIENTS
tit greater than 4. mark 4 }
QUALITY
Item 39 - Do not downgrade scores if amplitudes are increasing.
Item ^3 - This 2-part item (left and right) requires 2 judgments: one for
quality of performance and one for presence and direction of nystagmus.
Example - Subject is able to follow the target to the left
2 out of 5 times and exhibits nystagmus with a fast
component to the right. Code as follows:
43 STRING TEST
fulark tlie number of times child successfully
followed the five motions
NYSTAGfVIUS
flighl Leit
DOCUMENTATION
;& . Raw score printout
b. Cluster score printout
c. Frequency tables
d. Means and standard deviations of cluster scores
e. Variance analyses
393
MANUAL FOR THE NEUROLOGICAL EXAMINATION FOR SOFT SIGNS
Abbott Laboratories and John H^ Close, M.D.
I ntroduct ion
This scored neurological examination is designed to assist the observer
in determining whether neurological soft signs are present in a child.
Because this is not a test of learning, it is important that the patient
fully understand what is expected of him. The examiner (who need not
necessarily be a physician) should demonstrate every task to be performed
while giving the verbal instructions in the test description. Prefacing
instructions should be used in an identical manner from one child to the
next, utilizing a set routine of presentation. The time usually required
to perform this test is 15 to 20 minutes.
At the beginning of testing, the ch i Td ' s attention should be obtained
by making the statement, "Pay attention and watch what I do because you
will have to do it after me." Since many items require stopwatch timing,
the caution must be given, "Don't start until I say NOW, Okay?" immediately
after the description and demonstration of each task. Proper instruction
and clear demonstration are important contributors to the effectiveness
of this scored examination.
A positive atmosphere should be maintained throughout the examination,
accompanied by verbal praise and reinforcement. Incentive, such as the
promise of a choice of a toy upon completion of testing from a box of in-
expensive toys, may also be used.
Materials and Equipment
The room used for the test should be adequately lit, have a minimum
noise level and be as free as possible for extraneous materials. One wall
should be darkened by a black felt cloth or blackboard to provide a black
background for the test of opt icoki nes ia . Other needed items include the
examiner's chair (facing away from the dark wall), a chair for the patient
which faces a table or desk, and a convenient drawer for examining materi-
als. Adhe.sive tape, 1 1/2 inches in width should be used to make a six-
foot long, straight line on the floor, away from any nearby obstructions.
The following materials are needed:
a. A standard-lined 8 1/2 inch by 11 inch writing tablet. On the
cardboard back, clearly ink geometrically attractive figures of
a square, a six, a circle, a three, and an X, approximately one
' i nch h igh .
a603X
39^
Three or four sharp, soft lead pencils.
A ba 1 1 point pen.
A toy cricket or other hand-held device for making clicking noises.
A stop watch (expensive models are unnecessary).
A two-point discriminator with one-centimeter separation.
A ring (simple wedding band type).
A car key.
A coi n (n ickel ) .
A standard two-inch safety pin.
Box of small, cheap toys.
III. Administration and Scoring
Rapport should be established by a few minutes of conversation. Acclim-
atization to test circumstances may then be phased in by one or two simple
unscored tasks, such as, "Can you show me your right foot? Goodl Now point
to your left ear." (Gentle correction is used with an incorrect gesture,
and then the gesture repeated). Above all, a completely encouraging, non-
punitive atmosphere is required. In all the directions that follow, quota-
tion marks indicate verbal instructions; parentheses enclose a physical des-
cription of the demonstration. Right or left handedness should be recorded
before the test begins. (item 10, PANESS - Page 1).
NOTE - WHEN THE CHILD SIMPLY DOES NOT DO A TEST, MARK "9" = NOT ASCERTAINED.
A. Tests 1 - 20
1 . F i nger to Nose
"I want you to touch a finger to (Extend the arm laterally
your nose. Begin with your arm with the hand in a loose
out here." fist, index finger extended
as pointer.)
"Now do like this." (Make a wide sweep medially
to touch the nose.)
Score: 1 - Smoothly and accurately performed.
2 - Slowly, jerkily, and missing the target, then
correcting. (if 10 seconds pass with no attempt,
instruct and demonstrate again.)
3 - Same as 2; but done only after encouragement or a
repeat instruction and demonstration.
k - Same as 3: but without correcting target error.
395
2. Contralateral Finger to Nose
"Now do the other hand." (Demonstrate again.)
Score as in Test No. 1
3. Finger to Nose, Eyes Closed
"Now close your eyes and do that (No demonstration necessary.)
aga in."
Score as in Test No. 1
k. Contralateral Finger to Nose, with Eyes Closed
"Close your eyes again and do it (No demonstration necessary.)
with the other hand."
Score as in Test No. 1.
5. Heel to Shin
"Touch your heel against the front (Demonstrate the heel touch-
of your other leg, up high like ing just beneath the patella.)
this."
Score as in Test No. 1. Either foot may be used acceptably.
6. Contralateral Heel to Shin
"Now do it with the other heel." (Demonstrate again.)
Score as in Test No. 1
7. 'Heel to Shin, Eyes Closed
"Now close your eyes and do that (No demonstration necessary.)
last one again."
Score as in Test No. 1
8. Contralateral Heel to Shin, Eyes Closed
"Now close your eyes and try it (No demonstration necessary.)
wi th the other heel ."
Score as in Test No. I
For questions 9 - 16, the child is told to turn to the table, where a
sheet of paper is taken from the pad and placed in front of the child and
the date written in the upper right-hand margin. Tape or thumbtacks may be
396
used to fix the page in front of the child securely. The child is then
given a pencil and told to write or print his name at the upper left.
No matter how poorly this is performed, the child should be told that
it is we 1 I done .
For drawing on the child's hand, one should try to imagine a frame
that consists of a line bordering one-half inch within the proximal,
distal, and lateral margins of the hand. All numbers and figures should
be drawn in the palm in the same aspect that the child would look at it
when reading. All figures should be drawn with the nonwriting end of the
ball point pen. On all graphes thes ia and stereognost ic samples, the child
should be told, "Now turn your face up toward the ceiling and close your
eyes." One must be certain that the demonstration cannot be visualized.
Having been told this, take the palm of the child's hand in your hand and
slowly (about three seconds) and smoothly draw a number or figure, the
base of which should be at the thenar and hypothenar portions of the palm.
The child should then be told, "Open your eyes and draw the figure on the
paper." Practice one or more times with each hand until the child under-
stands the procedure. The actual examinations are then initiated.
The child is told, "Draw on the paper each of the things I draw in
your hands while your eyes are closed. I may draw another number, or I
may draw figures, like a circle or square."
9. - 16. Graphesthes ia
"Now turn your face up and 9- Draw a square - right hand
close your eyes while I 10. Draw an x - left hand
draw. There. Now open 11. Draw a circle - right hand
your eyes and see if you 12. Draw a square - left hand
can draw it." 13. Draw an x - right hand
These verbal instructions ]k. Draw a 3 - left hand
are used prior to each of 15. Draw a circle - right hand
the tasks listed to the right. 16. Draw a 3 - left hand
If the child is unsuccessful after the first tracing, make the remark,
"That's fine, close your eyes and let me do it again." If after the
second time the child is still unable to draw the figure, raise the pad
off the table so that the figures drawn on the back are visible. "Can
you pick out the one I drew? Fine, draw it." The child is allowed to
draw the figure while still visualizing the example on the back of the
pad.
Scoring: "I" is marked if the child does the figure correctly after
the f i rst trial.
"2" is marked if the child does it successfully after the
second example.
"3" is marked if the child picks it from those drawn on the
pad.
"4" is marked if the child is still unsuccessful after two
examples and the visualization of the figure on the pad.
397
Questions 17-20 involve stereognos is . Different objects are placed
in the hands without bilateral repetition of the same object. The method
of testing and of scoring here is similar to that in the preceding descrip-
tion. The child's face should be directed toward the ceiling with eyes
closed at all times when the objects might be in sight. The box of objects
is kept beneath the table out of sight. Each object is placed in the child's
hand in the order described on the examination form for a period of approximate-
ly five seconds, and then the child is told, "Now give it back. Without look-
ing, tell me what it is." If at that point the child is unable to identify the
object, it is replaced in the hand with the remark, "Feel it and think what it
could be," After five seconds, it is removed and replaced in the box with the
other objects. If the child is still unable to identify it, the box is
brought into sight with the question, "Can you pick it out of here?"
Scoring: "1" is marked if the child names the object successfully
on the f i rst trial.
"2" is marked if the child names the object after the
second placement in the hand.
"3" is marked if the child is successful only after see-
ing the object.
"k" is marked if the child is unable to pick the object
out of the box.
B. Questions 21 - 29
Here, the straight line taped on the floor is used for testing. As long
as the patient's foot is touching the tape in any way, it is not considered a
miss .
21 . Walking Tiptoe
"Walk this line to the end up (Demonstrate while up on the
on your toes." balls of the feet; arms hang-
ing naturally, carefully walk
the 1 i ne .)
"Be sure you stay on the line."
The examiner should wait at the end of the line. This serves two
purposes; first, he remains close to the child to protect against
falling; and secondly, he will be positioned for the next demonstra-
tion, the return trip. An error count is made for each time the
child misses the line or puts a foot down flatfooted. This actual
count, 0, 1,2, or 3, is scored. If a greater number of misses occurs,
score as "3".
398
22. Heel Walking
"Now go back on your heels like (Arms at side, walk on
this." heels on the line.)
Score: The same method as in Test No. 21 is used.
23. Hopping on One Foot
"Can you hop all the way (Demonstrate a hop on the
without missing the line? line.)
Be sure not to put the
other foot down."
The examiner should again remain at the end of the line.
Scoring: An error occurs if the child misses the line
or if the elevated foot is allowed to touch
the floor.
2k. Hopping on the Other Foot
"Now hop back on the other foot." (Demonstrate accordingly.)
Score as in Test No. 23
25. Tandem Walking Forward
"Now be sure you put your heel (Demonstrate heel -toe walking
against your toe and walk to on line and remain at the end.)
the end staying on the line."
Score: An error consists of not placing the heel to toe
or missing the line completely.
26. Tandem Wal king Backward
"Now do the same thing backwards." (Demonstrate accordingly.)
Score as in Test No. 25
In test Nos . 27, 28, and 29 the child is seated at the side of the
table with hands on knees. Three (3) clear examples are given in
each case before actual counting begins. The examples should always
be given exactly the same way. The test should be performed on the
dominant side; in a right-handed child the right cheek and right
hand should be employed. Again, the child's face is directed upward
with the eyes tightly closed.
27. Face-Hand Test
"I am going to brush your hand (with a light fluff of cotton in
and face at the same time." each hand, the dorsum of the hand
and the cheek beneath the malar
eminence should be brushed simul-
taneously and softly with as near-
ly equal pressure as is possible.)
399
27. Face-Hand Test (Continued)
"Did you feel it?"
"Now I'm going to brush only
your face." (This is then performed.)
"Did you feel it?"
On the third example, the hand only is brushed, and again with
the forewarning:
"Now I'm going to brush only
your hand," (This is then performed.)
Begin actual test -
"Now I'm going to do this some (First, hand only;
more and I want you to tell me Second, face only;
what I do each time." Third, face-hand combin-
ation; each time asking
the child: "There, what
did I do?")
Scoring: If the child misses none of these, "0" is marked;
if he misses one, "1" is marked; and so on, up to
a total of missing all three.
28. Face-Noise Test
This test is similar, except that the face is brushed at the same
time a cricket toy is clicked in the ipsilateral ear. Again, three
variations are performed as examples. First, the cricket only is
clicked; second, the cricket is clicked and the face is brushed;
third, the cricket is clicked without brushing the face. Note that
the cricket is clicked in every example.
Begin actual test --
(First, the cricket is clicked "Can you tell me what
and face simultaneously brushed; I did?"
Second, the cricket is clicked "Can you tell me what
without brushing; I did?"
Third, the cricket is clicked "Can you tell me what
and face brushed again.) I did?"
Scoring: As in the case of Test No. 27, the number of errors is
counted; if the child misses none of the trials, "0" is
marked; if 1 of the examples is missed, "I" is marked;
if two are missed, "2" is marked; and if all three are
missed, "3" is marked.
ifOO
29. Two-Point Discrimination
Again, three examples are given utilizing the one-centimeter separation,
two-point discriminator on the dorsum of the digiti minimi.
"You see, I have only touched you (Only one point is touched.)
wi th one point ."
"I used two points on you that (Both points are used.)
time, could you tell it?"
'Now only one point again.'
(One point only is again used.)
Begin actual test '--
"What did I do that time?"
"What did I do that time?"
"What did I do that time?"
(Us i ng two poi nts .)
(Using one point.)
(Us i ng two poi nts .)
Scoring: Same as in Tests 27 and 28, appropriate number is
marked for 0 through 3 errors.
C. Questions 30 - 36
These tests require the use of a stopwatch and accurate timing of the
child's performance. It is necessary that the child know clearly when the
test starts, and that he is told to keep doing the task until the examiner
tells him to stop. For scoring purposes, if the child persists in the task
for 20 seconds or more "1" is marked; 15 to 19 seconds, "2" is marked; 10
to 14 seconds, "3" is marked; and 0 to 9 seconds, "4" is marked. At the
outset of these tests the child is told, "Now I am going to tell you some
things to do; be sure that you don't stirt doing each one of them until I
say 'begin'. Do you understand? Also, be sure you continue doing them
until I tell you to stop."
30. Tongue Extrusion
"Watch me now."
"Did you see that I did? Al 1
right, now when I tell you to
start do it a long time until
I tell you to stop. Ready -
beginl"
(The examiner should stick out
his tongue for a period of
three to four seconds.)
401
31 . Arms Extended
"Hold your arms in front of
you like this until I tell
you to stop."
"Could you see how I did that?
Are you ready to start? All
right - beginl"
Presence of drift does not alter
task.
(The arms shoujd be extended
directly in front of the
examiner, palms down.)
the timed nature of scoring in this
32. Eyes Closed
"Watch how tightly I can close
my eyes .
(Close the eyes very tightly.)
Now you do it when I tell you
to. Ready - beginl"
33. Stand on One Foot
"Now I'm going to stand on one
foot without moving it."
"It doesn't matter which foot
you stand on. Did you see how
I did that? Are you ready?
Beg in'."
3k. Stand on the Other Foot
"Now do the same thing when I
tell you to start, standing on
the other foot. Are you ready?
Beginl"
35. Romberg
"Now stand up like this on both
feet but keep your eyes closed.'
'VAre you ready to do that?
All right, beginl"
(Stand up on either foot with the
arms hanging naturally down at
the sides.)
(No demonstration necessary.)
(The examiner stands in front
of the child on both feet,
erectly, with his hands at his
sides and his eyes tightly
closed.)
402
36. Tandem Romberg
"Now put one heel against the (Demonstrate eyes closed
other toe and stand with your tandem stance, arms at
eyes closed until I tell you to sides.)
stop. Either foot may be in
front."
D. Questions 37 - ^3
In these tests, the examiner should assure himself of exactly what
constitutes a four-per-second beat. A general tendency is to make this
beat faster than it should be. The examiner should appraise his own
sense of rhythm by listening to a four-per-second example; either with
a clock or, if available, a metronome. A typical alarm clock or wrist
watch (but not a stopwatch) ticks at a four-per-second rate.
Each test is of five seconds duration. The child is seated at the
table facing the dark backgroupd wall, and the examiner's demonstrations
should be clear and perhaps exaggerated. The child should be allowed
three or four seconds practice at Nos . 37, 39. ^1 , and k3 . If a mistake
IS seen for which the child would be downgraded, such as a lack of smooth
delivery, the child should be informed. He should also be told at the
outset not tq move the rest of his body, but rather just the part that
IS supposed to be moving.
Adventitious movement will be considered any movement unnecessary to
the task at hand, whether it be a jerk, twitch, grimace, body contortion,
sticking out of the tongue, etc. Contralateral rigidity is not considered
adventitious. The starting point of each of these tasks for the purpose
of timing should be aclear-cut signal.
37. Finger Tapping
"Now watch ho^y I tap only my (Demonstrate sitting erectly
finger just this fast. Notice with the tapping motion
thPt I leave my other arm down mainly comprised of finger
at my side." action not hand motion.)
'You see that I am just moving
my finger and not my hand and
arm? Would you like to prac-
tice t|iat quickly before we
§tart?"
At this point, if the child is going too slowly he should be told
"Go a little faster", and allowed to practice again.
"That looks good. Are you ready
now? All right, begin."
403
Scoring: The examiner is actually grading tiiree things at once.
A brief familiarization and practice is needed to
accomplish this. The first type of scoring is the
actual count of the number of taps performed in the
five-second period. The child must be shown the proper
rate of tapping at the beginning. The number of taps
is scored in the proper position. Simultaneously, one
is making mental note of adventitious movements. Their
number represents a separate score and is indicated by
a marl< in the proper position.
"Q.uality" is also scored 1 through k; the examiner marks
the appropriate number based on his best judgment of per-
formance. This evaluation is not meant to reflect absolute-
ly correct rhythmicity, but rather the smoothness of delivery
overall. Points should not be taken away if the child ends
the task at a more rapid or more slow tapping rate than that
with which he began, as long as he phases in and out of such
changes smoothly. We downgrade the child for sporadicism, or
for the appearance of "bursts" in his sequencing. If the
child only makes one such change in rhythm, he will receive
a score of 1 in the quality position; if he makes this error
twice, he will receive a score of 2; three times, a score of
3; and a score of k could represent a completely arrhythmic
performance.
38. Finger Tapping - Other Hand
"Now we are going to do it with
the other hand; why don't you
practice that for a moment?"
(No repeat demonstration
necessary.)
"That's fine. Are you ready
now? Begin."
39.
Scoring as in Test No. 37
Foot Tapping
"Now watch how I sit and tap only
my foot just this fast. Would
you like to practice that for a
moment?"
(Demonstrate accordingly.
The heel remains on the floor.
Assure that there is moderate
extension at the knee or the
resultant angle on the foot
makes the task difficult.)
"That's fine. Are you ready
now? Begin."
Scoring as in Test No. 37
kok
'+0. Foot Tapping - Other Foot
"Now let's do it with the other (No repeat demonstration
foot; you may practice for a necessary.)
moment."
Scoring as in Test No. 37
k] . Finger and Foot Synchronization
"Now we are going to try the (Examiner must be careful
finger and the foot at the to synchronize finger and
same time. You must tap them foot tapping through several
together at the same rate you repetitions at an adequately
have been tapping them separately. fast rate. Like sides are
Watch how I do it." always paired; right hand with
right foot; left hand with
left foot.)
"Do you want to practice that now?"
"That's fine, do you think you are
ready to start? All right. Begin."
Scoring: The scoring of tap count and adventitious movement
count is the same here as in previous examples.
However, the "Quality" score now reflects the actual
number of times the child deviates from synchronized
tapping. A complication of this scoring immediately
becomes obvious; that is, if the child is unsynchron ized
from the start. In such a circumstance one must grade
quality according to the amount of time during the test
asyncnrony is apparent. A quality score of 1 is well
synchronized, hand and foot, through the entire study.
If the child is not wel 1 -synchronized for some portion
of the test, divide total test time into thirds. If
the child's tapping is not synchronized for one-third
of the time, a quality score of 2 is recorded; if two-
thirds of the time asynchrony is demonstrated, a score
of 3 is received; and a quality score of ^ is recorded
for gross asynchrony throughout.
42. Synchronous Finger and Foot Tapping - the Opposite Side
"Now I want you to tap your foot (No repeat demonstra-
and finger on the other side tion necessary.)
together. Do you want to practice
that? All right, begin."
Scoring as in Test No. k] .
405
43. String Test
This is an opt icoki net ic test performed with a rapid and a slow
component. An object on the examiner's hand should serve as a target
on which the child may fix his gaze; a ring on a finger or a piece of
chalk between fingers is adequate. The motion is made against the dark
background, and tfirough a distance of about two feet. The test hand is
moved away from the body rather quickly, then brought back to the
examiner's side more slowly. It is performed approximately two feet
from the child with first the right and then the left hand. The examiner
should step to the right or left far enough so that the demonstrating
hand will be directly in front of the child's face. The child's head
must remain still, following only with the eyes.
"Now I 'm going to pretend that (The hand is moved away from
I am pulling on a piece of the body in a quick motion and
string several times that is then more slowly brought back
hooked to my belt. I want you medially. This is done five
to follow my hand with your consecutive times rhythmically.)
eyes everywhere it moves. But
you can't move your head. It
may help you if you watch this
ring on my finger."
"Now I'm going to do it on the
other side."
It is permissible for the examiner to place a hand on the child's head,
if it would help to stabilize him. The number of times the patient
successfully follows the target movement out of the possible five is
scored. I'f nystagmus is present, the direction of the fast component
should be noted.
406
THE
PSYCHOLOGIST
PACKET
The Psychologist Packet consists of a series of formats upon which data
from psychological tests may be transcribed. Unlike the other packets, the
Psychologist Packet does not contain the actual scales - merely locations where
scores may be encoded. There are two sets of scales - one for children and one
for adults. Wherever possible, scales were selected which had applicability to
both populations. Two measures of test behavior per se have also been included.
The inventory of scales is:
CHILDREN
ADULTS
Wechsler Intelligence Scale for Children
Porteus Mazes
Wide Range Achievement Test
Goodenough-Harr is Draw-a-Man Test
Bender Gestalt Test - Koppitz Scoring
Psychological Examination Behavior Profile
Wechsler Adult Intelligence Scale
Porteus Mazes
Bender Gestalt - Pascal -Suttel 1 Scoring
Wechsler Memory Scale
Friedhoff Task Behavior Scale
All of the scales in each set are formatted to fit on one General Scoring
Sheet. Matrices for the Children's and Adult Psychometric Scales are given in
Figures 2^ and 25. It is essential that the rater ALWAYS USE THE ASSIGNED SHEET
NUMBER for the packet - Sheet Number 15 for both the Children's and the Adult
sections. Remember that PERIOD number changes; but Sheet Number remains constant
regardless of the time of assessment.
Should an investigator wish to encode other psychometric or psychological
information, he must follow the procedures outlined for the encoding of non-
standard data, (pp 59-64). Modifications of any of the standard scales are con-
sidered "non standard instruments"; e.g., the Canter scoring of the Bender Gestalt.
While entitled "Psychologist Packet", psychometr ists or other individuals with
appropriate testing experience may administer the scales. Supervision by a pro-
fessional psychologist is suggested when non-professional test administrators are
emp 1 oyed .
408
PSYCHOMETRIC
SCALES-CHILDREN
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET {50-GSS)
—
PATIENT INITIALS
NUMBER MALES 001 TO 499 NUMBER
FEMALES 50C
TO
998
—
::A: ::ft: "C: "D: ::£:: ::ft: :«:
FIRST
::K: ::i;: zztAz zzUz zdOz ::P:: ::Qr
INITIAL
-U: ::Vt: :i«: ::)e: ::¥:: ::Z::
:«: ::i::
M
CHILDR
::*:
FIGURE
r:8:: ::»:: ::2:: :3:: ::4::
PATIEN1
::3:: ::*::
2k :3:: :^::
::5::
::&:
::5::
::fc:
z.bzz
::fc:
z.Jzz
z.Jzz
z.lzz
::8::
::»::
::8::
::»::
::9::
::9::
^
:UI;: ::ft: "C: =:&: -tz
s
r:|£: rrt: riM: -Mz r3D:
::F:: :aS:
ECOND
"::f^: :«
NITIAL
::£:
ftTRICES
EN'S PS
SCALE
FOR ,^-_, ,^,,
YCHOMETRIC "ATER
-:: ::4::
::5::
::5::
::&::
::fc:
::?::
::8::
::8::
::»::
::»::
^
.;U- "W: :W: ::X: ::¥::
::3:: :^::
::£:
::£:
Veeks
::a:
::6:: ::?::
::fc: ::7::
Months
::»::
::8::
::8::
::»::
:rf::
—
::£>:: | n«K | ::£: ::!: ::*:
SHEET "S:
::li:
z^:
:Z:
-ft:
-Z&Z
::*:
::2:
PERIOD
::e:: ::|:: ::2:: ::3:: ::4::
Hours Doys V
::ft: ::*: ::2::
—
::Q:: ::3r: ::£: ::3:: ::4:
"O. 1^1
—
Row
'Mtee QiK>cieftt ==*=
::5:: ::&::
zjzz
::&:
-^
Row
' =Inf brrna'ticm --*-
::5::
::6c:
::?::
::&::
::S:
-~
2::tt: ::t: ' ' ::3:: ::*:
::5:; ::6::
:7::
::8::
::St
2::ft: ::a::"::2:: ::3:: ::4::
r:5::
r:fc:
"?::
::8::
:=S:
"~"
3::a: ::*: :" Tzg:: ::*:
.-...« MAZE
"♦Qtiantr-itaEive S4ore
7::
:S:
::&:
"ft:
::Sb
::St
4-0:: -:a;=" zz2:: ::3:: ::4::
::£:
::5::
::&:
::&::
::?::
::8::
:*
:*
^
5::tt: ::3:: "■ ::3:: ::4::
rii: ::6::
:7::
::&:
::9:
SAfitfemeFtic = ==*:
::5::
::fc:
::7::
::8::
:*
—"
6::0:: ::a:: " ::*: ::*:
::S: :;6::
:J::
::&:
::9:
6::e:: ::3::" ::2:: ::3:; :l4::
7:S-iTnil=arlties --^'-
::5:r
::5::
::6::
::6::
::?::
::7::
::8::
::8::
:*
:*
^
7 Standard Sesre
::5;: ::6::
:?::
::&:
::9:
^_
8::e:: ::1:: l" ::3:: ::*:
9:8:: ::3:: "^^ ::3:: ::*:
GOOD
:*:
::9:
::9:
8::et: ::3::" ::2:: ::*: ::4::
9:VOCafeulary ^:: :^:
::S::
::5::
::6::
:*:
::7::
::Jr:
:*:
:*:
:*
:*
^
lOQ^jality ScG^e==4::
"5:: rrfc:
:S:
-ft:
::St
10:*: ::J::" :*: :*: :3t:
:*:
;::6::
::7::
:*:
:*
■~~
1 1 ::&: ::J:: :':i:: ::J:: ::*:
::5:: ..(cz
::K:
::ft:
zz9z
11 :Mgife &pan : ::'t:
12::e:: ::3::"::2:: :i: :A:
l3:P:ict«re Coispl©.,:
::S::
::&:
::5::
rrfc:
:rfc:
::6::
::?::
::?::
::7::
::8::
::8::
::8::
:*:
::»::
^~
i2Fig A -3==
ISFtg 1 :*:
irS:
::^.:
==- =
::ft:
::St
—
::5::
::ft
^_
14Fig 2 ::3::
15El.g S ::3:.
::5::
::ft:
::8::
::&:
::ft:
::9t
::9r;
::9:
::9t
::*:
14:*: ::J::" ::2:: :*: :l4::
15 :?i entire Ar^^ange
16::e:: ::J::"::2:: :*: :=t:
17:Sl0Glk Besign ::4c:
r8::a:: ::a::"::2:: :*: ::4=:
::5:: ::6::
WiSC
::5:: ::6::
::&: ::fc:
.If::
::?::
::7::
::7::
::8::
::»::
::«::
::8::
::8::
:*:
::S=:
::S=:
::»::
::9::
—
::ft:
=^.
—
l6Fig.4 ^\
—
i7Ftg 5 --=3==
18F4-g:^ ::*:
"%ENDK
=5=-
:rJ::
::?::
^
l9Fte 7 -3==
::5::
::?::
::ft:
-8::
::*:
I9:@bjeet Ass«mb4y
20 ::e:: ::J::"r2:: :*: ::4::
::&:
::5::
lift:
::fc:
:ifc:
llfc:
::?::
::?::
::?::
::8::
::«::
::8::
::9=:
::8t:
::St:
■^
20Fie 8 ^{
::9t
—
Jilfetal Soores:: .-a-
::5:: ::&;:
::?::
izft:
::9t
~
22::ft: ::i? ' zzi: ::a:: ~Mz
:ri: ::6::
::J::
::ft:
::*
22::e:: ::3::"::2:: ::3:: ::4::
23=^erbal f Q =*^ ==*=
nS:
::S::
::6::
::6::
::3br
::3t:
::8::
::8::
::»::
::St:
—
23s^paTatiQn-3- (t)
::5:: ::&:
::J::
::ft:
zz9z
~
24Fearful=ness3- (=2=)
::&: ::fc:
::?::
rrftl
::9t:
24::e:= ::3::"::2:: z-Szz :l4::
::S:
::«(::
::^:
::8::
::*:
^
25Rfipp^rt ^ ==3== (-8=)
::5:: ::fc:
irK:
::&:
:;9t:
25::e:: ::3:: " ::2:: ::3:: :=4l=
::5::
::6::
::^r
::8::
::St3
__
26e&nM=deftee - (4)
::i: ::fc:
::S:
::&:
::*:
26:FerfornianG« I^Q
::5::
::6::
::?::
::»::
:*:
^
27Rteaetivity - (4)
::5:: ::6::
::K:
::ft:
::9t:
27 r:e:: ::J:: " ::2:: :*: :^:
::S::
zzfcr
::?::
:*:
=*1
^~
28e©op^raGion- (€)
rrft: ::&:
::i:
::ft:
::9tr
28::e:: ::3:: " ::2:: :*: zz4zz
::S::
::fc:
::7::
::»::
:*^
29F^us:feradioa : (7:)
::?::
::8::
::9t:
29:11%1:1 IQ :*: =-t:
::S:
::6c:
::5i::
::«::
=*
~
aOBepe^deriey -■ (S)
::J::
::ft:
:r9b:
30 ::&:: ::J:: " :*: :*: :^:
::&:
::6::
::^:
::»::
::*:
—
3iAtteftti6n ^an?^
32 Seal -2== -*=(10)
::5:: ::fc:
-a: ::6::
::?::
::K:
::a::
::ft:
:r9t:
::St:
31:*: ::J::"::2:: :*: ::4r:
::S::
::6::
::Jb:
::8::
::9tJ
32 =!tea-tSing -- ^ (=3?-)
-S:
::6::
::^:
::»:
::8::
~
33Aetiv. Level- (11)
__5:: ::fc:
::?::
::&:
::9b:
33:*: r":- :*: :^:: r:4z:
::S:
::«c:
::S:
::»:
::9::
^
34Nat.= AcC±=^.=^-(12)
::&: ::fc:
::ft:
::8::
::9b:
34 :*: t zrt: ::3:: ::4::
::S:
::6::
::^:
::8::
::*:
^
35 gEmuffunie atienl3)
36 A&s e* t t'fenB^ s 1 4)
::&: ::fc:
::£: ::fc:
::?::
::?::
::ft:
::&:
::9::
::9::
35=gpellifig ^ m
36 :*: « :*: r^:: :^:
WR AT
;:3t:
zzjiz
::&:
::8::
::St:
^
37HEJSfeili€y ::3::(1:5)
::&: ::6::
::&: ::fc:
::?::
::8::
::e::
i:Sb:
::»::
37:*: i" ::2:: ::3:: -M--
::&:
::ec=
::3l:i
=:3tr
==8::
==8::
"^
38:*: ::!:: :i: ::3:: ::<::
~
39:ifc: ::Jrr rr£. i^iz -4"
r:5:: ::fcr
::?::
::8::
::9b:
39 :*: ^< : :^:: -z3.z :^-:
::S::
::fc:
::S:
"8::
i:*:
40:*: :ii:: zzizz r:3:: r^;:
::5:: ::fc:
iii: rrfcr
i:t:
40 :*: i^ ::2:: :*: ::«::
::S::
"fc:
-?::
::»::
::*::
41 lA= ::3:: ::2:: ::3:: ::4::
410
41 :*: ::l:: -zi:: :4:: :2»::
::*:
::6::
::Jb:
::»::
::S::
o
ofe; 12 3 4 5
6
7
8
3/s; 11 12 13 14 15
76
77
78
79
20
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
—
PATIENT INITIALS
NUMBER MALES 001 TO 499
MUMBER
FEMALES SOC
TO
998
—
zztiz lift: ::e: ::D: ::&=
FIRST
"K: ::t:: zMz :±t= -zQz
INITIAL
"tl: r:W: =iW; "X: .zY-z
::F::
::ft:
::£:
zrStz
::M:
--■/--
::X:
ADU
::»:
::ft:
::*: :*:
FIGURE 25
::1:: ::2:: :3:: :^:: ::S::
PATIENT
:3:: ::«:: ::&:
::3:: :^:: ::S::
::fc:
::fc:
r:fc:
::f::
::?:=
rr?:r
::&:
::»:
::8::
::*:
::»::
::»::
^
t-Jtz rzft: --C-- "E>: --taz
SECOND
::!£: ::t:: zMz :*t: :«:
z.r-z
::£:
:«:
:«:
^TRICES FOR
LT PSYCHOMETF
SCALES
UC ^^^= ^^^^ RATER =^'=
::3:: ::4:: ::a::
::*::
::fc:
::?::
::?::
::*:
::*:
::»::
::9::
„ ,
INITIAL
;:tt; ::W: :dW: ::Xr :*:
::3:: :^::
::S::
'°::.:
Weeks
..:3:
::&::
::fc:
r:7::
::?::
Months
:3»::
::»::
::8::
::9::
^
-.:a: 1^ r=2:z .=1: ::4:: SHEET
::S:
::ft:
::&:
PERK
zzifz ::o:: ::l:: ::2:: ::3:: ::4::
Hours Doys
::&: z-ttz ::*: ::2::
—
rrflt: zrj.: rriz rrl: ::*: NO'l
^
—
Row
1 «az"« Qu?Jti«nt
::5::
::&:
::S:
::&:
::S::
Rov
1 iftt&rmat^ioa :=*:
::&:
::ec
::?::
::*:
::»::
__
2::0:: =:i::":r2:: ::*: ::*::
::5::
::&:
::*:
::&:
::Sb:
2::ft: ::a:J ' -.±z rri: ::*:
::5::
::&::
::7::
::*:
::»:
•~"
3::ft: i:*;"::*: :ij:r ::*:
IM A ZE
::8::
::9::
3 e0mp*eheHsd.on *:
::5i:
::fc:
::?::
::8::
::9:
—
^^t^tiafititteti^e =Seore
::»:
::S::
4::e:: ::3:J ' ::2:: ::»: ::*:
::S::
::&:
::?::
::8::
:*
__
5::e:: ::*: " "i: "J:: ::«:
::&:
::&:
::Jt:
::8::
::*:
5A%ithmetic==*= ==*:
::5::
::*::
::7::
::8::
:*
—"
6::e:: "J::""*: "J:: ::*:
::S:
::fc:
::3I::
::&:
lit:
6::a:: ::3:J' ::2:: ::3:: ::*:
7Siini:laE-i:ti€S ::*:
::5::
::S::
::*::
::6::
::?::
::?::
::e::
:*:
:*
:*
—
7::e:: -T>j.g -i "*" -^=
::&:
::6::
::K:
::&:
::9::
—
8-6:= ::^I:""^: ::»:: ::4:r
::&:
::*:
::Jt:
::&:
::»:
8 1:8:: :=!::?' ::£: :*: ::*:
::S::
::6::
::7:r
:*:
:*:
—
9::ft: zMg' 2 -*= ==*:
::S::
::fc:
::Z::
::8::
::St:
9 Vocabulary t- -=4::
:*:
:*:
::7::
:*:
:*
_
10::e:: i:)"""fc: rij:: :^:
::&:
::&:
::3t:
::ft:
::9t:
1 0 :*: ::!::' ' :*: :*: :--4::
:*:
:*:
::!::
:*:
:*
""
n-e:: :B-ig ^ "J:- ■^■■
::5::
::6::
::3t:
::8::
::9::
ll&igtt S^n -= ==4::
::5::
::&::
::Ji:
::8::
::»:
—
12::e:: ::)"":: J:: :ij:: :i4:r
::5;:
::&:
::31::
::&:
::*:
12:*: ::)::" :*: :*: ::4::
::5::
::«c:
::7::
::8::
::«:
~~
13:*: =Pxg 4 =*^ -^
14::fi:: ::3:: "::2:: ::&: ::*:
::5::
::&:
::K:
::&:
::St:
l3Pi:ct?Ure €on^ let-ion
::S:
::4::
::^:
::8::
:.r-
::&:
::fc:
::3t:
::»::
::St:
14::e:: zzU^' ::2:: :4:: ::4::
::&:
::4::
:;^:
::8::
::9::
—
1S::a:: :P4g 5 -^t: ::*:
16::Q:: ::3:: "::2:: ::!: ::*:
17::Q:: :Bdg 6 ::*: ::*:
::&: ::6:: ::J::
B EN D PS
::a::
::ft:
::&:
::9t:
::9b:
::9::
ISFicfcure Araaang^nent ::&:
16::e:: ::J::" ::i:: :*: :3t: ::S::
17 Block D*si^n ^^ s^
WAIS
::*:: ::Jt:
-"ft:
::»:
::8::
::»:
::»::
::S:
^
18::fi:: ::ir "::2:t ::a:: ::*:
: j:
::6::
::J;:
::&:
::9::
18:*: :-J::" ::2:: :*: ::4::
::£:
::6c:
::?::
::8::
::»:
~~
19::ft: :Pdg 7 -&: ::*:
::&:
::&:
::K:
::8::
::9b:
i9€ft3J6fet Ass:*abiy
::S::
::t:
::?::
::8::
::9::
—
20::fi:: ::i: "::*: ::a:: ::4:
::5::
::&:
::7::
::&:
::Sk:
I0::a:: ::3:J' ::2:: ::»: ::*:
::»:
::&::
::?::
::8::
::9::
,
21::fi: :Sig fi ::&: ::4:
::5::
::&:
::7::
::ft:
::9::
2iMgit S^b^i ^-t=
::&:
::6::
..r.z
::8::
::»::
— ■
22::ft: ::*:"::»: ::&: ::*:
::5::
::6::
::J::
::&:
::9t:
22::e:: ::3::" ::J:: ::*: ::4::
::*:
::&:
zzT.z
::8::
::9::
~
23=€DnfilgaT=at*Dn Score
::&:
::fc:
::3!::
::8::
;:9t:
23 Verbal iQ ==*: ::*:
::&:
::&:
zzjzz
::8::
::»::
_.
24::a:: ::3:: "::2:: ::3:: ::ir:
::5::
::6::
::3I::
::&:
::St:
24::e:: ::3::" ::2:: :*: ::*:
::S::
::6::
zzT-z
::*:
::S=:
~~
2S=lfocal Seore= =^=
::&:
r:fc:
::?::
::ft:
::9t:
25::e:: ::3::" :.-2:: :*: ::4::
::S::
::6::
::^:
::*:
::»::
—
26::e:: ::]:: "::2:= ::3:: ::4::
::5::
:rfc:
::?::
::§::
::*:
26 f erf <3nH*nc^ IQ
::*:
zztnz
zzT-z
::8::
::»::
zz
27::a:: rr3i: "::2:: ::3:: ::*:
::&:
::6::
::3I::
::&:
::9::
S7::e:: ::J::"::?:: :*: ::4::
28 ::*: ::!::" ::2:: :*: ::4r:
::&:
::&:
::6c:
::fc:
z.r.z
zzT-Z
::8::
::*:
::»::
::St:
~^"
28-Inf£jTmatie*i- -*=
::&:
::fc:
::3!::
::&:
::fc:
— ,
29r:«rtfetaciem- -*=
::&:
::fc:
::S:
::B::
::9t:
29?uli -IQ :*= =-U:
::5::
::6::
zzT--.
::«::
::»::
:z
30::eone=ro4 --■-^-- *^
::S::
::fc-
::7::
::B::
::9t:
JO ::&: ::3::" ::*: :*: ::4::
::&:
::<(::
z.r-z
::8::
::»::
_
31 ::feogi=Ga-l Mefttory
32::ft: ::J:: ^^ ::a: ::*:
::5::
::&:
::fc:
::fc:
::?!::
::S:
::&:
::8::
::9t:
::fc:
Jl :*: ::)::" ::2:: :*: ::4::
::*:
::&::
z-r-z
::8::
:*:
~
32 ::e::
G©op*rafcion (1)
::S:
::6::
::7::
::»::
::St:
~
33=Mgl=ts Fol^ai?^^
::&:
::6::
::K:
::&:
::9t:
33 :*:
Gir-asf-- ^ --^--(2)
::S::
::6::
::/::
::*:
::»::
n
34::B4gi^s Baetewa^d
35:^epr«diicti©n '-
WMEM
::R:
::S:
::a::
::a::
::9::
::9::
34:*:
35 :*:
Withdrawn ::4::(4)
::S::
::6c: ::Jt:
-FTBS
::8::
::»;:
::Jt:
::*:
~
36::e:: ::!:: JJ : :J:: :=4::
::S::
::6::
::R:
::e::
::«::
36:*:
Agitatt^n =^=(5)
::S::
::6::
::3t:
::*:
::»::
zz
38 :A: ::h: ::k:: ::3:: ::*::
::5::
::&:
::fc:
::fc:
zzJzz
::S:
::a::
::8c:
::9::
::9::
37:*:
38 :*:
A^f=€heflisiV€(6)
::&:
::&:
::<f:
::fc:
::?::
::?::
::a:
::*:
::*:
::*:
^
39=^eradTy €|uGtlei*t
40:*: ::h: ^ : :J:: ::4::
::&:
::fc:
::fc:
::S:
::K:
::a::
::8t:
::*:
::*:
39 :*:
Rela*iaft =^-(8)
::&:
::S:
::6::
::6::
::?::
::Jb:
::8::
::&:
::9::
::*:
"^ 3::
::»:: :*: ::3:: ::4::
41 :*: ::]:: :V . :*': zzi.z
::&:
::fc:
::?::
::&:
::9::
411 !:: ::l:: ::2:: ::3:: :2j::
::&:
::6::
77
::?::
rs
::8::
79
::Jt:
20
c
ols: 1 P .1 4 a
"S"
7
T"
—3"
"JT
1 12 13 U IB
PSYCHOMETRIC SCALES
Code 15 for Sheet Number when encoding any or all of the
standard Children's Psychometric Scales.
The texts for all children's scales are printed on PINK templates.
IVIH-9-60 (Wise)
62 (WRAT)
61 (MAZE)
63 (GOOD)
64
66
Wechsler Intelligence Scale for Children
Wide Range Achievement Test
Porteus Mazes
Goodenough-Harris Drawing Test
(BENDK) Bender Gestalt Test - Koppitz Scoring
(PEBP) Psychological Examination Behavior Profile
Mark on right half of scoring sheet on row specif ied (Cols. 11
-20)
ROW
NO.
WECHSLER INTELLIGENCE SCALE FOR CHILDREN
(60-wiSC) (Code 15 for Sheet Number)
INSTRUCTIONS: Code scaled scores, NOT raw scores, in 2 digits.
code
lO's in 3 digits. When using "short forms" or abbreviated versions of
Wise, be sure to encode subtests and IQ's on the proper rows.
Leave
blank all unused rows.
Information . . .
12
Comprehension . .
3-4
Arithmetic ....
5-6
Similarities ....
78
Vocabulary . . .
9-10
Digit Span ....
11 12
Picture Completion .
13 14
Picture Arrangement
15-16
Block Design . . .
17-18
Object Assembly . .
19-20
Coding or Mazes . .
21 22
Verbal IQ . . . .
2325
Performance 10 . .
26 28
Full IQ
29-31
WIDE RANGE ACHIEVEMENT TEST
(62-WRAT) ICode ISfor Sheet Number
Code Standard Scores in 3 digits Reading
3234
Spelling
35-37
Arithmetic
38 40
IVIark on left half of scoring sheet on rows specified
PORTEUS MAZES
(Code 15 for Sheet Number)
Code 3 digits for each of the two scores
. . . Maze Quotient
. . . Qualitative Score
GOODENOUGH-HARRIS DRAWING TEST
(Code 15 for Sheet Number) (63-GOOD)
Code 3 digits for Standard Score; 2 digits for Quality Scale
. . . Standard Score
. . . Quality Scale
BENDER GESTALT TEST - Koppitz Scoring
(Code 15 for Sheet Number) (64-BENDK)
For each figure, record the errors by encoding all appropriate
numbers on the ROW designated. Encode "0" for rio errors.
Encode Total Score in 2 digits.
Figure A
0 = No errors
1 = Distortion of Shape
3 = Disproportion
5 = Rotation
7 = Integration
Figure 1
0 = No errors
1 = Circles for Dots
3 = Rotation
5 = Perseveration
Figure 2
0 = No errors
1 = Rotation
3 = Row added, omitted
5 = Perseveration
Figure 3
0 = No errors
1 = Circles for Dots
3 = Rotation
5 = Shape Lost
7 = Lines for Dots
412
PSYCHOMETRIC SCALES
ROW
Continue marking on left half of scoring sheet on row specified
ROW
NO.
Mark on left half of scoring sheet on row specified. (Cols. 1-5)
16
17
BENDER GESTALT TEST-Koppitz Scoring (Continued)
PSYCHOLOGICAL EXAMINATION BEHAVIOR PROFILE
(Code 15 for Sheet Number) (66-PEBP)
Adapted from the Collaborative Study on Cerebral Palsy, Mental
Retardation and Other Neurological and Sensory Disorders of In-
fancy and Childhood, Perinatal Research Branch, National Institute
of Neurological Diseases and Stroke, National Institutes of Health
INSTRUCTIONS: Rateeach item on the basis of behavior observed
or elicited during the psychological examination.
Figure 4 0 = No errors
1 = Rotation
3 = Integration
Figure 5 0 = No errors
1 = Circles for Dots
3 = Rotation
5 = Shape Lost
7 = Line for Dots
23
1. SEPARATION FROM MOTHER
0= Shows no concern; eager to leave mother and go with
examiner
1 = Shows very little concern
2 = May show some initial reticence, which is felt to be
entirely appropriate
3 = More than usual amount of concern
4 = Very upset, cries, clings to mother
18
Figure 6 0 = No errors
1 = Angles in Curves
3 = Straight Line
5 = Integration
7 = Perseveration
24
2. FEARFULNESS
0 = No apparent awareness of strange situation
1 = Very little fear evidenced
2 = Normal amount of caution in the situation
3 = Inhibited and uneasy throughout with some slowing of
responses
4 = Very fearful and apprehensive
19
Figure 7 0 = No errors
1 = Disproportion
3 = Incorrect Angles
5 = Rotation
7 = Integration
20
Figure 8 0 = No errors
1 = Incorrect Angles
3 = Rotation
25
3. RAPPORT WITH EXAMINER
0 = Exceptionally shy; withdrawn
1 = Shy; waits for friendly gestures
2 = Perhaps some initial shyness; feels at ease
3 = Very friendly and at ease
4 = extreme friendliness
21 22
Total Bender Score
26
4. SELF-CONFIDENCE
0 = Lacks self-confidence; extremely self-critical
1 = Distrusts own ability
2 = Adequately self-confident
3 = More than usual amount of self-confidence
4 = Very self-confident
413
PSYCHOMETRIC SCALES
CHILDREN
ROW
NO.
Continue marking on left half of scoring sfieet on row specified
27
Psychological Examination Behavior Profile - Continued
5. EMOTIONAL REACTIVITY
0 = Extremely flat; no change in facial expression
1 = Somewhat flat; little change in emotional tone
2 = Normal responsiveness; affect appropriate to situation
3 = Mood more variable than average
4 = Extreme instability of emotional responses, marked
emotional lability
28
6. DEGREE OF COOPERATION
0 = Extreme negativism
1 = Resistive to demands or directions a good deal of the time
2 = Cooperative with reasonable amount of discomfort and
anxiety
3 = Accepts direction or demands more easily
4 = Extremely suggestible and conforming
29
7. LEVEL OF FRUSTRATION TOLERANCE
0 = Withdraws completely
1 = Occasionally withdraws from task where difficulty is
encountered
2 = Attempts to cope with difficult situations
3 = Becomes quite upset by difficulty
4 = Extreme acting out behavior and/or crying
30
8. DEGREE OF DEPENDENCY
0 = Very self-reliant; refuses help
1 = Rarely needs reassurance
2 = Dependent in appropriate situations
3 = Demands more attention than average
4 = Constant need for attention or help
31
—
9. DURATION OF ATTENTION SPAN
0 = Attends to tasks very briefly
1 = Spends short time with tasks
2 = Spends adequate amount of time on tasks
3 = Spends more than average time on tasks
4 = Highly perseverative
ROW
NO.
Pi.BP— Continued Marii on left half of scoring sheet
GOAL ORIENTATION
0 = No effort to reach a goal
1 = Briefly attempts to achieve goal
2 = Able to keep goal or direction in mind
3 = Keeps goal and questions in mind
4 = Compulsive absorption with task
LEVEL OF ACTIVITY
0 = Extreme inactivity and passivity; placid, sluggish
1 = Little activity; content to sit still most of the time
2 = Normal arnount of activity
3 = Unusual amount of activity and restlessness
4 = Extreme overactivity and restlessness; can't sit still
NATURE OF ACTIVITY
0 = Extreme rigidity, unable to shift activity or approach
to task
1 = Some rigidity
2 = Flexible behavioral patterns; activity appropriate to
different situations
3 = Behavior frequently impulsive
4 = Extremely impulsive; explosive and uncontrolled behavior
NATURE OF COMMUNICATION
0 = Little or no verbal communication
1 = Verbal or non-verbal responses confined to answering
directed questions
2 = Readily answers questions; may elaborate
3 = Answers questions freely
4 = Difficult to follow child's thinking
ASSERTIVENESS
0 = Extremely assertive, willful personality
1 = Quite forceful, unnecessarily rough and careless in
handling materials
2 = Self-assertive but accepting of the situation and capable
of control
3 = Passive acceptance; permits self to be somewhat controlled
by exarrjiner and situation
4 = Extreme passivity; malleability and acquiescence to
everything
HOSTILITY
0 = Very hostile, obstructive
1 = Unusual amount of hostility present
2 = No unusual amount of hostility evidenced
3 = Very agreeable child who rarely shows hostility even where
it migtit be
4= Ingratiating child ^^^
414
WECHSLER INTELLIGENCE SCALE FOR CHILDREN
(060-WISC)
The Wechsler Scales (WISC and WISC-R) are widely used standardized measures
of intelligence, or, in Wechsler's words, "for assessing an individual's potential
for purposive and useful behavior". The 19^9 WISC was a logical outgrowth of the
original Wechs ler-Bel levue Scales. An extensive revision of the WISC - designated
as the WISC-R - was published in 197^ ^nd it is this version which is recommended
for use. The WISC-R - like its predecessor - consists of 12 subtests - 10 of which
are considered mandatory. Wechsler strongly urges the inclusion of Digit Span and
Mazes in clinical situations because of the diagnostic information they add.
REFERENCES 1. Wechsler, D., Manual for the Wechsler Intelligence Scale
for Children, Psychological Corporation, New York, 19^9-
2. Wechsler, D., Wechsler Intelligence Scale for Children -
Revised, Psychological Corporation, New York, 197^-
3. Wechsler, D., Wechsler Preschool and Primary Scale of
Intelligence, Psychological Corporation, New York, 1 967 .
Manuals and materials for the WISC, WISC-R and WPPS I may be
obtained from the publisher
APPLICABILITY WISC - 5 to 15 years. WISC-R - 6 to 16 years
UTILIZATION At the discretion of the investigator. May be used at the
initial assessment only or as a change measure.
CARD FORMAT - ITEMS
CARD 01 = (19x, II 12, 313)
I tern Column Item Column
Information
20 ■
- 21
Comprehension
22 ■
- 23
Arithmetic
Ik ■
- 25
S imi lar i t ies
26 ■
■ 27
Vocabulary
28 ■
■ 29
Digit Span
30 •
- 31
Picture Completion
32 •
- 33
Picture Arrangement 3^ - 35
Block Design 36 - 37
Object Assembly 38 - 39
Coding or Mazes hO - 41
Verbal IQ kl - kk
Performance IQ ^5 - ^7
Full la 48 - 50
SPECIAL INSTRUCTIONS
1. The Instructions given in the WISC or WISC-R Manuals on the scoring of items
should be followed by the test administrator. Be sure to encode SCALED SCORES,
not raw scores. When using an abbreviated WISC encode each of the subtests
used'and the pro-rated IQ's in thei r appropriate data fields. When the WISC-R
is employed the investigator should note the part by adding the letter R to
60-WISC on page 4 of the Data Sh ipment (07I -DS) ; i.e., 60-WISC-R.
415
Abbreviated Versions - Many investigators employ "sinort" versions of the
Wechsler scales; i.e., a selected number of subtests rather than the full
set. These versions may be encoded according to the procedures for non-
standard scales or may be encoded directly in the matrix for the full WISC
as f ol lows :
i) Each subtest and/or prorated IQ. must be encoded in its
standard location.
2) The investigator MUST make note of the fact on the Data
Shipment form and give the composition of his abbreviated
vers ion.
Example: The abbreviated WISC consists of Information, Comprehension,
Vocabulary and a prorated Verbal |Q. Encode as follows:
Row
:: .2::
i: ::2::
iiii
i.3r:
tNFORMAfmN
zA" :5i:
:*:
:*:
::7ii
::r_i
--*:
:*:
:*:
:*:
3 ©:: ----
4:«=: ----
:: :2::
'^'COMPREHENSmN
ii3i: --A-.-. 1:5::
1:6::
:*:
::7i:
i:7:i
:*:
I*:
^*3
:*:
s-^- ----
:: 1:2::
:i3::
:3::
:;3ii
"Jii
.Aiz 1-5::
:-*i i*r
i=*:i il5:i
zAzz i*r
:*:
:*:
1*1
:*:
iiT^i
iiT::
:r7i:
llTii
:*:
:*:
:*i
:*:
1*1
1*1
I*:
r*:
10=*: -.-.
:: :«;:
II ::2li
113::
r:3:l
VOCABULA'^"
z-Azz 1:6::
1*1
ii7ii
zztzz
:*:
:*r
1*1
Ilifl;: -.-
11 l«:i
ii3:i
:^l ::5i:
1*1
zzTzz
1*1
1*1
23:*:
:: zzSr-Z
I*:
i^l I*: I*:
Il7:i
1*1
:*i
24:*:
l; zzS-z
i:3li
:^:VERBAL*JCli*:
liT::
I*:
1*1
25*: II
:i3:i
11*: 1*1 1*1
ii^-l
I*:
I*:
NOTE - WECHSLER PRESCHOOL AND PRIMARY SCALE OF INTELLIGENCE - This scale may
also be employed for the appropriate age group {k - 6-^ years) and may be en-
coded in the same data field as the WISC or WISC-R. The investigator should
note the fact that the WPSS I was used by crossing out "60-WISC" on page k of
416
the Data Shipment (071-DS)ancl inserting "WPPSI". The format for encoding
scaled scores is;
I tern
Col umn
I tem
Col umn
1 nformat ion
20
- 21
Comprehens ion
22
- 23
Ar i thmet ic
2k
- 25
S imi lar it ies
26
- 27
Vocabulary
28
- 29
Sentences
30
- 31
Picture Completion
32
- 33
Animal House
3k
- 35
Block Design
36
- 37
Geometric Design
38
- 39
Mazes
40
- 41
Verbal IQ.
42
- 44
Performance IQ
45
- 47
Full Id
48
- 50
DOCUMENTATION
a. Scaled score printout
b. Means and standard deviations
c. Variance analyses - when appropriate
WIDE RANGE ACHIEVEMENT TEST (062-WRAT)
The Wide Range Achievement Test (WRAT) is a relatively brief test which
assesses the level of skill in 3 areas - Reading, Spelling and Arithmetic. Its
content is concerned primarily with the mastery of the mechanics of the basic
subjects rather than their comprehension. As its name implies, it is applicable
from kindergarten to college.
REFERENCES
APPLICABILITY
UTILIZATION
1. Jastak, J. F., and Jastak, S. R., WRAT Manual,
Guidance Associates , Wilmington, Delaware, 1965.
Materials may be purchased from Psychological
Corporation, 304 E. 45th Street, New York, New
York. 10017
2. National Health Survey, School Achievement of
Children 6-11 years as Measured by the Reading
and Arithmetic Subtests of the Wide Range Achieve-
ment Test, PHS Publication No. 1000 - Series 11 -
No. 103, U. S. Government Printing Office, Washington,
D. C. June, 1970.
5 years old to adulthood
Once at pretreatment ; at least one posttreatment assess-
ment. Additional ratings are at the discretion of the
investigator.
CARD FORMAT - ITEMS CARD 01 = (19x, 313)
Item Column
Reading
Spel 1 ing
Arithmetic
20 - 22
23 - 25
26 - 28
417
SPECIAL INSTRUCTIONS
1. Test administrators should follow the instructions given in the WRAT Manual,
2. Standard scores for the Reading and Arithmetic subtests should be obtained
from Tables 31 and 32 rather than from Jastak's manual. These tables have
been reproduced from the National Health Survey. (Reference 2 above) and
are based on a much larger probability sample of 7100 children aged 6 to 1 1
y^ars. Unfortunately, the Spelling subtest was not employed in the Nations'
Health Survey so the standard scores given in the jastak manual should be
used for this subtest.
USE OF WRAT FOR ADULTS - Investigators wishing to use the WRAT with adult popula-
tions must encode the scale as a non-standard instrument. (See instructions
(p. 59 ) ■ A 9 X 10 matrix (9 rows and 10 columns) is required and should be en-
coded as foil ows :
Read i ng
Spel 1 i ng
A r i thmet ic
-C
©:: ::
:: r2::
.a
zAz-
:i&:
:*:
:-7-:
"8::
::9:r
«:: ::
:: .:2r-.
:*:
Z-A-.Z
::5::
:*::
::7::
I*:
:;»:
O:: ::
;: :2::
:i:
:d4::
:i5::
zdBzz
"7::
::&:
:A:
©:: -.:
:: :2::
-a.-.
:4i:
::&:
::&:
::7::
::&:
::ai
S-.: .:
:: :2::
:3::
lA:
::&:
::&:
::7::
::&:
:i9?--
1&.Z :=
:: i2-
:3::
:3*:r
;5::
"&:
:r7::
"ft:
::a:
Sr: ::
:: :2::
:i:
1-4::
:i5::
::&:
::7r:
::a:
::&:
-:&-. ::
:: ::2::
:3::
;:4-
::5::
-a:
::7::
:ift:
zia.
:«:: ::
(:: --:Zz.
:i:
:d4::
::&:
::&:
::7-
::a=
-a:
The standard scores given in the Jastak manual (Reference 1 above) should be encoded,
Be sure to describe the matrix location and the Sheet Number in Item 11 -of the Data
Shipment (071-DS).
DOCUMENTATION
a. Standard score printout
b. Means and standard deviations
c. Variance analyses
PORTEUS MAZES
(061-MAZE)
Introduced about 60 years ago, the Porteus Maze Test is a nonverbal test which
has been used in a wide diversity of settings and has been shown to be sensitive to
drug effects in both children and adults. There are 3 series of mazes - the Original
series of 12, an Extension series of 8 and a Supplement series of 8. The latter two
series have been developed to reduce practice effects when retesting subjects and the
author considers them to be equivalent tests.
k]8
TABLE 31
Table for converting raw Bcores on the Reading subtest of the Wide Range Achievement Test to standard
scores, for children, 6-11 years, by 6-month-age Intervals: United States, 1963-65
Age In months
72-77 78-83 84-89 90-95 96-101 102-107 108-113 lU-119 120-125 126-131 132-137 138-143
Standard score
069
063
056
049
*
071
064
057
050
*
072
065
058
051
*
074
067
059
052
*
075
068
060
053
*
077
069
062
055
051
078
070
063
055
052
079
072
064
057
053
081
073
055
058
054
082
074
066
059
055
084
075
067
050
057
085
077
069
061
058
087
078
070
063
059
088
079
071
064
060
089
080
072
065
061
091
082
073
066
062
092
083
074
067
053
094
084
076
068
064
095
085
077
069
065
097
086
078
071
066
098
088
079
072
067
100
089
080
073
068
101
090
081
074
069
102
091
083
075
070
104
093
084
076
072
105
094
085
077
073
107
095
086
079
074
108
096
087
080
075
110
098
088
081
076
111
099
089
082
077
112
100
091
083
078
114
101
092
084
079
115
103
093
085
080
117
104
094
087
081
118
105
095
088
082
120
106
096
089
083
121
107
098
090
084
123
109
099
091
085
124
110
100
092
086
125
111
101
093
088
127
112
102
095
089
128
114
103
096
090
130
115
105
097
091
131,
116
105
098
092
133
117
107
099
093
134
119
108
100
094
136
120
109
101
095
137
121
110
103
096
138
122
112
104
097
140
124
113
105
098
141
125
114
106
099
042
043
044
045
047
048
049
050
051
053
054
055
056
057
058
060
061
062
063
064
066
067
058
069
070
072
073
074
075
076
077
079
080
081
082
083
085
086
087
088
089
091
092
093
094
095
042
043
044
045
046
048
049
050
051
052
053
054
055
055
058
059
060
061
062
063
064
065
066
067
069
070
071
072
073
074
075
076
077
079
080
081
082
083
084
085
086
087
088
090
091
092
043
044
045
046
047
048
049
050
051
052
053
054
055
055
057
058
060
061
052
063
064
065
055
067
068
069
070
071
072
073
074
075
075
077
078
079
080
081
083
084
085
086
087
088
089
090
038
040
041
042
043
044
045
046
047
048
049
050
051
052
053
054
055
056
057
058
059
061
062
063
054
065
066
067
068
069
070
071
072
073
074
075
076
077
078
079
081
082
083
084
085
086
039
040
041
042
043
044
045
046
047
048
049
050
051
052
053
054
055
056
057
058
059
050
061
062
053
064
065
065
067
068
069
070
071
072
073
074
075
076
077
078
080
081
082
083
084
085
037
038
039
040
041
042
043
045
046
047
048
049
050
051
052
053
054
055
056
057
058
059
060
061
062
063
064
055
067
058
059
070
071
072
073
074
075
076
077
078
079
080
081
033
034
035
036
037
038
039
040
041
043
044
045
046
047
048
049
050
051
052
053
054
055
056
058
059
050
051
062
063
064
065
066
067
068
069
070
071
073
074
075
076
077
078
419
TABLE 31 (Continued)
Table for converting raw scores on th^ Reading subtest of the Wide Range Achievement Test to standard
scores, for children, 6-11 years, by b-month-age intervals: United States, 1953-65— Con.
Age In months
72-77 78-83 8^-89 90-95 96-101 102-107 108-113 1U-H9 120-125 126-131 132-137 138-143
Standard score
051
052
053
054
055
056
057
058
059
060
061
062
063
064
065
066
067
068
069-
070-
071
072
073-
074-
075-
076-
077-
078-
079-
080-
081-
082-
083-
084-
085-
086-
087-
088-
089-
090-
091-
092-
093-
094-
095-
096-
097-
098-
099-
100-
143
126
115
107
101
096
093
091
087
086
082
144
127
116
108
102
098
094
092
088
087
083
146
128
117
109
103
099
095
093
089
088
084
147
130
119
HI
104
100
096
094
090
089
085
148
131
120
112
105
101
097
095
091
090
086
150
132
121
113
106
102
098
096
092
091
088
151
133
122
114
107
104
099
097
093
092
089
153
135
123
115
108
105
101
098
094
093
090
154
136
124
116
109
106
102
099
095
094
091
156
137
126
117
110
107
103
100
096
095
092
157
138
127
119
111
108
104
101
097
096
093
159
140
128
120
112
110
105
102
098
097
094
160
141
129
121
113
111
106
103
099
098
095
161
142
130
122
114
112
107
104
100
099
096
163
143
131
123
116
113
108
106
102
100
097
164
145
133
124
117
114
109
107
103
101
098
166
146
134
125
118
115
111
108
104
102
099
167
147
135
127
119
117
112
109
105
103
100
169
148
136
128
120
118
113
110
106
104
101
170
149
137
129
121
119
114
111
107
105
102
*
*
138
130
122
120
115
112
108
106
103
*
*
139
131
123
121
116
113
109
107
104
*
*
141
132
124
123
117
114
110
108
105
*
*
142
133
125
124
118
115
111
109
106
*
*
143
135
126
125
119
116
112
110
107
*
*
144
136
127
126
120
117
113
111
109
*
*
145
137
128
127
122
118
114
112
110
*
*
146
138
129
128
123
119
115
113
111
*
*
148
139
131
130
124
120
116
114
112
*
*
149
140
132
131
125
121
117
115
113
*
*
150
141
133
132
126
122
118
116
114
*
*
151
143
134
133
127
123
119
117
115
*
*
152
144
135
134
128
124
120
118
116
*
*
153
145
136
136
129
125
121
119
117
*
*
155
146
137
137
130
126
123
120
118
*
*
*
*
138
138
132
127
124
121
119
*
*
*
*
139
139
133
129
125
122
120
*
*
*
*
140
140
134
130
126
123
121
*
*
*
*
141
142
135
131
127
125
122
*
*
*
*
142
143
136
132
128
126
123
*
*
■*
*
143
144
137
133
129
127
124
*
*
*
*
144
145
138
134
130
128
125
*
*
*
*
146
146
139
135
131
129
126
*
*
*
*
147
147
140
136
132
130
127
*
*
*
*
148
149
141
137
133
131
128
*
*
*
*
*
*
143
138
134
132
129
*
*
*
*
*
*
144
139
135
133
131
*
*
*
*
*
*
145
140
136
134
132
*
*
*
*
*
*
146
141
137
135
133
*
*
*
4r
*
*
147
142
138
136
134
420
TABLE 32
Table for converting raw scores on the Arithmetic eubteat of the Wide Range Achievement Test to standard
scores, for children, 6-11 years, by 6-monCh-age Intervals: United States, 1963-65
Age in months
78-83 I 84-89
\
102-107 108-113 114-119
120-125 126-131 132-137 138-143
Standard score
050
053
056
Q60
041
045
048
051
*
*
*
*
*
*
*
*
063
066
070
073
054
057
060
064
*
050
053
056
*
032
036
040
*
*
*
076
079
083
086
067
070
073
076
059
063
066
069
043
047
051
054
039
043
046
050
089
093
096
099
080
083
086
089
072
075
078
082
058
062
065
069
053
057
061
064
102
106
109
112
092
095
099
102
085
088
091
094
073
076
080
084
068
071
075
078
116
119
122
125
105
108
111
115
098
101
104
107
088
091
095
099
082
085
089
092
129
132
135
139
118
121
124
127
110
114
117
120
102
106
110
113
096
100
103
107
142
145
148
152
130
134
137
140
123
126
130
133
117
121
124
128
110
114
117
121
155
158
162
165
143
146
149
153
136
139
142
146
132
135
139
143
124
128
131
135
168
171
175
178
156
159
162
165
149
152
155
158
146
150
154
157
138
142
146
149
181
*
*
*
169
*
*
162
165
168
*
161
165
169
*
153
156
160
163
*
*
*
*
*
*
*
*
*
*
167
170
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
•k
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
•k
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
*
028
032
035
039
043
047
051
054
058
062
066
069
073
077
081
085
088
092
096
100
104
107
111
115
119
123
126
130
134
138
141
145
149
153
157
160
164
168
035
038
042
045
049
052
055
059
062
066
069
073
076
080
083
087
090
094
097
101
104
108
111
115
118
122
125
128
132
135
139
142
146
149
153
156
160
163
167
170
174
035
038
041
044
048
051
054
057
061
064
067
070
074
077
080
083
087
090
093
097
100
103
106
110
113
116
119
123
126
129
132
136
139
142
145
149
152
155
158
162
165
036
039
042
045
048
051
054
057
060
063
066
068
071
074
077
080
083
086
089
092
095
098
101
104
106
109
112
115
118
121
124
127
130
133
136
139
141
144
147
150
153
156
159
162
165
168
171
174
176
179
038
041
043
046
048
051
054
056
059
061
064
066
069
072
074
077
079
082
085
087
090
092
095
097
100
103
105
108
110
113
116
118
121
123
126
128
131
134
136
139
141
144
147
149
152
154
157
159
162
165
041
043
045
047
050
052
054
057
059
061
063
066
068
070
072
075
077
079
081
084
086
088
091
093
095
097
100
102
104
106
109
111
113
115
118
120
122
125
127
129
131
134
136
138
140
143
145
147
150
152
154
156
159
161
040
042
044
046
048
051
053
055
057
059
061
063
065
067
069
072
074
076
078
080
082
084
086
088
090
092
095
097
099
101
103
105
107
109
111
113
116
118
120
122
124
126
128
130
132
134
136
139
141
143
145
147
149
151
^21
REFERENCE Porteus, S. D., Porteus Maze Tests: Fifty Years
Application, Pacific Books, Palo Alto, California,
1965. Materials for the Porteus Maze Tests may be
purchased from the Psychological Corporation,
30^ E. ^Sth Street, New York, New York, IOOI7.
APPLICABILITY Children - 3 to l4 years through Adult
UTILIZATION Once at pretreatment ; at least one posttreatment
assessment. Additional ratings are at the discre-
tion of the investigator.
CARD FORMAT CARD 01 = (19x, 213)
I tem Col umn
Maze Quotient 20 - 22
Qualitative Score 23 - 25
SPECIAL INSTRUCTIONS
Instructions for the test are given in Porteus Maze Tests (see Reference) and
should be followed by the test administrator.
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
GOODENOUGH-HARRIS FIGURE DRAWING TEST (O63-GOOD)
The Goodenough-Harr is Figure Drawing Test (GOOD) - often referred to as the
"Draw a Man" test - is a brief, convenient, non-language measure of intellectual
or conceptual maturity. The original I926 scoring and norms have been revised and
extended by Harris.
REFERENCES 1. Harris, D. B., Children's Drawings as Measures
of Intellectual Maturity. Harcourt, Brace and
World, New .York, I963.
2. National Health Survey, Intellectual Maturity of
Children as Measured by the Goodenough-Harr is
Drawing Test, PHS Publication No. lOOO-Series 11-
No. 105, U. S. Government Printing Office, Wash-
ington, D. C, December, 1970.
APPLICABILITY Optimum usage - 6 - 11 years
422
UTILIZATION Once at pretreatment ; at least one post-treatment
rating; additional ratings are at the discretion
of the investigator.
CARD FORMAT CARD 01 = ( 1 9x , 13, 12)
I tern Col umn
Standard Score 20 - 22
Qual ity Score 23 - 2k
SPECIAL INSTRUCTIONS
1. Instructions for the administration and scoring of the test are contained in
Harris' book; (See Reference No. 1) and should be followed by the test examiner
with the exception that only the score for the first figure drawn by the child
should be encoded.
2. Standard scores as given in Tables 33 to 36 should be encoded in Rows 7-9,
Columns 1 - 10. These standard scores are based on a probability sample of
approximately 7^00 non- i nst i tut iona ] ized children aged 6 through 11 years.
(See Reference No. 2). Be sure to use the appropriate table when converting
raw scores into standard scores; e.g., use Table 28 when a man figure is drawn
first by a boy.
DOCUMENTATION
a. Standard score printout
b. Means and standard deviations of standard scores and quality scores
c. Variance analyses
BENDER GESTALT TEST - Koppitz Scoring (064-BENDK)
The Bender Gestalt Test is a non-verbal perceptual test and was originally
introduced in 1938. A developmental scoring system was published by Koppitz in
1963 to provide a means to measure perceptual maturity, possible neurological
impairment and emotional adjustment in children. The scoring system was standard-
ized on more than 1200 public school children.
REFERENCE Koppitz, E. M., The Bender Gestalt Test for
Young Children, Grune and Stratton, New York,
1964.
APPLICABILITY 5 to 11 years
UTILIZATION Once at pretreatment, at least one posttreatment
rating. Additional ratings are at the discretion
of the investigator.
423
TABLE 33
Goodenough-Ha rr is
Figure Drawing Test
Standard Scores for
Man Figure Drawn by Boy
(National Health Survey)
00
01 ■
02
03-
Cl-
os-
07-
08-
09-
Age (years)
8
Standard score
23
2h-
25
26-
27-
28-
29-
30-
31 -
32-
33-
35-
36-
37-
38-
39-
l40-
Ul-
U2-
1*3-
US-
kl-
hi,-
SC-
SI-
52-
53-
bh-
55-
56-
57-
56-
59-
60-
61 -
62-
63-
61,-
65-
66-
67-
68-
69-
70-
71-
7i-
73
bh
52
57
51*
59
57
62
59
bk
61
67
61*
69
66
72
68
Ih
71
76
73
79
76
81
78
81*
80
86
83
89
85
91
88
3h
90
96
92
99
95
01
97
01*
99
o6
102
09
101*
11
107
13
109
16
111
19
111*
21
116
21*
118
26
121
29
123
31
126
31*
128
36
130
39
133
1*1
135
Uh
138
1*6
11*0
1*9
11*2
51
|l4S
51*
I '47
56
11*9
58
152
61
151*
63
157
66
159
68
161
71
161*
73
166
76
168
78
171
■k
173
-■.-
176
V.-
178
;■.-
180
■!;
183
1*8
50
53
55
57
59
61
61*
66
68
70
72
75
77
79
81
83
85
88
90
92
91*
96
99
101
103
105
107
no
112
111*
116
118
120
123
12s
127
129
131
1 3'*
136
138
1 1*0
11*2
1145
\hl
11*9
151
153
156
158
160
162
161*
166
169
171
173
175
177
180
1.6
1*8
50
52
51*
56
58
60
62
61*
66
68
70
72
71*
76
78
81
83
85
87
89
91
93
95
97
99
101
103
105
107
109
111
113
115
117
119
121
123
125
127
129
131
133
135
137
139
11*1
|i*3
11*5
11*7
11*9
151
153
155
157
159
161
163
165
167
169
171
173
175
177
1*6
1*7
1*9
51
53
55
57
58
60
62
61*
66
68
70
71
73
75
77
79
81
82
81*
86
88
90
92
93
95
97
99
10)
103
105
106
108
110
112
III*
116
117
119
I2t
123
125
127
128
130
132
13'*
136
138
11*0
|i*i
11.3
11*5
1 1*7
1 1*9
151
152
151*
156
158
160
162
163
165
167
169
171
173
175
klk
1*6
i*«
50
51
53
55
56
58
60
62
63
65
67
69
70
72
71*
76
77
79
81
83
81*
86
68
89
91
93
95
96
98
100
t02
103
105
107
109
no
112
ni«
116
117
119
121
122
121*
126
128
129
131
133
135
136
138
|l*0
|1*2
11*3
11*5
11*7
11*9
150
152
151*
155
4 57
159
161
162
161*
166
168
169
171
173
TABLE Ik
Goodenough-Harr i s
Figure Drawing Test
Standard Scores for
Woman Figure Drawn by Boy
(National Health Survey)
Ik-
ko-
kz-
ki-
Uh-
Ub-
ue-
ki-
k%-
u^-
50-
51 -
52-
53-
514-
55-
56-
57-
58-
59-
60-
61-
62-
63-
64-
65-
66-
67-
Ase (yedfs)
Standard score
51
53
56
58
61
63
66
68
71
73
76
79
81
8A
86
h7
^3
51
53
55
58
60
62
6U
66
69
71
73
75
77
79
82
8h
k(>
kS
50
52
Sk
56
58
60
62
(A
66
68
70
72
7k
76
kl
k8
50
52
Sk
56
58
60
62
63
65
67
69
71
73
75
77
78
US
kB
50
5)
53
55
57
59
61
62
Sk
66
91
86
82
80
79
94
88
84
82
81
96
90
86
84
82
99
93
88
86
84
101
95
90
88
86
104
97
92
90
88
107
99
94
9Z
90
109
101
96
93
92
112
104
98
95
93
114
106
100
97
95
117
108
102
99
97
119
110
104
101
99
122
112
106
103
101
124
114
108
105
103
127
117
110
106
104
129
119
112
103
106
132
121
114
no
108
135
123
116
112
110
137
125
118
114
112
140
128
120
116
114
142
130
122
118
115
145
132
124
120
117
147
13^4
126
121
119
150
136
128
123
121
152
139
130
125
123
155
141
132
127
125
157
143
13'^
129
126
160
145
136
131
128
162
147
138
133
130
165
149
140
135
132
168
152
142
136
n**
170
154
144
138
136
173
156
146
140
137
175
158
148
142
139
178
160
150
144
141
ISO
163
152
146
143
183
165
154
148
145
185
167
156
150
147
■,v
169
158
151
148
1/1
160
153
150
174
162
155
152
pe
164
157
154
-.V
178
165
159
156
167
161
157
169
163
159
■:;
171
165
161
-.';
173
166
163
*
V.-
175
168
165
iV
i-
*
170
167
f
"
172
174
168
170
*
*
176
172
*.
*
K
178
174
■k
i-
*
176
-■•-
*
*
178
<
»
>*
. *
179
i+25
TABLE 35
Goodenough-Harr is
Figure Drawing Test
Standard Scores for
Man Figure Drawn by Girl
(National Health Survey)
00
01
02
03
Ok
05
06
07
08
09
10
n
12
13
\k
15
16
17
18
19
20
21
22
23
2'*
25
26
27 ■
28 •
29 ■
30 •
31 •
32 -
33 •
3'4 ■
35 ■
36 -
37 -
38 ■
39 -
Uo -
k] -
'*2 -
i43 -
W -
kS -
k(, ■
Uf -
k8 -
i.9 -
50 -
51 -
52 -
53 -
S^ -
55 -
56 -
57 -
58 -
55 -
60 -
61 -
62 -
63 -
6k -
6§ -
66 -
67 -
68 -
69'-
70 -
71 -
72-
73 -
Age (years)
7 8 9
40
Standard score
61
61
56
6-5
63
S6
65
65
60
67
66
61
69
68
63
72
70
65
7**
72
67
76
7^^
69
78
76
71
80
78
73
82
80
7^*
8k
82
76
86
8^4
78
88
86
80
90
88
82
92
90
81*
<)k
92
86
96
93
87
98
95
89
100
97
91
103
99
93
105
101
<)5
107
103
97
109
105
99
in
107
100
113
109
102
115
III
\0k
117
113
106
iiq
115
108
121
117
no
123
119
III
125
120
113
127
122
115
129
12'*
117
132
126
119
ni*
128
121
136
130
123
138
132
121*
||40
\3k
126
11*2
136
128
\kh
138
130
]k(>
\ko
132
\kS
\k2
131*
150
\kk
136
152
\kS
137
\Sk
ik7
139
156
\ks
11*1
158
151
I'*3
160
153
11*5
163
155
11*7
165
157
11*9
159
150
161
152
163
151.
165
156
167
158
-.v
i-
160
i
162
163
165
*
*
167
53
55
56
58
60
62
63
65
67
69
70
72
ik
75
77
79
81
9?
81*
86
88
8?
91
93
95
9i5
98
100
102
103
105
107
109
no
112
111*
116
117
119
121
122
1 21*
126
128
129
131
133
135
136
138
11*0
1 1*2
11*3
11*5
11*7
11*9
150
152
151*
156
157
159
161
163
161*
166
50
52
53
55
57
58
60
62
63
65
67
68
70
72
73
75
77
78
80
81
83
85
86
88
90
91
93
9ii
96
98
100
101
103
105
106
108
110
III
113
IIS
116
118
119
121
123
121)
12^
128
129
lil
133
131*
136
138
139
11*1
11*3
\kk
11*6
11*8
1 1*9
151
152
151*
156
157
159
161
162
161*
166
426
51
53
SI*
56
II
60
62
6i»
65
66
68
70
71
73
7'»
76
77
79
80
8?
83
85
87
68
90
91
93
9i»
96
97
99
100
102
loi»
I OS
'°g
108
no
111
Ml
lib
116
li7
H9
121
122
I2'»
125
127
128
i3o
131
133
131*
''t
138
139
lUl
142
IM*
11*5
11*7
148
iso
151
153
156
158
159
161
162
164
TABLE 36
Goodenough-Harr i s
Figure Drawing Test
Standard Scores for
Woman Figure Drawn by Girl
(National Health Survey)
00
01
02
03
ou
05
06
07
08
09
10
n
12
13
\u
IS
16
17
16
19
20
21
22
23
2k
25
26
26
29
30
31
32
33
3'*
35
36
37
38
39
««0
U]
«»2
'♦3
W»
^5
U6
^7
U8
i<9
50
51
52
53
su
55
56
57
58
53
60
6)
62
6i
6k
65
66
67
68
69
70
71
72
73
^9
i<6
51
1.9
53
51
55
53
57
55
60
57
62
59
614
62
66
6U
69
66
71
68
73
70
75
72
78
7''
80
77
82
79
8U
81
87
83
89
85
91
87
93
90
96
92
98
9'*
100
96
(02
98
105
100
107
102
109
105
III
107
ni«
109
116
III
118
113
120
115
123
118
125
120
127
122
129
I2'4
132
126
U**
128
136
130
138
133
\U\
135
l'*3
137
^ks
139
l'*7
\k\
150
l'«3
15?
1'46
I5'4
}k&
156
150
159
152
161
15^.
156
158
161
163
165
Age (years)
8 '.
Siandard score
1*2
i,U
ii6
'<8
50
52
i'*
56
58
60
63
65
67
69
71
73
75
77
79
81
63
§5
87
89
91
93
95
97
99
101
103
105
107
109
111
113
115
117
119
122
12'*
126
128
130
132
^3'*
136
138
I '40
1^42
\kk
]U6
]h8
150
152
15'4
156
158
160
162
16*4
i+27
140
38
37
1-1
39
39
"43
141
k\
^i
^3
k2
k7
^45
kk
U9
k7
ke
51
k8
k8
53
50
kS
55
52
51
57
514
53
59
56
55
61
58
56
63
59
58
6^4
61
60
66
63
62
68
65
63
70
67
65
72
68
67
7^4
70
69
76
72
70
78
7'4
72
80
76
7**
82
77
76
8k
79
77
85
81
79
87
83
81
89
85
82
91
86
81*
93
88
86
95
90
88
97
92
89
99
9^
91
101
95
93
103
97
95
105
99
96
107
101
98
108
103
100
110
105
102
112
106
103
III*
108
105
116
110
107
118
112
109
120
IIU
110
122
115
112
12^4
117
\lk
126
119
116
128
121
117
130
123
119
131
12'*
121
133
126
123
135
128
121*
137
130
126
139
132
128
\k\
133
130
I'43
135
131
1145
137
133
1^7
139
135
\kS
1'4l
137
151
1'43
138
153
11414
|1*0
15'4
I146
11*2
156
11*8
11*1+
158
150
11*5
160
152
J^7
162
155
11*9
16't
155
151
157
152
*
159
15'*
-.'.-
161
156
*
162
158
16'*
159
i!
*
161
V.-
*
163
■ 4
165
CARD FORMAT
CARD
Item
Col
umn
Fig. A
20
- 21
Fig. 1
22
- 23
Fig. 2
24
- 25
Fig. 3
26
- 27
Fig. 4
28
- 29
CARD 01 = (19x, 1012)
I ten
Fig. 5
Fig. 6
Fig. 7
Fig. 8
Total Score
Col umn
30 - 31
32 - 33
3^+ - 35
36 - 37
38 - 39
SPECIAL INSTRUCTIONS
Follow the instructions given in the Koppitz Manual (See Reference).
On data decks, a 2-digit coding system has been designed to record the
types of errors made by the subject. The codes are:
Response Pos
t ions
Des igns for which
Code
0
1
3
5
7
code is legal
Score
01
X
All
1
02
X
All
1
03
X
X
All
2
Ok
X
A, 1.2, 3, 5, 6, 7
1
05
X
X
A, 1,2, 3, 5, 6, 7
2
06
X
X
A, 1,2, 3, 5, 6, 7
2
07
X
X
X
A, 1,2, 3, 5. 6, 7
3
08
X
A, 3, 5, 6, 7
1
09
X
X
A, 3, 5, 6, 7
2
10
X
X
A, 3, 5, 6, 7
2
11
X
X
X
A. 3, 5, 6, 7
3
12
X
X
A, 3, 5. 6. 7
2
13
X
X
X
A, 3, 5, 6, 7
3
]k
X
X
X
A, 3, 5, 6, 7
3
15
X
X
X
X
A, 3, 5, 6, 7
4
16
X
All
0
Examples: 07
08
16
in Cols. 24-25 = 3 errors on Des. 2: rotation,
rows added and perseveration'
in Cols. 32-35 = 1 error on Des. 6: perseveration
in any column pair = no errors on the particular
des ign
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
428
PSYCHOLOGICAL EXAMINATION BEHAVIOR PROFILE
(066-PEBP)
The Psychological Examination Behavior Profile (PEBP) is a 15-item scale
formatted for use with the General Scoring Sheet. The scale is designed to
assess the behavior of the subject during the administration of psychological
tests. The PEBP was developed as part of a collaborative study conducted by
the Perinatal Research Branch, National Institute of Health.
REFERENCE
APPLICABILITY
UTILIZATION
Manual for the Collaborative Study on Cerebral
Palsy Mental Retardation and Other Neurological
and Sensory Disorders of Infancy and Childhood,
Perinatal Research Branch, National Institute of
Neurological Diseases and Stroke, National Insti-
tute of Health, Public Health Service, Department
of Health, Education and Welfare, Part lll-E,
April, 1970.
For children, 5-15 years old.
To be used in conjunction with each psychological
examinat ion.
TIME SPAN RATED
CARD FORMAT
Item
Column
1
20
2
21
3
22
k
23
5
2k
6
25
7
26
The duration of the psychological examination.
CARD 01 = (19x, 1511 , 12)
Item Column
8*
27
9
28
10
29
11
30
12
31
13
32
1^*
33
15^v
3^
Total Score
35 - 36
* = Items reflected in scoring
Total Score = Sum of Items 1 through 15
Total Score Range = 0 - 60
429
SPECIAL INSTRUCTIONS
A. On the PEBP form itself, only cue words are provided for each scale point.
A more detailed description of each scale point is given below to aid the
rater in making his judgments.
1. Separation from Mother - The range is from "shows no concern" to "very upset".
0 = Shows no concern; eager to leave mother and go with examiner.
1 = Shows very little concern; shows little cautiousness and comes
with examiner without preamble, needs little or no explanations.
2 = May show some initial reticence, which is felt to be entirely
appropriate; separates from mother after some minimal reassurances
and explanations.
3 = More than usual amount of concern; more disturbed than most, but
finally is able to separate; may need continuing reassurances.
4 = Very upset, cries, clings to mother, may have tantrum or withdraw,
refusing to look at or talk to the examiner; mother's presence
may be required in the test room.
2. Tearfulness - The range is from "no apparent awareness of strange situation"
to "very fearful and apprehensive".
0 = No apparent awareness of strange situation; completely unafraid, and
behavior uninhibited.
1 = Very little fear evidenced; quickly at ease in the situation.
2 = Normal amount of caution in the situation but able to cope with it.
3 = Inhibited and uneasy throughout with some slowing of responses.
k = Very fearful and apprehensive; acute discomfort interferes significantly
with test performance.
3. Rapport with Examiner - The range is from "exceptionally shy" to "extreme
f r iendl iness".
0 = Exceptionally shy; withdrawn; unresponsive or ignores any friendly
overtures .
1 = Shy; waits for friendly gestures; very little social interaction or
social contact on his own initiative.
2 = Perhaps some initial shyness; feels at ease; relates in a friendly
manner.
3 = Very friendly; and at ease.
k = Extreme friendliness; focuses on social interaction with little or
no interest in test materials.
k. Self-Conf idence - The range is from "lacks self-confidence" to "very self-
confident".
0 = Lacks self-confidence; extremely self-critical; may refuse to attempt
many tasks because they seem too difficult.
1 = Distrusts own ability; tends to minimize his performance and often
points out what is wrong.
2 = Adequately self-confident; usually sure of himself but recognizes
difficulty of certain tasks and may be a little hesitant with them.
430
3 = More than usual amount of self-confidence; works easily without
tensions and is usually satisfied with his performance.
k = Very self-confident; child extremely proud of performance and acts
as if he can tackle anything.
5. Emotional Reactivity - The range is from "extremely flat" to "extreme
instability of emotional responses".
0 = Extremely flat; no change in facial expression; responds to all
activities in same manner.
1 = Somewhat flat; little change in emotional tone, some slight varia-
tions at times.
2 = Normal responsiveness; affect appropriate to situation.
3 = Mood more variable than average; may be motivated internally or
exaggerated responsiveness to situation.
k = Extreme instability of emotional responses; marked emotional lability;
either overreactive to external situations or to undetermined stimuli.
6. Degree of Cooperation - The range is from "extreme negativism" to
"extremely suggestible and conforming".
0 = Extreme negativism; continually resistant to directions or demands
of the situation; examiner's suggestions or directions have little
obvious effect on child.
1 = Resistive to demands or directions a good deal of the time; willing
to comply only when faced with success, or requires considerable
prompting to elicit response.
2 = Cooperative with reasonable amount of discomfort and anxiety when
faced with difficulty or failure, responds well to directions most
of the time.
3 = Accepts direetion or demands more easily; eager to conform even when
faced with failure; rarely attempts to do anything unless examiner
has explicitly stated it.
k = Extremely suggestible and conforming; no apparent discomfort when
faced with failure, completely dependent upon specific directions
from examiner.
7. Level of Frustration Tolerance - The range is from "withdraws completely"
to "extreme acting out behavior and/or crying".
0 = Withdraws completely; refuses to continue or attempt any task which
appears too difficult for him.
1 = Occasionally withdraws from task where difficulty is encountered or
appears too difficult for success.
2 = Attempts to cope with difficult situations; does not become unduly
upset if task is too difficult.
3 = Becomes quite upset by difficulty; may react with some disorganized
behavior; some anger may be displayed against the test materials or
examiner; may resort to crying.
M = Extreme acting out behavior and/or crying; considerable anger displayed;
behavior becomes uncontrolled and continuation of examination may
become impossible or very difficult.
431
8. Degree of Dependence - The range is from "very self-reliant to "constant
need for attention or help".
0 = Very self-reliant; refuses help; extreme overt confidence.
1 = Rarely needs reassurance; primarily absorbed with test materials;
little attention demanded.
2 = Dependent in appropriate situations; enjoys attention but can function
easily without it; adequately confident.
3 = Demands more attention than average; needs frequent help, reassurance,
approval and encouragement.
k = Constant need for attention or help; cannot function without continual
approval or support.
9. Duration of Attention Span - The range is from "attends to tasks very briefly"
to "highly perseverat ive".
0 = Attends to tasks very briefly; highly distractible, fleeting and sporadic
attention; lack of concentration interferes significantly with test
performance.
1 = Spends short time with tasks; easily distractible; frequently needs help
in maintaining attention; brief attention may interfere somewhat with
test performance.
2 = Spends adequate amount of time on tasks; able to concentrate until success-
ful or until failure is clear.
3 = Spends more than average time on tasks; eventually is able to turn to new
activity.
k = Highly perseverat ive; unable to shift attention; fixated at one task;
requires examiner's intervention in order to change activity.
10. Goal Orientation - The range is from "no effort to reach a goal" to "compulsive
absorption with task".
0 = No effort to reach a goal; extremely lacking in persistence or unable to
keep goal or questions in mind.
1 = Briefly attempts to achieve goal; easily forgets goal or question, or
fails to persist; less than average ability to continue to completion.
2 = Able to keep goal or directions in mind; able to persist until completion;
able to "give up" when appropriate.
3 = Keeps goal and questions in mind; persists for more than usual amount of
time; continues effort beyond necessary point.
4 = Compulsive absorption with task; unwilling or unable to "give up"; resists
or ignores examiner's attempts to change activity.
11. Level of Activity - The range is from "extreme inactivity and passivity" to
"extreme overactivity and restlessness".
0 = Extreme inactivity and passivity; placid, sluggish; posture adjustments
in chair may be slow and infrequent.
1 = Litt1,e activity; content to sit still most of the time.
2 = Normal amount of activity; able to sit quietly when interested; may fidget
and become restless at times.
3 = Unusual amount of activity and restlessness; very seldom able to sit
quietly.
k = Extreme overactivity and restlessness; can't sit still; constantly in
motion; activities not in response to specific external stimulation.
432
12. Nature of Activity - The range is from "extreme rigidity" to "extremely
impuls i ve".
0 = Extreme rigidity; unable to shift activity or approach to task;
cannot vary or adapt responses; stays with one aspect of task.
1 = Some rigidity; tends to be inflexible in most situations but does
shift approach in some instances; at times can change to appropriate
response to task.
2 = Flexible behavioral patterns; activity appropriate to different
s i tuat ions .
3 = Behavior frequently impulsive; fluid and sometimes uncontrollable.
h = Extremely impulsive; explosive and uncontrolled behavior.
13. Nature of Communication - The range is from "little or no verbal communica-
tion" to "difficult to follow child's thinking".
0 = Little or no verbal communication; uses gestures and/or pantomime;
verbal communication limited to "yes" and "no", or one or two words.
1 = Verbal or non-verbal responses confined to answering directed
questions; communication generally elicited rather than initiated by
child.
2 = Readily answers questions; may elaborate responses; may initiate
conversation; content generally appropriate and easily followed.
3 = Answers questions freely, initially appropriate but tends to lose
main idea by elaborations or free associations; at times content
seems inappropriate or illogical.
k = Difficult to follow child's thinking; content usually irrelevant
and inappropriate; at times bizarre.
14. Assert iveness - The range is from "extremely assertive, wilful personality"
to "extreme passivity".
0 = Extremely assertive, wilful personality; approach dominating, aggressive
and lacking in reserve; attempts to manipulate session, and resists
externally imposed limitations.
1 = Quite forceful, unnecessarily rough and careless in handling materials;
littJe inhibited by examiner's presence from doing exactly what he
wants; often ignores imposed limits.
2 = Self-assertive but accepting of the situation and capable of control
and reserve when demanded; looks for feedback and becomes less assertive;
more pliant, when this is indicated.
3 = Passive acceptance; permits self to be somewhat controlled by examiner
and situation; rarely shows inclination to want to do something different
from what examiner suggests.
k = Extreme passivity; malleability, and acquiescence to everything, with no
trace of resistance; seems extremely overcompl iant .
433
15. Hostility - The range is from "very hostile, obstructive" to "ingratiating
child".
0 = Very hostile, obstructive; engages in overt physical or verbal attacks
on examiner, test materials or testing room objects. May have tantrums.
1 = Unusual amount of hostility present; very uncooperative and/or becomes
angry when restrictions are imposed; may introduce frequent aggressive
themes into verbal productions. May want to engage in irrelevant con-
versation and games, thus indirectly refusing or hindering progress in
test ing.
2 = No unusual amount of hostility evidenced; negative behavior or affect
is generally appropriate and controlled.
3 = Very agreeable child who rarely shows hostility, even where it might be
appropriate; never seems to balk at any imposed limitations or react in
displeased manner to them.
k = Ingratiating child. Desire to please examiner seems to be the main
determinant of behavior,
B. Interpretation of Scores - The items of the PEBP are bipolar. Scale point
"2" is a neutral or zero point between the poles and represents "normal" or
appropriate behavior. I tern scores at the lower end (0.1) tend to reflect
low levels of arousal or interaction; while higher scores (3.^) indicate
high arousal and interaction. Similarly, a total score of 30 represents
"normal" or appropriate behavior. Total scores below 30 indicate lower levels
of arousal; while total scores above 30 represent higher levels of arousal.
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
k3k
PERFORMANCE TESTS FOR MEASURING PSYCHOPHARMACOLOG I CAL EFFECTS ON CHILDREN
Robert L. Sprague
Children's Research Center
Uni vers i ty of ll 1 inois
The following recommendations have used a few basic assumptions about experi-
mentation in the area of psychopharmacology . One, if the area of research interest
is psychotropic drugs, then it seems that one of the target areas of measurement
should be the behavior of the child. Two, in measuring behavior of the child, one
should measure this behavior as precisely as can be done within the limits of the
methods available today. This means that the test used should have high reliabili-
ty, I.e., it should give the same results when repeated if there has been no change
in the child. The test should also have validity, which means that the tests
actually are measuring what they purport to measure and furthermore, the test
should be related in a logical fashion to a theoretical system. Three, since one
of the primary characteristics of children is development, then the behavioral tests
should measure what is thought to be important in developmental processes.
Listed below are major subdivisions of important developmental processes in
ch i Idren.
The cognitive area of development is one of the most important for children.
Children have learning as their main occupation: both formally in school and in-
formally in the family. It is almost trite to say that what they learn shapes
their life for the future. For these obvious reasons, tests which measure the
effects of psychotropic drugs on learning should be included in the battery of tests.
The development of standardized tests in this area is quite uneven in that there
has been heavy emphasis on the creation of psychological tests to assess Intellec-
tual development with relatively little emphasis on tests to measure current learn-
ing efficiency and current memory ability of the children. Recent theoretical
developments in the area of attention should hot be ignored because often psycho-
tropic drugs are administered to improve the attention of the distractable child.
These theoretical foundations give a foothold for beginning of sound experimentation
in this area.
Motor development is another major area which should be investigated. Unfortu-
nately, there has been relatively little emphasis on the development of standardized
tests to assess the development of motor ability in children. Consequently, only
one test which measures one aspect of motor development has been suggested.
Social development is extremely important for the child, but again, unfortu-
nately, relatively few standardized tests have been developed to measure the social
ability of the child. Most of this information must then necessarily be taken from
rating scales which attempt to assess the social behavior of the child in a variety
of situations. Dr. Conners has prepared material in this area.
Finally, the academic achievement of the child or what he learns from formalized
instruction in the public school is of prime interest. Most problem children who
receive psychotropic drugs also have problems with academic performance, therefore
it is felt that academic achievement should be evaluated.
435
Recommended Performance Tests
1 . Intel lectual Tests
A. Draw-A-Person
This test is listed first because clinicians often give it to start
a testing session with the child by using something that is easy
and understandable. It can give information both about the child's
intellectual level and his motor ability.
B. Porteus Mazes
This test has repeatedly been shown to be sensitive to drug effects.
It is relatively quick and with some practice easy to administer.
Optional Tests
C. Wechsler Intelligence Scale for Children
Since this IQ test is so commonly given in clinics across the nation,
it is also listed. It is suggested as an optional test because it
requires about 1 - 1 1/2 hours to administer, and many research pro-
jects might not have the necessary personnel nor the time.
d. Peabody Picture Vocabulary Test
This is a fairly reliable, very quick intelligence test that can be
given in cases where an intellectual estimate is needed but not enough
time is available to administer the WISC.
2. Learning Tests - Optional
It is quite difficult to satisfactorily measure learning without using some
equipment. Equipment is needed to obtain a precise measurement, e.g., latency
of responding, which is the length of time (usually in tenths of a second) from
the onset of a stimulus until the child responds. Although the equipment is
somewhat expensive and requires some technical knowledge to operate, it is felt
that the precision which comes with the use of this kind of apparatus warrants
its inclusion. It should be also pointed out that in other areas, such as clini-
cal chemistry, laboratory apparatus is accepted as absolutely necessary to con-
duct the investigations.
Commercial equipment available from three companies has been listed in the
back of this report. This is only a sample of the equipment available and is not
intended to be exhaustive, although the companies probably represent the best
equipment that is available today for the type of behavioral assessment suggested
herein. Experimenters planning to use these learning measures should be warned
that some minimum amount of knowledge about this equipment is needed. Most of
these firms offer extensive manuals in the use of their equipment and some of the
firms even offer short workshops to teach the unsophisticated how to use their
equipment. Most psychologists, particularly those with training in experimental
psychology, can readily utilize such equipment. Thus, any project that has the
services of a psychologist probably can benefit from this kind of equipment.
436
A. Continuous Performance Task
This task has been used extensively in assessing the effects of
psychotropic drugs on human behavior. This type of task is
within the ability of a wide range of children, and it is relative-
ly easy to program.
B. Paired Associate Learning
This is one of the oldest techniques to evaluate learning ability
in both adults and children. A variety of stimuli and responses
can be utilized that are appropriate with children. For example,
pictures from the picture vocabulary subtest of the Stanford Binet
or fjictures from the Peabody Picture Vocabulary Test can be paired
with numbers or letters to form an acceptable paired associate task.
C. Recognition Memory
Recognition tests are generally enjoyable for the child. They can
be used to measure the attention of the child and also to investi-
gate both short-term and long-term memory of the child. Some of the
most useful data coming from this test is the latency data.
3. Motor Performance
The motor test of the Kl«5ve-Matthews modified version of the Halsted Battery
would provide a useful measure of motor performance. These tests include tapping
speed, steadiness task, and finger mazes. All of the tests give reliable quanti-
tative information. The tests can be purchased from Dr. Halgrim Kl«5ve, Neuro-
psychology Laboratory, Department of Neurology, University of Wisconsin Medical
Center, 1300 University Avenue, Madison, Wisconsin 53706,
A. Stab i 1 imetr ic Cushion
The s tab i 1 imetr ic cushion developed and used by Sprague might be of
use in situations where the child is seated at a school desk or seated
at a table while performing psychological or behavioral tasks. It
measures rather accurately the amount of wiggling, and it has been
shown to be sensitive to drug effects. Anyone interested in this de-
vice should contact Robert Sprague, Children's Research Center, Univer-
sity of Illinois, Champaign, Illinois 61820.
k. Achievement Tests
A. Wide Range Achievement Test
There are a variety of achievement tests on the market, but most of
them are lengthy and difficult to administer. For these reasons, the
WRAT has been suggested because it is simple and easy to administer.
5. Apparatus to Measure Learning Performance
Listed below are sets of apparatus from three different companies which cuuld
be utilized to measure the effects of psychotropic drugs on learning performance
of children. Each of the sets have some advantages and some disadvantages, but it
is thought that they are representative samples of the kind of equipment that can
^37
be purchased commercially to measure learning performance in children. These
lists have been developed with four types of performance measures in view:
(1) the continuous performance task, (2) paired-associates learning task,
(3) recognition and memory task, and [k) match to sample task.
A. Behavioral Controls, Inc.
1506 West Pierce Street
Milwaukee, Wisconsin 532^6
Telephone: 414-671-1255
The advantage of equipment manufactured by Behavior Controls is that it is
small and compact, it is self contained, and it requires relatively little skill
or equipment to make the stimulus material.
The disadvantages of this equipment (as 1 isted -below) are that it provides no
printout of the responses and latency. To obtain a printout, additional equipment
must be purchased. Further disadvantages are that it permits less precise control
of the time intervals between the presentation of the stimuli which are of some
considerable importance if one measures latency of responding accurately, and the
changing of the stimulus material is somewhat more difficult than the other two sets
of apparatus in that the machine must be opened up and a length of fan folded mate-
rial changed.
Quantity I tern
SR-400 Stimulus Programmer with press panel cover
Standard 400 cover
5M Fan folded program paper
4 hole indexing punch
4 choice auxilliary control console
Dual 4-digit reset response counters
Timing control module
Continuous loop attachment
Continuous performance/delayed response module
Component mounting and display console
Function control network
Set-sample programs and operating instructions for
each mode of use
FOB Milwaukee $3,450
B. Behavior Apparatus Builders
305 Water Street
St . Joseph, I 1 1 inois
Telephone: 217-469-7108
The advantage of the equipment built by Behavior Apparatus Builders is that
it automatically provides a printout on a roll- of paper of the number of correct
responses, the number of the trial, and the latency in tenths of a second; one can
program as many stimuli as needed; the stimuli can easily be changed by simply plac-
ing on or removing a Kodak slide tray; and the equipment is automatically programmed
with a paper tape reader.
438
The disadvantages of the equipment are that it consists of three major units
which are a projection tunnel, a Kodak projector and base, and a relay rack of
equipment which means that it is somewhat bulky in comparison with the Behavior
Controls equipment. In order to make the stimuli, some photography is necessary
because the stimuli are on 35mm slides which are projected by the Kodak projector.
Some knowledge of programming equipment is essential to use the equipment satis-
factor i ly .
Quantity I tern
1 Projection tunnel
1 Reinforcement-dispensing system
1 Shutter-projector control
1 Paper tape reader
1 Manual paper tape punch
2 Dual relays
3 Pulse formers
1 Adjustable timer
2 Power panels
1 2k VDC power supply
1 Automatic printer with 6 channels
of data printout
TOTAL (S) $3,^63
The above price does not include the Kodak Carousel projector, a relay rack
for the programming equipment, and cross patch cords for interconnecting the pro-
gramming equipment.
C. Lehigh Valley Electronics, Inc.
Box 125
Fogelsville, Pennsylvania 18051
Telephone: 215-285-^211
The advantages of the Human Test System built by Lehigh Valley is that there
are a great number of other types of modules available for the system and a great
variety of programming equipment including a computer system which could be at-
tached to the Human Test System.
The disadvantages of the apparatus as currently listed are considerable in
that it will only handle one of the four tests listed in the introduction, namely
the recognition memory task. It would be possible to buy equipment from Lehigh
Valley which would handle all four tests, but this would require more expense and
more equipment or a special order. The apparatus as it now stands would require
extensive knowledge of programming equipment to operate it satisfactorily.
^39
Quantity
part #
1
111-10
1
520-13
1
520-22
3
521-41
1
521 -7^
2
1357
6
1360
3
1419
1
1660
I tern
Projector with slide reader and control
panel
Two-rail console for projector
Connector harness
Rear screen projection key
Coin dispenser
Pulse formers
Dual relays
Timers
Printer
1384 Timing pulse generator
TOTAL (S $3,149
REFERENCES
1. Bandura, A. Principles of behavior modification. New York: Holt, 1969.
2. Barnes, K. R. Effects of methyl phen idate and thioridazine on learning,
reaction time and activity level in hyperactive emotionally disturbed
children. Unpublished B. S. thesis at University of Illinois, 1968.
3. Belmont, J. M. & Butterfield, E. C. The relations of short-term memory
to development and intelligence. In L. P. Lipsitt S- H. W. Reese (Eds.),
Advances in child development and behavior. Vol. 4. New York: Academic
Press, 1969. Pp. 29-82.
4. Brady, J. P. Drugs in behavior therapy. In D. H. Efron, J. 0. Cole,
J. Levine, & J. R. Wittenborn (Eds.), Psychopharmacology: A review of
progress 1957-1967, Public Health Service Number I836, I968. Pp. 271-280.
5. Conners, C. K., Eisenberg, L., & Sharpe, L. Effects of methylphen idate
(Ritalin) on paired-associate learning and Porteus Maze performance in
emotionally disturbed children. Journal of Consulting Psychology, 1964,
28, 14-22.
6. Conners, C. K. & Rothschild, G. H. Drugs and learning in children. In
J. Hellmuth (Ed.) Learning Disorders, Vol. 3- Seattle: Special child
publications, I968. Pp. 193-223-
7. Cytryn, L., Gilbert, A., & Eisenberg, L. The effectiveness of tranquil iz-
ing drugs plus supportive psychotherapy in treating behavior disorders of
children: A double-blind study of eighty outpatients. American Journal
of Orthopsychiatry, I96O, 30, 113-128.
440
8. Edelson, R. I. & Sprague, R. L. Conditioning of activity in a classroom
for institutionalized retardates. Paper read at Amer ican Assoc iat ion on
Mental Deficiency, San Francisco, May, 1969.
9. Eisenberg, L., Conners, C. K., & Sharpe, L. A controlled study of the
differential application of outpatient psychiatric treatment for children.
Japanese Journal of Child Psychiatry, 1965, 6, 125-132.
10. Epstein, L. C, Lasagna, L., Conners, C. K., & Rodriguez, A. Correlation
of dextroamphetamine excretion and drug response in hyperactive children.
Journal of Nervous and Mental Disease, 1968, 1^+6, 136-1^6.
11. Freeman, R. D. Drug effects on learning in children: A selective review
of the past thirty years. Journal of Special Education, 1966, 1, 17-^3.
12. Helper, M. M., Wilcott, R. C. & Garfield, S. L. Effects of chlorpromaz ine
on learning and related processes in emotionally disturbed children.
Journal of Consulting Psychology, 1963, 27, 1-9.
13. Knights, R. M. Normative data on tests for evaluating brain damage in
children from 5 to 14 years of age. Research Bulletin No. 20, September I966,
University of Western Ontario.
14. Knights, R, M. & Hinton, G. The effects of methyl phen idate (Ritalin) on the
motor skills and behavior of children with learning problems. Research
Bulletin No. 102, University of Western Ontario, I968.
15. MacKintosh, N. J. Selective attention in animal discrimination learning.
Psychological Bulletin, 1965, 64, 124-150.
16. Milichap, J. G. & Boldrey, E. E. Studies in hyperkinetic behavior. II.
Laboratory and clinical evaluations of drug treatments. Neurology, I967.
17. 467-471 & 519.
17- Overton, D. A. Dissociated learning in drug states (State dependent
learning). In D. H. Efron, J. 0. Cole, J. Levine, £■ J. R. Wittenborn.
Psychopharmacology : A review of progress 1957-'967. Public Health Service
Publication No. 1 836 , I968, Pp. 918-930.
18. Rosenblum, S. Practices and problems in the use of tranquilizers with
exceptional children. In E. Trapp & P. Himelstein (Eds.) Readings on the
exceptional child. New York: Appleton, I962. Pp. 639-657.
19. Russell, R. W. Drugs as tools in behavioral research. In L. Uhr &
J. G. Miller (Eds.), Drugs and behavior. New York: Wiley, I96O. Pp. 19-40.
20. Schulman, J. L. t Reisman, J. M. An objective measure of hyperactivity.
American Journal of Mental Deficiency, 1959, 64, 455-456.
441
21. Scott, K. G. Short-term memory in the retarded child. Progress Report
No. 1 , June 1 969 •
22. Scott, K. G. A multiple-choice audio-visual discrimination apparatus
with quick interchange display and response panels. Journal of
Experimental Child Psychology, in press.
23. Sprague, R. L. S- Toppe, L. K. Relationship between activity level and
delay of reinforcement. Journal of Experimental Child Psychology, I966,
3, 390-397.
2k. Sprague, R. L. S- Werry, J. S. (Eds.) Survey of research on psychopharma-
cology of children. Unpublished manuscript. University of Illinois, I968.
25. Sprague, R. L., Werry, J. S., & Davis, K. V. Psychotropic drug effects on
learning and activity level of children. Paper presented at the meeting
of the Gatlinburg Conference on Research and Theory in Mental Retardation,
Gatlinburg, Tenn., March I969.
26. Sprague, R. L., Werry, J. S., Greenwold, W. E., & Jones, H. Dosage effects
of methylphenidate on learning of children. Paper presented at the meeting
of the Psychonomic Society, St. Louis, November, 1969-
27. Turner, R. CNS stimulant drugs and conditioning treatment of nocturnal
enuresis: A long term follow up study. Behavior, Research and Therapy,
1966, k, 225-228.
28. Werry, J. S. & Sprague, R. L. Hyperactivity. In C. G. Costello (Ed.),
Symptoms of Psychopathology . New York: Wiley, in press.
29. Young, G. & Turner, E. CNS stimulant drugs and conditioning treatment of
nocturnal enuresis. Behavior, Research and Therapy, 1965, 3, 93-101.
30. Zeaman, D. & House, B. J. The role of attention in retardate discrimina-
tion learning. In N. R. Ellis (Ed.), Handbook of mental deficiency.
New York: McGraw, I963. Pp. 159-223.
kk2
PSYCHOMETRIC
SCALES-ADULT
PSYCHOMETRIC SCALES
ADULT
Code 15 for Sheet Number when encoding any or all of the
standard Adult Psychometric Scales.
The texts for all adult scales are printed on GREEN templates.
MH-9-67 (WAIS) Wechsler Adult Intelligence Scale
70 (FTBS) Friedhoff Task Behavior Scale
61 (MAZE) Porteus Mazes
68 (BEIMDPS) Bender Gestalt Test - Pascal Suttell Scoring
69 (WMEM) Wechsler Memory Scale
Mark on right half of scoring sheet on row specif ied (Cols. 11-20)
ROW
NO.
WECHSLER ADULT INTELLIGENCE SCALE
(67WAIS) (Code 15 for Sheet Number)
INSTRUCTIONS: Code scaled scores, NOT raw scores, in 2 digits; code
Continue marking on right half of scoring sheet on row specified
ROW
NO.
FRIEDHOFF TASK BEHAVIOR SCALE - Continued
IQ's in 3 digits. When using "short forms" or abbreviated versions of
WAIS, be sure to encode subtests and IQ's on the proper rows. Leave
33
2. GRASP INSTRUCTIONS
blank all unused rows.
1 = Good Understands quickly
Information
1-2
2 = Fair Occasional repetition and correction
required
Comprehension ....
31
3 = Poor Constant repetition and correction
required
4 = Very poor Unable to understand
5-6
3. SHOWS ANNOYANCE OR HOSTILITY
34
Similarities
7-8
1 = Not at all
Vocabulary
9-10
2= A little
3 = Quite a bit
Digit Span
11-12
4 = Extremely
4. WITHDRAWN
35
Picture Completion . . .
13-14
1 = Not at all
Picture Arrangement
15 16
2 = A little
3= Quite a bit
Block Design
17-18
4 = Extremely
5. SHOWS AGITATION OR EXCITEMENT
36
Object Assembly ....
19-20
1 = Not at all
Digit Symbol
21-22
2= A little
3 = Quite a bit
Verbal IQ
23-25
4 = Extremely
6. APPEARS APPREHENSIVE OR TENSE
37
Performance 10 . . . .
26-28
1 = Not at all
Full IQ
29-31
2 = A little
3 = Quite a bit
4 = Extremely
FRIEDHOFF TASK BEHAVIOR SCALE
(70-FTBS) (Code 15 for Sheet Number)
7. ATTENTION TO TASK
38
INSTRUCTIONS: At the close of the testing session please rate the
patient on the following aspects of his behavior and performance.
1 = Good Complete attention
2 = Fair Usually attentive
3 = Poor Attention limited and wandering
1. COOPERATION
■l = Good No urging needed
32
4 = Very poor Complete inattention
8. RELATIONSHIP WITH TEST ADMINISTRATOR
39
2= Fair Little urging
1 = Good Friendly, at ease
3 = Poor Much urging
2 = Fair Reserved, took a while before warming
4 = Very poor Refuses completely
up
3 = Poor III at ease, uncomfortable
4 = Very poor Preoccupied; ignored me; acted as if
1 weren't present; practically no
444
interpersonal contact
PSYCHOMETRIC SCALES
ADULT
ROW
NO.
Mark on left half of scoring sheet on rows specified
PORTEUS MAZES
(Code 15 for Sheet Number) (61 -MAZE)
Code 3 digits for each of the 2 scores
1-3
. . . Maze Quotient
4-6
. . . Qualitative Score
BENDER GESTALT TEST - Pascal, Suttell Scoring
(Code 15 for Sheet Number) (68-BENDPS)
Code score for each design in 2 digits; code total score in 3 digits
7-8
Figure 1 (Record total score for design)
9-10
Figure 2
11-12
Figure 3
13-14
Figure 4
15-16
Figure 5
17-18
Figure 6
19-20
Figure 7
21-22
Figure 8
23-24
Configuration Score
25-27
Total Test Score
WECHSLER MEMORY SCALE
(Code 15 for Sheet Number) (69-WMEM)
Unless otherwise indicated, code scores in 1 digit
28
. . . Personal and Current Information
29
Orientation
30
Mental Control
31-32
Logical Memory (Code in 2 digits)
33
Digits Forward
34
Digits Backward
35-36
Visual Reproduction (Code in 2 digits)
37-38
Associate Learning (Code in 2 digits)
39-41
MEMORY QUOTIENT (Code in 3 digits)
kkS
This section is formatted to encode five psychological scales on a single
General Scoring Sheet. Other psychometric data may be encoded according to the
instructions given in the section "Encoding of Non-Standard Data". (pp. 59-64),
WECHSLER ADULT INTELLIGENCE SCALE
(067-WAIS)
Introduced by Wechsler in 1955, the WAIS is a revision and restandard izat ion
of the original Wechsler scales. As, with its precursor, the WAIS is composed of
verbal and performance subtests yielding a total score which is converted into an
age-related IQ..
REFERENCES
APPLICABILITY
UTILIZATION
1. Wechsler, D., Manual for the Wechsler Adult
Intelligence Scale, Psychological Corporation,
New York, 1955-
2. Matarazzo, J. D., Wechsler 's Measurement and
Appraisal of Adult Intelligence, 5th Ed.
Williams and Wilkens, Baltimore, 1972.
Materials for the WAIS may be obtained from
the Psychological Corporation, 304 E. 45th
Street, New York, New York. 100 17
Adults 16 to 75 years
At the discretion of the investigator. May be
used at initial assessment only or as a change
measure.
CARD FORMAT
Item
' I nformat ion
Comprehens ion
Ar i thmet ic
S imi lar i t ies
Vocabulary
Digit S pa n
Picture Completion
SPECIAL INSTRUCTIONS
CARD 01 = (19x, II 12, 313)
Column Item
20-21
22 - 23
2k - 25
26 - 27
28 - 29
30 - 31
32 - 33
Picture Arrangement
Block Design
Object Assembly
Digit Symbol
Verbal |Q
Performance IQ.
Full la
Col umn
34 - 35
36 - 37
38 - 39
kO - k]
kl - hk
k5 - 47
48 - 50
The instructions given in the WAIS Manual (Reference 1) should be followed
by the test administrator. Be sure to encode SCALED SCORES, not raw scores. When
using any abbreviated WAIS, encode the scaled scores of the subjects used and the
prorated IQ's in their appropriate rows and columns.
446
Example: The psychologist plans to employ only k WA I S subtests: Information,
Vocabulary, Block Design and Digit Symbol. She should encode these subtests -
and the prorated IQ.'s as follows:
.1 nformat ion
Vocabulary
Block Des ign
Digit Symbol
Prorated Verbal \Q_
Prorated Performance IQ,
Prorated Ful 1 \Q.
21 ---.&:
22 ::e:
23 ::a:
24 ---.oz
25 ---.&:
26 ::e:
27 :;e:
28 --zoz
29irez
30:*
31 :ie:
-t: r:3=:
:r2:: :=3::
r:i: ::3::
i:2:: :=*::
zzf. :*:
i:J:r i*i
lit: i=3=:
::2:r r*r
iri: :*:
::2=: :*:
=:*:: =:3::
S:
::6::
::?::
::8::
::*
&:
r:6::
zir--.
::8::
::»:
tr
::6::
z.r-z
::8::
::»:
S::
::6::
zzT-Z
::ft:
::»:.
S:
::fc:
::?::
r:ft:
--9z
*:
::fc:
::?::
::8::
::*
ft:
::«(::
::J::
::«::
::*
ft:
::6::
::?::
::ft:
::»:
ft:
::6::
::?::
::»::
::»:
ft:
::fc:
::?::
::»::
-z9z
ft:
::6::
::?::
::8::
::*
DOCUMENTATION
a. Scaled score printout
b. Means and standard deviations
c. Variance analyses
kk7
BENDER GESTALT TEST (O68-BENDPS) - Pasca 1 -Suttel 1 Scoring
In wide use since its introduction by Bender, the BENDPS is a nonverbal
visua 1 -motor test which has been employed for the estimation of maturation,
intelligence, psychological disturbance and cortical impairment. Pascal and
Suttel 1 published their scoring system in 1951 and have attempted to differ-
entiate cortical deficit ('"organ ic i ty") from psychogenic disorders.
REFERENCES 1. Pascal, G. R., and Suttell, B. J., The Bender
Gestalt Test, Grune and Stratton, New York, 1951
2. Bender, L., A Visual Motor Gestalt Test and its
Clinical Use, American Orthopsych iat r ic Associa-
tion, Monograph No. 3, New York, 1938.
Test material may be obtained from the Psychological Corporation, New York.
APPLICABILITY
UTILIZATION
15 years to adul t
Once at pretreatment ; at least one posttreatment
rating. Additional ratings are at the discretion
of the investigator.
CARD FORMAT
1 tern
Col
umn
Fig. 1
20
- 21
Fig. 2
22
- 23
Fig. 3
2k
- 25
Fig. k
26
- 27
Fig. 5
28
- 29
CARD 01 = (19x, 912, 13)
I tem
Col umn
Fig. 6 30-31
Fig. 7 32-33
Fig. 8 3^-35
Config. Score 36 - 37
Total Score 38 - ^0
SPECIAL INSTRUCTIONS
Instructions for s;:oring the test are contained in the Pasca 1 1 -Suttel 1 volume.
(See Reference 1). Investigators wishing to employ other scoring systems should en-
code the data according to the instructions for "Encoding Non-Standard Data" (pp. 59-64)
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
448
WECHSLER MEMORY SCALE
(O69-WMEM)
The Wechsler Memory Scale (WMEM) , is a brief, widely used measure of memory
deficit. It consists of 7 subtests winose raw scores are summated to obtain a
memory quotient. Two forms of the scale are available and are considered to be
equivalent. It is suggested that investigators alternate the 2 forms to reduce
practice effects.
REFERENCE
APPLICABILITY
UTILIZATION
CARD FORMAT
(
1 tern
Column
Information
20
Orientation
21
Control
22
Logical
23 - 24
Digits Forward
25
Wechsler, D., and Stone, C. P., Manual for
Wechsler Memory Scale, Psychological Corporation,
New York. (Originally published in J. of Psychol.
19, 87-95, 19^5). Materials for the WMEM may be
obtained from the Psychological Corporation.
Adul ts
Once at pretreatment ; at least one posttreatment
rating. Additional ratings are at the discretion
of the investigator.
CARD 01 = (19x, 311 , 12, 211 , 212, 13)
tern
Digits Backward
Reproduct ion
Assoc. Learning
Memory Quot lent
Col umn
26
27 - 28
29 - 30
31 - 33
SPECIAL INSTRUCTIONS
Instructions for scoring the items are contained in the manual (see Reference)
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
kkS
FRIEDHOFF TASK BEHAVIOR SCALE
(070-FTBS)
The Friedhoff Task Behavior Scale (FTBS) is an 8-item, 4-point scale for the
assessment of the subject's behavior during the administration of psychological
tests. It is the adult analogue of the Psychological Examination Behavior Profile
and, like the PEBP, is formatted for use with the GSS .
REFERENCE
APPLICABILITY
UTILIZATION
TIME SPAN RATED
CARD FORMAT
! tern
1 . Cooperation
2. Grasp
3. Annoyance
k. Withdrawn
Friedhoff, A. J. and Alpert, M., The Effect of
Chlorpromazine on the Variability of Motor Task
Performance in Schizophrenics, J. Nerv. Ment. Dis.,
130, 110-116, i960.
Adult Populations
To be used in conjunction with each psychological examination,
The duration of the psychological examination.
CARD 01 = (19x, 811, 12)
Column Item
20
21
22
23
5. Agitation
6. Apprehensive
7. Attention
8. Relationship
Total Score
Column
2k
25
26
27
28 - 29
Total Score = Sum of items 1 through 8. Total Score Range =8-32.
SPECIAL INSTRUCTIONS
Clues for each scale point are given on the scale itself.
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
450
ASSEMBLING
DATA
FOR SHIPMENT
Perhaps the least exhilarating aspect of research is the data collection phase
since it demands close and constant attention to a myriad of details. However, the
care expended here is subsequently justified in the analytic phase. Since the great-
est amount of processing time is spent in creating an error-free data set, it is as
much in the interest of the Biometric Laboratory to campaign for strict data control
as it is in the investigator's interest.
Experience has shown that processing time is reduced substantially when an in-
vestigator establishes his own control procedures prior to sending data for computer
processing. This is best accomplished when the responsibilities for data control and
coordination are assigned to some member of his research staff. The data coordinator
has the task of seeing that the requirements of the protocol - particularly the data
collection aspects - are carried out. By constructing an overall assessment table
showing rater assignment and required rating instruments, the coordinator can drasti-
cally reduce subsequent "missing data" problems. By monitoring each set of ratings
as they are obtained, the coordinator can ensure the completeness and correctness of
the encoding. To accomplish this, the coordinator must be thoroughly familiar with
the proper encoding procedures for all the instruments used in a study. In the past,
the Biometric Laboratory has conducted several group workshops for coordinators in
the use of the ECDEU Battery and has found the resultant interchange of information
most rewarding. Consultation with coordinators on the problems of data collection
continues to be a function of the Laboratory and investigators are welcome to make
use of this service.
ASSEMBLING DATA FOR SHIPMENT
Predominantly, input data has been received at the Biometric Laboratory in the
form of completed op-scan sheets which represent the data collection for an entire
study. In preparing a data set for shipment, the following instructions should be
noted:
1. Check all forms for completeness both in the ID block and in the
data matrix. Erase extraneous marks or writing. Check to see that
a #2 pencil was used. Above all, do not use staples or clips: do
not punch holes in the forms, etc.
2. Only the original copy (white) should be sent as it alone can be op-
scanned. The yellow copy should be retained by the investigator.
Xeroxed copies cannot be op-scanned and therefore should not be sent.
If a form is mutilated, recopy the data on another form.
3. Sorting data in a uniform manner serves to alert the unit coordinator
to missing ratings or other errors and, later, aids BLIPS editors to
locate a specific form during their editing procedures. Two of the
most frequently-used sorting arrangements are:
452
Subjects and periods ordered within Sheet and/or Form as follows:
Treatment Group A
Sheet or Form Number (in numeric order)
Subject 001 Period 00
Subject 001 Period 01
Subject 001 Period 02
Subject 001 Period k
Subject 002
Subject 002
Subject 002
Subject 002
Period 00
Period 01
Period 02
Pe r i od k
Subject n Period 00
Sheet or Form Number
(as above)
Treatment Group B (Repeat as in "A")
Sheets, forms and periods ordered by subject as follows:
Treatment Group A
Subject 001
Sheet 01
Sheet 01
Sheet 01
Sheet 01
Sheet 03
Sheet 03
Form n
Period 00
Period 01
Period 02
Pe r i od k
Period 00
Period 01
Period 00
Treatment Group B (Repeat as in "A")
k. Note in the above sorting examples (3a and 3b) that data is always separated
into treatment groups. Identify each treatment group by writing its name on
a sheet of paper and placing it on top of the data and tie the data together
to make a bundle of each group's data.
Example:
453
5. Make sure that you've enclosed the completed Data Shipment (07I-DS).
If you have additional special requests or comments, state them in
a letter even though you may have discussed them previously by tele-
phone.
6. Place all the data into a stout box and wrap securely. Please enclose
ONLY ONE STUDY TO A BOX. More than one box may, of course, be used
for large studies. To avoid mistakes, however, we urge that you do not
enclose 2 or more different studies in a single box.
7. Mail to: ECDEU DATA ANALYSES
BIOMETRIC LABORATORY
11501 HUFF COURT
KENSINGTON, MARYLAND 20795
When data is received at the Laboratory, a notice will be sent acknowledg-
ing its receipt and giving an estimate of turnaround time. If, after a
reasonable time, you do not receive this notice, notify the Laboratory so
that tracing can begin.
ALTERNATIVE TYPES OF DATA SUBMISSIONS
In the majority of cases, submission of "complete study" data is logistical ly
the preferred one since much of BLIPS has been predicated on this kind of input.
Increasingly, however, investigators have made inquiries concerning alternative ways
of submitting data. Consequently, the following types of data submissions are
acceptable:
1. Partial submissions - Often, there is a need to examine data before
a study is completed; e.g., multi-phase studies where one phase of
the design is dependent upon the results of a preceding one. Given
the need, investigators should inform the Biometric Laboratory of
their requirements in detail - giving as much "lead-time" as possible.
2. Card Input - Data submitted in this manner is acceptable as long as it
conforms to the standard ECDEU card formats. (p. 26 ). Investigators
should recognize the need to undertake their own editing of the source
documents; since BLIPS editing will necessarily be limited to the cards
themselves. When absolutely necessary, card input with formats other
than ECDEU will be accepted - provided the precise "non-standard" formats
are stated.
3. Tape Input - Tapes may be submitted provided the following specifications
are met:
Tape Restrictions
a. 9 track
b. 1600 bits per inch
c. Maximum block size = 32,000
d. IBM mode
Information Required
a. Blocking factor
b. Number of records
c. Label information
As noted with card formats, BLIPS editing is limited to the tape*,
k5k
071 DS
DATA
SHIPMENT
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
FOR BIOMETRIC LABORATORY USE
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU NUMBER
DATA SHIPMENT (DS)
DATE RECEIVED
PRINCIPAL INVESTIGATOR/S
TITLE OF STUDY
1. Have you previously submitted a Research Plan Report (21 -RPR) for this study?
D Yes
D No (If "No," please complete an RPR and enclose along with data. Studies can not be processed without an RPR.)
2. Were there any revisions from the original protocol as described on the RPR which you have submitted?
D Yes (If "Yes," please submit revised RPR)
D No
INSTRUCTIONS
The Data Shipment form has been designed to facilitate processing of studies and to
involve the investigator in the decision process regarding analyses to a greater extent than
heretofore possible. In completing the form, the investigator can select or delete ratings
and/or raters for analyses; construct a factorial design and request special analyses. For
the Biometric Laboratory, the Data Shipment will serve as a "master control form" -
selecting the appropriate programs for use in processing and analyses. Errors of patient
assignment and/or period (rating) utilization can be minimized. Further, output displays
can be labeled by drug name and/or other factor names. Since the form serves such a
crucial role, A DATA SHIPMENT FORM MUST ACCOMPANY THE DATA WHEN IT
IS MAILED TO THE BIOMETRIC LABORATORY. Answer all items as completely as
possible. Should the form be inappropriate for your data or should you be uncertain
about its completion, please contact the Laboratory.
ITEM I - INVENTORY OF FORMS
1. New and Old Scales
For each scale, check whether new or old versions of the
scales have been used in the study. The use of both the
old and new versions of a single scale in a single study is
discouraged since it complicates processing and increases
the probability of error.
2. Sheet Number
Sheet numbers routinely assigned to the standard scales are
preprinted on the DS. When non-standard scales are
employed, the investigator must assign the same Sheet
number to a given data set throughout the study. Any. 2-
digit number not already assigned may be used.
3. Time Unit
Indicate whether the time units are hours = H; days = D;
weeks = W or months = M.
4. Periods
For each scale, record all time periods (ratings) which were
made during the study. The initial (first) rating should be
designated "00"; others by the week (or other time unit)
when they were made. CIRCLE the ratings where drug
medication began and ended. UNDERLINE those periods
(ratings) you wish to employ in subsequent analyses.
EXAMPLES:
a. A pretreatment rating is obtained following which medi-
cation is begun. Ratings are then made at 2 weeks and
4 weeks when medication is stopped. The investigator
wishes to use only the first and la^t ratings in analyses.
The correct coding is:
02
MH 9-71
4-73
k5S
Ratings are made at the beginning and end of a 2-week
drying out period following which medication begins.
Ratings are also made at 4 and 6 weeks when medi-
cation is stopped. A final rating is made 2 weeks later.
The investigator wishes to use all ratings in analyses.
The appropriate coding is:
00
I DRY I
04
MEDICATION
Begin
End
08
FoMowu^*
For CROSSOVER designs, designate the medication
changeover points by x's. For example, three drugs A,
B and C are alternated every 4 weeks and ratings are
made every 2 weeks. Only ratings at the beginning and
end of medications are to be used in analyses. The
appropriate coding is:
02
06
B
10
5. Last Available Rating
A check in this box signifies that there was an uneven end
point in the study, i.e., patients were terminated after
different durations of treatment. For example; in a 4-week
study with weekly ratings, the investigator found that all
subjects completed at least 2 weeks of treatment and were
rated at weeks 00, 01 and 02. However, some subjects
were so improved that they could be terminated prior to
the 4th week. He wishes to use all subjects in a repeated
model design. He wishes to use the first 3 ratings (00, 01,
02) and the final rating for each subject whether it is the
03 or 04 week rating. The appropriate coding is:
01
02
■J in the
appropriate
column
6. Rater
For each scale, give the number/s of the rater/s. Circle
those rater numbers which you wish used in analyses.
ITEM IV - VARIANCE ANALYSES
The present analyses of variance/covariance (AVACOV) pro-
gram used in BLIPS allows for a 4-factor design. RESERVING
ONE FACTOR FOR PERIOD EFFECT, the investigator may
designate the number of additional factors (maximum of 3) he
wishes to employ in his statistical design. In the usual clinical
trial. Factor 1 would be named "DRUG" and the drug/s
employed in the study labeled as Group A, B, C, etc. Factors
2 and 3 can be any designated effect that the investigator
wishes to study, e.g., age, diagnosis, hospital, chronicity,
dosage, experimental manipulation, etc. A maximum of 10
groups may be categorized under any one factor. Part 2 of
Item 4 asks for a choice of the standard variance models; while
Part 3 provides for requests for special analyses.
EXAMPLES:
a. For a study in which only one drug (UGH) was employ-
ed; the coding is:
FACTOR 1.
Group A
Name
Drug
Ugh
This, in essence, would indicate a one-way analyses of
periods.
b. Two drugs - WOW and GEE - were employed in the
study, in addition, and the investigator wishes to test
the effect of diagnosis - schizophrenic vs. nonschizo-
phrenic. The coding is:
FACTOR 1 Name
Group A
Group B
FACTOR 2 Name
Group A
Group B
ITEMV - PATIENT IDENTIFICATION
Drug
Diagnosis
Schizophrenic
Non-Schizophrenic
ITEM II - NON-ECDEU FORMS
This item is to be completed in the same manner as Item I
with the exceptions of the columns named "Form" and
"Matrix". Under Form, give the title of the scale or data set.
For Sheet Number use any number not already assigned. Use
the same Sheet Number for the same data set for all assessment
periods. Under Matrix, give the numbers of the rows which
encompass the items of the scale; e.g., a 25 item scale coded
in Rows 1 to 25; give the numbers of the columns which
encompass the scale points, e.g., a 5 point scale coded in
Column 16 to 20. If the scale contains items with different
number of scale points, e.g., some 3 point, 4 point and 5 point
items, give the dimensions of the largest set of scale points,
e.g., 5 points.
This listing will be used for editing and processing procedures.
In addition to the patient's number, sex and initials, the
investigator is asked to categorize the factorial assignment of
the patient. By specifically categorizing each subject, subse-
quent analyses can be checked for misassignment. Males are
numbered 001 to 499; females 500 to 998.
EXAMPLE:
Patient 507, a female whose initials are ZZ, received the
drug WOW during the study and she is nor schizophrenic.
(See Item IV, example b. above). The coding is:
Patient
Number
507
Factor Assignment
ZZ
ITEM III
RATER IDENTIFICATION
This item becomes crucial if investigators contemplate con-
ducting reliability studies across a number of trials. It is
suggested that investigators try to use the same number for a
rater who participates in a series of trials as this will simplify
identification for both the investigator and the Biometric
Laboratory. Do NOT use duplicate numbers in a single study.
ITEM VI - OUTPUT
Check whether one or two copies of the data package and one
or two decks of cards are desired.
ITEM VII - DOSAGE DATA
This information is requested ONCE on this form rather than
asking raters to complete it at every dosage change.
MH 9-71
4-73
^57
I. INVENTORY OF FORMS
SCALES
SHEET
NUMBER
SCALES
TIME
UNIT
PERIODS
CHECK IF
LAST
AVAILABLE
RATING TO
BE USED
GIVE RATER
NUMBER/STO
BE USED IN
ANALYSES
New
Check
Old
Check
27-CPRS
01
28-CGI
01
12-CGI
29-DOTES
02
03TESS
30-CDS
03
03
31-CDC
04
04-DSR
'
32PTR
<
33-TWIS
34-CBI
20
35-TQ
36-PQ
III
37-PTQ
38-STESS
39-NOSIE
20
07NOSIE
40-PLUT
20
ill
41-PANESS
11
42-NGI
20
07NOSIE
43-CPDI
10
44-CSH
11
■APDI
12
01 PDI
^^ -TRAITS
13
46-PMR
-
47-BPRS
01
06 BPRS
48-HAMA
01
49-HAMD
01
08 HAM
51-ASI
01
■
52-WITT
01
11-WITT
53-SCL90
10-SRSS
54-SAS
MH 9-71
4-73
k58
I. INVENTORY OF FORMS
SCALES
SHEET
NUMBER
SCALES
TIME
UNIT
PERIODS
CHECK IF
LAST
AVAILABLE
RATING TO
BE USED
GIVE RATER
NUMBER/S TO
New
Check
Old
Check
BE USED IN
ANALYSES
55- LAB
T-;;;'-'
05LD
56-POMS
57-SADJ
14
58-DRI
14
||:||;i; -
-.:.::'
—
■-■■■ ' ■
15
-rl-'--"— !■""-;
'^
60-WISC
61-MAZE
15
15
S*ftS
62-WRAT
15
63-GOOD
;| llll
64-BENDK
15
I- ixSii:
■:■:■■ i ^'iS
65- FROST
15
66-PEBP
16
15
67-WAIS
15
68-BENDPS
69-WMEM
15
70-FTBS
16
:
MH 9-71
4-73
459
NON-ECDEU FORMS
Complete this section only if you are submitting data from scales which are not part of the ECDEU Assessment battery.
Copies of the scales and any relevant material would be appreciated and would aid in processing.
TITLE
OF
SHEET
NUMBER
MATRIX - Coded in the
following location
TIME
UNIT
PERIODS
CHECK IF
LAST
AVAILABLE
RATING TO
BE USED
RATER
NUMBER/STO
FORM
ROW
COLUMN
BE USED
From
To
From To
III. RATER IDENTIFICATION
Complete items for all raters utilized in the study.
RATER
NUMBER
RATER'S NAME
(First initial and last name)
RATER
NUMBER
RATER'S NAME
(First initial and last name)
NOTE: When "multiple raters" are used; i.e., 2 or more individuals performing simultaneous or
concurrent ratings of the same subject, and the Investigator wishes to include this dimension
in analyses, the raters should be identified under a factor entitled "Rater" (Item IV).
MH 9-71
4-73
460
IV, VARIANCE ANALYSES
FACTOR
IDENTIFICATION:
Group A
Group B
Group C
Group D
Group E
Group F
Group A
Group B
Group C
Group O
Group E
Group F
Group A
Group B
Group C
Group D
Group E
Group F
VARIANCE
MODEL DESIRED
3.
SPECIAL
ANALYSES:
(Describe)
Analyses of Variance - Regular Model
Analyses of Variance - Repeated Model
Analyses of Covariance - Regular Model
Analyses of Covariance - Repeated Model
MH9-71
4-73
461
PATIENT IDENTIFICATION
Please complete all items. Use additional sheets if necessary. Males are numbered 001 to 499; females 500 to 998.
PATIENT
NUMBER
SEX
(M or F)
INITIALS
(First - last)
FACTOR ASSIGNMENT
PATIENT
NUMBER
SEX
(MorF)
INITIALS
(First - last)
FACTOR ASSIGNMENT
MH 9-71
4-73
462
VI. OUTPUT
A. Number of Data packages requested:
B. Number of Card decks requested:
C. If two data packages/card decks are requested, should both sets be sent to you?
Dyes
D NO If NO. give name and address of other recipient:
D. Do you want the original data forms returned to you? DYES
To another address? D YES D NO
If YES, give name and address of recipient:
D NO
VII. DOSAGE DATA
Check appropriate units for dosages coded on Dosage Record and Treatment Emergent Symptoms (DOTES) for each
treatment group.
DRUG
UNITS (Check)
GROUP
mg
meg
gm
mg/kg
Other (Specify):
A
B
C
D
E
F
FOR BIOMETRIC LABORATORY USE ONLY
CODE:
Start
Finish
Comments
OPSCAN:
EDIT:
ANALYSES:
Date mailed:
MH 9-7^
A-73
Editor:
i+63
Developed within the ECDEU program, the Data Shipment contains 7 items and is
designed to supply information necessary for BLIPS processing. Not in opscan
format, the data from DS are key-punched and serve as control cards to select the
appropriate programs for processing.
APPLICABILITY -
UTILIZATION
CARD FORMATS -
All research populations
Once per study - when shipping data to the
Biometric Laboratory
Cards generated from the DS are used internally
by the Biometric Laboratory for data processing.
SPECIAL INSTRUCTIONS
Instructions are printed directly on the form. Since DS information is
essential to BLIPS processing, this form is MANDATORY and must be submitted
with shipments of data. If uncertain about completing the DS or any of its
items, the investigator is urged to contact the Biometric Laboratory.
I tern 1. Inventory of Forms - The shaded areas within the item indicate that
no entries are required. These data are used to:
a. Identify and locate each scale used in a study.
b. Record the total number of assessment periods as well as
those to be used in subsequent analyses.
c. Call forth the appropriate programs for the editing and routine
displaying of the data.
CDS - While t'he Children's Diagnostic Scale (CDS) is usually employed only at
pretreatment , some investigators may want to use the first 8 items for repeated
assessment. Encoding of these two usages is as follows:
At pretreatment only
As repeated measures (pre-post)
PQ. and TQ. - Since the Parent Questionnaire and Teacher Questionnaire can be used
for repeated assessments by themselves or in conjunction with the Parent-Teacher
Questionnaire, (PTQ), investigators may have difficulty in describing their usage
k6k
of these scales. Examples - In a 6-week study, the investigator
■makes an initial rating and 3 subsequent ratings at 2-week intervals using
the PQ. and TQ. at each rating. Encode as follows:
35-TQ
36-PQ-
1/
Xv-X-X-;-;-:';
Hi
u/
w
n
37-PTQ
■1
^ ' /
The investigator, using the same assessment schedule as above, uses the
PQ and TQ. only at the initial rating - substituting the PTQ. at the 3 subsequent
ratings. Encode as follows:
35-TQ
/
v/
oo ^
^5"
36-PQ
/
v^
CK>.
'/
37-PTQ
/
w
c>-i-,o«f^ ou
11,^
STESS - This scale may be rated by the subject and/or a parent or other
knowledgeable adult. If the investigator wishes to indicate that he has
used concurrent ratings - the subject (S = 00) rating each week for h
weeks and his mother (M = 11) rating every 2 weeks for 4 weeks, he would
encode as follows:
38-STESS
/
^
£:
PMR - No recording of PERIODS is necessary for Prior Medication Record. The
lack of shading on the form is an error and it should have been printed as
fol lows :
vn**n******««««««««**«wi
46-PMR
Item II. Non-ECDEU Forms - This item serves the same purpose as Item I, but
requires an alternative set of programs for processing. Location of the data
matrices for each non-standard scale is particularly crucial. To insure pre-
cise labeling and correct interpretation in data displays, it is strongly
465
suggested that a copy of the instrument - showing items and scale points - be
sent to the Biometric Laboratory. If the data is composed of factor or cluster
scores, their names, the data fields they occupy and the range of the scale
points should be given. Should the investigator wish to have the Biometric
Laboratory "factor score" the items on the basis of his own factor analysis,
inclusion of the item composition of each factor is required. The more Informa-
tion an investigator can supply about a non-standard data set; the less likely
it will be that BLIPS makes an error.
I tern \\l-3- Special Analyses - The investigator can describe additional analyses
here. It should be kept in mind that special analyses requests will have a lower
priority than routine (standard) analyses. An investigator requesting special in
addition to standard analyses will receive lower p-riority ONLY for the special
requests .
Item v. Patient Identification - This item provides both a clerical and a com-
puter check of patient identity and treatment assignment. The item conveys the
necessary information for the identification of data while maintaining the anonyni-
mity of the subject. Only the principal investigator will know the identity of the
subjects and this identity cannot be ascertained from the data package or, later,
when the data are entered into the data bank. By asking for treatment assignment
once, the rater's task will be reduced, i.e., he need not encode treatment assign-
ment for each subject on several scales as the earlier BLIPS required.
Item Vl. Output - Here the investigator can specify how many copies of the data
package and card decks he desires as well as to whom they should be sent. It is
necessary to state the number at this time, since a later request for an addition-
al package would require a complete "rerun" of the study. By requesting here that
a copy of the data package be sent to another part, e.g., a drug firm, the investi-
gator is assumed to be giving his formal' consent for such transmission of data.
Item VII. Dosage Data - By asking for this information here and only once, raters
will be spared the task of marking "units" ad nauseum throughout a study. Computer
programming will insert "units" in the appropriate data displays.
466
DOCUMENTATION
(The Data Package)
Documentation refers to the presentation of data in a manner which describes
what happened during a study and permits inferences to be drawn from it. It is
vital, therefore, that the documentation depict the events of the tr'hal as accu-
rately and comprehensibly as possible. All too frequently, failure to document a
trial properly has led to incomplete or ambiguous findings which make it impossible
to arrive at a substantive judgment of the trial itself or to compare its results
with other similar trials. The effects of the drug cannot be assessed under these
conditions and its true merits may be obscured.
For many, the first exposure to computer output can be bewildering. The neo-
phyte finds himself lost in the bulk of the package; and, even upon finding the loca-
tion he desires, he is confused by the way in which the data is presented. He must
learn to "decipher" the output before he can begin to interpret the findings of his
study. Experience with the adult standard package has shown that there are almost as
many inquiries relating to "deciphering" as there are regarding the interpretation of
results. In the majority of these instances, more elaborate labeling - in English -
would have avoided the need for "deciphering".
In the 10 years of its existence, the BLIPS data package has undergone repeated
changes in an attempt to increase its clarity and comprehensiveness. The pressure of
service requirements necessitated the introduction of changes in the package one by
one - rather than by a systematic overhaul. Coincident with the introduction of the
new Battery, rnajor revision of the Biometric Laboratory Information Processing System
has been undertaken. The major goals of this revision (called BLIPS II) are to in-
crease the efficiency and general izab i I i ty of processing and to enhance the clarity
of documentation. The concept of a standard data package remains; since, in concert
with a standard assessment battery, it has proven advantageous as a method of docu-
menting the single trial and for facilitating comparisons across several trials. In
order that the uniqueness of a trial is not lost, however, a greater degree of varia-
tion within the standard package has been introduced in the form of increased display
and analytic options.
THE PROCESSING SYSTEM (BLIPS II)
The Biometric Laboratory Information Processing System (BLIPS) is a fully opera-
tional, integrated series of computer programs that produce documentation for a vari-
ety of scientific data inputs. Since I967, BLIPS has produced documentation for over
500 clinical drug trials conducted by 80 different investigators and involving approx-
imately 17,000 patients. Based on a common assessment battery and standard documenta-
tion, BLIPS, nevertheless, attempts to minimize the constraints placed upon the invest!
gator.
In its original version, BLIPS consists of numerous programs which were each de-
signed to process a particular form. This created processing and analytic weaknesses
whenever deviations from preprogrammed designs occurred. In 1972, BLIPS was extensive-
ly modified - and designated as BLIPS II - with the following objectives in mind:
1. Flexibility to process any scientific data which may be converted to
computer readable form.
2. Exhaustive verification of data validity.
3. Simplification of external controls to a level at which non-technical
personnel can manage routine system operations.
468
k. Capability to produce a final documentation report tailored to
the investigator's needs.
Acceptable input data may be any type which can be converted into computer read-
able form. At the present, however, most data are recorded on assessment instruments
designed to be processed by an optical scan reader device. Through use of the univer-
sal answer sheet and certain control information, any non-standard assessment instru-
ment may also be entered into the system. The merits of such non-standard instruments
can be analyzed and, if warranted, added to the standard Battery, thereby increasing
i ts capab i 1 i ty.
The verification of data validity is executed by an error detection and correc-
tion subsystem which is called the preprocessor. The preprocessor consists of basic
and specialized functions which detect missing information, duplicate identification
fields, invalid entries and the logical consistency of interrelated items either with-
in a single form or across several forms; e.g., the natural mother's age should not be
less than or equal to her children's ages. When errors are detected, they are correc-
ted via punched cards. These cards contain all the necessary information to locate
the exact field within the data file where the correction is to be inserted and corres-
pond in format to an error listing which is produced as a visual aid. The correction
cards are resubmitted to the system. The preprocessor will then make the corrections
and reprocess the data set. This process is repeated until no further errors are
detected .
To maintain the external control at a level which non-technical personnel can
manage, the transformation and analysis of the data is done via a semi -automated sub-
system called DATRAN. Fixed control information needed to process the data is stored
permanently on disk, while the variable control information, e.g., the number of pa-
tients, the number of assessment periods, etc., is generated via a series of programs
which examine the data as well as the Data Shipment form, completed by the investigator,
In addition to self-generating complex control information, the subsystem will select
the appropriate combination of procedures necessary to fully analyze the data. This
selection is performed by testing criterion variables such as forms used in the drug
trial, number of patients in the study, analysis desired, etc. The subsystem will run
fully automated until new assessment instruments are introduced. Then additional con^
trol information must be generated to process the new entries.
To obtain a final documentation report tailored to meet most of the needs of the
investigator, an output generator subsystem transforms the output obtained from exist-
ing analysis programs. This subsystem provides extensive labeling information; merges
several data sets, and combines the results to facilitate comparisons and make inter-
pretation an easier task for the investigator. An indexed, paginated document is the
final product,
CONTENTS OF STANDARD DATA PACKAGE
The bulkiness of a data package necessarily varies from study to study depending
upon the number of subjects, scales, and rating periods. The output for a given scale,
however, is standardized regardless of the size of a study. For small studies, this
may give the package the appearance of overelaborateness ; while, for larger studies,
the output may seem pedestrian. This lack of precise tailoring is inevitable, however,
in a system which attempts to cover the diversity which exists among psychotropic drug
trials. The usual order of presentation in the data package is as follows:
469
1 . Table of Contents
2. Narrative Summary
3. Patient Listing
k. Data Inventory
5. Demographic Data
a. Adult or Children's Personal Data Inventory
b. Prior Medication Record
c. Children's Symptom History
d. Children's Diagnostic Scale and Children's Diagnostic Classification
e. Patient Termination Record
6. F^ficacy Data
a. Psychiatric Rating Scales; --'-e.g., 028-CG I , 047-BPRS, 049-HAMD, etc.
b. Paraprofessional Rating Scales; e.g., 035-T(i, 039-NOSIE, etc.
c. Self-Rating Scales; e.g., 05^-SAS , 073-SDS, etc.
d. Psychological Tests; e.g., 060-WISC, 062-WRAT, etc.
e. Social Adjustment Scales; e.g., 057-SADJ
"Within each subgroup, scales are ordered by number.
7. Adverse Reaction Data
a. Dosage Record and Treatment Emergent Symptoms (Including 033-TWIS)
b. Laboratory Data
c. Subject's Treatment Emergent Symptom Scale
8. Medical Data
Physical and Neurological Examination for Soft Signs
9. Non-standard Data
Scales are ordered by number
10. Multi-instrument displays
Presentations of data from two or more scales
11. Error Diagnostics
Data displays for the individual assessment instrument are arranged as follows:
Legend
Raw score printout
Computed score printout
Means and standard deviations
Frequency tables
Cross tabulations
Graphic displays
Variance analyses
While not every display is present for each and every instrument, the order of, the
displays is maintained throughout.
The standard package has evolved through the continual exchange of ideas among
investigators, Biometric Laboratory and Psychopharmacology Researcli Branch. Data
displays have been designed to provide maximal acuity and relevance to the clinician.
Information regarding the individual subject as well as the various treatment groups
has been provided in a variety of displays to increase the utility of the analyses
and to provide meaningful clinical comparisons. In the design of the standard data
package, a basic objective has been the utilization of all items in the assessment
battery. Considering the great expenditure in time, effort and resources which goes
into the collection of data, it is obligatory to generate an output which maximally
utilizes the available material. Output has been therefore universally generated on
an idiographic and a nomothetic level - enabling the investigator to follow the pro-
gress of individual subjects as well as to compare various treatment groups.
kyo
There are a number of genera] features in the new package which should increase
i ts ut i 1 i ty .
1. Consistent with legibility, the bulkiness of the package
has been reduced by conserving space whenever possible.
2. Since study protocols and the number of scales used are
not fixed by BLIPS, pagination of the package has been
difficult to routinize. These problems, however, have
been overcome, and pagination is now a standard part of
the data package.
3. Preceding each data subset, i.e., all the data relating
to one assessment instrument, a legend - defining all
terms used in the subsequent displays - is provided.
k. For convenience in comparing treatment groups, equivalent
data displays are juxtaposed on the same page. In earlier
data packages, all displays relating to a treatment group
were located together - making direct comparisons between
groups difficult. Using the cross tabulat i ve display as an
example, the earlier package had the following alignment
on a s ingle page:
GROUP 1
ITEM 1
ITEM 2
The new alignment juxtaposes treatment groups as follows:
GROUP 1 GROUP 2 GROUP 1 GROUP 2
OR
ITEM 1
GROUP 3 GROUP k
ITEM 2
ITEM 2
ITEM 1
^71
EDITING AND ERROR DIAGNOSTICS
The editing of data has been, by far, the most time-consuming element in BLIPS.
The procedure has been complicated by the fact that errors can enter the system by
three avenues: the rater, BLIPS editors and machine (op-scan) malfunctions. Errors
by BLIPS editors have been substantially reduced by shifting the responsibility for
coding the identification block to the investigator. While experience with the
system has reduced errors from all sources, the preparation of data for analyses re-
mains most vulnerable to delays. In dealing with the problem, the central premise
has been to transfer human effort to computer operations insofar as possible. Thus,
there has been a continuous development of editing programs especially designed to
prepare diverse data sets for standard BLIPS analyses.
The frequency of errors attributable to the rater seems inversely proportional
to the length of his experience with the forms. Neophyte raters tend to make a high-
er proportion of errors of commission in comparison to errors of omission. These con-
sist primarily of illegal marks and enscribers, mutilated forms and unidentifiable
subjects or assessment periods. With experience, these correnission errors diminish
and errors of omission remain the primary problem.
The major portion of error detection is carried out by computer programs. An
error is first specifically located, then define'd and space provided for correction
in an error diagnostics listing. Any and all errors are cited even though, in a
specific study, certain items may have been purposely deleted by the investigator.
Number and frequency of errors is summarized for each form and a table of this
summary comprises part of the error diagnostics listing. (Table 37). Both the
quality and quantity of errors serve as bases for the decision whether to proceed
with analyses. A significant proportion of errors in any given study can be corrected
by BLIPS personnel. For example, poorly erased changes or extraneous marks within the
response areas of the forms will often produce multiple op-scan punches. Such errors
are usually readily detectable and can be corrected without recourse to the investiga-
tor. However, BLIPS editors never presume what an ambiguous response should or might
represent. In all cases, resolution of the ambiguity resides with the investigator.
The error citations employed in error diagnostics are defined as follows:
CITATION DEFINITION
Missing I tern or part of item is missing, e.g.,
item requiring 3 digits is encoded with
two.
Illegal I tern requiring only one entry contains
two or more entries or the entry is out
of range; e.g., a 4 is encoded for a
3-point item.
Logical Two or more items are logically inconsistent;
e.g., one cannot be the 5th child of a cohort
of 3. diarrhea and constipation are present
s imul taneously.
Identification Error occurs within the identification block.
Data Error occurs within the data matrix.
472
s
a- o
O LU
2 Q.
O —
Q- (-
II
2 ^
^5
< o
< Qi
P= O
o u.
<
00 =)
CC Q
O —
CC CO
Q£ LU
LU DC
^
o
o —
Q. t/)
o
CO en
?
LU —
II
II
i
&5
— — X
tj
CJ
a:
q:
UJ
LU
Q.
a.
o
Q
z
z
< <
>-
>-
o
o
■z.
■z.
LU
LU
r)
3
o'o'
LU
LU
CC
a:
X. X
X X
X X
Ul >4.
^73
RAW AND COMPUTED SCORE LISTINGS
When the editing process is completed and retrieval of erroneous data accom-
plished, raw and computed scores are generated in tabular form. Descriptive head-
ings; e.g., patient, period and rater numbers, are given along the top of the table:
data are displayed in columns. (Table 38). When possible, items are labeled, but
for lengthy scales, item numbers are used. Spacing between sets of items, e.g.,
every 5, every 10, etc., aids in locating a specific item.
Computed scores are obtained by combining raw item scores according to some
rule or set of operations. Most common are factor scores in which item scores are
statistically combined on the basis of a factor analysis. Empirical clusters; i.e.,
combinations on the basis of logical decisions developed from clinical experience,
are another example. Since many of the scales used in the Pediatric Battery are new-
ly developed, cluster scores will be employed until sufficient data are collected for
factor analytic procedures. Displays for computed scores follow the same format as
raw scores.
MEANS AND STANDARD DEVIATIONS
These displays differ from raw and derived score printouts in that they present
nomothetic (group) rather than idiographic (individual) data. Means, standard devia-
tions and number of subjects involved in their calculations are displayed by period
along the vertical; items by group(s) and total sample appear as headings along the
horizontal. (Table 39). Grand item means and standard deviations for each group and
the total sample are displayed following the last assessment period.
FREQUENCY TABLES
This display is used primarily for categorical data such as demographic items,
descriptive events, etc. Items and their response positions are listed vertically;
frequency and percent of occurrence by group and total sample along the horizontal.
(Table 40) , -Means and standard deviations are also supplied where relevant. Because
of their complexity, some items, e.g.. Family Psychiatric History, require special
formatting or computation; e.g.. Social Class.
CROSS-TABULATION
The purpose of cross-tabulation is to condense and organize data so that direc-
tional changes can be readily detected. The usual comparison is between pre and
post-treatment data although any two sets of data may be compared. The schema below
illustrates some general principles of interpretation. The diagonal (AD) contains
those cells in which patients exhibit no pre/post changes in rating. The upper
triangle, ABD, contains cells in which some degree of improvement is rated. As
cells approach pole B, greater degrees of improvement are implied. Conversely, the
lower triangle, ACD, reflects degrees of exacerbation - greater degrees as pole C
kjk
o —
< <■
XXX
XXX
XXX
h- 0
-1 H
o
<^
_J CO
— LU
Q
> t/1
3 H
C£.
LU .
cf\
0^ LU
t^
CO —
OQ a:
z
o. —
CC •'
CO LU
LU
r3
LU QC
< 3:
s
0 •
CO IXl
a:
^13
z
CC 0
•SL OQ
ixl
0
C3 2
=> 2:
03
CO to
—
Z ■=>
■z.
LU CH
CO
h- C3
■z.
ID
SI LU
CO
2 =5
\-
2
< DQ
<
LU a:
2 Q
Z 2:
■£. Q
LU 0
a:
rs
Q.
1-
— —
LU
2: 2:
Z)
2) CO
H a:
1-
LU
0
< LU
g
H Ll.
CC
en LU
Ol q.
— 0
CD
H 1-
II II
II
II
II
II
\- C£.
1-
CO
0.
CM
< LU
^
LU
CJ3
^
— X X X
^
q; o CM o
LU o — o
0. o o o
CM o
— o
o o
^
— — CM
000
000
his
^K
o
Ll.
to
z: <
Q
■z. a
^ 2
O UJ
3 z
2 <
— 1- a:
o o
Q Q.
1- 3 o
Qi —
< Q- U-
•— h-
z: 3
— s:
^^
o
> o-~.
Z Q£
LU (_> LLl
■Z. D
2: 0
Q 1-
S o
rs
QC <
_J x
Q O —
s: Q-
0 0
a: a:
id^
< 3 Q-
LU UJ
Q < o
z 2 q:
_j q:
Q. —
to Qi
< £>-
3: 1-
2: 0
1- Dc: Q-
co o <
< z
LO liJ
25^ .
L.
X Z LU
O CO
LU
LU — 1
Z Q —
• 3:
Q > Q-
< LU
Q 1-
z — 2:
t- QC
o
rf 0 <
^-~.< ixl
z -J >
— CC
al O
0 LU
3: ZD LU
LU Lj.
tx: LU
wo X
Q-
< QC
_I O
<
Irt < —
C3 P
0 CO H
2 CJ X
z <
0 Q Z
S LU ^^
— s
— 0 LU
1-
Q£ —
S QC
^s
LU Q^ LU
< to
Q- UJ X
Q. LU
^
a. i-
=)-^0£:
x >
X
O Q O
o o
0 _J a:
(T l« O
^ a.
< _i 0
ta^-^irt
LU < U.
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
XXX
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
XXX
XXX
XXX
if76
-^ <
>- O CJ
3 a.
X Q- <
o* ?
UJ Q. O •
OC O (/) UJ
U. O- I—
o <
II z —
< OC
UJ a.
—I to o
s <
X X X X
X X X X
X X X X X X
X X X X X X
— (/> —
a:
_l o o o —
CO o. a. Q. (/) z
«t c/) to «/> to <
— UJ UJ LU — lD o
oc oc oc QC £ z: to
<
^77
Js approached. The cell at pole A contains patients who are asymptomat.ic;
pole B, the zenith of treatment success; pole C, the nadir of treatment
failure and pole D, the "untouchables" - sickest at pretreatment and sick-
est at posttreatment .
PRETREATMENT
PRETREATMENT TOTALS
Table 4l represents a cross-tabulation of the BPRS symptom, Somatic Concern.
The distribution of 15 pre and pK)st treatment ratings on a 7-point scale ranging
from Wn PRESENT to EXTREMELY SEVERE is shown. Pretreatment scores (presum) are
read horizontally; (7 = Not Present; 2 = Very Mild; k = Mild, etc.); posttreatment
scores (postsum) vertically (8 = Not Present; k = Very Mild, etc.). The diagonal
of the matrix is emphasized by underlining. Scores which fall here reflect static
scores, i.e., scores which remain at the same intensity level at both ratings.
When both pre and posttreatment scores are "NOT PRESENT", this is designated as
asymptomatic. Asymptomatic is, of course, a variant of a static score and, in the
example, there are 4 asymptomatic subjects. Any scores above the diagonal represent
improvement; any below .represent worsening (increased severity). Three subjects,
for example, changed from "Mild" at pretreatment to "Very Mild" at posttreatment.
One subject changed from "Not Present" at pretreatment to "Moderately Severe" at
posttreatment - a change of k points in a negative direction.
478
rf —I X
£ LU
\- ca -Zi
UJ O
JJ < p
J} —1
o
oo
h-
</)
—
3C
CO >
_
CO
>
2
1-
o
1-
1—
1
>
1—
—
z
1
o
CD
o
LU
0
CJ 1-
0
CJ
t-
LU
a:
LU
UJ
2:
CD
LU —
CC
LU
<
CO
LU
Q
—3
1—
— )
<
,-^
-3 CO
Q-
—5
C3
o:
OQ
UJ
CO
<
CO
CO
K
LU
OQ 0
2:
CD
LU
0
X.
z
r>
Z3
<
C3
=> Q-
ID
■z.
3
CO
ID
—
CO
Q.
CO
h-
Z
00
^ — '
CO
\-
z
<
Z CO
<
>-
^
C3
0
h-Qi_JLU_lQig-SQOg-9c:i — o
h- I— ef ^) <£ LU LU — LU CO
tOLUf— col— O ' \— al 'I— ZO
ODiO^OcoO<;LUO<:LU2
Q-O-l— col— <2£Q-22|— ^-'
< CQ LU
Z _J O LU
O _] 3
— 3: O
Q :s I- -I
LU —
o J- 3 z
^o -
D- Z • Qi
< CO <
LU Z LU
CD r<~i O O-
— a.
Z D. I- <
< 2 —
O O CO — I
□i o _i
CO t3 Q. —
CD S
< -H
h- CO X LU
CO D_ CJ — I
(/5 ID — OD
O O CC <
Q£ q: —
CD tS Q Qi
^ <
-J- OJ < >
CO LU — Q
CO < LU
>■ I— CO
-i > a: CO
LU LU _J LU LU
I— I— UJ O CO
<; < LU z: CO CO
cc cc a: LU <c <:
O LU LU LU q:
— I Q Q > h- I— I—
— O O UJ X o o
2: s: z: CO UJ z z
CO Z c» -J- — — —
CO <
- tJ
CC CO
0
H 0
< 2:
C3 —
— H
CO S
LU
^
> 0
z —
0.
— Qc:
C3
1-
<
<oooooooo|o
z
COOO o o o o o|o o
LU
>o o o o o o|o o o
10
coo o o o o|o o o o
0<NOOO|OOOOCsJ
molo o o o oj-
S— — lOOOOOOcM
>
c-d-l o — — — ooor^
Q-2: — oco>co<rD
z>X2:s:coLuzco
QLOCOI-I— Q£LU<|-:SLUZ|—
h-JS
Cross-tabulation accomplishes data reduction and facilitates interpretation of
group results without losing sight of the individual patient. The exact nature of
changes between two ratings can be followed in detail irrespective of sample size or
tests of significance. Cross-tabulations can be examined to ascertain whether the
result is due to modest unidirectional changes in a large proportion of the sample
or to dramatic changes in a few individuals. Noting bipolar changes, the investiga-
tor may find that specific subgroups are responding differentially under the same
drug condition. It should be remembered, however, that cross-tabulation involves
comparison between only two ratings. Investigators are cautioned that changes may
have occurred at other points in the course of the study, e.g., pre vs. posttreat-
ment ratings will not reveal changes which occur at the midpoint of a study. Perusal
of other data sets; e.g., means and SD, variance analyses, will alert the investiga-
tor to the possibility of change not revealed in the cross-tabulations.
GRAPHIC DISPLAYS
These displays are of two types. The first presents data derived from a single
assessment instrument in unaltered raw form. Only the format is changed to facili-
tate rapid assimilation of results. In Figure 26 pre and posttreatment factor means
obtained from a hypothetical scale are shown and, further, data for 2 treatment groups
are juxtaposed - greatly increasing the usefulness of the display. Graphics of this
type will be employed in BLIPS II to a much greater extent to present, in addition to
the traditional pre-post differences, data from diagnostic instruments; e.g.. Children'
Diagnostic Scale and from analogous instruments; e.g., Depression Status Inventory vs.
Self-Rating Depression Scale; Parent vs. Teacher Questionnaires, the 10 common items
from each, as rated by the parent vs. the teacher.
The second type of graphic involves the conversion of data from several assess-
ment instruments into standard scores and their presentation in one composite display.
Conversion into standard scores, of course, does not alter the relative magnitude of
data while permitting instruments with differing scale points to be plotted together
for rapid comparison. (Figure 27). Routinely, standard scores will be based on sam-
ple parameters. For each variable, the sample mean and standard deviation will be cal-
culated and a standard score, for each treatment group derived on that basis. The for-
mula for conversion is:
Group Standard Score = 50 + 10 (Group Mn - Sample Mn)
Sample SD
Norms for various research populations are currently being constructed for most of
the standard ECDEU assessment instruments and will be employed in future BLIPS docu-
men tat ion.
480
I
« 1
0) in
O
Ql a.
: }
* I
I -
i t
I i
i !
o
u.
II
I :
I -4
5 ■
481
»- < a: Ci <
Ck lu >
— o i «i
uj <;
DC -J
ID O-
(J3 LO
'
482
DATA INVENTORY
The Data Inventory serves two purposes:
1. For an individual study, a subject by subject itemization of each
form present in the data matrix.
2. Across studies, the source material for a cumulative inventory of
the contents of the ECDEU data bank.
Table ^2 illustrates the display provided for the individual study. The dots indicate
"present" - the crosses "absent". Totals are provided for each form by subject, assess-
ment period and grand sum. The inventory gives the investigator an accurate picture of
the magnitude and distribution of his data matrix and provides a basis for decisions on
further data transformations or analyses.
Cumulative inventories are generated across all studies in the ECDEU data bank. The
number of forms, subjects, studies and items is summed for each rating scale as well as
across all scales. This display - while not part of the standard data package - provides
periodic information to members of the ECDEU program regarding the magnitude and distri-
bution of the total data bank at a given time and, in conjunction with preceding inven-
tories, an estimate of the rate of growth of the bank. It also provides a general esti-
mate of the amount of data available for any particular research purpose.
THE ANALYTIC COHORT
Preceding each statistical analyses, a listing of subjects excluded from that anal-
ysis along with the reason for exclusion is given. (Table ^3) . The display continues
with a listing of all subjects included in the analysis as well as the periods and raters
used. Specification of the analytic cohort has proved to be highly desirable for inter-
preting the results of any statistical analyses performed.
NARRATIVE SUMMARY
The Narrative Summary provides the investigator or reviewer with an overview of the
study. Though brief, it contains sufficient detail to enable the reader to grasp the
essential nature of the study and its results. As with all other segments of the stan-
dard package, the Narrative Summary is non-judgmental and contains only statements based
directly on the data received and the analyses performed. Final judgment as to the clin-
ical meaningful ness of the data or the efficacy of the drugs involved remains entirely
with the investigator. Narrative summaries consist of four paragraphs:
1. Description - Data are derived from the Research Plan Report and
consist of details of the research design, the drugs and dosages
employed and the research procedures.
2. Efficacy - derived primarily from variance analyses. All statis-
tici^lly significant findings - or their absence - are cited for
each of the psychopa thol og ica 1 rating scales employed.
3. Toxicity - Derived primarily from Dosage Record and Treatment
Emergent Symptom Scales. Toxicity is described in terms of the
number and kinds of symptoms evolving under each treatment condi-
tion, as well as the clinical actions necessitated by the emer-
gence of such symptoms.
k. Demography - Derived primarily from the Adult or Children's
Personal Data Inventory. Distributions for a number of pertinent
demographic variables are given for each treatment group.
483
~i <
0
0
2:
CQ P
0
0
3
=> O
^
—
z
1/5 1-
q:
CC
LlI
LLI
—1
>- Z
CL
Q.
<
ca X.
1-
=)
1-
1-
0
2: -J
C£. 0
^^
1-
0 0
1-
K
LU
Ll. — -
a:
11:
QC
1-
^ lU
0
0
0 _J
Ll.
Ll.
1-
^^
1-
CJ
z
LU
<
■z.
Z
CO
</> to
LU
—
LU •
_J
(/)
tn
a: 0
< >-
LLI
CO
Q. 0
P CD
CC
^
^
0
a.
z:
CO a:
h- Q
LU LU
Z
z:
z
_l Q-
> <
a:
Qc:
00
ck:
0
0
< :e
0.-V
u.
u.
1- CJ
1- -1
2 <
II
II
^^
UJ P
a:
> 0
•
X
€g
Z 1-
2: u-
5
3
LU 0
CO CO
X on
3:
txl oC
I o
I- u-
|_ o o
o 3 o _
— <N»X w— -^S
484
LU LlJ
_ CO
. LU
o ^ ^
I I I
o "^
^>
o _ ^ —
<£ Lr\ LA LA LTV
z:
<
Q.
o o o o
o
a:
1—
X
X
a:
LU
<
X
X
Ll_
CO
a.
X
X
Q
LU
<
Q
>-
1-
■— — CNI CN
Z)
m
<
O o o o
_I
a.
o o o o
C_)
o
X
LU
485
COMMENTS ON STATISTICAL PROCEDURES
P. A. deary and K. Yang
This discussion is divided into three areas. The first deals with the
repeated measures analysis of variance and the use of stricter criteria in
detecting significance for the within-subject variables. The second part
concerns the multiple comparisons problem. By focusing on two methods it is
expected that the decision to use a particular technique will be made clearer
to our audience. The last section is an explanation of the displays of the
statistical methods just discussed.
Those statistical techniques previously introduced in BLIPS I are not
discussed here. These comments are not intended as definitive but only as
guidance.
Repeated Measures Model
A popular research design in psychoJDharmacolog ical research is the analy-
s i.s of variance model in which a single dependent variable is measured on more
than one occasion on the same subjects. This is often called a repeated measures
analysis of variance. Several authors (1, 2, 3, ^) have discussed the problems
which arise when this type of analysis is performed. One of the more serious
problems is the distortions of p levels and confidence levels caused by the
heterogeneity of covariance. The conclusions drawn are that multivariate tests
are exact with repeated measurements but in many instances the n is too small.
It is suggested that the Greenhouse-Geisser three step procedure might be most
useful. However, even this approach is discouraged i f yO (populat ion correlation)
is not constant or relatively constant over treatments. That is, the assumption
of homogeneity of covariances between repeated measurements must be met. When
the design involves more than one factor the covariance assumptions are more strin-
gent. For example, in a two-factor experiment in which factor A with levels a^ and
32 is not repeated but factor B with occasions b, , b2. b., and b. is repeated, two
covariance assumptions must be made. First, the matrix of variances and covariances
among the several repeated assessments (b, through b^^) must be the same within each
level of the nonrepeated factor (the matrix must be the same within a, as within 32).
Second, the covariances pooled across levels of the independent factor must be
homogeneous. Procedures for testing these assumptions are given by Winer
(1971, pp. 594-599).
Figure 28 outlines the Greenhouse-Geisser procedure when employing univariate
analyses of repeated measures; (a) Use the regular degrees of freedom for the F tests
on the repeated factors. If the result is not significant the analysis is completed.
Clearly, if the obtained F value using the conventional degrees of freedom is not
significant then there is no need to examine the effect further using the more con-
servative test. (b) If the result of (a) is significant the most stringent test is
employed. The degrees of freedom for the numerator and denominator of the obtained
F are multiplied by the inverse of the degrees of freedom for the wi th in-subjects
variable. If the obtained F is still significant the analysis can stop at this point,
486
FI.GURE 28
GREENHOUSE-GEISSER PROCEDURE
^* Test Main Effects in Repeated Measures Model
b.
Not S ign i f icant
S ign if icant
i
Stop
Conservative test with reduced df^
\
Not Significant
S ign if icant
i
Stop
c. Use Univariate Apisroximate F test of Box
Need var iance/covariance matrix to get £^
487
(c) If step (b) indicates a lack of significance the researcher may try the
Box approximate F test in which ^, a function of the heterogeneity of the
variance and covariances, must be calculated. The degrees of freedom for
the numerator and the denominator for the obtained F are then each multiplied
by this function. These degrees of freedom will lie in the middle of the
most liberal and the most conservative sets of degrees of freedom.
The Greenhouse-Geisser procedure is routinely applied in the analysis of
Var iance-covar iance program (AVACOV) used in ECDEU analyses with the modifica-
tion that the Box approximate test is not used. When an obtained F is signifi-
cant at the .05 level, main effects and interactions using repeated measures
are further tested using the reduced degrees of freedom. If they still indi-
cate a significant result a (-v) is printed. A ( ) indicates significance was
not reached using the conservative degrees of freedom. At this point the pro-
cedure stops.
When a two-factor experiment in which factor A with levels a. and a is
repeated as is factor B with occasions b,, b2, b,, and b/^ AVACOV cannot 5^ em-
ployed. In this type of design the Statistical -^Analysis System (SAS) procedure
entitled Analysis of Variance and Covariance is employed." The model includes a
subject by factor A interaction, as well as a subject by factor B interaction,
and also a subject by factor A by factor B. These interactions are employed to
test the main effects A and B and the AB interact ion. 9 In the last section the
output from the AVACOV and the SAS procedure will be explained in more detail.
Multiple Comparisons Techniques
When an analysis of variance indicates a significant difference among two
or more means, paired comparisons aid the researcher in determining which differ-
ences contribute to the overall significance. It is generally agreed that the
use of t-tests to carry out all possible two-group comparison produces a high rate
of erroneous conclusions. Aside from this there is no consensus among statisti-
cians about the multiple comparisons methods most appropriate. Any single test
of a comparison has probability of a type 1 error. However, as the number of com-
parison increases the probability of at least one type 1 error increases. The
usual ^level , the probability that a single comparison results in a type Terror
is referred to as the error rate per comparison (EC). The probability tha^t an en-
tire set of comparisons contains at least one type 1 error is called the error rate
experimentwise (EW) . What is needed is a technique to adjust the EC downwards as
the total number of comparisons increases and adjusting in such a way that the
change in the number of comparisons does not alter EW. The literature is replete
with proposals for dealing with the multiple comparison-error rate problem. How-
ever, only the Scheffe and the Tukey A or HSD (honestly significant difference)
techniques hold the EW as T^for the entire possible set of contrasts. The Scheffe
method is very conservative and it is possible that a significant test of main
effects will not be followed by at least one significant contrast. The power of
the Scheffe test is equal to that of the overall F test only when detection of the
maximum possible contrast is at issue. Scheffe recommends use of Tukey 's B method
where sample sizes are equal and only paired comparisons are made. The Tukey B
method fixes experimentwise error rates at conventional levels. This method is
affected by those violations such as unequal sample size, unequal variances, non-
normal populations to the degree that they also influence the obtained F value.
488
Tukey B method is based on the distribution of Q, the studentized range
statistic. It is a compromise between the Tukey A which like the Scheffe
yields too few significances and the Newman-Keuls which can give too many
erroneous results. Briefly the procedure followed is:
Critical Value
(K,df) + Q (r
.df)]
/ 2
K = number of means in entire set
r = number of steps between the two means being compared
df = degrees of freedom for appropriate error term
Qr = M.
MS
/ n
if ri; are not equal use the harmonic means of the n.'s in the set
Qr
Mi
MS
is the test statistic and is known to have a distribution
known as the studentized range. Q.r must be greater than
the critical value for significance to be indicated
and M. are means for the two levels being compared
is the mean square for the error term used in testing
error
the effect
The treatment means are ordered from the lowest to the highest. In BLIPS II
output, these differences are given in the lower half of a matrix on the right in
which the upper half is occupied by the Qr statistics. Table kO of the sample
output display shows the treatment's means differences and the Qr statistics for
the study effect. The number 4.05 is the ratio of
1.8333 - 1.3351 /
1.1358
where n = harmonic mean = 75.0750
The critical value for means two steps apart is 3.31 which is the average of
the critical values for means 2 steps apart and 5 means in a set
Critical Value = (2.77 + 3.86) / 2 = 3.31
These values are given in the lower half of the matrix on the left of page 485. The
top half of matrix consists of " for those Qr's which are greater than the corres-
ponding critical value. In our sample output on page 485, 5 studies are compared.
The first comparison is treatment 1 versus treatment 4. Since the obtained Q of 5.96
is greater than the critical value of 3.86 an asterisk is placed in the upper portion
of this matrix. In reading the significances we can discover that study 1 is signifi-
cantly different from the other four but they are not different from one another.
489
SAMPLE OUTPUT
AVACOV
AVACOV (Analysis of Var iance-Covariance) is a modification of MANOVA.
Tiiis program can perform analyses of variance on models consisting of four
factors each with ten levels. It has the ability to analyze repeated mea-
sures on one factor only. Analysis of covariance can also be performed.
Additional features consist of:
1. Detection of F-Ratio's significant at the .05 probability
level - with asterisks indicating significance.
2. Multiple Comparisons - Tukey B Method - run when main effects
are significant at .05 level.
3. Means, standard deviations, and variances are output options
for main effects and for interactions.
4. For the repeated measures designs when the main effects and/or
interactions are significant they are tested again against the
Greenhouse-Geisser conservative criterion. If they are still
significant an (") is assigned.
Tables 4^ ,45 , and 46 are sample outputs of AVACOV. The variable is the
depression factor of the BPRS scale. (The design is 5 studies by 2 drugs by
3 periods) - where the 3 periods represent repeated measures. The source table
is displayed in Table 44. Df represent degrees of freedom. The letters placed
next to the appropriate df are there to illustrate which df are used to form
which Mean Squares and which Mean Squares form which tests or F-Ratios. The "
under Sig (.05) are significant using the table df. The (-) under the Sig (.05) ■
GG Column where GG means Greenhouse-Geisser are indications that the effect is
still significant using the stricter criteria of fewer degrees of freedom. We
can see that three significant effects were obtained and that two of these three
were still significant after testing with the stricter criteria. The df for this
design are defined below the source table.
The significant main effects, that is, studies and periods, are reexamined
via multiple comparisons in Table45 . The mean and standard deviation are pre-
sented for each study - they represent the cumulation across both drug groups and
all three periods in the first study. The matrices which contain the multiple
comparison statistics were explained earlier. The means and standard deviations
for the two drugs represent 213 different entries for the I NV group and 210 for
the Kontrol group; 213 represents the summing across the five studies and three
rating periods; 210 represents the summing across the five studies and three
rating periods for all the control subjects. The means and standard deviations
for the period levels cumulate across drug and study. The multiple comparison
for the significant period effects indicates that periods 2 and 3 are different
from period 1 but not from each other.
490
Table 41 displays the last page of the AVACOV output which is the cell means
and standard deviations. Cell III represents study 1, I NV drug period 00; cell
523 represents study 5, Kontrol drug and period 02.
SAS Output
When the design of the study calls for a repeated measures across two factors -
as in a rater by period design - then AVACOV cannot be used. A special analysis
has to be performed and as an example of special analyses, the ANOVA procedure of
the SAS, Statistical Analysis System will be given. The program allows the research-
er to specify his own model and also the error terms he wishes to use to test various
effects. In our example, a two factor repeated measurements design - rater by period
we wish to use a subject by rater to test rater effect, a subject by period to test
period effect and a subject by rater by period to test a rater by period interaction.
Table 47 displays the source table for ANOVA. Again we are looking at BPRS factor,
depression, whose mean is 1.81. The differences in this table from the source table
of AVACOV are:
1. Corrected total is listed under source - its df and sum of
squares are the sum of source items 1 -7 df and sum of squares.
2. LSD .01 - least significant difference at .01 and LSD .05 -
least significant difference at .05 level. Any two means
whose difference exceed this value are declared significantly
different. This is another approach to the problem of regulat-
ing and apportioning the type 1 error rate."
3. The tests of interest can be isolated in such a way that there
is no confusion as to which error term was used. The probability
associated with each F-Ratio is given. In our example we see
that a significant rater effect is present with the probability
of obtaining a F-value as large or larger of only .04.
This program expands the analytic facility of BLIPS \\. In the future new
statistical techniques which are routinely used in the output package will be re-
viewed and explained in a similar manner.
491
<^
s
O 1^ ^'^ pi^ o^
00 oa CM m o
-:l- 00
J- 00
o —
— r^ J- — CO cr\
— *
o
J-'
O
r^
O
a^
II
II
II
II
II
II
II
CM
CM
CM
w—
—
CM
■^
^
^
~V
•^
^
\
f»-»
J-
LTV
vD
1^
00
en
CSl
fv^
-f
LA
vO
r-~
00
(Tl
1 II
II
II
II
II
II
II
II
C OQ
O
o
LLl
u.
o
I
■: \
■^
^
^
\
-^
~-^
^
-> ^
_J
2:
Z
o
Q-
CD-
Qi
3 VD
00
(T\
vO
vO
ro
or\
CM
r\ 00
LA
1—
J-
CM
00
r-
CM
r\ o^
-i-
CM
rv~>
CM
CM
O
CSJ
<v->
00
rA
O
CTi
o
O^
00 ^ CM
(/) O Q-
<4- M- H-
o o o
^ ^ ^
II li II
ta X —
13 13 —
XXX
J-
o*
CM
00
OA
00
vf)
a^
vo
vD
p^
vO
CO
PA
vO
00
OA CA CA OA
OO 00 CM OA
UA — LA
II II II
O LLl Ll.
— CMOOJ-OOCvlJ- — CM
PA vD
— CM
O to
H LU
^i
O to —
CO <
(_> O LLl >—
— LU OQ
OC I- Z
K <; r>
LLl lD z
£ O- LU
o LLl z: — I
— OC LLl OQ
OO — I <
to 00 —
iLi QC o q:
X Q- Q£ <
I- BO 0- >
lO —
— to
to to
to to to
U-
II
<
— 3:
X X
< —
II II
CO o
492
LA — '
— X
LTV OC —
— I- Qi
— X
QC —
I- QC
(^
vO
vO —
3;
CM
O CM
cc
-d-
O O
a.
a.
LA
ro cr»-3-
Z
eg
O
O O Cvl
—
000 CO
o CM cr» cA —
LA LA Lf\ r^ I—
. • . . <
0000 I—
e
CA 0
±
r^o
LA LA
Q_ Ixl
a. 3
=) 0
_i
z
CA
OA
— z
r^
CM
<n
0
0
0 to
— LLl
1- 0
to 2
— Ixl
rA\£)
H Q£
0
CM
P U.
0
0
to a.
1 —
CO
^
— CM rA LA-d"
^
^
— to
z
UJ u)
000 — 0
— CA-:}- CTv —
LA OA (7\ CO PA
PA rA LA <.0 CM
rAOO <x> o a^
X X
1- H
i$
— CO
CC Dd
PA LA
UJ LLl
Q. 3
PA PA
a. 0
=3 —1
2 z
— vO
LAvO CTi
so-*
o^ cr\ LA
— 00 j-
r^r^
CO LA CM
PA LA 1^
--^ to
-;; LLl
vO r^
CO vO vO
PA PA PA
UJ _J
— <
— CO J- VO
Li. 0
PA LA r^oo
— -^
• • • •
Z 1-
PA 0
f— ^ ^
PA PA PA PA
t3 — :
1— 1—
-*-a- -d-
— Qc:
CM CM
^- ^— ^
to 0
Q- — ^« •!«
X X
a: a:
I- 1-
^f
li. Li.
—I _l
Q- 3
Q- O
3 -J
PA LLl _J
J- — —
O PA Z I—
. . t3 —
PA PA — CC
to O
— CM PA-d" LA
>- -J — I _l — I — 1
O LU LLl LLl LU LLl
3 > > > > >
— CM PA LA J-
•— CM to — CM PA
CJ UJ UJ — UJ UJ LU
=> > > OC > > >
Q^ LU UJ UJ UJ UJ UJ
O _l _J CL —I -J — I
493
^
^
00 ^ 00
LA O^ CNJ
O O —
— O ^
o — ^ o
00 —
o ^
— ^ CM
CSI — —
cr\ —
CM —
O vD
^
O CM
— o
^ CM
cr\ —
CSI —
— _ CM
or\ .— CM
CM — —
-:t LA LA
1^ vO
ViJ
CA
CM
PA
LA
CM
LA
CM
CA
CA
LA
o^
CA
(J\
CM
1—
\o
en
vO
,—
r^
CA
00
VD
m
^
(T>
vO
\o
o
00
ai
CM
O
r^
VO
r^
O
cn
r~^
J-
1^
S^
CM
CM
CM CA — CM CA
CM CM — — —
' — — CM CM CM
ksh
00 LTi CTl
ro f»^ vo
r<~> — CO
cr\ ir\ cr\
CT\ C^ rr\
^ :=
r^
Lr\
00
o
-d-
o^
o
00
LA
00
CM
r-~
rr\
ro
CM
rr\
vO
00
J-
La
J-
LU
—
00
:?
00
:?
00
rA
rA
<
:?
J-
, —
-j-
1 —
ro
<T\
r^
00
(j\
r^
00
o
3
■J-
0^
,
-d-
1^
cr\
r^
LTv
r^
LA
00
cy
■4-
^—
,—
J-
r--
cr\
cr\
1 —
CTl
OA
r-^
O^
rA
00
^
rA
,—
a^
r^
00
vD
OJ
ri~i
vD
CN
rA
LA
o\
vD
—
C-J
vO
CT\
\o
oo
LA
^O
CO
LA
O
c-J
^
c^
o
o
O
O
—
O
O
^
o
—
O
o
i:^.
00 CO rA CM <vl
PM
CM
\D
CM
CM
\0
CM
CM
vO
CM
CM
vD
CM
CM
vfi
CM
vO
CM
_
J-
r^
CM
<—
< —
00 — VD CT^
OO J- — -It CM 00
CM CM r^ o^
rg CM vo oo
CM ^ CM
vf)
00
vn
a)
vO
00
^o
00
o"
— CM VD
CM — —
vD
vO
^ °
OD D£ I— Q£ 00 CD
=> LLl < LLl => 3
(/) a. £ 0. CO (/>
•— CM CA J- LA so
o q: o
— o —
UJ Q£ LU
ex: a:
O LLl
ai (-
Qc:
^ LLl ^
o en
— LU
Q£ O OC
O — LU
oc a: H
a£ uj <
^95
REFERENCES
1. Gaito, John. Repeated Measurements Designs and Tests of Null
Hypotheses. Educational and Psychological Measurement, 1973, 33,
69-75.
2. Gaito, John. Repeated Measurements Designs and Counterbalancing.
Psychological Bulletin, 1961, 58, 46-5^.
3. McCall, Robert B., and Appelbaum, Mark I. Bias in the Analysis
of Repeated-Measures Design: Some Alternative Approaches. Child
Development, 1973, ^^, 401-415.
ko Geisser, S., and Greenhouse, S. W. An Extension of Box's Results
on the Use of the F Distribution in Multivariate Analysis. Annals
of Mathematical Statistics, 1958, 29, 885-891.
5. Greenhouse, S. W. and Geisser, S. On Methods in the Analysis of
Profile Data. Psychometr i ka , 1959, 2k, 95-112.
6. Winer, B. J. Statistical Principles in Experimental Design. (2nd ed.)
New York: McGraw-Hill, 1971.
7. Petrinovich, Lewis F. and Hardyck, Curtis D. Error Rates for Multiple
Comparison Methods: Some Evidence Concerning the Frequency of Erroneous
Conclusions. Psychological Bulletin, I969, Vol. 71, No. 1, 43-54.
8. Bau, A. J. and Goodnight, J. H. Statistical Analyses System (SAS),
North Carolina State University, 1971.
9. Myers, Jerome L. Fundamentals of Experimental Design. Boston: Allyn
and Bacon, I966.
10. Guy, W.'and R. R. Bonato, Manual for the ECDEU Assessment Battery,
National Institute of Mental Health, DHEW, July, 1970.
496
059 RCR
RESEARCH
COMPLETION
REPORT
DEPARTMENT OF HEALTH, EDUCATION. AND WELFARE
DO NOT WRITE IN THIS BOX
PUBLIC HEALTH SERVICE
ALCOHOL, OF)UG ABUSE. AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
UNIT/STUDY NO.
PSYCHOPHARMACOLOGY RESEARCH BRANCH
RPR NO.
RESEARCH COMPLETION REPORT (RCR)
RCR NO.
GENERAL INSTRUCTIONS
The Research Completion Report (RCR) is a companion form of the Research Plan Report
(RPR). In contrast to the RPR's emphasis on the planning phase of research, the RCR is
designed to collect data on the results of the study and the investigator's interpretatiofjs an^
conclusions in a format suitable for computer processing. The two forms — in concert — will
provide a better understanding of the research process qua process as well as document the
specific study. The investigator is asked to make every effort to complete the form according
to the instructions. If aspects of the study cannot be described appropriately under ^ given
item or if the space provided is inadequate for your response, please describe the details on a
separate sheet and attach to the form. Specific instructions for this form (RCR) ar^ given
on pages 13, 14, and 15 and should be read PRIOR TO COMPLETING THE FORM.
I. IDENTIFICATION
NAME OF INVESTIGATOR/S
TITLE OF STUDY
PLANNING PHASE
DATA COLLECTION PHASE
ANALYTIC PHASE
Initiated
CorT\pleted
Initiated
Completed
Initiated
Completed
Mo. Yr.
Mo. Yr.
Mo. Yr.
Mo. Yr.
Mo. Yr.
Mo. Yr.
DYes
DYes
1. Has a Research Plan Report (21-RPR) for this study been submitted? .... 1
2. If YES, give Unit and Study numbers assigned
If NO, please complete ^n RPR for the study.
3. Is this RCR a revision or modification of a previously submitted one? .... 1
If you concur, the Research Completion Report which you submit - in conjunction
with the Research Plan Report - may be released to the scientific community in the
form of a short narrative description of the study. Chemical formulae may be held
confidential even if other information is released.
4. May data on this form be given to the scientific community? 1 Q Yes
5. Should chemical formulae be held confidential? 1 D Yps
6. Have data from this study been sent to the Biometrlc Laboratory? 1 □ Yes
7. If NO, will data be sent? 1 D Ye$
Mail this completed form to:
ECOEU Data Analyses
Biometric Laboratory
George Washington University
11501 Huff Court
Kensington, Maryland 20795
2 a No
2nNo
2nNo
2nNo
2nNo
2nNo
MH-9-59
12-74
FORM APPROVED
0MB NO. 68-R965
498
DO NOT WRITE HERE - FOR BIOMETRIC LABORATORY USE ONLY
DO NOT
UNIT
NO.
STUDY
NO.
REVISION
FORM
RECEIPT
Mo. /Year
RPR
NO.
STATUS
ALL CARDS
Col.
17 18
Code
CODE:
59
CARD
COLUMN:
2A
5-7
8-9
10
11-12
13-16
75-78
79-80
01
II. DISPOSITION OF STUDY
1. Was the study (as a whole) discontinued before its planned completion?
1 □ YES
2 n NO
Abbreviated?
1 □ YES
2 □ NO
3. Significantly modified from original protocol (other than by abbreviation)?
If answers to 1 , 2, and 3 are all "NO", go to Item 7.
1 n YES
2 DnO
If YES to any of the above, was the decision to discontinue/abbreviate/modify made by:
(Check all applicable)
01 n Investigator 03 CZI Government regulatory agency
02 □ Pharmaceutical Firm 04 □ Other (Specify):
22-23
24-25
26-27
What was/were the reason/s for the disposition?
01 CH Ineffectiveness of drug/s
02 D Occurrence of adverse reactions
03 d Withdrawal or reduction
of financial support
(Check most important. Maximum of 3):
04 n Loss of key personnel
05 CH Problems in obtaining population
06 n Other (Specify):
28-29
30-31
32-33
If the Study was abbreviated or modified, what was/were the procedure/s?
(Check most important Maximum of 3):
01 n INCREASE
02 □ INCREASE
03 n EXTENSION
04 □ ADDITION
05 □ ADDITION
06 □ EXPANSION
13 n Other (Specify):
07 n DECREASE
08 n DECREASE
09 n REDUCTION
10 n REDUCTION
11 D DELETION
in sample size
in dosage
of duration of treatment
of frequency of assessment
of assessment instruments
12 CH CONSTRICTION of population (by diagnosis, age, symptoms, etc.
34-35
36-37
38-39
II
. RESEARCH PLAN
7. Was the research plan satisfactory to test
the study hypothesis/es?
Not
Applicable
Definitely
NO
Inclined
to say
NO
Undecided
Inclined
to say
YES
Definitely
YES
40
0
2
3
4
5
7
DURATION
0
2
3
' 4
5
41
8. Was the duration of the drying out period
satisfactory?
9. If NO drying out period was employed in the
study, do you, in retrospect, believe one
should have been employed?
0
2
3
4
42
9
10. Was the duration of the drug administration
period sufficient?
0
2
3
4
5
43
10
1 1 . Was the duration of the followup period
sufficient?
0
2
3
44
11
1 2. If NO followup period was employed, do you,
in retrospect, believe one should have been
employed?
0
2
3
4
5
45
12
1 3. For crossover designs, were any of the treatment
sequences of insufficient duration?
0
2
3
4
5
46
13
14. For crossover designs, were there significant
"carry-over effects"; i.e., one treatment
affecting the subsequent treatment?
0
2
3
4
5
47
14
MH-9-
12 74
^99
DOSAGE
Not
Applicable
Definitely
NO
Inclined
to say
NO
Undecided
Inclined
to say
YES
Definitely
YES
Col.
Do you feel that optimal dose levels for the
test drug/s were attained in this study?
Code
15. Test Drug No. 1
0
1
2
i
4
5
48
15
16. Test Drug No. 2
0
1
2
3
b
49
16
If the answer to Item 16 or 16 is box 1, 2, or 3 check reason/s for your judgment.
(Check most Important. Maximum of 3):
17. TEST DRUG NO. 1 18. TEST DRUG NO. 2
01 n Initial dosage too low 01 CD Initial dosage too low
02 n Dosage increased too slowly 02 d Dosage increased too slowly
03 d Effective level never reached 03 d Effective level never reached
04 D Dosage increased too rapidly 04 D Dosage increased too rapidly
05 CD Initial dosage too high 05 CD Initial dosage too high
06 CD Effective level exceeded 06 CD Effective level exceeded
07 D Other (Specify below): 07 □ Other (Specify below):
50-51
52-53
54-55
17
56-57
58-59
60-61
18
FOR TEST vs. COMPARISON DRUG STUDIES:
Not
Applicable
Definitely
NO
Inclined
to say
NO
Undecided
Inclined
to say
YES
Definitely
YES
62
Was the comparison drug/s utilized in the study
aptly chosen; i.e., did it closely resemble the
test drug in clinical action?
19. Comparison Drug No. 1
0
1
2
3
4
S
20. Comparison Drug No. 2
0
1
2
3
4
5
63
20
21. For Test vs. Comparison drug/s: Was dosage
equivalence among the drugs achieved?
0
1
2
3
4
b
64
21
22. If the answers to items 19, 20, or 21 were box 1, 2, or 3, please describe difficulties:
65-66
67-68
69-70
22
IV. RESEARCH EXECUTION
23. Were there problems in the execution of the
Not
Applicable
Definitely
NO
Inclined
to say
NO
Undecided
Inclined
to say
YES
Definitely
YES
17-18
CARD
02
study, i.e., in the conduct of the trial and
collection of the data?
0
1
2
3
4
5
19
23
DOSAGE ADMINISTRATION
0
1
2
3
4
5
20
24
24. As a consequence of its form; i.e., tablet, capsule,
etc., were there significant problems in dispensing
the Test Drug medication?
25. Were there significant dosage violations by the
subjects or their families, i.e., not taking specified
amounts, taking prohibited medications, lapses in
medication, etc.?
6
1
2
3
5
21
25
26. Were there significant dosage deviations by staff
in violation of the protocol?
0
1
2
3
4
5
22
26
CONTROL PROCEDURES
0
1
2
3
4
5
23
27
27. Were there significant violations of blind
conditions by the subjects/families?
28. By the staff?
0
1
2
3
4
5
24
28
29. Was there significant introduction by staff of
other drug therapies in violation of the protocol?
0
1
2
3
4
5
25
29
30. Non-drug therapies?
0
1
2
3
4
5
26
30
MH-9-
12-74
500
ASSESSMENT PROCEDURES
Adequate ?
Col.
Code
For the assessment areas listed, rate whether the
frequency of assessment and/or sensitivity of the
instruments were sufficient to provide an
adequate test of your hypotheses
Not
Applicable
Definitely
NO
Inclined
to say
Na
Undecided
Inclined
to say
YES
Definitely
YES
27
31
31. Demographic
0
2
3
4
5
32. Diagnostic
0
2
3
4
5
28
3i
33. Therapeutic Efficacy
0
2
3
4
5
29
33
34. Psychometric/Performance
0
2
3
4
5
30
34
35. Adverse Reactions
0
2
3
4
5
31
35
36. Laboratory Tests
0
i
3
4
5
32
36
37. Medical Assessment Procedures
0
2
3
4
5
33
37
Other (Specify):
38.
0
2
3
4
5
3436
38
39.
0
2
3
4
5
37-39
39
40. If the answers to any of the above (items 31 — 39) were box 1, 2, or 3, please describe difficulties:
40-41
42-43
44-45
40
STATISTICS
Not
Applicable
Definitely
NO
Inclined
to say
NO
Undecided
Inclined
to say
YES
Definitely
YES
46
41
41. In multidrug studies, were there significant
demographic differences among the groups
(treatments)?
0
1
2
3
4
5
42. Were there significant pretreatment differences
in severity and/or type of psychopathology
among the groups (treatments)?
0
1
2
3
4
5
47
42
43. Was there differential utilization of permissible
concurrent drug therapies; i.e., significantly
greater use in one group than another?
0
1
2
3
4
5
48
43
44. Differential utilization of permissible non-drug
therapies?
0
1
2
3
4
5
49
44
45. If BIOMETRIC LABORATORY ANALYSES
were performed, were the routine BLIPS analyses
complete and free from significant error?
0
1
2
3
4
5
50
45
V. RESEARCH RESULTS
46. How many subjects were screened (evaluated) for the study? Total r
dumber
51-53
46
47. How many subjects were accepted into the study? Total
Number
54-56
47
MH-9-59
12-74
501
What was/were the reason/s for rejection?
CARD
02
Number of
Subjects
Col, Code
48.
Subject refusal
57-59
48
49.
Family member (guardian) refusal
60.62
49
50,
Psychiatric exclusion criteria
63-65
50
51.
Medical exclusion criteria
66-68
51
52.
Failure to meet target symptom/diagnostic criteria
69-71
52
53.
Other (Specify):
72-76
53
54.
Of the subjects accepted into the study, how many completed the protocol
17-18
CARD
03
requirements; i.e
, completed the planned treatment i-eqime? Total Number
19-21
54
What was/were the reason/s for premature termination;
i.e., failure to complete the protocol?
22-24
55
Number of
Subjects
55.
Subject withdrawal from treatment; i.e., refused continued participation
56.
Family (guardian) withdrawal from treatment
25-27
56
57.
Protocol violation by subject/family
28-30
57
58.
Protocol violation by staff
31-33
58
59.
Ineffectiveness of treatment; i.e., deterioration of clinical course
34-36
59
60.
Occurrence of adverse reaction
37-39
60
61.
Intercurrent medical illness
40-42
61
62.
Other (Specify):
43-47
62
63.
Of the protocol c
Dmpleters, how many were utilized in major statistical analyses? Total Number
48-50
63
What was/were the reason/s for exclusion from analyses?
51-53
64
Number of
Subjects
64.
Missed assessments (due to subject)
65.
Missed assessments (due to staff)
54-56
S5
66.
Missing data on assessment instrument/s
57-59
56
67
Incorrect rating procedures
60-62
37
68.
Other (Specify):
63-67
38
MH-9-59
12-74
502
69.
Do you consider the rate of attrition:
Col.
Code
1 □ Unusually low 2 D Usual or expected 3 □ Excessive
4 CD Uncertain
68
69
70.
Did the pattern of attrition seem to be: (Check one):
1 □ Random 2 □ Systematic 3 D Uncertain
69
70
If bias is suspected, in which subset/s (group) of the sample did it occur?
(Check all applicable and designate subset by name)
17-18
CARD
04
Specific drug (treatment) group
Test
Comparison
Placebo
19-22
71
No. 1
No. 2
No. 1
No. 2
71.
01
02
03
04
05
Other Treatment Group (Specify):
72.
Specific sex □ Male □ Female
23-24
72
73.
Specific aae arouo (Specify):
25-28
73
74.
Specific diagnostic qrouo (Specify):
2932
74
75.
Specific treatment period — including pretreatment (Specify):
33-36
75
76.
Specific treatment agency (ward, hospital, clinic, school, etc.)
(Specify):
37-40
76
77.
Other subset/s (Specify):
41-46
77
MH-9-59
12-74
503
ADVERSE REACTIONS
What were the clinically important DRUG-RELATED adverse reactions which emerged under
the Test Drug and Comparison Drug conditions and what was the MOST STRINGENT ACTION
required as a consequence of their emergence? Under column labeled "Drug", indicate under
which drug condition/s the symptom emerged {T1, T2, CI, C2, PBO) and then check the most
stringent action.
DRUG
ACTION TAKEN
Col.
17-18
NAME OF
ADVERSE REACTION
None
Increased
Surveillance
Contraactive
RX
Change
Dose
Change Dose
Plus
Contraactive
RX
Suspend
RX
Discontinue
RX
CARD
0
1
2
3
4
5
6
05
78.
19-28
78
79.
29-38
79
flO.
39-48
80
81.
49-58
81
82.
59-68
82
17-18
CARD 06
83.
19-28
S3
84.
29-38
84
85.
39-48
8B
86.
49-58
86
87.
59-68
87
MH-S-S9
12-74
50^
D I
<
2
E
()
uy
3
O
C
te
to
0)
H
o
ji
r
<
(U
(1)
^
.*;
^
co
^
5
(U
S
-a
•S
D
i: 5
c J>
-D V LU
10 Q-
E :5
? E
_ £J I-
— *-• IXJ
|i i
rr ^ --
MH-9-59
12-74
Oo
O H
w
UJ -
505
«
1-
_l
D
m
oc
n_
o
z
o
H
<
H
UJ
IT
0.
GC
UJ
K
Z
■a
«
3
St
a. ^
C
C
(J
^-
(/}
1—
_i
HI
3
o
z
w
<-l
lU
U- UJ
q:
_i
Z-'
<
a
o
v>
1-
w
H
u.y
<
°I5
H
UJ —
a. H
CO
>
m
u. _1
O m
UJ<
sS
UJ <
5E
<<
z>
UJ
_1
<
o
v>
u.
O
UJ
5
<
z
506
VII. RESEARCH CONCLUSIONS
88. What was/were the hypothesis/es of this study?
47-52
CARD
04
88
Not
Applicable
Definitely
NO
Inclined
to say
NO
Undecided
Inclined
to say
YES
Definitely
YES
53
89
0
1
2
3
4
5
89. Do you feel that the study provided a valid
test of the hypothesis/es?
90. On balance, do the results support the major
hypothesis/es of the study?
54
90
91 . Pleax describe your conclusions regarding the hypothesis/es:
55-60
91
MH-9-59
12-74
507
CLINICAL ACTION
92. FOR SINGLE TEST DRUG/S - was the clinical action of the test drug/s as presumed;
i.e., as anticipated or hypothesized?
(Check one):
1 n Clinical action as presumed with NO unexpected or secondary therapeutic action
2 n Clinical action as presumed WITH unexpected or secondary therapeutic action
Specify secondary action
3 CH Presumed clinical action NOT apparent BUT unexpected secondary action noted
Specify secondary action
4 im Presumed clinical action NOT apparent and NO unexpected or secondary action noted
5 CH Other — f.or responses which cannot be categorized above — please specify:
Col.
61-65
Code
92
93. FOR COMBINATION TEST DRUG/S - were the clinical actions of ALL the components
as anticipated?
1 D Yes
94. COMMENTS
2 n No
3 n Undecided
CLINICAL COMPARISONS
17-18
CARD
07
95. For Test Drug Only Studies; i.e., studies in which no comparison (control) drug is employed,
which standard drug/s do you feel it most resembles in clinical action?
19-28
95
96. In your judgment, what is the dose equivalent of the test drug to the standard/s given in the item above?
29-33
96
97. Comparative Index — This item is analogous to the Efficacy Index which appears on the ECDEU scale.
Clinical Global Impressions. The investigator is asked to judge the overall efficacy and toxicity of the
test drug in comparison to the standard drug. Check the ONE single box which best reflects your clinical
judgment. (For Test Drug Only Studies, compare test drug with standard named in item 95)
34-35
97
TOXICITY
EFFICACY
Less
Toxic
Equally
Toxic
More
Toxic
Much More
Toxic
1
2
3
4
4 Greatly Superior
3 Superior
2 Equivalent
1 Inferior
MH-9-59
12-74
508
CLINICAL INFERENCE
CARD
07
98. How do the statistical results compare with clinical judgments?
(Check one):
01 CD No statistical analyses performed
02 n Statistical results strongly confirm and coincide with clinical judgment
03 CD Statistically, results generally confirm with some exceptions
04 CD Positive statistical findings are not clinically meaningful
05 CD Negative or equivocal statistical findings do not confirm clinical judgment
06 CD Not possible to answer
07 D Other (Specify):
36-37
98
qp Comments
38-43
95
VIII. FUTURE PLANS
100. What priority would you assign to any further investigation of this test drug (or hypothesis)?
(Check one): HIGHEST HIGH MODERATE LOW LOWEST
1 n 20 sD 4n bD
High Priority % -.^ Low Priority
101. What recommendation/s would you make for further research?
Rank your recommendations (maximum of 3) on the basis of priority:
.Replication of study/hypothesis
.Comparison trial against PBO
.Comparison trial against standard
.Comparison trial against both
.Crossover design
.Larger sample
.Other (Specify)
Dosage alteration
Different dosage regime
Duration alteration
Different population
No further investigation
.Other (Specify).
.Other (Specify).
102. Do you plan to conduct further studies of this drug (or hypothesis)
at your research unit?
1 n YES 2nN0 SDUNDECIDED
103. What are your plans to publish (disseminate) the results of this study?
(Check all applicable):
01 CD No plans to publish
02 CD Article to be submitted for publication but no decision as to specific journal
03 CD Article submitted to specific journal or book
Name of journal/book
04 CD Oral presentation of results at professional meeting
Specify meeting
05 D Other (Specify):
MH-9-59
12-74
509
SPECIAL INSTRUCTIONS
The primary purpose of the Research Completion Report (RCR) is to obtain from the
investigator a summary of his study and its results. As such, the RCR attempts to docu-
ment conclusions pertinent to a single drug trial and, simultaneously, assemble a data base
for the methodological examination of psychotropic drug trials as a generic process.
Investigators are encouraged to amplify any of their responses by the insertion of
additional pages. When there are several such "insertions," please label each separate
comment with the appropriate Item Number. To facilitate reference, items are numbered
consecutively regardless of headings and subheadings.
I. IDENTIFICATION
Phases of Study — The separation into three phases may
be artificial for some studies; e.g., aspects of the analytic
phase may be carried out concurrent with data collection.
Since the purpose of the item is to obtain estimates of
the times required to complete various aspects of clinical
trials, investigators are asked to make the best estimates
possible within the context of these categories.
Research Plan Report (RPR) - Together, the RPR and
RCR constitute a detailed description of a given trial.
It is necessary, therefore, to request that investigators
complete both of these forms ■ whether or not they
submit the actual data of the trial to the Biometric
Laboratory.
II. DISPOSITION OF STUDY
Disposition refers to the abandonment, abbreviation or
significant modification of the entire study rather than
the disposition of individual subjects. Abbreviation
refers to reduction in data collection phase from that
planned in the original protocol.
III. RESEARCH PLAN and
IV. RESEARCH EXECUTION
These sections contain items to be rated on a five-point
scale. A sixth response position "Not Applicable" is
provided for those items which are not relevant to a
given study. For some items, space is provided for 2 test
drugs and/or 2 comparison drugs. Be sure to encode
your responses in the appropriate boxes.
V. RESEARCH RESULTS
Items in this section describe the course of events from
the initial screening pool to the final analytic cohort.
Items 46 through 69— The investigator is asked to record
the numbers of subjects and their dispositions at each
step.
Example - Continued
Example:
46.
47.
Itenfi
Number Screened
Number Accepted
48.
50.
51.
Subject Refusal
Psychiatric Exclusion
Medical Exclusion
Response
25
20
1
2
2
MH-9-59
12-74
PAGE 13
510
hem
54. Number Completers
56. Family Withdrawal
61. Intercurrent Illness
63. Number Used in Analysis
66. Missing Data
Response
18
16
Note that the investigator omits those items (reasons)
which are not pertinent.
Items 71 through 77 — Bias here refers to systematic
differences among the treatment groups or other subsets
of the sample which tend to distort, restrict or confound
the interpretation of the results.
Examples:
72. Specific Sex — A trial in which only males are pre-
maturely terminated.
73. Specific Age Group — Only older subjects show
response to treatment.
74. Specific Diagnostic Group — In a trial utilizing
subjects with heterogeneous depressive diagnoses,
only involutional melancholies show positive
change.
75. Specific Treatment Period — Significant pretreat-
ment differences exist among the groups.
76. Specific Treatment Agency — Subjects residing on
one of the three wards utilized in a trial show a set
of adverse reactions not observed on the other
wards.
Items 78 through 87 - Adverse Reactions - Complete
this item for all appropriate studies; i.e.. Test Drug Only
or Test vs. Comparison Drug. Clinically important ad-
verse reactions should include those judged to be drug-
related and clinically important on the basis of the
stringency of the action undertaken as a consequence of
their emergence. "Actions" are aligned in order of strin-
gency; i.e., from "None" to "Discontinue RX"
VI. STATISTICAL RESULTS
This section perpnits the investigator to record all statis-
tical results - BLIPS and/or his own - that he wishes.
The interpretation of al| results - including BLIPS — is
the prerogative of the investigator.
Nonsignificant Results — For those assessment instru-
ments used in the study which do not yield any
statistically significant results, record the name of the
Instrunient and write "n.s." or "no significance" under
th© column "Interpretation of Results."
Type of Variable — Refers to composition of the variable;
e.g., I = Item C = Cluster
F = Factor T = Total Score
exhibits an antidepressant action. A drug may exhibit
both its main presumed action and a secondary one or it
may not exhibit the presumed action but demonstrate
an unexpected one.
Item 95 — Clinical Comparisons — Test Drug Only —
If the Test Drug is unique and does not closely resemble
any standard drugs in its clinical action, state this fact.
Item 96 — Dose Equivalent — Make the best estimate of
equivalence.
Example: The Test Drug most resembles chlorproma-
zine. The investigator might state the equivalence as:
200 mg of Test Drug = 100 mg of CPZ Test Drug to
CPZ = 2:1.
Type of Statistic — Refers to statistical operation per-
formed; e.g..
VAR
VARR
COV
COV-R
T
X2
= Analyses of variance - regular model
= Analyses of variance - repeated measures
= Analyses of covariance - regular
= Analyses of covariance - repeated measures
= "t" test
= Chi square
Significance Level — Refers to the probability level to be
exceeded if support of the hypothesis being tested is
warranted. While the p = .05 level is the "establish-
ment level," investigators may select the level which is
considered best to reflect their conclusions.
Type of Effect — Refers to effect in the statistical sense;
eg-
G = Group (treatment) effect
P = Period (time) effect
GxP = Interaction (Group x Period)
Interpretation of Effect — Refers to the direction of
change, magnitude of effect, differential change, etc.
BLIPS Results - If the investigator checks "YES", all
significant BLIPS results will be encoded automatically
foV him. If he wishes to select only part of the BLIPS
intergretation, the investigator should record the appro-
priate results and check "NO" to the question. The
investigator may, of course, enter other statistical results
in addition to "automatic" BLIPS results. Examples of
encoding are given in Table 1.
VII. RESEARCH CONCLUSIONS
Items 88 through ^1 — Hypotheses, in many cases, may
correspond to the "Purpose/s" recorded on the RPR.
Item 90 refers to the c|inic9l hypothesis rather than the
statistical one. Example: The null hypothesis states
that there is no significant difference between the two
treatments; while the clinical hypothesis states that the
test drug is .nore efficacious than the placeljo.
Items 92 through 94 — Clinical Action — Complete only
the pertinent section/s. Presumed clinical action refers
to the verification of the presumed or anticipated main
therapeu "^ action of the drug; i.e., if the drug was pre-
sumed to Pe a neuroleptic, did it indeed exhibit this
action during the study. Secondary clinical action refers
to the observation of a clinical action other than the
presumed on^: e ' drug which is presumed a neuroleptic
Item 97 — Comparative Index — Only ONE box should
be checked.
Example: The Test Drug is judged to be equally effica-
cious to the Comparison Drug but more toxic. Code as
follows:
TOXICITY 1
Less
Toxic
Equally
Toxic
More
Toxic
Much
More Toxic
4 Greatly Superior
1
2
3
4
3 Superior
2 Equivalent
X
1 Inferior
For Test Drug Only studies, compare the Test Drug to
the standard drug you feel it most resembles; i.e., the
one given in Item 95.
Item 98 — Clinical Inference — The purpose of this
section is to obtain from the investigator a judgment
relating the statistical results to clinically meaningful
changes. Essentially, the investigator is asked to judge
whether the magnitude and/or direction of the changes
obtained by statistical methods — be they significant or
not — have clinical relevance.
VIII. FUTURE PLANS
Item 100 — Priority — Refers to the jeneral priority you
would set for your OWN RESEARCH UNIT taking into
consideration the merits of the study itself in the context
of your other research activities. "1" = highest priority;
"5" = lowest.
Item 101 — Recommendations — This it jm requires the
RANKING rather than mere checkinr jf items. The
rankings should reflect the order in wl ch you feel fur-
ther research might proceed —whether ir not you intend
to carry our the recommendations at . our research unit.
Example: Based on the results of a sm' ' Test Drug Only
study, the investigator recommends that a trial using a
standard drug should be undertaken as the next step.
He also has a hunch that the drug, a neuroleptic, might
have antidepressant effects. He marks a "1" beside
"Comparison trial against standard" and a "2" beside one
of the "Others" and specifies that he wishes to examine
"antidepressant action."
MH-9-59
12-74
PAGE 14
511
01
Q. P
O
u
S o
»
00
1
1 1
PC
O
c
s; o
ts
o
O -H
13
3
W *J
Pi
Qc:
M «
a
o
Pi c
&5
H
to o
^S
H
U PQ
o 0)
H
H PL*
o *J
60
CO 0)
1
H --
1
O 43
M
«Q
W 3
<i
H
4J
l-j CO
W
(0
PQ
a
M
t-t
:=> U
o
8
^
w <a
M
4-1
■o
H
fj
CO
Pd r-l
o
•i-l
w o
t_l
m
BC
J=
o
p-
p<
y
o
z c
5 «
O
o
w
CO
O J=
Ph
fU
fi<
PU
>" u
C 4J H 4J
MH-9-59
12-74
•H >, *J r-l
O P4 Oi CO
PAGE 15
512
Developed within the ECDEU program, the Research Completion Report is a 103-
item instrument designed to collect information on the execution, results and con-
clusions of a clinical trial in computer-compatible form. Together with the Re-
search Plan Report, the RCR permits a detailed historical reconstruction of the in-
dividual trial as well as providing data for subsequent collation with other trials.
The Research Completion Report replaces the Evaluation Summary Form (22-ESF) .
APPLICABILITY - For all research populations
UTILIZATION - Once per study. To be completed after
the completion of the trial and the
analyses of the data.
SPECIAL INSTRUCTIONS
Investigators should be thoroughly familiar with the instructions printed on
the form itself. Since it is impossible to construct a form which will be
adequate in all circumstances, investigators are urged to augment their re-
sponses - through the use of additional sheets - whenever the constraints of the
RCR format make explanations difficult.
At first glance, the RCR looks long and formidable. Investigators should keep
in mind, however, that the majority of items require only a checkmark and, in
any given trial, not all items are relevant - hence can be omitted. The poten-
tial usefulness of this type of data is such that we feel the time and effort
involved will be justified.
Use of the RCR - When data analyses are performed by the Biometric Laboratory,
an RCR will be sent to the investigator along with his data package. After re-
viewing the BLIPS analyses and any additional analyses that he may have performed,
the investigator completes the RCR and returns it to the Biometric Laboratory.
The form will then be coded and a computer printout of the data will be mailed
to the investigator.
NOTE - Investigators are urged, however, to complete an RCR - along with a Research
Plan Report - whether or not data are sent to the Laboratory.
DOCUMENTATION
Like its counterpart - the RPR - documentation for the Research Completion
Report is two-fold. For the individual study, printouts will be generated -
utilizing both RPR and RCR data - to provide an historical narrative. For general
documentation, RPR and RCR data will be assembled in a data file for methodological
research.
513
APPENDICES
APPENDIX 1
OCCUPATIONAL CATEGORIES
(from Hoi 1 ingshead, Two-Factor Index of Social Position)
Code 1. Higher Executives, Proprietors of
Large Concerns or Major Profes-
sionals
a. Higher Executives
Bank Presidents; Vice-Presidents
Judges (Superior Courts)
Large Businesses, e.g.. Director,
Presidents, Vice-Presidents,
Assistant Vice-Presidents,
Executive Secretary,
Treasurer.
Military, Comm. Officers, Major & above.
Officials of the Executive Branch of Gov-
ernment, Federal, State, Local, e.g..
Mayor; City Manager, City Plan Direc-
tor, Internal Revenue Directors.
Research Directors, Large Firms
b. Proprietors of Large Concerns
Brokers
Contractors
Dairy Owners
Lumber Dealers
b. Major Professionals
Accountants (C.P.A.)
Actuaries
Agronomists
Architects
Artists, Portrait
Astronomers
Auditors
Bacteriologists
Chemical Engineers
Chemists
Clergymen (Professionally Trained)
Dentists
Economists
Engineers (College Grad.)
Foresters
Geologists
Lawyers
Metallurgists
Physicians
Physicists, Research
Psychologists, Practicing
Symphony Conductor
Teachers, University, College
Veterinarians (Veterinary Surgeons)
Code 2. Business Managers in Large Concerns
Proprietors Of Medium-Sized Busi-
nesses, and Lesser Professionals
a. Business Managers in Large Concerns
Advertising Directors
Branch Managers
Brokerage Salesmen
District Managers
Executive Assistants
Export Managers, Int. Concern
Govt. Officials, minor, e.g.. Internal
Revenue Agents
Farm Managers
Office Managers
Personnel Managers
Police Chief; Sheriff
Postmaster
Production Managers
Sales Engineers
Sales Managers, National Concerns
Store Managers
b. Proprietors of Medium-Sized Businesses
Advertising Owners
Clothing Store Owners
Manufacturer's Representatives
Poultry Business
Contractors
Express Company Owners
Fruits, Wholesale
Furniture Business
Jewelers
Labor Relations Consultants
Purchasing Managers
Real Estate Brokers
Rug Business
Store Owners
Theater Owners
516
c. Lesser Professionals
Accountants (Not CPA)
Chiropodists
Chiropractors
Correction Officers
Director of Community House
Engineers (Not College Grad.)
Finance Writers
Health Educators
Librarians
Military, Comm. Officers, Lts., Captains
Musicians (Symphony Orchestra)
Nurses
Opticians
Pharmacists
Public Health Officer (M.P.H.)
Research Assistants, University (Full-
time)
Social Workers
Teachers, Elementary and High
Code 3. Adminiistratiive Personnel, Owners of
Small Independent Businesses, Minor
Professionals end Farmers
a. Administrative Personnel
Advertising Agents
Chief Clerks
Credit Managers
Insurance Agents
Managers, Dept. Stores
Passenger Agents — R.R.
Private Secretaries
Sales Representatives
Purchasing Agents
Section Heads, Federal, State, and Local
Govt, Offices
Section Heads, Large Businesses and In-
dustries
Service Managers
Shop Managers
Store Managers (Chain)
Traffic Managers
b. Owners of Small Independent Businesses
Art Gallery
Auto Accessories
Awnings
Bakery
Beauty Shop
Boatyard
Brokerage, Insurance
Car Dealers
Cattle Dealers
Cigarette Machines
Cleaning Shops
5 cents & 10 cents Stores
Florist
Food Equipment
Food Products
Foundry
Funeral Directors
Furniture
Garage
Gas Station
Glassware
Clothing
Coal Businesses
Contracting Businesses
Convalescent Homes
Decorating
Dog Supplies
Dry CJoods
Engraving Business
Feed
Finance Co., Local
Fire Extinguishers
Painting Contracting
Plumbing
Poultry Producers
Publicity & Public Relations
Real Estate
Records and Radio
Restaurant
Roofing Contractor
Shoe
Signs
Grocery-General
Hotel Proprietors
Inst, of Music
Jewelry
Machinery Brokers
Manufacturing
Monuments
Package Store (Liquor)
Tavern
Taxi Company
tire Shop
Trucking
Trucks and Tractors
Upholstery
Wholesale Outlets
Window Shades
517
Minor Professionals
b. Technicians
Actors and Showmen
Army M/Sgt.; Navy, C.P.O.
Artists, Commercial
Appraisers (Estimators)
Clergymen (Not professionally trained)
Concern Managers
Deputy Sheriffs
Dispatchers, R.R. Train
-Interior Decorators
Interpreters, Court
Laboratory Assistants
Landscape Planners
Morticians
Oral Hygienists
Photographers
Phys io -therapists
Piano Teachers
Radio, T.V, Announcers
Reporters, Court
Reporters, Newspapers
Surveyors
Title Searchers
Tool Designers
Travel Agents
Yard Masters, R.R.
d. Formers
Owners of large farms
Code 4. Clerical and Sales Workers, Techrai-
cians. Owners of Little Businesses,
and Formers
a. Clerical and Sales Workers
Bank Clerks and Tellers
Bill Collectors
Bookkeepers
Business Machine Operators, Office
Claims Examiners
Clerical or Stenographic
Conductors, R.R.
Employment Interviewers
Factory Storekeeper
Factory Supervisor
Post Office Clerks
Route Managers
Sales Clerks
Shipping Clerks
Supervisors, Utilities, Factories
Toll Station Supervisors
Warehouse Clerks
Dental Technicians
Draftsmen
Driving Teachers
Expeditor, Factory
Experimental Tester
Instructors, Telephone Co., Factory
Inspectors, Weights, Sanitary Inspectors,
R.R.; Factory
Investigators
Laboratory Technicians
Locomotive Engineers
Operators, P.B.X.
Proofreaders
Safety Supervisors
Supervisors of Maintenance
Technical Assistants
Telephone Company Supervisors
Timekeepers
Tower Operators, R.R.
Truck Dispatchers
Window Trimmers (store)
c. Owners of Little Bisinesses
Flower Stand
Newsstand
Tailor Shop
d. Formers
Owners of Medium-Sized Farms
Code 5. Skilled Manual Employees ondFormers
o. Skilled Manual Employees
Auto Body Repairers
Bakers
Barbers
Blacksmiths
Bookbinders
Boilermakers
Brakeman, R.R.
Brewers
Bulldozer Operators
Butchers
Cabinet Makers
Cable Splicers
Carpenters
Casters (Founders)
Cement Finishers
518
Skilled Manual Employees (cont'd)
Cheese Makers
Chefs
Compositors
DIemakers
Diesel Engine Repair & Maintenance
(Trained)
Diesel Shovel Operators
Machinists (Trained)
Maintenance Foremen
Installers, Electrical Appliances
Masons
Masseurs
Mechanics (Trained)
Millwrights
Moulders (Trained)
Painters
Paperhangers
Patrolmen, R.R.
Pattern and Model Makers
Piano Builders
Piano Tuners
Plumbers
Policemen, City
Postmen
Printers
Radio T.V., Maintenance
Electricians
Electrotypers
Exterminators
Engravers
Fitters, Gas, Steam
Fireman, City
Firemen, R.R.
Foremen, Construction, Dairy
Gardeners, Landscape (Trained)
Glassblowers
Glaziers
Gunsmiths
Gauge Makers
Hair Stylists
Heat Tr eaters
Horticulturists
Lineman, Utility
Linoleum Layers (Trained)
Linotype Operators
Lithographers
Locksmiths
Loom Fixers
Repairmen, Home Appliances
Rope Splicers
Sheetmetal Workers (Trained)
Ships miths
Shoe Repairmen (Trained)
Stationary Engineers (Licensed)
Stewards, Club
Switchman, R. R.
Tailors (Trained)
Teletype Operators
Toolmakers
Track Supervisors, R.R.
Tractor-Trailor Trans.
Typographers
Upholsterers (Trained)
Watchmakers
Weavers
Welders
Yard Supervisors, R. R.
b. Farmers
Owners of Little Farms
Tenant Farmers Who Own Farm Equipment
Code 6. Machine Operators, Semi-skilled Em-
ployees and Farmers
a. Machine Operotors
Aides, Hospital
Apprentices, Electricians, Printers,
Steamfitters, Toolmakers
Assembly Line Workers
Bartenders
Bingo Tenders
Bridge Tenders
Building Superintendents (Oust.)
Bus Drivers
Checkers
Coin Machine Fillers
Cooks, Short Order
Delivery Men
Dressmakers, Machine
Elevator Operators
Enlisted Men, Military Services
Filers, Benders, Buffers
Foundry Workers
Garage and Gas Station Assistants
Greenhouse Workers
Guards, Doorkeepers, Watchmen
Timers
Tire Moulders
Trainmen, R. R.
Truck Drivers, General
Walters-Waitresses
Weighers
519
b. Semi-skilled Employees
Hairdressers
Housekeepers
Meat Cutters and Packers
Meter Readers
Operators, Factory Machines
Oilers, R. R.
Practical Nurses
Pressers, Clothing
Pump Operators
Receivers and Checkers
Roofers
Set-up Men, Factories
Shapers
Signalmen, R. R.
Solderers, Factory
Sprayers, Paint
Steelworkers (Not skilled)
Stranders, Wire Machines
Strippers, Rubber Factory
Taxi Drivers
Testers
Welders, Spot
Winders, Machine
Wiredrawers, Machine
Wine Bottlers
Wood Workers, Machine
Wrappers, Stores and Factories
c. Farmers
Tenant Farmers Who Own Little Equip-
ment
Code 7. Unskilled Employees and Formers
a. Unskilled Employees
Amusement Park Workers (Bowling Alleys,
Pool Rooms)
Ash Removers
Attendants, Parking Lots
Cafeteria Workers
Car Cleaners, R.R.
Car Helpers, R. R.
Carriers, Coal
Countermen
Dairy Workers
Deck Hands
Domestics
Farm Helpers
Fishermen (Clam Diggers)
Freight Handlers
Garbage Collectors
Grave Diggers
Hod Carriers
Hog Killers
Hospital Workers, Unspecified
Hostlers, R. R.
Janitors (Sweepers)
Laborers, Construction
Laborers, Unspecified
Laundry Workers
Messengers
Platform Men, R. R.
Peddlers
Porters
Roofer's Helpers
Shirt Folders
Shoe Shiners
Sorters, Rag & Salvage
Stagehands
Stevedores
Stock Handlers
Street Cleaners
Unskilled Factory workers
Truckman, R. R.
Waitress - "Hash Houses"
Washers, Cars
Window Cleaners
b- Farmers
Share Cropper
520
APPENDIX 2
LIST OF DSM-I) AND ICD-8 DIAGNOSES
These two lists of diagnoses have been juxtaposed for your convenience. For
detailed explanations of the diagnoses please refer to:
DSM-11 - Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association
3rd Edition
Washington, D. C, I968
ICDA-8 - Eighth Revision
International Classification of Diseases
Vol ume 1 ,
Public Health Publication No. I693,
U.S. Dept. HEW, Public Health Service
U. S. Government Printing Office,
Washington, D. C. 20402
NOTE - For uniformity in coding, some code numbers have been changed to a 4-digit
number. Such changes have been noted by asterisks (--) • (The original 5-digit
DSM-11 code number is given in parentheses following the diagnostic name.) For
encoding diagnosis on ECDEU forms, always use the U-digit BLIPS number which pre-
cedes each diagnosis. Decimal points are omitted in BLIPS coding.
To encode one of the diagnoses under the heading of "Mental Retardation", use
the first 3 digits plus one of the 10 qualifiers.
Example - Moderate mental retardation associated with chromosomal abnormality is
coded as follows: 312 + 5 = 3125.
521
DSM-I I
1 . MENTAL RETARDATION
310 - Border! ine
311 - Mild
312 - Moderate
313 - Severe
314 - Profound
315 - Unspecified
Code with above: Following or associated with
0 - Infection or intoxication
1 - Trauma or physical agent
2 - Disorders of metabolism, growth,
or nutrition
3 - Gross Brain Disease (postnatal)
k - Unknown prenatal influence
5 - Chromosomal abnormality
6 - Prematurity
7 - Major psychiatric disorder
8 - Psycho-social (environmental)
depr i vat ion
9 - Other condition
M. ORGANIC BRAIN SYNDROMES (OBS)
A. PSYCHOSES
Senile and pre-seni le dement ia
2900 - Senile dementia
2901 - Pre-seni le dementia
Alcoholic psychosis
2910 - Delirium tremens
2911 - Korsakov's psychosis
2912 - Other alcoholic hallucinosis
2913 - Alcohol paranoid state
2914 - Acute alcohol intoxication
2915 -Alcoholic deterioration
2916 - Pathological intoxication
2919 - Other alcoholic psychosis
Psychosis associated with intracranial
infect ion
2920 - General paralysis
2921 - Other Syphilis of CNS
2922 - Epidemic encephalitis
2923 - Other and unspecified encephalitis
2929 - Other intracranial infection
WHO (I CD -8)
MENTAL DISORDERS (290-315)
MENTAL RETARDATION (310-315)
310
311
312
313
31^+
315
Borderl ine
Mild
Moderate
Severe
Profound
Unspecified
Code with above: Following or associated with
0 - Infection or intoxication
1 - Trauma or physical agent
2 - Disorders of metabolism, growth,
or nutrition
3 - Gross Brain Disease (postnatal)
't - Unknown prenatal influence
5 - Chromosomal abnormality
6 - Prematurity
7 - Major psychiatric disorder
8 - Psycho-social (environmental)
deprivation
9 - Other condition
PSYCHOSES (290-299)
290 Senile and pre-senile dementia
2900 - Senile dementia
2901 - Pre-senile dementia
291 Alcoholic psychosis
2910 - Delirium trtemens
2911 - Korsakov's psychosis
2912 - Other alcoholic hallucinosis
21^13 - Alcoholic paranoia
2914 - Acute alcohol intoxication
2919 - Other and unspecified alcoholic
psychosis
292 Psychosis associated with intracranial
infect ion
2920 - General paralysis
2921 - Other syphilis of CNS
2922 - Epidemic encfephalitis
2923 - Other and unspecified encephalitis
2929 - Other and unspecified intracranial
infection
522
DSM-I I
II. ORGANIC BRAIN SYNDROMES (OBS) continued
Psychosis associated with other cerebral
cond i t ion
2930 - Cerebral arteriosclerosis
2931 - Other cerebrovascular disturbance
2932 - Epi lepsy
2933 - I ntj-acrania] neoplasm
293^ - Degenerative disease of the CNS
2935 - Brain trauma
2939 - Other cerebral condition
Psychosis associated with other physical
condi t ion
29^0 - Endocrine disorder
29^+1 - Metabolic and nutritional disorder
29^2 - Systemic infection
29^+3 " Drug or poison intoxication
(other than alcohol )
294^+ - Childbirth
29^+8 - Other and unspecified physical
condi t ion
B. NON-PSYCHOTIC OBS
3090 - Intracranial infection
3201>'-- Alcohol" (simple drunkenness)
(309.13)
3202"— Other drug, poison or systemic
intoxication-v (309. 1^)
3092 - Brain trauma
3093 - Circulatory disturbance
309^+ - Epi lepsy
3095 - Disturbance of metabolism,
growth or nutrition
3096 - Senile or presenile brain diseas
3097 - Intracranial neoplasm
3098 - Degenerative disease of the CNS
3099 - Other physical condition
WHO (ICD -8)
MENTAL DISORDERS (290-315)
293 Psychosis associated with other cerebral
cond i t ion
2930 - Cerebral arteriosclerosis
2931 - Other cerebrovascular disturbances
2932 - Epilepsy
2933 - Intracranial neoplasm
293^+ - Degenerative disease of the CNS
2935 - Brain trauma
2939 - Other cerebral condition
29^+ Psychosis associated with other physical
cond i t ion
29^0 - Endocrine disorder
29^1 - Metabolic and nutritional disorder
29^2 - Systemic infection
29^+3 - Drug or poison intoxication
(other than alcohol)
29^^ - Childbirth
29^8 - Other physical condition
29^+9 - Unspecified physical condition
309 Mental disorders not specified as
psychotic associated with physical
cond i t ions .
3090 - Intracranial infection
3091 - Drug, poison or systemic
intoxication
3092 - Brain trauma
3093 - Circulatory disturbance
309^ - Epilepsy
3095 - Disturbance of metabolism,
growth or nutrition
3096 - Senile or presenile brain disease
3097 - Intracranial neoplasm
3098 - Degenerative disease of the CNS
3099 - Other or unspecified physical
condi t ion
523
DSM-I I
III. PSYCHOSES NOT ATTRIBUTED TO PHYSICAL
CONDITIONS LISTED PREVIOUSLY
Schizophrenia
2950 - Simple
2951 - Hebephrenic
2952 - Catatonic
3301 "- Catatonic type, excited
(295.23)
3302-.'.-- Catatonic type, withdrawn
(295.24)
2953 - Paranoid
2954 - Acute schizophrenic episode
2955 - Latent
2956 - Residual
2957 - Schizo-affective
3303"- Schizo-affective, excited
(295.73)
3304-v- Schizo-affective, depressed
(295.74)
2958 - Childhood
2959 - Chronic undifferentiated
(295.90)
3306-v- other schizophrenia (295.99)
Major affective disorders
2960 - Involutional melancholia
2961 - Manic-depressive illness, manic
2962 - Manic-depressive illness, depressed
2963 - Manic-depressive illness, circular
340 bv- Manic-depressive, circular,
manic, (296.33)
3402"- Manic-depressive, circular,
depressed (296.34)
2968 - Other major affective disorder
Paranoid states
2970 - Paranoia
2971 - Involutional paranoid state
2979 - Other paranoid state
Other psychoses
2980 - Psychotic depressive reaction
299O"— Psychotic reaction without
clearly defined structural
change other than above
WHO (I CD -8)
MENTAL DISORDERS (290-315)
295 Schizophrenia
2950 - Simple
2951 - Hebephrenic
2952 - Catatonic
2953 - Paranoid
2954 - Acute schizophrenic episode
2955 - Latent
2956 - Residua]
2957 - Schizo-affective
2958 - Other
2959 - Unspecified type
296 Affective Psychoses
2960 - Involutional melancholia
2961 - Manic-depressive psychosis, manic
2962 - Manic-depressive psychosis,
depressed
2963 - Manic-depressive psychos is ,ci rcular
2968 - Other major affective disorder
2969 - Unspecified
297 Paranoid states
2970 - Paranoia
2971 - Involutional paraphrenia
2979 - Other
298 Other psychoses
2980 - Psychotic depressive reaction
2981 - Reactive excitation
2982 - Reactive confusion
2983 - Acute paranoid reaction
2989 - Reactive psychosis, unspecified
299 Unspecified psychosis (encode 2990)
I
524
DSM-I I
V. NEUROSES
3000 - Anxiety
3001 - Hysterical
3501*- Hysterical, conversion type
(300.13)
3502*- Hysterical, dissociative type
(300. lit)
3002 - Phobic
3003 - Obsessive compulsive
3004 - Depressive
3005 - Neurasthenic
3006 - Depersonalization
3007 - Hypochondriacal
3008 - Other neurosis
V. PERSONALITY DISORDERS AND CERTAIN
OTHER NON-PSYCHOTIC MENTAL DISORDERS
Personality disorders
3010 - Paranoid
301 1 - Cyclothymic
3012 - Schizoid
3013 - Explosive
3014 - Obsessive compulsive
3015 - Hysterical
3016 - Asthenic
3017 - Antisocial
360b'-- Passive-aggresive (301.81)
3602*- Inadequate (301.82)
3603*- Other specified types (301,89)
Sexual deviation
3020 - Homosexual i ty
3021 - Fetishism
3022 - Pedophil ia
3023 - Transvestitism
3024 - Exhibitionism
3025 - Voyeurism
3026 - Sadism
3027 - Masochism
3028 - Other sexual deviation
WHO (I CD -8)
MENTAL DISORDERS (290-315)
300 NEUROSES
3000 - Anxiety
3001 - Hysterical
3002 - Phobic
3003 - Obsessive compulsive
3004 - Depress i ve
3005 - Neurasthenic
3006 - Depersonalization syndrome
3007 - Hypochondriacal
3008 - Other neurosis
3009 - Unspecified neurosis
301 Personality disorders
3010 - Paranoid
301 1 - Affective
3012 - Schizoid
3013 - Explosive
3014 - Anankast ic
3015 - Hysterical
3016 - Asthenic
3017 - Antisocial
3018
3019
Other
Unspec i f ied
302 Sexual deviation
3020 - Homosexual 1 ty
3021 - Fetishism
3022 - Pedophi I ia
3023 - Transvestitism
3024 - Exhibitionism
3025 - Voyeurism
3026 - Sadism
3027 - Masochism
3028 - Other
3029 - Unspecified
525
DSM-I I
Alcohol ism
3030 - Episodic excsssive drinking
3031 - Habitual excessive drinking
3032 - Alcoiiol addiction
3039 - Other alcoholism
Drug Dependence
30^0 - Opium, opium alkaloids and their
der i vat i ves
3041 - Synthetic analgesics with morphine-
1 ike effects
30U2 - Barbiturates
30^43 - Other hypnotics and sedatives or
"tranqu i 1 izers"
'iOkk - Cocaine
30^+5 - Cannabis sativa (hashish, marihuana)
30^+6 - Other psycho-stimulants
30^+7 - Hallucinogens
30^8 - Other drug dependence
VI. PSYCHOPHYSIOLOGIC DISORDERS
3050 - Skin
3051 - Musculoskeletal
3052 - Respiratory
3053 - Cardiovascular
3054 - Hemic and lymphatic
3055 - Gastro-intest inal
3056 - Geni to-ur inary
3057 - Endocrine
3058 - Organ of special sense
3059 - Other type
WHO (I CD -8)
MENTAL DISORDERS
(290-315)
nee
VI I . SPECIAL SYMPTOMS
3060 - Speech disturbance
3061 - Specific learning disturbance
3062 - Tic
3063 - Other psychomotor disorder
3064 - Disorders of sleep
3065 - Feeding disturbance
3066 - Enuresis
3067 - Encopresis
3068 - Cephalalgia
3069 - Other special symptom
303 Alcohol ism
3030 - Episodic excessive drinking
3031 - Habitual excessive drinking
3032 -Alcohol addiction
3039 - Other and unspecified alcoholism
304 Drug Dependence
3040 - Opium, opium alkaloids and their
der ivat ives
3041 - Synthetic analgesics with morphine-
1 i ke effects
3042 - Barbiturates
3043 - Other hypnotics and sedatives or
"tranqui 1 izers"
3044 - Cocaine
3045 - Cannabis sativa (hashish,
mar ihuana)
3046 - Other psycho-stimulants
3047 - Hal luc inogens
3048 - Other
3049 - Unspecified
305 Physical disorders of presumably
psychogenic origin
3050 - Skin
3051 - Musculoskeletal
3052 - Respiratory
3053 - Cardiovascular
3054 - Hemic and lymphatic
3055 - Gastro-intest inal
3056 - Geni to-ur inary
3057 " Endocrine
3058 - Organ of special sense
3059 - Other
306 Special symptoms not classified elsewhere
3060 - Stammering and stuttering
3061 - Specific learning disturbance
3062 - Tics
3063 - Other psychomotor disorders
3064 - Specific disorders of sleep
3065 - Feeding disturbances
3066 - Enuresis
3067 - Encopresis
3068 - Cephalalgia
3069 - Other
526
DSM-I I
VIM. TRANSIENT SITUATIONAL DISTURBANCES
3070 - Adjustment reaction of infancy
3071 - Adjustment reaction of childhood
3072 - Adjustment reaction of adolescence
3073 - Adjustment reaction of adult life
3074 - Adjustment reaction of late life
IX,
BEHAVIOR DISORDERS OF CHILDHOOD
AND ADOLESCENCE
3080 - Hyperkinetic reaction
3081 - Withdrawing reaction
3082 - Overanxious reaction
3083 - Runaway reaction
308^+ - Unsocial ized aggressive reaction
3085 - Group delinquent reaction
3089 - Other reaction
X.
WHO (I CD -8)
MENTAL DISORDERS
(290-315)
3070* Transient situational d isturbances (307)
308OA Behavior disorders of childhood (308)
CONDITIONS WITHOUT MANIFEST PSYCHIATRIC
DISORDER AND NON-SPECIFIC CONDITIONS '
Social maladjustment without manifest psychiatric
d isorder
- Marital maladjustment
- Social maladjustment
- Occupational maladjustment
- Dyssocial behavior
- Other social maladjustment
3160
3161
3162
3163
3169
Non-specific conditions
3170 - Non-specific conditions
No Mental Disorder
3180 - No mental disorder
XI. NON-DIAGNOSTIC TERMS FOR ADMI N ISTRATI VE USE
3190 - Diagnosis deferred
3191 - Boarder
3192 - Experiment only
3'193 - Other
527
APPENDIX 3
FORMATS FOR NON-STANDARD INSTRUMENTS
The following group of assessment instruments reflect the variety of input
which can be processed by BLIPS and, at the same time, suggest alternative means
for the assessment of treatment effects. The selection is not meant to be defin-
itive. Rather, it is a pot-pourri of devices: some new - some venerable; some
self-rated - some physician rated; some sharply focussed - some quite general.
The instruments are presented in the same style as the standard ECDEU scales
though with a greater emphasis on encoding.
Here are some general instructions which apyply to all non-standard instruments
(Also see "Encoding Non-Standard Data, pp. 59-6^).
1. While the precise location on the General Scoring Sheet for a
scale can vary from study to study, the location must remain
constant within a study.
2. Similarly, the Sheet Number assigned - any number between 80 and
99 - must be constant within a study.
3. All non-standard data must be described in I tern II of The Data
Shipment (07I-DS).
k. Several instruments and/or data sets can be encoded on a single
GSS, but - again - the location pattern must be constant through-
out a study.
5. As an alternative to transcribing data onto the GSS, investigators
may submit card decks. Should the card format differ from the
standard ECDEU format, its description must accompany the data.
528
PROFILE OF MOOD STATES (056 - POMS)
McNair, Lorr and Droppleman
1.
Friendly
2.
Tense
3-
Angry
^.
Worn out
5-
Unhappy
6.
Clear-headed
7.
Lively
8.
Confused
9.
Sorry for
things done
10.
Shaky
n.
Listless
12.
Peeved
13-
Cons iderate
lU.
Sad
15.
Active
16.
On edge
17.
Grouchy
18.
Blue
19.
Energetic
20.
Panicky
21.
Hopeless
22.
Relaxed
23-
Unworthy
2*4.
Spiteful
25.
Sympa thet ic
26.
Uneasy
27.
Restless
28.
Unable to
concentrate
29.
Fa t igued
30.
Helpful
31.
Annoyed
32.
Di scouraged
33.
Resentful
3^.
Nervous
35.
Lonely
36.
Miserable
37.
Muddled
38.
Cheerful
39.
Bitter
'40.
Exhausted
Ul.
Anxious
^ 5
^ ^ JQ >*
fO 0) 0) —
— *-> CD a)
♦-'+-' nj E
(0 ^ U (]} 0)
0) 4J t_
4J .— tj 4-»
O O 3 X
2: < 2: c/uj
6
1 2 3 '4
Ui.
Ready to
fight
^.'3-
Good natured
Uk.
G 1 oomy
kS-
Desperate
he.
Sluggish
U7.
Rebel 1 lous
U8.
Helpless
hS.
Weary
50.
Bewi Idered
51.
Alert
52.
Deceived
53.
Furious
5h.
Efficient
55.
Trust ing
56.
Ful 1 of pep
57.
Bad-tempered
58.
Worthless
59-
Forgetful
60.
Carefree
61.
Terri f ied
62.
Gui Ity
63.
Vigorous
6*4.
Uncertain
about things
65.
Bushed
529
The POMS is a self-rated scale consisting of 65 adjectives and has been
designed to assess feelings, affect and mood and their changes under therapeutic
intervention or experimental manipulation. The POMS has been extensively
evaluated and normative samples for psychiatric and normal subjects are available.
REFERENCE
APPLICABILITY
UTILIZATION
TIME SPAN RATED
ENCODING INSTRUCTIONS
CARD FORMAT - ITEMS
McNair, D. M., Lorr, M., and Droppleman, L. F.,
Manual for the Profile of Mood States, Educational
and Industrial Testing Service, San Diego,
California, I97I.
Psychiatric outpatients and normal subjects
Once at pretreatment ; at least one post-treatment
rating. Additional ratings are at the discretion
of the investigator.
During the past week including today.
POMS rating forms and instruction manual must be ob-
tained from the publisher. (See Reference).
Scoring is also available from the publisher.
Investigators who desire BLIPS processing may find it
more convenient to punch data directly on cards using
the formats given below.
CARD 01 = (19x, 5611)
tern
Column
Item
Column
Item
Column
1
20
20
29
39
58
2
21
21
ko
40
59
3
22
22
k]
41
60
k
23
23
42
42
61
5
2k
2k
k3
43
62
6
25
25
kk
44
63
7
26
26
kS
45
64
8
27
27
kS
46
65
9
28
28
47
47
66
10
29
29
48
48
67
11
30
30
kS
49
68
12
31
31
50
50
69
13
32
32
51
51
70
14
33
33
52
52
71
15
34
3k
53
53
72
16
35
35
5k
54
73
17
36
36
55
55
74
18
37
37
56
56
75
19
38
38
57
530
tern
Column
61
2k
62
25
63
26
Sk
27
65
28
Factor
Column
IV
38 - 43
V
kk - ks
VI
50 - 55
Total
56 - 59
CARD 02 = (19x, 911)
I tem Col umn
57 20
58 21
59 22
60 23
CARD FORMAT - FACTORS (CARD 51 = (19x,6f6.2, f4.0)
Factor Column
I 20-25
II 26-31
III 32-37
FACTOR COMPOSITION
1. Tension-Anxiety k. Vigor
2 Tense 26 Uneasy 7 Lively 51 Alert
10 Shaky 27 Restless 15 Active 56 Full of pep
16 On edge 3^+ Nervous 19 Energetic 60 Carefree
20 panicky k] Anxious 38 Cineerful 64 Vigorous
22 Relaxed
5. Fatigue
2. Depression-Dejection k Worn-out 46 Sluggish
5 Unhappy 36 Miserable 11 Listless 4-9 Weary
9 Sorry 44 Gloomy 29 Fatigued 65 Bushed
14 Sad 45 Desperate 40 Exhausted
18 Blue 48 Helpless
21 Hopeless 58 Worthless 6. Confusion
23 Unworthy 61 Terrified 8 Confused 54 Efficient
32 Discouraged 62 Guilty 28 Unable to concentrate 59 Forgetful
35 Lonely 37 Muddled 64 Uncertain
50 Bewildered about things
3 . Anxiety-Host i 1 i ty
3 Angry 39 Bitter
12 Peeved 42 Ready to fight
17 Grouchy 47 Rebellious
24 Spiteful 52 Deceived
31 Annoyed 53 Furious
57 Bad-tempered
SPECIAL INSTRUCTIONS
For a detailed description of the POMS, its validity, reliability and
normative data, the reader is referred to author's Manual.
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Factor means and standard deviations
d. Variance analyses
531
FROSTIG DEVELOPMENTAL TEST OF VISUAL PERCEPTION (065 - FROST)
The FROST is designed to measure the development of perceptual skills in
children and to obtain a Perceptual Quotient which reflects expected development
for given age levels. The test contains 5 subtests - each possessing relatively
distinct functions. It may be administered either individually or to groups.
REFERENCES
1. Frostig, M., Maslow, P., Lefever, D. W., and
Whittlesey, J. R. B., The Marianne Frostig
Developmental Test of Visual Perception, I963,
Standardization, Consulting Psychologist's
Press, 577 Col lege Avenue, Palo Alto, California
1963.
2. Frostig, M., Lefever, W., and Wh i tt 1 esey , J. R.
Administration and Scoring Manual, Consulting
Psychologist's Press, Palo Alto, California,
revised I966.
Test materials and manuals can be obtained from
the publ ishers .
APPLICABILITY
Norms available for children 4 to 8 years old.
Test applicable to older children with learning
difficulties. May also be useful for assessing
perceptual difficulties in bra in- injured adults,
UTILIZATION
Once at pretreatment; at least one posttreatment
rating. Additional ratings are at the discretion
of the investigator.
ENCODING FORMAT
SCALED SCORES - not raw scores - must be encoded.
The test requires an 11 x 10 matrix, i.e., 11
rows and 10 columns. It may be encoded on either
the left or right half of the General Scoring
Sheet. The matrix is as follows:
"0;=
--^--
;:*;
==*:
Eye-Motor Coordination
"8:r
"8:=
::Sb:
::Sb:
Figure - Ground
"8:=
:i8::
::»::
::&:
--0:--
-.zTz
zzt-.
Constancy of Shape
==8:1
"ft:
::Sb:
::9::
-t^--
r;)"
"ii
= Pos it ion in Space --3t:
"ftr
::*:
::ft;
")=-
"S::
Spatial Relationships
"ft:
::9::
zzt:z
Perceptual Q,uotient :
::ft:
"ft:
::ft:
::*:
::Sb:
::»::
532
CARD FORMAT - (19x, 312, 211, 13)
Subtest
1
Col umn
20-21
2
22 - 23
3
2k - 25
k
26
5
27
Perceptual Quoti
ient
28 - 30
SPECIAL INSTRUCTIONS - Raters should familiarize themselves with the manuals
referred to under References.
DOCUMENTATION
a. Scaled score printout
b. Means and standard deviations
c. Variance analyses
533
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
STUDY
PATIENT
FORM
PERIOD
RATER
HOSPITAL
PUBLIC HEALTH SERVICE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
117
(1-6)
(7-9)
(10-12)
(13-15)
(16-17)
(79-80)
ABNORMAL INVOLUNTARY
PATIENT'S NAME
MOVEMENT SCALE
(AIMS)
RATER
DATE
INSTRUCTIONS: Complete Examination Procedure (reverse side) before
maicing ratings.
MOVEMENT RATINGS: Rate highest severity observed.
Rate movements that occur upon activation one less than
those observed spontaneously.
Code: 0 = None
1 = Minimal, may be extreme i
2 = Mild
3 = Moderate
4 = Severe
1. Muscles of Facial Expression
e.g., movements of forehead, eyebrows, periorbital area, cheeks;
include frowning, blinking, smiling, grimacing
(Circle One)
CARD 01
(18-19)
0 12 3
4
(20)
FACIAL
AND ORAL
2.
Lips and Perioral Area
e.g., puckering, pouting, smacking
0 12 3
4
(21)
MOVEMENTS:
3.
Jaw
e.g., biting, clenching, chewing, mouth opening, lateral movement
0 12 3
4
(22)
4.
Tongue
Rate only increase in movement both in and out of mouth,
NOT inability to sustain movement
0 12 3
4
(23)
EXTREMITY
MOVEMENTS:
5.
Upper (arms, wrists, hands, fingers)
Include choreic movements, (I.e., rapid, objectively purposeless,
irregular, spontaneous), athetoid movements (i.e., slow, irregular,
complex, serpentine).
Do NOT include tremor (i.e., repetitive, regular, rhythmic)
0 12 3
4
(24)
6.
Lower (legs, l<nees, anicles, toes)
e.g., lateral knee movement, foot tapping, heel dropping, foot
squirming, inversion and eversion of foot
0 12 3
4
(25)
TRUNK
MOVEMENTS:
7.
Neck, shoulders, hips
e.g., rocking, twisting, squirming, pelvic gyrations
0 12 3
4
(26)
GLOBAL
S.
Severity of abnormal movements
None, normal
Minimal
Mild
Moderate
Severe
0
1
2
3
4
(27)
JUDGMENTS:
9.
Incapacitation due to abnormal movements
None, normal
Minimal
Mild
Moderate
Severe
0
1
2
3
4
(28)
10.
Patient's awareness of abnormal movements No awareness
Rate only patient's report Aware, no distress
Aware, mild distress
Aware, moderate distress
Aware, severe distress
0
1
2
3
4
(29)
DENTAL
11.
Current problems with teeth and/or dentures
No
Yes
0
1
(30)
12.
Does patient usually wear dentures?
No
Yes
0
1
(31)
MH-9-117
11-74
534
EXAMINATION PROCEDURE
Either before or after completing the Examination Procedure observe the patient
unobtrusively, at rest (e.g., in waiting room).
The chair to be used in this examination should be a hard, firm one without arms.
1. Ask patient whether there is anything in his/her mouth (i.e., gum, candy, etc.)
and if there is, to remove it.
2. Ask patient about the current condition of his/her teeth. Ask patient if he/she
wears dentures. Do teeth or dentures bother patient now?
3. Ask patient whether he/she notices any movements in mouth, face, hands, or feet.
If yes, ask to describe and to what extent they currently bother patient or interfere
with his/her activities
4. Have patient sit in chair with hands on knees, legs slightly apart, and feet flat on
floor. (Look at entire body for movements while in this position).
5. Ask patient to sit with hands hanging unsupported. If male, between legs, if female
and wearing a dress, hanging over knees. (Observe hands and other body areas.)
6. Ask piatient to open mouth. (Observe tongue at rest within mouth.) Do this twice.
7. Ask patient to protrude tongue. (Observe abnormalities of tongue movement.)
Do this twice.
8. Ask patient to tap thumb, with each finger, as rapidly as possible for 10-15 seconds;
separately with right hand, then with left hand. (Observe facial and leg movements.)
9. Flex and extend patient's left and right arms (one at a time.) (Note any rigidity
and rate on DOTES.)
10. Ask patient to stand up. (Observe in profile. Observe all body areas again, hips
included.)
11. Ask patient to extend both arms outstretched in front with palms down. (Observe
trunk, legs, and mouth.)
■ 12. Have patient walk a few paces, turn, and walk back to chair. (Observe hands and
gait.) Do this twice.
Activated movements
MH-9-117 (Back) PAGE 2
11-74
535
The AIMS is a 12-item scale designed to record in detail the occurrence
of dyskinetic movements. In the development of this scale, the Psychopharma-
cology Research Branch has had the benefit of consulting with many of the
scientists who have previously devised rating scales for dyskinetic movements
and the continuing advice of a formal consultant neurologist (Dr. FToger Duvoisin)
One of the units in a PRB collaborative study (St. Paul Ramsey Hospital) had
separately undertaken the development of a rating scale and had actively carried
out studies with patients showing dyskinetic movements utilizing video-recording
techniques. Preliminary versions of the AIMS were used to rate video recordings
of patients with dyskinetic movements and although no formal interrater relia-
bility studies have been conducted there was relatively good consensus among the
group doing the ratings. Because of the great need for an assessment instrument
in this field, the scale is being made available to the larger scientific commu-
nity through the ECDEU Battery despite the fact that it has not been validated
using psychometric procedures.
APPLICABILITY
Patients receiving neuroleptic drugs
UTILIZATION
Once at pretreatment ; at least one post-
treatment rating. Additional ratings are
at the discretion of the investigator.
TIME SPAN RATED
ENCODING FORMAT
Period of the examination only.
Available in non-opscan format, the AIMS
can also be transcribed to the General
Scoring Sheet should the investigator
desire BLIPS processing. A 12 x 5 matrix
is required; i.e., 12 rows and 5 columns,
as fol lows :
I tem
lOr:©::
|2iOi:
:2rr rdS"
:2;; :3=:
:a:r zzizz
:2r.- z-Szz
536
CARD
FORMAT -
(19x, 121,
12)
1 tern
1
Column
20
2
21
3
22
k
23
5
2k
6
25
Item
Colum
7
26
8
27
9
28
10
29
11
30
12
31
Total
32-33
Total Score = Sum of the items. Total Score Range =0 - k2 .
DOCUMENTATION:
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
537
Crichton Geriatric Rating Scale
201- CRICHT
1 JS.!:«° ?
o ,« 2
^ 5 g rt S J3
ULi kI " fl (1 o
C g E g S o SJ
«S x> .5 o .5 r:>, o
> .1 " « ■s g S- «
8
1, "o
a " S
03 a
5 ;;-9tt 2 5.^ &
'2 • - a t: b >/i J? S
u 15 _*;!'«>
:§ 3 1 a ^-g
•si a
W OX) S 8 -o
■a o cr
I/l ^ ^ 3 S r) u
o V .0 -a o
.2 i « b S '5
b ts "^ 5 s e
Q ?: a «
•a g
e.a
■6.0 c ° ^
iS 8
;; c K a
5i.S §°5i3^
■B §"^'§
U^S2
•H 8 s- a.|
D .a .9 a 2
5^ g
>
T3 ^ Dt
■a k5 S 8
jj t S D, a
■9 cTja
iV "O 'S
11
i " 2 '5
-is I
JJ c c E
Q.S§83
c S af S g &
p-5a-§iJE.g
■a
•s -3
pL, X>
£H2
Jail J .§
.3 „• e u -a -o i e
■ii ? ** l3 fc
«i „ wo .0
.b g a S s
llsgg
(S^gsiS.
D -a S 3 5 .9
8 I
5>f
wi c o c o t3 "w
- •<i u 6 o, tt '5
•=> s ■? g -S 3 b '8
•3 o I
ill
S O O 0 =• 3
.t3 K h - "O 0
D.SsS
•S a
1:1
^ 3
5-S
G
> 5 •« i 3 a
o o «^
•- *" a
,ra -a 5
p5 go
538
The 11-item CRICHT was developed as part of a geriatric treatment program
and was designed to assess the level of behavioral functioning. Derived from
clinical observation, the items are rated on a 5-point scale - ranging from
normality (1) to complete failure of function (5).
REFERENCE Robinson, R, A., The Diagnosis and Prognosis of
Dementia, Current Achievements in Geriatrics,
W. F. Anderson, Ed., Cassell 1964, 190-203.
APPLICABILITY Elderly psychiatric patients.
UTILIZATION Once at pretreatment ; at least one posttrea tment
rating. Additional ratings are at the discretion
of the investigator.
TIME SPAN TO BE RATED None stated by author. Now or within the past
week is suggested.
ENCODING FORMAT The 201 - CRICHT requires a 11 x 5 matrix; i.e.,
11 rows and 5 columns. The matrix may be located
in any one of the k quadrants of the General Scor-
ing Sheet. Either of the following formats can be
used for encoding:
SCALE POINTS
123^5 123^5
I tem
1 ziftr
"i:
i:2:r
"i:
"*=
"S:
r:(c:
z:?::
zzt:
zzSzz
2 ----&-.
"t:
----i--
"i:
-*:
"ii
"fcz
zzTzz
zz8::
:z9zz
3---.B:--
-r3.r
zzSzz
"i:
:z4::
"5::
"fc:
zzTzz
zzfc:
zzSz:
4----6:--
r=J=.
=:2:r
::»::
::4==
iiir
"fcr
zz7zr
zzt:
zzjzz
S----e:-.
..air
"2:=
"3=:
::*=
"i:
"6r:
zzjzz
zz8:z
:z9ii
6^=6:=
r=a=.
==2:=
-Szz
i:*:
OR
"i:
zztzz
zz7z:
zz8::
zzSzz
7=:e:z
rrj"
rzi:
---3zz
::4:i
zzi:
zzfc:
zz8zz
zz9zz
8 --A--
.=J~
-izz
::3::
zzjtr
r:S::
=z6:z
zz7zz
zz8zz
zz»:r
9:Ar
--3zz
zz3zz
r:4:z
rzti
zz6zz
zz7zz
=z8zz
;r9zz
10:*-
-i-
--*=
::3i--
::4rr
lii
rz6zz
:z7zz
zz8zz
rz9zz
11 =A:
zzjrr
:i2=:
zi:
::4:z
iiS::
zzfcz
zzTz:
zzgzz
zzSzz
Total score need not be encoded as it will be
derived by computer programming.
539
CARD FORMAT -
19x, I
IN, 12)
Item
1
Col umn
20
2
21
3
22
k
23
5
2k
6
25
1 tem
Col umn
7
26
8
27
9
28
10
29
11
30
Total
31 - 32
Total Score = Sum of the 10 items. Total Score provides a useful Index of
deterioration according to the author:
Total Score
Deter iorat ion
10-20
21 - 30
31 +
Mild
Moderate
Severe
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
540
Beck Depression Inventory 203-BECK
Instructions
This is a questionnaire. On the questionnaire are groups of statements. Please read
the entire group of statements in each category. Then pick out the one statement in that
group which best describes the way you feel today, that is, right now! Circle the number
beside the statement you have chosen. If several statements in the group seem to apply
equally well, circle each one.
Be sure to read all the slatemenis in each group before making your choice.
(Sadness)
0 I do not feel sad
1 I feel sad or blue
2 I am blue or sad all the time and I can't snap out of it
3 I am so sad or unhappy that I can't stand it
(Pessimism)
0 I am not particularly pessimistic or discouraged about the future
1 I feel discouraged about the future
2 I feel I have nothmg to look forward to
3 I feel that the future is hopeless and that things cannot improve
(Sense of Failure;
0 I do not feel like a failure
1 I feel I have failed more than the average person
2 As I look back on my life, all I can see is a lot of failures
3 I feel I am a complete failure as a person (parent, husband, wife)
(Dissatisfaction)
0 I am not particularly dissatisfied
1 I don't enjoy things the way I used to
2 I don't get satisfaction out of anything anymore
11.
12,
13.
Note:
The
from
3 I am dissatisfied with everything
(Guilt)
0 I don't feel particularly guilty
1 I feel bad or unworthy a good part of the time
2 I feel quite guilty
3 1 feel as though I am very bad or worthless
(Self-Dislike)
0 1 don't feel disappointed in myself
1 I am disappointed in myself
2 I am disgusted with myself
3 I hate myself
(Self-Harm)
0 I don't have any thoughts of harming myself
1 I feel I would be better off dead
2 I have definite plans about committing suicide
3 I would kill myself iflhadthe chance
(Social Withdrawal)
0 I have not lost interest in other people
1 I am less interested in other people than I used to be
2 I have lost most of my interest in other people and have little feeling for them
3 I have lost all of my interest in other people and don't care about them at all
(Indecisiveness)
0 I make decisions about as well as ever
1 I try to put off making decisions
2 I have great difficulty in making decisions
3 I can't make any decisions at all any more
(Self-Image Change)
0 I don't feel I look any worse than I used to
1 I am worried that I am looking old or unattractive
2 I feel that there are permanent changes in my appearance and they make me
iook unattractive
3 I feel that I am ugly or repulsive looking
Sk\
(Work Difficulty)
0 I can work about as well as before
1 It takes extra effort to get started at doing something
2 I have to push myself very hard to do anything
3 I can't do any work at all
(Fatigability)
0 I don't get any more tired than usual
1 I get tired more easily than I used to
2 I get tired from doing anything
3 I get too tired to do anything
(Anorexia)
0 My appetite is no worse than usual
1 My appetite is not as good as it used to be
2 My appetite is much worse now
3 I have no appetite at all any more
item titles should be omitted
the subject's copy of the scale,
The short form of the BECK consists of 13 items from the original 21-item
scale and has been developed to measure the depth of depression as well as for
the rapid screening of depressed patients. A self-rating instrument, the
clinically derived items are rated on a ^-point scale (0-3). The authors
state that the 13-item version correlates O.96 with the longer 21-item scale
and 0.61 with clinician's ratings of depression.
REFERENCES
Beck, A. T., Depression: Clinical, Experimental
and Theoretical Aspects, Hoeber Medical Division,
Harper and Row, New York, 1 9^7 •
2. Beck, A. T. and Beamesderfer , A., Assessment of
Depression: The Depression Inventory in Psycho-
logical Measurements in Psychopharmacology ,
Vol. 7, 151-169, Ed. P. Pichot, Karger, Basel,
197^.
APPLICABILITY
Psychiatric and medical patients with depressive
i I 1 ness
UTILIZATION
Once at pret reatment ; at least one post-treatment
rating. Additional ratings are at the discretion
of the investigator.
TIME SPAN RATED
ENCODING FORMAT
"Right now", i.e., at the time of the rating
A 13 X 4 matrix. I.e., 13 rows and 4 columns are
required to encode the BECK on the General Scoring
Sheet. This matrix may be located in any one of
the four GSS quadrants. EITHER of following matrices
may be used:
Scale Points
I tem
1 :zO:r ::
i: :i2::
::3:
2 -.--fk-. -.-.
:: i:2:i
:z3:
3 ::£>:: zz
:r ::2::
::3:
A -zttz z:
i: iiir
::3:
5 iiBt: :i
:: zri:
::3:
6 ift: rr
:: ::2::
::3r
7 ==&. .=
:r ::2i:
::3:
8==e:. :r
ir ::2::
r:3i
9 rift: ::
:: ::2::
zzSz
\Q.^.z z:
r: lit:
::3:
1 1 :*: r;
;: zzi:
::3:
12:*: n
;: ;A:
zz3z
13::fc: :i
:; zziiz
::3:
OR
::5::
zrfc:
::7ii
::8:
iii:
z-biz
:i?ii
::8:
::5::
::&::
::S:
zziiz
zzitz
::8:
zziiz
zzbzz
::S:
zzSzz
::6:i
::8:
zzSzz
zzttzz
zzSz
::5ri
zzbzz
i:7i:
-z&z
::5:i
::6::
zz&z
zziiz
zzbzz
::7i;
;r8:
zziiz
zzbzz
zzr-z
::8:
:.5::
zzbzz
::7:i
z-i:
5kl
CARD FORMAT - (I9x, 131 1 , 12)
tern
Column
1
20
2
21
3
22
k
23
5
2k
6
25
7
26
Item
Column
8
27
9
28
10
29
11
30
12
31
13
32
Total
33 - 3^
Total Score = Sum of all items
Total Score Range =0-39
The authors have provided the following estimates of the severity of depression
based on Total Score:
Score
0 - 4
5 - 7
8 - 15
16+
Sever i ty
None or minimal
Mild
Moderate
Severe
SPECIAL INSTRUCTIONS
Raters are urged to familiarize themselves with the volume cited in
Reference 1. As with all self-rating instruments, the examiner should make
certain that the patient fully understands the instructions and that the
scale is properly and - as far as possible - completely filled out.
DOCUMENTATION:
a. Raw score printout
b. Total score means and standard deviations
c. Variance analyses
543
GUILD MEMORY TEST
[205-GUILD)
The GUILD was designed to be used in conjunction with and as an adjunct to
the Wechsler Adult Intelligence Scale, It consists of 6 subtests designed to
measure different facets of memory. There are 2 forms of the test (A and B)
which are considered equivalent and which may be used interchangeably for repeated
testing.
REFERENCE
Gilbert, Jeanne G., Guild Memory Test Manual,
Unico National Mental Health Research Center,
17 Mulberry Street, Newark, New Jersey 07102
The Manual contains the test items.
APPLICABILITY
UTILIZATION
Same population range as WAIS; 16 to adult
Once at pretreatment ; at least one posttreatment
rating. Additional ratings are at the discretion
of the investigator.
ENCODING
To encode the test on the General Scoring Sheet a
10 X 10 matrix, i.e., 10 rows and 10 columns is re-
quired. This matrix may be located on either half
of the GSS. Specifically, the SCALED SCORES are en-
coded as fol lows :
:: zzir-z
Paragraphs 1
:3:: .JO^z rqj::
and 2
::b:: zzr-Z
.:8::
::8::
-%z
:«:: r:
:: ::2::
::3: Paired Associates t-_-_
"ft:
::»:
:: z:S:.z
Des igns
::6:: zSt-z
:.&: ::7::
::9::
r:9::
:*i :at: zz^z
Digits
::3:: :^. ^ ::»::
::6:: ::T::
::9::
:: zzSr-z
Retention (Para.
1 and 2)
»:
*:
::S:
"ft:
:«:: ::
- --'- R
etention (Paired
Assoc.)
-»:
::»:
CARD FORMAT (19x, 12, ll, 2 1 2, 12, II )
I tem
Paragraphs 1 and 2
pa ired Associates
Des igns
Digits
Retention (Para. 1 and 2)
Retention (Period Assoc.)
20 - 21
22
23 - Ih
25 - 26
27 - 28
29
544
SPECIAL INSTRUCTIONS
Instructions for administration and scoring are contained in Manual
cited above. Remember that scaled scores - NOT RAW SCORES - must be en-
coded. To convert from raw to scaled scores, use the following table:
SCALED SCORES
Retent
ion
RAW
Paragraph
Pa i red
Paragraph
Paired
SCORE
1 and 2
Assoc.
Des igns
pig its
1 and 2
Assoc.
19
8
10
18
9
18
15
15
17
17
]k
09
16
16
13
7
]k
8
15
12
08
13
15
lit
11
]k
7
13
6
07
12
13
12
10
12
11
09
5
06
11
11
6
10
08
10
9
07
05
10
09
8
06
k
09
08
5
7
Ok
07
6
05
08
06
k
5
Ok
3
03
k
03
07
05
3
02
06
Ok
3
2
1
01
2
02
05
03
02
0
00
1
01
04
01
2
DOCUMENTATION:
a. Scaled score printout
b. Means and standard deviations
c. Variance analyses
545
Physician Questionnaire
208-
PHYS
Rickels and Howard
Not Very
Preiant Mild
Mild
Moderatt
Moderataly
Saver*
Severe
Ext.
Severe
1. Anxiety
1
2
3
4
5
6
7
(Apprehensive, tense, worried,
frightened, anxious, nervous)
2. Depressive Mood
1
2
3
4
5
6
7
(Feelings of depression, unhappiness;
sorrow, pessimism, sadness;
hopelessness, tearfulness)
3. Irritability
1
2
3
4
5
6
7
(Easily annoyed or angered)
4. Hostility
1
2
3
4
6
6
7
(Expression of anger toward others)
S. Phobia— Obsession— Compulsion
1
2
3
4
S
6
7
(Unrealistic fears, repetitive
unwanted thoughts or actions)
6. Hypochondriasis
1
2
3
4
5
6
7
(Preoccupation with physical health)
7. Somatization
1
2
3
4
5
6
7
(Number and intensity of somatic & autonomic
symptoms, [excluding headaches] , backache,
G.I., sweating, trembling, dizziness,
heart palpitations, etc.)
8, Insomnia
1
2
3
4
5
6
7
9. Appetite Disturbance
1
2
3
4
5
6
7
Decreased D 1
Increased D 2
ia Headaches
(Frequency and intensity)
1
2
3
4
5
6
7
ll.Psvchomotor retardation
(Slowness of thought, speech,
motor activity)
1
2
3
4
S
6
7
12. Fatigue, tiredness, lethargy
1
2
3
4
B
6
7
13. Impairment of interpersonal relationshipt
(Home, work, social)
1
2
3
4
S
6
7
14.* Degree of Global Psychopathology (OJP):
How ill is this patient now, compared to
your experience with other neurotic patients?
Not III
1
Vary
Mild
2
Mild
3
Moderate
4
Moderataly
Sever*
S
Severe
6
Extremely
Severe
7
. „ ■
546
The revised PHYS consists of 13 items plus a global rating of psycliopatliology .
The original version of the scale consisted of the first 10 items and the "global".
The PHYS was developed by Rickels and Howard as a simple measure of neurotic symp-
tomatology and focussed on commonly observed symptoms familiar to non-psychiatric
physicians. The scale has proved sensitive to changes occurring under drug treatment
REFERENCE
Rickels, K. and Howard, K., The Physician
Questionnaire: A Useful Tool in Psychiatric
Drug Research, Psychopharmacol og ia , I7,
338-3^^, 1970.
APPLICABILITY
UTILIZATION
Neurotic outpatients
Once' at pretrea tment ; at least once at post-
treatment. Additional assessments are at the
investigator's discretion.
TIME SPAN RATED
Now or within the last week
ENCODING FORMAT
1 ::
-.- :2i:
:3::
zzUzz
2
:: :2::
r3::
zAzz
3
:: i2::
:3::
zAzz
4
:: :2::
:3::
:*:
5
:: :«::
:3:i
:d4:i
t
:: ::2::
1-3..
zzAzz
7 ■---
:: :2::
li::
:^::
t
:: ri:
zziiz
:^::
9
:: !«::
li:
zAzz
9a ::
:: :«::
:: :*r
:*:
:*
11
:r :«::
::3;:
:*
12
:: :2::
:3:--
:3«:
:: :2:i
.a-z
-Az
I:: i^::
zzizz
-Az
=5=: :£::
zzSzz r&r
:i: :*:
:;&: :*:
:=&: :*:
::&: :*:
:*: :&=
zzSzz :&:
::&:: :*:
i5:: :*:
To encode the PHYS on the General Scoring Sheet,
a 15 X 7 matrix, i.e., 15 rows and 7 columns, is
required. The matrix may be located in either
half of the GSS.
RMAT -
ITEMS CARD 01
= (19x,
Col umn
1 tern
Column
20
9
28
21
9a
29
22
10
30
23
11
31
24
12
32
25
13
33
26
]k
34
27
"Emot iona 1
35 - 36
"S oma t i c
37 - 38
-"Total
39 - 40
1511,312)
I tem
1
2
3
4
5
6
7
" Emotional Cluster = Sum of I terns 1 - 5 Range=5 - 35
-" Somatic Cluster = Sum of Items 6-10 Range=5 - 35
-V Total Score = Sum of Items 1-13 (except 9a)
Range= 13 - 9'
CARD FORMAT - FACTORS CARD 51 = (19x, 3F6.2)
Factor
1
2
3
Col umn
20 - 25
26-31
32 - 37
547
FACTOR COMPOSITION
Factor 1 - Anxiety
1 . Anxiety
3. I rr itabi 1 i ty
k. Hosti 1 ity
5. Phobia
Factor 2 - Somatic Concern
Factor 3 - Depression
2. Depressive Mood
8. Insomnia
9. Appetite Disturbance
10. Headaches
6. Hypochondriasis
7. Somatization
DOCUMENTATION
a. Raw score printout
b. Factor and cluster score printout
c. Factor means and standard deviations
d. Variance analyses
5^8
INPATIENT MULTIDIMENSIONAL PSYCHIATRIC SCALE (210-IMPS)
Lorr, McNair, Klett and Lasky
COMPARED TO THE NORMAL PERSON TO WHAT DEGREE
DOES HE. ..
— en —
1. Manifest speech that is slowed, deliberate, or labored? ^^J^iT: ^*^< " —
<
0) 0)
2. Give answers that are irrelevant or unrelated in any immediately o ©"'—©a.-^'"
conceivable way to the question asked or topic discussed? ^><2::eo'q2:iu
CUES: Do not rate here wandering or rambling conversation which veers away qi y ■> l r c t q
from the topic at issue (see Item 4). Also do not rate the coherence of the answer.
3. Give answers that are grammatically disconnected, incoherent, or
scattered, i.e., not sensible or not understandable?
CUES: Judge the grammatical structure of his speech, not the content
which may or may not be bizarre.
4. Tend to ramble, wander, or drift off the subject or away from the
point at issue in responding to questions or topics discussed?
CUES: Do not rate here responses that are obviously unrelated to the
question asked (see Item 2)
5. Verbally express feelings of hostility, ill will, or dislike of others?>
CUES: Makes hostile comments regarding others such as attendants, other
patients, his family, or persons in authority. Reports conflicts on the ward.
b. Exhibit postures that are peculiar, unnatural, rigid, or bizarre?
CUES: Head twisted to one side; or arm and hand held oddly. Judge
the degree of peculiarity of the posture.
7. Express or exhibit feelings and emotions openly, impulsively, or
without apparent restraint or control?
CUES: Shows temper outbursts; weeps or vto'ings hands ih loud
complaint; jokes or talks boisterously; gestures excitedly.
8. Exhibit indifference or apathy towards such matters as his treatment,
his release from the hospital, or plans for the future?
CUES: Content to stay. Willing to "leave it to the doctor." Sees no
need for treatment. Seems to have no goals or expectations.
9. Manifest speech that is hurried, accelerated, or pushed?
CUES: Pressure of speech.
10. Manifest overt signs of tension?
CUES: Moves or shifts restlessly; body musculature appears taut, strained
or tense; fingers clothing; scratches, drums or fiddles with objects; face or
neck muscles twitch; exhibits startle reactions; palms fee! sweaty.
1 1 . Express a feeling or attitude of contempt, disdain, or scorn
towards other people as unworthy or beneath him?
CUES: Derogatory or snide comments about others; sarcasm or
ridicule of others; condescending.
12. Exhibit an elevation in mood, a sense of well-being or euphoria,
or an optimistic and hopeful attitude towards himself and others?
CUES: Everything is wonderful and this is the best of all possible worlds.
5it9
COMPARED TO THE NORMAL PERSON TO WHAT
DEGREE DOES HE. ..
- •£ >- - >.
. ■ — "— 0> -^ CO r— >,
< ~ ^ 0) ■W >.—
13. Exhibit a facial expressior that is fixed, immobile, and without <'^^.^"2*'".5^ ^
discernible play of feeling or expression. ^ ^ j - -g .t: '^ t ^
O « — O 3 — (0 X
14. Tend to blame, criticize, condemn, or otherwise hold himself
responsible for past or present, real or fancied, thought or actions? ° 23it5678
CUES: Blames self for failure, difficulties, and frustrations In
family relations, work, or finances.
15. Exhibit in demeanor and/or in verbalizations an attitude of self-
importance, superiority, or conceit?
CUES: Speech is pompous or stilted; boasts of his accomplishments;
demands and expects special privileges.
16. Manliest movements or gestures that are slowed, deliberate,
labored, or delayed?
CUES: Acts as if he is fatigued; walking and moving seem to require
special effort.
17. Dramatize or seek to attract the attention of others to himself
or his symptoms?
CUES: Seems to enjoy being observed by others; histrionic in his
gestures; affected or artificial; a "show-off."
18. Manifest a hostile, sullen, or morose attitude towards others,
by tone of voice, demeanor, or facial expression?
CUES: Seems to have a chip on his shoulder; slams door or bangs
chair; sarcastic tone. Try not to judge on the basis of content of remarks.
19. Exhibit a deficit in his memory for events of the last week?
CUES: Does not know what he had for supper last night, what he
did yesterday, or what treatments he received the past week.
20. Manifest speech that is loud, boisterous, and/or intense in tone?
21 . Report or admit being uneasy or anxious in anticipation of
specific future difficulties or problems?
CUES: Won-ied about his symptoms, his family, or his finances.
22. Manifest blocking, halting, or irregular interruptions in his speech?
CUES: Stuttering or stammering should not be rated here.
23. Exhibit apathy, indifference, or lack of response in feeling to a
discussion of his own problems, of his family.^or to his surroundings?
CUES: Doesn't laugh, smile, or react when kidded; neither sad nor
angry; doesn't seem to care what goes on; discusses emotional mattari
In A flat, detached manner.
• 550 -_— — ^— ^— ^—
COMPARED TO THE NORMAL PERSON TO WHAT >.
DEGREE DOES HE... ■;: «
^ . — -c >~— >»
— 0> ^ CO '— >.
«t — © V *J >• —
24. Reportor admit feeling anxious, apprehensive, or worried in *jZ^13 >.«"* c^ ?
anticipation of vague indefinable future misfortunes or outcomes? ** >..-^ «SZ;" 2
4-> l-_l— -Q— I/) U4-I
CUES: Feels worried about cominu events tjut doesn't know why. o o •- o a — <o x
25. Manifest irritability, grouchiness annoyance, or anger? 01 23^5678
CUES: Tone of voice; sharpness of response; explosiveness of
retorts; use of profane or obscene language resulting from irritation.
26. Exhibit overactivity, restlessness, and/or acceleration in body
movements?
CUES: Paces or shifts about restessly. Bearing, posture and
gestures suggest excitement or agitation.
27. Exhibit in his general demeanor or in his verbalizations an
attitude of self-depreciation, inadequacy, or inferiority?
CUES: Talks about his faults and lack of accomplishment.
Underrates his skills.
28. Tend to blame, criticize, or hold other people, objects or
circumstances responsible for his difficulties, failures, or
frustrations?
29. Manifest verbally or in demeanor a dejection or depression in
mood and a despondent or despairing attitude?
CUES: Says he doesn't want to talk; complains of loss of interest
and enjoyment, lack of energy; discouraged about being helped;
expresses lack of hope; may wish he were dead; refMrts crying spells
or tearfulness; expects the worst, everything %ems flat and stale.
30. Exhibit a slovenly, unkempt, or disordered appearance and/or
asocial manners?
31 . Express feelings of guilt, sorrow or remorse for having done
wrong, that are accompanied by a desire to make amends?
CUES: Says he has been a terrible father or husband: claims sexual
misdeeds; recounts past "sins"; has let people down and brought
sufferFng upon others; has neglected his friends, family or work, wants
to atone for his sins or misdeeds.
32. Express feelings of bitterness and resentment because he feels
others have wronged, cheated, injured, or slighted him?
33. Manifest speech that is low, weak, whisperea, or difficult to
hear?
34. Manifest in facial expression, posture, voice, and manner, a
mood of dejection and sadness?
CUES: Rate only on the basis of extemal appearance and manifest
behavior.
'. 551
COMPARED TO THE NORMAL PERSON TO WHAT
DEGREE DOES HE. ..
___^ — — — — — JC >.— >■
_ a» — CO — >.
35. Express feelings of dejection, sadness, and unhappiness? t-Z,!^ >.«'*^^2
CUES: Rate only on the basis of what the patient spontaneously ^ u*Ii!5-o~*»)'if*j
reoorts or admits to on questioning. Do not rate external Ofl> v-os— loX
appearance here.
0123^5678
36. Complain, criticize, gripe, or find fault with people and conditions
in or out of the hospital?
CUES: Complains about everything and anything: The medical care,
the food, the aides, fellow patients, the routine, the hospital, people
in general.
37. Exhibit an excess of speech?
CUES: Difficult to stop flow of speech once started or to get a word
in edgewise. Judge the amount of speech and not Its rate nr relevance.
38. Express suspicion of people or their motivesr
CUES: Expresses lack of trust in others; feels or suspects others are hostile"
towards him; questions motives of examiner; questions fidelity of wife.
39. Express feelings of ciscouragement, loss of hope, or despair about
the future.
CUES: Doubts things will improve. Discouraged about being helped.
Despairs of finding solutions. Feels hopeless and "at the end of the rope."
Says: "I'll never get well" or its equivalent.
40. Try to dominate, control, or direct the conduct of the interview?
CUES: Number of times he interrupts, or "talks down" the interviewer.
Tries to control or dominate the conversation.
41 . Fail to respond to questions, answer In monosyllables, or give only
minimal responses?
CUES: Answers "yes" or "no"; stares blankly; has to be pushed to aet an
answer. Judge amount, not rate or relevance of speech.
42. Express attitudes and feelings indicative of reduced self-esteern?
CUES: Says he has failed as a person (friend, husband, parent, etc.) Says
he is useless, worthless, a failure.
43., Show a lack of insight regarding himself or an inability to recognize that
he has problems?
CUES: Offers physical illness as an explanation. Believes he is in a rest home or
prison. Asks to be sent home immediately. Denies Illness or need for treatment.
44. Show outer signs of inner agitation and anxiety?
CUES: Wrings hands, pulls on hair or skin, bites nails, purses or bites lips;
moans and sighs.
45. Express sense of personal helplessness and powerlessness to alter or remedy
his condition. ^^„
552
Answer the following on the basis of the patient's reports or admissions. «
If a symptom is not present, rate "not at all." — j « £ c
— t- E *■> 9)
ID — U. 4->
»- I- O <«-
•M o O
TO WHAT EXTENT DOES HE APPEAR PREOCCUPIED WITH. . . " S i2 IE ^
DC fO O
Z O < U. >
46. Suicidal thoughts or impulses? (Says life is not worth living. Wishes he 0 2 44 6 8
were dead. Threatens or plans suicide.)
47. Unwanted thoughts that recur persistently and are difficult to control?
(He must recognize these ideas as irrational.)
48. Specific morbid fears of objects, persons or situations? (e.g., crowds,
enclosed spaces, catching a disease.)
49. Urges or compulsions to perform a repetitive act or ritual which he
recognizes to be unnecessary or illogical, but difficult to control? (e.fl.,
counting, handwashing.)
50. Delusional beliefs or convictions? (e.g., ideas of persecution, reference,
control, etc.)
51. Hallucinatory sounds or voices? (e.g., singing, buzzing, laughing, blaming
voices.)
HOW OFTEN DURING THE INTERVIEW DID HE. . .
52. Grin or giggle inappropriately? (Exclude reactions resulting from embarrass-
ment.)
53. Grimace peculiarly or otherwise exhibit unusual or bizarre frowns or other
facial expressions?
54. Exhibit peculiar, inappropriate, or bizarre repetitive gestures and/or
manneristic body movements (e.g., rhythmic neck twisting, lip smacking,
odd gestures)?
55. Use phrases or coin words not found in the ordinary language or the
dictionary (neologisms)?
56. Mechanically repeat certain words or fixed phrases in a seemingly meaning-
less way (stereotypy)?
57. Talk, mutter, or mumble to himself without an apparent provoking stimulus?
58. Glance around at and/or appear to be startled as if hearing voices?
553
— in C
— I « « C
Inquire about the patient's view of his cognitive functioning, ability to make
decisions, level of interest in people, work and sex, energy level, and ease of
sleeping for the past week. If, and only if, he admits or complains of
disturbances, ask how frequently these occur. — i^ e " «
n •- u- *j
>- I- o«»-
*J o o
HOW OFTEN DURING THE PAST WEEK DID HE. . . " « * ^ >.
«J o u. •- i_
o c no)
— — z o < u. >
59. Experience difficulty in making decisions, even about little things, 0 2^68
without help?
60. Observe a decrease in, or loss of, ability to concentrate, remember things,
or solve problems?
61. Feel tired, worn out, or lacking in energy?
62. Observe a reduction or loss of interest or enjoyment in people, social
activities or hobbies?
63. Experience a difficulty or inability to get started, to work at, or to
keep interest up in anything?
64. Experience a decrease in, or loss of, sexual interest, pleasure or F>otency?
65. Experience difficulty in falling asleep or remaining asleep without
sedatives?
Answer on the basis of evidence obtained in the interview that the patient NOW
has or during the past week had hallucinatory experiences or delusional beliefs.
HOW OFTEN DID HE. ..
66. Hear voices that accused, blamed, or said "bad" things abput him? (e.g.,
he is a spy, homosexual, murderer.)
67. Hear voices that praised, extolled, or spoke to him about divine missions?
68. Hear voices that threatened punishment, torture, or death?
69. Hear voices that ordered him to carry out or perform certain tasks?
70. See actual visions? (Note: Check carefully as this is infrequent except in
organic cases.)
71. Have other hallucinatory experiences: Tactual, gustatory, olfactory? (e.g.,
sensations of crawling on the skin, smells queer or foul odors, food or drink
tastes peculiar or "bad.")
72. Experience self-estrangement, i.e., feel or think he is no longer same person;
feel changed, unreal, unfamiliar, or detached? (e.g., feel numb, dead, like a
corpse, or without feeling; as though floating in space.)
"■"""""■"■"""^ 554 . .
DOES HE BELIEVE THAT. . . o S
_ 0 8
73. Some people talk about, refer to, or watch him?
74. He is being blocked, cheated, deprived, discriminated against, or persecuted?
75. Certain people are plotting or conspiring against him? (e.g., secret police,
criminals, international spies.)
76. Certain people are trying to or now do control his actions or thinking?
77. Certain external forces (e.g., machines, electronic devices) are influencing
or controlling his behavior and thinking?
78. He has unusual or extraordinary abilities, powers, or knowledge? (e.g.,
scientific or religious.)
79. He is a well-known present day or historical personality? (e.g., president,
Christ.)
80. He is unworthy, sinful, evil, and/or guilty of unpardonable sins and crimes?
81. Familiar things, people, or surroundings have changed and are unreal?
82. His body is diseased, distorted, or that his internal organs are rotted or
missing?
83. He has a distinct divine mission, that he received commands from God, or
that he has other religious "calls" ?
DOES HE KNOW. .. o«
! 0
84. That he is in a hospital?
85. In what state the hospital is located or the nearest large city?
86. The name of at least one person in the hospital?
87. The season of the year? (Allow for transitional periods.)
88. The calendar year?
89. His own age?
555
Extensively revised in 1966, the IMPS consists of 89 items rated on the
basis of observations made during a psychiatric interview. The scale has been
designed to measure psychotic syndromes and has undergone extensive psychometric
analysis.
REFERENCES
APPLICABILITY
UTILIZATION
TIME SPAN RATED
ENCODING INSTRUCTIONS
CARD F
ORMAT -
Item
Column
1
20
2
21
3
22
k
23
5
24
6
25
7
26
8
27
9
28
10
29
11
30
12
31
13
32
14
33
ITEMS
1. Lorr, M., Klett, C. J., McNair, D.M. and
Lasky, J. J., Manual: Inpatient Multidimensional
Psychiatric Scale, Consulting Psychologists Press,
Palo Alto, California, I963.
2. Lorr, M. and Klett, C. J., Inpatient Multidimensional
Psychiatric Scale, (Revised Edition), Consulting
Psychologists Press, 577 Col lege Avenue, Palo Alto,
Cal ifornia, I966.
Functional psychotic or severely neurotic adults
who can be interviewed.
Once at pretreatment; at least one post-treatment
rating. Additional ratings are at the discretion
of the investigator.
Observations based on behavior during the interview.
IMPS rating forms and instruction manual must be ob-
tained from the publisher. (See Reference 2).
Investigators who desire BLIPS processing may find it
more convenient to have the data punched directly on
cards rather than transcribing the data to General
Scoring Sheets. Instructions for transcribing,
however, may be obtained from the Biometric Laboratory.
Card formats are given below.
CARD 01 = (19x, 5611)
1 tem
Column
15
34
16
35
17
36
18
37
19
38
20
39
21
40
22
41
23
42
24
43
25
44
26
45
27
46
28
47
Item
Column
Item
29
48
43
30
49
44
31
50
45
32
51
46
33
52
47
34
53
48
35
54
49
36
55
50
37
56
51
38
57
52
39
58
53
40
59
54
41
60
55
42
61
56
Column
62
63
64
65
66
67
68
69
70
71
72
73
74
75
556
CARD 02 = (19x, 3311)
1 tem
Column
57
20
58
21
59
22
60
23
61
24
62
25
63
26
64
27
65
28
66
29
67
30
I tem
68
69
70
71
72
73
74
75
76
77
78
Col umn
31
32
33
34
35
36
37
38
39
40
41
CARD FORMAT - FACTORS
CARD 52 = (19x, F6.2)
Factor
10
CARD 51 = (19x, 9F6.2)
Factor
Column
1
20 - 25
2
26 - 31
3
32 - 37
4
38 - 43
Factor
5
6
7
I tem
79
80
81
82
83
84
85
86
87
88
89
Column
42
43
44
45
46
47
48
49
50
51
52
Column
44 - 49
50 - 55
56 - 61
62 - 67
68- 73
Column
36 - 41
FACTOR COMPOSITION
Exci tement
7. Unrestrained
9. Hurried speech
12. Elevated mood
17. Dramatization
20. Loud
26. Overactive
37. Excess speech
40. Dominates
Hostile and Belligerence
5. Verbal
1 1 . Contempt
18. Attitude
25. Irritability
28. Blames others
32. Bitter
36. Complaints
38. Suspicious
3. Paranoid Projection
50. Delusional
73. Reference
74. Persecution
75. Conspiracy
76. People controlling
77. External controlling
82. Body destruction
4. Grandiose Expans iveness
15. Superiority
67. Voices extol 1
78. Unusual powers
79. Great personality
83. Divine mission
557
FACTOR COMPOSITION
(Continued)
5. Perceptual Distortion
51 . Hears voices
66. Voices accuse
68. Voices threaten
69. Voices order
70. Visions
71. Other hallucinations
81 . Ideas of change
6. Anxious Intropunitiveness
\k. Blames self
21. Anxiety (specific)
2k. Apprehens ive
27. Self depreciating
29. Depressed
31. Guilt
43. Insight
kS. Suicidal
k7 . Obsessive
48. Phobic
80. Sinfulness
7. Retardation and Apathy
1 . Slowed speech
8. Lack of goals
13. Fixed facies
16. Slowed movements
19. Memory deficit
22. Speech blocking
23. Apathy
30. Slovenly
33. Whispered speech
k] . Failure to answer
8. Disorientation
8k. Hospital
85. State
86. Knows no one
87. Season
88. Yepir
89. Age
9. Motor Disturbances
6. Posturing
10. Tension
52. Giggl ing
53'» Grimacing
Sk. Repetitive movements
57. Talks to self
58. Startled glances
10. Conceptual Disorganization
;2. Irrelevant
3. Incoherent
k. Rambl ing
55. Neologisms
56. Stereotypy
Items not included
in
any fact(
ar:
3k
kk
6p
65
35
k5
6i
72
39
kS
63
kl
59
64
SPECIAL INSTRUCTIONS - Detailed descriptions on administration, statistical analyses
and norms are provided in Lorr and Klett's Manual (See Reference), and raters are ad-
vised to familiarize themselves with its contents.
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Factor means and standard deviations
d. Variance analyses
558
PHYSICIAN'S OUIPAIIENI PSYCHOPAIHOLOGY SCALE
(21 I -POPS)
PATIENT: DATE:
RATER: Q PRE DRUG ["] ON DRUG [~~| POST DRUG
The symptoins below are described by physical signs observed and/or discomforts expressed by patients. Please
use individual descriptions to orient your ratings. Rate every symptom using these terms:
0 = Absent, 1 = Very Mild, 2 = Mild, J = Moderate, >* = Severe, 5 = Disabling
RATING
1 ANXIETY - experiencing subjective feelings such as worry, fears of surroundings,
apprehension of the future.
2 I I DEPRESSIVE MOOD - sadness, despondence, feeling helpless and/or hopeless.
3 I HYPERACTIVITY - energy spent excessively in rapid, frequent movements.
I* r~j PSYCHOPHYSIOLOGIC DISTURBANCES- headaches, gastrointestinal upset, respiratory effects,
cardiovascular effects.
5 TENSION - subjective feeling of being wound up, taut, energy pressing for release,
sensing explosive potential.
6 UNEASINESS - ill at ease, sensitive to criticism, emotionally upset.
7 I GUILT FEELINGS - concern, distress or remorse for personal activities in the past.
8 r~j FEELING OF INFERIORITY - feelings of inadequacy, negative self-image, loss of confidence.
9 (_] LOSS OF INTEREST - reduced desire to work or to participate in activities.
10 I I AGITATION - restlessness, fidgetting, shifting, pacing.
11 I I MOTOR DISTURBANCE - involuntary muscular movements, tremor, or other manifestations of
nervousness that interfere with purposeful activity.
12 FATIGUE - constantly feeling tired, washed out, lacking energy.
13 I I HYPOCHONDRIASIS - vague somatic complaints, malaise, unsupported complaints of physical illness.
Hr |_J SKELETAL MUSCULAR DISCOMFORT - complaints of aches and pains of muscles and ioints.
15 I j SLEEP DISTURBANCE - insomnia, cannot go to sleep, irregular sleep pattern, or early awakening.
Copyright by Spencer M. Free, Jr., and John E. Overall
559
Revised from the Physician's Rating List and renamed, the POPS has been
designed to assess the primary symptom dimensions of outpatient psychopathology .
Consisting of 15 items which were clinically derived from the factors of several
standard rating scales, the POPS employs generally familiar concepts and is suit-
able for rating by persons who are not specifically mental health professionals.
REFERENCES
1. Free, S. M. , and Guthrie, M. B., A Rating
Scale for Evaluating Clinical Response in
Psychoneurotic Outpatients, J. Clin.
Pharmacol., 9, 3, 187-19^, May-June, I969.
2. Free, S. M., Factor Analysis of Outpatient
Clinical Data, J. Clin. Pharmacol., 9, 3,
195-199, May-June, I969.
3. Overall, J., Psychometric Characteristics
of the Physicians Rating List, Psychometric
Laboratory Reports, University of Texas
Medical Branch, Galveston, June, 1971.
APPLICABILITY
UTILIZATION
Psychoneurotic outpatient adults
Once at pret reatment ; at least one posttreat-
ment rating. Additional ratings are at the
discretion of the investigator.
TIME SPAN RATED
None specified by authors. Suggest "now or
wi th in last week."
ENCODING FORMAT
The POPS requires a 15 x 6 matrix; i.e.,
15 rows and 6 columns. This matrix may
be located in either half of the GSS as
fol lows :
I tern
1 ::0:r zz
tz zz±z
zz3:z
ZZitZ
zzS:
2 -.-.&-- -.-.
tz zz2:z
zzii
zz4:z
zzi
3z-.{t-. Z-.
izz zz2zz
zzSzz
zz4zz
zz5z
4 ----&:-- -.-.
zz zziz
zzSzz
z:4=z
zzi
S-tfc. =.
zz zz2:z
zzSzz
zz4zz
zzSz
6==fc= ----
zz zztz
zz3zz
z:4z=
zzi
Jz.Bz. z:
zz zz2:z
zzSzz
zz4zz
zzS:
S-A- ,.
zz zz2:z
zzSzz
zz4zz
zzS:
9 ---Az r=
zz zz2zz
zz3zz
zz4zz
zzSzz
10:*= ==
zz zz2zz
z:3:z
zzdzz
zzSzz
1 1 izOzz :=
zz zz2zz
zzSzz
zz4zz
zzSz:
12z=a:r zz
zz zz2zz
zzSzz
zz4zz
zztz
13:rezz zz
zz zz2zz
zzSzz
zz4zz
zzS::
Uzzfcz zz
zz zz2zz
zzSzz
zz4zz
zzt:
ISzzfcz zz
zz zz2zz
zzSzz
zz(tz
zzSzz
560
CARD FORMAT - ITEMS (19x, I5ll)
I tern Column Item Column
1 20 8 27
2 21 9 28
3 22 10 29
4 23 11 30
5 2k 12 31
6 25 13 32
7 26 14 33
15 34
CARD FORMAT - FACTORS CARD 51 = (19x, 4f6.2, f4.0)
Factor Column
1 20-25
2 26-31
3 32-37
4 38-43
Total 44 - 47
Total Score = Sum of 15 items Total Score Range =0-75
FACTOR COMPOSITION - This factor composition is based on a recent analysis of the
ratings obtained from 328 outpatients. (Overall and Free, Personal Communication
1976, to be publ ished) .
1. ANXIETY 3 PSYCHOMOTOR ACTIVITY
1 Anxiety 3 Hyperactivity
5 Tension 10 Agitation
6 Uneasiness 11 Motor Disturbance
2. DEPRESSION 4 SOMATIZATION
2 Depressive Mood 4 Psychophysiological D 1 si.urbances
7 Guilt Feelings 13 Hypochondriasis
8 Feeling of Inferiority 14 Skeletal Muscular Discomfort
9 Loss of Interest
I terns not included in factor structure: 12, 15
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Factor means and standard deviations
d. Variance analyses
561
MEMORY FOR DESIGNS TEST (212
F. K. Graham and B. S. Kendall
MFD)
The MFD Test consists of 15 geometric designs which the subject is required
to reproduce from memory. It has proved useful as an adjunct in a test battery
for the assessment of brain damage in a wide variety of settings. The time re-
quired for administration is short and the test has been effective in differentiat-
ing functional behavior disorders from brain injury.
REFERENCE
APPLICABILITY
UTILIZATION
ENCODING FORMAT
Graham, F. K., and Kendall, B. S., Memory for Designs
Test: General Revised Manual, Perceptual and Motor
Skills, Monograph Supplement 2-VII, 11, 1^7-188, I960,
Materials for MFD may be obtained from Psychological
Test Specialists, Box ]kk] , Missoula, Montana 59801
Children (8.5 years and up) and adults
Once at pretreatment; at least one posttreatment rating,
Additional ratings are at the discretion of the investi-
gator.
The MFD requires a 15 x 4 matrix; i.e., 15 rows and k
columns, to encode the raw design scores and a 2 x 10
matrix; i.e., 2 rows and 10 columns, to encode the
difference score. The matrix may be located in either
half of the General Scoring Sheet.
Des ign
Difference Score
1 -.-.Stz
2-&.
::t-.
::2::
::2::
::*:
3-.-.(t--
::3::
::2::
::*:
A-&:.
::J::
::2::
::*:
5::a::
..i..
::2::
::*:
6::eL:
..i..
::2::
:*:
7::et:
::a::
::fc:
:*:
8::a:=
i:!::
::t:
:*:
9::et:
::a::
::fc:
:*:
10=*:
::!::
:*:
:*:
11:*:
::!::
:*:
::3::
12:*:
::J::
:*:
:*:
13:*:
::J::
:*:
:*:
14:*:
::»::
:*:
:*:
15:*:
::1::
:*:
:*:
,— =*=
::)::
::*:
zO::
:U::
::*::
::fc:
::ft:
::►:
::»:
L:*:
::)::
::Jfc:
:*:
-.-M:
::»:
::fc:
::»i:
::«::
-.-.r.
562
Des ign
Column
10
29
11
30
12
31
13
32
14
33
15
34
DATA FIELD FORMAT (19x, 1511, 12)
Des ign Col umn
1 20
2 21
3 22
k 23
5 2k
6 25
7 26 Difference Score 35 - 36
8 27
9 28
Calculation of Difference Score (from Graham-Kendall Manual)
Predicted Score = Vocabulary value- Chronological age value
Total Raw Score = Sum of 15 designs
Difference Score = Total raw score - predicted score
SPECIAL INSTRUCTIONS - Raters should consult the manual for administration and
scoring procedures. According to the authors, total raw scores may be inter-
preted as fol lows :
0
- k
Norma 1
5
-11
Borderl ine
12
+
Brain damage
Difference Scores may be interpreted:
0 - 1 Normal
2-6 Borderl ine
7 + Brain damage
DOCUMENTATION
a. Raw score printout
b. Total raw and difference score means and standard deviations
c. Variance analyses
563
r
Phillips Scale of Premorbid
Adjustment in Schizophrenia
Farina and Garmezy Modification
A. Recent Sexual Adjustment
(Note. — Score as sexual contact; when information
is not explicitly given, use inference to get at this
actual sexual behavior.)
1. Stable heterosexual relation and marriage 0
2. Continued heterosexual relation and marriage
but unable to establish home 1
3. Continued heterosexual relation and marriage
broken by permanent separation 2
4. (a) Continued heterosexual relation and mar-
riage but with low sexual drive 3
(Note. — If only informant is mother,
don't score sexual adjustment. Prorate
from rest of Premorbid History section.
Look here for evidences of frigidity, dis-
taste, avoidance, infrequency. Don't score
on matters of technique.)
(b) Continued heterosexual relation with deep
emotional meaning but emotionally unable
to develop it into marriage 3
(Note. — This must involve actual phys-
ical contact. Petting behavior is acceptable
here. Mutua(/'fy of feeling is not necessary,
but sexual behavior is, i.e., no adoration
from afar.)
5. (a) Casual but continued heterosejAja! rela-
tions, i.e., "affairs" but nothing more 4
(Note. — "Casual" here implies lack of
emotional meaning, although sexual
behavior is consistent and regular.)
(b) Homosexual contacts with lack of or
chronic failure in heterosexual experiences 4
6. (a) Occasional casual heterosexual or homo-
sexual experiences with no deep emotional
bond 5
(Note. — ^This differs from 5(a) on the di-
mension of frequency. Contacts less often
here.)
(b) Solitary masturbation with no active at-
tempt at homosexual or heterosexual
experiences 5
7. No sexual interest in either men or women 6
213-PHIL
B. Social Aspects of Sexual Life During
Adolescence and Immediately Beyond
1. Always showed a healthy interest in the oppo-
site sex — with a "steady" during adolescence 0
(Note. — "Steady" implies the exclusiveness
of the dating relationship [neither partner
(fates anyone else] as well as frequency and
emotional attachment.)
2. Started dating regularly in adolescence 1
(Note. — This implies twosomeness, pairing
off Into couples, as distinguished from 3,
below.)
3. Always mixed closely with boys and girls 2
(Note. — This involved membership in a
"crowd" — interest in and attachment to oth-
ers, but without the initiative factor for males,
the selection factor for females.)
4. Consistent deep interest in same sex attach-
ments with restricted or no interest in oppo-
site sex _ 3
5. (a) Casual same sex attachments with inade-
quate attempts at adjustments to going out
with opposite sex 4
(Note. — This differs from 4 on the basis
of the consistency and meaningfulness of
the same sex attachment.)
(b) Casual contacts with boys and girls 4
(Note. — This differs from 3 in that the
person was not a regular member of a
crowd and just associated with others on
occasion.)
6. (a) Casual contacts with same sex, with lack
of interest in the opposite sex 5
(b) Occasional contacts with opposite sex 5
7. No desire to be with boys and girls: never went
out with opposite sex ~. 6
(Scale points are at the right of
the items.)
56it
213- PHIL (Cont'd)
C. Social Aspects of Recent Sexual Life —
30 Years of Age and Above
1. Married and has children, living as a family
unit 0
2. Married and has children but unable to estab-
lish or maintain a family home 1
3. Has been married and had children but perma-
nently separated 2
4. (a) Married, but considerable marital discord 3
(b) Single — has had encagement or deep het-
erosexual relationship but was emotionally
unable to carry it through to marriage 3
5. Single, with short engagements or relationships
with the opposite sex which do not appear to
have had much emotional depth for both part-
ners, i.e., affairs 4
6. (a) Single, has dated some, but without other
indications of a continuous interest in the
opposite sex 5
(Note. — Implication here is that person
has dates every once in awhile but that this
behavior is not habitual — doesn't play an
important part of his/her life, i.e., tal<e-or-
leave attitude.)
(b) Single, consistent deep interest in same
sex attachments, no interest in opposite
sex 5
7. (a) Single, occasional same sex contacts, no
interest in opposite sex 6
(b) Single, interested in neither men nor
women 6
C. (continued) Social Aspects of Recent Sexual
Ufe — Below 30 Years of Age
1. Married, living as a family unit, with or with-
out children 0
2. (a) Married, with or without children, but un-
able to establish or maintain a family home 1
(b) Single, but engaged or in a deep hetero-
sexual relationship (presumably leading
toward marriage) 1
3. Single, has had engagement or deep heterosex-
ual relationship but has been emotionally
unable to carry if through to marriage 2
4. Single, consistent deep interest in attachments
to persons of either sex 3
(Note. — This implies a habitual interest in
object relations, a consistent desire for human
intimacy, but has never settled into a meaning-
ful, continued relationship with one partner In
particular.)
5. Single, casual relationships with persons of
either sex 4
(Note. — Has dated more often than implied
by 6 below, less often than implied by 4 above.
Differentiate on the basis of frequency, regular-
ity of social-sexual activity.)
6. Single, has dated a few persons casually, but
without other indications of a continuous inter-
est in object relationships 5
(Note. — Dating here the exception rather
than the rule. Person has had occasional social-
sexual contact, but doesn't actively seek out
other persons. This behavior not consistent,
nor an important part of his life. His contacts
have been soleiy casual, i.e., with prostitutes to
satisfy sex drive; no warmth or capacity to
establish human relationships.)
7. (a) Single, never interested in or never associ-
ated with either men or women; asocial 6
(b) Antisocial; destructive, belligerent acting
out against others 6
565
3.
213- PHIL ( Cont'd )
D. Persona/ Relations: History
(Note. — Score here is determined by the
time of life at which person withdraws, narrows
his range of social contacts. The earlier this
occurs, the higher the score will be.)
1. Always has been a leader, and has always had
iTiany close friends ^
(Note. — Score for "closeness" if record
states close friends, or describes frequent con-
tact, shared activity.)
2. Always has had a number of close friends but
did not habitually play a leading role 1
(Note. — From childhood until breakdown,
person had extensive social contacts.)
(a) From adolescence on had a few close
friends ^
(Note. — This may involve a drop in the
number of close friends after adolescence,
but person has retained relationships in-
volving mutual give andtake with several
people through this period.)
(b) From adolescence on had a few casual
friends — - ^
(Note. — Person maintains relationships
with several persons, even though these re-
lationships may lack real emotional depth.
Throughout life he has kept up contact with
others.)
From adolescence on stopped having friendS 4
(Note. — Cultivated human relationships dur-
ing childhood, but has withdrawn since
puberty.)
(a) No intimate friends after childhood 5
(Note. — Withdrawal began earlier — bo-
fore puberty.)
(b) Casual, but never any deep, intimate, mu-
tual friendships 5
(Note. — Implies no close friends, even
during childhood, but did maintain contacts
on a superficial level, as distini^uished
from 6 below.)
, Never worried abou« boys or girls; no desire
to be with boys and girls 6
4.
Recent Adjustment in Personal Relations
(Note. — Score here the period prior to the
noticeable change in behavior which preceded
symptoms and hospitalization. Any changes
noted within 6 months to a year prior to hos-
pitalization will constitute a "change" by this
definition. Score period prior to these chnnges.)
Habitually mixed with others, was usually a
leader 0
(Note.— Again, this involves extensive social
contacts.)
Habitually mixed with others, but not a leader 1
Mixed only with a close friend or group of
friends 3
(Note. — Distinguished from 4 below on the
basis of consistency and frequency of con-
tacts.)
No close friends or very few friends or had
friends but never quite accepted by them 4
Quiet or aloof or seclusive or preferred to be
by self 5
Antisocial, actively avoided contact, acted out
against others 6
566
The PHIL is designed as a prognostic instrument for schizophrenic patients.
The scale consists of 5 items which are rated on the basis of historical data
obtained from case records or interviews with the subject or other knowledgeable
respondents. A number of reliability and validity studies have demonstrated the
sensitivity of the scale.
REFERENCES
APPLICABILITY
UTILIZATION
ENCODING FORMAT
1. Phillips, L., Case History Data and Prognosis in
Schizophrenia, J. Nerv. Ment. Dis., 117, 515-525,
1953.
2. Garmezy, N., Process and Reactive Schizophrenia:
Some Conceptions and Issues, The Role and Methodology
of Classification in Psychiatry and Psychopathology ,
Katz, M. M., Cole, J. 0., and Barton, W. E,, eds.,
Public Health Service Publication No. 1584, U.S.
Government Printing Office, Washington, D. C. 1968.
Schizophrenic subjects
Once at pretreatment
The PHIL requires a 5 x 7 matrix, i.e., 5 rows and
7 columns. The matrix may be located on either half
of the General Scoring Sheet. PERIOD for the scale
should be designated as 000. The format is as follows;
I tern A :*
B :«:
C
D
t:: :*: -ziz-- :*:
t:: :*: :*: -*:
:«:: ::(:: :*: :*: :*:
:«:: "t-^ *: *= "*
E :«:: ::(:: i*: :*: -A^--
::6:: ::&:
CARD FORMAT - CARD 01 = (19x, 511, 12)
Item
Column
A
20
B
21
C
22
Item
Col umn
D
23
E
2k
Total
25 - 26
Total Score = Sum of the items. Total Score Range =0-30
Total scores may be categorized as follows:
Poor Premorbid 17 and up
Ambiguous 13 - 16
Good Premorbid = 12 and below
DOCUMENTATION
a. Raw score printout
b. Total score means and standard deviations
c. Variance analyses
567
1 .MOOD
DEPRESSION
2. CONFUSION
3. MENTAL
ALERTNESS
4. MOTIVATION
INITIATIVE
5. IRRITABILITY
(Cantankerousness)
6. HOSTILITY
7. BOTHERSOME
8. INDIFFERENCE
TO SURROUNDINGS
9 . UNSOCIABILITY
12. FATIGUE
Dejected, despondent, helpless, hope-
less, preoccupation with defeat or
neglect by family or friends, hypochon-
driacal concern, functional somatic
complaints, early imking. Rate on
patient^ statements, attitude and
behavior.
Lack of proper association for sur-
roundings , persons and time - ' not
vith it." Slowing of thought pro-
cesses and impaired comprehension,
recognition and performance; dis-
organization. Rate on patient response
and behavior at interview and on re-
ported episodes since last interview.
KOI vur
PDESEHT MILD
MODES- U-
MILD MOOM- »TEIY SEVEIE HEMELT
HE SEVEJE SEVEliE
Reduction of attentiveness, concen-
tration, responsiveness, alacrity
and clarity of thought, impairment
of judgment and ability to make
decisions. Rate on structured ques-
tions and response at intei-view.
Lack of spontaneous interest in
initiating or completing tasks,
routine duties and even attending
to individual needs . Rate on ob-
served behavior rather than patientb
statements.
Edgy, testy, easily frristrated, low
tolerance threshold to aggravation
and stress or challenging situations.
Rate on patientfe response and general
attitude at interview.
Verbal aggressiveness, animosity,
contempt, quarrelsome, assaultive.
Rate on impression at interview and
patientb observed attitude and
behavior towards others.
Frequent unnecessary requests for
advice or assistance, interference
with others, restlessness. Rate on
behavior at and outside the inter-
view situation.
Lack of interest in everyday events,
pastimes' and environment where
interest previously existed, e.g.
news, TV, heat, cold, noise. Rate on
patient's statements and observed
behavior at and outside interview.
Poor relationships with others, un-
friendly, negative reaction to social
and communal recreational activities,
aloof. Rate on observed behavior and
not on patientfe own impressions.
Sluggish, listless, tired, weary,
worn out, bushed. Rate on patient's
statements ajid observed response to
normal daily activities outside
interview situation. j^g
SANDOZ CLINICAL
ASSESSMENT-GERIATRIC
238-SCAG
10 . UNCOOPERATIVENESS
11. EMOTIONAL
LABILITY
13. SELF-CARE
14. APPETITE
(Anorexia)
15. DIZZINESS
16. ANXIETY
17. IMPAIRMENT OF
RECENT MEMORY
1 8 . DISORIENTATION
19. OVERALL
IMPRESSION
OF PATIENT
Poor compliance with instructions or
requests for participation. Perfor-
mance with ill grace, resentment or
lack of consideration for others.
Rate on attitude and responses at
interview and ohserved behavior
outside interview situation.
NOT VOT
riESoa HiLS
HIUI HODD'
MODU' U
HUY StVEK nWtlY
StVHE SEKtSl
Instability and inappropriateness
of emotional response, e.g. laughing
or crying or other undue positive or
negative response to non-provoking
situations as the interviewer sees
them.
Impairment of ability to attend to
personal hygiene, dressing, grooming,
eating and getting about. Rate on
observation of patient at and out-
side interview situation and not
on statements of patient.
Disinclination for food, inadequate
intake, necessity for dietary supple-
ments, loss of weight. Rate on
obsearved attitude towards eating,
food intake encouragement required
and loss of weight.
In addition to true vertigo, dizzi-
ness in this context includes spells
of uncertainty of movement and
balance, subjective sensations in the
head apart from paiii, e.g. light-
headedness. Rate on physical exami-
nation as well as patient's subjective
experience.
Worry, apprehension, overconcern for
present or future, fears, complaints
of functional somatic symptoms, e.g.
headache, dry mouth, etc. Rate on
patientfe own subjective experience and
on physical signs, e.g. trembling,
sighing, sweating, etc., if present.
Reduction in ability to recall recent
events and actions of importance to
the patient, e.g. visits by members
of family, content of meals, notable
environmental changes, personal
activities. Rate on structured perti-
nent questions and not on reported
performance.
Reduced awareness of place and time,
identification of persons, including
self. Rate on response to questions
at interview only.
238-SCAG
(CONT'D)
Considering your total clinical
experience and knowledge of the
patient, indicate the patient's
status at this time, taking into
account physical, psychic and
mental functioning.
I_ 569
The SCAG was recently developed by Sandoz Pharmaceuticals for the rating of
geriatric patients. The scale consists of 18 symptoms plus a global rating. The
scale points (7) are similar to those employed on the Brief Psychiatric Rating
Scale. The SCAG appears to differentiate among subjects of various degrees of
impa i rment .
REFERENCE
APPLICABILITY
UTILIZATION
TIME SPAN RATED
ENCODING FORMAT
Shader, R. I., Harmatz, J. S., and Salzman, C,
A New Scale for Clinical Assessment in Geriatric
Populations: Sandoz Clinical Assessment -
Geriatric (SCAG), J. of Amer .Ger iat .Soc. ,
XXI I , 3, 107-113, March, 197^.
Geriatric populations
Once at pretreatment ; at least one posttreatment
assessment. Additional ratings are at the discre-
tion of the investigator
Now or within the past week
To encode the SCAG on the General Scoring Sheet, a
matrix of 19 x 7 is required; i.e., 19 rows ^nd 7
columns. The matrix may be located in either half
of the GSS. The matrix is as follows:
I tems
1 ::
t: "2::
iri:
r:*:
::5::
::6c:
z.fzz
2 ----
fc- iii;
-zSi--
zz-tz
rii:
nfc:
:r7r:
3 ----
:: =:2:=
-i;
i;*:
ni:
==fc:
::7::
4 ----
" iii:
::3::
;;*:
::5::
r:&;
i:7::
5
:r iri:
"3::
1=*:
;:S:r
z-bzz
"7::
6 ----
;: "tr
iiS::
::4:;
lit:
::fc:
zzjz:
7 -.--
=1 ::2:r
r^r
;^:
::5::
"-fcr
"7::
8 ----
r; rii:
-Szz
ziit:
.-rt:
;=6;:
::7=:
9 ----
:: lit:
zz3zz
==4=:
;J;=
:^i
::7::
10 ==
:: ==t:
::3r:
=^r
:rii
:=6=:
::7:
11 ::
:: rztr
-.:3==
zzizz
i:t:
:;fc:
zzr-
12 ^:
--; :r2::
-.*:
:=4;i
:-.S:i
rifc:
"^
13 -.-.
i: ::2r=
:±:
:^:
::S::
::6:;
::^
14 ----
:i -.iizz
i^:
:^r
:=5::
"fci
::7:
15 ■---
- =i:
zz3zz
:^:
"Sr
"fc:
::?:
16 ----
:: irt:
:;3=;
:^x
::S:-
"it:
..r.
17 ■-.
ir lit;
r^r
:^;
"S:=
;:fc:
::»:
18 -.--
~ z-t:-
r*:
;:at=
:;S:;
;:fc:
::T:
19 ----
" "2:;
:-^z
::4::
"»:
"fc:
::T:
570
CARD FORMAT - CARD 01 = (19x, 1911, i^)
Item
Column
Item
Column
Item
Column
1 tem
Col umn
1
20
6
25
11
30
16
35
2
21
7
26
12
31
17
36
3
22
8
27
13
32
18
37
k
23
9
28
]k
33
19
38
5
2k
10
29
15
3^
Total
39 - kl
Total Score = Sum of Items 1-11
Total Score Range = 19 - 126
SPECIAL INSTRUCTIONS - The cues printed on the scale for each of the items
indicate the context to be used by the rater.
DOCUMENTATION
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
571
CLYDE MOOO SCALE (239-CLYDE)
Dean J. Clyde
• IDDDDDDDDDDDDDDDDDDDDDDDD
»P DDDDDDDDDDDanDDDDDDDDDn D
cy to
-iDDDDDDnDDDDDDDDDDDDDDDDD
-lIDDDDDDDDDDDDDDDDDnDDDnna
S4J jc E c _
%. tj at 0 0 0*0
Q CO -T4^M~oa)
p— OOO — ■ — 0»*JC« — Cift _
3-04-<j:»j ■ojscinnic)C)>">-*-' o)«)«)>*-
v._ I tJ-D>.c<o— <0">i-O-«><n >• — j:—«)*-'
>-io«)E-^«-«-^'o— O>UI0l-«)>-50)N-2<£J-p —
0 I.— i_oO>-<0EUCnl-<) to -O Q.O— NOS"-"- —
•~«i-jOiD — .— .-_c«o»oro^-3Ca>v-jo — vopOO
m \o r^ CO <T\ o —
01 CM eg CM 04 f^ r>-
' iDDDDDDDDDDDDDDDDDDnDDDDD
X
UJ
-1= DDDDDDDDDDDDDDDDnDDDDDDD
-i DDDDDDDDDDDDDDDDDnDDDDDD
-si DDDnDnDDDDDDDDnDDDDDnDDD
iDOvre-c: 3 «i3*->©>.in— >. — >•
c — — ■04->>>o .o>t3««-c3q.o>"oj:>- in«-
i.ouc>-— 1- c— 4-»nioiQ.ccoQ. >*— fl>
-OS— vravoOT}— mvi — — lo-^uaw in3*j-o
oo"*-Q.a)cE-oci-cio<*-*jj:«--oo)"OinQ.*J —
ot_«4-v< — 033 — aioo«)ioc3t_»_.— (oOE — o
014J «)-0 O — JC >-J£-0 O.QT3M- 3Ji<*- 01«) Cl>^ — ■— «-Q
— cMr^-4'iA\Dr^ooa\0'— cNir^j- u^\0 I^ooo^o — csir^j-
— — — .— _ —*— — — ^- CMCMCMCSCM
572
The CLYDE is a ^8-item scale for measuring aspects of mood that may be
influenced by drugs and may be employed as a self-rating as well as an
observer-rated instrument. The scale has been shown to be sensitive to drug
effects ,
REFERENCE
APPLICABILITY
UTILIZATION
TIME SPAN RATED
ENCODING FORMAT
Clyde, D. J., Manual for the Clyde Mood Scale
Clyde Computing Service,
Box 166, Coconut Grove Station
Miami , Florida 33133
1963
This manual may be obtained from the author.
Wide range of patients and normals
Once at pretreatment ; at least one posttreatment
assessment. Additional assessments are at the
discretion of the investigator.
"Now"; at the time of the rating.
To encode the scale on the General Scoring Sheet,
a 24 X 8 matrix; i.e., 2k rows and 8 columns are
required. The matrix may be located in the 2
quadrants of either half of the GSS. The follow-
ing format should be used:
TEM
1
::l:: 2--
:3::
::<::
2
::(:: ^
:3::
:3»::
3
---\-. -rZ-
:3::
:*:
4
::(:: :2::
:3::
:34::
5
::(:: -^Z--
:3::
:3*::
6
::t:: .:£:--
:3::
:^::
7
----t--. :2::
:3i:
:*:
S
:it:: -^Zzz
:i:
-:4--
9
::tr: -rZ--
:i:
:*:
10
:rt:: ::fc=
1.3::
ra4::
11
::t:: :2::
:3::
:34::
12
::t:: :2::
i3::
IJ»::
13
::t:: -i-
:3::
zA-..
14
::»:: :2=:
-3--
::<::
15
:=ti: :2::
1:3::
rD4::
16
::t:: -:Z-
:3::
:^::
17
::t:: ^2"
r3::
r:4::
18
::t" --^--
:3;:
:3i:r
19
-■4--- r^::
:3::
134;:
20
::t- -^
.^..
:*
21
:it:: :2::
:i:
:<:
22
::(:: -rZ--
:3::
:5»:
23
::!:: -Zz-
:3::
::<::
24
::!:: :2::
:3::
:5>::
1
2
3
4
25
■:i:
:&:
::?::
:A:
26
:i-:
:&:
::7:r
:ra-.
27
-.5::
:*:
::7:i
r*:
28
:5::
:*:
::7::
-z&z
29
::&:
:*:
::7::
--.&..
30
:5::
:-^:
::7::
-..&■-
31
::5::
:*:
::7:i
::&:
32
:i5::
:*:
::7::
:Ai
33
-zS^z
:*:
::7::
"ft:
34
ri-:
:*r
::7::
:*:
35
::5::
:*:
::7::
:*:
36
:5::
:&:
::7r:
:*:
37
:5::
:*:
::7::
:*:
38
::5::
:--&:
zzT.z
--*-
39
;:5c:
:*:
zzT-Z
::e::
40
:i:
:*:
.zT-Z
-z&z
41
:*:
:*:
::7::
ZZ&-.
-12
:=&::
:*:
:-7::
:*r
^3
=*:
:*:
zzt.z
:*:
^4
:*:
:*:
:i7::
:*:
15
:5::
:&:
::7.:
:A:
16
:i:
:&:
::7::
::&:
47
:i:
--*:
::7::
:ift:
^8
:5::
:-€::
::7::
=--a:
573
CARD
FORMAT - ITEMS
Item
Column
Item
Colu
1
20
13
32
2
21
]k
33
3
22
15
3k
k
23
15
35
5
2k
17
36
6
25
18
37
7
26
19
38
8
27
20
39
9
28
21
ko
10
29
22
k]
11
30
23
k2
12
31
2k
k3
CARD 01 = (19x, k8[])
Item
Col umn
1 tern
Column
25
kk
37
56
26
k5
38
57
27
kS
39
58
28
kl
ko
59
29
48
k]
60
30
kS
k2
61
31
50
k3
62
32
51
kk
63
33
52
ks
Sk
3k
53
ke
65
35
5k
kl
66
36
55
k8
67
CARD FORMAT - FACTORS
CARD 51 = (19x, 6F6.2)
Factor
Column
1
20 - 25
2
26 - 31
3
32 - 37
Factor
Column
k
38 - k3
5
kk - ks
6
50 - 55
FACTOR COMPOSITION
1 . Friendly
1 . good-natured
9. kind
28. warm-hearted
37. pleasant
2. Aggressive
8. rude
12. boastful
36. sarcastic
47. forceful
3. Clear thinking
3. efficient
5. clear thinking
30. alert
k2. able to concentrate
k. Sleepy
]k. fatigued
19. sleepy
31. tired
41 . drowsy
5. Unhappy
2. troubled
20. sad
45. downhearted
46. worried
6. Dizzy
23. jittery
29. sick to the stomach
32. shaky
43. dizzy
NOTE - Higher scores reflect greater "pathology" for all factors except
Factors 1 and 3.
DOCUMENTATION:
-a. Raw score printout
b. Factor score printout
c. Factor means and standard deviations
d. Variance analyses
574
I . Headaches
2. Nervousness or
shaklness inside
3. Being unable to get rid
of bad thoughts or ideas
'+• Faintness or dizziness
5. Loss of sexual interest
or pleasure
6. Feeling critical of
others
7 . Bad dreams
8. Difficulty in speaking
when you are excited
9. Trouble remembering
things
10. Worried about sloppiness
or carelessness
1 1 . Feeling easily annoyed
or irritated
12. Pains in the heart
or chest
13. Itching
1^. Feeling low in energy
or slowed down
15- Thoughts of ending
your life
28.
29.
30.
31.
32.
33.
3^.
35.
36.
37.
38.
39.
16.
Sweating
17.
Trembling
i+2
IB.
Feeling confused
k3
19.
Poor appetite
20.
Crying easily
hk
21.
Feeling shy or uneasy
with the opposite sex
k5
22.
A feeling of being
trapped or caught
23.
Suddenly scared for
no reason
kb
2k.
Temper outbursts you
could not control
^7
25.
Constipation
26.
Blaming yourself for
Feeling blocked or
stymied in getting
things done
Feeling lonely
Feeling blue
Worrying or stewing
about things
Feeling no interest
in things
Feeling fearful
Your feelings being
easily hurt
Having to ask others
what you should do
Feeling others do not
understand you or are
unsympathetic
Feeling that people are
unfriendly or dislike
you
Having to do things very
slowly in order to be
sure you are doing them
right
Heart pounding or racing
Nausea or upset stomach
Feeling inferior to
others
Soreness of your
muscles
Loose bowel movements
Difficulty in falling
asleep or staying
asleep
Having to check and
double-check what you
do
Difficulty making
decisions
Wanting to be alone
Hopkins Symptom Checklist
(240-HSCL)
Derogatis, Lipman, Rickels,
Uhlenhuth and Covi
NOT AT * OUITEA B-
All liniE BIT T8TMEIT
kg. Trouble getting your
breath
kS. Hot or cold spells
50. Having to avoid certain
places or activities
because they frighten
you
51 . Your mind going blank
52. Numbness or tingling in
parts of your body
53. A lump in your throat
Sk. Feeling hopeless about
the future
55. Trouble concentrating
56. Weakness in parts of
your body
57 . Feeling tense or keyed
up
58. Heaving feelings in your
arms or legs
things
27. Pains in the lower part
of your back
575
Precursor of the SCL-90, the HSCL is a 58-item, self-rated scale designed
to measure the presence and intensity of symptomatology in a wide variety of
subjects. Normative data has been established for the scale and its sensitivity
to change has also been demonstrated.
REFERENCES -
Derogatis, L. R., Lipman, R. S., Rickels, K.,
Uhlenhuth, E. H. and Covi, L., The Hopkins
Symptom Checklist (HSCL) : A Measure of Primary
Symptom Dimensions, in Psychological Measure-
meat: Modern Problems in Pharmacotherapy,
P. Pichot, Ed., S. Karger, Basel, 1973.
Derogatis, L. R., Lipman, R. S., Rickels, K.,
Uhlenhuth, E. H., and Covi, L., The Hopkins
Symptom Checklist (HSCL): A Self-Report Symptom
Inventory, Behavioral Science, 19» ', '"15,
January 197^.
APPLICABILITY -
UTILIZATION -
TIME SPAN RATED
ENCODING FORMAT
30
1 ::±7 ..±.
iiSi
2 -i.. -.-.%-.
lit:
3 -i
:: ::2:=
lit:
4 ----^
=: 1=2::
::tl
5 =3
" ==2::
lit:
6 -i
II :.2:i
::t:
7 =3
ir ii2::
::t:
8 1=3
-.-. lit:
iiti
9 ::J
II lit:
iiti
10 ==1
II 1*1
i:3::
11 ---^
II :*i
:3::
12 ----
i: iiti
:±i
13 ■--'
II lit:
lit:
14 ==
:: lit:
==t=
15 ----
II ::ti
lit:
16 ■---
:i iiti
:it=
17 ==
II ::t:
:*:
18 ==
i: lit:
::t=
19 =:
1= ::t:
==ti
20 :=
1=1 ==1::
::ti
21 --=
1:: "t:
:it:
22 ==
1:: =:*::
::t=
23==
1== irt:
:=t:
24 ==
J== ::»::
lit:
25 ==
J:: :-%-.
:=3==
26 ==
\---. :=!::
::*=
27 ==
\-.-. ---t-.
==t:
28 ==
V-z :=Jii
:*=
29 ==
in lit:
==t=
::*:
11411
iifci
iifc:
::ii
lit:
lit:
iiii
liti
ilti
lit:
liti
"ftl
llti
Iiti
iifti
litl
::fti
lit:
rrti
lift:
iijii
:i6:=
"fc:
iifc:
iiti
::*::
iifri
iifci
58
3 4
-.zTz-- iiti
Iltl
:*:
:*:
zzT-z lit:
iifii ::t:
:it: iiti
iiti ::t:
::t: uti
iiTii lit:
zzT-Z liti
::ti iiti
lit: ==8:=
:iti ::t=
::ti iiti
lit: ==8::
::ti :=t:
iiti ZZtLZ
zzT-z ~t:
lit: ~8:i
zztzz ==8:=
lit: ::t=
:=t= lit:
Outpatient neurotics
Once at pretreatment ; at least one post-treatment
assessment. Additional ratings are at the discre-
tion of the' investigator.
During the past week.
To encode the HSCL on the General Scoring Sheet,
a 58 X 4 matrix is required. The matrix may be
located on either half of the GSS as is shown on
the left.
CARD FORMAT - ITEMS
CARD 01 = (19x, 5611)
1 tem
1
2
3
h
5
6
7
8
9
10
11
12
13
15
16
17
18
19
20
21
22
Col umn
20
21
22
23
Ih
25
26
27
28
29
30
31
32
33
35
36
37
38
39
40
I tem
23
Ik
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
i+0
itl
kl
43
Column
Item
kl
45
43
46
hh
47
k5
48
46
49
47
50
k8
51
49
52
50
53
51
54
52
55
53
56
54
55
56
57
58
59
60
61
62
63
Col umn
64
65
66
67
68
69
70
71
72
73
74
75
576
CARD 02 = (19x, 211)
Item
Column
57
20
58
21
CARD FORMAT - FACTORS
CARD 51 = (19x, 56F6.2)
Factor
Column
1
20 - 25
2
26 - 31
3
32 - 37
Factor
Column
k
38 - 43
5
kk - ks
FACTOR COMPOSITION - The composition of the factors (called symptom dimensions) is
given in Table k8 . Factor means and standard deviations for 3 normative groups -
anxious and depressed neurotics and a sample of non- inst i tut iona 1 ized residents of
Oakland, California - are as follows;
NEUROTIC
OAKLAND
FACTOR
Anxious
(1435
Depressed (367)
"Normals
'(735)
MN
SD
MN
SD
MN
SD
1.
Somat izat ion
1.91
.59
1.89
.53
1.15
.27
2.
Obsess ive-Compuls ive
1.95
.67
2.30
.68
1.16
.27
3.
Interpersonal Sensitivity
2.00
.68
2.33
.67
1.12
.24
k.
Depress ion
2.04
.63
2.62
.63
1.14
.28
5.
Anxiety
2.22
.67
2.45
.68
1.13
.26
I terns not included in any factor are:
3, 7. 8, 13, 16, 18, 21, 25, 35, 40, 43, 44, 47
ITEM COMPATIBILITY - The first 58 items of the SCL-90 are the same as those
contained in the HSCL with these nine exceptions: 7, 8, 13, 16, 18, 25, 35, 43, 47.
However, the SCL-90 utilizes a 5-point scale in contrast to the HSCL's 4-point scale.
INSTRUCTIONS - The instructions to the subject are as follows:
Below is a list of problems and complaints that people sometimes have.
Please read each one carefully. After you have done so, please darken
one of the four spaces to the right that best describes HOW MUCH THAT
PROBLEM HAS BOTHERED OR DISTRESSED YOU DURING THE PAST WEEK, INCLUDING
TODAY.
Mark only one space for each problem and do not skip any items. Make
your marks carefully. If you change your mind, erase your first mark
completely.
It is wise to observe the subject as he proceeds to make sure he understands
the task.
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Factor means and standard deviation
d. Variance analyses
577
•o
>.
O
01 1
o
a
t-H tn
U-I
tH
ul ul
OJ
1
• u
(S
rt c
60
o
1
a a
TJ
u
Vj -H C
ft
01
c o
C
01
rH
a
tH OJ
rH
rt S *H
cd
JN
>
-r^
u
OJ
OJ
a
O Ul
a
p
(X
.-1 o
3 C -O
(U
QJ O
D
ra
■H
U 01
3
ra
1
00
c
ra
3
OJ
o
o
o
a
B
O O Q)
1^
tfl -H
to
o
■H
01 o-ta
01
ra
a
m a
tH
00
o
to
o m
00
6
p.
J-J
Ul
Ul
TJ
a
4J
e
rt P -H
rH C
T3
o
o
c
o
-o
a
ji
tH
tH
> ra .-1
>%
O QJ
d)
o
U-t OJ
u
•a
j:
>*
a
<n o
TJ
o «
iJ
B
c
o
o j:
o
ra
00
Ul 3
-a
ra
bO -r^ TS O
0)
0) -H
G
ra
u-t
o
e
tH
OJ
o a
ra
o
c
-O Q) O
H TD
.H
m o
a
c
c
Ul
o
3
OJ
>
rH
^
v-i j: --1
1
qj
U-l
ra
00
o
o
-Q
c
> o
0)
(Ul
o u
o
u
C o
-H
T3
o.
iw
a Ul
1
•H
c o
ra
iJ -H
01
■H U
4J
U
ra
1
O
tH
-c o
ra
OJ
td
|S g-
01
c
(J
0) c
-rH
ra
a
oo
UJ
rH
ra
&
QJ 4J
j2 a
a
OJ
Ul
O -C M-i
o
a
ra
00
0) O
OJ
c
o
tj
ra
(4H
n,^ i
-o
01
M
OJ
00 T-l
u
T3 tH
i o;-
01
XJ
0)
01
^M
r-l
>
c -o
a
1)
OJ 5 o
J.J
n
3
tt
c u
-i;
-T-l
m
Ul
n c
TJ
o
c
o a
ra
J3
o
o rt
c
e
MH
tH
u
3 §:3
(U
tJ ra
Q
a.
ra
«
•r^
Ul
o
OJ
o
X
4-1
00
rH
a, c
m B
s
S
o
Ul
Ul
B rH
c
a
c
-H
o at
ra
^.
ra
3 o
c
c
•X3
ra
o
o a
-o
t4-) j-i -a
>
j::
ra
TJ
o
ra
o
^
4-1 Ul
SI
■c^
u) c
m 'M
3
o
c
t-l
4-1
o
C OJ
OJ
o
Ul >^ QJ
3
^
■o
o
■J-i c
ra
o
m
a
rH
ra
e c
Ul
3
T-i
o-
u u
■H
OJ
c
>N CJ
D.
O
c
G c
01
o
c
?
0)
T-l
a.
OJ
T)
-o
a o
OJ
u
■H
■T^ u -,-(
01 U-i
o
>
tn >,
^
X
B
>
01
c
rH
Ut
U-l
VM
c^J (U (fl
a
.-1 o
T3
•H
OJ
T-l
j-t
ra
OJ
u^
<U
r-i ^ a. -H
c
T3
c
3
o •
0)
S
Q
D. JJ
(U 01
o
•H
a
a
c
o
OJ
>^
Ul
01
a o -
a
u a
ra
O .H
a
>
C
01
c
4-1 U
ra
4J
c
d
O 0)
o
>w
u 3
O
o
a
OJ OJ
UH
•a
O "O OJ
o
c u
•n
x:
-a
3
ra
«
i-i
a.
tH
a th
c
01
c ^
o -o
c
4J
c
r-l tH
.n
o.
Ul
><
a S
o
•o
o o
■s g.
ra
ra u
c
00
TJ
ra
tH
3
c
c
flj
tJ
>>
0)
u u
3
QJ
Ul
>
tH
a
a
Z
rH
OJ
C - "O
<u
C (11
J3
CO
B
c ra
OJ
c
Ul
rH
rH
u-i
C
00
U
0
s
O >> oi
^
ki
01 o.
Ul
O.
ra
4-1
O 4J
c
c
-H 1-. _QJ
iJ
S -H
OJ
<u
o
0!
E
O
ra
TJ
Ul
o
T3
tH
Q
-a
o
•^ ra
-H
■H
ra -
c
•o
T-l
ra
S
3
OJ
T3 OJ
rH
■o o
SI
>
X
TJ >,
«
c
TJ
OJ UH
T3
-g
o
C 33
T3
-H
3
§ii
00
c
OJ
AJ
t^
3
a tH
c
6
a
:3 u -
C
OT C
O.
£
c
o
x:
f-i
o
o
-o
rH
tH C
rt
'_< H -x:
a
0)
c
Vk-I U
-r<l
u
tj
c
tJ
u< ra
a
m
n cu (u
x: .-1
tH
-r^
«
o
O
OJ
c
U-l
Ji
ra
C
>* « T3
JJ o
OJ 1-1
o
c
o
Ul
ra
<J
S
01
bO -a i» 3
01
TJ
OJ
ra
ra
a
o j:
u
c
^^ .-H
3
e^
ra
«
ra OJ
3
u
•o
o
O 00
01
a
■1-*
>* o
iJ
M
a
o
U-t
o
ra
c
o
TJ
OJ
a
c:
00
^ - c
03
O tJ
^
I-I
tJ c
u
o
3
c
c
a j=
a
tA
T^ ,H -H
iH
3
ra 1-1
c
c
o
tH
o
a
3
01
.^
T3 ft
3
j=
3
-o
o
j=
o
■H
c
TJ
j-i
a
^ -c
o
u
Ci.
O C (0
iJ u
O
c
ra
AJ TJ
c
3
OJ
c
•a
OJ
01
OJ
C 4.1
>
ra
a
JD -H Vj
JZ
ra
c
c
i-l
o
o
<-*
Ul
O tH
Ul
a
Ul
1-1 fO
3 .
J=. "3-
i-i
«
m a
ra
i-i
o
OJ
a
tH 3
&
0 -a
JJ
60 -a
e
o
C
o
e
4J
o.
c
a
o <u c
T3
c
c
01
>%
o ><
01
o
U-J
o
J3
B
c
o
C >.
u o
03 U
tn o
o
4-1
u
i-1 CJ
3
O
a
■rl
X
OJ
OJ rH
a
o
Q
to C
0 -H
u
c
o. ra
a.
OJ
T-l
4-1
B rH
tH
C i-( *-»
O OJ
ra
3
1,^
ra
c
OJ
ra
tH a
u
c
O O CO
^ to
(U
3
o
-o
a.
c
o
o
o
•o O
OJ
tH
a
-W
-H U U
00 (U
■H iJ
B
s
1-<
U) 0)
1
I-I
OJ
o
OJ
tJ
J=
tH
0)
tH
c
4-1
o.
i-l
C
3
01
U-I
TJ
OJ
a.
m
Ul
a c
a
d
01
C 10 T3
(U (^
(U m
<u rt
.-1
3
Ul
o
CO
tH tH
a
a
TI
jir
<j td 0)
-C 01
(53
O
c
)-i
■H
g5
c
X
>,
c
o
JC rH
01
o
g
H
a GO 0
XJ 1-1
3
o
T3
to
ra
o.
tn
4J
-o
O
tH
o
H O
^
a
CO
-a-
.
tn
m
o
00
04
•
m
c
•<f
^£>
2J
■H
CM
CO
ON
CM
en
J
en
• m
rH
J3
*n
00 tn
-*
o
en
en
**
n •
tn
CM
<n
^ m
w-t
c^
-rH
-.H
o
u H
m
CO >o
-* •<»•
ON
n
<n
C OJ
rH
CM
O 4J
t-(
a%
-o
a>
O M
-3-
00*
o -»
fH -
0^ -»
.-1 <n
.H -
-vO
m
lO
CM
a
Qi
a
rH
(3
O
«
O
CJ
C >.
M
1
o u
d
AJ
01
01 -H
o
4
>
n >
■H
c
■rt
0> 1-1
a
>«
o
•H
a
o. u
U
Q 1^
to
I-I -rl
01
a
o ra
1
01
01 O
*J C
Ul
■rt
2
O. 0)
o
ji
C 01
0>
5
i.^
UJ
o
M Ul
ca
W Q
-
<M
l«^
.*
in
578
DEPARTMENT Of HEAITH, EDUCATION, AND WELFARE ■ PUBLIC HEAITH SERVld
NATIONAL INSTITUTE OF MENTAL HEALTH
PATIENfT ReCORD FOR DRUG STUDY
SELF-RATING SYMPTOM SCALE DO NOT MARK IN THIS AREA
NAME Of HOSPITAl AND STUDT
—
:0: =1= :*; :*: r5*= .-*: =«: T^zz =»; i»:
PATISn
-.^-. z:^ T^z z^z -.^0= I*-. :«; i*= i«: r*:
:0: ==1= :»= =*t :*: ;:»: r«z :5^ :*: :*:
PATIENT'S NAME il„,. OUA i~^. ual
HOSPITAL NO.
—
--«r =1:: =«: :*= r3«= :=S= i«: =3^ :*= =*:
RATBt
r^t r=»= :«z =3:r. r«= rS:r :«; r^= !♦= :*:
RATEII
DATE FORM COMPLETED
"*" FOdM
^m NO-
—
:0;: =J= !«: ;*: ;<= =*: =«= lijt: :«: :«:
PERIOD
:0; :Un ra= ;*-. z:^ r:S= =«= =T= --«t :«:
INSTRUCTIONS
Listed below ore 35 iymptoms or problems thot people sometimes hove. Pleose read eoch one carefully
and decide how much the symptom bothered or distressed you during the past week, NOT AT ALL, A LITTLE,
QUITE A BIT, or EXTREMELY. Mork the column thot opplies to you. Do not skip ony items.
EXAMPLE
HOW MUCH WERE YOU BOTHERED BY:
If "noise" bothered you "A LITTLE," you would mark
the spoce to the right under "A LITTLE" as shown.
HOW MUCH WERE YOU BOTHERED BY:
1 Sweoting
2 Trouble getting your breath
3 Suddenly scored for no reoson
4 Difficulty in specking when you
are excited
5 Feeling low in energy or
slowed down
6 Poins in the heort or chest
7 Trouble remembering things
8 Hot or cold spells
9 Blaming yourself for things
10 A lump in your throat
1 1 Feeling fearful
12 Numbness or tingling of parts
of your body
13 Feeling critical of others
14 Having to avoid certoin things,
ploces, or activities because they
frighten you
15 Having to do things very slowly
In order to be sure you were
doing them right
16 Heavy feelings In your arms and
legs
17 Fointness or dizziness
MM-9-10 (3.47)
:3:: -V-
=3:: .-4::
:»: -.-Jiz:
:3=: :*:
=3:: :=*::
:»: :*:
:*: ZZOZ-.
I*: -.Tt:-
:3:: :JV:
:*: ;*:
:»: ■■•*-
:»: :*:
:»= :«:
::»: zz/t:
=«: :at::
HOW MUCH WERE YOU
BOTHERED BY:
18 Crying eosily
19 Nervousness or shakiness
inside
20 Your feelings being easily
hurt
21 Constipotion
22 Loss of sexual Interest or
pleasure
23 Feeling easily annoyed or
irritated
24 Poor appetite
25 Difficulty making decisions
26 Difficulty in falling osleep
or staying asleep
27 Feeling hopeless about the
future
28 Feeling blue
29 Feeling lonely
30 Temper outbursts you could
not control
31 Heodaches
32 Heart pounding or racing
33 Trouble concentrating
34 Your mind going blank
35 Thoughts of ending your life
:rl:: -.^.z
irt:: I*:
::):: --3::
zzl.z :»:
:n:: :»:
in- =3::
::|r: :«:
.z\.-. z^-.
::»:: :*:
::1:: i^:
::);: :«:
=r1:: :«:
z.y.z :«:
::1:: :«:
::1:: :«:
zztLz zzZ-
::J:: :«:
r;»:: ::2:
:»: :=*:
:»: :*:
:»: :^:
:»: ■-*-.
:*: :H::
:»: :*:
:»: ::*:
:»: :*:
:a: :*:
.3:: .-A::
:»: -■■A-
:*: :=*:
:3: :^:
:3: .-Ji.
::»: :=»:
:;S-- ■■■A-
:*: ::*:
::S: .-A-.
579
The SRSS consists of 35 items selected from the 58-item HSCL on the basis
of factor saturation, proportional frequency of occurrence and clinical relevance
in drug trials. Part of the original ECDEU Battery, the SRSS was superceded by
the SCL-90.
REFERENCE -
APPLICABILITY -
UTILIZATION -
TIME SPAN RATED
ENCODING FORMAT
1 ::t: ::2: "3
2 lit: ::2:: ::3
3
It:
-.zZ-.
::J::
"*
4
-t:
::2::
:--*:
n*
5
-i----
"2::
::J::
::*
6
-i----
::2: =
-J::
.n*.
7
-i----
:=!::
::J::
n*.
8
::2::
"3:=
lup-
9
-i..
"2::
"3:-
::*-
10
-i----
i:2::
----3:--
i;4:
11
:!::
:.-2::
--S:--
nJt-
1?
zzTzz
:i3=:
lUt-
13
rj:r
"2:
=z3=:
=14;
14
iri:
=:3cr
::*
15
::2::
::a:i
::*
16
H:=
iii:
;:!:
.z4z
17
zh-.
"i:
i.-atr
zzic
18
i±=
lii:
"ir
i:4:
19
:i:
i:2:r
1:3:.-
;:*
20
:i:
riii
r=i:
"*
21
:±:
r:4i
;:*:
r:4
22
:±:
:-*:
iia:
ri*
23
;h=
::2::
:Ar
r:4:
24
.a:z
zrt:
;Ji=
::4:
25
-.i..
::2::
:r3::
n4i
26
-i..
::2::
::!:
zziz
27
-i..
-.zizz
r;i=
iid:
28
:3:r
"tz
"ii
i=*
29
=3:i
nil
nil
lit
30
:J::
iri:
=i4=
nt
31
:tr
:i4i
nil
i:t
32
iti
:=2::
rri:
:=*
33
rJii
:a=:
:Jir
=:4=
34
:»::
ii=
:J:i
= 3il
35
-:!::
i:2=:
iJn
z=4i
Lipman, R, S., et al. Sensitivity of Symptom arjd
Nonsymptom-Focused Criteria of Outpatient Drug
Efficacy, Amer. J. Psychiat., 1965, 122: 2^-27,
Neurotic outpatients primarily. Has also been
employed with inpatient populations.
Once at pretreatment ; at least one post-treatment
ratihg. Additional ratings are at the discretion
of the investigator.
During the past week.
A limited supply of the opscan SRSS are
still available. When these supplies
are exhausted, investigators may encode
the SRSS on the General Scoring Sheet by
using a 35 x U matrix; i.e., 35 rows and
k columns. This matrix may be encoded in
any quadrant of the GSS, as is shown on
the left.
CARD FORMAT - ITEMS
CARD 01 = (19x, 3511)
1 tern
Col umn
1
20
2
21
3
22
it
23
5
2k
6
25
7
26
8
27
9
28
10
29
11
30
12
31
13
32
lit
33
15
34
16
35
17
36
18
37
Item
Colu
19
38
20
39
21
40
22
41
23
42
24
43
25
44
26
45
27
46
28
47
29
48
30
49
31
50
32
51
33
52
34
53
35
54
580
CARD FORMAT - FACTORS
CARD 51 = (19x, 5F6.2, F4.0)
Factor
Column
1
20-25
2
26-31
3
32-37
Factor
Col umn
4
38-43
5
kk-kS
Total
50-53
Total Score = Sum of 35 Items
FACTOR COMPOSITION
Total Score Range = 35 - 140
These factors were derived from a factor analysis performed by Lipman et al
on a sample of 1519 neurotic subjects.
FACTOR I GENERAL NEUROTIC FEELINGS
9. Blaming yourself for things
13. Feeling critical of others
20. Your feelings being easily hurt
23. Feeling easily annoyed or irritated
27. Feeling hopeless about the future
28. Feel ing bl ue
29. Feel i ng lonely
30. Temper outbursts you could not control
35. Thoughts of ending your life
FACTOR 2 SOMATIZATION
1 . Sweating
2. Trouble getting your breath
6. Pains in the heart or chest
8. Hot or cold spel Is
10. A lump in your throat
12. Numbness or tingling
16. Heavy feelings in your arms and legs
17- Faintness or dizziness
26. Difficulty in falling asleep
31 . Headaches
32. Heart pounding or racing
FACTOR 3 COGNITIVE PERFORMANCE-DIFFICULTY
4. Difficulty in speaking
7. Trouble remembering things
15. Having to do things very slowly
25. Difficulty making decisions
33. Trouble concentrating
34. Your mind going blank
FACTOR 4 DEPRESSION
18. Crying eas i ly
22. Loss of sexual interest or pleasure
24. Poor appetite
FACTOR 5 FEAR/ANXIETY
3. Suddenly scared for no reason
1 1 . Feel ing fearful
14. Having to avoid certain things
19. Nervousness or shakiness inside
I terns omitted
5
21
Two sets of means and standard deviation? are provided for the investigator.
The anxious neurotic outpatients provided the sample upon which the factor analysis
was performed. The ECDEU sample employed the same factor structure to derive its
means and standard deviations.
General Neurotic Feelings
Somat izat ion
Cognitive Performance
Fear-Anxiety
Depress ion
(n = 1519)
Mean S'
2.06
1.96
1.93
1.96
2.07
tpat ients
ECDEU
Population
(n
= 238)
n. Dev.
Mean
Stan. Dev.
1.14
2.21
0.76
1.08
1 .89
0.54
1.16
2.02
0.75
1.37
1.97
0.85
1.28
2.18
0.81
581
ITEM COMPARABILITY
The SRSS items and their counterparts in the Hopkins
Symptom Checklist (HSCL) are:
SRSS
HSCL
SRSS
HSCL
SRSS
HSCL
1
16
13
6
25
46
2
48
14
50
26
44
3
23
15
38
27
54
k
8
16
58
28
30
5
\k
17
4
29
29
6
12
18
20
30
24
7
9
19
2
31
1
8
49
20
34
32
39
9
26
21
25
33
55
10
53
22
5
34
51
11
33
23
11
35
15
12
52
24
19
DOCUMENTATION
a. Raw score printout
b. Factor score printout
c. Factor means and standard deviations
d. Variance analyses
582
GLOBAL ASSESSMENT SCALE (2^1 -GAS)
R. L. Spitzer, M. Gibbon and J. Endicott
Rate the subject's lowest level of functioning in the last week by selecting
the lowest range which describes his functioning on a hypothetical continuum
of mental heal th- i 1 1 ness . For example, a subject whose "behavior is consider-
ably influenced by delusions" (range 21-30) should be given a rating in that
range even though he has "major impairment in several areas" (range 31-40).
Use intermediary levels when appropriate (e.g., 35, 58, 63). Rate actual func-
tioning independent of whether or not subject is receiving and may be helped
by medication or some other form of treatment.
100 No symptoms, superior functioning in a wide range of activities, life's
problems never seem to get out of hand, is sought out by others because
91 of his warmth and integrity.
90 Transient symptoms may occur, but good functioning in all areas, inter-
I ested and involved in a wide range of activities, socially effective,
I generally satisfied with life, "everyday" worries that only occias ional ly
81 get out of hand.
8p Minimal symptoms may be present but no more than slight impairment in
I functioning, varying degrees of "everyday" worries and problems that some-
71 times get out of hand.
70 Some mild symptoms (e.g., depressive mood and mild insomnia) OR some diffi-
I culty in several areas of functioning, but generally functioning pretty well,
I has some meaningful interpersonal relationships and most untrained people
61 would not consider him "sick".
60 Moderate symptoms OR generally functioning with some difficulty (e.g., few
I friends and flat affect, depressed mood, and pathological self-doubt, eu-
51 phoric mood and pressure of speech, moderately severe antisocial behavior).
50 Any serious symptomatology or impairment in functioning that most clinicians
I would think obviously requires treatment or attention (e.g., suicidal pre-
I occupation or gesture, severe obsessional rituals, frequent anxiety attacks,
^1 serious antisocial behavior, compulsive drinking).
40 Major impairment in several areas, such as work, family relations, judgment,
thinking, or mood (e.g., depressed woman avoids friends, neglects family, un-
able to do housework), OR some impairment in reality testing or communication
(e.g., speech is at times obscure, illogical, or irrelevant), OR single
31 serious suicide attempt.
30 Unable to function in almost all areas (e.g., stays in bed all day), OR be-
havior is considerably influenced by either delusions or hallucinations, OR
serious impairment in communication (e.g., sometimes incoherent or unrespon-
21 sive) or judgment (e.g., acts grossly inappropriately).
20 Needs some supervision to prevent hurting self or others, or to maintain
minimal personal hygiene (e.g., repeated suicide attempts, frequently violent,
manic excitement, smears feces), OR gross impairment in communication (e.g.,
II largely incoherent or mute).
10 Needs constant supervision for several days to prevent hurting self or others,
I or makes no attempt to maintain minimal personal hygiene.
01
583
The GAS consists of a single scale (item) for evaluating the overall function-
ing of a subject on a continuum from psychological or psychiatric illness to health.
The GAS has been shown to be sensitive to change in a variety of clinical situations
REFERENCE
APPLICABILITY
UTILIZATION
TIME SPAN RATED
ENCODING FORMAT
Endicott, J., Spitzer, R. L., Fliess, J. L.
and Cohen, J. The Global Assessment Scale:
A Procedure for Measuring Overall Severity of
Psychiatric Disturbance, Personal Communication, I976,
Adult populations
Once at pretreatment; at least one post-treatment
assessment. Additional ratings are at the discretion
of the investigator
Within the last week
To encode GAS on the General Scoring Sheet, a 2 x 10
matrix; i.e., 2 rows and 10 columns, is required and
may be located in either half of the GSS. The matrix
is as fol lows:
-.-.±z
"ir i:tc= z-J---
"t: --:(cz z-.r.-
zzt:-. ::St:
NOTE
100 is encoded as 00.
CARD FORMAT
CARD 01 = (]9x, 12)
SPECIAL INSTRUCTIONS (Adapted from the authors)
The scale values range from 01, which represents the hypothet ically sickest
possible individual, to 100, the hypothet ica 1 ly healthiest. The scale is divided
into ten equal intervals: 01 - 10, 11 - 20, and so on to 81 - 90 and 91-100. The
defining characteristics of each 10 point interval comprise the scale. The two
highest intervals, 81 - 90 and 91 - 100, are for those unusually fortunate indivi-
duals who not only are without significant psychopathology but also exhibit many
traits often referred to as "positive mental health", such as superior functioning,
a wide range of interests, social effectiveness, warmth and integrity. The next
interval, 7I - 80, is for individuals with no or only minimal psychopathology but
who do not possess the positive mental health features noted above. Although some
individuals rated above 70 may seek some form of assistance for psychological prob-
lems, the vast majority of individuals in treatment will be rated between 1 and 70.
Most outpatients will be rated 31 to 70, and most inpatient? between 1 and ^0.
In making a rating one first selects the lowest interval which describes the
subject's functioning .during the preceding week. For example, a subject whose
"behavior is considerably influenced by delusions" (range 21 - 30) should be given
a rating in that range even though he has "marked impairment in several areas"
(ranges 3I - hO) . In order to determine the scale point within the ten point
interval, the defining characteristics of the two adjacent intervals are examined
to determine whether the subject is closer to one or the other. For example, a
subject in the range 21 - 30 who is much closer to the 11-20 range than the
31 - kO range would be given a specific rating of 21, 22, or 23. A subject who
seems to be equidistant from the two adjoining ranges is given a rating of 2k, 25,
26, or 27.
584
Since the ratings are for overall functioning during a speci f ic" t ime period;
it is important that the rating be based on functioning and symptomatology during
that time period and not be influenced by considerations of prognosis, previous
diagnosis, or the presumed nature of the underlying disorder. In a similar fashion,
the rating should not be influenced by whether or not the patient is receiving medi-
cation or some other form of help.
The information needed to make the rating can come from any source: direct
interview of the patient, a reliable informant, or a case record. Little informa-
tion may be needed to make a rating at the low end of the scale. For example, know-
ledge that the individual makes repeated suicidal attempts and thus requires constant
supervision is sufficient, by itself, to warrant rating a patient in the 1 - 10
range. On the other hand, before an individual can be given a very high rating it
is necessary not only to determine the absence of psychopathol ogy and any serious
impairment in functioning, but also to ascertain the presence of signs of "positive
mental health".
Because the scale covers the entire range of severity it can be used in
any situation or study where an overall assessment of severity of illness or
degree of health is needed. In most studies only a portion of the scale will
be actually used. For example, community studies will rarely have individuals
in the lowest range, whereas studies involving newly admitted psychiatric
patients will rarely have individuals in the highest intervals. However, many
individuals who may have been rated in a very low range on admission may be
sufficiently recovered at follow-up and warrant a rating in orte of the higher
intervals .
DOCUMENTATION:
a. Raw score printout
b. Means and standard deviations
c. Variance analyses
585
242 - TARTU
TARTU PSYCHOMETRIC BATTERY
1 . OPERANT MEMORY TEST
2. LEARNING TEST
3. WORD ASSOCIATION TEST
4. CALCULA,TION TEST
5. PROOF-READING TEST
6. MOTOR REFLEX TEST
586
TABLE kS
NAME
HOSPITAL NO
DATE
OPERAJiT MEMORY TEST
Inunediate reply
Delayed reply
response
time
response
time
BOOK
HORSE
CHir«INEY
SNOW
TABLE
SPARROW
INK
SHOE
MAPLE
FISH
CEILING
WIND
total correct:
total incorrect:
Mn.
Time
difference correct immediate
and correct delayed responses;
Mn.
Time -
Tested by:
587
TABLE 50
NAME
LEARNING TEST
HOSPITAL NO
DATE
T
R 1 A
L S
1
2
3
4
5
6
7
8
9
10
BED
SPOON
CAT
ANCHOR
NEWS
SURFACE
PILLOW
NUT
LAKE
NOSE
Incorrect
resppnses:
time: (sec)
no. correct:
time/no. corr:
no. incorrect:
deviation:
totals: no. corr.:
no. incorr:
time:
mean: time/corr. resp.:
LI
CI
Tested by:
588
TABLE 51
WORD ASSOCIATION TEST
NAME:
HOSPITAL NO.
DATE
SIGNAL
RESPONSE
LATENCY C sec)
DEVIATION
CHAIR
BOOK
SUMMER
FLOOR
WIFE
ARM
CIRCLE
SPOON
ROSE
ANIMAL
BELT
DOCTOR
METAL
HILL
CHANCE
SHAPE
WATER
SPIRIT
PICTURE
ROAD
No. a
No. 1
da:
total:
nada:
meanr
Tested by:
589
u
r-i ID|
ll ro cn j fo ^ I
m r-t\ m odI r~ cmI in in
mini cMcvl cjr->I inoo| ■»j'r-
'* <M| 'S' ■^
00 rgl (» ■sj'l ro rfl C^ in
«.0 CmI iH «5
CNJ nl «) col 00 ml vo <•
"I CO ml ■>* ml cNj fnj
en \o\ r^ ml a^ oo| ^ col
OJ CO
VO ^
n CM
rH Hi c\j ml n rsjl a\ c-
)j 'S' ml c^ a\j VO col
)| rM rsij rH f\jj ^ roj
r* rol VO c^l ^ •HI <r> (Til rg VO
00 vol ^ vol 00 ool VO 00
ll o\ ro| CO ml 00 rnl
)| to •<ti 00 voj «* ml
VO "*| CM ooj m fvij •-< f^l
m mj VO i-tj r* ml m rg|
CA rg! ro ml H ml eg ^1
00 f-
VO r^l
00 m|
^ cg|
00 oo|
m voj
r^ ml mm
■^ rg| 00 VO
m ml CM ool p* ml m- cr.
oi ^1 00 CO rf ^\ 00 mj i-j rg
m ool m ml <r» rgl m mI m ^f
00 vol H vol VO t^j CM 031 (n \o
m %f
r- 00
rg ^ I
o\ ^j- 1
VO VO
VO
m
"«?
m
CM
u
>
u
590
TABLE 53
Name
Hospital No.
Date
PROOF-READING TEST
R
N
U
A
K
V
R
E
A
M
U
K
A
0
N
E
M
U
R
V
M
V
N
E
S
A
0
N
S
K
0
R
M
S
E
0
V
S
0
U
E
A
0
V
R
0
u
M
S
N
N
S
K
U
A
M
K
V
E
R
V
N
E
K
S
U
A
R
A
M
K
M
R
N
S
V
E
U
K
0
U
K
V
S
M
R
0
E
N
A
A
U
M
E
0
N
S
R
V
K
591
TABLE 54
NAME
HOSPITAL N0._
DATE
MOTOR REFLEX TEST
PART 1
Stim.
Interv.
(sec)
Stimulus
Resp. positive stim.
latency
(sec)
deviation
1
-
Y
2
20
Y
3
15
Y
4
25
Y
5
10
Y
6
30
Y
7
15
Y
8
25
Y
9
25
Y
10
20
Y
11
30
Y
12
15
Y
13
20
Y
14
10
Y
15
25
Y
total:
mean:
No. absent responses;
Tested by:
592
TABLE 55
NAME
MOTOR REFLEX TEST
PART 2
HOSPITAL NO
DATE
Stim.
Interstim.
Interval
Stimulus
Resp. pos. stim.
Resp. diff. stim.
latency (sec)
latency (sec)
deviation
1
30
R
2
10
Y
3
25
Y
4
15
G
5
15
Y
6
25
G
7
15
R
8
20
Y
9
10
Y
10
15
G
11
25
Y
12
15
R
13
20
R
14
30
Y
15
10
Y
16
10
G
17
20
Y
18
15
R
19
30
Y
20
10
G
total
mean
Diff, latency Part 2:
Tested by;
- Part 1:
no. dis inhibitions;
593
The TARTU is presented as one example of the way in which multiple psychometric/
psychophysiological tests may be encoded on the GSS. Developed by Juri Saarma, M.D.,
of Tartu State University, Estonia SSR, USSR, this battery has been employed in a num-
ber of drug trials - particularly by Thomas Ban, M.D., McG i 1 1 University, Montreal.
Consisting of six familiar and frequently used tests presented to the subject in a
standardized manner, the TARTU is representative of assessment and encoding procedures
in this area. The entire TARTU requires approximately 1 hour to administer.
APPLICABILITY Adult populations
UTILIZATION Once at pretreatment ; at least one posttreatment
rating. Additional assessments are at the discre-
tion of the investigator.
ENCODING FORMAT The locations for each of the tests are given in
Figure 28. The locations of specific variables
are given within the descriptive sections for
each test.
CARD FORMATS - When entire battery is employed
CARD 01 = (19x, F4.1, 2F2.0, f4.1, 3F2.0, 2F3.0, kFkA, 2F2.0, 3F3.0)
Test Column
Operant Memory
1. Mn. Time- Immediate 20 - 23
2. Total Correct-Immediate 2k - 25
3. Total -I ncorrect-lmmed iate 26 - 27
k. Mn. Time-Delayed 28 - 31
5. Total Correct-Delayed 32 - 33
6. Total Incorrect-Delayed 34 - 35
7. Difference between 2 and 5 36-37
Learn i ng
1. Learning Index 38 - kO
2. Confabulation Index k] - 43
3. Mn. Learning Time 44-47
4. Mn, Deviation 48-5]
Word Associat ion
1 . Mean Latency 52 - 55
2. Mn. Deviation 56 - 59
3. Number Adequate 60 - 6I
4. Number Inadequate 62 - 63
Calculation
1 . Mn. Additions 64 - 66
2. Mn. Deviation 67 - 69
3. Mn. Error 70 - 72
594
DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE
ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION
NATIONAL INSTITUTE OF MENTAL HEALTH
ECDEU GENERAL SCORING SHEET (50-GSS)
PATIENT INITIALS
::A: ::B:
::K;: "t:
■-:U: ::\ii
I NUMBER MALES 001 TO 499
::fc:
FIRST
INITIAL
:-J(z r:ft:
SECOND
INITIAL
SHEET
NO.
FIGURE 28
DATA MATRIX FOR
TARTU PSYCHOMETRIC
BATTERY
:rS:: :3:: :=4::
::^:: ::3:: ::4::
NUMBER FEMALES 500 TO 998
::5:: "fc: ::?:: rrfc: ::»::
lENT
::5:: ::5:: z-fzz "ft: z:9::
rii: i:6.: ::7:: ::8:: ::»::
:::S::
::&:
1 :a: ::
t: ::2::
::3::
::*:
::&:
::&:
:7::
::&:
::9:: (
2::C: ::
t: ::2::
::3::
::*:
::&:
::fc:
:K:
::&:
:r9::
3::a: ::
):: ::»:
::3::
::*:
::&:
::&:
:K:
::a:
::ft:
4::a: ::
):: r:2::
::3::
::*:
::S::
::fc:
:?t:
::a:
::9::
5::a: ::
:: ::2::
::S::
::*:
::5::
::fc:
:Z::
::8::
::ft:
6::0:: ::
:: ::2::
::3::
::*:
::&:
r:fc:
:Z::
::&:
::ft:
7::e:r ::
:: ::2::
::3::
::*:
::&:
::fc:
:K:
::a:
r:9::
8:6:: ::
:r ::2::
::*:
::*:
::5::
::&:
:K:
::8::
::9::
9 1:6:: ::
--■- OPERANT MEMORY
TEST
::ft:
::9::
10::e:: ::
:: zzizz
::3::
::4::
::&:
■ ::fc:
:K:
::ft:
::Sb:
n::e:: ::
:: zzizz
::3::
zzizz
::5::
::&:
:7::
::&:
::9t:
12::e:: ::
:: ::2::
::3::
::4::
::&:
::fc:
::3i:
::&:
::9t:
13::e:: ::
1:: ::2:
zz3zz
::4::
::5::
::&:
::?::
::ft:
::9::
14::Q:: ::
3:: ::2::
::3::
::*:
::5::
::fc:
::?.:
::ft:
::9::
15::Q:: ::
J:: ::2::
::3b:
::*:
::&:
::&:
::S:
::&:
::ft:
16::Q:: ::
3:: ::2::
::3::
::*:
::&:
::&:
::?::
::a::
::9::
17::D:: ::
3:: ::2::
::3::
::*::
::5::
::fc:
::?::
::&:
::9t:
18:rQ:: ::
hz ::2::
::3::
::4:
::&:
:rfc:
::J::
::ft:
::9::
19::ft: ::
i: ::2::
::3::
_:*:
::&:
::&:
::Z::
::ft:
::ft:
20 ::ft: ::
i: ::i:
::a::
::*:
::5::
::t:
::?::
::&:
::9::
21 ::fi:: ::
±: ::2::
::3::
::*:
::&:
::&:
::?::
::ft:
::9::
22::ft: ::
±: ::i:
::3::
::*:
::&:
rifc:
::3!::
::e::
::9k:
23 :A: :.
3:: ::2::
::3::
::4::
::&:
::fc:
::?::
::&:
::9t:
24::e:: :;
J:: ::2::
::3::
:3t:
::5::
::fc:
::?::
::&:
::a::
25 ::e:: ::
3:: ::2::
:;3::
::4::
::5::
-&;;
::^:
::&:
::9::
26 ::&: ::
3:: "2::
LEARNING
TEST
::7::
::&:
::9::
27 ::e:: ::
3:: ::2::
::3::
::4r::
::&:
::fc:
::?::
::&:
::9t:
28::e:: r:
3:: ::2::
::3::
::4::
::5::
::6::
::?::
::&:
::Sb:
29 ::£>:: ::
3:: zzizz
iri:
::4::
::5::
:rfc:
::?::
::a::
::9:r
30::Q:: ::
Izz ::2::
>:3::
::±:
::&:
::fcr
::7:i
riB::
::*:
31 ::0:: ::
3:: "i:
::3c:
::*:
::5::
::&:
::?::
zzBiz
::9::
32 ::£»:: ::
3:: ::2::
:;i:
::4::
::5::
::fc:
::?::
::ft:
::9::
33::e:: ::
3:: z:2zz
::3::
=34::
::5::
:r6::
::?::
::&:
;:9::
34::6:: ::
5:: :-2::
::3::
:d4::
::5::
::fc:
::J:r
-ft:
::9::
35 :A: ::
1:: ::2::
::3::
::4::
::5::
::fc:
::K:
::8::
::9::
36:rez: :
37 1:6:: :
'" WORD
ASSOCIATION TEST
t:
izz
::9::
::9::
38:*: r
3:: :i:
::3::
zzizz
::i::
zzb-z
::?::
::ft:
::9:r
39:*:
3:: zzizz
r:3::
::4::
::5::
::fc:
::7::
::&:
::9::
40:*:
3:: ::2::
:*:
::4r:
::S::
rifc:
::?::
::ft:
::9::
41:
Cols:
::t:
3
::£: ::fc:
6 7
::3::
-z3zz
Days
::i:
PERIOD
:6:: ::7:: ::8::
:&: ::7:: ::8::
:a:
1 ::&:
2::£k:
3::B::
4::£k:
::2:: ::3:: ::*: ::5:: ::6:: z.J
WORD ASSOCIATION TEST
::2:: ::!: ::*: ::&: :
7::
5 ::&: ::3:: ::2:: ::S::
6 ::a:: ::3:: ::2:: zzSzz
7 ::e:: ::3:: ::2:: :*"
8 ::a:: ::3:: ::2:: :*:
9::6:: ::3:: PAT. HI
10:*:
n :*:
12:*:
13::e::
::2:: :^::
::2:: ::3::
:r2:: ::3::
::2:: zz3zz
14::e::
1 5 ::e::
1 6 ::e::
17::e::
1 8 ::&:
1 9 ::e::
::5:: ::6::
::7::
::8::
:*
::5:: ::6::
r:7::
::8::
:*
::5:: ::6::
::7-
:*:
:*
::£: ::6::
::7::
:*:
:*
TEST
::7::
:*:
:*
:i: :*:
::7::
:*:
:*
::5:r ::6::
::7::
::8::
::9:
::5:: ::6::
::7::
::&:
::*
::S:: ::6::
zzr-z
::&:
::»:
::&: ::fc:
::?::
:*:
t
::S:: ::6::
::7::
:*:
::9:
PROOP-READING
-izz zzizz
::2:: ::3::
20 ::&:
21 ::e::
22 ::&: ::3
:: ::£:
::3::
::4::
:S:
::6::
z.r-z
::&:
::»::
23 ::a:: ::3
:: ::2::
:*:
::4::
:&:
::6::
zzr-z
::&:
::9:-
24 ::e:: ::3
:: ::2::
::3::
::4::
:S:r
::4::
::?::
zzSzz
::>:
25 ==6:: ::3
:: ::2::
:iS::
r:4::
:&:
::6::
::?::
::8::
::»:
26 ::e:: ::3
:: zzizz
i:3::
::4::
:5::
::6::
::7^:
::&:
zz9z
27 ::er: ::
:: ::2::
::3::
::4::
:&:
::6::
::7::
::«::
::9::
28::e:: ::
r: ::2::
:*:
::4;:
:&:
r:fc:
::?::
::8::
::9::
29:re:: ::
30 :*: ::
" MOTOR
::
REFLEX
TEST
::7::
::?::
::&:
::9::
;:»::
31 :*: ::
:: ::,£:
::3::
*::
:S::
r:U:
::?::
::&:
::»::
32 :*: ::
:: ztizz
:*:
::4r:
:S:
::6::
::7::
::8::
::9::
33 :*: ::
:: ::2::
::3::
:^:
:&:
::6::
::?::
::6::
::*:
34 :*:
:: :*:
::3::
::4=:
:&:
::6::
::ir::
::&:
::*::
35:*: ::
:: ::2::
::3::
::4::
:&:
zztzz
::7::
::&:
::St:
36 :*: ::
:: ::2::
::3::
::4::
::&:
r:fc:
::Jt:
::»::
::»::
37 :*: ::
:: ::a::
::3::
i:4=:
::S:
::6::
::?::
::8::
::fc:
38 :*: ::
:: :r2::
:3::
zzizz
::S::
::6::
::7:
::»::
::fc:
39 :*: ::
:: ::2::
::3::
:=!::
::5::
::fc:
::?::
::&:
::9::
595
10
12
::2::
73
::3::
14
IS
::S:
76
77
::?:: ::&:
78 79
::9::|
CARD 02 = (19x, F4.1, 2F2.0, 4F3.1, F4.1, F2.0)
Test Column
Proof Reading
1. Completion Time 20 - 23
2. No. Errors 2k - 25
Motor Reflex
1 . No. Absent 26 - 2?
2. Latency-Part I 28-30
3. Deviation-Part I 31-33
k. Latency-Part II 3^-36
5. Deviation-Part II 37-39
6. Difference-Latency ko - 43
7. No. Negative Stimuli 44-/^5
GENERAL INSTRUCTIONS
The TARTU should be administered under standardized conditions. The testing
room should be quiet and free from distracting stimuli. It should be furnished
with a table and 2 chairs. The subject should be seated across from the experi-^
menter in such a way that he is not able to see the presentation material.
Additional apparatus include:
1. Pencils
2. Stop watch
3. Recording sheets for each of the tests
k. Motor reflex apparatus
SPECIFIC TEST INSTRUCTIONS
Operant Memory Test
Experimental Design - The subject is given two groups of three words and asked to
recall them immediately after presentation of the words arid again after a slight
delay. The procedure is then repeated with two other groups of three words. The
scores are the number of seconds for the immediate apd delayed responses; the num-
ber of correct and incorrect responses.
Time for Administration - 5 minutes
Procedure - Before starting the test, the following instructions are given to the
subject (S) by the experimenter (E) :
"I am going to give you a simple memory test. I shall read three words to
you and will ask you to repeat them. Then I shall read you another three words,
and I shall ask you to repeat them also. Then, I shall ask you to recall the
first three words, and then the second group of three words. We shall then repeat
the whole procedure for a second time again with different words. Any questions?"
596
The first three words on the recording sheet (Table 49) are read to S, then
S is immediately asked to repeat them. The time taken from the command until the
end of last word repeated by S is measured by means of a stop watch. The second
group of three words is read to S by E according to the same procedure. Then E
asks S to recall the first group of three words, after which S is asked to recall
the second group of three words. The words repeated by S and the time taken for
each group of three words are recorded by E. The entire procedure is repeated in
the same way with the third and fourth groups of three words.
Variables
1. Mean time for immediate response. It is calculated by dividing the sum
of the times for the k (immediate) groups of three words by k.
2. Total number of correct immediate responses.
3. Total number of incorrect immediate responses.
k. Mean time for delayed response. It is calculated by dividing the sum of
the times of the k (delayed) groups of three words by k.
5. Total number of correct delayed responses.
6. Total number of incorrect delayed responses.
7. The difference between the number of correctly recalled immediate responses
(measurement 2) and the number of correctly recalled delayed responses,
(measurement 5) •
ENCODING FORMAT - The Operant Memory Test should be encoded as follows:
Encode the fields as follows:
(Decimal point is not encoded)
XXX. X
XX«
XX'
XXX. X*
XX «
XX
XX'
Location
1 ::tt: "t:
2:ra: ----±-. r:*: -.:± -^ . —^ --^- -=^' *"
Mean time Iramediate Kesponscs
4;;a: "t: "2:: --3^-- --0:--
::6:i ::?:: lift:
ij Correct Immediate Responses
\° r:J:: ::?:; ::j:: ::«:: ::3;: -.:t: zzr-z ::B::
5^
7 O --a-z
_ ^ Incorrect Immediate Responses
10::Q:
i;Ji: ..2zz
fzz --:6:: iiSt:
:iSt:
Mean time Delayed Responses
1 1 nO:: i;l:: z-Tz- r:J:: -zAzz imr r:D:: zzr.z ::8:: iiSt
12:=fc:
Cols: 1
iri: ::&: ::3b: rrfc: rrS::
Correct Delayed Responses
^3 ^
E-i Incor-rect Delayed Responses
16"> =ra:: =;it: ::3:: ::*: ni: ::fc: "?:: ::a:
17 lift: :iJi:
18-0:: ::i:
Difference
10
597
Learning Test
Experimental Design - The subject is told that his (her) task is to learn ten words.
Then the, words are read to subject by the experimenter ten consecutive times. After
each reading, the subject is asked to repeat them. The scores are expressed in ter'.s
of time, i.e., number of seconds required for repeating the words each time and the
number of correct and incorrect responses.
Time for Administration - 15 minutes
Procedure - Before starting the test, the following instructions are given to S:
"We will now do another memory task. 1 am going to read ten words which I would
like you to learn by heart. Please listen carefully. When I have read you all ten
words, I will ask you to repeat all the words you can remember. Please tell me when
you have recalled all the words you can. Then I will read all ten words to you again
and you will try to recall once again as many words as you can. We will continue in
the same way until you can easily recall all ten words. I am going to read the words
to you in the same order each time, but you can repeat them in any sequence. Do you
have any questions?"
Ten words are read slowly (with 2 second intervals) by E to S. Upon completion
E asks S to repeat the words he (she) has just heard. E records the total time spent
in repeating the recalled words and the number of correctly and incorrectly recalled
words on the recording sheet (Table 50). The same procedure is repeated ten times.
Different words are used for each trial with the same S.
Var iabl es
1. Learning Index, (Li), i.e., mean number of correct responses for the 10 presenta-
tions. It is calculated by dividing the total number of correct responses by 10.
2. Confabulation Index, (Cl), i.e., mean number of incorrect responses for the 10
presentations. It is calculated by dividing the total number of incorrect responses
by 10.
3. Learning Time, i.e., mean time for learning one word correctly. It is calculated by
dividing the total learning time for the 10 presentations by the total number of
correct responses (measurement 1).
k. Deviation of Learning Time, i.e., mean deviation of learning time for each particu-
lar word from the mean learning time of the whole test. It is calculated by divid-
ing the total of all the differences between the mean learning time for each of the
10 words and the mean learning time (measurement 3) by 10.
ENCODING FORMAT - The Learning Test should be encoded as follows:
XX. X
XX. X
XXX. X
XXX. X
TT
:£>::
r=±;
ziir
::3:; ::*:
::5:: ;:6:: ::^-
^;:a::
z9iz
20
ittr
::i-.
=-2::
Learning
Index ---^
f^'
:9::
21
;a:
=i±=
r=2::
::a:: ::4:
::&: ::fc: ::J::
::&:
:9:^
22
-.&-.
==±:
iri:
::a: ::*:
zzSiz ::fc: ::?::
::&:
:9::
23
iflrr
r:li:
;: Confabulation Index:
::B::
:9t:
24
r&i
r:Jr:
zzSzz
::a:: z.i.z
rii: ::fc: ::?::
::e::
:9::
25
rB::
;=3:=
i:2::
::3:: ::<)::
::5:: ::fc: ::?::
::&:
;9::
26
rti
"M
ean
Leaxning
Time Csec
.;
:9::
27
rfc:
;iJ.-:
-t;
::3:: zizz
::&: ::fc: ::?::
::a:
:*:
28
r&r
r=3i.-
1:2::
::3:: ::*:
::&: zzfuz ::?::
::ft:
:9::
29
=6::
"3=:
::S::
::3:: ::*::
::£:: ::fc: ::?::
::&:
:9::
30
riean
Deviation of
Learning
Time
31
--
—
..^. ..^.
'-'--•- -°- -'-
--"--
-'--
32
zttz
::t:
::2::
::!: ::*:
::5:: ::fc: ::?::
::&:
:»::.
Ck>ls: 1
10
598
Word Association Test
Experimental Design - The subject is instructed to respond to each of the 20 words
with the very first word which comes to his (her) mind. The score is the mean
latency time, the mean deviation about this mean latency time, and number of adequate
and inadequate responses.
Time for Administration - 7 minutes
Procedure - Before starting the test the following instructions are given to S:
"I am now going to see how you respond to words. I am going to give you a word
and I would like you to say the very first word which comes to your mind in connection
with the word which I say. Try to answer as quickly as you can. The answer should be
only one single word. Any questions?"
E presents the 20 words to S - one by one. The latency times and the responses
are recorded on the sheet. (Table 5T). Different words are used for each trial with
the same S .
Variables
1
2
Mean latency time. It is calculated by dividing the sum of the individual
latency times by 20.
Mean deviation of latency time. It is calculated by dividing the sum of the
deviations of each individual latency time from the mean latency time (measurement
1) by 20.
Number of adequate responses. The total number of word responses which are
connected with the stimulus word by content.
Number of inadequate responses. The total number of word responses which are
not connected with the stimulus word by content.
ENCODING FORMAT - The Word Association Test is encoded as follows
XXX. X-
XXX. X.
33 laBr: -.:lr:
::2ir :J:r :34:z ::5:i iifci zJfzz zz%zz
ii9::
34 lA: ::1=:
35 lA. rrJzr
, Mean Latency Csec.; ^
"fcr
:;9:r
36 =:e-_= zrlrr
=ir i:3:l -zAzz iii: zzbzz ::?:: :;&:
:;9ii
37 i:©:: i:!::
lit: iJ:i r:4:: zzSzz zzbzz ::?:: "8:1
ii9:i
^^ Mean
39i:ei: :rl::
Deviation of Latency (sec
Ti2=: zz2,z. "4:: -^= --bz- -?== -8::
•>
-9::
40rrfl:r ;:3:-
i:2=: rJ:: r.4;: zzbzz rifc: z.Jzz ;r8::
:;9::
Co\s: 1
10
XX.
XX
2::a
NumLer of Adequate fS^esponscs
Number of Inadequate Responses
Cols: 11 12 13 14 15
16 17 18 19 2U
599
Calculation Test
Experimental Design - The subject is given a sheet of paper with s\>i rows of two
digits, 25 digit-pairs in each row. He (she) is asked to add the digit-pairs and
write the answer underneath as quickly as he (she) can. S is given a time limit
of 15 seconds per row. The scores comprise the mean number of digit-pairs added,
the mean deviation about this mean, and the mean number of errors.
Time for Administration - 5 minutes
Procedure - Before starting the test, the following instructions are given to s:
"The next task will be simple addition. I am going to give you a sheet of
paper with six rows of digits on it. You have to add each digit-pair in the row
and write your answer beneath the row in the free space. You will start when I
say "Ready - Start" and continue adding the digit-pairs in the row until I say
"Start next row". Complete as many additions in each row in the given time as
you can. Any questions?"
E places the test sheet (Table 52.) in front of S and gives the command "Ready
Start". Fifteen seconds measured by means of a stop-watch are given for each row
and S is instructed "Start next row" at that time. The same test sheet is used
for all trials with the same S.
Variables
1. Mean number of additions performed. It is calculated by dividing the sum
of all completed additions by 6.
2. Mean deviation of performances. It is calculated by dividing the sum of
the deviations of the number of additions of each row from the mean number
of additions (measurement 1) by 6.
3. Mean number of errors. It is calculated by dividing the sum of all the
additions incorrectly performed by 6.
ENCODING FORMAT - The Calculation Test is encoded as follows:
XX. X
XX. X
XX. X
5 -a:: :i3i: :;2:: zzSi: zzJti. iri: :rt: z.J.z ;:8::
= =9::
6::ec: ^6311 tiuiD"bcr of Addltlons "8=.-
=.-^:
7 :=6:: iz3:i ;:2:; :i3:: . r^iti rzSi: zzbzz ::7:r :;8::
zzT-:
8 =:&: 1=3=-- ==2:= ==3== r=4=: =:5;: zzbzz -.:7:: zzSzz
::*::
^--^Uean Deviation of Perrormance
:r9=:
10==O== ==!== :=2== :=3" ::4:: ::5:r zziizz =;7== :=S=:
:=»;
1 ] ==e=: =;J;; ==2=: ==3:= ::4=: ==5== ==6== ==7== ==8::
:=9=
I2:=e:= ==1: Mean Number of Errors ~-'-^-
::9::
1 3 ==e=: ==!== ==2== zz3zz zAzz ==5:: ::6:: =-7:: ==&=
= :9:
Cols: 11 12 13 14 15
16 17 18 19 20
600
Proof -Read ing Test
Experimental Design - The subject is given a sheet of paper with 100 letters, i.e.,
ten rows with ten letters in each, and is requested to cross out a particular letter
as many times as it occurs. The scores are expressed in terms of time, i.e., the
number of seconds required to complete the task, and the number of errors made.
Time for Administration - 5 minutes
Procedure - Before starting the test, the following instructions are given to S:
"The next task will be very simple. I am going to give you a sheet of paper,
with letters typed on it. Your task will be to cross out the letter ... (in each
particular testing a different letter is used) as many times as you see it. Please
try to complete this test as quickly as you can. Do you have any questions?"
The sheet of paper with 100 letters (Table 53) is placed in front of S. Then
E calls "Ready - Start". Time to complete the task is measured by means of a stop
watch .
Var iables
1. Time to complete the task
2. Number of errors (both omissions and commissions).
ENCODING FORMAT - The Proof-Read ing Test is encoded as follows:
XXX. X
XX
14
itt: ;ij:: ::2=: rj:: r:4z: ::5:: "fc: :;7r: rit:
::9:
15
16
"Total Time to Complete (sec.)
::9::
::S::
17
zQiz =i3:: ::2:: zzSz: zzizz r:5:: ri6i: =i?i: 1:8:1
::»::
18
19
zQzz ::J:: "2:: rii: =:?:: ::&:
Number of Errors
:e:: ::1:: :il.. z.r.z ::8::
::9::
::9::
Cols: 11 12 13 14 IS
16 17 18 19 20
Motor Reflex Test
Experimental Design - The subject is instructed to press a button as quickly as
possible at the onset of a positive conditional stimulus (a particular coloured
light) and not to react to negative conditional stimuli (other coloured lights,
different from the particular colour used as the positive conditional stimulus).
Part 1 consists of the presentation of fifteen positive conditional stimuli.
Part 2 consists of the presentation of a mixture of ten positive and ten negative
conditional stiqiuli.
601
The scores are the mean latency time upon the positive conditional stimuli
of part 1; the mean latency time upon the positive conditional stimuli of Part 2;
the mean deviations about the mean latency times upon the positive conditional
stimuli of Part 1 and Part 2; the number of ho responses upon the positive condi-
tional stimuli; and the number of responses upon the negative conditional stimuli
of Part T.
Time for Administration - 20 minutes
Apparatus - Motor Reflex Test Apparatus: screen upon which four different
coloured lights, i.e., green (G), red (R) , yellow (Y) and blue (B) , can be
presented; electric timer to the accuracy of 1/lOOth of a second. S is seated
at the table across from E facing the "stimulator screen". The reaction time
button is in front of S. The switches of the light - stimuli and the timer are
facing E, not visible to S.
Procedure - Before starting the test, the following instructions are given to S:
"We will now do a reaction time test. Place your finger on the button in
front of you. Every time you see the (one of the four colours is named,
according to a schedule) light come on, press the button down as quickly as you
can. If any other light comes on, do not push the button. Any questions?"
In Part 1 of the test, 15 positive conditional light stimuli are administered,
In Part 2 of the test, a random mixture of 10 positive and 10 negative conditional
stimuli are given. Different positive and negative conditional stimuli are used
for each trial with the same S.
Variables
1. Number of absent responses to the presentation of the 25 positive
conditional stimuli.
2. Latency time upon the positive conditional stimuli of Part I. It
is calculated by dividing the sum of the last 10 latency times to the
positive conditional stimuli of Part 1 by 10. The first 5 latency
periods of Part I are excluded.
3. Deviation of latency time about the positive conditional stimuli of
part I. It is calculated by dividing the sum of the deviations of
the latency times to the last 10 positive conditional stimuli from
the mean latency time of Part 1 (measurement 2) by 10.
h. Latency time upon the positive conditional stimuli of Part 2. It is
calculated by dividing the sum of the latency times to the positive
conditional stimuli of Part 2 by 10.
5. Deviation of latency time about the positive conditional stimuli of
Part 2. It is calculated by dividing the sum of the deviations of
the latency times to the positive conditional stimuli from the mean
latency time of Part 2 (measurement W) by 10.
602
6. Difference of latency times upon the positive conditional stimuli of
part 1 and Part 2. It is calculated by subtracting measurement 2
from measurement k.
7. Number of reactions to negative conditional stimuli.
ENCODING FORMAT - The Motor Reflex Test is encoded as follows:
XX
XX. X
XX. X
XX. X'
XX. X
XXX. X -
XX
20 ::e:: H " -•>- -<»^
Number of
21 -.-.&,. -. - -^- -^:
Absent Besponses
.^- ..=,.. --V- -;r- •—8::
::9:
::9:
22 :--&-. i:3:: ::2:: ::i:
-.z4i-. ::£: ::6:: ::J^:
::&:
::9::
23 ::( Latency of
Response -Part
I :
::9::
24 ::e:: ::J:: ::2:: --3z:
:liU: ::5:: ::t: :;?:;
::&:
::9::
25 ::&: :J:: ::2:: :-_3:r
zz4z-. ::S:: ::fc: ::?::
::8::
;:S::
26 ::e Deviation
of Latency-Part
I
::S::
27 : a:: ::!:: ::2;: :*:
----4zi ;:5:: ::fc: :;?::
::&: •
::9::
28 ::e:: :r3:c r:2:r :rS::
zzizz ::5:: ::fc: ::?::
::&:
::9::
29^ Latency of
Response - Part
;:9::
30 ::&: ::):: ::2;: :^:
::4:: ::S: ::6:: ::?::
:r8::
::9::
31 :A: ::!:: :r2:i -r:3=:
::4;: ::5:; ::6:: ::^:
::&:
::9::
32 : Deviation, o
f Latency -^Part
::§::
33 ::©:: ::!:: ::2:: ::3r:
::4:: ::S:: ::6:: ::?::
::&:
::S::
34 ::«:: ::!:: ::2:: ::3::
::4--: r:S:.- ::t: ::?::
::8::
::9::
35 ::«:: -:
Difference in Latency
36 ::©:: ::!:: "^ --
::8::
::&:
;:9t:
::9::
37 :.-»:: ::l:r :r2:: :=3::
zzAzz :., r:fc: -::r-:
::&:
::fc:
38 ::er-
N-umber Responses to Neg.. St
im.
::?::
::S::
Co/s; 7 7 J 2 73 14
15
16 17 18 19 20
DOCUMENTATION:
a. Raw score printout
b. Means and standard deviations
c. Variance analysis
603
DHEW Publication No. (ADM) 76-338
Printed 1976
Live Music Archive
Librivox Free Audio
Metropolitan Museum
Cleveland Museum of Art
Internet Arcade
Console Living Room
Books to Borrow
Open Library
TV News
Understanding 9/11